,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
4858,GO:0051017,0.00422037956804203,0.999791839347109,5,6,actin filament bundle assembly,BP,PIK3R1;ITGB5;SDC4;CTGF;ESPN
5580,GO:0061572,0.00422037956804203,0.999791839347109,5,6,actin filament bundle organization,BP,PIK3R1;ITGB5;SDC4;CTGF;ESPN
1217,GO:0007266,0.0116656877272236,1,3,3,Rho protein signal transduction,BP,RHOJ;RHOB;ITGA3
2412,GO:0030038,0.0150964467796245,0.999097314969915,4,5,contractile actin filament bundle assembly,BP,PIK3R1;ITGB5;SDC4;CTGF
3782,GO:0043149,0.0150964467796245,0.999097314969915,4,5,stress fiber assembly,BP,PIK3R1;ITGB5;SDC4;CTGF
5719,GO:0070663,0.0176939871679322,0.997216650521763,5,10,regulation of leukocyte proliferation,BP,PNP;CDKN1A;KITLG;SDC4;TICAM1
1160,GO:0007050,0.0206058558606336,0.997368273968061,4,8,cell cycle arrest,BP,CDKN1A;GAS6;HMGN5;FOXO4
1035,GO:0006694,0.0208565366454586,0.995045707773358,7,16,steroid biosynthetic process,BP,HMGCS2;DKK3;HSD17B3;CYP11A1;HSD3B2;DHCR7;DHH
2640,GO:0031032,0.0220406328157337,0.996132726035593,6,10,actomyosin structure organization,BP,ACTN2;PIK3R1;ITGB5;SDC4;FHOD3;CTGF
1144,GO:0007015,0.0241114184193337,0.993829094808693,8,16,actin filament organization,BP,ACTN2;PIK3R1;PLEKHH2;ITGB5;SDC4;FHOD3;CTGF;ESPN
1229,GO:0007338,0.0241999754088408,0.998681211160985,3,4,single fertilization,BP,HEXB;MFGE8;SERPINA5
3842,GO:0043297,0.0251639613365028,1,2,2,apical junction assembly,BP,CLDN1;CLDN3
5739,GO:0070830,0.0251639613365028,1,2,2,bicellular tight junction assembly,BP,CLDN1;CLDN3
1216,GO:0007265,0.0254501687344092,0.995569296780855,5,10,Ras protein signal transduction,BP,CDKN1A;RHOJ;KITLG;RHOB;ITGA3
5769,GO:0071156,0.0274072644796735,0.997743225319565,3,5,regulation of cell cycle arrest,BP,CDKN1A;HMGN5;FOXO4
3574,GO:0042113,0.028976716589259,0.996835582360389,4,6,B cell activation,BP,CDKN1A;PIK3R1;DLL1;TICAM1
14,GO:0000086,0.0291069075669915,0.998286481709862,3,4,G2/M transition of mitotic cell cycle,BP,CDKN1A;PHLDA1;FOXO4
4095,GO:0044839,0.0291069075669915,0.998286481709862,3,4,cell cycle G2/M phase transition,BP,CDKN1A;PHLDA1;FOXO4
6081,GO:0072523,0.031232925173596,0.998105650648582,3,4,purine-containing compound catabolic process,BP,PNP;PDE4B;AOX1
5721,GO:0070665,0.0322989352560565,0.99521887563652,4,8,positive regulation of leukocyte proliferation,BP,PNP;CDKN1A;KITLG;TICAM1
1342,GO:0008202,0.0332727783923507,0.990860178528593,7,18,steroid metabolic process,BP,HMGCS2;DKK3;HSD17B3;CYP11A1;HSD3B2;DHCR7;DHH
1177,GO:0007160,0.0339769399099013,0.991812585673301,7,13,cell-matrix adhesion,BP,ACTN2;PIK3R1;LAMA5;ITGB5;SDC4;ITGA3;CTGF
713,GO:0005178,0.0343047834731193,0.994513669836377,5,8,integrin binding,MF,ACTN2;MFGE8;LAMA5;ITGA3;CTGF
3066,GO:0032944,0.0397764428025786,0.993266106843494,4,9,regulation of mononuclear cell proliferation,BP,PNP;CDKN1A;SDC4;TICAM1
4728,GO:0050670,0.0397764428025786,0.993266106843494,4,9,regulation of lymphocyte proliferation,BP,PNP;CDKN1A;SDC4;TICAM1
2782,GO:0031901,0.0403647106110415,1,2,2,early endosome membrane,CC,SNX21;TMEM163
2406,GO:0030029,0.0418346277103179,0.982975024617458,13,34,actin filament-based process,BP,ACTN2;MYO7A;NUAK2;RHOJ;PIK3R1;PLEKHH2;ITGB5;SDC4;FHOD3;PDE4B;CTGF;ESPN;DAAM2
2652,GO:0031091,0.0424620097575696,0.997059845378,3,4,platelet alpha granule,CC,ACTN2;GAS6;SERPINA5
3639,GO:0042446,0.0424769399593532,0.990992843777987,5,11,hormone biosynthetic process,BP,DKK3;HSD17B3;CYP11A1;HSD3B2;DHCR7
238,GO:0001968,0.0442230867717543,0.996882743425323,3,4,fibronectin binding,MF,SDC4;ITGA3;CTGF
6533,GO:1901136,0.0446229453830851,0.99214438229555,4,9,carbohydrate derivative catabolic process,BP,PNP;HEXB;SDC4;PDE4B
3251,GO:0034605,0.045784970045548,1,2,2,cellular response to heat,BP,CDKN1A;SLC52A3
3114,GO:0033158,0.0458874540652628,1,2,2,regulation of protein import into nucleus, translocation,BP,CDKN1A;GAS6
829,GO:0005813,0.0477180576605331,0.992665212694287,4,7,centrosome,CC,PRKACB;CAMSAP3;PDE4B;MARK4
4810,GO:0050867,0.0481123348626475,0.987452611546813,6,14,positive regulation of cell activation,BP,PNP;CDKN1A;PIK3R1;GAS6;TICAM1;CTGF
4213,GO:0045621,0.0484958086560493,1,2,2,positive regulation of lymphocyte differentiation,BP,PNP;GAS6
3638,GO:0042445,0.0485334595264793,0.988901800376816,5,12,hormone metabolic process,BP,DKK3;HSD17B3;CYP11A1;HSD3B2;DHCR7
3033,GO:0032814,0.0498425970002258,1,2,2,regulation of natural killer cell activation,BP,GAS6;TICAM1
3034,GO:0032816,0.0498425970002258,1,2,2,positive regulation of natural killer cell activation,BP,GAS6;TICAM1
3809,GO:0043228,0.0501345555198708,0.974533331802078,21,68,non-membrane-bounded organelle,CC,ACTN2;PNP;MYO7A;CDKN1A;FRMPD1;KITLG;PHLDA1;MRI1;PLEKHH2;MRO;PRKACB;CAMSAP3;SDC4;FHOD3;HMGN5;PTPN7;PDE4B;ACSL4;ESPN;CGN;MARK4
3813,GO:0043232,0.0501345555198708,0.974533331802078,21,68,intracellular non-membrane-bounded organelle,CC,ACTN2;PNP;MYO7A;CDKN1A;FRMPD1;KITLG;PHLDA1;MRI1;PLEKHH2;MRO;PRKACB;CAMSAP3;SDC4;FHOD3;HMGN5;PTPN7;PDE4B;ACSL4;ESPN;CGN;MARK4
3771,GO:0043094,0.0502209540679841,1,2,2,cellular metabolic compound salvage,BP,PNP;MRI1
4106,GO:0045023,0.0503073628919452,1,2,2,G0 to G1 transition,BP,FOXO4;CTGF
5667,GO:0070316,0.0503073628919452,1,2,2,regulation of G0 to G1 transition,BP,FOXO4;CTGF
3213,GO:0034349,0.0519750630759496,1,2,2,glial cell apoptotic process,BP,GAS6;DLL1
3214,GO:0034350,0.0519750630759496,1,2,2,regulation of glial cell apoptotic process,BP,GAS6;DLL1
3215,GO:0034351,0.0519750630759496,1,2,2,negative regulation of glial cell apoptotic process,BP,GAS6;DLL1
2849,GO:0032231,0.0520809941989396,0.996051930185051,3,4,regulation of actin filament bundle assembly,BP,PIK3R1;SDC4;CTGF
5014,GO:0051492,0.0520809941989396,0.996051930185051,3,4,regulation of stress fiber assembly,BP,PIK3R1;SDC4;CTGF
6414,GO:0098858,0.0521947057061327,0.989488443740569,5,9,actin-based cell projection,CC,ACTN2;MYO7A;KITLG;ITGA3;ESPN
6177,GO:0090136,0.0523042453886758,1,2,2,epithelial cell-cell adhesion,BP,ITGB5;CAMSAP3
2411,GO:0030036,0.05451168699148,0.978359394049201,11,29,actin cytoskeleton organization,BP,ACTN2;NUAK2;RHOJ;PIK3R1;PLEKHH2;ITGB5;SDC4;FHOD3;CTGF;ESPN;DAAM2
2981,GO:0032640,0.0551702204211846,0.993897339570948,3,5,tumor necrosis factor production,BP,PIK3R1;GAS6;TICAM1
2995,GO:0032680,0.0551702204211846,0.993897339570948,3,5,regulation of tumor necrosis factor production,BP,PIK3R1;GAS6;TICAM1
5881,GO:0071706,0.0551702204211846,0.993897339570948,3,5,tumor necrosis factor superfamily cytokine production,BP,PIK3R1;GAS6;TICAM1
6823,GO:1903555,0.0551702204211846,0.993897339570948,3,5,regulation of tumor necrosis factor superfamily cytokine production,BP,PIK3R1;GAS6;TICAM1
1971,GO:0016229,0.056588598399024,0.995904529912178,2,4,steroid dehydrogenase activity,MF,HSD17B3;HSD3B2
3165,GO:0033764,0.056588598399024,0.995904529912178,2,4,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD17B3;HSD3B2
4945,GO:0051249,0.0574085248225274,0.983927140240462,6,15,regulation of lymphocyte activation,BP,PNP;CDKN1A;PIK3R1;SDC4;GAS6;TICAM1
4480,GO:0047035,0.0579312368188867,1,1,1,testosterone dehydrogenase (NAD+) activity,MF,HSD17B3
4481,GO:0047045,0.0579312368188867,1,1,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,HSD17B3
2977,GO:0032623,0.0593768096585775,1,2,2,interleukin-2 production,BP,PNP;PDE4B
1143,GO:0007010,0.0613069083910919,0.972150434374348,14,40,cytoskeleton organization,BP,ACTN2;NUAK2;RHOJ;PIK3R1;PLEKHH2;LAMA5;ITGB5;CAMSAP3;SDC4;FHOD3;CTGF;ESPN;DAAM2;MARK4
4263,GO:0045786,0.0613135754755953,0.981656574612398,6,18,negative regulation of cell cycle,BP,CDKN1A;RHOB;PRKACB;GAS6;HMGN5;FOXO4
5180,GO:0060041,0.0622264850597795,0.996569449930971,2,3,retina development in camera-type eye,BP,RHOJ;DLL1
4947,GO:0051251,0.0654022915979513,0.983628466616998,5,12,positive regulation of lymphocyte activation,BP,PNP;CDKN1A;PIK3R1;GAS6;TICAM1
3951,GO:0043954,0.0660217488317014,1,2,2,cellular component maintenance,BP,CAMSAP3;ITGA3
167,GO:0001764,0.0661382640898141,1,2,2,neuron migration,BP,GAS6;ITGA3
2808,GO:0031983,0.0669477006473891,0.983119997286983,5,12,vesicle lumen,CC,ACTN2;PNP;HEXB;GAS6;CRISPLD2
3291,GO:0034774,0.0669477006473891,0.983119997286983,5,12,secretory granule lumen,CC,ACTN2;PNP;HEXB;GAS6;CRISPLD2
5232,GO:0060205,0.0669477006473891,0.983119997286983,5,12,cytoplasmic vesicle lumen,CC,ACTN2;PNP;HEXB;GAS6;CRISPLD2
1889,GO:0015631,0.0687651729465482,0.987928018853073,4,7,tubulin binding,MF,REEP1;CAMSAP3;PDE4B;MARK4
807,GO:0005769,0.0689697143277784,0.985854538740568,4,9,early endosome,CC,RHOB;SNX21;RIN3;TMEM163
3263,GO:0034644,0.0689877183458661,1,2,2,cellular response to UV,BP,CDKN1A;PIK3R1
162,GO:0001755,0.0711130586874084,0.991195793880091,3,5,neural crest cell migration,BP,NRTN;KITLG;LAMA5
826,GO:0005801,0.0711833212205497,1,2,2,cis-Golgi network,CC,PIK3R1;CTGF
1505,GO:0009566,0.0715945637027664,0.991109158758835,3,5,fertilization,BP,HEXB;MFGE8;SERPINA5
527,GO:0003382,0.0726952836198181,1,1,1,epithelial cell morphogenesis,BP,CLDN3
3068,GO:0032946,0.0728595619738878,0.988420602405623,3,7,positive regulation of mononuclear cell proliferation,BP,PNP;CDKN1A;TICAM1
4729,GO:0050671,0.0728595619738878,0.988420602405623,3,7,positive regulation of lymphocyte proliferation,BP,PNP;CDKN1A;TICAM1
2402,GO:0030016,0.0742654140723304,0.985278247793056,4,8,myofibril,CC,ACTN2;SDC4;FHOD3;PDE4B
1320,GO:0008092,0.0758813712265199,0.966255643181547,12,34,cytoskeletal protein binding,MF,ACTN2;MYO7A;REEP1;PLEKHH2;CAMSAP3;FHOD3;RAB39B;PDE4B;ESPN;CGN;DAAM2;MARK4
3749,GO:0043015,0.0777484165408143,1,2,2,gamma-tubulin binding,MF,PDE4B;MARK4
5201,GO:0060076,0.0781477553598619,1,2,2,excitatory synapse,CC,PDE4B;ITGA3
123,GO:0001573,0.0783838317617648,1,2,2,ganglioside metabolic process,BP,HEXB;ITGB8
4891,GO:0051130,0.0801645087595762,0.966246441401306,10,30,positive regulation of cellular component organization,BP,ACTN2;PIK3R1;MFGE8;SDC4;GAS6;DLL1;CLDN1;ITGA3;CTGF;ESPN
1207,GO:0007229,0.0802628643609678,0.981429534082198,5,9,integrin-mediated signaling pathway,BP,LAMA5;ITGB5;ITGB8;ITGA3;CTGF
6085,GO:0072557,0.0808421289292234,1,1,1,IPAF inflammasome complex,CC,CASP4
6303,GO:0097200,0.0808421289292234,1,1,1,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,CASP4
6906,GO:1904645,0.0808421289292234,1,1,1,response to beta-amyloid,BP,CASP4
6907,GO:1904646,0.0808421289292234,1,1,1,cellular response to beta-amyloid,BP,CASP4
4808,GO:0050865,0.0820231325239371,0.971527521017186,7,19,regulation of cell activation,BP,PNP;CDKN1A;PIK3R1;SDC4;GAS6;TICAM1;CTGF
11,GO:0000077,0.082816105825133,0.994579570098179,2,3,DNA damage checkpoint,BP,CDKN1A;FOXO4
2742,GO:0031570,0.082816105825133,0.994579570098179,2,3,DNA integrity checkpoint,BP,CDKN1A;FOXO4
4084,GO:0044773,0.082816105825133,0.994579570098179,2,3,mitotic DNA damage checkpoint,BP,CDKN1A;FOXO4
4085,GO:0044774,0.082816105825133,0.994579570098179,2,3,mitotic DNA integrity checkpoint,BP,CDKN1A;FOXO4
5771,GO:0071158,0.082816105825133,0.994579570098179,2,3,positive regulation of cell cycle arrest,BP,CDKN1A;FOXO4
5015,GO:0051493,0.0835232666105133,0.969304755584214,8,20,regulation of cytoskeleton organization,BP,ACTN2;PIK3R1;PLEKHH2;CAMSAP3;SDC4;FHOD3;CTGF;ESPN
6645,GO:1902107,0.0866231139623797,0.988263729548211,3,5,positive regulation of leukocyte differentiation,BP,PNP;KITLG;GAS6
6847,GO:1903708,0.0866231139623797,0.988263729548211,3,5,positive regulation of hemopoiesis,BP,PNP;KITLG;GAS6
926,GO:0006195,0.0878876483694022,0.99403452762878,2,3,purine nucleotide catabolic process,BP,PNP;PDE4B
6568,GO:1901565,0.0893720100888778,0.97366342238022,5,15,organonitrogen compound catabolic process,BP,PNP;HEXB;SDC4;PDE4B;AOX1
175,GO:0001786,0.090260626184369,0.993772213252496,2,3,phosphatidylserine binding,MF,MFGE8;GAS6
4967,GO:0051291,0.0903485583286389,0.990125241408508,2,5,protein heterooligomerization,BP,CLDN1;CLDN3
2460,GO:0030198,0.0910244642313943,0.967495006047125,8,17,extracellular matrix organization,BP,LAMA1;LAMA5;ITGB5;ITGB8;GAS6;CRISPLD2;ITGA3;CTGF
3759,GO:0043062,0.0910244642313943,0.967495006047125,8,17,extracellular structure organization,BP,LAMA1;LAMA5;ITGB5;ITGB8;GAS6;CRISPLD2;ITGA3;CTGF
1189,GO:0007179,0.0919128075007678,0.980263589808229,4,8,transforming growth factor beta receptor signaling pathway,BP,DKK3;ITGB5;ITGA3;CGN
5717,GO:0070661,0.0932851444424448,0.97317497990938,5,13,leukocyte proliferation,BP,PNP;CDKN1A;KITLG;SDC4;TICAM1
5702,GO:0070542,0.0965327787987938,0.984031159131785,3,6,response to fatty acid,BP,CLDN1;PDK4;CTGF
1303,GO:0008017,0.0969202785483204,0.986160992336229,3,5,microtubule binding,MF,REEP1;CAMSAP3;MARK4
796,GO:0005740,0.097199101192109,0.963640315777941,7,22,mitochondrial envelope,CC,HMGCS2;REEP1;SLC25A53;CYP11A1;HSD3B2;ACSL4;PDK4
2800,GO:0031966,0.097199101192109,0.963640315777941,7,22,mitochondrial membrane,CC,HMGCS2;REEP1;SLC25A53;CYP11A1;HSD3B2;ACSL4;PDK4
1409,GO:0008630,0.0980295531548683,0.992881214208067,2,3,intrinsic apoptotic signaling pathway in response to DNA damage,BP,CDKN1A;PIK3R1
5845,GO:0071478,0.0995910456211973,0.983286802905098,3,6,cellular response to radiation,BP,CDKN1A;RHOB;PIK3R1
2619,GO:0030888,0.100296924746525,0.992611937172943,2,3,regulation of B cell proliferation,BP,CDKN1A;TICAM1
2620,GO:0030890,0.100296924746525,0.992611937172943,2,3,positive regulation of B cell proliferation,BP,CDKN1A;TICAM1
3568,GO:0042100,0.100296924746525,0.992611937172943,2,3,B cell proliferation,BP,CDKN1A;TICAM1
4807,GO:0050864,0.100296924746525,0.992611937172943,2,3,regulation of B cell activation,BP,CDKN1A;TICAM1
4813,GO:0050871,0.100296924746525,0.992611937172943,2,3,positive regulation of B cell activation,BP,CDKN1A;TICAM1
5846,GO:0071479,0.102364108770945,0.989478797090887,2,4,cellular response to ionizing radiation,BP,CDKN1A;RHOB
4211,GO:0045619,0.102439809815365,0.992353631001209,2,3,regulation of lymphocyte differentiation,BP,PNP;GAS6
6630,GO:1901988,0.10346444413411,0.989296010166822,2,4,negative regulation of cell cycle phase transition,BP,CDKN1A;FOXO4
6632,GO:1901991,0.10346444413411,0.989296010166822,2,4,negative regulation of mitotic cell cycle phase transition,BP,CDKN1A;FOXO4
3587,GO:0042175,0.103944044128708,0.957016308595639,8,28,nuclear outer membrane-endoplasmic reticulum membrane network,CC,REEP1;PIK3R1;HSD17B3;HSD3B2;CASP4;DHCR7;ACSL4;GPSM1
2748,GO:0031589,0.104096169853091,0.960144730955634,8,19,cell-substrate adhesion,BP,ACTN2;PIK3R1;LAMA5;ITGB5;SDC4;GAS6;ITGA3;CTGF
885,GO:0006026,0.105091808322691,0.992028840790556,2,3,aminoglycan catabolic process,BP,HEXB;SDC4
886,GO:0006027,0.105091808322691,0.992028840790556,2,3,glycosaminoglycan catabolic process,BP,HEXB;SDC4
384,GO:0002696,0.107435319117811,0.967648930266344,5,13,positive regulation of leukocyte activation,BP,PNP;CDKN1A;PIK3R1;GAS6;TICAM1
1167,GO:0007093,0.108135885795861,0.988505738365451,2,4,mitotic cell cycle checkpoint,BP,CDKN1A;FOXO4
2801,GO:0031967,0.10854001847257,0.95464044707379,8,28,organelle envelope,CC,HMGCS2;REEP1;SLC25A53;CYP11A1;HSD3B2;DHCR7;ACSL4;PDK4
2805,GO:0031975,0.10854001847257,0.95464044707379,8,28,envelope,CC,HMGCS2;REEP1;SLC25A53;CYP11A1;HSD3B2;DHCR7;ACSL4;PDK4
3657,GO:0042493,0.109413425541494,0.9615110198111,6,18,response to drug,BP,PNP;CDKN1A;GAS6;CLDN1;PDE4B;ITGA3
6300,GO:0097193,0.110288844888114,0.977709771310687,3,8,intrinsic apoptotic signaling pathway,BP,CDKN1A;PIK3R1;CASP4
775,GO:0005576,0.112142346583211,0.930741477992285,32,133,extracellular region,CC,ACTN2;PNP;LAMA1;NRTN;FRMPD1;RHOJ;DKK3;KITLG;RHOB;PRND;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;CMBL;PRKACB;ITGB8;SDC4;GAS6;SERPINA5;DLL1;CRISPLD2;CASP4;PON2;ACSL4;DHH;ITGA3;AOX1;CTGF;CLDN3;DAAM2
3283,GO:0034754,0.113311314259434,0.969936236802707,4,11,cellular hormone metabolic process,BP,DKK3;HSD17B3;CYP11A1;HSD3B2
585,GO:0004197,0.11388832572206,0.996612853025046,1,2,cysteine-type endopeptidase activity,MF,CASP4
1355,GO:0008234,0.11388832572206,0.996612853025046,1,2,cysteine-type peptidase activity,MF,CASP4
5594,GO:0061702,0.11388832572206,0.996612853025046,1,2,inflammasome complex,CC,CASP4
6087,GO:0072559,0.11388832572206,0.996612853025046,1,2,NLRP3 inflammasome complex,CC,CASP4
6286,GO:0097153,0.11388832572206,0.996612853025046,1,2,cysteine-type endopeptidase activity involved in apoptotic process,MF,CASP4
6289,GO:0097169,0.11388832572206,0.996612853025046,1,2,AIM2 inflammasome complex,CC,CASP4
1268,GO:0007568,0.11442479800008,0.970451804718953,4,10,aging,BP,CDKN1A;CLDN1;FOXO4;CTGF
4875,GO:0051056,0.114721538928678,0.971543317117897,4,9,regulation of small GTPase mediated signal transduction,BP,RHOJ;KITLG;RHOB;ITGA3
1787,GO:0014032,0.115794158453056,0.979149922073244,3,6,neural crest cell development,BP,NRTN;KITLG;LAMA5
1788,GO:0014033,0.115794158453056,0.979149922073244,3,6,neural crest cell differentiation,BP,NRTN;KITLG;LAMA5
6732,GO:1902903,0.116536543626748,0.960899096259348,6,14,regulation of supramolecular fiber organization,BP,ACTN2;PIK3R1;PLEKHH2;SDC4;FHOD3;CTGF
4156,GO:0045216,0.118999530022549,0.958231549184105,6,16,cell-cell junction organization,BP,ACTN2;LAMA5;CAMSAP3;SDC4;CLDN1;CLDN3
4101,GO:0044877,0.120986289187815,0.944604720317991,10,29,macromolecular complex binding,MF,ACTN2;MYO7A;CDKN1A;PIK3R1;MFGE8;LAMA5;HMGN5;ITGA3;CTGF;ESPN
5207,GO:0060090,0.121554167048465,0.989887128459647,2,3,binding, bridging,MF,PIK3R1;GAS6
1039,GO:0006702,0.121623594549358,0.986095736582842,2,4,androgen biosynthetic process,BP,HSD17B3;HSD3B2
3834,GO:0043277,0.121790702267725,0.989854789213497,2,3,apoptotic cell clearance,BP,MFGE8;GAS6
1495,GO:0009408,0.122250859420261,0.989791749660045,2,3,response to heat,BP,CDKN1A;SLC52A3
8,GO:0000060,0.122413922017263,0.989769370669453,2,3,protein import into nucleus, translocation,BP,CDKN1A;GAS6
382,GO:0002694,0.123570331311309,0.955488993648773,6,17,regulation of leukocyte activation,BP,PNP;CDKN1A;PIK3R1;SDC4;GAS6;TICAM1
1206,GO:0007224,0.123593570201101,0.985727929067762,2,4,smoothened signaling pathway,BP,PRKACB;DHH
4953,GO:0051260,0.124913176051977,0.96663098514745,4,10,protein homooligomerization,BP,ACTN2;PRND;CLDN1;CLDN3
374,GO:0002684,0.124977055798095,0.946491741015989,8,26,positive regulation of immune system process,BP,PNP;CDKN1A;KITLG;PIK3R1;PRKACB;GAS6;TICAM1;PDE4B
1029,GO:0006687,0.126389136385695,0.989217318071885,2,3,glycosphingolipid metabolic process,BP,HEXB;ITGB8
1443,GO:0009108,0.126634113490222,0.965990254303534,4,10,coenzyme biosynthetic process,BP,PNP;ACSF2;ACSL4;PDK4
572,GO:0004064,0.128374632626856,1,1,1,arylesterase activity,MF,PON2
2223,GO:0019372,0.128374632626856,1,1,1,lipoxygenase pathway,BP,PON2
4393,GO:0046573,0.128374632626856,1,1,1,lactonohydrolase activity,MF,PON2
6456,GO:0102007,0.128374632626856,1,1,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,PON2
2197,GO:0019209,0.129950451909935,0.988712176564623,2,3,kinase activator activity,MF,CDKN1A;GAS6
2496,GO:0030295,0.129950451909935,0.988712176564623,2,3,protein kinase activator activity,MF,CDKN1A;GAS6
177,GO:0001817,0.132177042053999,0.956467041997544,5,14,regulation of cytokine production,BP,PIK3R1;GAS6;DLL1;TICAM1;PDE4B
4761,GO:0050764,0.133179755680495,0.983881126450067,2,4,regulation of phagocytosis,BP,MFGE8;GAS6
4762,GO:0050766,0.133179755680495,0.983881126450067,2,4,positive regulation of phagocytosis,BP,MFGE8;GAS6
2657,GO:0031100,0.135554650807496,0.973678266299148,3,6,animal organ regeneration,BP,CDKN1A;GAS6;CLDN1
1305,GO:0008022,0.136104324168149,0.98781581581019,2,3,protein C-terminus binding,MF,LAMA1;CTGF
2850,GO:0032233,0.136176066415862,0.987805190749363,2,3,positive regulation of actin filament bundle assembly,BP,SDC4;CTGF
5018,GO:0051496,0.136176066415862,0.987805190749363,2,3,positive regulation of stress fiber assembly,BP,SDC4;CTGF
2123,GO:0017015,0.137792439546466,0.98756473560746,2,3,regulation of transforming growth factor beta receptor signaling pathway,BP,DKK3;ITGA3
6867,GO:1903844,0.137792439546466,0.98756473560746,2,3,regulation of cellular response to transforming growth factor beta stimulus,BP,DKK3;ITGA3
1158,GO:0007045,0.139453174364744,0.976235743737946,3,5,cell-substrate adherens junction assembly,BP,ACTN2;LAMA5;SDC4
3210,GO:0034333,0.139453174364744,0.976235743737946,3,5,adherens junction assembly,BP,ACTN2;LAMA5;SDC4
4510,GO:0048041,0.139453174364744,0.976235743737946,3,5,focal adhesion assembly,BP,ACTN2;LAMA5;SDC4
6734,GO:1902905,0.140900342968864,0.969740467335897,3,7,positive regulation of supramolecular fiber organization,BP,ACTN2;SDC4;CTGF
1464,GO:0009166,0.140905485251393,0.98232431060251,2,4,nucleotide catabolic process,BP,PNP;PDE4B
6545,GO:1901292,0.140905485251393,0.98232431060251,2,4,nucleoside phosphate catabolic process,BP,PNP;PDE4B
1025,GO:0006664,0.142907309862279,0.981911005403591,2,4,glycolipid metabolic process,BP,HEXB;ITGB8
6805,GO:1903509,0.142907309862279,0.981911005403591,2,4,liposaccharide metabolic process,BP,HEXB;ITGB8
6616,GO:1901888,0.143913488864714,0.986635604902685,2,3,regulation of cell junction assembly,BP,SDC4;CLDN1
6617,GO:1901890,0.143913488864714,0.986635604902685,2,3,positive regulation of cell junction assembly,BP,SDC4;CLDN1
3075,GO:0032970,0.145650441207316,0.941633089033661,7,18,regulation of actin filament-based process,BP,ACTN2;PIK3R1;PLEKHH2;SDC4;FHOD3;PDE4B;CTGF
557,GO:0003854,0.146625622343466,1,1,1,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,HSD3B2
1343,GO:0008203,0.14770546634386,0.965790166422731,3,8,cholesterol metabolic process,BP,HMGCS2;CYP11A1;DHCR7
6706,GO:1902652,0.14770546634386,0.965790166422731,3,8,secondary alcohol metabolic process,BP,HMGCS2;CYP11A1;DHCR7
2653,GO:0031093,0.147925810817838,0.986010652400184,2,3,platelet alpha granule lumen,CC,ACTN2;GAS6
4394,GO:0046578,0.148708343048202,0.980690320274329,2,4,regulation of Ras protein signal transduction,BP,KITLG;ITGA3
2113,GO:0016877,0.149240315251818,0.985803168803886,2,3,ligase activity, forming carbon-sulfur bonds,MF,ACSF2;ACSL4
2114,GO:0016878,0.149240315251818,0.985803168803886,2,3,acid-thiol ligase activity,MF,ACSF2;ACSL4
2432,GO:0030104,0.151166641646275,0.985496673079228,2,3,water homeostasis,BP,PRKACB;CLDN1
4824,GO:0050891,0.151166641646275,0.985496673079228,2,3,multicellular organismal water homeostasis,BP,PRKACB;CLDN1
1372,GO:0008333,0.152699991368238,0.985250629282453,2,3,endosome to lysosome transport,BP,GPRASP1;RHOB
2404,GO:0030018,0.152921216840636,0.968495113882368,3,6,Z disc,CC,ACTN2;FHOD3;PDE4B
2767,GO:0031674,0.152921216840636,0.968495113882368,3,6,I band,CC,ACTN2;FHOD3;PDE4B
4706,GO:0048864,0.153892329835885,0.96550925848241,3,7,stem cell development,BP,NRTN;KITLG;LAMA5
2451,GO:0030175,0.156230161752014,0.967468579146696,3,6,filopodium,CC,ACTN2;KITLG;ITGA3
1498,GO:0009411,0.157491547115717,0.984469919273575,2,3,response to UV,BP,CDKN1A;PIK3R1
1283,GO:0007605,0.158261029409141,0.955344220446049,4,9,sensory perception of sound,BP,MYO7A;HEXB;SLC52A3;ESPN
4843,GO:0050954,0.158261029409141,0.955344220446049,4,9,sensory perception of mechanical stimulus,BP,MYO7A;HEXB;SLC52A3;ESPN
3824,GO:0043256,0.158290836248926,1,2,2,laminin complex,CC,LAMA1;LAMA5
1036,GO:0006695,0.159176312557107,0.978401384172199,2,4,cholesterol biosynthetic process,BP,HMGCS2;DHCR7
1959,GO:0016126,0.159176312557107,0.978401384172199,2,4,sterol biosynthetic process,BP,HMGCS2;DHCR7
6707,GO:1902653,0.159176312557107,0.978401384172199,2,4,secondary alcohol biosynthetic process,BP,HMGCS2;DHCR7
1341,GO:0008201,0.159610351591519,0.961628346899311,3,8,heparin binding,MF,SERPINA5;CRISPLD2;CTGF
1368,GO:0008305,0.160263105208243,0.970683839867181,3,5,integrin complex,CC,ITGB5;ITGB8;ITGA3
6377,GO:0098636,0.160263105208243,0.970683839867181,3,5,protein complex involved in cell adhesion,CC,ITGB5;ITGB8;ITGA3
5017,GO:0051495,0.160660798422167,0.961252789836185,3,8,positive regulation of cytoskeleton organization,BP,ACTN2;SDC4;CTGF
835,GO:0005856,0.161001578666473,0.911497599543836,14,44,cytoskeleton,CC,ACTN2;PNP;MYO7A;FRMPD1;KITLG;PLEKHH2;PRKACB;CAMSAP3;FHOD3;PTPN7;PDE4B;ESPN;CGN;MARK4
4268,GO:0045807,0.162266541214015,0.962675260570718,3,7,positive regulation of endocytosis,BP,MFGE8;GAS6;DLL1
2195,GO:0019207,0.162447048731725,0.96550653116648,3,6,kinase regulator activity,MF,CDKN1A;PIK3R1;GAS6
3839,GO:0043292,0.163545683945746,0.951345533141859,4,10,contractile fiber,CC,ACTN2;SDC4;FHOD3;PDE4B
4046,GO:0044449,0.163545683945746,0.951345533141859,4,10,contractile fiber part,CC,ACTN2;SDC4;FHOD3;PDE4B
1425,GO:0009058,0.164063027795395,0.893894480481176,29,130,biosynthetic process,BP,ACTN2;PNP;ACSF2;CDKN1A;HMGCS2;DKK3;KITLG;PHLDA1;PIK3R1;MRI1;PRND;HEXB;HSD17B3;CYP11A1;SDC4;GAS6;HSD3B2;DLL1;TICAM1;HMGN5;ACCS;RBMS3;DHCR7;ACSL4;DHH;FOXO4;ITGA3;PDK4;CTGF
6845,GO:1903706,0.164377239920113,0.942718899543156,5,13,regulation of hemopoiesis,BP,PNP;KITLG;PIK3R1;GAS6;DLL1
7231,GO:2001257,0.164650291055093,0.983270055795828,2,3,regulation of cation channel activity,BP,ACTN2;PDE4B
819,GO:0005789,0.165868929376857,0.926048315215058,7,27,endoplasmic reticulum membrane,CC,REEP1;HSD17B3;HSD3B2;CASP4;DHCR7;ACSL4;GPSM1
2916,GO:0032403,0.16607426036474,0.92078477148898,9,27,protein complex binding,MF,ACTN2;MYO7A;CDKN1A;PIK3R1;MFGE8;LAMA5;ITGA3;CTGF;ESPN
4421,GO:0046718,0.166795894009954,0.964108252400744,3,6,viral entry into host cell,BP,ITGB5;GAS6;CLDN1
3799,GO:0043202,0.167261613050415,0.97327123961043,2,5,lysosomal lumen,CC,HEXB;SDC4
3015,GO:0032760,0.167330128249448,0.976541821478695,2,4,positive regulation of tumor necrosis factor production,BP,PIK3R1;TICAM1
6825,GO:1903557,0.167330128249448,0.976541821478695,2,4,positive regulation of tumor necrosis factor superfamily cytokine production,BP,PIK3R1;TICAM1
2231,GO:0019439,0.16816174692196,0.946707720314724,4,12,aromatic compound catabolic process,BP,PNP;PON2;PDE4B;AOX1
141,GO:0001669,0.170213896601744,0.982309847222401,2,3,acrosomal vesicle,CC,HEXB;SERPINA5
6306,GO:0097223,0.170213896601744,0.982309847222401,2,3,sperm part,CC,HEXB;SERPINA5
769,GO:0005543,0.170324023610328,0.938723853410402,5,14,phospholipid binding,MF,ACTN2;SNX21;MFGE8;GAS6;SERPINA5
261,GO:0002066,0.170893192261161,0.96277151729522,3,6,columnar/cuboidal epithelial cell development,BP,MYO7A;CDKN1A;DLL1
2494,GO:0030285,0.171034130329105,1,1,1,integral component of synaptic vesicle membrane,CC,TMEM163
6364,GO:0098563,0.171034130329105,1,1,1,intrinsic component of synaptic vesicle membrane,CC,TMEM163
1536,GO:0009791,0.17111367634152,0.975656185884556,2,4,post-embryonic development,BP,MYO7A;DHCR7
5535,GO:0061298,0.172564615495968,1,1,1,retina vasculature development in camera-type eye,BP,RHOJ
5536,GO:0061299,0.172564615495968,1,1,1,retina vasculature morphogenesis in camera-type eye,BP,RHOJ
625,GO:0004563,0.17302052896991,1,1,1,beta-N-acetylhexosaminidase activity,MF,HEXB
1030,GO:0006689,0.17302052896991,1,1,1,ganglioside catabolic process,BP,HEXB
1230,GO:0007341,0.17302052896991,1,1,1,penetration of zona pellucida,BP,HEXB
1290,GO:0007617,0.17302052896991,1,1,1,mating behavior,BP,HEXB
1291,GO:0007618,0.17302052896991,1,1,1,mating,BP,HEXB
1292,GO:0007619,0.17302052896991,1,1,1,courtship behavior,BP,HEXB
1310,GO:0008049,0.17302052896991,1,1,1,male courtship behavior,BP,HEXB
1374,GO:0008347,0.17302052896991,1,1,1,glial cell migration,BP,HEXB
1491,GO:0009313,0.17302052896991,1,1,1,oligosaccharide catabolic process,BP,HEXB
1929,GO:0015929,0.17302052896991,1,1,1,hexosaminidase activity,MF,HEXB
2187,GO:0019098,0.17302052896991,1,1,1,reproductive behavior,BP,HEXB
2469,GO:0030214,0.17302052896991,1,1,1,hyaluronan catabolic process,BP,HEXB
3618,GO:0042340,0.17302052896991,1,1,1,keratan sulfate catabolic process,BP,HEXB
3925,GO:0043615,0.17302052896991,1,1,1,astrocyte cell migration,BP,HEXB
5227,GO:0060179,0.17302052896991,1,1,1,male mating behavior,BP,HEXB
1109,GO:0006910,0.173550500486431,1,1,1,phagocytosis, recognition,BP,MFGE8
1110,GO:0006911,0.173550500486431,1,1,1,phagocytosis, engulfment,BP,MFGE8
1386,GO:0008429,0.173550500486431,1,1,1,phosphatidylethanolamine binding,MF,MFGE8
7123,GO:2000425,0.173550500486431,1,1,1,regulation of apoptotic cell clearance,BP,MFGE8
7124,GO:2000427,0.173550500486431,1,1,1,positive regulation of apoptotic cell clearance,BP,MFGE8
6327,GO:0097435,0.173739090124396,0.920488011183735,8,23,supramolecular fiber organization,BP,ACTN2;PIK3R1;PLEKHH2;ITGB5;SDC4;FHOD3;CTGF;ESPN
4917,GO:0051188,0.173887859074507,0.945381182659217,4,11,cofactor biosynthetic process,BP,PNP;ACSF2;ACSL4;PDK4
3065,GO:0032943,0.174699456457511,0.943772487513765,4,12,mononuclear cell proliferation,BP,PNP;CDKN1A;SDC4;TICAM1
4410,GO:0046651,0.174699456457511,0.943772487513765,4,12,lymphocyte proliferation,BP,PNP;CDKN1A;SDC4;TICAM1
1759,GO:0010948,0.175758055274035,0.954073328010778,3,9,negative regulation of cell cycle process,BP,CDKN1A;HMGN5;FOXO4
694,GO:0005113,0.176316158493559,1,1,1,patched binding,MF,DHH
2480,GO:0030238,0.176316158493559,1,1,1,male sex determination,BP,DHH
3131,GO:0033327,0.176316158493559,1,1,1,Leydig cell differentiation,BP,DHH
4795,GO:0050821,0.179887461461845,0.973546986437323,2,4,protein stabilization,BP,CDKN1A;PIK3R1
2403,GO:0030017,0.181167341840183,0.95597607969495,3,7,sarcomere,CC,ACTN2;FHOD3;PDE4B
1383,GO:0008386,0.18228481005975,1,1,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,CYP11A1
2070,GO:0016713,0.18228481005975,1,1,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,CYP11A1
6095,GO:0072593,0.18251153208718,0.931636167443749,5,15,reactive oxygen species metabolic process,BP,CDKN1A;TICAM1;PDK4;AOX1;CTGF
176,GO:0001816,0.182584184729542,0.924815154601045,6,18,cytokine production,BP,PNP;PIK3R1;GAS6;DLL1;TICAM1;PDE4B
5848,GO:0071482,0.183019179382356,0.980007559967688,2,3,cellular response to light stimulus,BP,CDKN1A;PIK3R1
1940,GO:0016032,0.184287893409438,0.923884277198816,6,18,viral process,BP,PIK3R1;MFGE8;ITGB5;GAS6;TICAM1;CLDN1
812,GO:0005775,0.184671645270322,0.966163298284972,2,6,vacuolar lumen,CC,HEXB;SDC4
1346,GO:0008209,0.185326223006307,0.968344187805557,2,5,androgen metabolic process,BP,HSD17B3;HSD3B2
664,GO:0004866,0.185367719471424,0.968332452936149,2,5,endopeptidase inhibitor activity,MF,GAS6;SERPINA5
2518,GO:0030414,0.185367719471424,0.968332452936149,2,5,peptidase inhibitor activity,MF,GAS6;SERPINA5
5511,GO:0061135,0.185367719471424,0.968332452936149,2,5,endopeptidase regulator activity,MF,GAS6;SERPINA5
1591,GO:0010212,0.186126359481923,0.968117579100036,2,5,response to ionizing radiation,BP,CDKN1A;RHOB
4008,GO:0044325,0.186206376626271,0.971979919828989,2,4,ion channel binding,MF,ACTN2;PDE4B
6329,GO:0097458,0.186500213213292,0.903707040925986,10,33,neuron part,CC,ACTN2;NRTN;MYO7A;TMEM163;RAB39B;PDE4B;ACSL4;ITGA3;ESPN;MARK4
3578,GO:0042129,0.186798505935587,0.967926670231713,2,5,regulation of T cell proliferation,BP,PNP;SDC4
4799,GO:0050839,0.187803522202346,0.925080269873019,6,15,cell adhesion molecule binding,MF,ACTN2;MFGE8;LAMA5;ITGA3;CTGF;CGN
3995,GO:0044272,0.187887838694944,0.940779871809401,4,10,sulfur compound biosynthetic process,BP,ACSF2;MRI1;ACSL4;PDK4
793,GO:0005730,0.188659356878091,0.936213959681541,4,13,nucleolus,CC,CDKN1A;PHLDA1;MRI1;MRO
3352,GO:0035384,0.189295096056335,0.956538105437305,3,6,thioester biosynthetic process,BP,ACSF2;ACSL4;PDK4
5864,GO:0071616,0.189295096056335,0.956538105437305,3,6,acyl-CoA biosynthetic process,BP,ACSF2;ACSL4;PDK4
3070,GO:0032956,0.189321618062535,0.923045650066559,6,16,regulation of actin cytoskeleton organization,BP,ACTN2;PIK3R1;PLEKHH2;SDC4;FHOD3;CTGF
6148,GO:0090004,0.189824152389186,0.978731581998483,2,3,positive regulation of establishment of protein localization to plasma membrane,BP,PIK3R1;ITGA3
6762,GO:1903078,0.189824152389186,0.978731581998483,2,3,positive regulation of protein localization to plasma membrane,BP,PIK3R1;ITGA3
6896,GO:1904377,0.189824152389186,0.978731581998483,2,3,positive regulation of protein localization to cell periphery,BP,PIK3R1;ITGA3
2979,GO:0032635,0.190054399055409,0.971005921724078,2,4,interleukin-6 production,BP,GAS6;TICAM1
2993,GO:0032675,0.190054399055409,0.971005921724078,2,4,regulation of interleukin-6 production,BP,GAS6;TICAM1
246,GO:0002020,0.19014079710908,0.966969926962313,2,5,protease binding,MF,SERPINA5;ITGA3
5210,GO:0060119,0.19053122429307,0.978596905412261,2,3,inner ear receptor cell development,BP,MYO7A;SDC4
5212,GO:0060122,0.19053122429307,0.978596905412261,2,3,inner ear receptor stereocilium organization,BP,MYO7A;SDC4
5918,GO:0071897,0.191136831032729,0.970729251214969,2,4,DNA biosynthetic process,BP,CDKN1A;CTGF
2108,GO:0016860,0.191615626181688,0.966543814284901,2,5,intramolecular oxidoreductase activity,MF,MRI1;HSD3B2
1958,GO:0016125,0.192891587332828,0.947231770067279,3,9,sterol metabolic process,BP,HMGCS2;CYP11A1;DHCR7
10,GO:0000075,0.193602026485274,0.965966086441998,2,5,cell cycle checkpoint,BP,CDKN1A;FOXO4
5064,GO:0051726,0.196504926067389,0.907989298367045,7,27,regulation of cell cycle,BP,CDKN1A;RHOB;PRKACB;GAS6;HMGN5;FOXO4;CTGF
6574,GO:1901576,0.197106179239881,0.869335493853786,28,127,organic substance biosynthetic process,BP,ACTN2;PNP;ACSF2;CDKN1A;HMGCS2;DKK3;KITLG;PHLDA1;PIK3R1;MRI1;PRND;HEXB;HSD17B3;CYP11A1;SDC4;GAS6;HSD3B2;DLL1;TICAM1;HMGN5;RBMS3;DHCR7;ACSL4;DHH;FOXO4;ITGA3;PDK4;CTGF
2924,GO:0032420,0.19714074014498,0.977318856008763,2,3,stereocilium,CC,MYO7A;ESPN
2925,GO:0032421,0.19714074014498,0.977318856008763,2,3,stereocilium bundle,CC,MYO7A;ESPN
6415,GO:0098862,0.19714074014498,0.977318856008763,2,3,cluster of actin-based cell projections,CC,MYO7A;ESPN
848,GO:0005902,0.197214587641949,0.977304380977391,2,3,microvillus,CC,MYO7A;ESPN
3811,GO:0043230,0.197470423553815,0.873716372622155,22,87,extracellular organelle,CC,ACTN2;PNP;FRMPD1;RHOJ;RHOB;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;CMBL;PRKACB;ITGB8;SDC4;GAS6;SERPINA5;CRISPLD2;ACSL4;ITGA3;AOX1;CLDN3;DAAM2
5610,GO:0070062,0.197470423553815,0.873716372622155,22,87,extracellular exosome,CC,ACTN2;PNP;FRMPD1;RHOJ;RHOB;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;CMBL;PRKACB;ITGB8;SDC4;GAS6;SERPINA5;CRISPLD2;ACSL4;ITGA3;AOX1;CLDN3;DAAM2
6826,GO:1903561,0.197470423553815,0.873716372622155,22,87,extracellular vesicle,CC,ACTN2;PNP;FRMPD1;RHOJ;RHOB;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;CMBL;PRKACB;ITGB8;SDC4;GAS6;SERPINA5;CRISPLD2;ACSL4;ITGA3;AOX1;CLDN3;DAAM2
656,GO:0004769,0.197567229480415,0.989303508158651,1,2,steroid delta-isomerase activity,MF,HSD3B2
4993,GO:0051385,0.198848953382374,0.968723825501174,2,4,response to mineralocorticoid,BP,CDKN1A;CTGF
554,GO:0003779,0.19887501915346,0.911470515591334,7,19,actin binding,MF,ACTN2;MYO7A;PLEKHH2;FHOD3;ESPN;CGN;DAAM2
1307,GO:0008037,0.199912086693166,0.976772670659827,2,3,cell recognition,BP,MFGE8;LAMA5
402,GO:0002757,0.200046553361704,0.933382275769097,4,11,immune response-activating signal transduction,BP,PIK3R1;PRKACB;TICAM1;PDE4B
407,GO:0002764,0.200046553361704,0.933382275769097,4,11,immune response-regulating signaling pathway,BP,PIK3R1;PRKACB;TICAM1;PDE4B
6629,GO:1901987,0.200701462728654,0.961176164578177,2,6,regulation of cell cycle phase transition,BP,CDKN1A;FOXO4
6631,GO:1901990,0.200701462728654,0.961176164578177,2,6,regulation of mitotic cell cycle phase transition,BP,CDKN1A;FOXO4
7067,GO:2000107,0.200991827225421,0.968155944596859,2,4,negative regulation of leukocyte apoptotic process,BP,KITLG;GAS6
2734,GO:0031491,0.201147299294167,1,1,1,nucleosome binding,MF,HMGN5
2735,GO:0031492,0.201147299294167,1,1,1,nucleosomal DNA binding,MF,HMGN5
6643,GO:1902105,0.203054545286827,0.931950808762332,4,11,regulation of leukocyte differentiation,BP,PNP;KITLG;PIK3R1;GAS6
5510,GO:0061134,0.203434976686214,0.960295839495667,2,6,peptidase regulator activity,MF,GAS6;SERPINA5
983,GO:0006508,0.204792357162553,0.902927526351807,7,27,proteolysis,BP,PRKACB;GAS6;SERPINA5;CASP4;DHH;FOXO4;CTGF
4186,GO:0045471,0.205319007423882,0.95968402218371,2,6,response to ethanol,BP,CLDN1;CLDN3
6699,GO:1902589,0.205523899880762,0.882482263690226,13,44,single-organism organelle organization,BP,ACTN2;NUAK2;RHOJ;PIK3R1;PLEKHH2;LAMA5;ITGB5;SDC4;FHOD3;CTGF;ESPN;DAAM2;MARK4
6454,GO:0101002,0.205761744362678,0.966875210944058,2,4,ficolin-1-rich granule,CC,PNP;CRISPLD2
6923,GO:1904813,0.205761744362678,0.966875210944058,2,4,ficolin-1-rich granule lumen,CC,PNP;CRISPLD2
767,GO:0005539,0.206853646444818,0.941395102683753,3,9,glycosaminoglycan binding,MF,SERPINA5;CRISPLD2;CTGF
50,GO:0000307,0.207797516544207,1,1,1,cyclin-dependent protein kinase holoenzyme complex,CC,CDKN1A
264,GO:0002069,0.207797516544207,1,1,1,columnar/cuboidal epithelial cell maturation,BP,CDKN1A
265,GO:0002070,0.207797516544207,1,1,1,epithelial cell maturation,BP,CDKN1A
662,GO:0004861,0.207797516544207,1,1,1,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN1A
1136,GO:0006978,0.207797516544207,1,1,1,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,CDKN1A
1588,GO:0010165,0.207797516544207,1,1,1,response to X-ray,BP,CDKN1A
1592,GO:0010224,0.207797516544207,1,1,1,response to UV-B,BP,CDKN1A
2036,GO:0016538,0.207797516544207,1,1,1,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN1A
2280,GO:0019912,0.207797516544207,1,1,1,cyclin-dependent protein kinase activating kinase activity,MF,CDKN1A
2512,GO:0030332,0.207797516544207,1,1,1,cyclin binding,MF,CDKN1A
3192,GO:0034198,0.207797516544207,1,1,1,cellular response to amino acid starvation,BP,CDKN1A
3484,GO:0036296,0.207797516544207,1,1,1,response to increased oxygen levels,BP,CDKN1A
3724,GO:0042772,0.207797516544207,1,1,1,DNA damage response, signal transduction resulting in transcription,BP,CDKN1A
4246,GO:0045736,0.207797516544207,1,1,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN1A
4416,GO:0046685,0.207797516544207,1,1,1,response to arsenic-containing substance,BP,CDKN1A
5159,GO:0055093,0.207797516544207,1,1,1,response to hyperoxia,BP,CDKN1A
5364,GO:0060574,0.207797516544207,1,1,1,intestinal epithelial cell maturation,BP,CDKN1A
5365,GO:0060575,0.207797516544207,1,1,1,intestinal epithelial cell differentiation,BP,CDKN1A
5366,GO:0060576,0.207797516544207,1,1,1,intestinal epithelial cell development,BP,CDKN1A
5704,GO:0070557,0.207797516544207,1,1,1,PCNA-p21 complex,CC,CDKN1A
5849,GO:0071493,0.207797516544207,1,1,1,cellular response to UV-B,BP,CDKN1A
6233,GO:0090399,0.207797516544207,1,1,1,replicative senescence,BP,CDKN1A
6234,GO:0090400,0.207797516544207,1,1,1,stress-induced premature senescence,BP,CDKN1A
6882,GO:1904030,0.207797516544207,1,1,1,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN1A
4044,GO:0044446,0.208361853609084,0.858244441170095,40,180,intracellular organelle part,CC,ACTN2;PNP;ACSF2;MYO7A;CDKN1A;HMGCS2;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PLEKHH2;HEXB;MRO;PRKACB;CAMSAP3;HSD17B3;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;FHOD3;TICAM1;TMEM163;HMGN5;CRISPLD2;CASP4;DHCR7;PDE4B;ACSL4;FOXO4;PDK4;AOX1;ESPN;CGN;GPSM1;MARK4
1154,GO:0007040,0.209013124882068,0.965989014361716,2,4,lysosome organization,BP,MYO7A;HEXB
6117,GO:0080171,0.209013124882068,0.965989014361716,2,4,lytic vacuole organization,BP,MYO7A;HEXB
4032,GO:0044429,0.210888021733751,0.893601302224264,8,32,mitochondrial part,CC,ACSF2;HMGCS2;REEP1;SLC25A53;CYP11A1;HSD3B2;ACSL4;PDK4
4264,GO:0045787,0.211604484426119,0.924955746912955,4,13,positive regulation of cell cycle,BP,CDKN1A;HMGN5;FOXO4;CTGF
777,GO:0005604,0.212421970588072,0.974231064966196,2,3,basement membrane,CC,LAMA1;LAMA5
778,GO:0005605,0.212421970588072,0.974231064966196,2,3,basal lamina,CC,LAMA1;LAMA5
4025,GO:0044420,0.212421970588072,0.974231064966196,2,3,extracellular matrix component,CC,LAMA1;LAMA5
3207,GO:0034330,0.21353380630007,0.907396945301543,6,18,cell junction organization,BP,ACTN2;LAMA5;CAMSAP3;SDC4;CLDN1;CLDN3
2416,GO:0030048,0.213786716184092,0.947663459880853,3,6,actin filament-based movement,BP,ACTN2;MYO7A;PDE4B
3206,GO:0034329,0.214385686312517,0.916072806040682,5,14,cell junction assembly,BP,ACTN2;LAMA5;SDC4;CLDN1;CLDN3
1026,GO:0006665,0.214714468625297,0.964409191546538,2,4,sphingolipid metabolic process,BP,HEXB;ITGB8
1027,GO:0006672,0.214714468625297,0.964409191546538,2,4,ceramide metabolic process,BP,HEXB;ITGB8
239,GO:0001972,0.21522002699458,1,1,1,retinoic acid binding,MF,SERPINA5
267,GO:0002080,0.21522002699458,1,1,1,acrosomal membrane,CC,SERPINA5
1231,GO:0007342,0.21522002699458,1,1,1,fusion of sperm to egg plasma membrane,BP,SERPINA5
2654,GO:0031094,0.21522002699458,1,1,1,platelet dense tubular network,CC,SERPINA5
2843,GO:0032190,0.21522002699458,1,1,1,acrosin binding,MF,SERPINA5
3456,GO:0036024,0.21522002699458,1,1,1,protein C inhibitor-TMPRSS7 complex,CC,SERPINA5
3457,GO:0036025,0.21522002699458,1,1,1,protein C inhibitor-TMPRSS11E complex,CC,SERPINA5
3458,GO:0036026,0.21522002699458,1,1,1,protein C inhibitor-PLAT complex,CC,SERPINA5
3459,GO:0036027,0.21522002699458,1,1,1,protein C inhibitor-PLAU complex,CC,SERPINA5
3460,GO:0036028,0.21522002699458,1,1,1,protein C inhibitor-thrombin complex,CC,SERPINA5
3461,GO:0036029,0.21522002699458,1,1,1,protein C inhibitor-KLK3 complex,CC,SERPINA5
3462,GO:0036030,0.21522002699458,1,1,1,protein C inhibitor-plasma kallikrein complex,CC,SERPINA5
4107,GO:0045026,0.21522002699458,1,1,1,plasma membrane fusion,BP,SERPINA5
5506,GO:0061107,0.21522002699458,1,1,1,seminal vesicle development,BP,SERPINA5
6291,GO:0097179,0.21522002699458,1,1,1,protease inhibitor complex,CC,SERPINA5
6292,GO:0097180,0.21522002699458,1,1,1,serine protease inhibitor complex,CC,SERPINA5
6293,GO:0097181,0.21522002699458,1,1,1,protein C inhibitor-coagulation factor V complex,CC,SERPINA5
6294,GO:0097182,0.21522002699458,1,1,1,protein C inhibitor-coagulation factor Xa complex,CC,SERPINA5
6295,GO:0097183,0.21522002699458,1,1,1,protein C inhibitor-coagulation factor XI complex,CC,SERPINA5
3178,GO:0034059,0.216698958541368,1,1,1,response to anoxia,BP,CTGF
3448,GO:0035988,0.216698958541368,1,1,1,chondrocyte proliferation,BP,CTGF
5656,GO:0070278,0.216698958541368,1,1,1,extracellular matrix constituent secretion,BP,CTGF
5669,GO:0070318,0.216698958541368,1,1,1,positive regulation of G0 to G1 transition,BP,CTGF
5770,GO:0071157,0.216828850702084,0.986965592623304,1,2,negative regulation of cell cycle arrest,BP,HMGN5
6437,GO:0099503,0.216863461960179,0.890458206032359,8,30,secretory vesicle,CC,ACTN2;PNP;HEXB;GAS6;SERPINA5;TMEM163;CRISPLD2;PDE4B
4709,GO:0048871,0.217363213879458,0.913179190453272,5,15,multicellular organismal homeostasis,BP,PRKACB;DLL1;CLDN1;PDK4;CTGF
2839,GO:0032153,0.217713205537281,1,1,1,cell division site,CC,RHOB
2840,GO:0032154,0.217713205537281,1,1,1,cleavage furrow,CC,RHOB
2841,GO:0032155,0.217713205537281,1,1,1,cell division site part,CC,RHOB
5661,GO:0070301,0.217713205537281,1,1,1,cellular response to hydrogen peroxide,BP,RHOB
6343,GO:0097610,0.217713205537281,1,1,1,cell surface furrow,CC,RHOB
606,GO:0004421,0.219612328827241,1,1,1,hydroxymethylglutaryl-CoA synthase activity,MF,HMGCS2
1367,GO:0008299,0.219612328827241,1,1,1,isoprenoid biosynthetic process,BP,HMGCS2
4462,GO:0046912,0.219612328827241,1,1,1,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,HMGCS2
255,GO:0002054,0.219900884559044,1,1,1,nucleobase binding,MF,PNP
256,GO:0002060,0.219900884559044,1,1,1,purine nucleobase binding,MF,PNP
653,GO:0004731,0.219900884559044,1,1,1,purine-nucleoside phosphorylase activity,MF,PNP
919,GO:0006148,0.219900884559044,1,1,1,inosine catabolic process,BP,PNP
920,GO:0006152,0.219900884559044,1,1,1,purine nucleoside catabolic process,BP,PNP
1053,GO:0006738,0.219900884559044,1,1,1,nicotinamide riboside catabolic process,BP,PNP
2082,GO:0016763,0.219900884559044,1,1,1,transferase activity, transferring pentosyl groups,MF,PNP
3236,GO:0034418,0.219900884559044,1,1,1,urate biosynthetic process,BP,PNP
3602,GO:0042301,0.219900884559044,1,1,1,phosphate ion binding,MF,PNP
3642,GO:0042454,0.219900884559044,1,1,1,ribonucleoside catabolic process,BP,PNP
3772,GO:0043101,0.219900884559044,1,1,1,purine-containing compound salvage,BP,PNP
4195,GO:0045582,0.219900884559044,1,1,1,positive regulation of T cell differentiation,BP,PNP
4327,GO:0046102,0.219900884559044,1,1,1,inosine metabolic process,BP,PNP
4332,GO:0046130,0.219900884559044,1,1,1,purine ribonucleoside catabolic process,BP,PNP
4357,GO:0046415,0.219900884559044,1,1,1,urate metabolic process,BP,PNP
4380,GO:0046495,0.219900884559044,1,1,1,nicotinamide riboside metabolic process,BP,PNP
4405,GO:0046634,0.219900884559044,1,1,1,regulation of alpha-beta T cell activation,BP,PNP
4406,GO:0046635,0.219900884559044,1,1,1,positive regulation of alpha-beta T cell activation,BP,PNP
4407,GO:0046637,0.219900884559044,1,1,1,regulation of alpha-beta T cell differentiation,BP,PNP
4408,GO:0046638,0.219900884559044,1,1,1,positive regulation of alpha-beta T cell differentiation,BP,PNP
5712,GO:0070637,0.219900884559044,1,1,1,pyridine nucleoside metabolic process,BP,PNP
5713,GO:0070638,0.219900884559044,1,1,1,pyridine nucleoside catabolic process,BP,PNP
5760,GO:0070970,0.219900884559044,1,1,1,interleukin-2 secretion,BP,PNP
6084,GO:0072526,0.219900884559044,1,1,1,pyridine-containing compound catabolic process,BP,PNP
2269,GO:0019887,0.220659090666085,0.962726805178798,2,4,protein kinase regulator activity,MF,CDKN1A;GAS6
6179,GO:0090150,0.221237071910201,0.905191983099256,6,16,establishment of protein localization to membrane,BP,ACTN2;REEP1;PIK3R1;LAMA5;GAS6;ITGA3
859,GO:0005924,0.221395734465739,0.902803861219538,6,18,cell-substrate adherens junction,CC,ACTN2;RHOB;ITGB5;MPZL1;SDC4;ITGA3
860,GO:0005925,0.221395734465739,0.902803861219538,6,18,focal adhesion,CC,ACTN2;RHOB;ITGB5;MPZL1;SDC4;ITGA3
854,GO:0005915,0.222339183921569,1,1,1,zonula adherens,CC,CAMSAP3
2844,GO:0032217,0.222339183921569,1,1,1,riboflavin transporter activity,MF,SLC52A3
2845,GO:0032218,0.222339183921569,1,1,1,riboflavin transport,BP,SLC52A3
3208,GO:0034331,0.222339183921569,1,1,1,cell junction maintenance,BP,CAMSAP3
3246,GO:0034453,0.222339183921569,1,1,1,microtubule anchoring,BP,CAMSAP3
4157,GO:0045217,0.222339183921569,1,1,1,cell-cell junction maintenance,BP,CAMSAP3
4158,GO:0045218,0.222339183921569,1,1,1,zonula adherens maintenance,BP,CAMSAP3
4856,GO:0051011,0.222339183921569,1,1,1,microtubule minus-end binding,MF,CAMSAP3
727,GO:0005245,0.222814534517084,1,1,1,voltage-gated calcium channel activity,MF,GAS6
735,GO:0005262,0.222814534517084,1,1,1,calcium channel activity,MF,GAS6
966,GO:0006465,0.222814534517084,1,1,1,signal peptide processing,BP,GAS6
1858,GO:0015085,0.222814534517084,1,1,1,calcium ion transmembrane transporter activity,MF,GAS6
2184,GO:0019062,0.222814534517084,1,1,1,virion attachment to host cell,BP,GAS6
2185,GO:0019064,0.222814534517084,1,1,1,fusion of virus membrane with host plasma membrane,BP,GAS6
2497,GO:0030296,0.222814534517084,1,1,1,protein tyrosine kinase activator activity,MF,GAS6
2962,GO:0032571,0.222814534517084,1,1,1,response to vitamin K,BP,GAS6
2999,GO:0032689,0.222814534517084,1,1,1,negative regulation of interferon-gamma production,BP,GAS6
3000,GO:0032692,0.222814534517084,1,1,1,negative regulation of interleukin-1 production,BP,GAS6
3003,GO:0032715,0.222814534517084,1,1,1,negative regulation of interleukin-6 production,BP,GAS6
3004,GO:0032720,0.222814534517084,1,1,1,negative regulation of tumor necrosis factor production,BP,GAS6
3035,GO:0032823,0.222814534517084,1,1,1,regulation of natural killer cell differentiation,BP,GAS6
3036,GO:0032825,0.222814534517084,1,1,1,positive regulation of natural killer cell differentiation,BP,GAS6
3115,GO:0033159,0.222814534517084,1,1,1,negative regulation of protein import into nucleus, translocation,BP,GAS6
3393,GO:0035701,0.222814534517084,1,1,1,hematopoietic stem cell migration,BP,GAS6
3399,GO:0035754,0.222814534517084,1,1,1,B cell chemotaxis,BP,GAS6
3534,GO:0039663,0.222814534517084,1,1,1,membrane fusion involved in viral entry into host cell,BP,GAS6
4022,GO:0044406,0.222814534517084,1,1,1,adhesion of symbiont to host,BP,GAS6
4060,GO:0044650,0.222814534517084,1,1,1,adhesion of symbiont to host cell,BP,GAS6
4089,GO:0044800,0.222814534517084,1,1,1,multi-organism membrane fusion,BP,GAS6
4092,GO:0044803,0.222814534517084,1,1,1,multi-organism membrane organization,BP,GAS6
4427,GO:0046813,0.222814534517084,1,1,1,receptor-mediated virion attachment to host cell,BP,GAS6
4432,GO:0046827,0.222814534517084,1,1,1,positive regulation of protein export from nucleus,BP,GAS6
4746,GO:0050710,0.222814534517084,1,1,1,negative regulation of cytokine secretion,BP,GAS6
4747,GO:0050711,0.222814534517084,1,1,1,negative regulation of interleukin-1 secretion,BP,GAS6
5628,GO:0070168,0.222814534517084,1,1,1,negative regulation of biomineral tissue development,BP,GAS6
5794,GO:0071307,0.222814534517084,1,1,1,cellular response to vitamin K,BP,GAS6
6092,GO:0072577,0.222814534517084,1,1,1,endothelial cell apoptotic process,BP,GAS6
6106,GO:0072661,0.222814534517084,1,1,1,protein targeting to plasma membrane,BP,GAS6
6260,GO:0097017,0.222814534517084,1,1,1,renal protein absorption,BP,GAS6
6261,GO:0097018,0.222814534517084,1,1,1,renal albumin absorption,BP,GAS6
6265,GO:0097048,0.222814534517084,1,1,1,dendritic cell apoptotic process,BP,GAS6
6307,GO:0097241,0.222814534517084,1,1,1,hematopoietic stem cell migration to bone marrow,BP,GAS6
6308,GO:0097252,0.222814534517084,1,1,1,oligodendrocyte apoptotic process,BP,GAS6
6480,GO:1900141,0.222814534517084,1,1,1,regulation of oligodendrocyte apoptotic process,BP,GAS6
6481,GO:1900142,0.222814534517084,1,1,1,negative regulation of oligodendrocyte apoptotic process,BP,GAS6
6482,GO:1900165,0.222814534517084,1,1,1,negative regulation of interleukin-6 secretion,BP,GAS6
6824,GO:1903556,0.222814534517084,1,1,1,negative regulation of tumor necrosis factor superfamily cytokine production,BP,GAS6
6884,GO:1904035,0.222814534517084,1,1,1,regulation of epithelial cell apoptotic process,BP,GAS6
6885,GO:1904036,0.222814534517084,1,1,1,negative regulation of epithelial cell apoptotic process,BP,GAS6
7109,GO:2000351,0.222814534517084,1,1,1,regulation of endothelial cell apoptotic process,BP,GAS6
7110,GO:2000352,0.222814534517084,1,1,1,negative regulation of endothelial cell apoptotic process,BP,GAS6
7135,GO:2000508,0.222814534517084,1,1,1,regulation of dendritic cell chemotaxis,BP,GAS6
7136,GO:2000510,0.222814534517084,1,1,1,positive regulation of dendritic cell chemotaxis,BP,GAS6
7137,GO:2000532,0.222814534517084,1,1,1,regulation of renal albumin absorption,BP,GAS6
7138,GO:2000533,0.222814534517084,1,1,1,negative regulation of renal albumin absorption,BP,GAS6
7155,GO:2000668,0.222814534517084,1,1,1,regulation of dendritic cell apoptotic process,BP,GAS6
7156,GO:2000669,0.222814534517084,1,1,1,negative regulation of dendritic cell apoptotic process,BP,GAS6
1786,GO:0014031,0.223836490748061,0.939336439448479,3,7,mesenchymal cell development,BP,NRTN;KITLG;LAMA5
5831,GO:0071398,0.224650787277643,0.961576929030761,2,4,cellular response to fatty acid,BP,CLDN1;PDK4
3757,GO:0043034,0.224876518289413,1,1,1,costamere,CC,SDC4
5608,GO:0070053,0.224876518289413,1,1,1,thrombospondin receptor activity,MF,SDC4
5925,GO:0071971,0.224876518289413,1,1,1,extracellular exosome assembly,BP,SDC4
6817,GO:1903541,0.224876518289413,1,1,1,regulation of exosomal secretion,BP,SDC4
6818,GO:1903543,0.224876518289413,1,1,1,positive regulation of exosomal secretion,BP,SDC4
6821,GO:1903551,0.224876518289413,1,1,1,regulation of extracellular exosome assembly,BP,SDC4
6822,GO:1903553,0.224876518289413,1,1,1,positive regulation of extracellular exosome assembly,BP,SDC4
2675,GO:0031210,0.225154175309246,0.985873770367886,1,2,phosphatidylcholine binding,MF,SERPINA5
4850,GO:0050997,0.225154175309246,0.985873770367886,1,2,quaternary ammonium group binding,MF,SERPINA5
5685,GO:0070405,0.225154175309246,0.985873770367886,1,2,ammonium ion binding,MF,SERPINA5
788,GO:0005640,0.225503183732339,1,1,1,nuclear outer membrane,CC,DHCR7
1558,GO:0009918,0.225503183732339,1,1,1,sterol delta7 reductase activity,MF,DHCR7
1960,GO:0016128,0.225503183732339,1,1,1,phytosteroid metabolic process,BP,DHCR7
1961,GO:0016129,0.225503183732339,1,1,1,phytosteroid biosynthetic process,BP,DHCR7
1962,GO:0016131,0.225503183732339,1,1,1,brassinosteroid metabolic process,BP,DHCR7
1963,GO:0016132,0.225503183732339,1,1,1,brassinosteroid biosynthetic process,BP,DHCR7
4487,GO:0047598,0.225503183732339,1,1,1,7-dehydrocholesterol reductase activity,MF,DHCR7
4078,GO:0044764,0.225550285903303,0.899410061680598,6,19,multi-organism cellular process,BP,PIK3R1;MFGE8;ITGB5;GAS6;TICAM1;CLDN1
659,GO:0004857,0.22574660252982,0.933127135890592,3,9,enzyme inhibitor activity,MF,CDKN1A;GAS6;SERPINA5
301,GO:0002281,0.225987007390583,1,1,1,macrophage activation involved in immune response,BP,TICAM1
2941,GO:0032481,0.225987007390583,1,1,1,positive regulation of type I interferon production,BP,TICAM1
3006,GO:0032728,0.225987007390583,1,1,1,positive regulation of interferon-beta production,BP,TICAM1
3190,GO:0034127,0.225987007390583,1,1,1,regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
3191,GO:0034128,0.225987007390583,1,1,1,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
4175,GO:0045359,0.225987007390583,1,1,1,positive regulation of interferon-beta biosynthetic process,BP,TICAM1
6702,GO:1902612,0.226428324797548,1,1,1,regulation of anti-Mullerian hormone signaling pathway,BP,DKK3
6703,GO:1902613,0.226428324797548,1,1,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,DKK3
7011,GO:1990262,0.226428324797548,1,1,1,anti-Mullerian hormone signaling pathway,BP,DKK3
549,GO:0003729,0.226577026887008,1,1,1,mRNA binding,MF,RBMS3
550,GO:0003730,0.226577026887008,1,1,1,mRNA 3'-UTR binding,MF,RBMS3
3201,GO:0034250,0.226577026887008,1,1,1,positive regulation of cellular amide metabolic process,BP,RBMS3
4243,GO:0045727,0.226577026887008,1,1,1,positive regulation of translation,BP,RBMS3
830,GO:0005815,0.229165684092367,0.919083902917169,4,11,microtubule organizing center,CC,PRKACB;CAMSAP3;PDE4B;MARK4
3390,GO:0035690,0.229295254423076,0.960218546334375,2,4,cellular response to drug,BP,GAS6;PDE4B
1017,GO:0006643,0.229446792004898,0.954788450538656,2,5,membrane lipid metabolic process,BP,HEXB;ITGB8
16,GO:0000097,0.230562580267107,1,1,1,sulfur amino acid biosynthetic process,BP,MRI1
130,GO:0001650,0.230562580267107,1,1,1,fibrillar center,CC,MRI1
1432,GO:0009067,0.230562580267107,1,1,1,aspartate family amino acid biosynthetic process,BP,MRI1
1440,GO:0009086,0.230562580267107,1,1,1,methionine biosynthetic process,BP,MRI1
2109,GO:0016861,0.230562580267107,1,1,1,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,MRI1
2233,GO:0019509,0.230562580267107,1,1,1,L-methionine salvage from methylthioadenosine,BP,MRI1
3773,GO:0043102,0.230562580267107,1,1,1,amino acid salvage,BP,MRI1
4049,GO:0044452,0.230562580267107,1,1,1,nucleolar part,CC,MRI1
4384,GO:0046523,0.230562580267107,1,1,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,MRI1
5784,GO:0071265,0.230562580267107,1,1,1,L-methionine biosynthetic process,BP,MRI1
5785,GO:0071267,0.230562580267107,1,1,1,L-methionine salvage,BP,MRI1
2857,GO:0032266,0.231829368290794,1,1,1,phosphatidylinositol-3-phosphate binding,MF,SNX21
2431,GO:0030101,0.233401341169785,0.958999250497818,2,4,natural killer cell activation,BP,GAS6;TICAM1
1168,GO:0007095,0.234090415347753,1,1,1,mitotic G2 DNA damage checkpoint,BP,FOXO4
2744,GO:0031572,0.234090415347753,1,1,1,G2 DNA damage checkpoint,BP,FOXO4
3430,GO:0035902,0.234090415347753,1,1,1,response to immobilization stress,BP,FOXO4
4093,GO:0044818,0.234090415347753,1,1,1,mitotic G2/M transition checkpoint,BP,FOXO4
5668,GO:0070317,0.234090415347753,1,1,1,negative regulation of G0 to G1 transition,BP,FOXO4
7030,GO:1990785,0.234090415347753,1,1,1,response to water-immersion restraint stress,BP,FOXO4
7032,GO:1990841,0.234090415347753,1,1,1,promoter-specific chromatin binding,MF,FOXO4
2112,GO:0016874,0.234538186240317,0.958658612182546,2,4,ligase activity,MF,ACSF2;ACSL4
1173,GO:0007155,0.234780490810299,0.849777747393736,19,67,cell adhesion,BP,ACTN2;PNP;LAMA1;KITLG;RHOB;PIK3R1;CLDN11;MFGE8;LAMA5;ITGB5;CAMSAP3;ITGB8;SDC4;GAS6;DLL1;CLDN1;ITGA3;CTGF;CLDN3
2368,GO:0022610,0.234780490810299,0.849777747393736,19,67,biological adhesion,BP,ACTN2;PNP;LAMA1;KITLG;RHOB;PIK3R1;CLDN11;MFGE8;LAMA5;ITGB5;CAMSAP3;ITGB8;SDC4;GAS6;DLL1;CLDN1;ITGA3;CTGF;CLDN3
373,GO:0002683,0.234852234953684,0.903398754364865,5,15,negative regulation of immune system process,BP,KITLG;PIK3R1;SDC4;DLL1;TICAM1
164,GO:0001757,0.235409884550959,1,1,1,somite specification,BP,DLL1
311,GO:0002313,0.235409884550959,1,1,1,mature B cell differentiation involved in immune response,BP,DLL1
312,GO:0002315,0.235409884550959,1,1,1,marginal zone B cell differentiation,BP,DLL1
317,GO:0002335,0.235409884550959,1,1,1,mature B cell differentiation,BP,DLL1
1239,GO:0007379,0.235409884550959,1,1,1,segment specification,BP,DLL1
2303,GO:0021679,0.235409884550959,1,1,1,cerebellar molecular layer development,BP,DLL1
2304,GO:0021680,0.235409884550959,1,1,1,cerebellar Purkinje cell layer development,BP,DLL1
2308,GO:0021687,0.235409884550959,1,1,1,cerebellar molecular layer morphogenesis,BP,DLL1
2309,GO:0021688,0.235409884550959,1,1,1,cerebellar molecular layer formation,BP,DLL1
2310,GO:0021692,0.235409884550959,1,1,1,cerebellar Purkinje cell layer morphogenesis,BP,DLL1
2311,GO:0021693,0.235409884550959,1,1,1,cerebellar Purkinje cell layer structural organization,BP,DLL1
2315,GO:0021698,0.235409884550959,1,1,1,cerebellar cortex structural organization,BP,DLL1
2631,GO:0030957,0.235409884550959,1,1,1,Tat protein binding,MF,DLL1
3001,GO:0032693,0.235409884550959,1,1,1,negative regulation of interleukin-10 production,BP,DLL1
3518,GO:0038084,0.235409884550959,1,1,1,vascular endothelial growth factor signaling pathway,BP,DLL1
4140,GO:0045168,0.235409884550959,1,1,1,cell-cell signaling involved in cell fate commitment,BP,DLL1
4347,GO:0046331,0.235409884550959,1,1,1,lateral inhibition,BP,DLL1
4593,GO:0048532,0.235409884550959,1,1,1,anatomical structure arrangement,BP,DLL1
4642,GO:0048665,0.235409884550959,1,1,1,neuron fate specification,BP,DLL1
5439,GO:0060844,0.235409884550959,1,1,1,arterial endothelial cell fate commitment,BP,DLL1
5440,GO:0060846,0.235409884550959,1,1,1,blood vessel endothelial cell fate commitment,BP,DLL1
5441,GO:0060847,0.235409884550959,1,1,1,endothelial cell fate specification,BP,DLL1
5442,GO:0060853,0.235409884550959,1,1,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,DLL1
6277,GO:0097101,0.235409884550959,1,1,1,blood vessel endothelial cell fate specification,BP,DLL1
6278,GO:0097102,0.235409884550959,1,1,1,endothelial tip cell fate specification,BP,DLL1
6512,GO:1900746,0.235409884550959,1,1,1,regulation of vascular endothelial growth factor signaling pathway,BP,DLL1
6690,GO:1902547,0.235409884550959,1,1,1,regulation of cellular response to vascular endothelial growth factor stimulus,BP,DLL1
7134,GO:2000505,0.235409884550959,1,1,1,regulation of energy homeostasis,BP,DLL1
179,GO:0001819,0.235938026566244,0.928491551313034,3,9,positive regulation of cytokine production,BP,PIK3R1;TICAM1;PDE4B
4021,GO:0044403,0.236007117200213,0.893102910810255,6,19,symbiosis, encompassing mutualism through parasitism,BP,PIK3R1;MFGE8;ITGB5;GAS6;TICAM1;CLDN1
4024,GO:0044419,0.236007117200213,0.893102910810255,6,19,interspecies interaction between organisms,BP,PIK3R1;MFGE8;ITGB5;GAS6;TICAM1;CLDN1
3723,GO:0042771,0.236360957825007,0.98432458305545,1,2,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CDKN1A
3271,GO:0034684,0.237308567354809,1,1,1,integrin alphav-beta5 complex,CC,ITGB5
1060,GO:0006766,0.237434540974788,0.930247376064691,3,8,vitamin metabolic process,BP,SLC52A3;CYP11A1;AOX1
4360,GO:0046434,0.237601075529285,0.948557596024321,2,6,organophosphate catabolic process,BP,PNP;PDE4B
1131,GO:0006970,0.238415667948276,1,1,1,response to osmotic stress,BP,CLDN1
1132,GO:0006972,0.238415667948276,1,1,1,hyperosmotic response,BP,CLDN1
1312,GO:0008065,0.238415667948276,1,1,1,establishment of blood-nerve barrier,BP,CLDN1
1521,GO:0009651,0.238415667948276,1,1,1,response to salt stress,BP,CLDN1
3144,GO:0033561,0.238415667948276,1,1,1,regulation of water loss via skin,BP,CLDN1
3671,GO:0042538,0.238415667948276,1,1,1,hyperosmotic salinity response,BP,CLDN1
5567,GO:0061436,0.238415667948276,1,1,1,establishment of skin barrier,BP,CLDN1
5597,GO:0061772,0.238415667948276,1,1,1,drug transport across blood-nerve barrier,BP,CLDN1
5789,GO:0071284,0.238415667948276,1,1,1,cellular response to lead ion,BP,CLDN1
6245,GO:0090557,0.238415667948276,1,1,1,establishment of endothelial intestinal barrier,BP,CLDN1
6788,GO:1903348,0.238415667948276,1,1,1,positive regulation of bicellular tight junction assembly,BP,CLDN1
6819,GO:1903544,0.238415667948276,1,1,1,response to butyrate,BP,CLDN1
6820,GO:1903545,0.238415667948276,1,1,1,cellular response to butyrate,BP,CLDN1
7176,GO:2000810,0.238415667948276,1,1,1,regulation of bicellular tight junction assembly,BP,CLDN1
1006,GO:0006611,0.239045546721469,0.983939735101924,1,2,protein export from nucleus,BP,GAS6
4431,GO:0046825,0.239045546721469,0.983939735101924,1,2,regulation of protein export from nucleus,BP,GAS6
4903,GO:0051168,0.239045546721469,0.983939735101924,1,2,nuclear export,BP,GAS6
1222,GO:0007272,0.241174381170082,0.928560545103224,3,8,ensheathment of neurons,BP,HEXB;CLDN11;DHH
1377,GO:0008366,0.241174381170082,0.928560545103224,3,8,axon ensheathment,BP,HEXB;CLDN11;DHH
2799,GO:0031965,0.241679497111925,0.983556928458881,1,2,nuclear membrane,CC,DHCR7
849,GO:0005903,0.242253871290753,1,1,1,brush border,CC,ESPN
2415,GO:0030046,0.242253871290753,1,1,1,parallel actin filament bundle assembly,BP,ESPN
2788,GO:0031941,0.242253871290753,1,1,1,filamentous actin,CC,ESPN
2926,GO:0032426,0.242253871290753,1,1,1,stereocilium tip,CC,ESPN
357,GO:0002576,0.242986758894541,0.956085514161995,2,4,platelet degranulation,BP,ACTN2;GAS6
331,GO:0002429,0.24320430888678,0.927638151728844,3,8,immune response-activating cell surface receptor signaling pathway,BP,PIK3R1;PRKACB;PDE4B
408,GO:0002768,0.24320430888678,0.927638151728844,3,8,immune response-regulating cell surface receptor signaling pathway,BP,PIK3R1;PRKACB;PDE4B
5609,GO:0070059,0.243513273920444,0.98328734926535,1,2,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,CASP4
1484,GO:0009267,0.243867778759316,0.911494336135101,4,11,cellular response to starvation,BP,CDKN1A;NUAK2;GAS6;PDK4
1133,GO:0006974,0.244038017567364,0.922783658158287,3,10,cellular response to DNA damage stimulus,BP,CDKN1A;PIK3R1;FOXO4
1575,GO:0009991,0.244798350328109,0.88873665989868,6,18,response to extracellular stimulus,BP,CDKN1A;NUAK2;GAS6;ACSL4;FOXO4;PDK4
2763,GO:0031667,0.244798350328109,0.88873665989868,6,18,response to nutrient levels,BP,CDKN1A;NUAK2;GAS6;ACSL4;FOXO4;PDK4
2107,GO:0016853,0.245466233731977,0.945662102015646,2,6,isomerase activity,MF,MRI1;HSD3B2
752,GO:0005501,0.245634429395214,0.982972369693323,1,2,retinoid binding,MF,SERPINA5
2257,GO:0019840,0.245634429395214,0.982972369693323,1,2,isoprenoid binding,MF,SERPINA5
1992,GO:0016327,0.24608702739992,0.9829047222696,1,2,apicolateral plasma membrane,CC,CLDN3
6586,GO:1901653,0.247116628066872,0.88731127488112,6,18,cellular response to peptide,BP,ACTN2;PIK3R1;PRKACB;CASP4;FOXO4;PDK4
654,GO:0004740,0.247902014406265,1,1,1,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,PDK4
894,GO:0006086,0.247902014406265,1,1,1,acetyl-CoA biosynthetic process from pyruvate,BP,PDK4
1617,GO:0010510,0.247902014406265,1,1,1,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,PDK4
3721,GO:0042762,0.247902014406265,1,1,1,regulation of sulfur metabolic process,BP,PDK4
4791,GO:0050812,0.247902014406265,1,1,1,regulation of acyl-CoA biosynthetic process,BP,PDK4
6305,GO:0097205,0.249274038497926,0.954122886767764,2,4,renal filtration,BP,GAS6;ITGA3
1148,GO:0007029,0.250015177406129,1,1,1,endoplasmic reticulum organization,BP,REEP1
2781,GO:0031849,0.250015177406129,1,1,1,olfactory receptor binding,MF,REEP1
5890,GO:0071782,0.250015177406129,1,1,1,endoplasmic reticulum tubular network,CC,REEP1
5891,GO:0071786,0.250015177406129,1,1,1,endoplasmic reticulum tubular network organization,BP,REEP1
6411,GO:0098827,0.250015177406129,1,1,1,endoplasmic reticulum subcompartment,CC,REEP1
2224,GO:0019377,0.250196126157647,0.982283458162323,1,2,glycolipid catabolic process,BP,HEXB
2440,GO:0030149,0.250196126157647,0.982283458162323,1,2,sphingolipid catabolic process,BP,HEXB
4368,GO:0046466,0.250196126157647,0.982283458162323,1,2,membrane lipid catabolic process,BP,HEXB
4374,GO:0046479,0.250196126157647,0.982283458162323,1,2,glycosphingolipid catabolic process,BP,HEXB
4383,GO:0046514,0.250196126157647,0.982283458162323,1,2,ceramide catabolic process,BP,HEXB
1566,GO:0009954,0.25043656880539,0.982246707729738,1,2,proximal/distal pattern formation,BP,DLL1
1942,GO:0016043,0.250478827481074,0.825146398656753,35,147,cellular component organization,BP,ACTN2;LAMA1;NRTN;MYO7A;CDKN1A;NUAK2;RHOJ;REEP1;PIK3R1;PRND;PLEKHH2;HEXB;MFGE8;LAMA5;ITGB5;CAMSAP3;ITGB8;SDC4;GAS6;SERPINA5;DLL1;FHOD3;RIN3;HMGN5;CRISPLD2;SEMA6C;RAB39B;CLDN1;ACSL4;ITGA3;CTGF;CLDN3;ESPN;DAAM2;MARK4
2456,GO:0030183,0.250784075683264,0.953645421705284,2,4,B cell differentiation,BP,PIK3R1;DLL1
6099,GO:0072604,0.250846837586437,0.98218389847928,1,2,interleukin-6 secretion,BP,GAS6
2485,GO:0030260,0.252677962169622,0.926913139603694,3,7,entry into host cell,BP,ITGB5;GAS6;CLDN1
4023,GO:0044409,0.252677962169622,0.926913139603694,3,7,entry into host,BP,ITGB5;GAS6;CLDN1
5059,GO:0051701,0.252677962169622,0.926913139603694,3,7,interaction with host,BP,ITGB5;GAS6;CLDN1
5075,GO:0051806,0.252677962169622,0.926913139603694,3,7,entry into cell of other organism involved in symbiotic interaction,BP,ITGB5;GAS6;CLDN1
5076,GO:0051828,0.252677962169622,0.926913139603694,3,7,entry into other organism involved in symbiotic interaction,BP,ITGB5;GAS6;CLDN1
2352,GO:0022402,0.252849499788639,0.866506008632881,8,30,cell cycle process,BP,CDKN1A;RHOB;PHLDA1;GAS6;HMGN5;FOXO4;CTGF;MARK4
2138,GO:0017112,0.253427136941665,1,1,1,Rab guanyl-nucleotide exchange factor activity,MF,RIN3
4037,GO:0044437,0.253976296127321,0.917945315161618,3,10,vacuolar part,CC,MYO7A;HEXB;SDC4
1269,GO:0007569,0.254801369903028,0.981571887717487,1,2,cell aging,BP,CDKN1A
1599,GO:0010332,0.254801369903028,0.981571887717487,1,2,response to gamma radiation,BP,CDKN1A
5847,GO:0071480,0.254801369903028,0.981571887717487,1,2,cellular response to gamma radiation,BP,CDKN1A
6232,GO:0090398,0.254801369903028,0.981571887717487,1,2,cellular senescence,BP,CDKN1A
553,GO:0003774,0.254881004431216,0.964660946078162,2,3,motor activity,MF,MYO7A;CGN
2021,GO:0016459,0.254881004431216,0.964660946078162,2,3,myosin complex,CC,MYO7A;CGN
2080,GO:0016757,0.254935179147306,0.942079686813084,2,6,transferase activity, transferring glycosyl groups,MF,PNP;HEXB
1159,GO:0007049,0.255078430305305,0.859388975542229,9,35,cell cycle,BP,CDKN1A;RHOB;PHLDA1;PRKACB;GAS6;HMGN5;FOXO4;CTGF;MARK4
5860,GO:0071559,0.255607074914462,0.891351546095282,5,15,response to transforming growth factor beta,BP,DKK3;ITGB5;CLDN1;ITGA3;CGN
5861,GO:0071560,0.255607074914462,0.891351546095282,5,15,cellular response to transforming growth factor beta stimulus,BP,DKK3;ITGB5;CLDN1;ITGA3;CGN
5113,GO:0052548,0.255829295026911,0.91409368055376,3,12,regulation of endopeptidase activity,BP,GAS6;SERPINA5;CTGF
852,GO:0005912,0.256494639588634,0.866935784060729,8,25,adherens junction,CC,ACTN2;RHOB;ITGB5;CAMSAP3;MPZL1;SDC4;DLL1;ITGA3
6587,GO:1901654,0.257685504914361,0.920918995468382,3,8,response to ketone,BP,CDKN1A;GAS6;CLDN1
6596,GO:1901681,0.257746387832532,0.916079144130815,3,10,sulfur compound binding,MF,SERPINA5;CRISPLD2;CTGF
980,GO:0006501,0.258153345974221,1,1,1,C-terminal protein lipidation,BP,PRND
2175,GO:0018410,0.258153345974221,1,1,1,C-terminal protein amino acid modification,BP,PRND
3940,GO:0043687,0.258153345974221,1,1,1,post-translational protein modification,BP,PRND
2388,GO:0022898,0.258485990448695,0.944681073411743,2,5,regulation of transmembrane transporter activity,BP,ACTN2;PDE4B
2917,GO:0032409,0.258485990448695,0.944681073411743,2,5,regulation of transporter activity,BP,ACTN2;PDE4B
2920,GO:0032412,0.258485990448695,0.944681073411743,2,5,regulation of ion transmembrane transporter activity,BP,ACTN2;PDE4B
4857,GO:0051015,0.258708866672626,0.924195762455623,3,7,actin filament binding,MF,ACTN2;MYO7A;ESPN
4155,GO:0045214,0.260298187764378,0.950582591705545,2,4,sarcomere organization,BP,ACTN2;FHOD3
6263,GO:0097028,0.260330036706271,0.980696078800311,1,2,dendritic cell differentiation,BP,GAS6
3887,GO:0043496,0.260904567013443,0.980603707064451,1,2,regulation of protein homodimerization activity,BP,TICAM1
4035,GO:0044432,0.261398352332555,0.853913172904221,9,38,endoplasmic reticulum part,CC,REEP1;PIK3R1;HSD17B3;GAS6;HSD3B2;CASP4;DHCR7;ACSL4;GPSM1
2976,GO:0032613,0.262996546671356,0.980265188899836,1,2,interleukin-10 production,BP,DLL1
2990,GO:0032653,0.262996546671356,0.980265188899836,1,2,regulation of interleukin-10 production,BP,DLL1
6146,GO:0090002,0.264467344404579,0.889601369154817,5,13,establishment of protein localization to plasma membrane,BP,ACTN2;PIK3R1;LAMA5;GAS6;ITGA3
5181,GO:0060042,0.265056170931555,0.979928562783641,1,2,retina morphogenesis in camera-type eye,BP,DLL1
5758,GO:0070925,0.265138406734337,0.877326898585527,6,17,organelle assembly,BP,ACTN2;MYO7A;LAMA5;SDC4;FHOD3;MARK4
1553,GO:0009897,0.266316795485333,0.916798187556058,3,8,external side of plasma membrane,CC,MFGE8;SERPINA5;ITGA3
6161,GO:0090068,0.266674064923067,0.913769270483412,3,9,positive regulation of cell cycle process,BP,CDKN1A;FOXO4;CTGF
1601,GO:0010389,0.26712083394366,0.979587769120187,1,2,regulation of G2/M transition of mitotic cell cycle,BP,FOXO4
1766,GO:0010972,0.26712083394366,0.979587769120187,1,2,negative regulation of G2/M transition of mitotic cell cycle,BP,FOXO4
6718,GO:1902749,0.26712083394366,0.979587769120187,1,2,regulation of cell cycle G2/M phase transition,BP,FOXO4
6719,GO:1902750,0.26712083394366,0.979587769120187,1,2,negative regulation of cell cycle G2/M phase transition,BP,FOXO4
1520,GO:0009636,0.267190365957829,0.913512458938853,3,9,response to toxic substance,BP,CDKN1A;PON2;CLDN1
6297,GO:0097190,0.267516749378324,0.877670503484233,5,22,apoptotic signaling pathway,BP,CDKN1A;KITLG;PIK3R1;TICAM1;CASP4
6579,GO:1901617,0.267745609527524,0.894824494706971,4,13,organic hydroxy compound biosynthetic process,BP,HMGCS2;DKK3;HSD17B3;DHCR7
293,GO:0002253,0.268348550263584,0.894481264316945,4,13,activation of immune response,BP,PIK3R1;PRKACB;TICAM1;PDE4B
574,GO:0004112,0.269024188878982,1,1,1,cyclic-nucleotide phosphodiesterase activity,MF,PDE4B
575,GO:0004114,0.269024188878982,1,1,1,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE4B
576,GO:0004115,0.269024188878982,1,1,1,3',5'-cyclic-AMP phosphodiesterase activity,MF,PDE4B
927,GO:0006198,0.269024188878982,1,1,1,cAMP catabolic process,BP,PDE4B
1472,GO:0009214,0.269024188878982,1,1,1,cyclic nucleotide catabolic process,BP,PDE4B
2991,GO:0032663,0.269024188878982,1,1,1,regulation of interleukin-2 production,BP,PDE4B
3012,GO:0032743,0.269024188878982,1,1,1,positive regulation of interleukin-2 production,BP,PDE4B
6529,GO:1901078,0.269024188878982,1,1,1,negative regulation of relaxation of muscle,BP,PDE4B
6559,GO:1901385,0.269024188878982,1,1,1,regulation of voltage-gated calcium channel activity,BP,PDE4B
6609,GO:1901841,0.269024188878982,1,1,1,regulation of high voltage-gated calcium channel activity,BP,PDE4B
6621,GO:1901898,0.269024188878982,1,1,1,negative regulation of relaxation of cardiac muscle,BP,PDE4B
6979,GO:1905477,0.269699353560825,0.947463176851024,2,4,positive regulation of protein localization to membrane,BP,PIK3R1;ITGA3
345,GO:0002479,0.270202651380703,0.97907282413907,1,2,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,ITGB5
5772,GO:0071214,0.270842784393707,0.911686745860941,3,9,cellular response to abiotic stimulus,BP,CDKN1A;RHOB;PIK3R1
372,GO:0002682,0.271401827489159,0.843171669977493,10,39,regulation of immune system process,BP,PNP;CDKN1A;KITLG;PIK3R1;PRKACB;SDC4;GAS6;DLL1;TICAM1;PDE4B
2049,GO:0016604,0.271542787180319,0.91133504310908,3,9,nuclear body,CC,CDKN1A;FOXO4;AOX1
1108,GO:0006909,0.271776802646369,0.894264044474106,4,12,phagocytosis,BP,MYO7A;PIK3R1;MFGE8;GAS6
3136,GO:0033489,0.271805798796844,0.978801973996625,1,2,cholesterol biosynthetic process via desmosterol,BP,DHCR7
3137,GO:0033490,0.271805798796844,0.978801973996625,1,2,cholesterol biosynthetic process via lathosterol,BP,DHCR7
798,GO:0005743,0.272433364709546,0.890698061801239,4,14,mitochondrial inner membrane,CC,HMGCS2;SLC25A53;HSD3B2;PDK4
1008,GO:0006629,0.273333355227055,0.82256328051152,16,73,lipid metabolic process,BP,ACSF2;HMGCS2;DKK3;KITLG;PIK3R1;HEXB;HSD17B3;ITGB8;CYP11A1;SDC4;HSD3B2;DHCR7;PON2;ACSL4;DHH;PDK4
5902,GO:0071840,0.273520173748459,0.806273650601376,35,148,cellular component organization or biogenesis,BP,ACTN2;LAMA1;NRTN;MYO7A;CDKN1A;NUAK2;RHOJ;REEP1;PIK3R1;PRND;PLEKHH2;HEXB;MFGE8;LAMA5;ITGB5;CAMSAP3;ITGB8;SDC4;GAS6;SERPINA5;DLL1;FHOD3;RIN3;HMGN5;CRISPLD2;SEMA6C;RAB39B;CLDN1;ACSL4;ITGA3;CTGF;CLDN3;ESPN;DAAM2;MARK4
1135,GO:0006977,0.274367923922092,0.978364852587423,1,2,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,CDKN1A
2743,GO:0031571,0.274367923922092,0.978364852587423,1,2,mitotic G1 DNA damage checkpoint,BP,CDKN1A
4087,GO:0044783,0.274367923922092,0.978364852587423,1,2,G1 DNA damage checkpoint,BP,CDKN1A
4094,GO:0044819,0.274367923922092,0.978364852587423,1,2,mitotic G1/S transition checkpoint,BP,CDKN1A
5904,GO:0071850,0.274367923922092,0.978364852587423,1,2,mitotic cell cycle arrest,BP,CDKN1A
6066,GO:0072395,0.274367923922092,0.978364852587423,1,2,signal transduction involved in cell cycle checkpoint,BP,CDKN1A
6067,GO:0072401,0.274367923922092,0.978364852587423,1,2,signal transduction involved in DNA integrity checkpoint,BP,CDKN1A
6068,GO:0072413,0.274367923922092,0.978364852587423,1,2,signal transduction involved in mitotic cell cycle checkpoint,BP,CDKN1A
6069,GO:0072422,0.274367923922092,0.978364852587423,1,2,signal transduction involved in DNA damage checkpoint,BP,CDKN1A
6070,GO:0072431,0.274367923922092,0.978364852587423,1,2,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,CDKN1A
6676,GO:1902400,0.274367923922092,0.978364852587423,1,2,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,CDKN1A
6677,GO:1902402,0.274367923922092,0.978364852587423,1,2,signal transduction involved in mitotic DNA damage checkpoint,BP,CDKN1A
6678,GO:1902403,0.274367923922092,0.978364852587423,1,2,signal transduction involved in mitotic DNA integrity checkpoint,BP,CDKN1A
6721,GO:1902807,0.274367923922092,0.978364852587423,1,2,negative regulation of cell cycle G1/S phase transition,BP,CDKN1A
7074,GO:2000134,0.274367923922092,0.978364852587423,1,2,negative regulation of G1/S transition of mitotic cell cycle,BP,CDKN1A
4054,GO:0044463,0.275465396829414,0.861400214930568,7,21,cell projection part,CC,ACTN2;MYO7A;PRKACB;PDE4B;ITGA3;ESPN;MARK4
1041,GO:0006704,0.275541690657971,0.938300153736941,2,5,glucocorticoid biosynthetic process,BP,DKK3;HSD3B2
4043,GO:0044445,0.275601469120152,0.933892629356171,2,6,cytosolic part,CC,TICAM1;CASP4
1295,GO:0007626,0.27617400514587,0.938057204589672,2,5,locomotory behavior,BP,HEXB;ESPN
4335,GO:0046165,0.276236871107681,0.938033025043177,2,5,alcohol biosynthetic process,BP,HMGCS2;DHCR7
640,GO:0004690,0.276458699131799,1,1,1,cyclic nucleotide-dependent protein kinase activity,MF,PRKACB
641,GO:0004691,0.276458699131799,1,1,1,cAMP-dependent protein kinase activity,MF,PRKACB
4288,GO:0045879,0.276458699131799,1,1,1,negative regulation of smoothened signaling pathway,BP,PRKACB
5432,GO:0060831,0.276458699131799,1,1,1,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
6317,GO:0097338,0.276458699131799,1,1,1,response to clozapine,BP,PRKACB
6581,GO:1901620,0.276458699131799,1,1,1,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
6582,GO:1901621,0.276458699131799,1,1,1,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
3365,GO:0035578,0.277268581084349,0.971016080370009,1,3,azurophil granule lumen,CC,HEXB
1608,GO:0010466,0.277573239289517,0.933084950659301,2,6,negative regulation of peptidase activity,BP,GAS6;SERPINA5
1761,GO:0010951,0.277573239289517,0.933084950659301,2,6,negative regulation of endopeptidase activity,BP,GAS6;SERPINA5
4286,GO:0045861,0.277573239289517,0.933084950659301,2,6,negative regulation of proteolysis,BP,GAS6;SERPINA5
4821,GO:0050885,0.2779318814188,0.944655064008659,2,4,neuromuscular process controlling balance,BP,MYO7A;HEXB
4705,GO:0048863,0.278142218103853,0.890639280442991,4,12,stem cell differentiation,BP,NRTN;KITLG;LAMA5;FOXO4
1719,GO:0010861,0.278422679482722,1,1,1,thyroid hormone receptor activator activity,MF,ACTN2
2410,GO:0030035,0.278422679482722,1,1,1,microspike assembly,BP,ACTN2
2517,GO:0030375,0.278422679482722,1,1,1,thyroid hormone receptor coactivator activity,MF,ACTN2
2600,GO:0030836,0.278422679482722,1,1,1,positive regulation of actin filament depolymerization,BP,ACTN2
2729,GO:0031432,0.278422679482722,1,1,1,titin binding,MF,ACTN2
3526,GO:0038166,0.278422679482722,1,1,1,angiotensin-activated signaling pathway,BP,ACTN2
3820,GO:0043243,0.278422679482722,1,1,1,positive regulation of protein complex disassembly,BP,ACTN2
4990,GO:0051373,0.278422679482722,1,1,1,FATZ binding,MF,ACTN2
5058,GO:0051695,0.278422679482722,1,1,1,actin filament uncapping,BP,ACTN2
5613,GO:0070080,0.278422679482722,1,1,1,titin Z domain binding,MF,ACTN2
6142,GO:0086097,0.278422679482722,1,1,1,phospholipase C-activating angiotensin-activated signaling pathway,BP,ACTN2
6517,GO:1901018,0.278422679482722,1,1,1,positive regulation of potassium ion transmembrane transporter activity,BP,ACTN2
6615,GO:1901881,0.278422679482722,1,1,1,positive regulation of protein depolymerization,BP,ACTN2
6897,GO:1904385,0.278422679482722,1,1,1,cellular response to angiotensin,BP,ACTN2
7026,GO:1990776,0.278422679482722,1,1,1,response to angiotensin,BP,ACTN2
7043,GO:2000008,0.278422679482722,1,1,1,regulation of protein localization to cell surface,BP,ACTN2
7044,GO:2000009,0.278422679482722,1,1,1,negative regulation of protein localization to cell surface,BP,ACTN2
7208,GO:2001135,0.278422679482722,1,1,1,regulation of endocytic recycling,BP,ACTN2
7209,GO:2001137,0.278422679482722,1,1,1,positive regulation of endocytic recycling,BP,ACTN2
7233,GO:2001259,0.278422679482722,1,1,1,positive regulation of cation channel activity,BP,ACTN2
4257,GO:0045766,0.279294532869605,0.944183337454204,2,4,positive regulation of angiogenesis,BP,RHOB;DLL1
1702,GO:0010811,0.279513908491693,0.944107208954314,2,4,positive regulation of cell-substrate adhesion,BP,SDC4;ITGA3
759,GO:0005516,0.279766360519419,0.944019538830876,2,4,calmodulin binding,MF,MYO7A;CAMSAP3
1013,GO:0006637,0.27990293596066,0.910136076697635,3,8,acyl-CoA metabolic process,BP,ACSF2;ACSL4;PDK4
3351,GO:0035383,0.27990293596066,0.910136076697635,3,8,thioester metabolic process,BP,ACSF2;ACSL4;PDK4
2263,GO:0019866,0.2818500340236,0.883912217225323,4,15,organelle inner membrane,CC,HMGCS2;SLC25A53;HSD3B2;PDK4
2419,GO:0030055,0.282207043868826,0.863848034620769,6,19,cell-substrate junction,CC,ACTN2;RHOB;ITGB5;MPZL1;SDC4;ITGA3
1065,GO:0006790,0.283762755886488,0.871532521272968,5,17,sulfur compound metabolic process,BP,ACSF2;MRI1;HEXB;ACSL4;PDK4
1922,GO:0015893,0.283958179655187,0.976681775360748,1,2,drug transport,BP,CLDN1
403,GO:0002758,0.285379292645928,0.929841741466702,2,6,innate immune response-activating signal transduction,BP,PRKACB;TICAM1
2302,GO:0021675,0.287054109311792,0.976122470216684,1,2,nerve development,BP,NRTN
4806,GO:0050863,0.287779039570087,0.903015136268699,3,9,regulation of T cell activation,BP,PNP;PIK3R1;SDC4
6752,GO:1903037,0.287779039570087,0.903015136268699,3,9,regulation of leukocyte cell-cell adhesion,BP,PNP;PIK3R1;SDC4
1407,GO:0008610,0.288203645459807,0.829230541421135,10,44,lipid biosynthetic process,BP,HMGCS2;DKK3;PIK3R1;HEXB;HSD17B3;CYP11A1;HSD3B2;DHCR7;DHH;PDK4
4027,GO:0044422,0.288721659090607,0.793180493246222,40,185,organelle part,CC,ACTN2;PNP;ACSF2;MYO7A;CDKN1A;HMGCS2;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PLEKHH2;HEXB;MRO;PRKACB;CAMSAP3;HSD17B3;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;FHOD3;TICAM1;TMEM163;HMGN5;CRISPLD2;CASP4;DHCR7;PDE4B;ACSL4;FOXO4;PDK4;AOX1;ESPN;CGN;GPSM1;MARK4
2430,GO:0030100,0.288819462172149,0.898151847918558,3,11,regulation of endocytosis,BP,MFGE8;GAS6;DLL1
259,GO:0002064,0.289755692635259,0.869001609152627,5,16,epithelial cell development,BP,MYO7A;CDKN1A;DLL1;CLDN1;CLDN3
755,GO:0005507,0.289848663252004,0.975610842582927,1,2,copper ion binding,MF,PRND
6301,GO:0097194,0.290066890946359,0.975570617888793,1,2,execution phase of apoptosis,BP,CASP4
2407,GO:0030030,0.290305790716586,0.822904197205363,12,42,cell projection organization,BP,ACTN2;NRTN;MYO7A;PIK3R1;LAMA5;CAMSAP3;SDC4;SEMA6C;ACSL4;ITGA3;ESPN;MARK4
4301,GO:0045930,0.290450688449854,0.924489933617044,2,7,negative regulation of mitotic cell cycle,BP,CDKN1A;FOXO4
1403,GO:0008589,0.290699733815974,0.975453746492142,1,2,regulation of smoothened signaling pathway,BP,PRKACB
2842,GO:0032182,0.290916133084662,1,1,1,ubiquitin-like protein binding,MF,MARK4
3781,GO:0043130,0.290916133084662,1,1,1,ubiquitin binding,MF,MARK4
4716,GO:0050321,0.290916133084662,1,1,1,tau-protein kinase activity,MF,MARK4
6349,GO:0097711,0.290916133084662,1,1,1,ciliary basal body docking,BP,MARK4
235,GO:0001960,0.291049172869766,0.975389070965756,1,2,negative regulation of cytokine-mediated signaling pathway,BP,GAS6
1700,GO:0010804,0.291049172869766,0.975389070965756,1,2,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
3752,GO:0043027,0.291049172869766,0.975389070965756,1,2,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,GAS6
5421,GO:0060761,0.291049172869766,0.975389070965756,1,2,negative regulation of response to cytokine stimulus,BP,GAS6
1304,GO:0008021,0.29151567193647,0.927240844165131,2,6,synaptic vesicle,CC,TMEM163;PDE4B
570,GO:0004031,0.291877485278859,1,1,1,aldehyde oxidase activity,MF,AOX1
658,GO:0004854,0.291877485278859,1,1,1,xanthine dehydrogenase activity,MF,AOX1
917,GO:0006144,0.291877485278859,1,1,1,purine nucleobase metabolic process,BP,AOX1
918,GO:0006145,0.291877485278859,1,1,1,purine nucleobase catabolic process,BP,AOX1
1446,GO:0009112,0.291877485278859,1,1,1,nucleobase metabolic process,BP,AOX1
1447,GO:0009115,0.291877485278859,1,1,1,xanthine catabolic process,BP,AOX1
2055,GO:0016623,0.291877485278859,1,1,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,AOX1
2074,GO:0016725,0.291877485278859,1,1,1,oxidoreductase activity, acting on CH or CH2 groups,MF,AOX1
2075,GO:0016726,0.291877485278859,1,1,1,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,AOX1
2118,GO:0016903,0.291877485278859,1,1,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,AOX1
3729,GO:0042816,0.291877485278859,1,1,1,vitamin B6 metabolic process,BP,AOX1
3905,GO:0043546,0.291877485278859,1,1,1,molybdopterin cofactor binding,MF,AOX1
4328,GO:0046110,0.291877485278859,1,1,1,xanthine metabolic process,BP,AOX1
4329,GO:0046113,0.291877485278859,1,1,1,nucleobase catabolic process,BP,AOX1
5021,GO:0051537,0.291877485278859,1,1,1,2 iron, 2 sulfur cluster binding,MF,AOX1
5045,GO:0051639,0.291908395896754,1,1,1,actin filament network formation,BP,FHOD3
5123,GO:0055003,0.291908395896754,1,1,1,cardiac myofibril assembly,BP,FHOD3
2408,GO:0030031,0.291979876992772,0.884940426123154,4,11,cell projection assembly,BP,ACTN2;LAMA5;ESPN;MARK4
3786,GO:0043168,0.292042109217124,0.800332302033101,21,87,anion binding,MF,ACTN2;PNP;ACSF2;MYO7A;NUAK2;RHOJ;RHOB;SNX21;MFGE8;PRKACB;GAS6;SERPINA5;CRISPLD2;ACCS;RAB39B;PDE4B;ACSL4;PDK4;AOX1;CTGF;MARK4
3270,GO:0034667,0.29232507508724,1,1,1,integrin alpha3-beta1 complex,CC,ITGA3
3297,GO:0035023,0.29232507508724,1,1,1,regulation of Rho protein signal transduction,BP,ITGA3
3298,GO:0035024,0.29232507508724,1,1,1,negative regulation of Rho protein signal transduction,BP,ITGA3
3383,GO:0035640,0.29232507508724,1,1,1,exploration behavior,BP,ITGA3
3817,GO:0043236,0.29232507508724,1,1,1,laminin binding,MF,ITGA3
4396,GO:0046580,0.29232507508724,1,1,1,negative regulation of Ras protein signal transduction,BP,ITGA3
4800,GO:0050840,0.29232507508724,1,1,1,extracellular matrix binding,MF,ITGA3
4877,GO:0051058,0.29232507508724,1,1,1,negative regulation of small GTPase mediated signal transduction,BP,ITGA3
5838,GO:0071437,0.29232507508724,1,1,1,invadopodium,CC,ITGA3
5839,GO:0071438,0.29232507508724,1,1,1,invadopodium membrane,CC,ITGA3
6271,GO:0097062,0.29232507508724,1,1,1,dendritic spine maintenance,BP,ITGA3
888,GO:0006066,0.292768487235251,0.895999044278111,3,11,alcohol metabolic process,BP,HMGCS2;CYP11A1;DHCR7
6104,GO:0072657,0.293398807561468,0.856424698457929,6,19,protein localization to membrane,BP,ACTN2;REEP1;PIK3R1;LAMA5;GAS6;ITGA3
2633,GO:0030971,0.29456926397341,0.938759776191826,2,4,receptor tyrosine kinase binding,MF,PIK3R1;GAS6
7029,GO:1990782,0.29456926397341,0.938759776191826,2,4,protein tyrosine kinase binding,MF,PIK3R1;GAS6
1156,GO:0007043,0.295027762826512,0.925731808775378,2,6,cell-cell junction assembly,BP,CLDN1;CLDN3
3690,GO:0042594,0.295449534846534,0.8805509776506,4,12,response to starvation,BP,CDKN1A;NUAK2;GAS6;PDK4
2807,GO:0031982,0.29605441033058,0.78870922828593,31,133,vesicle,CC,ACTN2;PNP;MYO7A;FRMPD1;RHOJ;RHOB;SNX21;PHLDA1;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;CMBL;PRKACB;ITGB8;SDC4;GAS6;SERPINA5;DLL1;TICAM1;RIN3;TMEM163;CRISPLD2;RAB39B;PDE4B;ACSL4;ITGA3;AOX1;CLDN3;DAAM2
3654,GO:0042490,0.296106042797086,0.90641783661609,3,7,mechanoreceptor differentiation,BP,MYO7A;SDC4;DLL1
5208,GO:0060113,0.296106042797086,0.90641783661609,3,7,inner ear receptor cell differentiation,BP,MYO7A;SDC4;DLL1
1363,GO:0008284,0.296380140998246,0.834002302873423,8,34,positive regulation of cell proliferation,BP,PNP;CDKN1A;KITLG;GAS6;DLL1;TICAM1;HMGN5;CTGF
3795,GO:0043197,0.296780986362346,0.937953680302388,2,4,dendritic spine,CC,ACTN2;PDE4B
4004,GO:0044309,0.296780986362346,0.937953680302388,2,4,neuron spine,CC,ACTN2;PDE4B
178,GO:0001818,0.296913495599716,0.924915411250884,2,6,negative regulation of cytokine production,BP,GAS6;DLL1
1215,GO:0007264,0.298553603623574,0.860899539119512,5,18,small GTPase mediated signal transduction,BP,CDKN1A;RHOJ;KITLG;RHOB;ITGA3
614,GO:0004467,0.298809584745832,1,1,1,long-chain fatty acid-CoA ligase activity,MF,ACSL4
2797,GO:0031957,0.298809584745832,1,1,1,very long-chain fatty acid-CoA ligase activity,MF,ACSL4
4488,GO:0047676,0.298809584745832,1,1,1,arachidonate-CoA ligase activity,MF,ACSL4
5217,GO:0060136,0.298809584745832,1,1,1,embryonic process involved in female pregnancy,BP,ACSL4
5725,GO:0070672,0.298809584745832,1,1,1,response to interleukin-15,BP,ACSL4
6462,GO:0102391,0.298809584745832,1,1,1,decanoate--CoA ligase activity,MF,ACSL4
5112,GO:0052547,0.299803377107289,0.889175894651505,3,13,regulation of peptidase activity,BP,GAS6;SERPINA5;CTGF
4082,GO:0044770,0.300913415706375,0.893506088976653,3,10,cell cycle phase transition,BP,CDKN1A;PHLDA1;FOXO4
4083,GO:0044772,0.300913415706375,0.893506088976653,3,10,mitotic cell cycle phase transition,BP,CDKN1A;PHLDA1;FOXO4
1042,GO:0006705,0.30149503980029,0.927948954285584,2,5,mineralocorticoid biosynthetic process,BP,DKK3;HSD3B2
1349,GO:0008212,0.30149503980029,0.927948954285584,2,5,mineralocorticoid metabolic process,BP,DKK3;HSD3B2
4952,GO:0051259,0.301891656040469,0.870553024163056,4,16,protein oligomerization,BP,ACTN2;PRND;CLDN1;CLDN3
4889,GO:0051128,0.302008022067178,0.801173549257,16,63,regulation of cellular component organization,BP,ACTN2;CDKN1A;RHOJ;PIK3R1;PLEKHH2;HEXB;MFGE8;CAMSAP3;SDC4;GAS6;DLL1;FHOD3;CLDN1;ITGA3;CTGF;ESPN
1460,GO:0009154,0.302421426166256,0.973228518604482,1,2,purine ribonucleotide catabolic process,BP,PDE4B
1480,GO:0009261,0.302421426166256,0.973228518604482,1,2,ribonucleotide catabolic process,BP,PDE4B
296,GO:0002263,0.302447717008206,0.858346448904622,5,18,cell activation involved in immune response,BP,PNP;HEXB;DLL1;TICAM1;CRISPLD2
320,GO:0002366,0.302447717008206,0.858346448904622,5,18,leukocyte activation involved in immune response,BP,PNP;HEXB;DLL1;TICAM1;CRISPLD2
1483,GO:0009266,0.302662469100791,0.92746492611352,2,5,response to temperature stimulus,BP,CDKN1A;SLC52A3
282,GO:0002218,0.303596723884376,0.918558757924201,2,7,activation of innate immune response,BP,PRKACB;TICAM1
6075,GO:0072509,0.304043997941085,0.972911354490159,1,2,divalent inorganic cation transmembrane transporter activity,MF,GAS6
712,GO:0005173,0.304707229393913,1,1,1,stem cell factor receptor binding,MF,KITLG
1645,GO:0010623,0.304707229393913,1,1,1,programmed cell death involved in cell development,BP,KITLG
3087,GO:0033023,0.304707229393913,1,1,1,mast cell homeostasis,BP,KITLG
3088,GO:0033024,0.304707229393913,1,1,1,mast cell apoptotic process,BP,KITLG
3089,GO:0033025,0.304707229393913,1,1,1,regulation of mast cell apoptotic process,BP,KITLG
3090,GO:0033026,0.304707229393913,1,1,1,negative regulation of mast cell apoptotic process,BP,KITLG
3091,GO:0033028,0.304707229393913,1,1,1,myeloid cell apoptotic process,BP,KITLG
3092,GO:0033032,0.304707229393913,1,1,1,regulation of myeloid cell apoptotic process,BP,KITLG
3093,GO:0033033,0.304707229393913,1,1,1,negative regulation of myeloid cell apoptotic process,BP,KITLG
3322,GO:0035234,0.304707229393913,1,1,1,ectopic germ cell programmed cell death,BP,KITLG
4216,GO:0045634,0.304707229393913,1,1,1,regulation of melanocyte differentiation,BP,KITLG
4217,GO:0045636,0.304707229393913,1,1,1,positive regulation of melanocyte differentiation,BP,KITLG
4513,GO:0048070,0.304707229393913,1,1,1,regulation of developmental pigmentation,BP,KITLG
4514,GO:0048087,0.304707229393913,1,1,1,positive regulation of developmental pigmentation,BP,KITLG
4839,GO:0050932,0.304707229393913,1,1,1,regulation of pigment cell differentiation,BP,KITLG
4840,GO:0050942,0.304707229393913,1,1,1,positive regulation of pigment cell differentiation,BP,KITLG
5718,GO:0070662,0.304707229393913,1,1,1,mast cell proliferation,BP,KITLG
5722,GO:0070666,0.304707229393913,1,1,1,regulation of mast cell proliferation,BP,KITLG
5723,GO:0070668,0.304707229393913,1,1,1,positive regulation of mast cell proliferation,BP,KITLG
6636,GO:1902033,0.304707229393913,1,1,1,regulation of hematopoietic stem cell proliferation,BP,KITLG
6637,GO:1902035,0.304707229393913,1,1,1,positive regulation of hematopoietic stem cell proliferation,BP,KITLG
343,GO:0002474,0.305075807380053,0.964344000520758,1,3,antigen processing and presentation of peptide antigen via MHC class I,BP,ITGB5
344,GO:0002478,0.305075807380053,0.964344000520758,1,3,antigen processing and presentation of exogenous peptide antigen,BP,ITGB5
2267,GO:0019884,0.305075807380053,0.964344000520758,1,3,antigen processing and presentation of exogenous antigen,BP,ITGB5
3687,GO:0042590,0.305075807380053,0.964344000520758,1,3,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,ITGB5
6060,GO:0072341,0.305283700348764,0.926372310830566,2,5,modified amino acid binding,MF,MFGE8;GAS6
4169,GO:0045350,0.30555130542305,0.972614708638671,1,2,interferon-beta biosynthetic process,BP,TICAM1
4170,GO:0045351,0.30555130542305,0.972614708638671,1,2,type I interferon biosynthetic process,BP,TICAM1
4173,GO:0045357,0.30555130542305,0.972614708638671,1,2,regulation of interferon-beta biosynthetic process,BP,TICAM1
1375,GO:0008360,0.305606448503849,0.9210961079746,2,6,regulation of cell shape,BP,RHOJ;HEXB
3841,GO:0043296,0.30620633400002,0.857046415621904,5,17,apical junction complex,CC,CLDN11;CAMSAP3;CLDN1;CLDN3;CGN
820,GO:0005790,0.307238134453432,0.972280425577052,1,2,smooth endoplasmic reticulum,CC,HSD3B2
2615,GO:0030868,0.307238134453432,0.972280425577052,1,2,smooth endoplasmic reticulum membrane,CC,HSD3B2
6326,GO:0097425,0.307238134453432,0.972280425577052,1,2,smooth endoplasmic reticulum part,CC,HSD3B2
15,GO:0000096,0.309782920949919,0.971771489867278,1,2,sulfur amino acid metabolic process,BP,MRI1
994,GO:0006555,0.309782920949919,0.971771489867278,1,2,methionine metabolic process,BP,MRI1
1431,GO:0009066,0.309782920949919,0.971771489867278,1,2,aspartate family amino acid metabolic process,BP,MRI1
1888,GO:0015630,0.310330142375888,0.869564977687895,4,13,microtubule cytoskeleton,CC,PRKACB;CAMSAP3;PDE4B;MARK4
4409,GO:0046649,0.311074469278645,0.833110577852471,7,25,lymphocyte activation,BP,PNP;CDKN1A;PIK3R1;SDC4;GAS6;DLL1;TICAM1
6147,GO:0090003,0.311427276236998,0.932481397388416,2,4,regulation of establishment of protein localization to plasma membrane,BP,PIK3R1;ITGA3
6760,GO:1903076,0.311427276236998,0.932481397388416,2,4,regulation of protein localization to plasma membrane,BP,PIK3R1;ITGA3
6854,GO:1903729,0.311427276236998,0.932481397388416,2,4,regulation of plasma membrane organization,BP,PIK3R1;ITGA3
6894,GO:1904375,0.311427276236998,0.932481397388416,2,4,regulation of protein localization to cell periphery,BP,PIK3R1;ITGA3
1500,GO:0009435,0.312018560226005,0.971319764988204,1,2,NAD biosynthetic process,BP,PNP
2216,GO:0019359,0.312018560226005,0.971319764988204,1,2,nicotinamide nucleotide biosynthetic process,BP,PNP
2218,GO:0019363,0.312018560226005,0.971319764988204,1,2,pyridine nucleotide biosynthetic process,BP,PNP
3216,GO:0034356,0.312018560226005,0.971319764988204,1,2,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,PNP
6083,GO:0072525,0.312018560226005,0.971319764988204,1,2,pyridine-containing compound biosynthetic process,BP,PNP
1127,GO:0006955,0.312711042995366,0.806846650345343,11,46,immune response,BP,PNP;PIK3R1;HEXB;PRKACB;GAS6;DLL1;TICAM1;CRISPLD2;CASP4;CLDN1;PDE4B
6601,GO:1901700,0.313406343148695,0.793760601685065,15,62,response to oxygen-containing compound,BP,ACTN2;CDKN1A;RHOB;PIK3R1;PRKACB;GAS6;TICAM1;CASP4;CLDN1;PDE4B;DHH;FOXO4;PDK4;CTGF;CLDN3
3233,GO:0034394,0.314011428746697,0.962026019470899,1,3,protein localization to cell surface,BP,ACTN2
4218,GO:0045637,0.314133655355512,0.892392871296062,3,8,regulation of myeloid cell differentiation,BP,KITLG;PIK3R1;DLL1
4026,GO:0044421,0.314746447524818,0.775096325295526,27,119,extracellular region part,CC,ACTN2;PNP;LAMA1;FRMPD1;RHOJ;DKK3;KITLG;RHOB;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;CMBL;PRKACB;ITGB8;SDC4;GAS6;SERPINA5;CRISPLD2;ACSL4;DHH;ITGA3;AOX1;CTGF;CLDN3;DAAM2
1062,GO:0006771,0.314957750571703,0.970719276528232,1,2,riboflavin metabolic process,BP,SLC52A3
3708,GO:0042726,0.314957750571703,0.970719276528232,1,2,flavin-containing compound metabolic process,BP,SLC52A3
3348,GO:0035336,0.315697440274703,0.930841679187947,2,4,long-chain fatty-acyl-CoA metabolic process,BP,ACSF2;ACSL4
3349,GO:0035337,0.315697440274703,0.930841679187947,2,4,fatty-acyl-CoA metabolic process,BP,ACSF2;ACSL4
3350,GO:0035338,0.315697440274703,0.930841679187947,2,4,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSF2;ACSL4
4471,GO:0046949,0.315697440274703,0.930841679187947,2,4,fatty-acyl-CoA biosynthetic process,BP,ACSF2;ACSL4
230,GO:0001953,0.315998438278532,1,1,1,negative regulation of cell-matrix adhesion,BP,PIK3R1
681,GO:0005068,0.315998438278532,1,1,1,transmembrane receptor protein tyrosine kinase adaptor activity,MF,PIK3R1
704,GO:0005159,0.315998438278532,1,1,1,insulin-like growth factor receptor binding,MF,PIK3R1
708,GO:0005165,0.315998438278532,1,1,1,neurotrophin receptor binding,MF,PIK3R1
709,GO:0005167,0.315998438278532,1,1,1,neurotrophin TRK receptor binding,MF,PIK3R1
710,GO:0005168,0.315998438278532,1,1,1,neurotrophin TRKA receptor binding,MF,PIK3R1
2570,GO:0030674,0.315998438278532,1,1,1,protein binding, bridging,MF,PIK3R1
3108,GO:0033120,0.315998438278532,1,1,1,positive regulation of RNA splicing,BP,PIK3R1
3374,GO:0035591,0.315998438278532,1,1,1,signaling adaptor activity,MF,PIK3R1
3486,GO:0036312,0.315998438278532,1,1,1,phosphatidylinositol 3-kinase regulatory subunit binding,MF,PIK3R1
3780,GO:0043125,0.315998438278532,1,1,1,ErbB-3 class receptor binding,MF,PIK3R1
3880,GO:0043484,0.315998438278532,1,1,1,regulation of RNA splicing,BP,PIK3R1
3913,GO:0043559,0.315998438278532,1,1,1,insulin binding,MF,PIK3R1
4401,GO:0046626,0.315998438278532,1,1,1,regulation of insulin receptor signaling pathway,BP,PIK3R1
5019,GO:0051531,0.315998438278532,1,1,1,NFAT protein import into nucleus,BP,PIK3R1
6264,GO:0097038,0.315998438278532,1,1,1,perinuclear endoplasmic reticulum,CC,PIK3R1
6474,GO:1900101,0.315998438278532,1,1,1,regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
6475,GO:1900103,0.315998438278532,1,1,1,positive regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
7022,GO:1990578,0.315998438278532,1,1,1,perinuclear endoplasmic reticulum membrane,CC,PIK3R1
2764,GO:0031668,0.316611845201267,0.867752940671859,4,12,cellular response to extracellular stimulus,BP,CDKN1A;NUAK2;GAS6;PDK4
2765,GO:0031669,0.316611845201267,0.867752940671859,4,12,cellular response to nutrient levels,BP,CDKN1A;NUAK2;GAS6;PDK4
3753,GO:0043028,0.316674191157383,0.961318490192912,1,3,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,GAS6
754,GO:0005506,0.316956591192399,0.915970414084138,2,6,iron ion binding,MF,CYP11A1;AOX1
539,GO:0003682,0.31705130884141,0.930317596651025,2,4,chromatin binding,MF,HMGN5;FOXO4
3029,GO:0032801,0.317707581335451,1,1,1,receptor catabolic process,BP,GPRASP1
7007,GO:1990172,0.317707581335451,1,1,1,G-protein coupled receptor catabolic process,BP,GPRASP1
46,GO:0000287,0.318163233646406,0.915416188125662,2,6,magnesium ion binding,MF,NUAK2;PRKACB
4153,GO:0045210,0.318553818659413,1,1,1,FasL biosynthetic process,BP,PHLDA1
1384,GO:0008395,0.319439995483848,0.969788983185816,1,2,steroid hydroxylase activity,MF,CYP11A1
1157,GO:0007044,0.3194533279692,0.894501881577761,3,7,cell-substrate junction assembly,BP,ACTN2;LAMA5;SDC4
3762,GO:0043067,0.31997762120668,0.793582686763612,13,56,regulation of programmed cell death,BP,ACTN2;CDKN1A;NUAK2;KITLG;RHOB;PIK3R1;GAS6;DLL1;HMGN5;CASP4;PDK4;CTGF;MARK4
666,GO:0004869,0.320013527699367,0.960420186526691,1,3,cysteine-type endopeptidase inhibitor activity,MF,GAS6
4091,GO:0044802,0.320135764780628,0.826558543190873,7,25,single-organism membrane organization,BP,ACTN2;REEP1;PIK3R1;LAMA5;GAS6;SERPINA5;ITGA3
2521,GO:0030426,0.322585737400455,0.969125501870486,1,2,growth cone,CC,ITGA3
2522,GO:0030427,0.322585737400455,0.969125501870486,1,2,site of polarized growth,CC,ITGA3
3807,GO:0043226,0.32377277330881,0.780359196487386,59,284,organelle,CC,ACTN2;PNP;ACSF2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NUAK2;RHOJ;KITLG;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PLEKHH2;HEXB;CLDN11;MFGE8;MRO;LAMA5;ITGB5;CMBL;PRKACB;CAMSAP3;HSD17B3;ITGB8;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;TMEM163;HMGN5;CRISPLD2;RAB39B;PTPN7;CASP4;DHCR7;PON2;PDE4B;ACSL4;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;CGN;GPSM1;DAAM2;MARK4
6554,GO:1901362,0.323780902481863,0.776159358086802,19,87,organic cyclic compound biosynthetic process,BP,ACTN2;PNP;CDKN1A;HMGCS2;DKK3;PIK3R1;HEXB;HSD17B3;CYP11A1;GAS6;HSD3B2;DLL1;TICAM1;HMGN5;DHCR7;DHH;FOXO4;ITGA3;CTGF
4152,GO:0045202,0.323959472018359,0.825509309938861,7,23,synapse,CC,ACTN2;MYO7A;LAMA5;TMEM163;PDE4B;ITGA3;PRRT1
1142,GO:0007009,0.324320781988184,0.848107902199774,5,15,plasma membrane organization,BP,ACTN2;PIK3R1;LAMA5;GAS6;ITGA3
6105,GO:0072659,0.324320781988184,0.848107902199774,5,15,protein localization to plasma membrane,BP,ACTN2;PIK3R1;LAMA5;GAS6;ITGA3
7028,GO:1990778,0.324320781988184,0.848107902199774,5,15,protein localization to cell periphery,BP,ACTN2;PIK3R1;LAMA5;GAS6;ITGA3
2131,GO:0017048,0.326600858617307,1,1,1,Rho GTPase binding,MF,DAAM2
104,GO:0001502,0.327559266144986,0.968058541422575,1,2,cartilage condensation,BP,CTGF
6391,GO:0098743,0.327559266144986,0.968058541422575,1,2,cell aggregation,BP,CTGF
810,GO:0005773,0.32813915854147,0.839003298015536,5,20,vacuole,CC,MYO7A;HEXB;SDC4;TICAM1;PON2
1492,GO:0009314,0.329338931347837,0.877424829967824,3,10,response to radiation,BP,CDKN1A;RHOB;PIK3R1
4492,GO:0048002,0.330212098586287,0.952826517994602,1,4,antigen processing and presentation of peptide antigen,BP,ITGB5
1327,GO:0008134,0.330356185599658,0.879710857311066,3,9,transcription factor binding,MF,PIK3R1;DLL1;FOXO4
861,GO:0005929,0.330660660398762,0.888555900224015,3,7,cilium,CC,MYO7A;PRKACB;MARK4
4041,GO:0044441,0.330660660398762,0.888555900224015,3,7,ciliary part,CC,MYO7A;PRKACB;MARK4
2971,GO:0032608,0.330662119781959,0.957472987568329,1,3,interferon-beta production,BP,TICAM1
2985,GO:0032648,0.330662119781959,0.957472987568329,1,3,regulation of interferon-beta production,BP,TICAM1
1223,GO:0007275,0.331367197953607,0.757130257094279,37,156,multicellular organism development,BP,ACTN2;PNP;LAMA1;NRTN;MYO7A;CDKN1A;RHOJ;DKK3;KITLG;RHOB;PIK3R1;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;PRKACB;CAMSAP3;HSD17B3;ITGB8;SDC4;GAS6;SERPINA5;DLL1;FHOD3;CRISPLD2;SEMA6C;DHCR7;CLDN1;ACSL4;DHH;FOXO4;ITGA3;CTGF;GPSM1;DAAM2;MARK4
1462,GO:0009164,0.332186661447323,0.967045872256734,1,2,nucleoside catabolic process,BP,PNP
1997,GO:0016338,0.334396386500847,0.872162983263156,3,11,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN11;CLDN1;CLDN3
3209,GO:0034332,0.335199029220402,0.88078554662922,3,8,adherens junction organization,BP,ACTN2;LAMA5;SDC4
1365,GO:0008286,0.335641874406134,0.880535847165211,3,8,insulin receptor signaling pathway,BP,PIK3R1;FOXO4;PDK4
7066,GO:2000106,0.335973970810087,0.912973049243296,2,5,regulation of leukocyte apoptotic process,BP,KITLG;GAS6
3877,GO:0043473,0.336053667282697,0.912936782336868,2,5,pigmentation,BP,MYO7A;KITLG
3993,GO:0044270,0.337157167203826,0.872830770729123,3,10,cellular nitrogen compound catabolic process,BP,PNP;PDE4B;AOX1
4419,GO:0046700,0.337157167203826,0.872830770729123,3,10,heterocycle catabolic process,BP,PNP;PDE4B;AOX1
460,GO:0003159,0.337747373690967,0.965803202816572,1,2,morphogenesis of an endothelium,BP,RHOB
5520,GO:0061154,0.337747373690967,0.965803202816572,1,2,endothelial tube morphogenesis,BP,RHOB
2656,GO:0031099,0.339576343612231,0.871394199562675,3,10,regeneration,BP,CDKN1A;GAS6;CLDN1
799,GO:0005758,0.339592471381502,0.965384605059337,1,2,mitochondrial intermembrane space,CC,HSD3B2
4193,GO:0045580,0.339603269233148,0.965382146103428,1,2,regulation of T cell differentiation,BP,PNP
1580,GO:0010008,0.340825619126091,0.848323729382025,4,14,endosome membrane,CC,RHOB;SNX21;TICAM1;TMEM163
4040,GO:0044440,0.340825619126091,0.848323729382025,4,14,endosomal part,CC,RHOB;SNX21;TICAM1;TMEM163
4033,GO:0044430,0.34274303098527,0.791706585600003,10,33,cytoskeletal part,CC,ACTN2;MYO7A;PLEKHH2;PRKACB;CAMSAP3;FHOD3;PDE4B;ESPN;CGN;MARK4
6431,GO:0099080,0.342744887842525,0.819738990213721,6,21,supramolecular complex,CC,ACTN2;CAMSAP3;SDC4;FHOD3;PDE4B;ESPN
6432,GO:0099081,0.342744887842525,0.819738990213721,6,21,supramolecular polymer,CC,ACTN2;CAMSAP3;SDC4;FHOD3;PDE4B;ESPN
6439,GO:0099512,0.342744887842525,0.819738990213721,6,21,supramolecular fiber,CC,ACTN2;CAMSAP3;SDC4;FHOD3;PDE4B;ESPN
6585,GO:1901652,0.342786208048668,0.810697538063495,7,24,response to peptide,BP,ACTN2;PIK3R1;PRKACB;CASP4;FOXO4;PDK4;CTGF
6322,GO:0097367,0.342931501160537,0.76689150538355,16,67,carbohydrate derivative binding,MF,PNP;ACSF2;MYO7A;NUAK2;RHOJ;RHOB;PRKACB;SERPINA5;CRISPLD2;RAB39B;PDE4B;ACSL4;ITGA3;PDK4;CTGF;MARK4
2299,GO:0021549,0.343653090266711,0.964452274164129,1,2,cerebellum development,BP,DLL1
2300,GO:0021575,0.343653090266711,0.964452274164129,1,2,hindbrain morphogenesis,BP,DLL1
2301,GO:0021587,0.343653090266711,0.964452274164129,1,2,cerebellum morphogenesis,BP,DLL1
2312,GO:0021695,0.343653090266711,0.964452274164129,1,2,cerebellar cortex development,BP,DLL1
2313,GO:0021696,0.343653090266711,0.964452274164129,1,2,cerebellar cortex morphogenesis,BP,DLL1
2314,GO:0021697,0.343653090266711,0.964452274164129,1,2,cerebellar cortex formation,BP,DLL1
2350,GO:0022037,0.343653090266711,0.964452274164129,1,2,metencephalon development,BP,DLL1
3067,GO:0032945,0.343824257708208,0.96441263681668,1,2,negative regulation of mononuclear cell proliferation,BP,SDC4
3579,GO:0042130,0.343824257708208,0.96441263681668,1,2,negative regulation of T cell proliferation,BP,SDC4
4730,GO:0050672,0.343824257708208,0.96441263681668,1,2,negative regulation of lymphocyte proliferation,BP,SDC4
4811,GO:0050868,0.343824257708208,0.96441263681668,1,2,negative regulation of T cell activation,BP,SDC4
5720,GO:0070664,0.343824257708208,0.96441263681668,1,2,negative regulation of leukocyte proliferation,BP,SDC4
6753,GO:1903038,0.343824257708208,0.96441263681668,1,2,negative regulation of leukocyte cell-cell adhesion,BP,SDC4
2463,GO:0030204,0.344696865466325,0.964210141391914,1,2,chondroitin sulfate metabolic process,BP,HEXB
2465,GO:0030207,0.344696865466325,0.964210141391914,1,2,chondroitin sulfate catabolic process,BP,HEXB
4722,GO:0050654,0.344696865466325,0.964210141391914,1,2,chondroitin sulfate proteoglycan metabolic process,BP,HEXB
1595,GO:0010256,0.345245426674184,0.820341159099217,6,19,endomembrane system organization,BP,ACTN2;REEP1;PIK3R1;LAMA5;GAS6;ITGA3
4790,GO:0050810,0.348475675421836,0.869133172598759,3,9,regulation of steroid biosynthetic process,BP,DKK3;DHCR7;DHH
837,GO:0005865,0.348834228214632,0.963240320420825,1,2,striated muscle thin filament,CC,FHOD3
3491,GO:0036379,0.348834228214632,0.963240320420825,1,2,myofilament,CC,FHOD3
283,GO:0002220,0.348869691965149,0.952135754148382,1,3,innate immune response activating cell surface receptor signaling pathway,BP,PRKACB
285,GO:0002223,0.348869691965149,0.952135754148382,1,3,stimulatory C-type lectin receptor signaling pathway,BP,PRKACB
4702,GO:0048856,0.349412266431395,0.741353901991459,38,162,anatomical structure development,BP,ACTN2;PNP;LAMA1;NRTN;MYO7A;CDKN1A;RHOJ;DKK3;KITLG;RHOB;PIK3R1;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;PRKACB;CAMSAP3;HSD17B3;ITGB8;SDC4;GAS6;SERPINA5;DLL1;FHOD3;CRISPLD2;SEMA6C;DHCR7;CLDN1;ACSL4;DHH;FOXO4;ITGA3;CTGF;CLDN3;GPSM1;DAAM2;MARK4
616,GO:0004497,0.35022056124529,0.951724477226532,1,3,monooxygenase activity,MF,CYP11A1
684,GO:0005088,0.350958471871903,0.839954648095363,4,15,Ras guanyl-nucleotide exchange factor activity,MF,ACTN2;NRTN;KITLG;RIN3
22,GO:0000146,0.351340599507167,1,1,1,microfilament motor activity,MF,MYO7A
161,GO:0001754,0.351340599507167,1,1,1,eye photoreceptor cell differentiation,BP,MYO7A
213,GO:0001917,0.351340599507167,1,1,1,photoreceptor inner segment,CC,MYO7A
274,GO:0002093,0.351340599507167,1,1,1,auditory receptor cell morphogenesis,BP,MYO7A
275,GO:0002139,0.351340599507167,1,1,1,stereocilia coupling link,CC,MYO7A
276,GO:0002140,0.351340599507167,1,1,1,stereocilia tip link,CC,MYO7A
1542,GO:0009886,0.351340599507167,1,1,1,post-embryonic animal morphogenesis,BP,MYO7A
2023,GO:0016461,0.351340599507167,1,1,1,unconventional myosin complex,CC,MYO7A
2621,GO:0030898,0.351340599507167,1,1,1,actin-dependent ATPase activity,MF,MYO7A
2731,GO:0031477,0.351340599507167,1,1,1,myosin VII complex,CC,MYO7A
3643,GO:0042461,0.351340599507167,1,1,1,photoreceptor cell development,BP,MYO7A
3644,GO:0042462,0.351340599507167,1,1,1,eye photoreceptor cell development,BP,MYO7A
4604,GO:0048563,0.351340599507167,1,1,1,post-embryonic animal organ morphogenesis,BP,MYO7A
4608,GO:0048569,0.351340599507167,1,1,1,post-embryonic animal organ development,BP,MYO7A
5205,GO:0060088,0.351340599507167,1,1,1,auditory receptor cell stereocilium organization,BP,MYO7A
5209,GO:0060117,0.351340599507167,1,1,1,auditory receptor cell development,BP,MYO7A
7016,GO:1990427,0.351340599507167,1,1,1,stereocilia tip-link density,CC,MYO7A
7018,GO:1990435,0.351340599507167,1,1,1,upper tip-link density,CC,MYO7A
5016,GO:0051494,0.351485422377604,0.877113110115845,3,7,negative regulation of cytoskeleton organization,BP,PLEKHH2;FHOD3;ESPN
2694,GO:0031300,0.351609360594441,0.962580769706883,1,2,intrinsic component of organelle membrane,CC,TMEM163
2695,GO:0031301,0.351609360594441,0.962580769706883,1,2,integral component of organelle membrane,CC,TMEM163
151,GO:0001709,0.352759860710097,0.962305193825727,1,2,cell fate determination,BP,DLL1
401,GO:0002756,0.353302575507355,0.962174761467395,1,2,MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
3389,GO:0035666,0.353302575507355,0.962174761467395,1,2,TRIF-dependent toll-like receptor signaling pathway,BP,TICAM1
6320,GO:0097342,0.353302575507355,0.962174761467395,1,2,ripoptosome,CC,TICAM1
310,GO:0002312,0.354614502958389,0.961858300685437,1,2,B cell activation involved in immune response,BP,DLL1
4141,GO:0045171,0.354927933769045,0.961782451947862,1,2,intercellular bridge,CC,PRKACB
193,GO:0001843,0.354930419034588,0.904127944377846,2,5,neural tube closure,BP,PRKACB;SDC4
4727,GO:0050663,0.35511515049471,0.904039570752915,2,5,cytokine secretion,BP,PNP;GAS6
170,GO:0001775,0.355438553624895,0.773335959375862,11,44,cell activation,BP,PNP;CDKN1A;RHOB;PIK3R1;HEXB;SDC4;GAS6;DLL1;TICAM1;CRISPLD2;CTGF
3252,GO:0034612,0.355901632568873,0.887314276342618,2,9,response to tumor necrosis factor,BP,GAS6;CLDN1
5811,GO:0071356,0.355901632568873,0.887314276342618,2,9,cellular response to tumor necrosis factor,BP,GAS6;CLDN1
2052,GO:0016614,0.358645556828596,0.855280944482757,3,12,oxidoreductase activity, acting on CH-OH group of donors,MF,HSD17B3;HSD3B2;AOX1
4395,GO:0046579,0.358955820575451,0.949012995974477,1,3,positive regulation of Ras protein signal transduction,BP,KITLG
4876,GO:0051057,0.358955820575451,0.949012995974477,1,3,positive regulation of small GTPase mediated signal transduction,BP,KITLG
771,GO:0005546,0.359140440700493,0.902103378518195,2,5,phosphatidylinositol-4,5-bisphosphate binding,MF,ACTN2;SNX21
1752,GO:0010923,0.359592546789704,0.960642483282501,1,2,negative regulation of phosphatase activity,BP,CAMSAP3
3340,GO:0035305,0.359592546789704,0.960642483282501,1,2,negative regulation of dephosphorylation,BP,CAMSAP3
4955,GO:0051262,0.360299270896169,0.948587924659811,1,3,protein tetramerization,BP,ACTN2
4966,GO:0051289,0.360299270896169,0.948587924659811,1,3,protein homotetramerization,BP,ACTN2
3617,GO:0042339,0.36067841566987,0.960374097504031,1,2,keratan sulfate metabolic process,BP,HEXB
2264,GO:0019867,0.361682588820264,0.889741492249904,2,7,outer membrane,CC,DHCR7;ACSL4
2802,GO:0031968,0.361682588820264,0.889741492249904,2,7,organelle outer membrane,CC,DHCR7;ACSL4
1153,GO:0007034,0.361858123366927,0.900784729519942,2,5,vacuolar transport,BP,GPRASP1;RHOB
1155,GO:0007041,0.361858123366927,0.900784729519942,2,5,lysosomal transport,BP,GPRASP1;RHOB
3590,GO:0042181,0.362145445475742,0.893971356731984,2,6,ketone biosynthetic process,BP,DKK3;HSD17B3
2281,GO:0019915,0.362501908910397,0.959920822724087,1,2,lipid storage,BP,HEXB
1704,GO:0010817,0.3628962171749,0.81428816522111,5,20,regulation of hormone levels,BP,DKK3;HSD17B3;CYP11A1;HSD3B2;DHCR7
3974,GO:0044232,0.36295999855968,0.959806444229988,1,2,organelle membrane contact site,CC,ACSL4
3975,GO:0044233,0.36295999855968,0.959806444229988,1,2,ER-mitochondrion membrane contact site,CC,ACSL4
4827,GO:0050900,0.3632120462892,0.803576253550799,6,22,leukocyte migration,BP,KITLG;PIK3R1;SDC4;GAS6;PDE4B;ITGA3
4048,GO:0044451,0.364550751158973,0.856145233494776,3,10,nucleoplasm part,CC,CDKN1A;FOXO4;AOX1
4518,GO:0048146,0.365117651068425,0.89243340869262,2,6,positive regulation of fibroblast proliferation,BP,CDKN1A;GAS6
1045,GO:0006720,0.365614072928675,0.887633717392053,2,7,isoprenoid metabolic process,BP,HMGCS2;SDC4
6578,GO:1901615,0.365995688722243,0.811047823321543,5,21,organic hydroxy compound metabolic process,BP,HMGCS2;DKK3;HSD17B3;CYP11A1;DHCR7
4219,GO:0045638,0.3665619527826,0.898480510623341,2,5,negative regulation of myeloid cell differentiation,BP,PIK3R1;DLL1
4318,GO:0045989,0.367392555598008,0.958689086408297,1,2,positive regulation of striated muscle contraction,BP,CTGF
5325,GO:0060452,0.367392555598008,0.958689086408297,1,2,positive regulation of cardiac muscle contraction,BP,CTGF
1061,GO:0006767,0.368070386789067,0.890894202178802,2,6,water-soluble vitamin metabolic process,BP,SLC52A3;AOX1
1348,GO:0008211,0.368670059726466,0.890580220244714,2,6,glucocorticoid metabolic process,BP,DKK3;HSD3B2
298,GO:0002275,0.369979826805892,0.826894272345337,4,15,myeloid cell activation involved in immune response,BP,PNP;HEXB;TICAM1;CRISPLD2
1094,GO:0006878,0.370678515679174,0.957848266392057,1,2,cellular copper ion homeostasis,BP,PRND
5144,GO:0055070,0.370678515679174,0.957848266392057,1,2,copper ion homeostasis,BP,PRND
4069,GO:0044711,0.370685339186084,0.750397983051319,13,63,single-organism biosynthetic process,BP,PNP;HMGCS2;DKK3;PIK3R1;MRI1;HEXB;HSD17B3;CYP11A1;HSD3B2;DHCR7;DHH;PDK4;CTGF
5378,GO:0060606,0.371010548205792,0.889350287451674,2,6,tube closure,BP,PRKACB;SDC4
53,GO:0000323,0.371067027257876,0.823370485001989,4,17,lytic vacuole,CC,MYO7A;HEXB;SDC4;PON2
803,GO:0005764,0.371067027257876,0.823370485001989,4,17,lysosome,CC,MYO7A;HEXB;SDC4;PON2
3569,GO:0042102,0.371803241024764,0.944858761167903,1,3,positive regulation of T cell proliferation,BP,PNP
6058,GO:0072332,0.371829904113155,0.944849930561917,1,3,intrinsic apoptotic signaling pathway by p53 class mediator,BP,CDKN1A
6325,GO:0097421,0.372863065213762,0.957283343304425,1,2,liver regeneration,BP,CLDN1
3581,GO:0042149,0.37306014655762,0.957232144033144,1,2,cellular response to glucose starvation,BP,NUAK2
2507,GO:0030323,0.37348010231164,0.808894003638291,5,18,respiratory tube development,BP,LAMA5;CRISPLD2;DHCR7;ITGA3;CTGF
2508,GO:0030324,0.37348010231164,0.808894003638291,5,18,lung development,BP,LAMA5;CRISPLD2;DHCR7;ITGA3;CTGF
2895,GO:0032355,0.373981644392296,0.883079647223061,2,7,response to estradiol,BP,DHH;CTGF
1757,GO:0010941,0.374580472860108,0.748050922414714,13,58,regulation of cell death,BP,ACTN2;CDKN1A;NUAK2;KITLG;RHOB;PIK3R1;GAS6;DLL1;HMGN5;CASP4;PDK4;CTGF;MARK4
4828,GO:0050905,0.374596038044216,0.894480390399886,2,5,neuromuscular process,BP,MYO7A;HEXB
3726,GO:0042802,0.374932103782588,0.754926426580795,11,52,identical protein binding,MF,ACTN2;MYO7A;MRI1;PLEKHH2;HEXB;CLDN11;ACCS;PON2;CLDN1;FOXO4;CLDN3
3272,GO:0034686,0.375342185081993,1,1,1,integrin alphav-beta8 complex,CC,ITGB8
7017,GO:1990430,0.375342185081993,1,1,1,extracellular matrix protein binding,MF,ITGB8
3838,GO:0043281,0.375359820531197,0.876380492122907,2,9,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,GAS6;CTGF
7071,GO:2000116,0.375359820531197,0.876380492122907,2,9,regulation of cysteine-type endopeptidase activity,BP,GAS6;CTGF
2110,GO:0016863,0.376497411381346,0.94329057717036,1,3,intramolecular oxidoreductase activity, transposing C=C bonds,MF,HSD3B2
128,GO:0001618,0.377308457485156,0.893111385036937,2,5,virus receptor activity,MF,ITGB5;CLDN1
2909,GO:0032386,0.377393884535059,0.823465947138763,4,14,regulation of intracellular transport,BP,CDKN1A;REEP1;PIK3R1;GAS6
1730,GO:0010876,0.377523830665035,0.843078132230084,3,12,lipid localization,BP,HEXB;SERPINA5;ACSL4
229,GO:0001952,0.378385829485285,0.89256501025325,2,5,regulation of cell-matrix adhesion,BP,PIK3R1;SDC4
6864,GO:1903828,0.379128807065773,0.892187354001999,2,5,negative regulation of cellular protein localization,BP,ACTN2;GAS6
5129,GO:0055013,0.379589251026122,0.891952955067271,2,5,cardiac muscle cell development,BP,ACTN2;FHOD3
1227,GO:0007286,0.380054191176911,0.955389896060695,1,2,spermatid development,BP,DHH
4583,GO:0048515,0.380054191176911,0.955389896060695,1,2,spermatid differentiation,BP,DHH
4984,GO:0051346,0.380441102516385,0.841152713715529,3,12,negative regulation of hydrolase activity,BP,CAMSAP3;GAS6;SERPINA5
3345,GO:0035315,0.380862354710661,0.903249993163078,2,4,hair cell differentiation,BP,MYO7A;DLL1
3655,GO:0042491,0.380862354710661,0.903249993163078,2,4,auditory receptor cell differentiation,BP,MYO7A;DLL1
1991,GO:0016324,0.381673486485487,0.825190295351903,4,12,apical plasma membrane,CC,MYO7A;SLC52A3;DLL1;CLDN1
4925,GO:0051205,0.383048813160081,0.954585944045435,1,2,protein insertion into membrane,BP,REEP1
5681,GO:0070382,0.383624180566452,0.877715997173693,2,7,exocytic vesicle,CC,TMEM163;PDE4B
5479,GO:0061024,0.384346698796436,0.760756528247432,9,35,membrane organization,BP,ACTN2;REEP1;PIK3R1;MFGE8;LAMA5;GAS6;SERPINA5;RIN3;ITGA3
5741,GO:0070848,0.3843547334823,0.76713322898043,8,32,response to growth factor,BP,DKK3;ITGB5;GAS6;DLL1;CLDN1;ITGA3;CTGF;CGN
5815,GO:0071363,0.3843547334823,0.76713322898043,8,32,cellular response to growth factor stimulus,BP,DKK3;ITGB5;GAS6;DLL1;CLDN1;ITGA3;CTGF;CGN
3582,GO:0042157,0.384681723001177,0.877120147374217,2,7,lipoprotein metabolic process,BP,PRND;PRKACB
661,GO:0004860,0.384836407589814,0.954101662187379,1,2,protein kinase inhibitor activity,MF,CDKN1A
2198,GO:0019210,0.384836407589814,0.954101662187379,1,2,kinase inhibitor activity,MF,CDKN1A
2495,GO:0030291,0.384836407589814,0.954101662187379,1,2,protein serine/threonine kinase inhibitor activity,MF,CDKN1A
569,GO:0003996,0.385558029045584,0.953905235011014,1,2,acyl-CoA ligase activity,MF,ACSF2
2003,GO:0016405,0.385558029045584,0.953905235011014,1,2,CoA-ligase activity,MF,ACSF2
1311,GO:0008064,0.385561904359257,0.850861478238844,3,8,regulation of actin polymerization or depolymerization,BP,ACTN2;PLEKHH2;FHOD3
2596,GO:0030832,0.385561904359257,0.850861478238844,3,8,regulation of actin filament length,BP,ACTN2;PLEKHH2;FHOD3
4086,GO:0044782,0.385628710808343,0.901036007481936,2,4,cilium organization,BP,LAMA5;MARK4
5245,GO:0060271,0.385628710808343,0.901036007481936,2,4,cilium assembly,BP,LAMA5;MARK4
70,GO:0000930,0.386131382804417,0.95374878401938,1,2,gamma-tubulin complex,CC,PDE4B
4047,GO:0044450,0.386131382804417,0.95374878401938,1,2,microtubule organizing center part,CC,PDE4B
1270,GO:0007584,0.386287901115249,0.888512043425259,2,5,response to nutrient,BP,GAS6;ACSL4
2477,GO:0030234,0.386561504176775,0.783838464307093,6,24,enzyme regulator activity,MF,CDKN1A;PIK3R1;GAS6;SERPINA5;RIN3;GPSM1
779,GO:0005606,0.386737256346186,1,1,1,laminin-1 complex,CC,LAMA1
780,GO:0005608,0.386737256346186,1,1,1,laminin-3 complex,CC,LAMA1
4996,GO:0051412,0.387071877665039,0.953491416138988,1,2,response to corticosterone,BP,CDKN1A
1699,GO:0010803,0.387074554144056,0.933023577500094,1,4,regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
3292,GO:0034976,0.387332983857374,0.880572939914062,2,6,response to endoplasmic reticulum stress,BP,PIK3R1;CASP4
2335,GO:0021904,0.387579664607266,0.953352079103855,1,2,dorsal/ventral neural tube patterning,BP,PRKACB
4517,GO:0048145,0.387885172770482,0.875306022094843,2,7,regulation of fibroblast proliferation,BP,CDKN1A;GAS6
715,GO:0005198,0.388721593627573,0.77345917020746,7,26,structural molecule activity,MF,ACTN2;LAMA1;CLDN11;LAMA5;MPZL1;CLDN1;CLDN3
3849,GO:0043330,0.390466421797878,0.952554865004813,1,2,response to exogenous dsRNA,BP,TICAM1
5934,GO:0072014,0.390521372475643,0.952539605545131,1,2,proximal tubule development,BP,DLL1
2361,GO:0022412,0.3908065853108,0.834224760425154,3,12,cellular process involved in reproduction in multicellular organism,BP,HEXB;SERPINA5;DHH
665,GO:0004867,0.391074657633464,0.952385786035263,1,2,serine-type endopeptidase inhibitor activity,MF,SERPINA5
4772,GO:0050778,0.391112329179893,0.811891065618966,4,15,positive regulation of immune response,BP,PIK3R1;PRKACB;TICAM1;PDE4B
1594,GO:0010243,0.391961704984189,0.755028095967558,9,34,response to organonitrogen compound,BP,ACTN2;CDKN1A;PIK3R1;PRKACB;CASP4;PDE4B;FOXO4;PDK4;CTGF
1139,GO:0006996,0.392130897672601,0.720456987118375,18,74,organelle organization,BP,ACTN2;MYO7A;NUAK2;RHOJ;REEP1;PIK3R1;PLEKHH2;HEXB;LAMA5;ITGB5;CAMSAP3;SDC4;FHOD3;HMGN5;CTGF;ESPN;DAAM2;MARK4
6270,GO:0097061,0.392602763257891,0.951959292109897,1,2,dendritic spine organization,BP,ITGA3
5648,GO:0070252,0.392651865373065,0.885189288552186,2,5,actin-mediated cell contraction,BP,ACTN2;PDE4B
377,GO:0002687,0.392665801680157,0.872572887642792,2,7,positive regulation of leukocyte migration,BP,KITLG;GAS6
2946,GO:0032504,0.393050936902604,0.769185500942786,7,27,multicellular organism reproduction,BP,KITLG;HEXB;CLDN11;SERPINA5;ACSL4;DHH;ITGA3
4621,GO:0048609,0.393050936902604,0.769185500942786,7,27,multicellular organismal reproductive process,BP,KITLG;HEXB;CLDN11;SERPINA5;ACSL4;DHH;ITGA3
6590,GO:1901658,0.39470630901368,0.936946027282065,1,3,glycosyl compound catabolic process,BP,PNP
3672,GO:0042542,0.394767050231037,0.951351046085462,1,2,response to hydrogen peroxide,BP,RHOB
124,GO:0001578,0.395036073895768,0.951275095627242,1,2,microtubule bundle formation,BP,MARK4
2450,GO:0030170,0.395600819070405,0.951115408846466,1,2,pyridoxal phosphate binding,MF,ACCS
5657,GO:0070279,0.395600819070405,0.951115408846466,1,2,vitamin B6 binding,MF,ACCS
4077,GO:0044763,0.396575105158107,0.718500644184636,59,280,single-organism cellular process,BP,ACTN2;PNP;LAMA1;NRTN;ACSF2;MYO7A;CDKN1A;HMGCS2;NUAK2;RHOJ;DKK3;KITLG;RHOB;REEP1;PHLDA1;PIK3R1;MRI1;PRND;PLEKHH2;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;PRKACB;SLC52A3;CAMSAP3;HSD17B3;ITGB8;MPZL1;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;HMGN5;CRISPLD2;SEMA6C;RAB39B;CASP4;DHCR7;PON2;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;GPSM1;DAAM2;MARK4
2756,GO:0031647,0.396799243413664,0.866504737495303,2,8,regulation of protein stability,BP,CDKN1A;PIK3R1
2088,GO:0016787,0.39766631072603,0.731279236515103,12,57,hydrolase activity,MF,MYO7A;RHOJ;RHOB;HEXB;CMBL;RAB39B;PTPN7;CASP4;PON2;PDE4B;DHH;CGN
2533,GO:0030507,0.39792966714027,0.895193628093216,2,4,spectrin binding,MF,MYO7A;CAMSAP3
5472,GO:0060996,0.398179265369423,0.950382039514752,1,2,dendritic spine development,BP,ACSL4
3358,GO:0035455,0.398725874052338,0.950225664363946,1,2,response to interferon-alpha,BP,GAS6
3359,GO:0035457,0.398725874052338,0.950225664363946,1,2,cellular response to interferon-alpha,BP,GAS6
6599,GO:1901698,0.398826534958248,0.742714671343599,10,39,response to nitrogen compound,BP,ACTN2;CDKN1A;PIK3R1;PRKACB;TICAM1;CASP4;PDE4B;FOXO4;PDK4;CTGF
5381,GO:0060627,0.399126775238528,0.787127823702466,5,20,regulation of vesicle-mediated transport,BP,ACTN2;MFGE8;SDC4;GAS6;DLL1
4911,GO:0051180,0.3995587901197,0.949986769498432,1,2,vitamin transport,BP,SLC52A3
1007,GO:0006612,0.399877900880836,0.949895046813806,1,2,protein targeting to membrane,BP,GAS6
446,GO:0003104,0.400121538014345,0.949824944434286,1,2,positive regulation of glomerular filtration,BP,GAS6
2972,GO:0032609,0.400425707070549,0.868070144504427,2,7,interferon-gamma production,BP,GAS6;PDE4B
2986,GO:0032649,0.400425707070549,0.868070144504427,2,7,regulation of interferon-gamma production,BP,GAS6;PDE4B
893,GO:0006085,0.400506388793025,0.949714080957135,1,2,acetyl-CoA biosynthetic process,BP,PDK4
6355,GO:0097734,0.401250385770208,0.94949930916933,1,2,extracellular exosome biogenesis,BP,SDC4
7008,GO:1990182,0.401250385770208,0.94949930916933,1,2,exosomal secretion,BP,SDC4
682,GO:0005080,0.401630352958127,0.949389394055082,1,2,protein kinase C binding,MF,SDC4
4403,GO:0046631,0.402665233776609,0.949089242499647,1,2,alpha-beta T cell activation,BP,PNP
4404,GO:0046632,0.402665233776609,0.949089242499647,1,2,alpha-beta T cell differentiation,BP,PNP
4190,GO:0045540,0.403081157873208,0.948968285518901,1,2,regulation of cholesterol biosynthetic process,BP,DHCR7
459,GO:0003158,0.40394407590735,0.806721984277113,4,13,endothelium development,BP,RHOB;LAMA5;DLL1;CLDN1
858,GO:0005923,0.404328056931761,0.802241878846255,4,15,bicellular tight junction,CC,CLDN11;CLDN1;CLDN3;CGN
5622,GO:0070160,0.404328056931761,0.802241878846255,4,15,occluding junction,CC,CLDN11;CLDN1;CLDN3;CGN
2936,GO:0032456,0.405454059437619,0.948274640057362,1,2,endocytic recycling,BP,ACTN2
6553,GO:1901361,0.40574343130012,0.824001747146269,3,12,organic cyclic compound catabolic process,BP,PNP;PDE4B;AOX1
2919,GO:0032411,0.405884390843284,0.948148193228861,1,2,positive regulation of transporter activity,BP,ACTN2
2922,GO:0032414,0.405884390843284,0.948148193228861,1,2,positive regulation of ion transmembrane transporter activity,BP,ACTN2
2790,GO:0031944,0.405957796160619,0.94812660405766,1,2,negative regulation of glucocorticoid metabolic process,BP,DKK3
2793,GO:0031947,0.405957796160619,0.94812660405766,1,2,negative regulation of glucocorticoid biosynthetic process,BP,DKK3
2885,GO:0032345,0.405957796160619,0.94812660405766,1,2,negative regulation of aldosterone metabolic process,BP,DKK3
2888,GO:0032348,0.405957796160619,0.94812660405766,1,2,negative regulation of aldosterone biosynthetic process,BP,DKK3
2891,GO:0032351,0.405957796160619,0.94812660405766,1,2,negative regulation of hormone metabolic process,BP,DKK3
2893,GO:0032353,0.405957796160619,0.94812660405766,1,2,negative regulation of hormone biosynthetic process,BP,DKK3
6155,GO:0090032,0.405957796160619,0.94812660405766,1,2,negative regulation of steroid hormone biosynthetic process,BP,DKK3
7062,GO:2000065,0.405957796160619,0.94812660405766,1,2,negative regulation of cortisol biosynthetic process,BP,DKK3
4486,GO:0047485,0.405998998105959,0.948114483629123,1,2,protein N-terminus binding,MF,MYO7A
623,GO:0004553,0.406060790932398,0.932773921522975,1,3,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,HEXB
1490,GO:0009311,0.406060790932398,0.932773921522975,1,3,oligosaccharide metabolic process,BP,HEXB
2092,GO:0016798,0.406060790932398,0.932773921522975,1,3,hydrolase activity, acting on glycosyl bonds,MF,HEXB
1518,GO:0009628,0.406527258501211,0.755013241749304,7,32,response to abiotic stimulus,BP,CDKN1A;RHOB;PIK3R1;SLC52A3;CLDN1;CTGF;CLDN3
1333,GO:0008154,0.406857703907612,0.832299561875691,3,9,actin polymerization or depolymerization,BP,ACTN2;PLEKHH2;FHOD3
3983,GO:0044249,0.406964631906027,0.695452182336257,25,122,cellular biosynthetic process,BP,ACTN2;PNP;ACSF2;CDKN1A;HMGCS2;DKK3;KITLG;PHLDA1;PIK3R1;MRI1;PRND;HEXB;HSD17B3;CYP11A1;GAS6;HSD3B2;DLL1;TICAM1;HMGN5;RBMS3;ACSL4;FOXO4;ITGA3;PDK4;CTGF
683,GO:0005085,0.407271568508256,0.798419225492504,4,16,guanyl-nucleotide exchange factor activity,MF,ACTN2;NRTN;KITLG;RIN3
1038,GO:0006700,0.407796879540408,0.869066329123292,2,6,C21-steroid hormone biosynthetic process,BP,DKK3;CYP11A1
1753,GO:0010927,0.407866503709583,0.877030188100005,2,5,cellular component assembly involved in morphogenesis,BP,ACTN2;FHOD3
2481,GO:0030239,0.407866503709583,0.877030188100005,2,5,myofibril assembly,BP,ACTN2;FHOD3
1848,GO:0014911,0.408851670601266,0.947270819309611,1,2,positive regulation of smooth muscle cell migration,BP,FOXO4
4898,GO:0051151,0.408851670601266,0.947270819309611,1,2,negative regulation of smooth muscle cell differentiation,BP,FOXO4
4256,GO:0045765,0.409528151982621,0.835516055877965,3,8,regulation of angiogenesis,BP,RHOB;DLL1;FOXO4
5166,GO:0055119,0.409757834234409,0.94700096711988,1,2,relaxation of cardiac muscle,BP,PDE4B
6528,GO:1901077,0.409757834234409,0.94700096711988,1,2,regulation of relaxation of muscle,BP,PDE4B
6620,GO:1901897,0.409757834234409,0.94700096711988,1,2,regulation of relaxation of cardiac muscle,BP,PDE4B
4622,GO:0048630,0.409837598435439,0.946977170581629,1,2,skeletal muscle tissue growth,BP,DLL1
4623,GO:0048631,0.409837598435439,0.946977170581629,1,2,regulation of skeletal muscle tissue growth,BP,DLL1
4624,GO:0048633,0.409837598435439,0.946977170581629,1,2,positive regulation of skeletal muscle tissue growth,BP,DLL1
4633,GO:0048643,0.409837598435439,0.946977170581629,1,2,positive regulation of skeletal muscle tissue development,BP,DLL1
3336,GO:0035295,0.409964317066633,0.732802142959856,10,40,tube development,BP,CDKN1A;RHOB;LAMA5;PRKACB;SDC4;DLL1;CRISPLD2;DHCR7;ITGA3;CTGF
5434,GO:0060839,0.410500263952199,0.946779203834233,1,2,endothelial cell fate commitment,BP,DLL1
1597,GO:0010288,0.410832450790845,0.946679783964296,1,2,response to lead ion,BP,CLDN1
781,GO:0005610,0.410873105686156,1,1,1,laminin-5 complex,CC,LAMA5
3765,GO:0043083,0.410873105686156,1,1,1,synaptic cleft,CC,LAMA5
3825,GO:0043259,0.410873105686156,1,1,1,laminin-10 complex,CC,LAMA5
3826,GO:0043260,0.410873105686156,1,1,1,laminin-11 complex,CC,LAMA5
3737,GO:0042981,0.412936375336186,0.718476184931463,12,55,regulation of apoptotic process,BP,ACTN2;CDKN1A;NUAK2;KITLG;RHOB;PIK3R1;GAS6;DLL1;HMGN5;CASP4;PDK4;CTGF
1366,GO:0008289,0.413199372452377,0.775089937619827,5,21,lipid binding,MF,ACTN2;SNX21;MFGE8;GAS6;SERPINA5
6281,GO:0097110,0.413629775732408,0.945837755863826,1,2,scaffold protein binding,MF,DLL1
1778,GO:0014002,0.413984934322454,0.945730230658553,1,2,astrocyte development,BP,DLL1
3605,GO:0042306,0.414196002406347,0.823523334580789,3,10,regulation of protein import into nucleus,BP,CDKN1A;PIK3R1;GAS6
6816,GO:1903533,0.414196002406347,0.823523334580789,3,10,regulation of protein targeting,BP,CDKN1A;PIK3R1;GAS6
6903,GO:1904589,0.414196002406347,0.823523334580789,3,10,regulation of protein import,BP,CDKN1A;PIK3R1;GAS6
2452,GO:0030176,0.415106322837124,0.929328092400837,1,3,integral component of endoplasmic reticulum membrane,CC,DHCR7
2681,GO:0031227,0.415106322837124,0.929328092400837,1,3,intrinsic component of endoplasmic reticulum membrane,CC,DHCR7
1063,GO:0006775,0.415171081202626,0.945370108250906,1,2,fat-soluble vitamin metabolic process,BP,CYP11A1
3622,GO:0042359,0.415171081202626,0.945370108250906,1,2,vitamin D metabolic process,BP,CYP11A1
650,GO:0004721,0.415518239880588,0.929168556315224,1,3,phosphoprotein phosphatase activity,MF,PTPN7
651,GO:0004725,0.415518239880588,0.929168556315224,1,3,protein tyrosine phosphatase activity,MF,PTPN7
3347,GO:0035335,0.415518239880588,0.929168556315224,1,3,peptidyl-tyrosine dephosphorylation,BP,PTPN7
6314,GO:0097305,0.415709334410135,0.855017699575934,2,8,response to alcohol,BP,CLDN1;CLDN3
6362,GO:0098552,0.41583534912926,0.798004141284972,4,13,side of membrane,CC,MFGE8;SERPINA5;PTPN7;ITGA3
2815,GO:0032008,0.416681561134851,0.944909252534812,1,2,positive regulation of TOR signaling,BP,GAS6
1776,GO:0012505,0.417217887724391,0.688429836999799,23,111,endomembrane system,CC,ACTN2;PNP;RHOB;REEP1;SNX21;PIK3R1;HEXB;HSD17B3;SDC4;GAS6;SERPINA5;HSD3B2;TICAM1;RIN3;TMEM163;CRISPLD2;RAB39B;CASP4;DHCR7;PDE4B;ACSL4;CTGF;GPSM1
1309,GO:0008047,0.417454492444107,0.815786457679421,3,12,enzyme activator activity,MF,CDKN1A;GAS6;RIN3
2292,GO:0021532,0.417527124053381,0.928387213856747,1,3,neural tube patterning,BP,PRKACB
842,GO:0005884,0.417957354902665,0.871448742840589,2,5,actin filament,CC,ACTN2;ESPN
1152,GO:0007033,0.418038671744223,0.863093235174305,2,6,vacuole organization,BP,MYO7A;HEXB
3999,GO:0044283,0.418550912105073,0.745603963866929,7,31,small molecule biosynthetic process,BP,PNP;HMGCS2;DKK3;MRI1;HSD17B3;DHCR7;PDK4
4770,GO:0050776,0.418746995788225,0.789781980575543,4,16,regulation of immune response,BP,PIK3R1;PRKACB;TICAM1;PDE4B
1113,GO:0006915,0.418919025261354,0.70608499135448,14,63,apoptotic process,BP,ACTN2;CDKN1A;NUAK2;KITLG;RHOB;PHLDA1;PIK3R1;GAS6;DLL1;TICAM1;HMGN5;CASP4;PDK4;CTGF
4918,GO:0051193,0.419509454986372,0.944039596079897,1,2,regulation of cofactor metabolic process,BP,PDK4
4921,GO:0051196,0.419509454986372,0.944039596079897,1,2,regulation of coenzyme metabolic process,BP,PDK4
5653,GO:0070266,0.419955585536139,0.927435342856522,1,3,necroptotic process,BP,TICAM1
6313,GO:0097300,0.419955585536139,0.927435342856522,1,3,programmed necrotic cell death,BP,TICAM1
2139,GO:0017124,0.420236672323139,0.943814506428188,1,2,SH3 domain binding,MF,ESPN
1414,GO:0008652,0.420631240754231,0.943692129781555,1,2,cellular amino acid biosynthetic process,BP,MRI1
6577,GO:1901607,0.420631240754231,0.943692129781555,1,2,alpha-amino acid biosynthetic process,BP,MRI1
3680,GO:0042578,0.420888996358028,0.855796934835033,2,7,phosphoric ester hydrolase activity,MF,PTPN7;PDE4B
2428,GO:0030098,0.421251448272123,0.791587618404269,4,14,lymphocyte differentiation,BP,PNP;PIK3R1;GAS6;DLL1
1598,GO:0010324,0.421621627619121,0.943384184808271,1,2,membrane invagination,BP,MFGE8
6428,GO:0099024,0.421621627619121,0.943384184808271,1,2,plasma membrane invagination,BP,MFGE8
5850,GO:0071495,0.422944009911614,0.707696979657881,13,52,cellular response to endogenous stimulus,BP,ACTN2;DKK3;PIK3R1;ITGB5;PRKACB;CASP4;CLDN1;PDE4B;FOXO4;ITGA3;PDK4;CTGF;CGN
4913,GO:0051183,0.422952900839169,0.926249365003996,1,3,vitamin transporter activity,MF,SLC52A3
231,GO:0001954,0.423420649787841,0.942821970364263,1,2,positive regulation of cell-matrix adhesion,BP,SDC4
5081,GO:0051893,0.423420649787841,0.942821970364263,1,2,regulation of focal adhesion assembly,BP,SDC4
5082,GO:0051894,0.423420649787841,0.942821970364263,1,2,positive regulation of focal adhesion assembly,BP,SDC4
6171,GO:0090109,0.423420649787841,0.942821970364263,1,2,regulation of cell-substrate junction assembly,BP,SDC4
6791,GO:1903391,0.423420649787841,0.942821970364263,1,2,regulation of adherens junction organization,BP,SDC4
6792,GO:1903393,0.423420649787841,0.942821970364263,1,2,positive regulation of adherens junction organization,BP,SDC4
172,GO:0001779,0.423636042814629,0.942754411683471,1,2,natural killer cell differentiation,BP,GAS6
5820,GO:0071375,0.424033776153219,0.771994658480572,5,17,cellular response to peptide hormone stimulus,BP,ACTN2;PIK3R1;PRKACB;FOXO4;PDK4
2679,GO:0031225,0.424485804556968,0.942487366929861,1,2,anchored component of membrane,CC,PRND
2204,GO:0019218,0.424520798649121,0.813240285063016,3,11,regulation of steroid metabolic process,BP,DKK3;DHCR7;DHH
112,GO:0001523,0.424842902033314,0.925495167909804,1,3,retinoid metabolic process,BP,SDC4
2910,GO:0032387,0.425677601847527,0.942111449138496,1,2,negative regulation of intracellular transport,BP,GAS6
3607,GO:0042308,0.425677601847527,0.942111449138496,1,2,negative regulation of protein import into nucleus,BP,GAS6
4429,GO:0046823,0.425677601847527,0.942111449138496,1,2,negative regulation of nucleocytoplasmic transport,BP,GAS6
6225,GO:0090317,0.425677601847527,0.942111449138496,1,2,negative regulation of intracellular protein transport,BP,GAS6
6904,GO:1904590,0.425677601847527,0.942111449138496,1,2,negative regulation of protein import,BP,GAS6
2738,GO:0031527,0.42579056985219,0.942075732575621,1,2,filopodium membrane,CC,ITGA3
2438,GO:0030141,0.425919585356721,0.750616941992353,6,26,secretory granule,CC,ACTN2;PNP;HEXB;GAS6;SERPINA5;CRISPLD2
171,GO:0001776,0.425937215711775,0.858387333085124,2,6,leukocyte homeostasis,BP,KITLG;PDE4B
3188,GO:0034121,0.425997030440935,0.942010419227054,1,2,regulation of toll-like receptor signaling pathway,BP,TICAM1
3189,GO:0034122,0.425997030440935,0.942010419227054,1,2,negative regulation of toll-like receptor signaling pathway,BP,TICAM1
6257,GO:0097009,0.426166850096682,0.941956660636427,1,2,energy homeostasis,BP,DLL1
302,GO:0002283,0.426204321703492,0.809532437061882,3,12,neutrophil activation involved in immune response,BP,PNP;HEXB;CRISPLD2
338,GO:0002446,0.426204321703492,0.809532437061882,3,12,neutrophil mediated immunity,BP,PNP;HEXB;CRISPLD2
3480,GO:0036230,0.426204321703492,0.809532437061882,3,12,granulocyte activation,BP,PNP;HEXB;CRISPLD2
3576,GO:0042119,0.426204321703492,0.809532437061882,3,12,neutrophil activation,BP,PNP;HEXB;CRISPLD2
3845,GO:0043312,0.426204321703492,0.809532437061882,3,12,neutrophil degranulation,BP,PNP;HEXB;CRISPLD2
4428,GO:0046822,0.426331299545913,0.811950665978739,3,11,regulation of nucleocytoplasmic transport,BP,CDKN1A;PIK3R1;GAS6
4133,GO:0045124,0.426380553730449,0.941888963143497,1,2,regulation of bone resorption,BP,PDK4
4437,GO:0046850,0.426380553730449,0.941888963143497,1,2,regulation of bone remodeling,BP,PDK4
4666,GO:0048731,0.427196746827809,0.672097715047106,34,148,system development,BP,ACTN2;PNP;NRTN;MYO7A;CDKN1A;RHOJ;DKK3;KITLG;RHOB;PIK3R1;HEXB;CLDN11;MFGE8;LAMA5;PRKACB;CAMSAP3;HSD17B3;ITGB8;SDC4;GAS6;SERPINA5;DLL1;FHOD3;CRISPLD2;SEMA6C;DHCR7;CLDN1;ACSL4;DHH;FOXO4;ITGA3;CTGF;GPSM1;MARK4
3744,GO:0042995,0.427254611840646,0.708663689827457,12,46,cell projection,CC,ACTN2;NRTN;MYO7A;KITLG;MRI1;PLEKHH2;PRKACB;RAB39B;PDE4B;ITGA3;ESPN;MARK4
6093,GO:0072583,0.428281061870453,0.924110486309818,1,3,clathrin-dependent endocytosis,BP,DLL1
5915,GO:0071887,0.428282989016847,0.856972895578537,2,6,leukocyte apoptotic process,BP,KITLG;GAS6
2516,GO:0030374,0.428496613510487,0.941215807989559,1,2,ligand-dependent nuclear receptor transcription coactivator activity,MF,ACTN2
204,GO:0001894,0.429164287370368,0.850666593635711,2,7,tissue homeostasis,BP,PDK4;CTGF
5834,GO:0071417,0.429316812590727,0.741245050432613,7,25,cellular response to organonitrogen compound,BP,ACTN2;PIK3R1;PRKACB;CASP4;PDE4B;FOXO4;PDK4
3745,GO:0043005,0.430201116250782,0.749801517377675,6,23,neuron projection,CC,ACTN2;NRTN;RAB39B;PDE4B;ITGA3;MARK4
4412,GO:0046661,0.430653682051712,0.806313841137434,3,12,male sex differentiation,BP,KITLG;HSD17B3;DHH
5355,GO:0060548,0.430782324971116,0.719610131868412,9,39,negative regulation of cell death,BP,CDKN1A;NUAK2;KITLG;PIK3R1;GAS6;DLL1;HMGN5;PDK4;CTGF
34,GO:0000226,0.431017713889408,0.845348595085572,2,8,microtubule cytoskeleton organization,BP,CAMSAP3;MARK4
1146,GO:0007017,0.431017713889408,0.845348595085572,2,8,microtubule-based process,BP,CAMSAP3;MARK4
5952,GO:0072070,0.431513190760598,0.940247267653617,1,2,loop of Henle development,BP,DLL1
3141,GO:0033554,0.432136405505794,0.711996699267812,10,44,cellular response to stress,BP,CDKN1A;NUAK2;RHOB;PIK3R1;SLC52A3;GAS6;CASP4;FOXO4;PDK4;CTGF
2550,GO:0030551,0.432518683402514,0.939922090192365,1,2,cyclic nucleotide binding,MF,PDE4B
2551,GO:0030552,0.432518683402514,0.939922090192365,1,2,cAMP binding,MF,PDE4B
703,GO:0005158,0.43288816486874,0.939802304201152,1,2,insulin receptor binding,MF,PIK3R1
1499,GO:0009416,0.433138929326036,0.854020201638622,2,6,response to light stimulus,BP,CDKN1A;PIK3R1
800,GO:0005759,0.433569973389739,0.774397238759271,4,19,mitochondrial matrix,CC,ACSF2;HMGCS2;CYP11A1;PDK4
3869,GO:0043434,0.43393717417631,0.747838717725274,6,22,response to peptide hormone,BP,ACTN2;PIK3R1;PRKACB;FOXO4;PDK4;CTGF
5906,GO:0071867,0.434582651472795,0.939250912943386,1,2,response to monoamine,BP,PDE4B
5907,GO:0071868,0.434582651472795,0.939250912943386,1,2,cellular response to monoamine stimulus,BP,PDE4B
5908,GO:0071869,0.434582651472795,0.939250912943386,1,2,response to catecholamine,BP,PDE4B
5909,GO:0071870,0.434582651472795,0.939250912943386,1,2,cellular response to catecholamine stimulus,BP,PDE4B
5910,GO:0071871,0.434582651472795,0.939250912943386,1,2,response to epinephrine,BP,PDE4B
5911,GO:0071872,0.434582651472795,0.939250912943386,1,2,cellular response to epinephrine stimulus,BP,PDE4B
4124,GO:0045089,0.434656429251993,0.843000795652634,2,8,positive regulation of innate immune response,BP,PRKACB;TICAM1
846,GO:0005891,0.434843377136102,0.939165774284071,1,2,voltage-gated calcium channel complex,CC,PDE4B
3280,GO:0034704,0.434843377136102,0.939165774284071,1,2,calcium channel complex,CC,PDE4B
1317,GO:0008081,0.435666687850976,0.938896403774508,1,2,phosphoric diester hydrolase activity,MF,PDE4B
4636,GO:0048646,0.437103755099495,0.698855146371213,12,49,anatomical structure formation involved in morphogenesis,BP,ACTN2;RHOB;MFGE8;LAMA5;ITGB5;PRKACB;SDC4;DLL1;FHOD3;FOXO4;ITGA3;CTGF
6991,GO:1905897,0.437452889987044,0.93830925887522,1,2,regulation of response to endoplasmic reticulum stress,BP,PIK3R1
6992,GO:1905898,0.437452889987044,0.93830925887522,1,2,positive regulation of response to endoplasmic reticulum stress,BP,PIK3R1
1450,GO:0009119,0.437587025367279,0.938265015488392,1,2,ribonucleoside metabolic process,BP,PNP
3600,GO:0042278,0.437587025367279,0.938265015488392,1,2,purine nucleoside metabolic process,BP,PNP
4331,GO:0046128,0.437587025367279,0.938265015488392,1,2,purine ribonucleoside metabolic process,BP,PNP
441,GO:0003091,0.438307755778751,0.938026925441943,1,2,renal water homeostasis,BP,PRKACB
866,GO:0005952,0.438307755778751,0.938026925441943,1,2,cAMP-dependent protein kinase complex,CC,PRKACB
3193,GO:0034199,0.438307755778751,0.938026925441943,1,2,activation of protein kinase A activity,BP,PRKACB
6340,GO:0097546,0.438307755778751,0.938026925441943,1,2,ciliary base,CC,PRKACB
4973,GO:0051302,0.438748464770749,0.919792693437712,1,3,regulation of cell division,BP,DLL1
2486,GO:0030274,0.441033652790077,0.937120878378336,1,2,LIM domain binding,MF,ACTN2
828,GO:0005811,0.441208766951162,0.918755205931659,1,3,lipid particle,CC,ACSL4
2434,GO:0030133,0.441217946150325,0.796417507948643,3,13,transport vesicle,CC,TMEM163;CRISPLD2;PDE4B
2803,GO:0031970,0.441267007787967,0.918730540906433,1,3,organelle envelope lumen,CC,HSD3B2
2552,GO:0030554,0.441578445583811,0.721381904746003,8,29,adenyl nucleotide binding,MF,ACSF2;MYO7A;NUAK2;PRKACB;PDE4B;ACSL4;PDK4;MARK4
2959,GO:0032559,0.441578445583811,0.721381904746003,8,29,adenyl ribonucleotide binding,MF,ACSF2;MYO7A;NUAK2;PRKACB;PDE4B;ACSL4;PDK4;MARK4
6844,GO:1903672,0.441726395221282,0.93688921467282,1,2,positive regulation of sprouting angiogenesis,BP,DLL1
4142,GO:0045177,0.441825074799277,0.778355117539128,4,13,apical part of cell,CC,MYO7A;SLC52A3;DLL1;CLDN1
2043,GO:0016579,0.442102842619526,0.918376026066911,1,3,protein deubiquitination,BP,FOXO4
5715,GO:0070646,0.442102842619526,0.918376026066911,1,3,protein modification by small protein removal,BP,FOXO4
2918,GO:0032410,0.442132061081464,0.936753288216859,1,2,negative regulation of transporter activity,BP,ACTN2
2921,GO:0032413,0.442132061081464,0.936753288216859,1,2,negative regulation of ion transmembrane transporter activity,BP,ACTN2
6515,GO:1901016,0.442132061081464,0.936753288216859,1,2,regulation of potassium ion transmembrane transporter activity,BP,ACTN2
6516,GO:1901017,0.442132061081464,0.936753288216859,1,2,negative regulation of potassium ion transmembrane transporter activity,BP,ACTN2
3447,GO:0035987,0.443117845503414,0.936422162397699,1,2,endodermal cell differentiation,BP,ITGB5
2417,GO:0030049,0.443137567787189,0.936415525809491,1,2,muscle filament sliding,BP,ACTN2
3126,GO:0033275,0.443137567787189,0.936415525809491,1,2,actin-myosin filament sliding,BP,ACTN2
4631,GO:0048641,0.443896026386904,0.917612053329696,1,3,regulation of skeletal muscle tissue development,BP,DLL1
2766,GO:0031670,0.44426838797857,0.936034223154309,1,2,cellular response to nutrient,BP,GAS6
5791,GO:0071295,0.44426838797857,0.936034223154309,1,2,cellular response to vitamin,BP,GAS6
295,GO:0002262,0.444594359394755,0.84692141922009,2,6,myeloid cell homeostasis,BP,KITLG;PDE4B
4262,GO:0045785,0.444822690710944,0.773501052183168,4,14,positive regulation of cell adhesion,BP,PNP;PIK3R1;SDC4;ITGA3
1069,GO:0006805,0.445123350963692,0.917086476003736,1,3,xenobiotic metabolic process,BP,CMBL
1497,GO:0009410,0.445123350963692,0.917086476003736,1,3,response to xenobiotic stimulus,BP,CMBL
5844,GO:0071466,0.445123350963692,0.917086476003736,1,3,cellular response to xenobiotic stimulus,BP,CMBL
1183,GO:0007167,0.445687957364463,0.690529241896314,12,51,enzyme linked receptor protein signaling pathway,BP,NRTN;DKK3;PIK3R1;ITGB5;MPZL1;GAS6;DLL1;FOXO4;ITGA3;PDK4;CTGF;CGN
1361,GO:0008277,0.445923124336028,0.84608577767051,2,6,regulation of G-protein coupled receptor protein signaling pathway,BP,GPRASP1;GPSM1
5020,GO:0051536,0.446386917588616,0.935315737564477,1,2,iron-sulfur cluster binding,MF,AOX1
5023,GO:0051540,0.446386917588616,0.935315737564477,1,2,metal cluster binding,MF,AOX1
3868,GO:0043433,0.446520541680272,0.91648549174887,1,3,negative regulation of sequence-specific DNA binding transcription factor activity,BP,GAS6
5115,GO:0052689,0.446602813978497,0.907520142828884,1,4,carboxylic ester hydrolase activity,MF,PON2
6558,GO:1901381,0.446717982285939,0.935202970272945,1,2,positive regulation of potassium ion transmembrane transport,BP,ACTN2
844,GO:0005887,0.446920609083326,0.700159049506055,10,41,integral component of plasma membrane,CC,ITGB5;SLC52A3;ITGB8;MPZL1;SDC4;DLL1;SLC18B1;CLDN1;ITGA3;CLDN3
5292,GO:0060401,0.447638900419221,0.91600239269457,1,3,cytosolic calcium ion transport,BP,CTGF
3589,GO:0042180,0.448075113296261,0.789439004070036,3,14,cellular ketone metabolic process,BP,DKK3;HSD17B3;PDK4
173,GO:0001780,0.450051956005727,0.934059947207999,1,2,neutrophil homeostasis,BP,PDE4B
6626,GO:1901981,0.450438817792604,0.843226755775686,2,6,phosphatidylinositol phosphate binding,MF,ACTN2;SNX21
6740,GO:1902936,0.450438817792604,0.843226755775686,2,6,phosphatidylinositol bisphosphate binding,MF,ACTN2;SNX21
1633,GO:0010564,0.450736166930817,0.761914604735161,4,18,regulation of cell cycle process,BP,CDKN1A;HMGN5;FOXO4;CTGF
4803,GO:0050851,0.45080399603636,0.836785090298911,2,7,antigen receptor-mediated signaling pathway,BP,PIK3R1;PDE4B
4804,GO:0050852,0.45080399603636,0.836785090298911,2,7,T cell receptor signaling pathway,BP,PIK3R1;PDE4B
6720,GO:1902806,0.451104677927958,0.905375273257919,1,4,regulation of cell cycle G1/S phase transition,BP,CDKN1A
7054,GO:2000045,0.451104677927958,0.905375273257919,1,4,regulation of G1/S transition of mitotic cell cycle,BP,CDKN1A
3465,GO:0036064,0.452761523230072,0.933121014880185,1,2,ciliary basal body,CC,MARK4
3783,GO:0043154,0.452911364688063,0.913700117788823,1,3,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,GAS6
7072,GO:2000117,0.452911364688063,0.913700117788823,1,3,negative regulation of cysteine-type endopeptidase activity,BP,GAS6
3933,GO:0043627,0.453092787130456,0.913620168008633,1,3,response to estrogen,BP,DHH
3774,GO:0043112,0.45339580348456,0.932899920260525,1,2,receptor metabolic process,BP,GPRASP1
1097,GO:0006886,0.453761411057301,0.744779316738929,5,19,intracellular protein transport,BP,MYO7A;CDKN1A;RHOB;PIK3R1;GAS6
5013,GO:0051491,0.453763168649818,0.932771639279551,1,2,positive regulation of filopodium assembly,BP,ESPN
1890,GO:0015645,0.453912861182324,0.932719320160542,1,2,fatty acid ligase activity,MF,ACSL4
5708,GO:0070588,0.454051250150384,0.834642922933056,2,7,calcium ion transmembrane transport,BP,GAS6;PDE4B
1226,GO:0007283,0.454448222081171,0.794737818750159,3,10,spermatogenesis,BP,CLDN11;SERPINA5;DHH
4531,GO:0048232,0.454448222081171,0.794737818750159,3,10,male gamete generation,BP,CLDN11;SERPINA5;DHH
2275,GO:0019901,0.454840925740831,0.745432310418714,5,18,protein kinase binding,MF,CDKN1A;PIK3R1;SDC4;GAS6;TICAM1
3967,GO:0044089,0.455422692636258,0.759516550406418,4,17,positive regulation of cellular component biogenesis,BP,SDC4;CLDN1;CTGF;ESPN
5559,GO:0061370,0.457699654504224,0.911573593952895,1,3,testosterone biosynthetic process,BP,HSD17B3
3039,GO:0032844,0.457865646975267,0.788792493976583,3,11,regulation of homeostatic process,BP,KITLG;DLL1;PDK4
4430,GO:0046824,0.458090516379396,0.838314124142073,2,6,positive regulation of nucleocytoplasmic transport,BP,PIK3R1;GAS6
4052,GO:0044456,0.45823435014682,0.742622615263662,5,18,synapse part,CC,ACTN2;LAMA5;TMEM163;PDE4B;ITGA3
2449,GO:0030168,0.459049251783292,0.791309671862534,3,10,platelet activation,BP,RHOB;PIK3R1;GAS6
191,GO:0001841,0.459667088152673,0.837291190724815,2,6,neural tube formation,BP,PRKACB;SDC4
1785,GO:0014020,0.459667088152673,0.837291190724815,2,6,primary neural tube formation,BP,PRKACB;SDC4
328,GO:0002407,0.459902934993195,0.930602931689554,1,2,dendritic cell chemotaxis,BP,GAS6
3487,GO:0036336,0.459902934993195,0.930602931689554,1,2,dendritic cell migration,BP,GAS6
1203,GO:0007220,0.46106663164706,0.93018658425103,1,2,Notch receptor processing,BP,DLL1
1138,GO:0006986,0.462015788876525,0.929845733797764,1,2,response to unfolded protein,BP,PIK3R1
2632,GO:0030968,0.462015788876525,0.929845733797764,1,2,endoplasmic reticulum unfolded protein response,BP,PIK3R1
3255,GO:0034620,0.462015788876525,0.929845733797764,1,2,cellular response to unfolded protein,BP,PIK3R1
3444,GO:0035966,0.462015788876525,0.929845733797764,1,2,response to topologically incorrect protein,BP,PIK3R1
3445,GO:0035967,0.462015788876525,0.929845733797764,1,2,cellular response to topologically incorrect protein,BP,PIK3R1
4568,GO:0048468,0.462546181966272,0.656420288428977,18,76,cell development,BP,ACTN2;NRTN;MYO7A;CDKN1A;KITLG;PIK3R1;HEXB;LAMA5;CAMSAP3;SDC4;DLL1;FHOD3;SEMA6C;CLDN1;ACSL4;DHH;ITGA3;CLDN3
2183,GO:0019058,0.462550226157677,0.793084813660892,3,9,viral life cycle,BP,ITGB5;GAS6;CLDN1
2568,GO:0030672,0.462558853945661,0.909380438319439,1,3,synaptic vesicle membrane,CC,TMEM163
6436,GO:0099501,0.462558853945661,0.909380438319439,1,3,exocytic vesicle membrane,CC,TMEM163
2028,GO:0016485,0.462617646350183,0.828916489585344,2,7,protein processing,BP,PRKACB;GAS6
2506,GO:0030318,0.463096366946831,0.929456305803063,1,2,melanocyte differentiation,BP,KITLG
761,GO:0005520,0.463462125968029,0.929324156056335,1,2,insulin-like growth factor binding,MF,CTGF
1077,GO:0006816,0.463835162703585,0.784258099086548,3,11,calcium ion transport,BP,GAS6;PDE4B;CTGF
1581,GO:0010033,0.465083739815366,0.648731617244791,20,96,response to organic substance,BP,ACTN2;CDKN1A;DKK3;PIK3R1;ITGB5;PRKACB;GAS6;DLL1;TICAM1;CASP4;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;CTGF;CLDN3;CGN
2445,GO:0030162,0.465787120708054,0.747305997099642,4,20,regulation of proteolysis,BP,PRKACB;GAS6;SERPINA5;CTGF
5007,GO:0051447,0.46768606211395,0.907027462977221,1,3,negative regulation of meiotic cell cycle,BP,PRKACB
2798,GO:0031960,0.467759453486657,0.781250697652336,3,11,response to corticosteroid,BP,CDKN1A;CLDN1;CTGF
3318,GO:0035162,0.467797732391874,0.927744735243982,1,2,embryonic hemopoiesis,BP,KITLG
4812,GO:0050870,0.467804939693095,0.825395336181544,2,7,positive regulation of T cell activation,BP,PNP;PIK3R1
6754,GO:1903039,0.467804939693095,0.825395336181544,2,7,positive regulation of leukocyte cell-cell adhesion,BP,PNP;PIK3R1
1993,GO:0016328,0.467921974260917,0.820633316942188,2,8,lateral plasma membrane,CC,CLDN1;CLDN3
3674,GO:0042552,0.468546467847547,0.824888657139787,2,7,myelination,BP,HEXB;DHH
5122,GO:0055002,0.469311388377715,0.830953017253087,2,6,striated muscle cell development,BP,ACTN2;FHOD3
1754,GO:0010934,0.469605218042878,0.927079184865853,1,2,macrophage cytokine production,BP,GAS6
1968,GO:0016197,0.469667391625288,0.779780893525851,3,11,endosomal transport,BP,ACTN2;GPRASP1;RHOB
4164,GO:0045321,0.469731171745042,0.685616619975497,9,38,leukocyte activation,BP,PNP;CDKN1A;PIK3R1;HEXB;SDC4;GAS6;DLL1;TICAM1;CRISPLD2
5623,GO:0070161,0.470913957306693,0.695695648623853,8,29,anchoring junction,CC,ACTN2;RHOB;ITGB5;CAMSAP3;MPZL1;SDC4;DLL1;ITGA3
5652,GO:0070265,0.471117526630128,0.895448591478723,1,4,necrotic cell death,BP,TICAM1
3923,GO:0043603,0.471402916658602,0.74501199808091,4,18,cellular amide metabolic process,BP,HEXB;ITGB8;GAS6;RBMS3
4252,GO:0045744,0.471555925071309,0.926356173519679,1,2,negative regulation of G-protein coupled receptor protein signaling pathway,BP,GPRASP1
3551,GO:0042033,0.471779824047696,0.926272872509725,1,2,chemokine biosynthetic process,BP,TICAM1
4119,GO:0045073,0.471779824047696,0.926272872509725,1,2,regulation of chemokine biosynthetic process,BP,TICAM1
4121,GO:0045080,0.471779824047696,0.926272872509725,1,2,positive regulation of chemokine biosynthetic process,BP,TICAM1
4760,GO:0050755,0.471779824047696,0.926272872509725,1,2,chemokine metabolic process,BP,TICAM1
1345,GO:0008207,0.472088906162,0.822456598801087,2,7,C21-steroid hormone metabolic process,BP,DKK3;CYP11A1
4123,GO:0045088,0.472806178196327,0.813646140080824,2,9,regulation of innate immune response,BP,PRKACB;TICAM1
1701,GO:0010810,0.473461861932241,0.784912556931984,3,9,regulation of cell-substrate adhesion,BP,PIK3R1;SDC4;ITGA3
3129,GO:0033293,0.475917308752898,0.892970518309771,1,4,monocarboxylic acid binding,MF,SERPINA5
4457,GO:0046890,0.477619466651372,0.741281062420112,4,17,regulation of lipid biosynthetic process,BP,DKK3;DHCR7;DHH;PDK4
3577,GO:0042127,0.477952222552627,0.659168170607561,12,58,regulation of cell proliferation,BP,PNP;CDKN1A;KITLG;LAMA5;SDC4;GAS6;DLL1;TICAM1;HMGN5;DHCR7;FOXO4;CTGF
5351,GO:0060541,0.478892325878511,0.722177702090208,5,20,respiratory system development,BP,LAMA5;CRISPLD2;DHCR7;ITGA3;CTGF
2546,GO:0030539,0.479716167236644,0.884945682932262,1,5,male genitalia development,BP,HSD17B3
2025,GO:0016477,0.479724173857778,0.655002714892968,13,56,cell migration,BP,LAMA1;NRTN;KITLG;RHOB;PIK3R1;HEXB;LAMA5;SDC4;GAS6;PDE4B;FOXO4;ITGA3;CTGF
555,GO:0003824,0.479828778357342,0.624340549981651,29,147,catalytic activity,MF,PNP;ACSF2;MYO7A;CDKN1A;HMGCS2;NUAK2;RHOJ;KITLG;RHOB;PIK3R1;MRI1;HEXB;CMBL;PRKACB;HSD17B3;CYP11A1;HSD3B2;RAB39B;PTPN7;CASP4;DHCR7;PON2;PDE4B;ACSL4;DHH;PDK4;AOX1;CGN;MARK4
2783,GO:0031902,0.480370803250348,0.901031409980778,1,3,late endosome membrane,CC,RHOB
882,GO:0006022,0.48209171166429,0.815485284421509,2,7,aminoglycan metabolic process,BP,HEXB;SDC4
2462,GO:0030203,0.48209171166429,0.815485284421509,2,7,glycosaminoglycan metabolic process,BP,HEXB;SDC4
1005,GO:0006606,0.482231022556767,0.769976409462193,3,11,protein import into nucleus,BP,CDKN1A;PIK3R1;GAS6
2128,GO:0017038,0.482231022556767,0.769976409462193,3,11,protein import,BP,CDKN1A;PIK3R1;GAS6
4075,GO:0044744,0.482231022556767,0.769976409462193,3,11,protein targeting to nucleus,BP,CDKN1A;PIK3R1;GAS6
4905,GO:0051170,0.482231022556767,0.769976409462193,3,11,nuclear import,BP,CDKN1A;PIK3R1;GAS6
6700,GO:1902593,0.482231022556767,0.769976409462193,3,11,single-organism nuclear import,BP,CDKN1A;PIK3R1;GAS6
4569,GO:0048469,0.482391549447761,0.889566803056667,1,4,cell maturation,BP,CDKN1A
1354,GO:0008233,0.482954072391895,0.806305526941605,2,9,peptidase activity,MF,CASP4;DHH
977,GO:0006497,0.482965523568399,0.899773683018825,1,3,protein lipidation,BP,PRND
3583,GO:0042158,0.482965523568399,0.899773683018825,1,3,lipoprotein biosynthetic process,BP,PRND
2266,GO:0019882,0.482984325746049,0.883131108324359,1,5,antigen processing and presentation,BP,ITGB5
4463,GO:0046914,0.48337809700439,0.714875200191378,5,23,transition metal ion binding,MF,PRND;CYP11A1;TMEM163;DHH;AOX1
6063,GO:0072359,0.483925011802028,0.656218424611032,12,49,circulatory system development,BP,ACTN2;RHOJ;RHOB;MFGE8;LAMA5;ITGB8;DLL1;FHOD3;DHCR7;FOXO4;ITGA3;CTGF
1049,GO:0006732,0.48444319318079,0.734072777807122,4,18,coenzyme metabolic process,BP,PNP;ACSF2;ACSL4;PDK4
4516,GO:0048144,0.486315729489377,0.807546265251203,2,8,fibroblast proliferation,BP,CDKN1A;GAS6
864,GO:0005943,0.48684356679275,0.920516985024218,1,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3R1
3914,GO:0043560,0.48684356679275,0.920516985024218,1,2,insulin receptor substrate binding,MF,PIK3R1
1279,GO:0007600,0.488341243686978,0.733963891467382,4,16,sensory perception,BP,MYO7A;HEXB;SLC52A3;ESPN
4739,GO:0050701,0.488883298911272,0.896864801061803,1,3,interleukin-1 secretion,BP,GAS6
4741,GO:0050704,0.488883298911272,0.896864801061803,1,3,regulation of interleukin-1 secretion,BP,GAS6
4743,GO:0050707,0.488883298911272,0.896864801061803,1,3,regulation of cytokine secretion,BP,GAS6
6122,GO:0086004,0.489052089156658,0.919647584646765,1,2,regulation of cardiac muscle cell contraction,BP,PDE4B
6763,GO:1903115,0.489052089156658,0.919647584646765,1,2,regulation of actin filament-based movement,BP,PDE4B
2548,GO:0030545,0.489309021444748,0.810358848513876,2,7,receptor regulator activity,MF,ACTN2;GAS6
2549,GO:0030546,0.489309021444748,0.810358848513876,2,7,receptor activator activity,MF,ACTN2;GAS6
5709,GO:0070613,0.489464125599196,0.896576245555532,1,3,regulation of protein processing,BP,PRKACB
6783,GO:1903317,0.489464125599196,0.896576245555532,1,3,regulation of protein maturation,BP,PRKACB
1529,GO:0009743,0.489625953805429,0.810131860665888,2,7,response to carbohydrate,BP,GAS6;CTGF
1531,GO:0009746,0.489625953805429,0.810131860665888,2,7,response to hexose,BP,GAS6;CTGF
1532,GO:0009749,0.489625953805429,0.810131860665888,2,7,response to glucose,BP,GAS6;CTGF
3203,GO:0034284,0.489625953805429,0.810131860665888,2,7,response to monosaccharide,BP,GAS6;CTGF
3052,GO:0032886,0.489741317301771,0.896438342993674,1,3,regulation of microtubule-based process,BP,CAMSAP3
5695,GO:0070507,0.489741317301771,0.896438342993674,1,3,regulation of microtubule cytoskeleton organization,BP,CAMSAP3
115,GO:0001541,0.489958670351795,0.896330122631514,1,3,ovarian follicle development,BP,KITLG
2364,GO:0022602,0.489958670351795,0.896330122631514,1,3,ovulation cycle process,BP,KITLG
3005,GO:0032722,0.490980373648742,0.895820383797307,1,3,positive regulation of chemokine production,BP,TICAM1
3013,GO:0032755,0.490980373648742,0.895820383797307,1,3,positive regulation of interleukin-6 production,BP,TICAM1
140,GO:0001667,0.491478113586843,0.695174160681844,6,25,ameboidal-type cell migration,BP,NRTN;KITLG;RHOB;LAMA5;SDC4;ITGA3
2636,GO:0031012,0.491694360856675,0.709777413633657,5,21,extracellular matrix,CC,LAMA1;MFGE8;LAMA5;CRISPLD2;CTGF
717,GO:0005201,0.491953266655845,0.918495400833643,1,2,extracellular matrix structural constituent,MF,LAMA1
7114,GO:2000379,0.491969523833349,0.803417534322933,2,8,positive regulation of reactive oxygen species metabolic process,BP,CDKN1A;TICAM1
6552,GO:1901360,0.49245866092639,0.617793286523779,23,117,organic cyclic compound metabolic process,BP,ACTN2;PNP;CDKN1A;HMGCS2;DKK3;KITLG;PIK3R1;HEXB;SLC52A3;HSD17B3;CYP11A1;GAS6;HSD3B2;DLL1;TICAM1;HMGN5;DHCR7;PDE4B;DHH;FOXO4;ITGA3;AOX1;CTGF
174,GO:0001784,0.492609261464446,0.918233275439071,1,2,phosphotyrosine binding,MF,PIK3R1
3295,GO:0035014,0.492609261464446,0.918233275439071,1,2,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R1
4163,GO:0045309,0.492609261464446,0.918233275439071,1,2,protein phosphorylated amino acid binding,MF,PIK3R1
4467,GO:0046935,0.492609261464446,0.918233275439071,1,2,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R1
4930,GO:0051219,0.492609261464446,0.918233275439071,1,2,phosphoprotein binding,MF,PIK3R1
3907,GO:0043548,0.492969881442856,0.918088924703089,1,2,phosphatidylinositol 3-kinase binding,MF,PIK3R1
1111,GO:0006913,0.493245542112021,0.75821537685603,3,12,nucleocytoplasmic transport,BP,CDKN1A;PIK3R1;GAS6
4904,GO:0051169,0.493245542112021,0.75821537685603,3,12,nuclear transport,BP,CDKN1A;PIK3R1;GAS6
4271,GO:0045823,0.493340411358637,0.894636412030601,1,3,positive regulation of heart contraction,BP,CTGF
4304,GO:0045933,0.493340411358637,0.894636412030601,1,3,positive regulation of muscle contraction,BP,CTGF
4131,GO:0045121,0.495034658022242,0.806233672169856,2,7,membrane raft,CC,SDC4;DLL1
6413,GO:0098857,0.495034658022242,0.806233672169856,2,7,membrane microdomain,CC,SDC4;DLL1
6977,GO:1905475,0.495483394452485,0.813039096033764,2,6,regulation of protein localization to membrane,BP,PIK3R1;ITGA3
228,GO:0001948,0.496631198250224,0.916613162750946,1,2,glycoprotein binding,MF,ITGA3
7105,GO:2000278,0.496745474886449,0.892912034847467,1,3,regulation of DNA biosynthetic process,BP,CDKN1A
1527,GO:0009725,0.497270810768472,0.660945255014614,9,37,response to hormone,BP,ACTN2;CDKN1A;PIK3R1;PRKACB;CLDN1;FOXO4;ITGA3;PDK4;CTGF
4570,GO:0048471,0.497460379900804,0.703532048091836,5,22,perinuclear region of cytoplasm,CC,CDKN1A;PIK3R1;PRKACB;ITGA3;CTGF
2714,GO:0031346,0.497603444159039,0.804366018013249,2,7,positive regulation of cell projection organization,BP,ITGA3;ESPN
4897,GO:0051150,0.499880867737107,0.891307226052693,1,3,regulation of smooth muscle cell differentiation,BP,FOXO4
3113,GO:0033157,0.500146379741963,0.752580178705569,3,12,regulation of intracellular protein transport,BP,CDKN1A;PIK3R1;GAS6
323,GO:0002376,0.500153520864029,0.624473492067904,16,76,immune system process,BP,PNP;CDKN1A;KITLG;PIK3R1;HEXB;ITGB5;PRKACB;SDC4;GAS6;DLL1;TICAM1;CRISPLD2;CASP4;CLDN1;PDE4B;ITGA3
2116,GO:0016887,0.500342170999644,0.915098302983791,1,2,ATPase activity,MF,MYO7A
3691,GO:0042623,0.500342170999644,0.915098302983791,1,2,ATPase activity, coupled,MF,MYO7A
3897,GO:0043531,0.500342170999644,0.915098302983791,1,2,ADP binding,MF,MYO7A
5680,GO:0070374,0.500354068569046,0.78598721431401,2,12,positive regulation of ERK1 and ERK2 cascade,BP,GAS6;CTGF
2274,GO:0019900,0.500786695756308,0.703066182077813,5,20,kinase binding,MF,CDKN1A;PIK3R1;SDC4;GAS6;TICAM1
1276,GO:0007596,0.501029802374007,0.704336814643276,5,19,blood coagulation,BP,RHOB;PIK3R1;PRKACB;GAS6;SERPINA5
1278,GO:0007599,0.501029802374007,0.704336814643276,5,19,hemostasis,BP,RHOB;PIK3R1;PRKACB;GAS6;SERPINA5
4792,GO:0050817,0.501029802374007,0.704336814643276,5,19,coagulation,BP,RHOB;PIK3R1;PRKACB;GAS6;SERPINA5
5851,GO:0071496,0.501326677574401,0.722875094463466,4,16,cellular response to external stimulus,BP,CDKN1A;NUAK2;GAS6;PDK4
3996,GO:0044273,0.501907433980631,0.878870981673601,1,4,sulfur compound catabolic process,BP,HEXB
431,GO:0003014,0.502509551886749,0.753682624445378,3,11,renal system process,BP,PRKACB;GAS6;ITGA3
4296,GO:0045921,0.50272598500418,0.889836768835406,1,3,positive regulation of exocytosis,BP,SDC4
5290,GO:0060396,0.502975152257161,0.914011722136027,1,2,growth hormone receptor signaling pathway,BP,PIK3R1
349,GO:0002521,0.503230847091975,0.700897213797644,5,20,leukocyte differentiation,BP,PNP;KITLG;PIK3R1;GAS6;DLL1
6399,GO:0098793,0.503340243328499,0.791068654614054,2,9,presynapse,CC,TMEM163;PDE4B
2429,GO:0030099,0.503471625521547,0.752894984900335,3,11,myeloid cell differentiation,BP,KITLG;PIK3R1;DLL1
2054,GO:0016616,0.504271040474594,0.787326325867516,2,10,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD17B3;HSD3B2
2418,GO:0030054,0.505089554215989,0.624838237233909,15,61,cell junction,CC,ACTN2;RHOB;PIK3R1;CLDN11;ITGB5;CAMSAP3;MPZL1;SDC4;DLL1;TMEM163;CLDN1;ITGA3;CLDN3;CGN;PRRT1
2975,GO:0032612,0.505467429000779,0.876847584207648,1,4,interleukin-1 production,BP,GAS6
2989,GO:0032652,0.505467429000779,0.876847584207648,1,4,regulation of interleukin-1 production,BP,GAS6
1676,GO:0010712,0.507057156296008,0.887572044015775,1,3,regulation of collagen metabolic process,BP,CTGF
1677,GO:0010714,0.507057156296008,0.887572044015775,1,3,positive regulation of collagen metabolic process,BP,CTGF
3072,GO:0032964,0.507057156296008,0.887572044015775,1,3,collagen biosynthetic process,BP,CTGF
3073,GO:0032965,0.507057156296008,0.887572044015775,1,3,regulation of collagen biosynthetic process,BP,CTGF
3074,GO:0032967,0.507057156296008,0.887572044015775,1,3,positive regulation of collagen biosynthetic process,BP,CTGF
3981,GO:0044246,0.507057156296008,0.887572044015775,1,3,regulation of multicellular organismal metabolic process,BP,CTGF
3984,GO:0044253,0.507057156296008,0.887572044015775,1,3,positive regulation of multicellular organismal metabolic process,BP,CTGF
2467,GO:0030212,0.507487372905453,0.887345348057345,1,3,hyaluronan metabolic process,BP,HEXB
2680,GO:0031226,0.507975865664911,0.643802777179568,10,42,intrinsic component of plasma membrane,CC,ITGB5;SLC52A3;ITGB8;MPZL1;SDC4;DLL1;SLC18B1;CLDN1;ITGA3;CLDN3
2733,GO:0031490,0.50803116907736,0.911897491015983,1,2,chromatin DNA binding,MF,HMGN5
1750,GO:0010921,0.508553126168099,0.886782404351823,1,3,regulation of phosphatase activity,BP,CAMSAP3
1330,GO:0008144,0.509926094632076,0.911095625485582,1,2,drug binding,MF,PNP
4512,GO:0048066,0.512408435456465,0.884729701432538,1,3,developmental pigmentation,BP,KITLG
4838,GO:0050931,0.512408435456465,0.884729701432538,1,3,pigment cell differentiation,BP,KITLG
2273,GO:0019899,0.512475520385291,0.633867952505706,11,46,enzyme binding,MF,CDKN1A;PIK3R1;PRKACB;SDC4;GAS6;SERPINA5;TICAM1;RIN3;FOXO4;ITGA3;DAAM2
2732,GO:0031489,0.512688365995142,0.88457965832087,1,3,myosin V binding,MF,RAB39B
5041,GO:0051604,0.513132812463829,0.787508471327301,2,8,protein maturation,BP,PRKACB;GAS6
1289,GO:0007613,0.513304754897352,0.884248794613389,1,3,memory,BP,ITGA3
2715,GO:0031347,0.513360199122197,0.736897559707866,3,14,regulation of defense response,BP,PRKACB;TICAM1;CASP4
383,GO:0002695,0.513715652442442,0.884027868019435,1,3,negative regulation of leukocyte activation,BP,SDC4
4946,GO:0051250,0.513715652442442,0.884027868019435,1,3,negative regulation of lymphocyte activation,BP,SDC4
3567,GO:0042098,0.514582133405842,0.786392292834118,2,8,T cell proliferation,BP,PNP;SDC4
2624,GO:0030902,0.51531496881297,0.883165171662271,1,3,hindbrain development,BP,DLL1
2809,GO:0031984,0.51542476696218,0.883105781375343,1,3,organelle subcompartment,CC,REEP1
297,GO:0002274,0.515520347511859,0.708697089671947,4,17,myeloid leukocyte activation,BP,PNP;HEXB;TICAM1;CRISPLD2
3593,GO:0042221,0.515876911363474,0.592136709617454,26,126,response to chemical,BP,ACTN2;PNP;NRTN;CDKN1A;DKK3;RHOB;PIK3R1;ITGB5;CMBL;PRKACB;GAS6;DLL1;TICAM1;SEMA6C;CASP4;PON2;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;CTGF;CLDN3;CGN
113,GO:0001525,0.516383442281055,0.6725697160372,6,25,angiogenesis,BP,RHOB;MFGE8;LAMA5;DLL1;FOXO4;CTGF
4956,GO:0051270,0.518865245489699,0.633471361643137,10,42,regulation of cellular component movement,BP,LAMA1;KITLG;RHOB;PIK3R1;LAMA5;SDC4;GAS6;PDE4B;FOXO4;ITGA3
1448,GO:0009116,0.518877835916165,0.881227234932728,1,3,nucleoside metabolic process,BP,PNP
3604,GO:0042304,0.519353928810517,0.868734851151006,1,4,regulation of fatty acid biosynthetic process,BP,PDK4
4844,GO:0050957,0.519477810863643,0.9069736253645,1,2,equilibrioception,BP,MYO7A
2804,GO:0031974,0.519513260896773,0.600293304855671,18,90,membrane-enclosed lumen,CC,ACTN2;PNP;ACSF2;CDKN1A;HMGCS2;PHLDA1;MRI1;HEXB;MRO;PRKACB;CYP11A1;SDC4;GAS6;HSD3B2;CRISPLD2;FOXO4;PDK4;AOX1
3814,GO:0043233,0.519513260896773,0.600293304855671,18,90,organelle lumen,CC,ACTN2;PNP;ACSF2;CDKN1A;HMGCS2;PHLDA1;MRI1;HEXB;MRO;PRKACB;CYP11A1;SDC4;GAS6;HSD3B2;CRISPLD2;FOXO4;PDK4;AOX1
5605,GO:0070013,0.519513260896773,0.600293304855671,18,90,intracellular organelle lumen,CC,ACTN2;PNP;ACSF2;CDKN1A;HMGCS2;PHLDA1;MRI1;HEXB;MRO;PRKACB;CYP11A1;SDC4;GAS6;HSD3B2;CRISPLD2;FOXO4;PDK4;AOX1
4472,GO:0046950,0.520455194738249,0.880362139171371,1,3,cellular ketone body metabolic process,BP,HMGCS2
4473,GO:0046951,0.520455194738249,0.880362139171371,1,3,ketone body biosynthetic process,BP,HMGCS2
6657,GO:1902224,0.520455194738249,0.880362139171371,1,3,ketone body metabolic process,BP,HMGCS2
284,GO:0002221,0.520764535841309,0.880191966573676,1,3,pattern recognition receptor signaling pathway,BP,TICAM1
286,GO:0002224,0.520764535841309,0.880191966573676,1,3,toll-like receptor signaling pathway,BP,TICAM1
3306,GO:0035091,0.52096610676247,0.78688981098363,2,7,phosphatidylinositol binding,MF,ACTN2;SNX21
3078,GO:0032989,0.520980445247232,0.63192805320189,10,41,cellular component morphogenesis,BP,ACTN2;NRTN;MYO7A;RHOJ;PIK3R1;HEXB;LAMA5;FHOD3;SEMA6C;CLDN3
4181,GO:0045429,0.521524128415168,0.879773385398942,1,3,positive regulation of nitric oxide biosynthetic process,BP,TICAM1
6899,GO:1904407,0.521524128415168,0.879773385398942,1,3,positive regulation of nitric oxide metabolic process,BP,TICAM1
4143,GO:0045178,0.521548678152274,0.879759839945694,1,3,basal part of cell,CC,CLDN11
929,GO:0006259,0.522560244166718,0.725571436446855,3,16,DNA metabolic process,BP,CDKN1A;KITLG;CTGF
4185,GO:0045453,0.523644308998016,0.878599612997247,1,3,bone resorption,BP,PDK4
4436,GO:0046849,0.523644308998016,0.878599612997247,1,3,bone remodeling,BP,PDK4
3095,GO:0033043,0.524339422934303,0.643509049632124,8,33,regulation of organelle organization,BP,ACTN2;PIK3R1;PLEKHH2;CAMSAP3;SDC4;FHOD3;CTGF;ESPN
5239,GO:0060249,0.524819917759565,0.778408394485797,2,8,anatomical structure homeostasis,BP,PDK4;CTGF
1103,GO:0006897,0.525275549037802,0.663360635433087,6,26,endocytosis,BP,MYO7A;PIK3R1;MFGE8;GAS6;DLL1;RIN3
4036,GO:0044433,0.525651945336058,0.62495313610335,10,47,cytoplasmic vesicle part,CC,ACTN2;PNP;RHOB;SNX21;HEXB;GAS6;SERPINA5;TICAM1;TMEM163;CRISPLD2
1887,GO:0015629,0.525767471747507,0.668915953182116,6,21,actin cytoskeleton,CC,ACTN2;MYO7A;PLEKHH2;FHOD3;ESPN;CGN
1176,GO:0007159,0.525955102734537,0.730893873382106,3,12,leukocyte cell-cell adhesion,BP,PNP;PIK3R1;SDC4
5480,GO:0061025,0.526063000528697,0.777427030225272,2,8,membrane fusion,BP,GAS6;SERPINA5
1522,GO:0009653,0.526782380866063,0.588772638571783,21,92,anatomical structure morphogenesis,BP,ACTN2;NRTN;MYO7A;RHOJ;DKK3;RHOB;PIK3R1;HEXB;MFGE8;LAMA5;ITGB5;PRKACB;SDC4;DLL1;FHOD3;CRISPLD2;SEMA6C;FOXO4;ITGA3;CTGF;CLDN3
4122,GO:0045087,0.527466636312388,0.691680852429433,4,22,innate immune response,BP,PRKACB;TICAM1;CASP4;CLDN1
1379,GO:0008375,0.527572195606539,0.876403814446192,1,3,acetylglucosaminyltransferase activity,MF,HEXB
1263,GO:0007530,0.528215835462778,0.876041353565087,1,3,sex determination,BP,DHH
3761,GO:0043066,0.5288178386079,0.636868988076887,8,37,negative regulation of apoptotic process,BP,CDKN1A;NUAK2;KITLG;PIK3R1;GAS6;DLL1;HMGN5;PDK4
3764,GO:0043069,0.5288178386079,0.636868988076887,8,37,negative regulation of programmed cell death,BP,CDKN1A;NUAK2;KITLG;PIK3R1;GAS6;DLL1;HMGN5;PDK4
270,GO:0002085,0.529245412340505,0.902617194148139,1,2,inhibition of neuroepithelial cell differentiation,BP,DLL1
1240,GO:0007386,0.529245412340505,0.902617194148139,1,2,compartment pattern specification,BP,DLL1
1819,GO:0014807,0.529245412340505,0.902617194148139,1,2,regulation of somitogenesis,BP,DLL1
2608,GO:0030857,0.529245412340505,0.902617194148139,1,2,negative regulation of epithelial cell differentiation,BP,DLL1
3548,GO:0040034,0.529245412340505,0.902617194148139,1,2,regulation of development, heterochronic,BP,DLL1
4205,GO:0045605,0.529245412340505,0.902617194148139,1,2,negative regulation of epidermal cell differentiation,BP,DLL1
4207,GO:0045607,0.529245412340505,0.902617194148139,1,2,regulation of auditory receptor cell differentiation,BP,DLL1
4208,GO:0045608,0.529245412340505,0.902617194148139,1,2,negative regulation of auditory receptor cell differentiation,BP,DLL1
4214,GO:0045631,0.529245412340505,0.902617194148139,1,2,regulation of mechanoreceptor differentiation,BP,DLL1
4215,GO:0045632,0.529245412340505,0.902617194148139,1,2,negative regulation of mechanoreceptor differentiation,BP,DLL1
4235,GO:0045683,0.529245412340505,0.902617194148139,1,2,negative regulation of epidermis development,BP,DLL1
4578,GO:0048505,0.529245412340505,0.902617194148139,1,2,regulation of timing of cell differentiation,BP,DLL1
5462,GO:0060972,0.529245412340505,0.902617194148139,1,2,left/right pattern formation,BP,DLL1
5762,GO:0070986,0.529245412340505,0.902617194148139,1,2,left/right axis specification,BP,DLL1
7190,GO:2000980,0.529245412340505,0.902617194148139,1,2,regulation of inner ear receptor cell differentiation,BP,DLL1
7191,GO:2000981,0.529245412340505,0.902617194148139,1,2,negative regulation of inner ear receptor cell differentiation,BP,DLL1
6186,GO:0090181,0.530730849921788,0.87461784429835,1,3,regulation of cholesterol metabolic process,BP,DHCR7
3138,GO:0033500,0.531459667529443,0.726141343670127,3,12,carbohydrate homeostasis,BP,PIK3R1;GAS6;PDK4
3689,GO:0042593,0.531459667529443,0.726141343670127,3,12,glucose homeostasis,BP,PIK3R1;GAS6;PDK4
2089,GO:0016788,0.531827091599387,0.719050675634017,3,15,hydrolase activity, acting on ester bonds,MF,PTPN7;PON2;PDE4B
292,GO:0002252,0.532184261006588,0.655994802001295,6,27,immune effector process,BP,PNP;PIK3R1;HEXB;DLL1;TICAM1;CRISPLD2
765,GO:0005524,0.53281864588383,0.647007241023202,7,27,ATP binding,MF,ACSF2;MYO7A;NUAK2;PRKACB;ACSL4;PDK4;MARK4
2357,GO:0022408,0.533454960658089,0.873062980944789,1,3,negative regulation of cell-cell adhesion,BP,SDC4
1197,GO:0007200,0.533468565605221,0.873055181425398,1,3,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,ACTN2
805,GO:0005766,0.533915846712172,0.852332667737549,1,5,primary lysosome,CC,HEXB
3683,GO:0042582,0.533915846712172,0.852332667737549,1,5,azurophil granule,CC,HEXB
5124,GO:0055006,0.534474352571055,0.784323565483473,2,6,cardiac cell development,BP,ACTN2;FHOD3
6518,GO:1901019,0.534977948696307,0.872187760082534,1,3,regulation of calcium ion transmembrane transporter activity,BP,PDE4B
3810,GO:0043229,0.535076625183119,0.576506656160412,51,255,intracellular organelle,CC,ACTN2;PNP;ACSF2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NUAK2;KITLG;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PLEKHH2;HEXB;MRO;LAMA5;ITGB5;PRKACB;CAMSAP3;HSD17B3;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;TMEM163;HMGN5;CRISPLD2;RAB39B;PTPN7;CASP4;DHCR7;PON2;PDE4B;ACSL4;FOXO4;PDK4;AOX1;CTGF;ESPN;CGN;GPSM1;MARK4
1938,GO:0016020,0.537115306944789,0.571478037724491,49,231,membrane,CC,ACTN2;LAMA1;MYO7A;FRMPD1;HMGCS2;RHOJ;KITLG;RHOB;REEP1;SNX21;PIK3R1;SLC25A53;PRND;PLEKHH2;HEXB;CLDN11;MFGE8;ITGB5;PRKACB;SLC52A3;HSD17B3;ITGB8;MPZL1;CYP11A1;SDC4;SERPINA5;HSD3B2;DLL1;TICAM1;TMEM163;SEMA6C;RAB39B;SLC18B1;PTPN7;CASP4;DHCR7;TMEM164;PON2;CLDN1;PDE4B;ACSL4;DHH;ITGA3;PDK4;CTGF;CLDN3;CGN;GPSM1;PRRT1
242,GO:0001977,0.537200272440864,0.870902968129698,1,3,renal system process involved in regulation of blood volume,BP,GAS6
438,GO:0003071,0.537200272440864,0.870902968129698,1,3,renal system process involved in regulation of systemic arterial blood pressure,BP,GAS6
442,GO:0003093,0.537200272440864,0.870902968129698,1,3,regulation of glomerular filtration,BP,GAS6
443,GO:0003094,0.537200272440864,0.870902968129698,1,3,glomerular filtration,BP,GAS6
817,GO:0005783,0.537558663163775,0.617509969668554,9,50,endoplasmic reticulum,CC,REEP1;PIK3R1;HSD17B3;GAS6;HSD3B2;CASP4;DHCR7;ACSL4;GPSM1
6219,GO:0090287,0.538005750603589,0.720430187012911,3,12,regulation of cellular response to growth factor stimulus,BP,DKK3;DLL1;ITGA3
2029,GO:0016491,0.538896249690654,0.660433437796983,5,28,oxidoreductase activity,MF,HSD17B3;CYP11A1;HSD3B2;DHCR7;AOX1
4915,GO:0051186,0.539049036720762,0.684447485899546,4,19,cofactor metabolic process,BP,PNP;ACSF2;ACSL4;PDK4
6405,GO:0098802,0.540655520057739,0.725533477095761,3,10,plasma membrane receptor complex,CC,ITGB5;ITGB8;ITGA3
6463,GO:0120025,0.540989844670499,0.606781242784924,11,45,plasma membrane bounded cell projection,CC,ACTN2;NRTN;MYO7A;KITLG;PLEKHH2;PRKACB;RAB39B;PDE4B;ITGA3;ESPN;MARK4
2760,GO:0031663,0.541069550579731,0.86864410877651,1,3,lipopolysaccharide-mediated signaling pathway,BP,TICAM1
4063,GO:0044702,0.541110063621592,0.604760112511319,11,50,single organism reproductive process,BP,KITLG;HEXB;CLDN11;MFGE8;PRKACB;HSD17B3;ITGB8;SERPINA5;ACSL4;DHH;ITGA3
2513,GO:0030334,0.541292216393757,0.618601520649721,9,38,regulation of cell migration,BP,LAMA1;KITLG;RHOB;PIK3R1;LAMA5;SDC4;GAS6;FOXO4;ITGA3
1847,GO:0014910,0.541607695394997,0.868327723906442,1,3,regulation of smooth muscle cell migration,BP,FOXO4
5692,GO:0070482,0.541704282943024,0.708618366540616,3,16,response to oxygen levels,BP,CDKN1A;CTGF;CLDN3
4972,GO:0051301,0.542330228357956,0.716621556669578,3,12,cell division,BP,RHOB;DLL1;MARK4
143,GO:0001678,0.5423775706989,0.770073527259863,2,7,cellular glucose homeostasis,BP,PIK3R1;GAS6
6600,GO:1901699,0.542779652516402,0.636554268793197,7,28,cellular response to nitrogen compound,BP,ACTN2;PIK3R1;PRKACB;CASP4;PDE4B;FOXO4;PDK4
2939,GO:0032479,0.542959066015832,0.854110984830824,1,4,regulation of type I interferon production,BP,TICAM1
2969,GO:0032606,0.542959066015832,0.854110984830824,1,4,type I interferon production,BP,TICAM1
4880,GO:0051092,0.543623078489173,0.85368391639169,1,4,positive regulation of NF-kappaB transcription factor activity,BP,TICAM1
1525,GO:0009719,0.543949493752968,0.588716216140211,14,64,response to endogenous stimulus,BP,ACTN2;CDKN1A;DKK3;PIK3R1;ITGB5;PRKACB;CASP4;CLDN1;PDE4B;FOXO4;ITGA3;PDK4;CTGF;CGN
3815,GO:0043234,0.544052227943338,0.593365842391369,13,56,protein complex,CC,LAMA1;MYO7A;CDKN1A;PIK3R1;LAMA5;ITGB5;ITGB8;SERPINA5;CASP4;PDE4B;ITGA3;ESPN;CGN
6162,GO:0090075,0.544657423730882,0.866524420569586,1,3,relaxation of muscle,BP,PDE4B
6602,GO:1901701,0.54486373686122,0.602163366945225,11,47,cellular response to oxygen-containing compound,BP,ACTN2;RHOB;PIK3R1;PRKACB;GAS6;TICAM1;CASP4;CLDN1;PDE4B;FOXO4;PDK4
1760,GO:0010950,0.544884802513331,0.839945001916292,1,6,positive regulation of endopeptidase activity,BP,CTGF
3837,GO:0043280,0.544884802513331,0.839945001916292,1,6,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CTGF
7204,GO:2001056,0.544884802513331,0.839945001916292,1,6,positive regulation of cysteine-type endopeptidase activity,BP,CTGF
2879,GO:0032330,0.545804407578487,0.852274772148252,1,4,regulation of chondrocyte differentiation,BP,CTGF
4325,GO:0046058,0.546399884157091,0.844019705225937,1,5,cAMP metabolic process,BP,PDE4B
5726,GO:0070673,0.546665568963094,0.865327378073538,1,3,response to interleukin-18,BP,CLDN1
2511,GO:0030330,0.547682413337396,0.851053934876887,1,4,DNA damage response, signal transduction by p53 class mediator,BP,CDKN1A
3722,GO:0042770,0.547682413337396,0.851053934876887,1,4,signal transduction in response to DNA damage,BP,CDKN1A
2717,GO:0031349,0.547703713569128,0.755548238493237,2,9,positive regulation of defense response,BP,PRKACB;TICAM1
5266,GO:0060325,0.548921188273522,0.863973636191027,1,3,face morphogenesis,BP,CRISPLD2
4708,GO:0048870,0.54893177135445,0.587986530347611,13,58,cell motility,BP,LAMA1;NRTN;KITLG;RHOB;PIK3R1;HEXB;LAMA5;SDC4;GAS6;PDE4B;FOXO4;ITGA3;CTGF
5055,GO:0051674,0.54893177135445,0.587986530347611,13,58,localization of cell,BP,LAMA1;NRTN;KITLG;RHOB;PIK3R1;HEXB;LAMA5;SDC4;GAS6;PDE4B;FOXO4;ITGA3;CTGF
6224,GO:0090316,0.549109234026039,0.764623030020473,2,7,positive regulation of intracellular protein transport,BP,PIK3R1;GAS6
1441,GO:0009100,0.549192855172877,0.754297446999562,2,9,glycoprotein metabolic process,BP,PHLDA1;HEXB
5060,GO:0051704,0.549215068112104,0.586718690630654,13,62,multi-organism process,BP,PIK3R1;HEXB;CLDN11;MFGE8;ITGB5;GAS6;SERPINA5;TICAM1;CLDN1;PDE4B;ACSL4;DHH;ITGA3
1989,GO:0016311,0.5493979222615,0.754124896168968,2,9,dephosphorylation,BP,CAMSAP3;PTPN7
195,GO:0001845,0.550189606362206,0.863208086170665,1,3,phagolysosome assembly,BP,MYO7A
5012,GO:0051489,0.550255809012213,0.863168044634571,1,3,regulation of filopodium assembly,BP,ESPN
3268,GO:0034655,0.550551339185631,0.753152984590305,2,9,nucleobase-containing compound catabolic process,BP,PNP;PDE4B
1572,GO:0009986,0.551521078359455,0.616677067418488,8,34,cell surface,CC,RHOB;MFGE8;ITGB5;ITGB8;MPZL1;SDC4;SERPINA5;ITGA3
4081,GO:0044767,0.551616029134735,0.551922052110682,38,172,single-organism developmental process,BP,ACTN2;PNP;LAMA1;NRTN;MYO7A;CDKN1A;RHOJ;DKK3;KITLG;RHOB;PIK3R1;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;PRKACB;CAMSAP3;HSD17B3;ITGB8;SDC4;GAS6;SERPINA5;DLL1;FHOD3;CRISPLD2;SEMA6C;DHCR7;CLDN1;ACSL4;DHH;FOXO4;ITGA3;CTGF;CLDN3;GPSM1;DAAM2;MARK4
1085,GO:0006839,0.551797753985298,0.848353761436715,1,4,mitochondrial transport,BP,SLC25A53
3287,GO:0034764,0.551938191607707,0.848261009878725,1,4,positive regulation of transmembrane transport,BP,ACTN2
3290,GO:0034767,0.551938191607707,0.848261009878725,1,4,positive regulation of ion transmembrane transport,BP,ACTN2
6888,GO:1904064,0.551938191607707,0.848261009878725,1,4,positive regulation of cation transmembrane transport,BP,ACTN2
1689,GO:0010761,0.552235126191077,0.861966975176699,1,3,fibroblast migration,BP,SDC4
1690,GO:0010762,0.552235126191077,0.861966975176699,1,3,regulation of fibroblast migration,BP,SDC4
4895,GO:0051148,0.552739582535167,0.761650409813772,2,7,negative regulation of muscle cell differentiation,BP,DLL1;FOXO4
3119,GO:0033209,0.553307690450163,0.834023823901461,1,6,tumor necrosis factor-mediated signaling pathway,BP,GAS6
1228,GO:0007292,0.553466365349417,0.839172668134305,1,5,female gamete generation,BP,HEXB
4571,GO:0048477,0.553466365349417,0.839172668134305,1,5,oogenesis,BP,HEXB
3043,GO:0032869,0.55360074819727,0.709953917763539,3,11,cellular response to insulin stimulus,BP,PIK3R1;FOXO4;PDK4
6691,GO:1902554,0.553855178000412,0.846990913227186,1,4,serine/threonine protein kinase complex,CC,CDKN1A
6735,GO:1902911,0.553855178000412,0.846990913227186,1,4,protein kinase complex,CC,CDKN1A
2514,GO:0030335,0.554275917805362,0.634054103227426,6,28,positive regulation of cell migration,BP,KITLG;RHOB;PIK3R1;GAS6;FOXO4;ITGA3
4958,GO:0051272,0.554275917805362,0.634054103227426,6,28,positive regulation of cellular component movement,BP,KITLG;RHOB;PIK3R1;GAS6;FOXO4;ITGA3
7082,GO:2000147,0.554275917805362,0.634054103227426,6,28,positive regulation of cell motility,BP,KITLG;RHOB;PIK3R1;GAS6;FOXO4;ITGA3
2286,GO:0019953,0.554383347822553,0.649968485166308,5,23,sexual reproduction,BP,HEXB;CLDN11;MFGE8;SERPINA5;DHH
5164,GO:0055117,0.554441041669864,0.760249137275951,2,7,regulation of cardiac muscle contraction,BP,PDE4B;CTGF
1775,GO:0012501,0.554755171516104,0.574327052738909,15,70,programmed cell death,BP,ACTN2;CDKN1A;NUAK2;KITLG;RHOB;PHLDA1;PIK3R1;GAS6;DLL1;TICAM1;HMGN5;CASP4;PDK4;CTGF;MARK4
404,GO:0002761,0.555015117637782,0.759775177121857,2,7,regulation of myeloid leukocyte differentiation,BP,KITLG;PIK3R1
1337,GO:0008194,0.556853220929939,0.844989437638456,1,4,UDP-glycosyltransferase activity,MF,HEXB
6396,GO:0098773,0.557359304452984,0.757833668056151,2,7,skin epidermis development,BP,LAMA5;DLL1
6756,GO:1903047,0.558067078188671,0.665373150351084,4,20,mitotic cell cycle process,BP,CDKN1A;PHLDA1;FOXO4;MARK4
5740,GO:0070838,0.558312172338967,0.699489590970112,3,13,divalent metal ion transport,BP,GAS6;PDE4B;CTGF
6077,GO:0072511,0.558312172338967,0.699489590970112,3,13,divalent inorganic cation transport,BP,GAS6;PDE4B;CTGF
1740,GO:0010894,0.558572710627075,0.858069886032427,1,3,negative regulation of steroid biosynthetic process,BP,DKK3
2789,GO:0031943,0.558572710627075,0.858069886032427,1,3,regulation of glucocorticoid metabolic process,BP,DKK3
2792,GO:0031946,0.558572710627075,0.858069886032427,1,3,regulation of glucocorticoid biosynthetic process,BP,DKK3
3265,GO:0034650,0.558572710627075,0.858069886032427,1,3,cortisol metabolic process,BP,DKK3
3266,GO:0034651,0.558572710627075,0.858069886032427,1,3,cortisol biosynthetic process,BP,DKK3
4309,GO:0045939,0.558572710627075,0.858069886032427,1,3,negative regulation of steroid metabolic process,BP,DKK3
7061,GO:2000064,0.558572710627075,0.858069886032427,1,3,regulation of cortisol biosynthetic process,BP,DKK3
2202,GO:0019216,0.558741215362576,0.646932497747459,5,22,regulation of lipid metabolic process,BP,DKK3;PIK3R1;DHCR7;DHH;PDK4
1098,GO:0006887,0.559941532633593,0.628544247692804,6,28,exocytosis,BP,ACTN2;PNP;HEXB;SDC4;GAS6;CRISPLD2
2124,GO:0017016,0.560423130107531,0.763783391974913,2,6,Ras GTPase binding,MF,RIN3;DAAM2
2691,GO:0031267,0.560423130107531,0.763783391974913,2,6,small GTPase binding,MF,RIN3;DAAM2
4860,GO:0051020,0.560423130107531,0.763783391974913,2,6,GTPase binding,MF,RIN3;DAAM2
3164,GO:0033762,0.56043695127338,0.856908473909106,1,3,response to glucagon,BP,PRKACB
5821,GO:0071377,0.56043695127338,0.856908473909106,1,3,cellular response to glucagon stimulus,BP,PRKACB
4320,GO:0045995,0.560633870288236,0.674318237261994,4,14,regulation of embryonic development,BP,LAMA1;LAMA5;PRKACB;DLL1
776,GO:0005578,0.561022004707166,0.667057703885231,4,17,proteinaceous extracellular matrix,CC,LAMA1;LAMA5;CRISPLD2;CTGF
1381,GO:0008380,0.561105567956633,0.842118670056083,1,4,RNA splicing,BP,PIK3R1
2081,GO:0016758,0.562351822210959,0.832928973375771,1,5,transferase activity, transferring hexosyl groups,MF,HEXB
6484,GO:1900181,0.562388862515492,0.855685031368764,1,3,negative regulation of protein localization to nucleus,BP,GAS6
5658,GO:0070293,0.564029181503745,0.854650996152085,1,3,renal absorption,BP,GAS6
6589,GO:1901657,0.564131465404111,0.840052850451843,1,4,glycosyl compound metabolic process,BP,PNP
1104,GO:0006898,0.564568222769596,0.831345240929799,1,5,receptor-mediated endocytosis,BP,DLL1
1426,GO:0009059,0.565407977014618,0.557296898728569,17,84,macromolecule biosynthetic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PHLDA1;PIK3R1;PRND;HEXB;SDC4;GAS6;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3;CTGF
148,GO:0001706,0.56828333274656,0.851943939915596,1,3,endoderm formation,BP,ITGB5
337,GO:0002444,0.56831662685806,0.687880542011486,3,14,myeloid leukocyte mediated immunity,BP,PNP;HEXB;CRISPLD2
3843,GO:0043299,0.56831662685806,0.687880542011486,3,14,leukocyte degranulation,BP,PNP;HEXB;CRISPLD2
4339,GO:0046320,0.568357649178621,0.837135171971636,1,4,regulation of fatty acid oxidation,BP,PDK4
406,GO:0002763,0.568764162754635,0.85163566008105,1,3,positive regulation of myeloid leukocyte differentiation,BP,KITLG
4220,GO:0045639,0.568764162754635,0.85163566008105,1,3,positive regulation of myeloid cell differentiation,BP,KITLG
2945,GO:0032502,0.568941540498989,0.534491421356689,38,173,developmental process,BP,ACTN2;PNP;LAMA1;NRTN;MYO7A;CDKN1A;RHOJ;DKK3;KITLG;RHOB;PIK3R1;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;PRKACB;CAMSAP3;HSD17B3;ITGB8;SDC4;GAS6;SERPINA5;DLL1;FHOD3;CRISPLD2;SEMA6C;DHCR7;CLDN1;ACSL4;DHH;FOXO4;ITGA3;CTGF;CLDN3;GPSM1;DAAM2;MARK4
68,GO:0000910,0.569429993083079,0.851207989318236,1,3,cytokinesis,BP,RHOB
7080,GO:2000145,0.569500961003038,0.590258458910162,9,39,regulation of cell motility,BP,LAMA1;KITLG;RHOB;PIK3R1;LAMA5;SDC4;GAS6;FOXO4;ITGA3
3509,GO:0038034,0.570983949246559,0.826700719573084,1,5,signal transduction in absence of ligand,BP,KITLG
6299,GO:0097192,0.570983949246559,0.826700719573084,1,5,extrinsic apoptotic signaling pathway in absence of ligand,BP,KITLG
321,GO:0002367,0.572110879496053,0.849476825266468,1,3,cytokine production involved in immune response,BP,GAS6
5502,GO:0061082,0.572110879496053,0.849476825266468,1,3,myeloid leukocyte cytokine production,BP,GAS6
5964,GO:0072091,0.572135913089424,0.881678061389444,1,2,regulation of stem cell proliferation,BP,KITLG
7152,GO:2000648,0.572135913089424,0.881678061389444,1,2,positive regulation of stem cell proliferation,BP,KITLG
3828,GO:0043267,0.57263127003419,0.849139071730959,1,3,negative regulation of potassium ion transport,BP,ACTN2
6556,GO:1901379,0.57263127003419,0.849139071730959,1,3,regulation of potassium ion transmembrane transport,BP,ACTN2
6557,GO:1901380,0.57263127003419,0.849139071730959,1,3,negative regulation of potassium ion transmembrane transport,BP,ACTN2
6887,GO:1904063,0.57263127003419,0.849139071730959,1,3,negative regulation of cation transmembrane transport,BP,ACTN2
2573,GO:0030695,0.572688100702769,0.744891709402221,2,7,GTPase regulator activity,MF,RIN3;GPSM1
5370,GO:0060589,0.572688100702769,0.744891709402221,2,7,nucleoside-triphosphatase regulator activity,MF,RIN3;GPSM1
225,GO:0001944,0.573015868216274,0.58673629313182,9,39,vasculature development,BP,RHOJ;RHOB;MFGE8;LAMA5;ITGB8;DLL1;DHCR7;FOXO4;CTGF
6062,GO:0072358,0.573015868216274,0.58673629313182,9,39,cardiovascular system development,BP,RHOJ;RHOB;MFGE8;LAMA5;ITGB8;DLL1;DHCR7;FOXO4;CTGF
3829,GO:0043268,0.573255914972231,0.848732913832467,1,3,positive regulation of potassium ion transport,BP,ACTN2
6440,GO:0099513,0.573397799217071,0.688403647944393,3,12,polymeric cytoskeletal fiber,CC,ACTN2;CAMSAP3;ESPN
6738,GO:1902930,0.573657572654415,0.848471320414524,1,3,regulation of alcohol biosynthetic process,BP,DHCR7
59,GO:0000785,0.574993933786447,0.847598558696061,1,3,chromatin,CC,HMGN5
792,GO:0005694,0.574993933786447,0.847598558696061,1,3,chromosome,CC,HMGN5
4030,GO:0044427,0.574993933786447,0.847598558696061,1,3,chromosomal part,CC,HMGN5
379,GO:0002690,0.57540537564869,0.847329102855704,1,3,positive regulation of leukocyte chemotaxis,BP,GAS6
794,GO:0005737,0.575742934346531,0.540721477978707,54,270,cytoplasm,CC,ACTN2;PNP;ACSF2;MYO7A;CDKN1A;FRMPD1;HMGCS2;GPRASP1;NUAK2;RHOJ;KITLG;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PLEKHH2;HEXB;ITGB5;CMBL;PRKACB;CAMSAP3;HSD17B3;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;TMEM163;CRISPLD2;RAB39B;PTPN7;RBMS3;CASP4;DHCR7;PON2;CLDN1;PDE4B;ACSL4;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;GPSM1;MARK4
3850,GO:0043331,0.576209491892708,0.831612639221059,1,4,response to dsRNA,BP,TICAM1
4111,GO:0045055,0.577738461264867,0.628424311649009,5,22,regulated exocytosis,BP,ACTN2;PNP;HEXB;GAS6;CRISPLD2
4065,GO:0044706,0.577979916962251,0.68411148683508,3,12,multi-multicellular organism process,BP,HEXB;ACSL4;ITGA3
1408,GO:0008625,0.578972057383762,0.829637680645926,1,4,extrinsic apoptotic signaling pathway via death domain receptors,BP,PIK3R1
896,GO:0006090,0.579103132069378,0.84489152249298,1,3,pyruvate metabolic process,BP,PDK4
545,GO:0003713,0.579655209106572,0.829146703275064,1,4,transcription coactivator activity,MF,ACTN2
6082,GO:0072524,0.58062897588292,0.726959782075541,2,9,pyridine-containing compound metabolic process,BP,PNP;AOX1
3785,GO:0043167,0.581253641031722,0.524647872172265,29,136,ion binding,MF,ACTN2;PNP;ACSF2;MYO7A;CDKN1A;NUAK2;RHOJ;RHOB;SNX21;PRND;MFGE8;PRKACB;CYP11A1;GAS6;SERPINA5;DLL1;TMEM163;CRISPLD2;ACCS;RAB39B;PON2;PDE4B;ACSL4;DHH;ITGA3;PDK4;AOX1;CTGF;MARK4
1185,GO:0007169,0.581761647428003,0.594367183143105,7,33,transmembrane receptor protein tyrosine kinase signaling pathway,BP,NRTN;PIK3R1;MPZL1;DLL1;FOXO4;PDK4;CTGF
685,GO:0005092,0.581907328207838,0.843023765915953,1,3,GDP-dissociation inhibitor activity,MF,GPSM1
2750,GO:0031625,0.582704207731448,0.729837339884004,2,8,ubiquitin protein ligase binding,MF,CDKN1A;PRKACB
4018,GO:0044389,0.582704207731448,0.729837339884004,2,8,ubiquitin-like protein ligase binding,MF,CDKN1A;PRKACB
4878,GO:0051090,0.583139889577239,0.724697422356025,2,9,regulation of sequence-specific DNA binding transcription factor activity,BP,GAS6;TICAM1
3543,GO:0040017,0.583260199932045,0.604665004084731,6,29,positive regulation of locomotion,BP,KITLG;RHOB;PIK3R1;GAS6;FOXO4;ITGA3
2039,GO:0016569,0.583754051529959,0.84178460831006,1,3,covalent chromatin modification,BP,HMGN5
3471,GO:0036094,0.583937319781036,0.54161086002238,16,76,small molecule binding,MF,PNP;ACSF2;MYO7A;NUAK2;RHOJ;RHOB;PRKACB;SERPINA5;ACCS;RAB39B;DHCR7;PDE4B;ACSL4;PDK4;AOX1;MARK4
1031,GO:0006690,0.58463332379585,0.816515746167599,1,5,icosanoid metabolic process,BP,PON2
6570,GO:1901568,0.58463332379585,0.816515746167599,1,5,fatty acid derivative metabolic process,BP,PON2
4064,GO:0044703,0.585937118372822,0.590816344413012,7,32,multi-organism reproductive process,BP,HEXB;CLDN11;MFGE8;SERPINA5;ACSL4;DHH;ITGA3
4992,GO:0051384,0.586056053337293,0.722054898631434,2,9,response to glucocorticoid,BP,CDKN1A;CLDN1
6886,GO:1904062,0.586516274827206,0.721636380100632,2,9,regulation of cation transmembrane transport,BP,ACTN2;PDE4B
5677,GO:0070371,0.586951621445919,0.710143376544523,2,13,ERK1 and ERK2 cascade,BP,GAS6;CTGF
5678,GO:0070372,0.586951621445919,0.710143376544523,2,13,regulation of ERK1 and ERK2 cascade,BP,GAS6;CTGF
1545,GO:0009889,0.587405682610003,0.53466977203152,17,86,regulation of biosynthetic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;RBMS3;DHCR7;DHH;FOXO4;ITGA3;PDK4;CTGF
5077,GO:0051875,0.587763860961593,0.839068806709734,1,3,pigment granule localization,BP,MYO7A
5086,GO:0051904,0.587763860961593,0.839068806709734,1,3,pigment granule transport,BP,MYO7A
5087,GO:0051905,0.587763860961593,0.839068806709734,1,3,establishment of pigment granule localization,BP,MYO7A
3647,GO:0042472,0.587825081722803,0.82319447924797,1,4,inner ear morphogenesis,BP,MYO7A
2669,GO:0031143,0.587848713563278,0.83901096160721,1,3,pseudopodium,CC,ACTN2
2442,GO:0030155,0.588403914472073,0.592592871869218,7,27,regulation of cell adhesion,BP,PNP;LAMA1;PIK3R1;LAMA5;SDC4;DLL1;ITGA3
638,GO:0004674,0.588615850649663,0.674015594046854,3,12,protein serine/threonine kinase activity,MF,NUAK2;PRKACB;MARK4
2719,GO:0031396,0.588747561756497,0.81336278727439,1,5,regulation of protein ubiquitination,BP,TICAM1
2721,GO:0031398,0.588747561756497,0.81336278727439,1,5,positive regulation of protein ubiquitination,BP,TICAM1
6785,GO:1903320,0.588747561756497,0.81336278727439,1,5,regulation of protein modification by small protein conjugation or removal,BP,TICAM1
6787,GO:1903322,0.588747561756497,0.81336278727439,1,5,positive regulation of protein modification by small protein conjugation or removal,BP,TICAM1
3125,GO:0033273,0.589858958212541,0.837635972117266,1,3,response to vitamin,BP,GAS6
4558,GO:0048333,0.590261384537537,0.837359657354345,1,3,mesodermal cell differentiation,BP,ITGA3
3181,GO:0034103,0.590362927305847,0.837289879900818,1,3,regulation of tissue remodeling,BP,PDK4
6229,GO:0090382,0.59161407336264,0.820382845092039,1,4,phagosome maturation,BP,MYO7A
3071,GO:0032963,0.592119520553798,0.820005295372368,1,4,collagen metabolic process,BP,CTGF
3987,GO:0044259,0.592119520553798,0.820005295372368,1,4,multicellular organismal macromolecule metabolic process,BP,CTGF
6096,GO:0072594,0.592174292473608,0.66761580273865,3,13,establishment of protein localization to organelle,BP,CDKN1A;PIK3R1;GAS6
2068,GO:0016705,0.592494937490364,0.810456821587611,1,5,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,CYP11A1
760,GO:0005518,0.592965612154576,0.835493662805958,1,3,collagen binding,MF,ITGA3
5592,GO:0061695,0.593588482959601,0.720015973914946,2,8,transferase complex, transferring phosphorus-containing groups,CC,CDKN1A;PIK3R1
1252,GO:0007431,0.594736302474168,0.818041254392455,1,4,salivary gland development,BP,LAMA5
1253,GO:0007435,0.594736302474168,0.818041254392455,1,4,salivary gland morphogenesis,BP,LAMA5
3334,GO:0035272,0.594736302474168,0.818041254392455,1,4,exocrine system development,BP,LAMA5
5322,GO:0060445,0.594736302474168,0.818041254392455,1,4,branching involved in salivary gland morphogenesis,BP,LAMA5
985,GO:0006518,0.594793288883925,0.704798683106389,2,12,peptide metabolic process,BP,GAS6;RBMS3
6846,GO:1903707,0.594889849990397,0.71882633206181,2,8,negative regulation of hemopoiesis,BP,PIK3R1;DLL1
4014,GO:0044346,0.595168619905517,0.833961600103693,1,3,fibroblast apoptotic process,BP,GAS6
7101,GO:2000269,0.595168619905517,0.833961600103693,1,3,regulation of fibroblast apoptotic process,BP,GAS6
7102,GO:2000270,0.595168619905517,0.833961600103693,1,3,negative regulation of fibroblast apoptotic process,BP,GAS6
2504,GO:0030316,0.595598966692575,0.833661061774864,1,3,osteoclast differentiation,BP,PIK3R1
4232,GO:0045670,0.595598966692575,0.833661061774864,1,3,regulation of osteoclast differentiation,BP,PIK3R1
4233,GO:0045671,0.595598966692575,0.833661061774864,1,3,negative regulation of osteoclast differentiation,BP,PIK3R1
2414,GO:0030042,0.596190129910184,0.733452980066938,2,6,actin filament depolymerization,BP,ACTN2;PLEKHH2
2598,GO:0030834,0.596190129910184,0.733452980066938,2,6,regulation of actin filament depolymerization,BP,ACTN2;PLEKHH2
3821,GO:0043244,0.596190129910184,0.733452980066938,2,6,regulation of protein complex disassembly,BP,ACTN2;PLEKHH2
4954,GO:0051261,0.596190129910184,0.733452980066938,2,6,protein depolymerization,BP,ACTN2;PLEKHH2
6613,GO:1901879,0.596190129910184,0.733452980066938,2,6,regulation of protein depolymerization,BP,ACTN2;PLEKHH2
1589,GO:0010171,0.596643956703693,0.816599465855942,1,4,body morphogenesis,BP,CRISPLD2
5264,GO:0060323,0.596643956703693,0.816599465855942,1,4,head morphogenesis,BP,CRISPLD2
1985,GO:0016301,0.59811169170495,0.57840780260196,7,32,kinase activity,MF,CDKN1A;NUAK2;KITLG;PIK3R1;PRKACB;PDK4;MARK4
2085,GO:0016773,0.59811169170495,0.57840780260196,7,32,phosphotransferase activity, alcohol group as acceptor,MF,CDKN1A;NUAK2;KITLG;PIK3R1;PRKACB;PDK4;MARK4
1652,GO:0010638,0.598733133902535,0.656587465919188,3,15,positive regulation of organelle organization,BP,ACTN2;SDC4;CTGF
862,GO:0005938,0.598855827458222,0.637501147441227,4,14,cell cortex,CC,ACTN2;MYO7A;PLEKHH2;CTGF
6445,GO:0099568,0.598855827458222,0.637501147441227,4,14,cytoplasmic region,CC,ACTN2;MYO7A;PLEKHH2;CTGF
4816,GO:0050877,0.599662728726034,0.605259541910766,5,23,neurological system process,BP,MYO7A;HEXB;SLC52A3;ITGA3;ESPN
1178,GO:0007162,0.599903358512405,0.720824401025894,2,7,negative regulation of cell adhesion,BP,PIK3R1;SDC4
5699,GO:0070527,0.600015437223844,0.830552824353531,1,3,platelet aggregation,BP,GAS6
6733,GO:1902904,0.60086158585591,0.729309395105664,2,6,negative regulation of supramolecular fiber organization,BP,PLEKHH2;FHOD3
4386,GO:0046530,0.60098590834695,0.865773028283624,1,2,photoreceptor cell differentiation,BP,MYO7A
795,GO:0005739,0.601298566947051,0.54559165985588,10,61,mitochondrion,CC,ACSF2;HMGCS2;REEP1;SLC25A53;CYP11A1;HSD3B2;CASP4;PON2;ACSL4;PDK4
4224,GO:0045661,0.601927294062198,0.829193659497666,1,3,regulation of myoblast differentiation,BP,DLL1
4225,GO:0045662,0.601927294062198,0.829193659497666,1,3,negative regulation of myoblast differentiation,BP,DLL1
4965,GO:0051287,0.604460711582579,0.810602526724733,1,4,NAD binding,MF,AOX1
1243,GO:0007399,0.605433911559488,0.517173465280149,17,78,nervous system development,BP,NRTN;MYO7A;PIK3R1;HEXB;CLDN11;PRKACB;CAMSAP3;SDC4;GAS6;DLL1;SEMA6C;CLDN1;ACSL4;DHH;ITGA3;GPSM1;MARK4
1352,GO:0008219,0.605470313123343,0.522268972805026,15,72,cell death,BP,ACTN2;CDKN1A;NUAK2;KITLG;RHOB;PHLDA1;PIK3R1;GAS6;DLL1;TICAM1;HMGN5;CASP4;PDK4;CTGF;MARK4
1004,GO:0006605,0.605680973140219,0.654373606821653,3,13,protein targeting,BP,CDKN1A;PIK3R1;GAS6
6883,GO:1904031,0.606007094545011,0.799702408073272,1,5,positive regulation of cyclin-dependent protein kinase activity,BP,CDKN1A
1351,GO:0008217,0.606382417723589,0.703178248625118,2,9,regulation of blood pressure,BP,GAS6;DLL1
3575,GO:0042116,0.606393588484666,0.825986020953016,1,3,macrophage activation,BP,TICAM1
188,GO:0001838,0.608012429848635,0.701629142760215,2,9,embryonic epithelial tube formation,BP,PRKACB;SDC4
2944,GO:0032501,0.608271235618766,0.494921954620373,42,194,multicellular organismal process,BP,ACTN2;PNP;LAMA1;NRTN;MYO7A;CDKN1A;RHOJ;DKK3;KITLG;RHOB;PIK3R1;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;PRKACB;SLC52A3;CAMSAP3;HSD17B3;ITGB8;SDC4;GAS6;SERPINA5;DLL1;FHOD3;TICAM1;CRISPLD2;SEMA6C;DHCR7;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;CTGF;ESPN;GPSM1;DAAM2;MARK4
6121,GO:0086003,0.608684733660874,0.824322715893846,1,3,cardiac muscle cell contraction,BP,PDE4B
411,GO:0002792,0.608770186200326,0.824260444080097,1,3,negative regulation of peptide secretion,BP,GAS6
4745,GO:0050709,0.608770186200326,0.824260444080097,1,3,negative regulation of protein secretion,BP,GAS6
3909,GO:0043550,0.608916417010651,0.824153841886789,1,3,regulation of lipid kinase activity,BP,PIK3R1
3910,GO:0043551,0.608916417010651,0.824153841886789,1,3,regulation of phosphatidylinositol 3-kinase activity,BP,PIK3R1
42,GO:0000278,0.609009449488187,0.613906101680433,4,21,mitotic cell cycle,BP,CDKN1A;PHLDA1;FOXO4;MARK4
3572,GO:0042108,0.609239724985558,0.806864461193532,1,4,positive regulation of cytokine biosynthetic process,BP,TICAM1
2051,GO:0016607,0.609413344182911,0.796921665773318,1,5,nuclear speck,CC,FOXO4
4184,GO:0045446,0.609640306947377,0.653498024557126,3,12,endothelial cell differentiation,BP,LAMA5;DLL1;CLDN1
1945,GO:0016050,0.610409224434149,0.699341593928871,2,9,vesicle organization,BP,MYO7A;SDC4
7112,GO:2000377,0.610500138285023,0.695353853317085,2,10,regulation of reactive oxygen species metabolic process,BP,CDKN1A;TICAM1
1758,GO:0010942,0.610780114347429,0.612089062911264,4,21,positive regulation of cell death,BP,CDKN1A;RHOB;CTGF;MARK4
3763,GO:0043068,0.610780114347429,0.612089062911264,4,21,positive regulation of programmed cell death,BP,CDKN1A;RHOB;CTGF;MARK4
2967,GO:0032602,0.610834326400864,0.805604908070088,1,4,chemokine production,BP,TICAM1
2982,GO:0032642,0.610834326400864,0.805604908070088,1,4,regulation of chemokine production,BP,TICAM1
4692,GO:0048839,0.612573248516019,0.647495788101102,3,13,inner ear development,BP,MYO7A;SDC4;DLL1
4817,GO:0050878,0.612904289538903,0.577013043971109,6,26,regulation of body fluid levels,BP,RHOB;PIK3R1;PRKACB;GAS6;SERPINA5;CLDN1
6395,GO:0098772,0.613029625228633,0.5426046271955,9,46,molecular function regulator,MF,ACTN2;NRTN;CDKN1A;KITLG;PIK3R1;GAS6;SERPINA5;RIN3;GPSM1
2084,GO:0016772,0.613215804662777,0.562086496574731,7,33,transferase activity, transferring phosphorus-containing groups,MF,CDKN1A;NUAK2;KITLG;PIK3R1;PRKACB;PDK4;MARK4
1762,GO:0010952,0.613567617455958,0.78252085296621,1,7,positive regulation of peptidase activity,BP,CTGF
1237,GO:0007368,0.613634732203463,0.696244731942265,2,9,determination of left/right symmetry,BP,DLL1;DAAM2
1540,GO:0009855,0.613634732203463,0.696244731942265,2,9,determination of bilateral symmetry,BP,DLL1;DAAM2
3997,GO:0044281,0.61369218407904,0.511907575610476,15,84,small molecule metabolic process,BP,PNP;ACSF2;HMGCS2;DKK3;MRI1;HEXB;SLC52A3;HSD17B3;CYP11A1;DHCR7;PON2;PDE4B;ACSL4;PDK4;AOX1
5272,GO:0060341,0.614116466419706,0.574775406652515,6,27,regulation of cellular localization,BP,ACTN2;CDKN1A;REEP1;PIK3R1;GAS6;ITGA3
5822,GO:0071378,0.616034949096955,0.818903717469501,1,3,cellular response to growth hormone stimulus,BP,PIK3R1
4144,GO:0045184,0.617433162825528,0.521232680652151,12,58,establishment of protein localization,BP,ACTN2;PNP;MYO7A;CDKN1A;RHOB;REEP1;SNX21;PIK3R1;LAMA5;GAS6;RAB39B;ITGA3
636,GO:0004672,0.61858923522992,0.584639813299255,5,24,protein kinase activity,MF,CDKN1A;NUAK2;PRKACB;PDK4;MARK4
303,GO:0002285,0.619126344712314,0.798954501530261,1,4,lymphocyte activation involved in immune response,BP,DLL1
332,GO:0002431,0.619764728105454,0.816104779727167,1,3,Fc receptor mediated stimulatory signaling pathway,BP,PIK3R1
333,GO:0002433,0.619764728105454,0.816104779727167,1,3,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3R1
3520,GO:0038094,0.619764728105454,0.816104779727167,1,3,Fc-gamma receptor signaling pathway,BP,PIK3R1
3522,GO:0038096,0.619764728105454,0.816104779727167,1,3,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3R1
2336,GO:0021915,0.619812185862678,0.695391249409549,2,8,neural tube development,BP,PRKACB;SDC4
6878,GO:1904019,0.619886743376372,0.816012649715544,1,3,epithelial cell apoptotic process,BP,GAS6
1401,GO:0008584,0.620682756062648,0.694549704586332,2,8,male gonad development,BP,KITLG;DHH
4392,GO:0046546,0.620682756062648,0.694549704586332,2,8,development of primary male sexual characteristics,BP,KITLG;DHH
1096,GO:0006885,0.620783055516877,0.787430676525565,1,5,regulation of pH,BP,PDK4
2288,GO:0020037,0.620870924135888,0.787356054144242,1,5,heme binding,MF,CYP11A1
4460,GO:0046906,0.620870924135888,0.787356054144242,1,5,tetrapyrrole binding,MF,CYP11A1
2912,GO:0032391,0.62108614576781,0.853725547113257,1,2,photoreceptor connecting cilium,CC,MYO7A
3424,GO:0035869,0.62108614576781,0.853725547113257,1,2,ciliary transition zone,CC,MYO7A
3338,GO:0035303,0.621121225916988,0.797329030182437,1,4,regulation of dephosphorylation,BP,CAMSAP3
6877,GO:1904018,0.621260486571694,0.700909440763621,2,7,positive regulation of vasculature development,BP,RHOB;DLL1
1422,GO:0009055,0.622225823872989,0.786202900523833,1,5,electron carrier activity,MF,AOX1
3707,GO:0042698,0.622388206940938,0.796291460646494,1,4,ovulation cycle,BP,KITLG
260,GO:0002065,0.622720354805957,0.640345466729285,3,12,columnar/cuboidal epithelial cell differentiation,BP,MYO7A;CDKN1A;DLL1
1897,GO:0015711,0.623167063797203,0.682967260633329,2,10,organic anion transport,BP,SLC52A3;ACSL4
3524,GO:0038128,0.62336722867429,0.795486926400432,1,4,ERBB2 signaling pathway,BP,PIK3R1
5043,GO:0051607,0.624213178025362,0.784502920240932,1,5,defense response to virus,BP,TICAM1
1224,GO:0007276,0.624436366254606,0.59918479444307,4,20,gamete generation,BP,HEXB;CLDN11;SERPINA5;DHH
4809,GO:0050866,0.62526661335455,0.793919109533746,1,4,negative regulation of cell activation,BP,SDC4
3097,GO:0033059,0.6257723424886,0.793500110776809,1,4,cellular pigmentation,BP,MYO7A
5835,GO:0071425,0.62656045364753,0.81091822057369,1,3,hematopoietic stem cell proliferation,BP,KITLG
1123,GO:0006942,0.6265673051654,0.688819652021956,2,8,regulation of striated muscle contraction,BP,PDE4B;CTGF
2091,GO:0016791,0.627142557896824,0.781978477027647,1,5,phosphatase activity,MF,PTPN7
4465,GO:0046916,0.627168218062099,0.79234021893782,1,4,cellular transition metal ion homeostasis,BP,PRND
4017,GO:0044381,0.627843030713791,0.809926588901272,1,3,glucose import in response to insulin stimulus,BP,PIK3R1
6472,GO:1900076,0.627843030713791,0.809926588901272,1,3,regulation of cellular response to insulin stimulus,BP,PIK3R1
6473,GO:1900078,0.627843030713791,0.809926588901272,1,3,positive regulation of cellular response to insulin stimulus,BP,PIK3R1
7236,GO:2001273,0.627843030713791,0.809926588901272,1,3,regulation of glucose import in response to insulin stimulus,BP,PIK3R1
7237,GO:2001275,0.627843030713791,0.809926588901272,1,3,positive regulation of glucose import in response to insulin stimulus,BP,PIK3R1
1090,GO:0006869,0.628016939516945,0.674920368867198,2,11,lipid transport,BP,SERPINA5;ACSL4
1225,GO:0007281,0.62835510991248,0.674579658760842,2,11,germ cell development,BP,HEXB;DHH
66,GO:0000902,0.628529389645243,0.536887310723942,8,36,cell morphogenesis,BP,NRTN;MYO7A;RHOJ;PIK3R1;HEXB;LAMA5;SEMA6C;CLDN3
887,GO:0006029,0.628725753532477,0.791040076758535,1,4,proteoglycan metabolic process,BP,HEXB
2726,GO:0031410,0.629016622418369,0.494650054259312,16,76,cytoplasmic vesicle,CC,ACTN2;PNP;MYO7A;RHOB;SNX21;PHLDA1;HEXB;ITGB5;GAS6;SERPINA5;DLL1;TICAM1;RIN3;TMEM163;CRISPLD2;PDE4B
6348,GO:0097708,0.629016622418369,0.494650054259312,16,76,intracellular vesicle,CC,ACTN2;PNP;MYO7A;RHOB;SNX21;PHLDA1;HEXB;ITGB5;GAS6;SERPINA5;DLL1;TICAM1;RIN3;TMEM163;CRISPLD2;PDE4B
969,GO:0006470,0.629285678146474,0.780117418063943,1,5,protein dephosphorylation,BP,PTPN7
2024,GO:0016462,0.630492201654329,0.570155383003388,5,26,pyrophosphatase activity,MF,MYO7A;RHOJ;RHOB;RAB39B;CGN
2096,GO:0016817,0.630492201654329,0.570155383003388,5,26,hydrolase activity, acting on acid anhydrides,MF,MYO7A;RHOJ;RHOB;RAB39B;CGN
2097,GO:0016818,0.630492201654329,0.570155383003388,5,26,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,MYO7A;RHOJ;RHOB;RAB39B;CGN
2137,GO:0017111,0.630492201654329,0.570155383003388,5,26,nucleoside-triphosphatase activity,MF,MYO7A;RHOJ;RHOB;RAB39B;CGN
5104,GO:0051961,0.630548462214646,0.684901425221306,2,8,negative regulation of nervous system development,BP,PRKACB;DLL1
6796,GO:1903428,0.631012573381239,0.789119787401537,1,4,positive regulation of reactive oxygen species biosynthetic process,BP,TICAM1
5856,GO:0071548,0.63102135151683,0.789112390018016,1,4,response to dexamethasone,BP,CLDN1
5433,GO:0060837,0.631029761009731,0.807444975400854,1,3,blood vessel endothelial cell differentiation,BP,DLL1
5437,GO:0060842,0.631029761009731,0.807444975400854,1,3,arterial endothelial cell differentiation,BP,DLL1
1046,GO:0006721,0.631075292268266,0.778554084757757,1,5,terpenoid metabolic process,BP,SDC4
1957,GO:0016101,0.631075292268266,0.778554084757757,1,5,diterpenoid metabolic process,BP,SDC4
2133,GO:0017076,0.631575776000817,0.511630458761842,11,52,purine nucleotide binding,MF,ACSF2;MYO7A;NUAK2;RHOJ;RHOB;PRKACB;RAB39B;PDE4B;ACSL4;PDK4;MARK4
2957,GO:0032553,0.631575776000817,0.511630458761842,11,52,ribonucleotide binding,MF,ACSF2;MYO7A;NUAK2;RHOJ;RHOB;PRKACB;RAB39B;PDE4B;ACSL4;PDK4;MARK4
2958,GO:0032555,0.631575776000817,0.511630458761842,11,52,purine ribonucleotide binding,MF,ACSF2;MYO7A;NUAK2;RHOJ;RHOB;PRKACB;RAB39B;PDE4B;ACSL4;PDK4;MARK4
2911,GO:0032388,0.631611284278169,0.6838496706794,2,8,positive regulation of intracellular transport,BP,PIK3R1;GAS6
3767,GO:0043086,0.631759037915405,0.588013504446205,4,23,negative regulation of catalytic activity,BP,CDKN1A;CAMSAP3;GAS6;SERPINA5
786,GO:0005635,0.631775669754248,0.766332276780579,1,7,nuclear envelope,CC,DHCR7
6007,GO:0072175,0.631804812137485,0.671090292797223,2,11,epithelial tube formation,BP,PRKACB;SDC4
3932,GO:0043624,0.632758547134012,0.682711628167233,2,8,cellular protein complex disassembly,BP,ACTN2;PLEKHH2
6368,GO:0098590,0.632975402298614,0.558163206447676,6,24,plasma membrane region,CC,MYO7A;SLC52A3;DLL1;CLDN1;ITGA3;CLDN3
1369,GO:0008307,0.635040373614796,0.804285378824138,1,3,structural constituent of muscle,MF,ACTN2
6379,GO:0098655,0.635199367892755,0.615846096070567,3,17,cation transmembrane transport,BP,ACTN2;GAS6;PDE4B
6383,GO:0098660,0.635199367892755,0.615846096070567,3,17,inorganic ion transmembrane transport,BP,ACTN2;GAS6;PDE4B
6385,GO:0098662,0.635199367892755,0.615846096070567,3,17,inorganic cation transmembrane transport,BP,ACTN2;GAS6;PDE4B
4507,GO:0048037,0.635443967130125,0.619175041277511,3,15,cofactor binding,MF,ACCS;DHCR7;AOX1
4435,GO:0046847,0.635551321657247,0.785268013479697,1,4,filopodium assembly,BP,ESPN
581,GO:0004175,0.635853801968838,0.767426431959913,1,6,endopeptidase activity,MF,CASP4
5799,GO:0071322,0.636711816675627,0.784274443411529,1,4,cellular response to carbohydrate stimulus,BP,GAS6
5800,GO:0071326,0.636711816675627,0.784274443411529,1,4,cellular response to monosaccharide stimulus,BP,GAS6
5801,GO:0071331,0.636711816675627,0.784274443411529,1,4,cellular response to hexose stimulus,BP,GAS6
5802,GO:0071333,0.636711816675627,0.784274443411529,1,4,cellular response to glucose stimulus,BP,GAS6
2290,GO:0021510,0.637185721332615,0.802578410430664,1,3,spinal cord development,BP,DLL1
3436,GO:0035924,0.637185721332615,0.802578410430664,1,3,cellular response to vascular endothelial growth factor stimulus,BP,DLL1
6650,GO:1902117,0.638401270710286,0.782821593497776,1,4,positive regulation of organelle assembly,BP,SDC4
6079,GO:0072521,0.638904874787648,0.615524584097448,3,15,purine-containing compound metabolic process,BP,PNP;PDE4B;AOX1
2,GO:0000003,0.639318439078234,0.502726370430208,11,54,reproduction,BP,KITLG;HEXB;CLDN11;MFGE8;PRKACB;HSD17B3;ITGB8;SERPINA5;ACSL4;DHH;ITGA3
2362,GO:0022414,0.639318439078234,0.502726370430208,11,54,reproductive process,BP,KITLG;HEXB;CLDN11;MFGE8;PRKACB;HSD17B3;ITGB8;SERPINA5;ACSL4;DHH;ITGA3
12,GO:0000079,0.639478680621615,0.764111188130122,1,6,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN1A
6881,GO:1904029,0.639478680621615,0.764111188130122,1,6,regulation of cyclin-dependent protein kinase activity,BP,CDKN1A
3743,GO:0042993,0.639610942249669,0.800634470067016,1,3,positive regulation of transcription factor import into nucleus,BP,PIK3R1
2651,GO:0031090,0.640852644256877,0.484206354843271,15,76,organelle membrane,CC,MYO7A;HMGCS2;RHOB;REEP1;SNX21;SLC25A53;CYP11A1;SERPINA5;HSD3B2;TICAM1;TMEM163;DHCR7;ACSL4;PDK4;GPSM1
3808,GO:0043227,0.64088647700677,0.469061422625317,51,262,membrane-bounded organelle,CC,ACTN2;PNP;ACSF2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NUAK2;RHOJ;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;HEXB;CLDN11;MFGE8;MRO;LAMA5;ITGB5;CMBL;PRKACB;HSD17B3;ITGB8;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;TICAM1;RIN3;TMEM163;HMGN5;CRISPLD2;RAB39B;CASP4;DHCR7;PON2;PDE4B;ACSL4;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;GPSM1;DAAM2
892,GO:0006084,0.641359514086075,0.780259228545239,1,4,acetyl-CoA metabolic process,BP,PDK4
28,GO:0000166,0.642153735836471,0.490758937579838,13,62,nucleotide binding,MF,ACSF2;MYO7A;NUAK2;RHOJ;RHOB;PRKACB;RAB39B;DHCR7;PDE4B;ACSL4;PDK4;AOX1;MARK4
6544,GO:1901265,0.642153735836471,0.490758937579838,13,62,nucleoside phosphate binding,MF,ACSF2;MYO7A;NUAK2;RHOJ;RHOB;PRKACB;RAB39B;DHCR7;PDE4B;ACSL4;PDK4;AOX1;MARK4
1653,GO:0010639,0.642564059038555,0.619800095437483,3,12,negative regulation of organelle organization,BP,PLEKHH2;FHOD3;ESPN
815,GO:0005778,0.643229796052219,0.767709551336391,1,5,peroxisomal membrane,CC,ACSL4
2784,GO:0031903,0.643229796052219,0.767709551336391,1,5,microbody membrane,CC,ACSL4
6943,GO:1904951,0.643369704831959,0.610782731023407,3,15,positive regulation of establishment of protein localization,BP,PIK3R1;GAS6;ITGA3
1116,GO:0006928,0.643606317852603,0.479782266803423,16,72,movement of cell or subcellular component,BP,ACTN2;LAMA1;NRTN;MYO7A;KITLG;RHOB;PIK3R1;HEXB;LAMA5;SDC4;GAS6;SEMA6C;PDE4B;FOXO4;ITGA3;CTGF
1071,GO:0006809,0.643609072253964,0.767364686823546,1,5,nitric oxide biosynthetic process,BP,TICAM1
4180,GO:0045428,0.643609072253964,0.767364686823546,1,5,regulation of nitric oxide biosynthetic process,BP,TICAM1
4338,GO:0046209,0.643609072253964,0.767364686823546,1,5,nitric oxide metabolic process,BP,TICAM1
7205,GO:2001057,0.643609072253964,0.767364686823546,1,5,reactive nitrogen species metabolic process,BP,TICAM1
2241,GO:0019674,0.643830034579504,0.767163589401882,1,5,NAD metabolic process,BP,PNP
6345,GO:0097651,0.644055328574284,0.797032265754039,1,3,phosphatidylinositol 3-kinase complex, class I,CC,PIK3R1
4537,GO:0048247,0.644065077546825,0.777895025757054,1,4,lymphocyte chemotaxis,BP,GAS6
2556,GO:0030595,0.644099293534847,0.665922940546161,2,9,leukocyte chemotaxis,BP,GAS6;PDE4B
4871,GO:0051052,0.64437361110854,0.655460664986514,2,12,regulation of DNA metabolic process,BP,CDKN1A;KITLG
1118,GO:0006936,0.644634870886849,0.577708945560772,4,20,muscle contraction,BP,ACTN2;ITGB5;PDE4B;CTGF
375,GO:0002685,0.644944220532778,0.660885174393164,2,10,regulation of leukocyte migration,BP,KITLG;GAS6
236,GO:0001961,0.645768318130359,0.776396448910588,1,4,positive regulation of cytokine-mediated signaling pathway,BP,GAS6
5420,GO:0060760,0.645768318130359,0.776396448910588,1,4,positive regulation of response to cytokine stimulus,BP,GAS6
4977,GO:0051336,0.645915629746333,0.514020371687126,8,45,regulation of hydrolase activity,BP,ACTN2;NRTN;KITLG;CAMSAP3;GAS6;SERPINA5;RIN3;CTGF
336,GO:0002443,0.646257163214545,0.605747180828147,3,16,leukocyte mediated immunity,BP,PNP;HEXB;CRISPLD2
4725,GO:0050661,0.647024560126539,0.775286057744585,1,4,NADP binding,MF,DHCR7
4724,GO:0050660,0.648820763871507,0.7736908295937,1,4,flavin adenine dinucleotide binding,MF,AOX1
2186,GO:0019079,0.649069778479965,0.792905263708633,1,3,viral genome replication,BP,GAS6
782,GO:0005615,0.649070843870484,0.495968795794391,10,56,extracellular space,CC,LAMA1;DKK3;KITLG;HEXB;MFGE8;LAMA5;GAS6;SERPINA5;DHH;CTGF
1544,GO:0009888,0.649242885287239,0.468035163004484,18,85,tissue development,BP,ACTN2;NRTN;MYO7A;CDKN1A;KITLG;RHOB;LAMA5;ITGB5;PRKACB;ITGB8;SDC4;GAS6;DLL1;FHOD3;CLDN1;ITGA3;CTGF;CLDN3
1286,GO:0007610,0.649448150246337,0.604267642420661,3,15,behavior,BP,HEXB;ITGA3;ESPN
150,GO:0001708,0.649478474180012,0.792565928753966,1,3,cell fate specification,BP,DLL1
4581,GO:0048513,0.649705612834451,0.4574444029366,24,115,animal organ development,BP,ACTN2;PNP;NRTN;MYO7A;CDKN1A;RHOJ;DKK3;KITLG;PIK3R1;LAMA5;HSD17B3;ITGB8;SDC4;GAS6;SERPINA5;DLL1;FHOD3;CRISPLD2;DHCR7;CLDN1;DHH;FOXO4;ITGA3;CTGF
2203,GO:0019217,0.649743174044574,0.754526720123076,1,6,regulation of fatty acid metabolic process,BP,PDK4
4643,GO:0048666,0.650365667680231,0.513371742036936,8,36,neuron development,BP,NRTN;MYO7A;PIK3R1;CAMSAP3;SDC4;SEMA6C;ACSL4;ITGA3
3787,GO:0043169,0.650654246764231,0.474144993026756,15,73,cation binding,MF,ACTN2;CDKN1A;NUAK2;PRND;PRKACB;CYP11A1;GAS6;SERPINA5;DLL1;TMEM163;PON2;PDE4B;DHH;ITGA3;AOX1
1188,GO:0007178,0.650739064263031,0.572556467999633,4,19,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,DKK3;ITGB5;ITGA3;CGN
3540,GO:0040012,0.650766260297205,0.503920695963414,9,42,regulation of locomotion,BP,LAMA1;KITLG;RHOB;PIK3R1;LAMA5;SDC4;GAS6;FOXO4;ITGA3
7104,GO:2000273,0.651395389663282,0.77138864387544,1,4,positive regulation of receptor activity,BP,ACTN2
2319,GO:0021782,0.651992260246725,0.77085228717822,1,4,glial cell development,BP,DLL1
1016,GO:0006641,0.652439866611242,0.751959551696638,1,6,triglyceride metabolic process,BP,ACSL4
5773,GO:0071216,0.653132698290104,0.652314901212046,2,10,cellular response to biotic stimulus,BP,TICAM1;PDE4B
5774,GO:0071219,0.653132698290104,0.652314901212046,2,10,cellular response to molecule of bacterial origin,BP,TICAM1;PDE4B
5775,GO:0071222,0.653132698290104,0.652314901212046,2,10,cellular response to lipopolysaccharide,BP,TICAM1;PDE4B
335,GO:0002440,0.653507875681264,0.758222066911585,1,5,production of molecular mediator of immune response,BP,GAS6
832,GO:0005829,0.653509348984212,0.453157548021185,24,118,cytosol,CC,ACTN2;PNP;MYO7A;CDKN1A;FRMPD1;GPRASP1;RHOJ;RHOB;PHLDA1;PIK3R1;MRI1;CMBL;PRKACB;TICAM1;RIN3;PTPN7;CASP4;DHCR7;PDE4B;FOXO4;AOX1;CTGF;GPSM1;MARK4
784,GO:0005623,0.653907201428844,0.54821070446084,69,342,cell,CC,ACTN2;PNP;NRTN;ACSF2;MYO7A;CDKN1A;FRMPD1;HMGCS2;GPRASP1;NUAK2;RHOJ;KITLG;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PRND;PLEKHH2;HEXB;CLDN11;MFGE8;MRO;LAMA5;ITGB5;CMBL;PRKACB;SLC52A3;CAMSAP3;HSD17B3;ITGB8;MPZL1;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;TMEM163;HMGN5;CRISPLD2;SEMA6C;RAB39B;SLC18B1;PTPN7;RBMS3;CASP4;DHCR7;PON2;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;CGN;GPSM1;PRRT1;MARK4
4055,GO:0044464,0.653907201428844,0.54821070446084,69,342,cell part,CC,ACTN2;PNP;NRTN;ACSF2;MYO7A;CDKN1A;FRMPD1;HMGCS2;GPRASP1;NUAK2;RHOJ;KITLG;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PRND;PLEKHH2;HEXB;CLDN11;MFGE8;MRO;LAMA5;ITGB5;CMBL;PRKACB;SLC52A3;CAMSAP3;HSD17B3;ITGB8;MPZL1;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;TMEM163;HMGN5;CRISPLD2;SEMA6C;RAB39B;SLC18B1;PTPN7;RBMS3;CASP4;DHCR7;PON2;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;CGN;GPSM1;PRRT1;MARK4
813,GO:0005776,0.656252515498229,0.766994780250516,1,4,autophagosome,CC,TICAM1
5795,GO:0071310,0.656336483096911,0.464851005401659,16,79,cellular response to organic substance,BP,ACTN2;DKK3;PIK3R1;ITGB5;PRKACB;GAS6;DLL1;TICAM1;CASP4;CLDN1;PDE4B;FOXO4;ITGA3;PDK4;CTGF;CGN
6865,GO:1903829,0.656643383878786,0.601497691666549,3,13,positive regulation of cellular protein localization,BP,PIK3R1;GAS6;ITGA3
6842,GO:1903670,0.656925264919905,0.78630327327244,1,3,regulation of sprouting angiogenesis,BP,DLL1
1539,GO:0009799,0.657017491259385,0.64819632841384,2,10,specification of symmetry,BP,DLL1;DAAM2
5601,GO:0065008,0.657238756925452,0.450169397900176,23,116,regulation of biological quality,BP,ACTN2;CDKN1A;RHOJ;DKK3;KITLG;RHOB;PIK3R1;PRND;PLEKHH2;HEXB;PRKACB;HSD17B3;CYP11A1;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;DHCR7;CLDN1;PDE4B;PDK4;CTGF
838,GO:0005874,0.657573911749654,0.754386103441246,1,5,microtubule,CC,CAMSAP3
806,GO:0005768,0.657578280239579,0.540806390942595,5,26,endosome,CC,RHOB;SNX21;TICAM1;RIN3;TMEM163
3519,GO:0038093,0.658236649772873,0.753756344357861,1,5,Fc receptor signaling pathway,BP,PIK3R1
3521,GO:0038095,0.658236649772873,0.753756344357861,1,5,Fc-epsilon receptor signaling pathway,BP,PIK3R1
1821,GO:0014812,0.658558923510348,0.764884867169167,1,4,muscle cell migration,BP,FOXO4
1846,GO:0014909,0.658558923510348,0.764884867169167,1,4,smooth muscle cell migration,BP,FOXO4
6284,GO:0097150,0.658675490777682,0.784809156319122,1,3,neuronal stem cell population maintenance,BP,DLL1
883,GO:0006023,0.659019548983678,0.764461656063474,1,4,aminoglycan biosynthetic process,BP,SDC4
884,GO:0006024,0.659019548983678,0.764461656063474,1,4,glycosaminoglycan biosynthetic process,BP,SDC4
808,GO:0005770,0.660464193107606,0.751630282034003,1,5,late endosome,CC,RHOB
6532,GO:1901135,0.661217066162942,0.520259259846435,6,32,carbohydrate derivative metabolic process,BP,PNP;PHLDA1;HEXB;ITGB8;SDC4;PDE4B
1635,GO:0010566,0.661305230436141,0.762352566697041,1,4,regulation of ketone biosynthetic process,BP,DKK3
2882,GO:0032341,0.661305230436141,0.762352566697041,1,4,aldosterone metabolic process,BP,DKK3
2883,GO:0032342,0.661305230436141,0.762352566697041,1,4,aldosterone biosynthetic process,BP,DKK3
2884,GO:0032344,0.661305230436141,0.762352566697041,1,4,regulation of aldosterone metabolic process,BP,DKK3
2887,GO:0032347,0.661305230436141,0.762352566697041,1,4,regulation of aldosterone biosynthetic process,BP,DKK3
2890,GO:0032350,0.661305230436141,0.762352566697041,1,4,regulation of hormone metabolic process,BP,DKK3
4336,GO:0046184,0.661305230436141,0.762352566697041,1,4,aldehyde biosynthetic process,BP,DKK3
4452,GO:0046885,0.661305230436141,0.762352566697041,1,4,regulation of hormone biosynthetic process,BP,DKK3
6153,GO:0090030,0.661305230436141,0.762352566697041,1,4,regulation of steroid hormone biosynthetic process,BP,DKK3
263,GO:0002068,0.661402894969781,0.762262110493465,1,4,glandular epithelial cell development,BP,DLL1
518,GO:0003309,0.661402894969781,0.762262110493465,1,4,type B pancreatic cell differentiation,BP,DLL1
519,GO:0003323,0.661402894969781,0.762262110493465,1,4,type B pancreatic cell development,BP,DLL1
3427,GO:0035883,0.661402894969781,0.762262110493465,1,4,enteroendocrine cell differentiation,BP,DLL1
4183,GO:0045445,0.66203915796605,0.761672129073864,1,4,myoblast differentiation,BP,DLL1
824,GO:0005796,0.662567601249508,0.642252463711745,2,10,Golgi lumen,CC,SDC4;GAS6
429,GO:0003012,0.662900800267867,0.55639308841426,4,21,muscle system process,BP,ACTN2;ITGB5;PDE4B;CTGF
4377,GO:0046486,0.663223731163053,0.581516299462053,3,20,glycerolipid metabolic process,BP,KITLG;PIK3R1;ACSL4
6057,GO:0072331,0.664281988382115,0.740437314887979,1,6,signal transduction by p53 class mediator,BP,CDKN1A
1182,GO:0007166,0.664474588788075,0.4470370212342,20,99,cell surface receptor signaling pathway,BP,LAMA1;NRTN;DKK3;KITLG;PIK3R1;LAMA5;ITGB5;PRKACB;ITGB8;MPZL1;GAS6;DLL1;TICAM1;PDE4B;DHH;FOXO4;ITGA3;PDK4;CTGF;CGN
120,GO:0001568,0.66522907255784,0.49643888829963,8,37,blood vessel development,BP,RHOB;MFGE8;LAMA5;ITGB8;DLL1;DHCR7;FOXO4;CTGF
13,GO:0000082,0.665544039562737,0.739185007530259,1,6,G1/S transition of mitotic cell cycle,BP,CDKN1A
4096,GO:0044843,0.665544039562737,0.739185007530259,1,6,cell cycle G1/S phase transition,BP,CDKN1A
1232,GO:0007346,0.665920381391585,0.628098385824857,2,14,regulation of mitotic cell cycle,BP,CDKN1A;FOXO4
3778,GO:0043123,0.666575786610036,0.738157684408845,1,6,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,TICAM1
804,GO:0005765,0.66720689666467,0.756836347387237,1,4,lysosomal membrane,CC,MYO7A
811,GO:0005774,0.66720689666467,0.756836347387237,1,4,vacuolar membrane,CC,MYO7A
6412,GO:0098852,0.66720689666467,0.756836347387237,1,4,lytic vacuole membrane,CC,MYO7A
3797,GO:0043200,0.667340025159273,0.75671072896156,1,4,response to amino acid,BP,CTGF
1014,GO:0006638,0.667516857479329,0.731915825251775,1,7,neutral lipid metabolic process,BP,ACSL4
1015,GO:0006639,0.667516857479329,0.731915825251775,1,7,acylglycerol metabolic process,BP,ACSL4
3170,GO:0033993,0.667574637683596,0.500102332307978,7,39,response to lipid,BP,CDKN1A;TICAM1;CLDN1;PDE4B;DHH;PDK4;CTGF
2713,GO:0031345,0.667623626135801,0.756442950859868,1,4,negative regulation of cell projection organization,BP,ITGA3
2356,GO:0022407,0.668411572335817,0.585827452209944,3,14,regulation of cell-cell adhesion,BP,PNP;PIK3R1;SDC4
693,GO:0005112,0.668875055527118,0.775929649849359,1,3,Notch binding,MF,DLL1
2559,GO:0030658,0.669378035943435,0.735351274696354,1,6,transport vesicle membrane,CC,TMEM163
4072,GO:0044724,0.669571310705935,0.742785730865152,1,5,single-organism carbohydrate catabolic process,BP,HEXB
6298,GO:0097191,0.669653700096609,0.623967685164258,2,14,extrinsic apoptotic signaling pathway,BP,KITLG;PIK3R1
1124,GO:0006950,0.670369836086107,0.444123911476657,18,93,response to stress,BP,CDKN1A;NUAK2;RHOB;PIK3R1;PRKACB;SLC52A3;SDC4;GAS6;SERPINA5;TICAM1;CASP4;PON2;CLDN1;FOXO4;PDK4;AOX1;CTGF;CLDN3
3827,GO:0043266,0.670665055906324,0.753556112422219,1,4,regulation of potassium ion transport,BP,ACTN2
3286,GO:0034763,0.67075112815961,0.753474011445648,1,4,negative regulation of transmembrane transport,BP,ACTN2
3289,GO:0034766,0.67075112815961,0.753474011445648,1,4,negative regulation of ion transmembrane transport,BP,ACTN2
356,GO:0002573,0.671513325177971,0.636886045704539,2,9,myeloid leukocyte differentiation,BP,KITLG;PIK3R1
67,GO:0000904,0.671662969171507,0.511628116027868,6,28,cell morphogenesis involved in differentiation,BP,NRTN;MYO7A;PIK3R1;LAMA5;SEMA6C;CLDN3
5361,GO:0060563,0.671723568040498,0.642312429284413,2,8,neuroepithelial cell differentiation,BP,MYO7A;DLL1
142,GO:0001676,0.672145984486564,0.752140396829901,1,4,long-chain fatty acid metabolic process,BP,ACSL4
3248,GO:0034504,0.672153810050684,0.581654202676723,3,14,protein localization to nucleus,BP,CDKN1A;PIK3R1;GAS6
6483,GO:1900180,0.672153810050684,0.581654202676723,3,14,regulation of protein localization to nucleus,BP,CDKN1A;PIK3R1;GAS6
797,GO:0005741,0.674414771448922,0.73024698489649,1,6,mitochondrial outer membrane,CC,ACSL4
3243,GO:0034446,0.675090477311663,0.770370744534246,1,3,substrate adhesion-dependent cell spreading,BP,LAMA5
4066,GO:0044707,0.67529249631943,0.423209176780143,40,187,single-multicellular organism process,BP,ACTN2;PNP;LAMA1;NRTN;MYO7A;CDKN1A;RHOJ;DKK3;KITLG;RHOB;PIK3R1;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;PRKACB;CAMSAP3;HSD17B3;ITGB8;SDC4;GAS6;SERPINA5;DLL1;FHOD3;TICAM1;CRISPLD2;SEMA6C;DHCR7;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;CTGF;GPSM1;DAAM2;MARK4
4255,GO:0045747,0.675534521254744,0.748876036133159,1,4,positive regulation of Notch signaling pathway,BP,DLL1
1634,GO:0010565,0.676552942850078,0.620607583374479,2,12,regulation of cellular ketone metabolic process,BP,DKK3;PDK4
6569,GO:1901566,0.677605939746186,0.533510041117024,4,28,organonitrogen compound biosynthetic process,BP,PNP;MRI1;SDC4;RBMS3
5121,GO:0055001,0.678115601647906,0.635345934774508,2,8,muscle cell development,BP,ACTN2;FHOD3
2355,GO:0022406,0.678361359750441,0.734011202422906,1,5,membrane docking,BP,MARK4
932,GO:0006275,0.679332884308059,0.725187262043233,1,6,regulation of DNA replication,BP,KITLG
4249,GO:0045740,0.679332884308059,0.725187262043233,1,6,positive regulation of DNA replication,BP,KITLG
163,GO:0001756,0.679483174705154,0.766372545487573,1,3,somitogenesis,BP,DLL1
3293,GO:0035004,0.679605253204081,0.620039415741719,2,11,phosphatidylinositol 3-kinase activity,MF,KITLG;PIK3R1
4466,GO:0046934,0.679605253204081,0.620039415741719,2,11,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,KITLG;PIK3R1
5120,GO:0052813,0.679605253204081,0.620039415741719,2,11,phosphatidylinositol bisphosphate kinase activity,MF,KITLG;PIK3R1
6812,GO:1903524,0.680392290851429,0.731949797004911,1,5,positive regulation of blood circulation,BP,CTGF
2367,GO:0022607,0.680796053808267,0.444427310616618,14,68,cellular component assembly,BP,ACTN2;MYO7A;PIK3R1;PRND;LAMA5;ITGB5;SDC4;GAS6;FHOD3;CLDN1;CTGF;CLDN3;ESPN;MARK4
378,GO:0002688,0.681203198877187,0.74333610966489,1,4,regulation of leukocyte chemotaxis,BP,GAS6
1768,GO:0010976,0.681684284649864,0.742861342344156,1,4,positive regulation of neuron projection development,BP,ITGA3
2256,GO:0019838,0.681762766217124,0.742783822566887,1,4,growth factor binding,MF,CTGF
940,GO:0006325,0.681968272607437,0.742580742908823,1,4,chromatin organization,BP,HMGN5
3042,GO:0032868,0.682516128483469,0.569950668842322,3,14,response to insulin,BP,PIK3R1;FOXO4;PDK4
4442,GO:0046872,0.683939252297154,0.440729772327206,14,69,metal ion binding,MF,ACTN2;CDKN1A;NUAK2;PRND;PRKACB;CYP11A1;GAS6;DLL1;TMEM163;PON2;PDE4B;DHH;ITGA3;AOX1
4167,GO:0045335,0.684877211086512,0.727351409938973,1,5,phagocytic vesicle,CC,ITGB5
1898,GO:0015718,0.685619343457154,0.72658431623458,1,5,monocarboxylic acid transport,BP,ACSL4
1923,GO:0015908,0.685619343457154,0.72658431623458,1,5,fatty acid transport,BP,ACSL4
6118,GO:0085029,0.686594020432513,0.759775280032778,1,3,extracellular matrix assembly,BP,GAS6
1703,GO:0010812,0.686738710559415,0.759639408997536,1,3,negative regulation of cell-substrate adhesion,BP,PIK3R1
6567,GO:1901564,0.686779343974122,0.453262947794726,10,60,organonitrogen compound metabolic process,BP,PNP;MRI1;HEXB;SLC52A3;ITGB8;SDC4;GAS6;RBMS3;PDE4B;AOX1
5333,GO:0060491,0.687132632063574,0.725014639078404,1,5,regulation of cell projection assembly,BP,ESPN
5083,GO:0051896,0.687867869162872,0.736693723808462,1,4,regulation of protein kinase B signaling,BP,GAS6
5084,GO:0051897,0.687867869162872,0.736693723808462,1,4,positive regulation of protein kinase B signaling,BP,GAS6
2366,GO:0022604,0.689367027181363,0.608957877416098,2,11,regulation of cell morphogenesis,BP,RHOJ;HEXB
405,GO:0002762,0.691046925334275,0.733475126400463,1,4,negative regulation of myeloid leukocyte differentiation,BP,PIK3R1
3970,GO:0044092,0.6921709630018,0.499261197005584,5,29,negative regulation of molecular function,BP,ACTN2;CDKN1A;CAMSAP3;GAS6;SERPINA5
1018,GO:0006644,0.692622426596617,0.547962896633212,3,20,phospholipid metabolic process,BP,KITLG;PIK3R1;HEXB
1398,GO:0008543,0.692808102898897,0.705254479080345,1,7,fibroblast growth factor receptor signaling pathway,BP,CTGF
5265,GO:0060324,0.692976741868202,0.731505247290808,1,4,face development,BP,CRISPLD2
1318,GO:0008083,0.693200661608215,0.547285545188132,3,20,growth factor activity,MF,NRTN;KITLG;CTGF
6695,GO:1902580,0.693446244791995,0.474146258709676,7,33,single-organism cellular localization,BP,ACTN2;MYO7A;CDKN1A;PIK3R1;LAMA5;GAS6;ITGA3
3539,GO:0040011,0.693624282522355,0.430476277661787,14,66,locomotion,BP,LAMA1;NRTN;KITLG;RHOB;PIK3R1;HEXB;LAMA5;SDC4;GAS6;SEMA6C;PDE4B;FOXO4;ITGA3;CTGF
1803,GO:0014070,0.693732089900902,0.471975167816462,7,36,response to organic cyclic compound,BP,CDKN1A;PRKACB;TICAM1;CLDN1;PDE4B;DHH;CTGF
3688,GO:0042592,0.694040620929301,0.441723327281606,11,56,homeostatic process,BP,KITLG;PIK3R1;PRND;HEXB;PRKACB;GAS6;DLL1;CLDN1;PDE4B;PDK4;CTGF
3803,GO:0043209,0.694936699448773,0.716801282060344,1,5,myelin sheath,CC,CLDN11
227,GO:0001947,0.695332471522908,0.729084000212197,1,4,heart looping,BP,DLL1
5560,GO:0061371,0.695332471522908,0.729084000212197,1,4,determination of heart left/right asymmetry,BP,DLL1
5186,GO:0060048,0.696506689946702,0.608847108006913,2,9,cardiac muscle contraction,BP,PDE4B;CTGF
135,GO:0001657,0.697223212894543,0.599867208028899,2,11,ureteric bud development,BP,LAMA5;SDC4
5999,GO:0072163,0.697223212894543,0.599867208028899,2,11,mesonephric epithelium development,BP,LAMA5;SDC4
6000,GO:0072164,0.697223212894543,0.599867208028899,2,11,mesonephric tubule development,BP,LAMA5;SDC4
3077,GO:0032984,0.697549012112589,0.607643487505893,2,9,macromolecular complex disassembly,BP,ACTN2;PLEKHH2
3818,GO:0043241,0.697549012112589,0.607643487505893,2,9,protein complex disassembly,BP,ACTN2;PLEKHH2
930,GO:0006260,0.698556583285712,0.698906159575874,1,7,DNA replication,BP,KITLG
6806,GO:1903510,0.699554869145968,0.711845695796553,1,5,mucopolysaccharide metabolic process,BP,HEXB
1300,GO:0008013,0.699677067020701,0.724570096211688,1,4,beta-catenin binding,MF,FOXO4
4600,GO:0048545,0.700629326286021,0.546540296297752,3,15,response to steroid hormone,BP,CDKN1A;CLDN1;CTGF
3985,GO:0044255,0.700751489407483,0.43780422595798,10,58,cellular lipid metabolic process,BP,ACSF2;HMGCS2;KITLG;PIK3R1;HEXB;ITGB8;SDC4;PON2;ACSL4;PDK4
726,GO:0005244,0.701215915055898,0.710045651960497,1,5,voltage-gated ion channel activity,MF,GAS6
2378,GO:0022832,0.701215915055898,0.710045651960497,1,5,voltage-gated channel activity,MF,GAS6
2383,GO:0022843,0.701215915055898,0.710045651960497,1,5,voltage-gated cation channel activity,MF,GAS6
4433,GO:0046834,0.701586443096018,0.591795264391021,2,12,lipid phosphorylation,BP,KITLG;PIK3R1
4439,GO:0046854,0.701586443096018,0.591795264391021,2,12,phosphatidylinositol phosphorylation,BP,KITLG;PIK3R1
4890,GO:0051129,0.701906815408268,0.514592921324798,4,19,negative regulation of cellular component organization,BP,PLEKHH2;FHOD3;ITGA3;ESPN
686,GO:0005096,0.701919648436116,0.722215213493392,1,4,GTPase activator activity,MF,RIN3
3094,GO:0033036,0.702090736409514,0.416571658491924,15,77,macromolecule localization,BP,ACTN2;PNP;MYO7A;CDKN1A;RHOB;REEP1;SNX21;PIK3R1;HEXB;LAMA5;GAS6;SERPINA5;RAB39B;ACSL4;ITGA3
962,GO:0006417,0.702740977426068,0.700037279802697,1,6,regulation of translation,BP,RBMS3
3199,GO:0034248,0.702740977426068,0.700037279802697,1,6,regulation of cellular amide metabolic process,BP,RBMS3
3382,GO:0035639,0.702850593558876,0.43759151669817,10,50,purine ribonucleoside triphosphate binding,MF,ACSF2;MYO7A;NUAK2;RHOJ;RHOB;PRKACB;RAB39B;ACSL4;PDK4;MARK4
1626,GO:0010556,0.703001648763453,0.418558960762634,14,73,regulation of macromolecule biosynthetic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3;CTGF
182,GO:0001823,0.703682032682591,0.589311779404737,2,12,mesonephros development,BP,LAMA5;SDC4
5050,GO:0051650,0.704084447361169,0.706914834142174,1,5,establishment of vesicle localization,BP,MYO7A
3976,GO:0044236,0.70428510217764,0.706694771263198,1,5,multicellular organism metabolic process,BP,CTGF
5298,GO:0060416,0.704288425131874,0.71970916490833,1,4,response to growth hormone,BP,PIK3R1
2554,GO:0030593,0.704842171225098,0.706083089586387,1,5,neutrophil chemotaxis,BP,PDE4B
5866,GO:0071621,0.704842171225098,0.706083089586387,1,5,granulocyte chemotaxis,BP,PDE4B
6338,GO:0097530,0.704842171225098,0.706083089586387,1,5,granulocyte migration,BP,PDE4B
7012,GO:1990266,0.704842171225098,0.706083089586387,1,5,neutrophil migration,BP,PDE4B
687,GO:0005102,0.705122939236936,0.415679587435401,14,76,receptor binding,MF,ACTN2;LAMA1;NRTN;KITLG;REEP1;PIK3R1;MFGE8;LAMA5;ITGB8;GAS6;DLL1;DHH;ITGA3;CTGF
3965,GO:0044087,0.705207815586125,0.473142260869994,6,28,regulation of cellular component biogenesis,BP,PIK3R1;SDC4;FHOD3;CLDN1;CTGF;ESPN
4618,GO:0048598,0.706260888818583,0.458630291582644,7,34,embryonic morphogenesis,BP,MYO7A;LAMA5;ITGB5;PRKACB;SDC4;DLL1;ITGA3
4494,GO:0048009,0.706494017168743,0.717358363381056,1,4,insulin-like growth factor receptor signaling pathway,BP,PIK3R1
2182,GO:0019003,0.707416945859485,0.694792774777494,1,6,GDP binding,MF,RHOB
160,GO:0001750,0.707978576935279,0.738958527065407,1,3,photoreceptor outer segment,CC,MYO7A
6352,GO:0097730,0.707978576935279,0.738958527065407,1,3,non-motile cilium,CC,MYO7A
6353,GO:0097731,0.707978576935279,0.738958527065407,1,3,9+0 non-motile cilium,CC,MYO7A
6354,GO:0097733,0.707978576935279,0.738958527065407,1,3,photoreceptor cell cilium,CC,MYO7A
199,GO:0001885,0.708631052166106,0.70189407252465,1,5,endothelial cell development,BP,CLDN1
5482,GO:0061028,0.708631052166106,0.70189407252465,1,5,establishment of endothelial barrier,BP,CLDN1
6863,GO:1903827,0.708921895358949,0.484087456084878,5,24,regulation of cellular protein localization,BP,ACTN2;CDKN1A;PIK3R1;GAS6;ITGA3
5390,GO:0060674,0.709130173851279,0.714526417152827,1,4,placenta blood vessel development,BP,ITGB8
5751,GO:0070887,0.709295749536566,0.400854809266022,18,92,cellular response to chemical stimulus,BP,ACTN2;DKK3;RHOB;PIK3R1;ITGB5;CMBL;PRKACB;GAS6;DLL1;TICAM1;CASP4;CLDN1;PDE4B;FOXO4;ITGA3;PDK4;CTGF;CGN
3264,GO:0034645,0.709632676824539,0.40757377007195,15,80,cellular macromolecule biosynthetic process,BP,CDKN1A;DKK3;KITLG;PHLDA1;PIK3R1;PRND;HEXB;GAS6;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3;CTGF
1535,GO:0009790,0.709645553085405,0.431207718524655,10,46,embryo development,BP,LAMA1;MYO7A;KITLG;LAMA5;ITGB5;PRKACB;SDC4;DLL1;ACSL4;ITGA3
4710,GO:0048872,0.709726639113539,0.588744595948153,2,10,homeostasis of number of cells,BP,KITLG;PDE4B
6402,GO:0098797,0.70982249012093,0.538028254119239,3,14,plasma membrane protein complex,CC,ITGB5;ITGB8;ITGA3
2057,GO:0016628,0.711571757315114,0.698607974754157,1,5,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,DHCR7
4934,GO:0051224,0.711656366611102,0.711789643161627,1,4,negative regulation of protein transport,BP,GAS6
4615,GO:0048592,0.71185523828318,0.586195157472456,2,10,eye morphogenesis,BP,MYO7A;DLL1
1250,GO:0007422,0.71186359734886,0.689734374741962,1,6,peripheral nervous system development,BP,CLDN1
1994,GO:0016331,0.711999940668658,0.530887123750273,3,16,morphogenesis of embryonic epithelium,BP,LAMA5;PRKACB;SDC4
3007,GO:0032729,0.712116054478863,0.689445080220746,1,6,positive regulation of interferon-gamma production,BP,PDE4B
4677,GO:0048762,0.712450748217548,0.53034259761731,3,16,mesenchymal cell differentiation,BP,NRTN;KITLG;LAMA5
2692,GO:0031294,0.712533759995621,0.71083380743761,1,4,lymphocyte costimulation,BP,PIK3R1
2693,GO:0031295,0.712533759995621,0.71083380743761,1,4,T cell costimulation,BP,PIK3R1
3329,GO:0035264,0.712759227990685,0.697272309536908,1,5,multicellular organism growth,BP,DHCR7
1280,GO:0007601,0.712915866476851,0.697095745891681,1,5,visual perception,BP,MYO7A
4842,GO:0050953,0.712915866476851,0.697095745891681,1,5,sensory perception of light stimulus,BP,MYO7A
5920,GO:0071901,0.713637638101544,0.687696642316955,1,6,negative regulation of protein serine/threonine kinase activity,BP,CDKN1A
439,GO:0003073,0.714121661431956,0.695733616500455,1,5,regulation of systemic arterial blood pressure,BP,GAS6
1246,GO:0007411,0.714279153592531,0.528129429513919,3,16,axon guidance,BP,NRTN;PIK3R1;SEMA6C
6334,GO:0097485,0.714279153592531,0.528129429513919,3,16,neuron projection guidance,BP,NRTN;PIK3R1;SEMA6C
6851,GO:1903725,0.714883237057248,0.686259140616955,1,6,regulation of phospholipid metabolic process,BP,PIK3R1
4204,GO:0045604,0.716165623419611,0.706847855113576,1,4,regulation of epidermal cell differentiation,BP,DLL1
2277,GO:0019903,0.716627959889502,0.706337021592395,1,4,protein phosphatase binding,MF,PIK3R1
2358,GO:0022409,0.716749712988882,0.580286312644722,2,10,positive regulation of cell-cell adhesion,BP,PNP;PIK3R1
1192,GO:0007186,0.717370187562879,0.494585553115433,4,20,G-protein coupled receptor signaling pathway,BP,ACTN2;GPRASP1;PRKACB;GPSM1
1947,GO:0016052,0.717676769966785,0.683014786146223,1,6,carbohydrate catabolic process,BP,HEXB
1967,GO:0016192,0.717992586713855,0.409455301383985,12,61,vesicle-mediated transport,BP,ACTN2;PNP;MYO7A;PIK3R1;HEXB;MFGE8;SDC4;GAS6;DLL1;RIN3;CRISPLD2;RAB39B
1193,GO:0007187,0.71834490211103,0.690921299817187,1,5,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,PRKACB
1194,GO:0007188,0.71834490211103,0.690921299817187,1,5,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,PRKACB
1442,GO:0009101,0.719228047638049,0.681200859857369,1,6,glycoprotein biosynthetic process,BP,PHLDA1
1800,GO:0014066,0.720008997156829,0.56956581033623,2,12,regulation of phosphatidylinositol 3-kinase signaling,BP,KITLG;PIK3R1
5360,GO:0060562,0.720068294570761,0.469686829282525,5,25,epithelial tube morphogenesis,BP,RHOB;LAMA5;PRKACB;SDC4;DLL1
3254,GO:0034614,0.720144163757083,0.688851242331324,1,5,cellular response to reactive oxygen species,BP,RHOB
2130,GO:0017046,0.720374869325323,0.702168236164162,1,4,peptide hormone binding,MF,PIK3R1
3678,GO:0042562,0.720374869325323,0.702168236164162,1,4,hormone binding,MF,PIK3R1
6367,GO:0098589,0.720634099669726,0.575549970202428,2,10,membrane region,CC,SDC4;DLL1
3184,GO:0034109,0.721181431408607,0.701264094003117,1,4,homotypic cell-cell adhesion,BP,GAS6
234,GO:0001959,0.721480843933807,0.67245220195122,1,7,regulation of cytokine-mediated signaling pathway,BP,GAS6
5419,GO:0060759,0.721480843933807,0.67245220195122,1,7,regulation of response to cytokine stimulus,BP,GAS6
4379,GO:0046488,0.722295800868101,0.562106530769835,2,14,phosphatidylinositol metabolic process,BP,KITLG;PIK3R1
2405,GO:0030027,0.723699597536369,0.576493616482405,2,9,lamellipodium,CC,KITLG;PLEKHH2
3922,GO:0043588,0.724335323960504,0.491399310581285,4,17,skin development,BP,LAMA5;DLL1;CLDN1;ITGA3
2515,GO:0030336,0.724511230360745,0.697505766886168,1,4,negative regulation of cell migration,BP,RHOB
6361,GO:0098542,0.724804206900531,0.663933308759185,1,8,defense response to other organism,BP,TICAM1
4707,GO:0048869,0.724848607149663,0.371670987057375,27,128,cellular developmental process,BP,ACTN2;PNP;NRTN;MYO7A;CDKN1A;RHOJ;KITLG;RHOB;PIK3R1;HEXB;LAMA5;ITGB5;CAMSAP3;SDC4;GAS6;DLL1;FHOD3;SEMA6C;DHCR7;CLDN1;ACSL4;DHH;FOXO4;ITGA3;CTGF;CLDN3;GPSM1
6684,GO:1902494,0.725071552675393,0.511497711740926,3,18,catalytic complex,CC,CDKN1A;PIK3R1;TICAM1
1565,GO:0009953,0.725145350371888,0.668047434265487,1,7,dorsal/ventral pattern formation,BP,PRKACB
6793,GO:1903409,0.725460623928693,0.673823161523971,1,6,reactive oxygen species biosynthetic process,BP,TICAM1
6794,GO:1903426,0.725460623928693,0.673823161523971,1,6,regulation of reactive oxygen species biosynthetic process,BP,TICAM1
2126,GO:0017022,0.726389640317626,0.681572223210971,1,5,myosin binding,MF,RAB39B
6373,GO:0098602,0.72725426984614,0.435126894692365,7,32,single organism cell adhesion,BP,PNP;PIK3R1;LAMA5;ITGB5;CAMSAP3;SDC4;GAS6
1651,GO:0010634,0.728661254567043,0.558807554831902,2,12,positive regulation of epithelial cell migration,BP,RHOB;ITGA3
4959,GO:0051276,0.729152451611744,0.6783051126774,1,5,chromosome organization,BP,HMGN5
2236,GO:0019538,0.729395497347357,0.36846734314752,24,129,protein metabolic process,BP,ACTN2;NRTN;CDKN1A;NUAK2;KITLG;PHLDA1;PIK3R1;PRND;HEXB;MFGE8;PRKACB;SDC4;GAS6;SERPINA5;DLL1;TICAM1;PTPN7;RBMS3;CASP4;DHH;FOXO4;PDK4;CTGF;MARK4
6404,GO:0098801,0.729454001977005,0.677946747391871,1,5,regulation of renal system process,BP,GAS6
959,GO:0006412,0.729559970364515,0.65809739161164,1,8,translation,BP,RBMS3
2520,GO:0030425,0.730199120010836,0.568455714214519,2,9,dendrite,CC,ACTN2;PDE4B
288,GO:0002237,0.730773564550433,0.504393313878609,3,18,response to molecule of bacterial origin,BP,TICAM1;CLDN1;PDE4B
2943,GO:0032496,0.730773564550433,0.504393313878609,3,18,response to lipopolysaccharide,BP,TICAM1;CLDN1;PDE4B
2832,GO:0032092,0.731034370230186,0.676062878168786,1,5,positive regulation of protein binding,BP,TICAM1
4884,GO:0051099,0.731034370230186,0.676062878168786,1,5,positive regulation of binding,BP,TICAM1
5005,GO:0051445,0.73108878452218,0.675997841589709,1,5,regulation of meiotic cell cycle,BP,PRKACB
4582,GO:0048514,0.731443919601153,0.44015002489662,6,30,blood vessel morphogenesis,BP,RHOB;MFGE8;LAMA5;DLL1;FOXO4;CTGF
2142,GO:0017137,0.731513347441757,0.689465307232558,1,4,Rab GTPase binding,MF,RIN3
1262,GO:0007519,0.731810629630743,0.675133994796777,1,5,skeletal muscle tissue development,BP,DLL1
5897,GO:0071822,0.731969923138645,0.43583154029953,6,36,protein complex subunit organization,BP,ACTN2;PRND;PLEKHH2;FHOD3;CLDN1;CLDN3
6588,GO:1901655,0.732024915700228,0.674877163718892,1,5,cellular response to ketone,BP,GAS6
3044,GO:0032870,0.732117802452921,0.457275969278108,5,23,cellular response to hormone stimulus,BP,ACTN2;PIK3R1;PRKACB;FOXO4;PDK4
3253,GO:0034613,0.732232762036107,0.410177335636649,9,44,cellular protein localization,BP,ACTN2;MYO7A;CDKN1A;RHOB;REEP1;PIK3R1;LAMA5;GAS6;ITGA3
5731,GO:0070727,0.732232762036107,0.410177335636649,9,44,cellular macromolecule localization,BP,ACTN2;MYO7A;CDKN1A;RHOB;REEP1;PIK3R1;LAMA5;GAS6;ITGA3
3552,GO:0042035,0.732249091036767,0.665620239264767,1,6,regulation of cytokine biosynthetic process,BP,TICAM1
3563,GO:0042089,0.732249091036767,0.665620239264767,1,6,cytokine biosynthetic process,BP,TICAM1
3571,GO:0042107,0.732249091036767,0.665620239264767,1,6,cytokine metabolic process,BP,TICAM1
6080,GO:0072522,0.733285535293457,0.658080804572024,1,7,purine-containing compound biosynthetic process,BP,PNP
6767,GO:1903169,0.733830941467122,0.67270543068945,1,5,regulation of calcium ion transmembrane transport,BP,PDE4B
3646,GO:0042471,0.734605894586625,0.662730683958342,1,6,ear morphogenesis,BP,MYO7A
3212,GO:0034341,0.735237774523288,0.655652467646997,1,7,response to interferon-gamma,BP,CLDN1
5807,GO:0071346,0.735237774523288,0.655652467646997,1,7,cellular response to interferon-gamma,BP,CLDN1
4028,GO:0044424,0.735618053337536,0.378576163290446,58,294,intracellular part,CC,ACTN2;PNP;ACSF2;MYO7A;CDKN1A;FRMPD1;HMGCS2;GPRASP1;NUAK2;RHOJ;KITLG;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PLEKHH2;HEXB;MRO;LAMA5;ITGB5;CMBL;PRKACB;CAMSAP3;HSD17B3;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;TMEM163;HMGN5;CRISPLD2;RAB39B;PTPN7;RBMS3;CASP4;DHCR7;PON2;CLDN1;PDE4B;ACSL4;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;CGN;GPSM1;MARK4
2509,GO:0030325,0.735726771280877,0.67041190656579,1,5,adrenal gland development,BP,DKK3
863,GO:0005942,0.736621884160116,0.6834790485593,1,4,phosphatidylinositol 3-kinase complex,CC,PIK3R1
4874,GO:0051055,0.736654386178588,0.660201392372983,1,6,negative regulation of lipid biosynthetic process,BP,DKK3
942,GO:0006352,0.737127817996344,0.682880559772415,1,4,DNA-templated transcription, initiation,BP,CTGF
949,GO:0006367,0.737127817996344,0.682880559772415,1,4,transcription initiation from RNA polymerase II promoter,BP,CTGF
3316,GO:0035148,0.737707244579448,0.547332893979579,2,12,tube formation,BP,PRKACB;SDC4
1515,GO:0009615,0.738590672026899,0.651446851570605,1,7,response to virus,BP,TICAM1
6555,GO:1901363,0.738912200460085,0.364836440481278,19,98,heterocyclic compound binding,MF,PNP;ACSF2;MYO7A;NUAK2;RHOJ;RHOB;PRKACB;CYP11A1;HMGN5;ACCS;RAB39B;RBMS3;DHCR7;PDE4B;ACSL4;FOXO4;PDK4;AOX1;MARK4
2638,GO:0031018,0.739353689012817,0.665984321261922,1,5,endocrine pancreas development,BP,DLL1
4029,GO:0044425,0.739501234014079,0.35244318522453,31,152,membrane part,CC,MYO7A;KITLG;REEP1;PIK3R1;SLC25A53;PRND;CLDN11;MFGE8;ITGB5;SLC52A3;HSD17B3;ITGB8;MPZL1;SDC4;SERPINA5;HSD3B2;DLL1;TMEM163;SEMA6C;SLC18B1;PTPN7;CASP4;DHCR7;TMEM164;CLDN1;PDE4B;ACSL4;ITGA3;CLDN3;GPSM1;PRRT1
4932,GO:0051222,0.741052557828619,0.543029156980849,2,12,positive regulation of protein transport,BP,PIK3R1;GAS6
783,GO:0005622,0.742104554781372,0.374943419845386,59,303,intracellular,CC,ACTN2;PNP;NRTN;ACSF2;MYO7A;CDKN1A;FRMPD1;HMGCS2;GPRASP1;NUAK2;RHOJ;KITLG;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PLEKHH2;HEXB;MRO;LAMA5;ITGB5;CMBL;PRKACB;CAMSAP3;HSD17B3;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;TMEM163;HMGN5;CRISPLD2;RAB39B;PTPN7;RBMS3;CASP4;DHCR7;PON2;CLDN1;PDE4B;ACSL4;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;CGN;GPSM1;MARK4
5503,GO:0061097,0.742511354964641,0.652877301409479,1,6,regulation of protein tyrosine kinase activity,BP,GAS6
5504,GO:0061098,0.742511354964641,0.652877301409479,1,6,positive regulation of protein tyrosine kinase activity,BP,GAS6
6374,GO:0098609,0.742882032388048,0.397387913560454,9,44,cell-cell adhesion,BP,PNP;PIK3R1;CLDN11;ITGB5;CAMSAP3;SDC4;GAS6;CLDN1;CLDN3
6649,GO:1902115,0.744362726603655,0.659782058009858,1,5,regulation of organelle assembly,BP,SDC4
1079,GO:0006820,0.744557003047801,0.535906893712528,2,13,anion transport,BP,SLC52A3;ACSL4
2637,GO:0031016,0.744633495532724,0.650189261722765,1,6,pancreas development,BP,DLL1
7010,GO:1990234,0.745014665010542,0.541002279246709,2,11,transferase complex,CC,CDKN1A;PIK3R1
5994,GO:0072148,0.745412273051574,0.672933012227636,1,4,epithelial cell fate commitment,BP,DLL1
4068,GO:0044710,0.745593846284695,0.348599514062905,25,143,single-organism metabolic process,BP,ACTN2;PNP;NRTN;ACSF2;HMGCS2;DKK3;KITLG;PIK3R1;MRI1;HEXB;SLC52A3;HSD17B3;ITGB8;CYP11A1;SDC4;GAS6;HSD3B2;DHCR7;PON2;PDE4B;ACSL4;DHH;PDK4;AOX1;CTGF
1851,GO:0015031,0.747490799380945,0.396706470046732,8,46,protein transport,BP,PNP;MYO7A;CDKN1A;RHOB;SNX21;PIK3R1;GAS6;RAB39B
6697,GO:1902582,0.747594882861907,0.455690737234423,4,21,single-organism intracellular transport,BP,MYO7A;CDKN1A;PIK3R1;GAS6
2000,GO:0016358,0.747646305322769,0.655660202264814,1,5,dendrite development,BP,ACSL4
1122,GO:0006941,0.749404620722085,0.539115055519361,2,10,striated muscle contraction,BP,PDE4B;CTGF
7051,GO:2000026,0.750712123122976,0.37043504177347,12,63,regulation of multicellular organismal development,BP,PNP;LAMA1;KITLG;RHOB;PIK3R1;LAMA5;PRKACB;GAS6;DLL1;FOXO4;ITGA3;CTGF
2859,GO:0032269,0.750771500273208,0.475057653629267,3,21,negative regulation of cellular protein metabolic process,BP,CDKN1A;GAS6;SERPINA5
4090,GO:0044801,0.751033857694754,0.641969124505229,1,6,single-organism membrane fusion,BP,SERPINA5
2678,GO:0031224,0.751076808385174,0.344797910931683,23,119,intrinsic component of membrane,CC,KITLG;REEP1;SLC25A53;PRND;CLDN11;ITGB5;SLC52A3;ITGB8;MPZL1;SDC4;HSD3B2;DLL1;TMEM163;SEMA6C;SLC18B1;DHCR7;TMEM164;CLDN1;PDE4B;ACSL4;ITGA3;CLDN3;PRRT1
1541,GO:0009880,0.751625421745589,0.641200671748854,1,6,embryonic pattern specification,BP,DLL1
6644,GO:1902106,0.751859578627971,0.640896086593273,1,6,negative regulation of leukocyte differentiation,BP,PIK3R1
6401,GO:0098796,0.753014945470032,0.481544705940655,3,15,membrane protein complex,CC,ITGB5;ITGB8;ITGA3
1264,GO:0007548,0.753642741846195,0.472435021416024,3,20,sex differentiation,BP,KITLG;HSD17B3;DHH
427,GO:0003008,0.753693402440158,0.366852930516727,12,63,system process,BP,ACTN2;MYO7A;HEXB;ITGB5;PRKACB;SLC52A3;GAS6;DLL1;PDE4B;ITGA3;CTGF;ESPN
3964,GO:0044085,0.754105934665557,0.359387391067884,14,71,cellular component biogenesis,BP,ACTN2;MYO7A;PIK3R1;PRND;LAMA5;ITGB5;SDC4;GAS6;FHOD3;CLDN1;CTGF;CLDN3;ESPN;MARK4
3324,GO:0035239,0.754479340956472,0.426107162940935,5,26,tube morphogenesis,BP,RHOB;LAMA5;PRKACB;SDC4;DLL1
2316,GO:0021700,0.755145598934884,0.630010863004212,1,7,developmental maturation,BP,CDKN1A
2838,GO:0032148,0.75575272259133,0.635797573947065,1,6,activation of protein kinase B activity,BP,GAS6
3919,GO:0043583,0.756331586623567,0.475061570216703,3,16,ear development,BP,MYO7A;SDC4;DLL1
3482,GO:0036293,0.756894492890601,0.515513057402406,2,15,response to decreased oxygen levels,BP,CTGF;CLDN3
2278,GO:0019904,0.757873358573799,0.441251364329892,4,22,protein domain specific binding,MF,ACTN2;MYO7A;ITGA3;ESPN
3740,GO:0042990,0.758142983310037,0.642176764742528,1,5,regulation of transcription factor import into nucleus,BP,PIK3R1
3741,GO:0042991,0.758142983310037,0.642176764742528,1,5,transcription factor import into nucleus,BP,PIK3R1
132,GO:0001654,0.758755375852426,0.468397356484235,3,18,eye development,BP,MYO7A;RHOJ;DLL1
5125,GO:0055007,0.758961342411968,0.526454893993448,2,10,cardiac muscle cell differentiation,BP,ACTN2;FHOD3
1385,GO:0008406,0.759038040880306,0.519310783197058,2,12,gonad development,BP,KITLG;DHH
4136,GO:0045137,0.759038040880306,0.519310783197058,2,12,development of primary sexual characteristics,BP,KITLG;DHH
1265,GO:0007565,0.759042531720266,0.526346085505897,2,10,female pregnancy,BP,ACSL4;ITGA3
843,GO:0005886,0.759320901282769,0.328807572594125,34,161,plasma membrane,CC,ACTN2;MYO7A;FRMPD1;RHOJ;KITLG;RHOB;PIK3R1;PRND;PLEKHH2;CLDN11;MFGE8;ITGB5;PRKACB;SLC52A3;ITGB8;MPZL1;SDC4;SERPINA5;DLL1;SEMA6C;RAB39B;SLC18B1;PTPN7;CASP4;PON2;CLDN1;PDE4B;DHH;ITGA3;CTGF;CLDN3;CGN;GPSM1;PRRT1
4833,GO:0050921,0.759401676708424,0.624312883315461,1,7,positive regulation of chemotaxis,BP,GAS6
1627,GO:0010557,0.75970781057651,0.375386324106822,9,48,positive regulation of macromolecule biosynthetic process,BP,KITLG;PIK3R1;HEXB;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;CTGF
2441,GO:0030154,0.760257273341146,0.33159561359183,26,125,cell differentiation,BP,ACTN2;PNP;NRTN;MYO7A;CDKN1A;KITLG;RHOB;PIK3R1;HEXB;LAMA5;ITGB5;CAMSAP3;SDC4;GAS6;DLL1;FHOD3;SEMA6C;DHCR7;CLDN1;ACSL4;DHH;FOXO4;ITGA3;CTGF;CLDN3;GPSM1
3040,GO:0032845,0.760451004037052,0.629556959298381,1,6,negative regulation of homeostatic process,BP,KITLG
4726,GO:0050662,0.760927640082605,0.516760302986081,2,12,coenzyme binding,MF,DHCR7;AOX1
6534,GO:1901137,0.762260824575008,0.510128353473315,2,14,carbohydrate derivative biosynthetic process,BP,PHLDA1;SDC4
4937,GO:0051235,0.762354506591056,0.627000816325151,1,6,maintenance of location,BP,HEXB
5497,GO:0061053,0.762366061786055,0.651670912665769,1,4,somite development,BP,DLL1
4013,GO:0044344,0.763142233569233,0.61431772370149,1,8,cellular response to fibroblast growth factor stimulus,BP,CTGF
5889,GO:0071774,0.763142233569233,0.61431772370149,1,8,response to fibroblast growth factor,BP,CTGF
5486,GO:0061035,0.763396368841094,0.625594872347373,1,6,regulation of cartilage development,BP,CTGF
1573,GO:0009987,0.763396485754218,0.376807701566884,65,323,cellular process,BP,ACTN2;PNP;LAMA1;NRTN;ACSF2;MYO7A;CDKN1A;HMGCS2;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;REEP1;PHLDA1;PIK3R1;MRI1;PRND;PLEKHH2;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;CMBL;PRKACB;SLC52A3;CAMSAP3;HSD17B3;ITGB8;MPZL1;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;HMGN5;CRISPLD2;SEMA6C;RAB39B;PTPN7;RBMS3;CASP4;DHCR7;PON2;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;CGN;GPSM1;DAAM2;MARK4
2672,GO:0031175,0.763609892879457,0.399390607310454,6,31,neuron projection development,BP,NRTN;PIK3R1;CAMSAP3;SEMA6C;ACSL4;ITGA3
1939,GO:0016021,0.763967384724812,0.330762070405155,22,116,integral component of membrane,CC,KITLG;REEP1;SLC25A53;CLDN11;ITGB5;SLC52A3;ITGB8;MPZL1;SDC4;HSD3B2;DLL1;TMEM163;SEMA6C;SLC18B1;DHCR7;TMEM164;CLDN1;PDE4B;ACSL4;ITGA3;CLDN3;PRRT1
1287,GO:0007611,0.76450675608272,0.624091074099721,1,6,learning or memory,BP,ITGA3
1516,GO:0009617,0.764821882799114,0.458905841365625,3,19,response to bacterium,BP,TICAM1;CLDN1;PDE4B
1463,GO:0009165,0.765265153061899,0.611389434458289,1,8,nucleotide biosynthetic process,BP,PNP
6546,GO:1901293,0.765265153061899,0.611389434458289,1,8,nucleoside phosphate biosynthetic process,BP,PNP
453,GO:0003143,0.765835987948844,0.631987059627229,1,5,embryonic heart tube morphogenesis,BP,DLL1
3299,GO:0035050,0.765835987948844,0.631987059627229,1,5,embryonic heart tube development,BP,DLL1
1512,GO:0009607,0.766028858655512,0.426751242347642,4,26,response to biotic stimulus,BP,TICAM1;CLDN1;PDE4B;PRRT1
3950,GO:0043933,0.76616040449791,0.392299054851478,6,38,macromolecular complex subunit organization,BP,ACTN2;PRND;PLEKHH2;FHOD3;CLDN1;CLDN3
3606,GO:0042307,0.766616770970187,0.630937861724151,1,5,positive regulation of protein import into nucleus,BP,PIK3R1
6905,GO:1904591,0.766616770970187,0.630937861724151,1,5,positive regulation of protein import,BP,PIK3R1
1331,GO:0008150,0.766859831061763,0.443077313308549,70,348,biological_process,BP,ACTN2;PNP;LAMA1;NRTN;ACSF2;MYO7A;CDKN1A;HMGCS2;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PRND;PLEKHH2;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;CMBL;PRKACB;SLC52A3;CAMSAP3;HSD17B3;ITGB8;MPZL1;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;HMGN5;CRISPLD2;SEMA6C;ACCS;RAB39B;SLC18B1;PTPN7;RBMS3;CASP4;DHCR7;PON2;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;CGN;GPSM1;DAAM2;PRRT1;MARK4
4502,GO:0048018,0.767762397692975,0.619649648521064,1,6,receptor agonist activity,MF,GAS6
6400,GO:0098794,0.768293956782064,0.518750851703448,2,9,postsynapse,CC,ACTN2;PDE4B
851,GO:0005911,0.768379722834083,0.394017643330596,6,30,cell-cell junction,CC,PIK3R1;CLDN11;CAMSAP3;CLDN1;CLDN3;CGN
4826,GO:0050896,0.768434942283882,0.319335087271596,43,212,response to stimulus,BP,ACTN2;PNP;LAMA1;NRTN;CDKN1A;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;PIK3R1;HEXB;LAMA5;ITGB5;CMBL;PRKACB;SLC52A3;ITGB8;MPZL1;SDC4;GAS6;SERPINA5;DLL1;TICAM1;RIN3;CRISPLD2;SEMA6C;CASP4;PON2;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;CGN;GPSM1;PRRT1
1911,GO:0015833,0.770688637181817,0.367608451044871,8,47,peptide transport,BP,PNP;MYO7A;CDKN1A;RHOB;SNX21;PIK3R1;GAS6;RAB39B
3731,GO:0042886,0.770688637181817,0.367608451044871,8,47,amide transport,BP,PNP;MYO7A;CDKN1A;RHOB;SNX21;PIK3R1;GAS6;RAB39B
4319,GO:0045992,0.771238631431314,0.62466914166495,1,5,negative regulation of embryonic development,BP,PRKACB
5163,GO:0055114,0.771338062662808,0.384854176725215,6,40,oxidation-reduction process,BP,HSD17B3;CYP11A1;HSD3B2;DHCR7;PDK4;AOX1
1672,GO:0010675,0.771493429411253,0.614499619629229,1,6,regulation of cellular carbohydrate metabolic process,BP,PDK4
1745,GO:0010906,0.771493429411253,0.614499619629229,1,6,regulation of glucose metabolic process,BP,PDK4
2427,GO:0030097,0.772504194344088,0.402862310844665,5,26,hemopoiesis,BP,PNP;KITLG;PIK3R1;GAS6;DLL1
1402,GO:0008585,0.772783580305699,0.61270365621932,1,6,female gonad development,BP,KITLG
4391,GO:0046545,0.772783580305699,0.61270365621932,1,6,development of primary female sexual characteristics,BP,KITLG
2033,GO:0016525,0.772945452575279,0.637748028708206,1,4,negative regulation of angiogenesis,BP,FOXO4
7081,GO:2000146,0.77374588060692,0.621226432516225,1,5,negative regulation of cell motility,BP,RHOB
2056,GO:0016627,0.773785784173415,0.611303106848311,1,6,oxidoreductase activity, acting on the CH-CH group of donors,MF,DHCR7
3599,GO:0042277,0.774191892450941,0.610734226154217,1,6,peptide binding,MF,PIK3R1
1362,GO:0008283,0.774852509804061,0.3401681957322,12,68,cell proliferation,BP,PNP;CDKN1A;KITLG;LAMA5;SDC4;GAS6;DLL1;TICAM1;HMGN5;DHCR7;FOXO4;CTGF
1119,GO:0006937,0.774948538198852,0.500667531758995,2,11,regulation of muscle contraction,BP,PDE4B;CTGF
5331,GO:0060485,0.775565960646079,0.445810117831715,3,18,mesenchyme development,BP,NRTN;KITLG;LAMA5
4579,GO:0048511,0.775737784167655,0.608561529642445,1,6,rhythmic process,BP,KITLG
4042,GO:0044444,0.77662039204922,0.312943997659309,47,248,cytoplasmic part,CC,ACTN2;PNP;ACSF2;MYO7A;CDKN1A;FRMPD1;HMGCS2;GPRASP1;RHOJ;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PLEKHH2;HEXB;ITGB5;CMBL;PRKACB;HSD17B3;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;TMEM163;CRISPLD2;RAB39B;PTPN7;CASP4;DHCR7;PON2;PDE4B;ACSL4;FOXO4;ITGA3;PDK4;AOX1;CTGF;GPSM1;MARK4
6406,GO:0098805,0.777005910579152,0.347079819387574,10,56,whole membrane,CC,MYO7A;RHOB;SNX21;SDC4;SERPINA5;DLL1;TICAM1;TMEM163;DHCR7;ACSL4
5152,GO:0055082,0.778871401328209,0.411416028127629,4,24,cellular chemical homeostasis,BP,PIK3R1;PRND;HEXB;GAS6
5148,GO:0055076,0.779699712058034,0.602940602874457,1,6,transition metal ion homeostasis,BP,PRND
1996,GO:0016337,0.780524289730378,0.378292248918118,6,30,single organismal cell-cell adhesion,BP,PNP;PIK3R1;ITGB5;CAMSAP3;SDC4;GAS6
547,GO:0003723,0.781139395818218,0.480300361727156,2,16,RNA binding,MF,HMGN5;RBMS3
4879,GO:0051091,0.783779879283714,0.590090489418172,1,7,positive regulation of sequence-specific DNA binding transcription factor activity,BP,TICAM1
224,GO:0001942,0.783880686478147,0.606999218868823,1,5,hair follicle development,BP,LAMA5
2353,GO:0022404,0.783880686478147,0.606999218868823,1,5,molting cycle process,BP,LAMA5
2354,GO:0022405,0.783880686478147,0.606999218868823,1,5,hair cycle process,BP,LAMA5
3603,GO:0042303,0.783880686478147,0.606999218868823,1,5,molting cycle,BP,LAMA5
3696,GO:0042633,0.783880686478147,0.606999218868823,1,5,hair cycle,BP,LAMA5
853,GO:0005913,0.784594485221303,0.605977925074402,1,5,cell-cell adherens junction,CC,CAMSAP3
3559,GO:0042060,0.784836725267503,0.371258140881552,6,32,wound healing,BP,RHOB;PIK3R1;PRKACB;SDC4;GAS6;SERPINA5
4894,GO:0051147,0.785592127172526,0.48560138908206,2,11,regulation of muscle cell differentiation,BP,DLL1;FOXO4
5604,GO:0070011,0.785604930093869,0.582274645687676,1,8,peptidase activity, acting on L-amino acid peptides,MF,CASP4
5895,GO:0071804,0.786422511331522,0.59322584667655,1,6,cellular potassium ion transport,BP,ACTN2
5896,GO:0071805,0.786422511331522,0.59322584667655,1,6,potassium ion transmembrane transport,BP,ACTN2
4869,GO:0051050,0.786446629111987,0.367418197284878,6,35,positive regulation of transport,BP,ACTN2;PIK3R1;MFGE8;SDC4;GAS6;DLL1
1513,GO:0009611,0.786462556071074,0.358084718008047,7,37,response to wounding,BP,RHOB;PIK3R1;PRKACB;SDC4;GAS6;SERPINA5;CTGF
4679,GO:0048771,0.786492825516382,0.580958261547398,1,8,tissue remodeling,BP,PDK4
3994,GO:0044271,0.786978999710769,0.317932494257677,14,82,cellular nitrogen compound biosynthetic process,BP,ACTN2;PNP;CDKN1A;DKK3;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3;CTGF
749,GO:0005488,0.787162685920716,0.323258799698162,60,302,binding,MF,ACTN2;PNP;LAMA1;NRTN;ACSF2;MYO7A;CDKN1A;FRMPD1;GPRASP1;NUAK2;RHOJ;KITLG;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;MRI1;PRND;PLEKHH2;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;PRKACB;CAMSAP3;ITGB8;MPZL1;CYP11A1;SDC4;GAS6;SERPINA5;DLL1;FHOD3;TICAM1;RIN3;TMEM163;HMGN5;CRISPLD2;ACCS;RAB39B;PTPN7;RBMS3;DHCR7;PON2;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;CGN;DAAM2;MARK4
774,GO:0005575,0.787356046322122,0.633098802748317,73,363,cellular_component,CC,ACTN2;PNP;LAMA1;NRTN;ACSF2;MYO7A;CDKN1A;FRMPD1;HMGCS2;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PRND;PLEKHH2;HEXB;CLDN11;MFGE8;MRO;LAMA5;ITGB5;CMBL;PRKACB;SLC52A3;CAMSAP3;HSD17B3;ITGB8;MPZL1;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;TMEM163;HMGN5;CRISPLD2;SEMA6C;RAB39B;SLC18B1;PTPN7;RBMS3;CASP4;DHCR7;TMEM164;PON2;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;CGN;GPSM1;DAAM2;PRRT1;MARK4
1256,GO:0007492,0.787449241221366,0.591722162952259,1,6,endoderm development,BP,ITGB5
4976,GO:0051321,0.787476140458751,0.591682695728704,1,6,meiotic cell cycle,BP,PRKACB
3992,GO:0044267,0.787542647307443,0.303594793491769,21,116,cellular protein metabolic process,BP,ACTN2;NRTN;CDKN1A;NUAK2;KITLG;PIK3R1;PRND;HEXB;MFGE8;PRKACB;SDC4;GAS6;SERPINA5;DLL1;TICAM1;PTPN7;RBMS3;FOXO4;PDK4;CTGF;MARK4
4641,GO:0048663,0.787729245825234,0.601461950004558,1,5,neuron fate commitment,BP,DLL1
1399,GO:0008544,0.788683159580677,0.404353811227223,4,19,epidermis development,BP,MYO7A;LAMA5;DLL1;CTGF
157,GO:0001738,0.789071117244841,0.599513345619484,1,5,morphogenesis of a polarized epithelium,BP,LAMA5
1019,GO:0006650,0.789199039779046,0.4672581757395,2,17,glycerophospholipid metabolic process,BP,KITLG;PIK3R1
250,GO:0002040,0.789612787228414,0.598724101514085,1,5,sprouting angiogenesis,BP,DLL1
4940,GO:0051240,0.790100594524678,0.33058497288834,10,56,positive regulation of multicellular organismal process,BP,PNP;KITLG;RHOB;PIK3R1;GAS6;DLL1;TICAM1;PDE4B;ITGA3;CTGF
3285,GO:0034762,0.79146025617692,0.47121775225158,2,13,regulation of transmembrane transport,BP,ACTN2;PDE4B
3288,GO:0034765,0.79146025617692,0.47121775225158,2,13,regulation of ion transmembrane transport,BP,ACTN2;PDE4B
6211,GO:0090257,0.791533031795656,0.473784151212012,2,12,regulation of muscle system process,BP,PDE4B;CTGF
734,GO:0005261,0.791635824421948,0.585534647022465,1,6,cation channel activity,MF,GAS6
2381,GO:0022836,0.791635824421948,0.585534647022465,1,6,gated channel activity,MF,GAS6
1611,GO:0010469,0.792089504400546,0.584858665936424,1,6,regulation of receptor activity,BP,ACTN2
3335,GO:0035282,0.79210026057222,0.595079932268545,1,5,segmentation,BP,DLL1
4873,GO:0051054,0.792291088231289,0.572263887882756,1,8,positive regulation of DNA metabolic process,BP,KITLG
6942,GO:1904950,0.792980534821416,0.593782482459227,1,5,negative regulation of establishment of protein localization,BP,GAS6
3497,GO:0036477,0.79386398572062,0.421957780662202,3,17,somatodendritic compartment,CC,ACTN2;PDE4B;ACSL4
6346,GO:0097659,0.793865008523454,0.316672701722808,12,67,nucleic acid-templated transcription,BP,ACTN2;CDKN1A;DKK3;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3;CTGF
5880,GO:0071705,0.79402342185132,0.330508163463098,9,54,nitrogen compound transport,BP,PNP;MYO7A;CDKN1A;RHOB;SNX21;PIK3R1;SLC52A3;GAS6;RAB39B
5154,GO:0055086,0.794160195299754,0.417213213282748,3,20,nucleobase-containing small molecule metabolic process,BP,PNP;PDE4B;AOX1
1712,GO:0010827,0.794244694419736,0.591911983436869,1,5,regulation of glucose transport,BP,PIK3R1
1713,GO:0010828,0.794244694419736,0.591911983436869,1,5,positive regulation of glucose transport,BP,PIK3R1
4342,GO:0046324,0.794244694419736,0.591911983436869,1,5,regulation of glucose import,BP,PIK3R1
4343,GO:0046326,0.794244694419736,0.591911983436869,1,5,positive regulation of glucose import,BP,PIK3R1
1415,GO:0008654,0.794478669518578,0.460972160948402,2,16,phospholipid biosynthetic process,BP,PIK3R1;HEXB
6287,GO:0097159,0.794532364519122,0.298325434495526,19,101,organic cyclic compound binding,MF,PNP;ACSF2;MYO7A;NUAK2;RHOJ;RHOB;PRKACB;CYP11A1;HMGN5;ACCS;RAB39B;RBMS3;DHCR7;PDE4B;ACSL4;FOXO4;PDK4;AOX1;MARK4
562,GO:0003924,0.794821753337346,0.414124472940645,3,22,GTPase activity,MF,RHOJ;RHOB;RAB39B
197,GO:0001882,0.795091608322105,0.386796669022869,4,27,nucleoside binding,MF,PNP;RHOJ;RHOB;RAB39B
5088,GO:0051924,0.795310120486521,0.580028758554309,1,6,regulation of calcium ion transport,BP,PDE4B
2519,GO:0030424,0.796573032442889,0.570972040573534,1,7,axon,CC,NRTN
1986,GO:0016303,0.796612543708535,0.565671258995815,1,8,1-phosphatidylinositol-3-kinase activity,MF,PIK3R1
3470,GO:0036092,0.796612543708535,0.565671258995815,1,8,phosphatidylinositol-3-phosphate biosynthetic process,BP,PIK3R1
5119,GO:0052742,0.796612543708535,0.565671258995815,1,8,phosphatidylinositol kinase activity,MF,PIK3R1
1642,GO:0010608,0.796906966784167,0.561210853843582,1,9,posttranscriptional regulation of gene expression,BP,RBMS3
6550,GO:1901342,0.797030164292113,0.42146876768518,3,15,regulation of vasculature development,BP,RHOB;DLL1;FOXO4
1616,GO:0010508,0.797090782204228,0.577334598808813,1,6,positive regulation of autophagy,BP,TICAM1
348,GO:0002520,0.797283712068663,0.36809401134954,5,28,immune system development,BP,PNP;KITLG;PIK3R1;GAS6;DLL1
4594,GO:0048534,0.797283712068663,0.36809401134954,5,28,hematopoietic or lymphoid organ development,BP,PNP;KITLG;PIK3R1;GAS6;DLL1
4758,GO:0050730,0.798155198459697,0.461365930919182,2,13,regulation of peptidyl-tyrosine phosphorylation,BP,KITLG;GAS6
4759,GO:0050731,0.798155198459697,0.461365930919182,2,13,positive regulation of peptidyl-tyrosine phosphorylation,BP,KITLG;GAS6
5633,GO:0070201,0.798251397760934,0.38398528168392,4,25,regulation of establishment of protein localization,BP,CDKN1A;PIK3R1;GAS6;ITGA3
3276,GO:0034698,0.798278285817566,0.585886001582528,1,5,response to gonadotropin,BP,ITGA3
3758,GO:0043043,0.79848389636511,0.555597329529185,1,10,peptide biosynthetic process,BP,RBMS3
3924,GO:0043604,0.79848389636511,0.555597329529185,1,10,amide biosynthetic process,BP,RBMS3
3158,GO:0033674,0.800230458426817,0.362034390960174,5,31,positive regulation of kinase activity,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6
4285,GO:0045860,0.800230458426817,0.362034390960174,5,31,positive regulation of protein kinase activity,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6
3573,GO:0042110,0.801179580990236,0.411493434522707,3,17,T cell activation,BP,PNP;PIK3R1;SDC4
4775,GO:0050790,0.803018383254668,0.300921450587062,13,77,regulation of catalytic activity,BP,ACTN2;NRTN;CDKN1A;KITLG;PIK3R1;PRKACB;CAMSAP3;SDC4;GAS6;SERPINA5;RIN3;CTGF;GPSM1
3560,GO:0042063,0.803102518316099,0.453977242033402,2,13,gliogenesis,BP,HEXB;DLL1
2951,GO:0032535,0.803175746366797,0.410470278949894,3,16,regulation of cellular component size,BP,ACTN2;PLEKHH2;FHOD3
1332,GO:0008152,0.803588157785757,0.279203410148653,45,240,metabolic process,BP,ACTN2;PNP;NRTN;ACSF2;CDKN1A;HMGCS2;GPRASP1;NUAK2;DKK3;KITLG;PHLDA1;PIK3R1;MRI1;PRND;HEXB;MFGE8;CMBL;PRKACB;SLC52A3;CAMSAP3;HSD17B3;ITGB8;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;TICAM1;HMGN5;ACCS;PTPN7;RBMS3;CASP4;DHCR7;PON2;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;MARK4
3906,GO:0043547,0.803871947307732,0.376113831950019,4,25,positive regulation of GTPase activity,BP,ACTN2;NRTN;KITLG;RIN3
2276,GO:0019902,0.805516148685985,0.574847015312684,1,5,phosphatase binding,MF,PIK3R1
2535,GO:0030510,0.80630079367624,0.573632428268192,1,5,regulation of BMP signaling pathway,BP,ITGA3
6235,GO:0090407,0.806308789707547,0.395854496767041,3,24,organophosphate biosynthetic process,BP,PNP;PIK3R1;HEXB
948,GO:0006366,0.806323967823272,0.321969716561737,8,46,transcription from RNA polymerase II promoter,BP,CDKN1A;PIK3R1;HEXB;DLL1;HMGN5;FOXO4;ITGA3;CTGF
6249,GO:0090596,0.806388713696426,0.446756699797171,2,14,sensory organ morphogenesis,BP,MYO7A;DLL1
4683,GO:0048806,0.806627923388655,0.545937658070116,1,9,genitalia development,BP,HSD17B3
7092,GO:2000209,0.807659120500352,0.571521389614894,1,5,regulation of anoikis,BP,PDK4
7177,GO:2000811,0.807659120500352,0.571521389614894,1,5,negative regulation of anoikis,BP,PDK4
3727,GO:0042803,0.807667786500936,0.368496736549785,4,28,protein homodimerization activity,MF,ACTN2;MYO7A;HEXB;ACCS
78,GO:0000981,0.807725484437692,0.56088146225088,1,6,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,FOXO4
4476,GO:0046982,0.808129771898304,0.399775700412719,3,18,protein heterodimerization activity,MF,PIK3R1;HEXB;ITGA3
1099,GO:0006888,0.808172246194006,0.570721122694174,1,5,ER to Golgi vesicle-mediated transport,BP,GAS6
2725,GO:0031406,0.808291191653376,0.547353292734702,1,8,carboxylic acid binding,MF,SERPINA5
3789,GO:0043177,0.808291191653376,0.547353292734702,1,8,organic acid binding,MF,SERPINA5
3020,GO:0032774,0.809609881600534,0.296504658491398,12,68,RNA biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3;CTGF
1649,GO:0010632,0.810449679036182,0.442828648833237,2,13,regulation of epithelial cell migration,BP,RHOB;ITGA3
953,GO:0006396,0.811131344660551,0.538685487467087,1,9,RNA processing,BP,PIK3R1
2611,GO:0030863,0.811445184547187,0.456358679450761,2,9,cortical cytoskeleton,CC,ACTN2;PLEKHH2
2612,GO:0030864,0.811445184547187,0.456358679450761,2,9,cortical actin cytoskeleton,CC,ACTN2;PLEKHH2
2360,GO:0022411,0.811576537201846,0.447050446853316,2,11,cellular component disassembly,BP,ACTN2;PLEKHH2
1073,GO:0006811,0.811868271294069,0.331899744198458,6,38,ion transport,BP,ACTN2;SLC52A3;GAS6;PDE4B;ACSL4;CTGF
3704,GO:0042692,0.812384280750717,0.366998316903261,4,22,muscle cell differentiation,BP,ACTN2;DLL1;FHOD3;FOXO4
5922,GO:0071944,0.812501266984504,0.265515527667852,34,164,cell periphery,CC,ACTN2;MYO7A;FRMPD1;RHOJ;KITLG;RHOB;PIK3R1;PRND;PLEKHH2;CLDN11;MFGE8;ITGB5;PRKACB;SLC52A3;ITGB8;MPZL1;SDC4;SERPINA5;DLL1;SEMA6C;RAB39B;SLC18B1;PTPN7;CASP4;PON2;CLDN1;PDE4B;DHH;ITGA3;CTGF;CLDN3;CGN;GPSM1;PRRT1
1404,GO:0008593,0.813132117732848,0.552269845653334,1,6,regulation of Notch signaling pathway,BP,DLL1
4644,GO:0048667,0.813243163405841,0.364677290381967,4,23,cell morphogenesis involved in neuron differentiation,BP,NRTN;MYO7A;PIK3R1;SEMA6C
3267,GO:0034654,0.813406967637543,0.287961403822397,13,75,nucleobase-containing compound biosynthetic process,BP,ACTN2;PNP;CDKN1A;DKK3;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3;CTGF
921,GO:0006163,0.813747024118343,0.435490783066669,2,14,purine nucleotide metabolic process,BP,PNP;PDE4B
1554,GO:0009898,0.81415058476933,0.56128252201059,1,5,cytoplasmic side of plasma membrane,CC,PTPN7
6363,GO:0098562,0.81415058476933,0.56128252201059,1,5,cytoplasmic side of membrane,CC,PTPN7
2249,GO:0019725,0.814167947495823,0.361473787174698,4,25,cellular homeostasis,BP,PIK3R1;PRND;HEXB;GAS6
2813,GO:0032006,0.814778282462497,0.549613587436007,1,6,regulation of TOR signaling,BP,GAS6
3832,GO:0043271,0.81495166003878,0.549332879355563,1,6,negative regulation of ion transport,BP,ACTN2
814,GO:0005777,0.81500832114707,0.532349365363002,1,9,peroxisome,CC,ACSL4
3681,GO:0042579,0.81500832114707,0.532349365363002,1,9,microbody,CC,ACSL4
4038,GO:0044438,0.81500832114707,0.532349365363002,1,9,microbody part,CC,ACSL4
4039,GO:0044439,0.81500832114707,0.532349365363002,1,9,peroxisomal part,CC,ACSL4
1066,GO:0006793,0.815062273689715,0.272462483855954,19,108,phosphorus metabolic process,BP,ACTN2;PNP;NRTN;ACSF2;CDKN1A;NUAK2;KITLG;PIK3R1;HEXB;PRKACB;CAMSAP3;SDC4;GAS6;PTPN7;PDE4B;ACSL4;PDK4;CTGF;MARK4
1802,GO:0014069,0.815601028770697,0.558960131856056,1,5,postsynaptic density,CC,PDE4B
2868,GO:0032279,0.815601028770697,0.558960131856056,1,5,asymmetric synapse,CC,PDE4B
6425,GO:0098984,0.815601028770697,0.558960131856056,1,5,neuron to neuron synapse,CC,PDE4B
6446,GO:0099572,0.815601028770697,0.558960131856056,1,5,postsynaptic specialization,CC,PDE4B
964,GO:0006461,0.815696920189367,0.339486378847247,5,33,protein complex assembly,BP,ACTN2;PRND;FHOD3;CLDN1;CLDN3
5655,GO:0070271,0.815696920189367,0.339486378847247,5,33,protein complex biogenesis,BP,ACTN2;PRND;FHOD3;CLDN1;CLDN3
1360,GO:0008270,0.81602989760704,0.434216344954075,2,13,zinc ion binding,MF,TMEM163;DHH
257,GO:0002062,0.817053716595929,0.528971275473245,1,9,chondrocyte differentiation,BP,CTGF
6337,GO:0097529,0.817287302725203,0.538134769802725,1,7,myeloid leukocyte migration,BP,PDE4B
2157,GO:0018130,0.817611191635567,0.282438570468297,13,76,heterocycle biosynthetic process,BP,ACTN2;PNP;CDKN1A;DKK3;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3;CTGF
4711,GO:0048878,0.818088676084421,0.314228735658998,7,41,chemical homeostasis,BP,PIK3R1;PRND;HEXB;PRKACB;GAS6;CLDN1;PDK4
5598,GO:0065003,0.818409281526777,0.335173924540013,5,34,macromolecular complex assembly,BP,ACTN2;PRND;FHOD3;CLDN1;CLDN3
1914,GO:0015849,0.818584317162239,0.535995840847304,1,7,organic acid transport,BP,ACSL4
4469,GO:0046942,0.818584317162239,0.535995840847304,1,7,carboxylic acid transport,BP,ACSL4
4823,GO:0050890,0.818911502415846,0.535454660197642,1,7,cognition,BP,ITGA3
1093,GO:0006875,0.81905157808117,0.427233150565747,2,14,cellular metal ion homeostasis,BP,PRND;HEXB
2701,GO:0031326,0.819063909091446,0.27758113623899,14,82,regulation of cellular biosynthetic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3;PDK4
2259,GO:0019842,0.819228140514442,0.534930303438809,1,7,vitamin binding,MF,ACCS
3747,GO:0043010,0.82040780665877,0.423172408779539,2,15,camera-type eye development,BP,RHOJ;DLL1
6109,GO:0072676,0.822280811098427,0.524388582222784,1,8,lymphocyte migration,BP,GAS6
1487,GO:0009306,0.822282860193557,0.420214633887981,2,15,protein secretion,BP,PNP;GAS6
7069,GO:2000112,0.822481216992571,0.279861773218563,12,68,regulation of cellular macromolecule biosynthetic process,BP,CDKN1A;DKK3;KITLG;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3
2271,GO:0019897,0.822535957340154,0.536873574825326,1,6,extrinsic component of plasma membrane,CC,MFGE8
2230,GO:0019438,0.823155585840748,0.275159703179413,13,77,aromatic compound biosynthetic process,BP,ACTN2;PNP;CDKN1A;DKK3;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3;CTGF
1050,GO:0006733,0.823546964686025,0.522252079958479,1,8,oxidoreduction coenzyme metabolic process,BP,PNP
2217,GO:0019362,0.823546964686025,0.522252079958479,1,8,pyridine nucleotide metabolic process,BP,PNP
4381,GO:0046496,0.823546964686025,0.522252079958479,1,8,nicotinamide nucleotide metabolic process,BP,PNP
92,GO:0001101,0.823967373792997,0.373514734917763,3,20,response to acid chemical,BP,CLDN1;PDK4;CTGF
909,GO:0006109,0.824373059170162,0.526323496855386,1,7,regulation of carbohydrate metabolic process,BP,PDK4
5153,GO:0055085,0.824571231432569,0.326925198696469,5,33,transmembrane transport,BP,ACTN2;SLC25A53;GAS6;SLC18B1;PDE4B
4933,GO:0051223,0.825350186702527,0.370297981116041,3,21,regulation of protein transport,BP,CDKN1A;PIK3R1;GAS6
5830,GO:0071396,0.826125706634121,0.344095895431392,4,25,cellular response to lipid,BP,TICAM1;CLDN1;PDE4B;PDK4
5602,GO:0065009,0.826158197352664,0.265796280321206,15,89,regulation of molecular function,BP,ACTN2;NRTN;CDKN1A;KITLG;PIK3R1;PRKACB;CAMSAP3;SDC4;GAS6;SERPINA5;TICAM1;RIN3;PDE4B;CTGF;GPSM1
4985,GO:0051347,0.82739699676577,0.322882882771192,5,33,positive regulation of transferase activity,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6
5878,GO:0071702,0.827621853049462,0.276417118868825,11,66,organic substance transport,BP,PNP;MYO7A;CDKN1A;RHOB;SNX21;PIK3R1;SLC52A3;GAS6;SERPINA5;RAB39B;ACSL4
5953,GO:0072073,0.827894224909431,0.370204065013099,3,18,kidney epithelium development,BP,LAMA5;SDC4;DLL1
1468,GO:0009187,0.828325586878788,0.51409811486271,1,8,cyclic nucleotide metabolic process,BP,PDE4B
4936,GO:0051234,0.828343294838364,0.248296321166123,27,142,establishment of localization,BP,ACTN2;PNP;MYO7A;CDKN1A;GPRASP1;RHOB;REEP1;SNX21;PIK3R1;SLC25A53;HEXB;MFGE8;LAMA5;SLC52A3;SDC4;GAS6;SERPINA5;DLL1;RIN3;CRISPLD2;RAB39B;SLC18B1;CLDN1;PDE4B;ACSL4;ITGA3;CTGF
4881,GO:0051093,0.831537183643137,0.317443627962827,5,32,negative regulation of developmental process,BP,PIK3R1;PRKACB;GAS6;DLL1;FOXO4
7086,GO:2000181,0.831881457155707,0.531976720391401,1,5,negative regulation of blood vessel morphogenesis,BP,FOXO4
3300,GO:0035051,0.832747386674637,0.413587474555669,2,11,cardiocyte differentiation,BP,ACTN2;FHOD3
5216,GO:0060135,0.832859913291473,0.519325257260472,1,6,maternal process involved in female pregnancy,BP,ITGA3
2712,GO:0031344,0.8334876111071,0.406418236792458,2,13,regulation of cell projection organization,BP,ITGA3;ESPN
146,GO:0001704,0.833555433779748,0.409004741278721,2,12,formation of primary germ layer,BP,ITGB5;ITGA3
1181,GO:0007165,0.833762106232992,0.239861473454734,31,159,signal transduction,BP,ACTN2;LAMA1;NRTN;CDKN1A;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;PIK3R1;LAMA5;ITGB5;PRKACB;ITGB8;MPZL1;SDC4;GAS6;DLL1;TICAM1;RIN3;CASP4;PDE4B;DHH;FOXO4;ITGA3;PDK4;CTGF;CLDN3;CGN;GPSM1
4656,GO:0048705,0.834189934450479,0.499664334159029,1,9,skeletal system morphogenesis,BP,CTGF
719,GO:0005216,0.834263912344265,0.503760498963475,1,8,ion channel activity,MF,GAS6
2382,GO:0022838,0.834263912344265,0.503760498963475,1,8,substrate-specific channel activity,MF,GAS6
4461,GO:0046907,0.834637420367578,0.292589463882008,7,38,intracellular transport,BP,MYO7A;CDKN1A;GPRASP1;RHOB;REEP1;PIK3R1;GAS6
2076,GO:0016740,0.83480287268524,0.271900448489349,10,57,transferase activity,MF,PNP;CDKN1A;HMGCS2;NUAK2;KITLG;PIK3R1;HEXB;PRKACB;PDK4;MARK4
3333,GO:0035270,0.834945529393446,0.401770767870995,2,14,endocrine system development,BP,DKK3;DLL1
1075,GO:0006813,0.835814478469062,0.506575224004686,1,7,potassium ion transport,BP,ACTN2
1208,GO:0007249,0.836142057448151,0.492870005076371,1,10,I-kappaB kinase/NF-kappaB signaling,BP,TICAM1
3777,GO:0043122,0.836142057448151,0.492870005076371,1,10,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TICAM1
2601,GO:0030837,0.836512740602615,0.523977220621691,1,5,negative regulation of actin filament polymerization,BP,FHOD3
2707,GO:0031333,0.836512740602615,0.523977220621691,1,5,negative regulation of protein complex assembly,BP,FHOD3
2862,GO:0032272,0.836512740602615,0.523977220621691,1,5,negative regulation of protein polymerization,BP,FHOD3
718,GO:0005215,0.836546252179391,0.325796365190024,4,29,transporter activity,MF,SLC25A53;SLC52A3;GAS6;SLC18B1
3971,GO:0044093,0.837063470116391,0.267582228615887,10,64,positive regulation of molecular function,BP,ACTN2;NRTN;CDKN1A;KITLG;PRKACB;SDC4;GAS6;TICAM1;RIN3;CTGF
5143,GO:0055067,0.837287751785988,0.498406571518065,1,8,monovalent inorganic cation homeostasis,BP,PDK4
5716,GO:0070647,0.837336453445066,0.397842629058343,2,14,protein modification by small protein conjugation or removal,BP,TICAM1;FOXO4
4929,GO:0051216,0.837548336375284,0.397493237765822,2,14,cartilage development,BP,ITGB8;CTGF
3063,GO:0032940,0.837789540758005,0.285350490386361,7,46,secretion by cell,BP,ACTN2;PNP;HEXB;SDC4;GAS6;CRISPLD2;CTGF
4227,GO:0045665,0.838057625550933,0.510219785415699,1,6,negative regulation of neuron differentiation,BP,DLL1
3134,GO:0033365,0.838062717684411,0.354456107517038,3,18,protein localization to organelle,BP,CDKN1A;PIK3R1;GAS6
6575,GO:1901605,0.838200887638363,0.496777595217541,1,8,alpha-amino acid metabolic process,BP,MRI1
4658,GO:0048708,0.838223307310956,0.502305898884832,1,7,astrocyte differentiation,BP,DLL1
4603,GO:0048562,0.839312741152298,0.394575591824301,2,14,embryonic organ morphogenesis,BP,MYO7A;DLL1
3831,GO:0043270,0.840665252690474,0.488095548728818,1,9,positive regulation of ion transport,BP,ACTN2
5349,GO:0060538,0.841766993713509,0.49595171676654,1,7,skeletal muscle organ development,BP,DLL1
3908,GO:0043549,0.842447932600843,0.288934950237877,6,38,regulation of kinase activity,BP,CDKN1A;KITLG;PIK3R1;PRKACB;SDC4;GAS6
2597,GO:0030833,0.842596082632459,0.502113835141817,1,6,regulation of actin filament polymerization,BP,FHOD3
4585,GO:0048519,0.843290427954439,0.230798631475385,25,132,negative regulation of biological process,BP,ACTN2;CDKN1A;GPRASP1;NUAK2;DKK3;KITLG;RHOB;PIK3R1;PLEKHH2;PRKACB;CAMSAP3;ITGB8;SDC4;GAS6;SERPINA5;DLL1;FHOD3;TICAM1;HMGN5;PDE4B;FOXO4;ITGA3;PDK4;CTGF;ESPN
425,GO:0003006,0.843592820323577,0.287281418710803,6,38,developmental process involved in reproduction,BP,KITLG;HEXB;HSD17B3;ITGB8;SERPINA5;DHH
4495,GO:0048010,0.844015061888659,0.486269630412619,1,8,vascular endothelial growth factor receptor signaling pathway,BP,PIK3R1
4061,GO:0044699,0.844379575134385,0.257470670562568,62,311,single-organism process,BP,ACTN2;PNP;LAMA1;NRTN;ACSF2;MYO7A;CDKN1A;HMGCS2;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;REEP1;PHLDA1;PIK3R1;MRI1;PRND;PLEKHH2;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;PRKACB;SLC52A3;CAMSAP3;HSD17B3;ITGB8;MPZL1;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;HMGN5;CRISPLD2;SEMA6C;RAB39B;CASP4;DHCR7;PON2;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;CGN;GPSM1;DAAM2;MARK4
4045,GO:0044448,0.844541661569465,0.398079379496624,2,10,cell cortex part,CC,ACTN2;PLEKHH2
756,GO:0005509,0.844837416871431,0.317848486751119,4,23,calcium ion binding,MF,ACTN2;GAS6;DLL1;DHH
2148,GO:0017157,0.845312292380792,0.489505072585831,1,7,regulation of exocytosis,BP,SDC4
5267,GO:0060326,0.845344763927543,0.386746800818188,2,13,cell chemotaxis,BP,GAS6;PDE4B
1023,GO:0006661,0.845783142049939,0.475378244999982,1,10,phosphatidylinositol biosynthetic process,BP,PIK3R1
4983,GO:0051345,0.846320739845918,0.293918428232331,5,36,positive regulation of hydrolase activity,BP,ACTN2;NRTN;KITLG;RIN3;CTGF
5928,GO:0072006,0.846398563725224,0.339864850277437,3,19,nephron development,BP,LAMA5;DLL1;ITGA3
4053,GO:0044459,0.846792121843368,0.240289149933879,15,76,plasma membrane part,CC,MYO7A;MFGE8;ITGB5;SLC52A3;ITGB8;MPZL1;SDC4;SERPINA5;DLL1;SLC18B1;PTPN7;CLDN1;PDE4B;ITGA3;CLDN3
1245,GO:0007409,0.84708367785231,0.337537840789331,3,20,axonogenesis,BP,NRTN;PIK3R1;SEMA6C
3645,GO:0042470,0.847303721165453,0.493547130135511,1,6,melanosome,CC,MYO7A
4678,GO:0048770,0.847303721165453,0.493547130135511,1,6,pigment granule,CC,MYO7A
5600,GO:0065007,0.847846065988982,0.226852521083907,49,249,biological regulation,BP,ACTN2;PNP;LAMA1;NRTN;CDKN1A;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;REEP1;PIK3R1;PRND;PLEKHH2;HEXB;MFGE8;LAMA5;ITGB5;PRKACB;CAMSAP3;HSD17B3;ITGB8;MPZL1;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;HMGN5;RBMS3;CASP4;DHCR7;CLDN1;PDE4B;DHH;FOXO4;ITGA3;PDK4;CTGF;CLDN3;ESPN;CGN;GPSM1;MARK4
6366,GO:0098588,0.84803711525585,0.253494057039169,10,59,bounding membrane of organelle,CC,MYO7A;RHOB;SNX21;SERPINA5;HSD3B2;TICAM1;TMEM163;DHCR7;ACSL4;GPSM1
1072,GO:0006810,0.848065515548974,0.22462156474581,25,135,transport,BP,ACTN2;PNP;MYO7A;CDKN1A;GPRASP1;RHOB;REEP1;SNX21;PIK3R1;SLC25A53;HEXB;MFGE8;SLC52A3;SDC4;GAS6;SERPINA5;DLL1;RIN3;CRISPLD2;RAB39B;SLC18B1;CLDN1;PDE4B;ACSL4;CTGF
6166,GO:0090092,0.848475602186062,0.381438392087718,2,13,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,DKK3;ITGA3
2599,GO:0030835,0.848555615005347,0.502449412631967,1,5,negative regulation of actin filament depolymerization,BP,PLEKHH2
3819,GO:0043242,0.848555615005347,0.502449412631967,1,5,negative regulation of protein complex disassembly,BP,PLEKHH2
6614,GO:1901880,0.848555615005347,0.502449412631967,1,5,negative regulation of protein depolymerization,BP,PLEKHH2
1948,GO:0016053,0.848584640340457,0.377078305084967,2,15,organic acid biosynthetic process,BP,MRI1;PDK4
4355,GO:0046394,0.848584640340457,0.377078305084967,2,15,carboxylic acid biosynthetic process,BP,MRI1;PDK4
3330,GO:0035265,0.8486587026807,0.470034990324018,1,10,organ growth,BP,DLL1
1137,GO:0006979,0.84874745516906,0.375147732177543,2,16,response to oxidative stress,BP,RHOB;PON2
1424,GO:0009057,0.8489025221692,0.334621456020546,3,20,macromolecule catabolic process,BP,GPRASP1;HEXB;SDC4
2413,GO:0030041,0.84952003647561,0.48173431320426,1,7,actin filament polymerization,BP,FHOD3
3856,GO:0043393,0.849682043127775,0.475794856047112,1,8,regulation of protein binding,BP,TICAM1
2398,GO:0030001,0.849841967732911,0.307556204405842,4,26,metal ion transport,BP,ACTN2;GAS6;PDE4B;CTGF
3195,GO:0034220,0.850479704814908,0.330006837298864,3,22,ion transmembrane transport,BP,ACTN2;GAS6;PDE4B
6390,GO:0098742,0.851774344296431,0.331214139079412,3,19,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CLDN11;CLDN1;CLDN3
698,GO:0005126,0.851846718697687,0.368412623585255,2,17,cytokine receptor binding,MF,KITLG;PIK3R1
2401,GO:0030010,0.852030738613399,0.477034178053673,1,7,establishment of cell polarity,BP,MARK4
430,GO:0003013,0.852100910329546,0.30405670722567,4,26,circulatory system process,BP,GAS6;DLL1;PDE4B;CTGF
1301,GO:0008015,0.852100910329546,0.30405670722567,4,26,blood circulation,BP,GAS6;DLL1;PDE4B;CTGF
5048,GO:0051648,0.852108708594678,0.476887442818393,1,7,vesicle localization,BP,MYO7A
5879,GO:0071704,0.852112051580187,0.217566659392625,42,230,organic substance metabolic process,BP,ACTN2;PNP;NRTN;ACSF2;CDKN1A;HMGCS2;GPRASP1;NUAK2;DKK3;KITLG;PHLDA1;PIK3R1;MRI1;PRND;HEXB;MFGE8;PRKACB;SLC52A3;HSD17B3;ITGB8;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;TICAM1;HMGN5;PTPN7;RBMS3;CASP4;DHCR7;PON2;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;MARK4
3833,GO:0043276,0.852214382018322,0.484432602081266,1,6,anoikis,BP,PDK4
4778,GO:0050794,0.853495877320703,0.216211828325884,44,223,regulation of cellular process,BP,ACTN2;PNP;LAMA1;NRTN;CDKN1A;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;PIK3R1;PLEKHH2;HEXB;MFGE8;LAMA5;ITGB5;PRKACB;CAMSAP3;ITGB8;MPZL1;SDC4;GAS6;SERPINA5;DLL1;FHOD3;TICAM1;RIN3;HMGN5;RBMS3;CASP4;DHCR7;CLDN1;PDE4B;DHH;FOXO4;ITGA3;PDK4;CTGF;CLDN3;ESPN;CGN;GPSM1;MARK4
6164,GO:0090087,0.853538261876813,0.32506116597306,3,22,regulation of peptide transport,BP,CDKN1A;PIK3R1;GAS6
3816,GO:0043235,0.853677111923003,0.332874157682167,3,16,receptor complex,CC,ITGB5;ITGB8;ITGA3
4371,GO:0046474,0.854303394561467,0.456630822561368,1,11,glycerophospholipid biosynthetic process,BP,PIK3R1
4162,GO:0045296,0.854320712562267,0.480465561996526,1,6,cadherin binding,MF,CGN
1009,GO:0006631,0.85459230798347,0.298216958481893,4,29,fatty acid metabolic process,BP,ACSF2;PON2;ACSL4;PDK4
4616,GO:0048593,0.854838269890731,0.466056058294066,1,8,camera-type eye morphogenesis,BP,DLL1
1646,GO:0010628,0.855443638700258,0.243641301370381,10,57,positive regulation of gene expression,BP,PIK3R1;HEXB;ITGB8;GAS6;DLL1;HMGN5;RBMS3;FOXO4;ITGA3;CTGF
1799,GO:0014065,0.857376023371544,0.361919312145302,2,15,phosphatidylinositol 3-kinase signaling,BP,KITLG;PIK3R1
4499,GO:0048015,0.857376023371544,0.361919312145302,2,15,phosphatidylinositol-mediated signaling,BP,KITLG;PIK3R1
4501,GO:0048017,0.857376023371544,0.361919312145302,2,15,inositol lipid-mediated signaling,BP,KITLG;PIK3R1
1241,GO:0007389,0.857392776063711,0.318774263139487,3,22,pattern specification process,BP,PRKACB;DLL1;DAAM2
3538,GO:0040008,0.857539374228637,0.295558763238472,4,26,regulation of growth,BP,CDKN1A;GAS6;DLL1;CTGF
1990,GO:0016323,0.857698376392691,0.466244148954813,1,7,basolateral plasma membrane,CC,ITGA3
4755,GO:0050727,0.857921552826285,0.46581404711746,1,7,regulation of inflammatory response,BP,CASP4
2384,GO:0022857,0.858034854415789,0.316844331223198,3,23,transmembrane transporter activity,MF,SLC25A53;GAS6;SLC18B1
1511,GO:0009605,0.858278340948955,0.228953883656813,13,74,response to external stimulus,BP,NRTN;CDKN1A;NUAK2;PIK3R1;GAS6;TICAM1;SEMA6C;CASP4;CLDN1;PDE4B;ACSL4;FOXO4;PDK4
3978,GO:0044238,0.858422659188471,0.208819807538919,40,220,primary metabolic process,BP,ACTN2;PNP;NRTN;ACSF2;CDKN1A;HMGCS2;NUAK2;DKK3;KITLG;PHLDA1;PIK3R1;MRI1;PRND;HEXB;MFGE8;PRKACB;HSD17B3;ITGB8;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;TICAM1;HMGN5;PTPN7;RBMS3;CASP4;DHCR7;PON2;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;MARK4
1321,GO:0008104,0.858790282384597,0.231207447437278,12,69,protein localization,BP,ACTN2;PNP;MYO7A;CDKN1A;RHOB;REEP1;SNX21;PIK3R1;LAMA5;GAS6;RAB39B;ITGA3
3120,GO:0033218,0.859188057162523,0.463365626351832,1,7,amide binding,MF,PIK3R1
1364,GO:0008285,0.85931954001921,0.290811119320508,4,29,negative regulation of cell proliferation,BP,CDKN1A;SDC4;DLL1;FOXO4
1764,GO:0010959,0.859406313948731,0.360267883904844,2,14,regulation of metal ion transport,BP,ACTN2;PDE4B
941,GO:0006351,0.859521584182198,0.233302470840651,11,66,transcription, DNA-templated,BP,CDKN1A;DKK3;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3;CTGF
1067,GO:0006796,0.859728419875445,0.21787336834898,17,102,phosphate-containing compound metabolic process,BP,ACTN2;PNP;NRTN;CDKN1A;NUAK2;KITLG;PIK3R1;HEXB;PRKACB;CAMSAP3;SDC4;GAS6;PTPN7;PDE4B;PDK4;CTGF;MARK4
6802,GO:1903506,0.860462972038203,0.232146797555664,11,65,regulation of nucleic acid-templated transcription,BP,ACTN2;CDKN1A;DKK3;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3
2676,GO:0031214,0.86062711498123,0.45487585167741,1,8,biomineral tissue development,BP,GAS6
5627,GO:0070167,0.86062711498123,0.45487585167741,1,8,regulation of biomineral tissue development,BP,GAS6
4764,GO:0050768,0.861445430612222,0.458969123206403,1,7,negative regulation of neurogenesis,BP,DLL1
2686,GO:0031253,0.861731152151279,0.466223372298252,1,6,cell projection membrane,CC,ITGA3
4944,GO:0051248,0.861849973462951,0.309045163832194,3,25,negative regulation of protein metabolic process,BP,CDKN1A;GAS6;SERPINA5
5053,GO:0051656,0.862852256151453,0.446167144077765,1,9,establishment of organelle localization,BP,MYO7A
3541,GO:0040013,0.862994958635066,0.455926775851324,1,7,negative regulation of locomotion,BP,RHOB
4957,GO:0051271,0.862994958635066,0.455926775851324,1,7,negative regulation of cellular component movement,BP,RHOB
181,GO:0001822,0.863217218864047,0.286573742428795,4,26,kidney development,BP,LAMA5;SDC4;DLL1;ITGA3
4282,GO:0045844,0.863524966503788,0.454881531889726,1,7,positive regulation of striated muscle tissue development,BP,DLL1
4627,GO:0048636,0.863524966503788,0.454881531889726,1,7,positive regulation of muscle organ development,BP,DLL1
6612,GO:1901863,0.863524966503788,0.454881531889726,1,7,positive regulation of muscle tissue development,BP,DLL1
4978,GO:0051338,0.863683750070296,0.256969790138902,6,40,regulation of transferase activity,BP,CDKN1A;KITLG;PIK3R1;PRKACB;SDC4;GAS6
136,GO:0001658,0.863881237543737,0.444129979267257,1,9,branching involved in ureteric bud morphogenesis,BP,LAMA5
5391,GO:0060675,0.863881237543737,0.444129979267257,1,9,ureteric bud morphogenesis,BP,LAMA5
6003,GO:0072171,0.863881237543737,0.444129979267257,1,9,mesonephric tubule morphogenesis,BP,LAMA5
2347,GO:0022008,0.864545987988356,0.227113378605695,11,61,neurogenesis,BP,NRTN;MYO7A;PIK3R1;HEXB;CAMSAP3;SDC4;GAS6;DLL1;SEMA6C;ACSL4;ITGA3
4777,GO:0050793,0.864692939997764,0.217682320257411,14,79,regulation of developmental process,BP,PNP;LAMA1;RHOJ;KITLG;RHOB;PIK3R1;HEXB;LAMA5;PRKACB;GAS6;DLL1;FOXO4;ITGA3;CTGF
200,GO:0001889,0.864920302311192,0.452118365162072,1,7,liver development,BP,CLDN1
5476,GO:0061008,0.864920302311192,0.452118365162072,1,7,hepaticobiliary system development,BP,CLDN1
1260,GO:0007507,0.86527102885075,0.284887580103048,4,24,heart development,BP,ACTN2;DLL1;FHOD3;ITGA3
891,GO:0006082,0.865332488253421,0.244586146952016,7,51,organic acid metabolic process,BP,PNP;ACSF2;MRI1;HEXB;PON2;ACSL4;PDK4
2861,GO:0032271,0.866156953092503,0.449655523361762,1,7,regulation of protein polymerization,BP,FHOD3
4892,GO:0051145,0.866271777471371,0.44371159763018,1,8,smooth muscle cell differentiation,BP,FOXO4
1538,GO:0009798,0.866486216392277,0.438933404173421,1,9,axis specification,BP,DLL1
117,GO:0001558,0.866886600664423,0.34695309939915,2,14,regulation of cell growth,BP,CDKN1A;CTGF
1944,GO:0016049,0.866886600664423,0.34695309939915,2,14,cell growth,BP,CDKN1A;CTGF
1047,GO:0006725,0.866964755870345,0.208109155012687,17,104,cellular aromatic compound metabolic process,BP,ACTN2;PNP;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;PON2;PDE4B;FOXO4;ITGA3;AOX1;CTGF
3110,GO:0033138,0.867073225465405,0.447822207861884,1,7,positive regulation of peptidyl-serine phosphorylation,BP,GAS6
4234,GO:0045682,0.867247118563555,0.447473451053337,1,7,regulation of epidermis development,BP,DLL1
3262,GO:0034641,0.869358538302963,0.202161456126117,19,114,cellular nitrogen compound metabolic process,BP,ACTN2;PNP;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;SLC52A3;ITGB8;GAS6;DLL1;TICAM1;HMGN5;RBMS3;PDE4B;FOXO4;ITGA3;AOX1;CTGF
2806,GO:0031981,0.869463186923774,0.23990557050624,7,45,nuclear lumen,CC,CDKN1A;PHLDA1;MRI1;MRO;PRKACB;FOXO4;AOX1
47,GO:0000302,0.870047263876869,0.436093405747368,1,8,response to reactive oxygen species,BP,RHOB
5777,GO:0071229,0.870401906478514,0.340586245007499,2,14,cellular response to acid chemical,BP,CLDN1;PDK4
536,GO:0003674,0.870422271665809,0.278871992988111,69,345,molecular_function,MF,ACTN2;PNP;LAMA1;NRTN;ACSF2;MYO7A;CDKN1A;FRMPD1;HMGCS2;GPRASP1;NUAK2;RHOJ;KITLG;RHOB;REEP1;SNX21;PHLDA1;PIK3R1;SLC25A53;MRI1;PRND;PLEKHH2;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;CMBL;PRKACB;SLC52A3;CAMSAP3;HSD17B3;ITGB8;MPZL1;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;FHOD3;TICAM1;RIN3;TMEM163;HMGN5;CRISPLD2;ACCS;RAB39B;SLC18B1;PTPN7;RBMS3;CASP4;DHCR7;PON2;CLDN1;PDE4B;ACSL4;DHH;FOXO4;ITGA3;PDK4;AOX1;CTGF;CLDN3;ESPN;CGN;GPSM1;DAAM2;MARK4
1632,GO:0010563,0.870638036130411,0.335230643860517,2,17,negative regulation of phosphorus metabolic process,BP,CDKN1A;CAMSAP3
4307,GO:0045936,0.870638036130411,0.335230643860517,2,17,negative regulation of phosphate metabolic process,BP,CDKN1A;CAMSAP3
2272,GO:0019898,0.871910881017972,0.342689477126022,2,12,extrinsic component of membrane,CC,PIK3R1;MFGE8
7096,GO:2000242,0.872028285282885,0.432046119766476,1,8,negative regulation of reproductive process,BP,PRKACB
2237,GO:0019637,0.872253923391197,0.253350280838146,5,39,organophosphate metabolic process,BP,PNP;KITLG;PIK3R1;HEXB;PDE4B
968,GO:0006469,0.872300554642445,0.423698323538118,1,10,negative regulation of protein kinase activity,BP,CDKN1A
3157,GO:0033673,0.872300554642445,0.423698323538118,1,10,negative regulation of kinase activity,BP,CDKN1A
7210,GO:2001141,0.872582686515065,0.215046503105033,11,66,regulation of RNA biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3
5963,GO:0072089,0.872668472863688,0.436466037189473,1,7,stem cell proliferation,BP,KITLG
2836,GO:0032103,0.872894356053302,0.425903573611417,1,9,positive regulation of response to external stimulus,BP,GAS6
2607,GO:0030856,0.8728996019668,0.430254890290655,1,8,regulation of epithelial cell differentiation,BP,DLL1
4620,GO:0048608,0.873686858333158,0.253400101928515,5,33,reproductive structure development,BP,KITLG;HSD17B3;ITGB8;SERPINA5;DHH
5575,GO:0061458,0.873686858333158,0.253400101928515,5,33,reproductive system development,BP,KITLG;HSD17B3;ITGB8;SERPINA5;DHH
3537,GO:0040007,0.874032183707308,0.252856173356873,5,33,growth,BP,CDKN1A;GAS6;DLL1;DHCR7;CTGF
1547,GO:0009891,0.874380642082733,0.220583410155657,9,56,positive regulation of biosynthetic process,BP,KITLG;PIK3R1;HEXB;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;CTGF
2685,GO:0031252,0.874667699312719,0.334971212931476,2,13,cell leading edge,CC,KITLG;PLEKHH2
1126,GO:0006954,0.875045459198069,0.290109353134539,3,21,inflammatory response,BP,TICAM1;CASP4;AOX1
1125,GO:0006952,0.875293441744342,0.249614529124764,5,36,defense response,BP,PRKACB;TICAM1;CASP4;CLDN1;AOX1
1091,GO:0006873,0.875521144277391,0.326286497179207,2,17,cellular ion homeostasis,BP,PRND;HEXB
2399,GO:0030003,0.875521144277391,0.326286497179207,2,17,cellular cation homeostasis,BP,PRND;HEXB
2471,GO:0030217,0.875564925697351,0.424732778318522,1,8,T cell differentiation,BP,PNP
4589,GO:0048523,0.875840427737299,0.189890349339399,23,127,negative regulation of cellular process,BP,ACTN2;CDKN1A;GPRASP1;NUAK2;DKK3;KITLG;RHOB;PIK3R1;PLEKHH2;PRKACB;CAMSAP3;SDC4;GAS6;SERPINA5;DLL1;FHOD3;TICAM1;HMGN5;FOXO4;ITGA3;PDK4;CTGF;ESPN
1638,GO:0010595,0.875978329162954,0.41950350665105,1,9,positive regulation of endothelial cell migration,BP,RHOB
1164,GO:0007067,0.87598657624971,0.419486275881127,1,9,mitotic nuclear division,BP,MARK4
1074,GO:0006812,0.876076955348048,0.26389744180837,4,29,cation transport,BP,ACTN2;GAS6;PDE4B;CTGF
4034,GO:0044431,0.876122528673071,0.288254902932505,3,21,Golgi apparatus part,CC,SDC4;GAS6;GPSM1
3049,GO:0032880,0.876560113476022,0.248861523163468,5,33,regulation of protein localization,BP,ACTN2;CDKN1A;PIK3R1;GAS6;ITGA3
3768,GO:0043087,0.876928499859088,0.263694912067703,4,27,regulation of GTPase activity,BP,ACTN2;NRTN;KITLG;RIN3
6269,GO:0097060,0.876939570009903,0.43549975854455,1,6,synaptic membrane,CC,ITGA3
3977,GO:0044237,0.877311453557935,0.184637847112405,41,224,cellular metabolic process,BP,ACTN2;PNP;NRTN;ACSF2;CDKN1A;HMGCS2;GPRASP1;NUAK2;DKK3;KITLG;PHLDA1;PIK3R1;MRI1;PRND;HEXB;MFGE8;CMBL;PRKACB;SLC52A3;CAMSAP3;HSD17B3;ITGB8;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;DLL1;TICAM1;HMGN5;PTPN7;RBMS3;PON2;PDE4B;ACSL4;FOXO4;ITGA3;PDK4;AOX1;CTGF;MARK4
945,GO:0006357,0.87733321912916,0.228396913705913,7,44,regulation of transcription from RNA polymerase II promoter,BP,CDKN1A;PIK3R1;HEXB;DLL1;HMGN5;FOXO4;ITGA3
2565,GO:0030667,0.877870350509805,0.415534038665478,1,9,secretory granule membrane,CC,SERPINA5
4986,GO:0051348,0.878003012848054,0.409053470722685,1,11,negative regulation of transferase activity,BP,CDKN1A
2500,GO:0030308,0.878406185647818,0.418773712156089,1,8,negative regulation of cell growth,BP,CDKN1A
4653,GO:0048699,0.878594765683469,0.211017037401859,10,56,generation of neurons,BP,NRTN;MYO7A;PIK3R1;CAMSAP3;SDC4;GAS6;DLL1;SEMA6C;ACSL4;ITGA3
409,GO:0002790,0.878794870049562,0.32021060227997,2,17,peptide secretion,BP,PNP;GAS6
3179,GO:0034097,0.878983503728678,0.280056507762349,3,25,response to cytokine,BP,GAS6;CLDN1;ACSL4
4031,GO:0044428,0.879613795506618,0.217696344832602,8,53,nuclear part,CC,CDKN1A;PHLDA1;MRI1;MRO;PRKACB;DHCR7;FOXO4;AOX1
4287,GO:0045862,0.879713612051453,0.403153137280368,1,12,positive regulation of proteolysis,BP,CTGF
3865,GO:0043412,0.879799996295401,0.190977288550139,17,100,macromolecule modification,BP,ACTN2;NRTN;CDKN1A;NUAK2;KITLG;PIK3R1;PRND;PRKACB;SDC4;GAS6;TICAM1;HMGN5;PTPN7;FOXO4;PDK4;CTGF;MARK4
4341,GO:0046323,0.88169280553523,0.417539227491443,1,7,glucose import,BP,PIK3R1
1092,GO:0006874,0.882536698992581,0.40560000058934,1,9,cellular calcium ion homeostasis,BP,HEXB
5146,GO:0055074,0.882536698992581,0.40560000058934,1,9,calcium ion homeostasis,BP,HEXB
6073,GO:0072503,0.882536698992581,0.40560000058934,1,9,cellular divalent inorganic cation homeostasis,BP,HEXB
6074,GO:0072507,0.882536698992581,0.40560000058934,1,9,divalent inorganic cation homeostasis,BP,HEXB
986,GO:0006520,0.882782155247587,0.3965888781881,1,12,cellular amino acid metabolic process,BP,MRI1
766,GO:0005525,0.883140594174059,0.27281717506999,3,25,GTP binding,MF,RHOJ;RHOB;RAB39B
2181,GO:0019001,0.883140594174059,0.27281717506999,3,25,guanyl nucleotide binding,MF,RHOJ;RHOB;RAB39B
2955,GO:0032549,0.883140594174059,0.27281717506999,3,25,ribonucleoside binding,MF,RHOJ;RHOB;RAB39B
2956,GO:0032550,0.883140594174059,0.27281717506999,3,25,purine ribonucleoside binding,MF,RHOJ;RHOB;RAB39B
2960,GO:0032561,0.883140594174059,0.27281717506999,3,25,guanyl ribonucleotide binding,MF,RHOJ;RHOB;RAB39B
3279,GO:0034703,0.884223034707567,0.40633229878312,1,8,cation channel complex,CC,PDE4B
3766,GO:0043085,0.885366012710136,0.203545233198728,9,62,positive regulation of catalytic activity,BP,ACTN2;NRTN;CDKN1A;KITLG;PRKACB;SDC4;GAS6;RIN3;CTGF
1238,GO:0007369,0.88569645800146,0.312009292767336,2,14,gastrulation,BP,ITGB5;ITGA3
544,GO:0003712,0.885835744986957,0.398449216455636,1,9,transcription cofactor activity,MF,ACTN2
4103,GO:0045017,0.885876400666365,0.387971446531862,1,13,glycerolipid biosynthetic process,BP,PIK3R1
1610,GO:0010468,0.887146576746152,0.18640045223848,14,81,regulation of gene expression,BP,CDKN1A;DKK3;PIK3R1;HEXB;PRKACB;ITGB8;GAS6;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3;CTGF
1070,GO:0006807,0.887506834164974,0.175551699216286,21,128,nitrogen compound metabolic process,BP,ACTN2;PNP;CDKN1A;DKK3;KITLG;PIK3R1;MRI1;HEXB;SLC52A3;ITGB8;SDC4;GAS6;DLL1;TICAM1;HMGN5;RBMS3;PDE4B;FOXO4;ITGA3;AOX1;CTGF
967,GO:0006468,0.887620007028599,0.190442938144626,12,72,protein phosphorylation,BP,ACTN2;NRTN;CDKN1A;NUAK2;KITLG;PIK3R1;PRKACB;SDC4;GAS6;PDK4;CTGF;MARK4
915,GO:0006139,0.887888641152627,0.18114010263218,16,99,nucleobase-containing compound metabolic process,BP,ACTN2;PNP;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;PDE4B;FOXO4;ITGA3;AOX1;CTGF
3250,GO:0034599,0.888223778979941,0.393204929220404,1,9,cellular response to oxidative stress,BP,RHOB
1117,GO:0006935,0.888400760121706,0.229838012510028,5,33,chemotaxis,BP,NRTN;PIK3R1;GAS6;SEMA6C;PDE4B
3616,GO:0042330,0.888400760121706,0.229838012510028,5,33,taxis,BP,NRTN;PIK3R1;GAS6;SEMA6C;PDE4B
5150,GO:0055080,0.88842929752439,0.264913822281977,3,23,cation homeostasis,BP,PRND;HEXB;PDK4
6394,GO:0098771,0.88842929752439,0.264913822281977,3,23,inorganic ion homeostasis,BP,PRND;HEXB;PDK4
668,GO:0004872,0.888640034990012,0.231511817854404,5,29,receptor activity,MF,ITGB5;ITGB8;SDC4;CLDN1;CLDN3
5206,GO:0060089,0.888640034990012,0.231511817854404,5,29,molecular transducer activity,MF,ITGB5;ITGB8;SDC4;CLDN1;CLDN3
262,GO:0002067,0.888664624019913,0.396604457548852,1,8,glandular epithelial cell differentiation,BP,DLL1
4198,GO:0045597,0.889965095478722,0.226858265349202,5,34,positive regulation of cell differentiation,BP,PNP;KITLG;GAS6;ITGA3;CTGF
3802,GO:0043207,0.890150445626094,0.260413679348355,3,25,response to external biotic stimulus,BP,TICAM1;CLDN1;PDE4B
5061,GO:0051707,0.890150445626094,0.260413679348355,3,25,response to other organism,BP,TICAM1;CLDN1;PDE4B
6222,GO:0090304,0.890607056753419,0.183178068200209,13,82,nucleic acid metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3;CTGF
5545,GO:0061326,0.890639109244183,0.30061391050438,2,15,renal tubule development,BP,LAMA5;DLL1
5931,GO:0072009,0.890639109244183,0.30061391050438,2,15,nephron epithelium development,BP,LAMA5;DLL1
5960,GO:0072080,0.890639109244183,0.30061391050438,2,15,nephron tubule development,BP,LAMA5;DLL1
878,GO:0006006,0.890746567309091,0.384168267742685,1,10,glucose metabolic process,BP,PDK4
4197,GO:0045596,0.890803603593675,0.26066739528407,3,23,negative regulation of cell differentiation,BP,PIK3R1;DLL1;FOXO4
4605,GO:0048565,0.890815567016748,0.391819627871166,1,8,digestive tract development,BP,CDKN1A
5167,GO:0055123,0.890815567016748,0.391819627871166,1,8,digestive system development,BP,CDKN1A
4375,GO:0046483,0.890901512421753,0.175431943649672,17,105,heterocycle metabolic process,BP,ACTN2;PNP;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;SLC52A3;GAS6;DLL1;TICAM1;HMGN5;PDE4B;FOXO4;ITGA3;AOX1;CTGF
4071,GO:0044723,0.891830538068438,0.293081457447724,2,19,single-organism carbohydrate metabolic process,BP,HEXB;PDK4
4284,GO:0045859,0.892500884351325,0.221937903097923,5,36,regulation of protein kinase activity,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6
4274,GO:0045833,0.892664259608006,0.383295957833054,1,9,negative regulation of lipid metabolic process,BP,DKK3
3649,GO:0042475,0.892722159733897,0.383165369476356,1,9,odontogenesis of dentin-containing tooth,BP,LAMA5
149,GO:0001707,0.893605239254436,0.385539761927127,1,8,mesoderm formation,BP,ITGA3
4557,GO:0048332,0.893605239254436,0.385539761927127,1,8,mesoderm morphogenesis,BP,ITGA3
667,GO:0004871,0.893819214806647,0.220951238085601,5,33,signal transducer activity,MF,PIK3R1;SDC4;GAS6;TICAM1;CLDN3
6115,GO:0080134,0.893893350913717,0.21964820722783,5,36,regulation of response to stress,BP,PIK3R1;PRKACB;TICAM1;CASP4;CTGF
2786,GO:0031929,0.894105135393673,0.384405420662583,1,8,TOR signaling,BP,GAS6
2455,GO:0030182,0.894404676450889,0.191735471690603,9,52,neuron differentiation,BP,NRTN;MYO7A;PIK3R1;CAMSAP3;SDC4;DLL1;SEMA6C;ACSL4;ITGA3
785,GO:0005634,0.894619700624989,0.173420137618449,15,93,nucleus,CC,PNP;CDKN1A;NUAK2;RHOB;PHLDA1;PIK3R1;MRI1;MRO;LAMA5;PRKACB;HMGN5;DHCR7;PON2;FOXO4;AOX1
6815,GO:1903532,0.894872393926958,0.369828579260641,1,12,positive regulation of secretion by cell,BP,SDC4
4443,GO:0046873,0.894900846970859,0.374796768509426,1,10,metal ion transmembrane transporter activity,MF,GAS6
1251,GO:0007423,0.895295281147714,0.2321701520058,4,28,sensory organ development,BP,MYO7A;RHOJ;SDC4;DLL1
1682,GO:0010721,0.896093330128007,0.375498889776093,1,9,negative regulation of cell development,BP,DLL1
2155,GO:0018108,0.8966944968099,0.284583655084169,2,18,peptidyl-tyrosine phosphorylation,BP,KITLG;GAS6
2168,GO:0018212,0.8966944968099,0.284583655084169,2,18,peptidyl-tyrosine modification,BP,KITLG;GAS6
4744,GO:0050708,0.897157583653932,0.366869125308398,1,11,regulation of protein secretion,BP,GAS6
4477,GO:0046983,0.8982532005886,0.202627418130036,6,42,protein dimerization activity,MF,ACTN2;MYO7A;PIK3R1;HEXB;ACCS;ITGA3
1808,GO:0014706,0.898738927325276,0.247946187115538,3,21,striated muscle tissue development,BP,ACTN2;DLL1;FHOD3
2433,GO:0030111,0.898794843371931,0.282935859272874,2,16,regulation of Wnt signaling pathway,BP,DKK3;ITGA3
1537,GO:0009792,0.898852501705694,0.227918670942089,4,25,embryo development ending in birth or egg hatching,BP,PRKACB;SDC4;DLL1;ACSL4
1258,GO:0007498,0.898973621311217,0.368848174785637,1,9,mesoderm development,BP,ITGA3
6485,GO:1900182,0.900028407761776,0.370748893699361,1,8,positive regulation of protein localization to nucleus,BP,PIK3R1
6693,GO:1902578,0.900055397399091,0.162939980596423,17,99,single-organism localization,BP,ACTN2;PNP;MYO7A;CDKN1A;PIK3R1;HEXB;MFGE8;LAMA5;SLC52A3;SDC4;GAS6;SERPINA5;CRISPLD2;CLDN1;ACSL4;ITGA3;CTGF
3885,GO:0043491,0.900225809736512,0.370286750251077,1,8,protein kinase B signaling,BP,GAS6
4079,GO:0044765,0.900580117840839,0.165077398044525,15,91,single-organism transport,BP,ACTN2;PNP;MYO7A;CDKN1A;PIK3R1;HEXB;MFGE8;SLC52A3;SDC4;GAS6;SERPINA5;CRISPLD2;CLDN1;ACSL4;CTGF
5546,GO:0061333,0.900905807519189,0.360915237096433,1,10,renal tubule morphogenesis,BP,LAMA5
5958,GO:0072078,0.900905807519189,0.360915237096433,1,10,nephron tubule morphogenesis,BP,LAMA5
5046,GO:0051640,0.901099297663018,0.360461112420429,1,10,organelle localization,BP,MYO7A
1953,GO:0016070,0.901485762622192,0.169925701721233,12,76,RNA metabolic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3;CTGF
4299,GO:0045926,0.90164803513525,0.359170835772725,1,10,negative regulation of growth,BP,CDKN1A
20,GO:0000139,0.901893405312324,0.362008474226227,1,9,Golgi membrane,CC,GPSM1
4228,GO:0045666,0.902262983276456,0.361135540849882,1,9,positive regulation of neuron differentiation,BP,ITGA3
198,GO:0001883,0.902967770257967,0.236453063615252,3,26,purine nucleoside binding,MF,RHOJ;RHOB;RAB39B
3760,GO:0043065,0.903164315917767,0.270567722635242,2,19,positive regulation of apoptotic process,BP,RHOB;CTGF
890,GO:0006081,0.903546589910164,0.358090936843574,1,9,cellular aldehyde metabolic process,BP,DKK3
4346,GO:0046330,0.903598019980158,0.351810658909379,1,11,positive regulation of JNK cascade,BP,CTGF
4906,GO:0051171,0.903910392809089,0.163984110954449,13,82,regulation of nitrogen compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3
5049,GO:0051649,0.90408162206608,0.18686133954274,7,44,establishment of localization in cell,BP,MYO7A;CDKN1A;GPRASP1;RHOB;REEP1;PIK3R1;GAS6
2703,GO:0031328,0.904335606037141,0.180038740077182,8,53,positive regulation of cellular biosynthetic process,BP,KITLG;PIK3R1;HEXB;DLL1;TICAM1;HMGN5;RBMS3;FOXO4
5062,GO:0051716,0.905837913055988,0.145651928717551,34,177,cellular response to stimulus,BP,ACTN2;LAMA1;NRTN;CDKN1A;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;PIK3R1;LAMA5;ITGB5;CMBL;PRKACB;SLC52A3;ITGB8;MPZL1;SDC4;GAS6;DLL1;TICAM1;RIN3;CASP4;CLDN1;PDE4B;DHH;FOXO4;ITGA3;PDK4;CTGF;CLDN3;CGN;GPSM1
944,GO:0006355,0.905872303409793,0.169511215714807,10,63,regulation of transcription, DNA-templated,BP,CDKN1A;DKK3;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3
6116,GO:0080135,0.906381771893272,0.264002772435422,2,19,regulation of cellular response to stress,BP,PIK3R1;CTGF
1179,GO:0007163,0.907183811731512,0.349353902346233,1,9,establishment or maintenance of cell polarity,BP,MARK4
3278,GO:0034702,0.908092579755489,0.343746641430514,1,10,ion channel complex,CC,PDE4B
6685,GO:1902495,0.908092579755489,0.343746641430514,1,10,transmembrane transporter complex,CC,PDE4B
7014,GO:1990351,0.908092579755489,0.343746641430514,1,10,transporter complex,CC,PDE4B
758,GO:0005515,0.908292899800476,0.146266108963801,48,255,protein binding,MF,ACTN2;LAMA1;NRTN;ACSF2;MYO7A;CDKN1A;FRMPD1;GPRASP1;NUAK2;RHOJ;KITLG;RHOB;REEP1;PHLDA1;PIK3R1;MRI1;PLEKHH2;HEXB;CLDN11;MFGE8;LAMA5;ITGB5;PRKACB;CAMSAP3;ITGB8;MPZL1;SDC4;GAS6;SERPINA5;DLL1;FHOD3;TICAM1;RIN3;ACCS;RAB39B;PTPN7;PON2;CLDN1;PDE4B;DHH;FOXO4;ITGA3;CTGF;CLDN3;ESPN;CGN;DAAM2;MARK4
424,GO:0003002,0.908302996160904,0.261064570306262,2,18,regionalization,BP,PRKACB;DLL1
3109,GO:0033135,0.909105637372894,0.349001941438959,1,8,regulation of peptidyl-serine phosphorylation,BP,GAS6
1767,GO:0010975,0.909190213206757,0.344462851552858,1,9,regulation of neuron projection development,BP,ITGA3
1058,GO:0006753,0.910272556222934,0.255954536074946,2,19,nucleoside phosphate metabolic process,BP,PNP;PDE4B
1449,GO:0009117,0.910272556222934,0.255954536074946,2,19,nucleotide metabolic process,BP,PNP;PDE4B
538,GO:0003677,0.91138819647027,0.258587554509326,2,15,DNA binding,MF,HMGN5;FOXO4
1647,GO:0010629,0.911816057716666,0.190527909847994,5,33,negative regulation of gene expression,BP,CDKN1A;DKK3;ITGB8;GAS6;CTGF
4789,GO:0050808,0.911998310841205,0.337529212596487,1,9,synapse organization,BP,RAB39B
2255,GO:0019827,0.9128326638986,0.335448746282339,1,9,stem cell population maintenance,BP,DLL1
6387,GO:0098727,0.9128326638986,0.335448746282339,1,9,maintenance of cell number,BP,DLL1
1261,GO:0007517,0.913202236958267,0.21901727203221,3,23,muscle organ development,BP,LAMA5;DLL1;FOXO4
4883,GO:0051098,0.913411610197965,0.330621459197456,1,10,regulation of binding,BP,TICAM1
1302,GO:0008016,0.913656347798602,0.25099411357919,2,17,regulation of heart contraction,BP,PDE4B;CTGF
965,GO:0006464,0.914294598171854,0.143743692293315,16,97,cellular protein modification process,BP,ACTN2;NRTN;CDKN1A;NUAK2;KITLG;PIK3R1;PRND;PRKACB;SDC4;GAS6;TICAM1;PTPN7;FOXO4;PDK4;CTGF;MARK4
3479,GO:0036211,0.914294598171854,0.143743692293315,16,97,protein modification process,BP,ACTN2;NRTN;CDKN1A;NUAK2;KITLG;PIK3R1;PRND;PRKACB;SDC4;GAS6;TICAM1;PTPN7;FOXO4;PDK4;CTGF;MARK4
3650,GO:0042476,0.914540876271464,0.327786475431401,1,10,odontogenesis,BP,LAMA5
4196,GO:0045595,0.915325407325917,0.16264050472947,8,53,regulation of cell differentiation,BP,PNP;KITLG;PIK3R1;GAS6;DLL1;FOXO4;ITGA3;CTGF
4893,GO:0051146,0.915520693096056,0.251524886681876,2,14,striated muscle cell differentiation,BP,ACTN2;FHOD3
5579,GO:0061564,0.916167941241676,0.213265749486054,3,23,axon development,BP,NRTN;PIK3R1;SEMA6C
5348,GO:0060537,0.916300376875506,0.213761516535151,3,22,muscle tissue development,BP,ACTN2;DLL1;FHOD3
2724,GO:0031401,0.916434274930313,0.165404805812778,7,51,positive regulation of protein modification process,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6;TICAM1;CTGF
4948,GO:0051252,0.917548597713878,0.148581287709397,11,69,regulation of RNA metabolic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3
4951,GO:0051258,0.917837834012854,0.319408414027252,1,10,protein polymerization,BP,FHOD3
4411,GO:0046660,0.918163140380625,0.31587539490627,1,11,female sex differentiation,BP,KITLG
133,GO:0001655,0.919176027591203,0.189044026592393,4,29,urogenital system development,BP,LAMA5;SDC4;DLL1;ITGA3
5927,GO:0072001,0.919176027591203,0.189044026592393,4,29,renal system development,BP,LAMA5;SDC4;DLL1;ITGA3
1582,GO:0010035,0.91936167215522,0.238755668625592,2,17,response to inorganic substance,BP,RHOB;CLDN1
3080,GO:0032991,0.919792018936806,0.137451376382672,15,86,macromolecular complex,CC,LAMA1;MYO7A;CDKN1A;PIK3R1;LAMA5;ITGB5;PRKACB;ITGB8;SERPINA5;TICAM1;CASP4;PDE4B;ITGA3;ESPN;CGN
5782,GO:0071248,0.920742140612708,0.315240179540977,1,9,cellular response to metal ion,BP,CLDN1
410,GO:0002791,0.921158634593889,0.305924086495486,1,12,regulation of peptide secretion,BP,GAS6
4908,GO:0051173,0.921639638514321,0.15243466431522,8,53,positive regulation of nitrogen compound metabolic process,BP,KITLG;PIK3R1;HEXB;DLL1;TICAM1;HMGN5;RBMS3;FOXO4
1876,GO:0015267,0.922019148649106,0.305878350373353,1,11,channel activity,MF,GAS6
2374,GO:0022803,0.922019148649106,0.305878350373353,1,11,passive transmembrane transporter activity,MF,GAS6
790,GO:0005654,0.922394431569988,0.170880421627697,5,36,nucleoplasm,CC,CDKN1A;MRI1;PRKACB;FOXO4;AOX1
2213,GO:0019318,0.922593882202051,0.302171628350296,1,12,hexose metabolic process,BP,PDK4
3079,GO:0032990,0.922620940655986,0.20053612709627,3,23,cell part morphogenesis,BP,NRTN;PIK3R1;SEMA6C
4686,GO:0048812,0.922620940655986,0.20053612709627,3,23,neuron projection morphogenesis,BP,NRTN;PIK3R1;SEMA6C
4703,GO:0048858,0.922620940655986,0.20053612709627,3,23,cell projection morphogenesis,BP,NRTN;PIK3R1;SEMA6C
4774,GO:0050789,0.922686176056592,0.124319142600267,45,235,regulation of biological process,BP,ACTN2;PNP;LAMA1;NRTN;CDKN1A;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;REEP1;PIK3R1;PLEKHH2;HEXB;MFGE8;LAMA5;ITGB5;PRKACB;CAMSAP3;ITGB8;MPZL1;SDC4;GAS6;SERPINA5;DLL1;FHOD3;TICAM1;RIN3;HMGN5;RBMS3;CASP4;DHCR7;CLDN1;PDE4B;DHH;FOXO4;ITGA3;PDK4;CTGF;CLDN3;ESPN;CGN;GPSM1;MARK4
4530,GO:0048193,0.922756709043708,0.309945429237248,1,9,Golgi vesicle transport,BP,GAS6
4941,GO:0051241,0.922808093232656,0.16151162917371,6,43,negative regulation of multicellular organismal process,BP,PIK3R1;PRKACB;GAS6;DLL1;PDE4B;FOXO4
4226,GO:0045664,0.922948694302978,0.232161051739192,2,16,regulation of neuron differentiation,BP,DLL1;ITGA3
4607,GO:0048568,0.924111620646245,0.197551701631751,3,23,embryonic organ development,BP,MYO7A;KITLG;DLL1
6165,GO:0090090,0.924491336804173,0.305335746382449,1,9,negative regulation of canonical Wnt signaling pathway,BP,DKK3
1637,GO:0010594,0.924509754069777,0.301969237563332,1,10,regulation of endothelial cell migration,BP,RHOB
874,GO:0005996,0.925104434575632,0.29370653436554,1,13,monosaccharide metabolic process,BP,PDK4
1202,GO:0007219,0.925321309764873,0.303113174594735,1,9,Notch signaling pathway,BP,DLL1
244,GO:0002009,0.925392633780038,0.16616902507606,5,34,morphogenesis of an epithelium,BP,RHOB;LAMA5;PRKACB;SDC4;DLL1
4909,GO:0051174,0.925430022754879,0.141771932280038,9,63,regulation of phosphorus metabolic process,BP,CDKN1A;KITLG;PIK3R1;PRKACB;CAMSAP3;SDC4;GAS6;PDK4;CTGF
139,GO:0001666,0.925528513862556,0.291029925668407,1,14,response to hypoxia,BP,CLDN3
5103,GO:0051960,0.925627742195813,0.195220620907298,3,22,regulation of nervous system development,BP,PRKACB;DLL1;ITGA3
1413,GO:0008645,0.925844274892262,0.301707009239966,1,9,hexose transport,BP,PIK3R1
1902,GO:0015749,0.925844274892262,0.301707009239966,1,9,monosaccharide transport,BP,PIK3R1
1903,GO:0015758,0.925844274892262,0.301707009239966,1,9,glucose transport,BP,PIK3R1
1210,GO:0007254,0.926130833815932,0.292791249034542,1,12,JNK cascade,BP,CTGF
4344,GO:0046328,0.926130833815932,0.292791249034542,1,12,regulation of JNK cascade,BP,CTGF
4882,GO:0051094,0.926250444753238,0.149595483763321,7,48,positive regulation of developmental process,BP,PNP;KITLG;RHOB;GAS6;DLL1;ITGA3;CTGF
3047,GO:0032874,0.926527477516524,0.291727197900673,1,12,positive regulation of stress-activated MAPK cascade,BP,CTGF
5664,GO:0070304,0.926527477516524,0.291727197900673,1,12,positive regulation of stress-activated protein kinase signaling cascade,BP,CTGF
868,GO:0005975,0.926714411663895,0.218196141299983,2,22,carbohydrate metabolic process,BP,HEXB;PDK4
3870,GO:0043436,0.926905035087975,0.153142361398532,6,50,oxoacid metabolic process,BP,ACSF2;MRI1;HEXB;PON2;ACSL4;PDK4
5962,GO:0072088,0.92694156205758,0.292790380052837,1,11,nephron epithelium morphogenesis,BP,LAMA5
6160,GO:0090066,0.928068082005789,0.189546726942278,3,23,regulation of anatomical structure size,BP,ACTN2;PLEKHH2;FHOD3
1010,GO:0006633,0.928847516407806,0.287619286941237,1,11,fatty acid biosynthetic process,BP,PDK4
818,GO:0005788,0.928989684642143,0.287231170500471,1,11,endoplasmic reticulum lumen,CC,GAS6
4832,GO:0050920,0.929154614200724,0.286780494530992,1,11,regulation of chemotaxis,BP,GAS6
2385,GO:0022890,0.929439808254145,0.283837104788684,1,12,inorganic cation transmembrane transporter activity,MF,GAS6
4459,GO:0046903,0.929801356806986,0.14307469845456,7,51,secretion,BP,ACTN2;PNP;HEXB;SDC4;GAS6;CRISPLD2;CTGF
4782,GO:0050801,0.929940516040757,0.183964494598253,3,26,ion homeostasis,BP,PRND;HEXB;PDK4
218,GO:0001933,0.929997023905866,0.282311666514903,1,12,negative regulation of protein phosphorylation,BP,CDKN1A
4910,GO:0051179,0.930318537697391,0.111890598404603,31,170,localization,BP,ACTN2;PNP;LAMA1;NRTN;MYO7A;CDKN1A;GPRASP1;KITLG;RHOB;REEP1;SNX21;PIK3R1;SLC25A53;HEXB;MFGE8;LAMA5;SLC52A3;SDC4;GAS6;SERPINA5;DLL1;RIN3;CRISPLD2;RAB39B;SLC18B1;CLDN1;PDE4B;ACSL4;FOXO4;ITGA3;CTGF
1569,GO:0009968,0.931854639577352,0.145963450443929,6,42,negative regulation of signal transduction,BP,GPRASP1;DKK3;PRKACB;GAS6;TICAM1;ITGA3
5499,GO:0061061,0.932009898475849,0.153787714328193,5,35,muscle structure development,BP,ACTN2;LAMA5;DLL1;FHOD3;FOXO4
4070,GO:0044712,0.932075724137915,0.161749180268384,4,38,single-organism catabolic process,BP,PNP;HEXB;PDE4B;AOX1
432,GO:0003015,0.932179814587193,0.209058039501316,2,18,heart process,BP,PDE4B;CTGF
5185,GO:0060047,0.932179814587193,0.209058039501316,2,18,heart contraction,BP,PDE4B;CTGF
3915,GO:0043565,0.932250559298089,0.284107719307825,1,9,sequence-specific DNA binding,MF,FOXO4
3628,GO:0042391,0.932631706015937,0.277171691183439,1,11,regulation of membrane potential,BP,ACTN2
2205,GO:0019219,0.932745061889492,0.122453235979079,12,77,regulation of nucleobase-containing compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;GAS6;DLL1;TICAM1;HMGN5;FOXO4;ITGA3
1186,GO:0007173,0.932812619158969,0.276666010495085,1,11,epidermal growth factor receptor signaling pathway,BP,PIK3R1
3523,GO:0038127,0.932812619158969,0.276666010495085,1,11,ERBB signaling pathway,BP,PIK3R1
6114,GO:0080090,0.933067875840066,0.112165344085778,20,120,regulation of primary metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;PRKACB;SDC4;GAS6;SERPINA5;DLL1;TICAM1;HMGN5;RBMS3;DHCR7;DHH;FOXO4;ITGA3;PDK4;CTGF
2723,GO:0031400,0.933158641225494,0.271769093446577,1,13,negative regulation of protein modification process,BP,CDKN1A
1648,GO:0010631,0.933396619387794,0.207303772241254,2,17,epithelial cell migration,BP,RHOB;ITGA3
1969,GO:0016202,0.933981323060887,0.27125018510305,1,12,regulation of striated muscle tissue development,BP,DLL1
4625,GO:0048634,0.933981323060887,0.27125018510305,1,12,regulation of muscle organ development,BP,DLL1
6610,GO:1901861,0.933981323060887,0.27125018510305,1,12,regulation of muscle tissue development,BP,DLL1
2484,GO:0030258,0.934141116089107,0.173615904984165,3,30,lipid modification,BP,KITLG;PIK3R1;PDK4
2078,GO:0016746,0.934458523344104,0.274637205413692,1,10,transferase activity, transferring acyl groups,MF,HMGCS2
2837,GO:0032147,0.934516233276875,0.202740942565439,2,19,activation of protein kinase activity,BP,PRKACB;GAS6
6174,GO:0090132,0.936567751946345,0.198871453403001,2,18,epithelium migration,BP,RHOB;ITGA3
1640,GO:0010604,0.936728977971469,0.111446661240044,15,94,positive regulation of macromolecule metabolic process,BP,CDKN1A;KITLG;PIK3R1;HEXB;PRKACB;ITGB8;SDC4;GAS6;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3;CTGF
2860,GO:0032270,0.936967415474409,0.12608386512482,8,60,positive regulation of cellular protein metabolic process,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6;TICAM1;RBMS3;CTGF
4588,GO:0048522,0.937451435561915,0.10496239836676,21,128,positive regulation of cellular process,BP,ACTN2;PNP;CDKN1A;KITLG;RHOB;PIK3R1;HEXB;MFGE8;PRKACB;SDC4;GAS6;DLL1;TICAM1;HMGN5;RBMS3;CLDN1;FOXO4;ITGA3;CTGF;ESPN;MARK4
3505,GO:0038023,0.938189283290999,0.195050111757199,2,18,signaling receptor activity,MF,SDC4;CLDN3
2365,GO:0022603,0.938320840741087,0.141231222270644,5,38,regulation of anatomical structure morphogenesis,BP,RHOJ;RHOB;HEXB;DLL1;FOXO4
1564,GO:0009952,0.938831302721904,0.259501710229917,1,11,anterior/posterior pattern specification,BP,DLL1
6551,GO:1901343,0.93898163170402,0.264813899677632,1,9,negative regulation of vasculature development,BP,FOXO4
103,GO:0001501,0.939644241690765,0.163263320331904,3,27,skeletal system development,BP,HEXB;ITGB8;CTGF
5781,GO:0071241,0.93982476722636,0.259154043455304,1,10,cellular response to inorganic substance,BP,CLDN1
3989,GO:0044262,0.939887104842806,0.256419535795631,1,11,cellular carbohydrate metabolic process,BP,PDK4
1891,GO:0015672,0.940429650324354,0.252739296911254,1,12,monovalent inorganic cation transport,BP,ACTN2
5142,GO:0055065,0.940436599982104,0.188810805641381,2,19,metal ion homeostasis,BP,PRND;HEXB
7095,GO:2000241,0.940733173211359,0.256476750110388,1,10,regulation of reproductive process,BP,PRKACB
4866,GO:0051047,0.941511737192977,0.246349224614703,1,14,positive regulation of secretion,BP,SDC4
3812,GO:0043231,0.941790830092259,0.0952402559102489,34,204,intracellular membrane-bounded organelle,CC,PNP;ACSF2;MYO7A;CDKN1A;HMGCS2;NUAK2;RHOB;REEP1;PHLDA1;PIK3R1;SLC25A53;MRI1;HEXB;MRO;LAMA5;PRKACB;HSD17B3;CYP11A1;SDC4;GAS6;SERPINA5;HSD3B2;TICAM1;HMGN5;RAB39B;CASP4;DHCR7;PON2;ACSL4;FOXO4;PDK4;AOX1;CTGF;GPSM1
4067,GO:0044708,0.942267305842123,0.247316193598182,1,12,single-organism behavior,BP,ITGA3
2454,GO:0030178,0.942729938931445,0.250531560377668,1,10,negative regulation of Wnt signaling pathway,BP,DKK3
1556,GO:0009913,0.943108546602776,0.188208542087399,2,14,epidermal cell differentiation,BP,MYO7A;DLL1
6172,GO:0090130,0.943316100819063,0.181879152993181,2,19,tissue migration,BP,RHOB;ITGA3
2655,GO:0031098,0.943754604044553,0.241157566308343,1,13,stress-activated protein kinase signaling cascade,BP,CTGF
3045,GO:0032872,0.943754604044553,0.241157566308343,1,13,regulation of stress-activated MAPK cascade,BP,CTGF
4995,GO:0051403,0.943754604044553,0.241157566308343,1,13,stress-activated MAPK cascade,BP,CTGF
5662,GO:0070302,0.943754604044553,0.241157566308343,1,13,regulation of stress-activated protein kinase signaling cascade,BP,CTGF
4669,GO:0048738,0.943812493285072,0.182531063616101,2,17,cardiac muscle tissue development,BP,ACTN2;FHOD3
4667,GO:0048732,0.943885211464738,0.141273614286357,4,29,gland development,BP,DKK3;LAMA5;SERPINA5;CLDN1
1412,GO:0008643,0.943963585206463,0.246816003571106,1,10,carbohydrate transport,BP,PIK3R1
1609,GO:0010467,0.944279582770902,0.100861362966943,14,91,gene expression,BP,CDKN1A;DKK3;PIK3R1;HEXB;PRKACB;ITGB8;GAS6;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3;CTGF
4629,GO:0048639,0.945197533044413,0.240569625413396,1,11,positive regulation of developmental growth,BP,DLL1
5806,GO:0071345,0.945677590574196,0.173491962493665,2,23,cellular response to cytokine stimulus,BP,GAS6;CLDN1
6814,GO:1903531,0.945966321628137,0.240712556861182,1,10,negative regulation of secretion by cell,BP,GAS6
4943,GO:0051247,0.946006273546287,0.110472537826393,8,61,positive regulation of protein metabolic process,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6;TICAM1;RBMS3;CTGF
219,GO:0001934,0.946135493132833,0.119229773551494,6,47,positive regulation of protein phosphorylation,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6;CTGF
3615,GO:0042327,0.946135493132833,0.119229773551494,6,47,positive regulation of phosphorylation,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6;CTGF
3830,GO:0043269,0.946300395423428,0.17381846887743,2,20,regulation of ion transport,BP,ACTN2;PDE4B
4664,GO:0048729,0.946371384659032,0.11965691225558,6,42,tissue morphogenesis,BP,RHOB;LAMA5;PRKACB;SDC4;DLL1;ITGA3
3614,GO:0042326,0.94642365008511,0.233092019696053,1,13,negative regulation of phosphorylation,BP,CDKN1A
5938,GO:0072028,0.946525862548358,0.234476471596922,1,12,nephron morphogenesis,BP,LAMA5
1370,GO:0008324,0.946704890042273,0.232233099936434,1,13,cation transmembrane transporter activity,MF,GAS6
1567,GO:0009966,0.947004832446102,0.0966272460212214,14,89,regulation of signal transduction,BP,ACTN2;GPRASP1;RHOJ;DKK3;KITLG;RHOB;PIK3R1;PRKACB;GAS6;DLL1;TICAM1;ITGA3;CTGF;GPSM1
1988,GO:0016310,0.947115102729752,0.0994008141670351,12,78,phosphorylation,BP,ACTN2;NRTN;CDKN1A;NUAK2;KITLG;PIK3R1;PRKACB;SDC4;GAS6;PDK4;CTGF;MARK4
4870,GO:0051051,0.947270652501843,0.173029863176572,2,18,negative regulation of transport,BP,ACTN2;GAS6
3988,GO:0044260,0.948178333886285,0.0869028612147611,26,153,cellular macromolecule metabolic process,BP,ACTN2;NRTN;CDKN1A;GPRASP1;NUAK2;DKK3;KITLG;PHLDA1;PIK3R1;PRND;HEXB;MFGE8;PRKACB;SDC4;GAS6;SERPINA5;DLL1;TICAM1;HMGN5;PTPN7;RBMS3;FOXO4;ITGA3;PDK4;CTGF;MARK4
5047,GO:0051641,0.948321470834681,0.101697937704874,10,63,cellular localization,BP,ACTN2;MYO7A;CDKN1A;GPRASP1;RHOB;REEP1;PIK3R1;LAMA5;GAS6;ITGA3
3788,GO:0043170,0.94844500809282,0.0858389310827635,29,169,macromolecule metabolic process,BP,ACTN2;NRTN;CDKN1A;GPRASP1;NUAK2;DKK3;KITLG;PHLDA1;PIK3R1;PRND;HEXB;MFGE8;PRKACB;ITGB8;SDC4;GAS6;SERPINA5;DLL1;TICAM1;HMGN5;PTPN7;RBMS3;CASP4;DHH;FOXO4;ITGA3;PDK4;CTGF;MARK4
1578,GO:0010001,0.948539296760998,0.228266172609863,1,12,glial cell differentiation,BP,DLL1
82,GO:0000989,0.948856764698629,0.229288078180424,1,11,transcription factor activity, transcription factor binding,MF,ACTN2
1458,GO:0009150,0.948903412958046,0.225457167770004,1,13,purine ribonucleotide metabolic process,BP,PDE4B
1478,GO:0009259,0.948903412958046,0.225457167770004,1,13,ribonucleotide metabolic process,BP,PDE4B
3751,GO:0043025,0.949371911281364,0.225670514135743,1,12,neuronal cell body,CC,ACSL4
3864,GO:0043410,0.949809687188013,0.140381440217848,3,29,positive regulation of MAPK cascade,BP,KITLG;GAS6;CTGF
2252,GO:0019752,0.95180899499736,0.113738489426794,5,47,carboxylic acid metabolic process,BP,ACSF2;MRI1;PON2;ACSL4;PDK4
3822,GO:0043254,0.952175135328402,0.218781167184971,1,11,regulation of protein complex assembly,BP,FHOD3
2534,GO:0030509,0.952635115552565,0.217302850588877,1,11,BMP signaling pathway,BP,ITGA3
5887,GO:0071772,0.952635115552565,0.217302850588877,1,11,response to BMP,BP,ITGA3
5888,GO:0071773,0.952635115552565,0.217302850588877,1,11,cellular response to BMP stimulus,BP,ITGA3
201,GO:0001890,0.952809175223386,0.216742013500824,1,11,placenta development,BP,ITGB8
105,GO:0001503,0.953246082918859,0.15709515651428,2,19,ossification,BP,DHH;CTGF
6810,GO:1903522,0.95360718641114,0.155448152372003,2,20,regulation of blood circulation,BP,PDE4B;CTGF
4939,GO:0051239,0.953645004671052,0.0848293255364982,15,95,regulation of multicellular organismal process,BP,PNP;LAMA1;KITLG;RHOB;PIK3R1;LAMA5;PRKACB;GAS6;DLL1;TICAM1;PDE4B;FOXO4;ITGA3;PDK4;CTGF
4610,GO:0048583,0.953956275194442,0.0833896113542989,16,100,regulation of response to stimulus,BP,ACTN2;GPRASP1;RHOJ;DKK3;KITLG;RHOB;PIK3R1;PRKACB;GAS6;DLL1;TICAM1;CASP4;PDE4B;ITGA3;CTGF;GPSM1
2153,GO:0018105,0.955561159872769,0.207767538347405,1,11,peptidyl-serine phosphorylation,BP,GAS6
2165,GO:0018209,0.955561159872769,0.207767538347405,1,11,peptidyl-serine modification,BP,GAS6
823,GO:0005794,0.956395139044957,0.106320854052932,5,37,Golgi apparatus,CC,SDC4;GAS6;RAB39B;CTGF;GPSM1
3746,GO:0043009,0.956514924126955,0.127187520553497,3,24,chordate embryonic development,BP,PRKACB;SDC4;DLL1
2722,GO:0031399,0.956548130955995,0.0950949991874543,7,55,regulation of protein modification process,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6;TICAM1;CTGF
2038,GO:0016567,0.956749693093372,0.200314977783047,1,13,protein ubiquitination,BP,TICAM1
2935,GO:0032446,0.956749693093372,0.200314977783047,1,13,protein modification by small protein conjugation,BP,TICAM1
2606,GO:0030855,0.957074561080115,0.0993244998417137,6,42,epithelial cell differentiation,BP,MYO7A;CDKN1A;LAMA5;DLL1;CLDN1;CLDN3
4300,GO:0045927,0.957529880306136,0.199313531744896,1,12,positive regulation of growth,BP,DLL1
2207,GO:0019221,0.957967478812005,0.191149782297079,1,18,cytokine-mediated signaling pathway,BP,GAS6
1614,GO:0010506,0.958813298601554,0.196888245510498,1,11,regulation of autophagy,BP,TICAM1
697,GO:0005125,0.958867032401691,0.193248143284873,1,13,cytokine activity,MF,KITLG
3048,GO:0032879,0.959030153852282,0.0761249119545331,15,94,regulation of localization,BP,ACTN2;LAMA1;CDKN1A;KITLG;RHOB;REEP1;PIK3R1;MFGE8;LAMA5;SDC4;GAS6;DLL1;PDE4B;FOXO4;ITGA3
1950,GO:0016055,0.959107104660504,0.140450398706547,2,21,Wnt signaling pathway,BP,DKK3;ITGA3
6464,GO:0198738,0.959107104660504,0.140450398706547,2,21,cell-cell signaling by wnt,BP,DKK3;ITGA3
2208,GO:0019222,0.959204353761355,0.071429478189337,22,133,regulation of metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;PRKACB;CAMSAP3;ITGB8;SDC4;GAS6;SERPINA5;DLL1;TICAM1;HMGN5;RBMS3;DHCR7;DHH;FOXO4;ITGA3;PDK4;CTGF
2206,GO:0019220,0.959247931078361,0.0867886619934742,8,62,regulation of phosphate metabolic process,BP,CDKN1A;KITLG;PIK3R1;PRKACB;CAMSAP3;SDC4;GAS6;CTGF
6056,GO:0072330,0.959307460799831,0.191761771556412,1,13,monocarboxylic acid biosynthetic process,BP,PDK4
2858,GO:0032268,0.95932086160111,0.084041913080132,9,69,regulation of cellular protein metabolic process,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6;SERPINA5;TICAM1;RBMS3;CTGF
5307,GO:0060429,0.959428960028614,0.0845014406721185,9,60,epithelium development,BP,MYO7A;CDKN1A;RHOB;LAMA5;PRKACB;SDC4;DLL1;CLDN1;CLDN3
3025,GO:0032787,0.959790713699729,0.105949049526139,4,36,monocarboxylic acid metabolic process,BP,ACSF2;PON2;ACSL4;PDK4
1853,GO:0015075,0.960016239496596,0.186911479045048,1,15,ion transmembrane transporter activity,MF,GAS6
81,GO:0000988,0.960208176228579,0.190258829778496,1,12,transcription factor activity, protein binding,MF,ACTN2
2226,GO:0019395,0.960343644535385,0.18482729185029,1,16,fatty acid oxidation,BP,PDK4
3242,GO:0034440,0.960343644535385,0.18482729185029,1,16,lipid oxidation,BP,PDK4
4867,GO:0051048,0.960803570266736,0.190073619508796,1,11,negative regulation of secretion,BP,GAS6
1641,GO:0010605,0.960842457942127,0.0910906893111236,6,48,negative regulation of macromolecule metabolic process,BP,CDKN1A;DKK3;ITGB8;GAS6;SERPINA5;CTGF
426,GO:0003007,0.961098250955741,0.185657715157814,1,13,heart morphogenesis,BP,DLL1
5470,GO:0060993,0.961499476393259,0.182975533400114,1,14,kidney morphogenesis,BP,LAMA5
5574,GO:0061448,0.961637113799036,0.133665802918397,2,21,connective tissue development,BP,ITGB8;CTGF
3982,GO:0044248,0.961693207152735,0.0853278042378875,7,56,cellular catabolic process,BP,PNP;GPRASP1;HEXB;TICAM1;PON2;PDE4B;AOX1
1583,GO:0010038,0.961789280011608,0.183275640971004,1,13,response to metal ion,BP,CLDN1
5431,GO:0060828,0.962245243148044,0.181695521804263,1,13,regulation of canonical Wnt signaling pathway,BP,DKK3
537,GO:0003676,0.96311534281513,0.10968024958219,3,29,nucleic acid binding,MF,HMGN5;RBMS3;FOXO4
4612,GO:0048585,0.963604030377184,0.0857467543083835,6,47,negative regulation of response to stimulus,BP,GPRASP1;DKK3;PRKACB;GAS6;TICAM1;ITGA3
6813,GO:1903530,0.963738820163939,0.126948152924574,2,23,regulation of secretion by cell,BP,SDC4;GAS6
3613,GO:0042325,0.963804793942712,0.081471901790425,7,54,regulation of phosphorylation,BP,CDKN1A;KITLG;PIK3R1;PRKACB;SDC4;GAS6;CTGF
43,GO:0000280,0.964240601370453,0.174700195837355,1,13,nuclear division,BP,MARK4
4547,GO:0048285,0.964240601370453,0.174700195837355,1,13,organelle fission,BP,MARK4
4868,GO:0051049,0.965230801749219,0.0735432738437675,9,66,regulation of transport,BP,ACTN2;CDKN1A;REEP1;PIK3R1;MFGE8;SDC4;GAS6;DLL1;PDE4B
2706,GO:0031331,0.965966552316137,0.168539140676977,1,13,positive regulation of cellular catabolic process,BP,TICAM1
27,GO:0000165,0.966467921844239,0.0843373749531963,5,44,MAPK cascade,BP,ACTN2;NRTN;KITLG;GAS6;CTGF
1172,GO:0007154,0.967658151245104,0.056357671301586,31,175,cell communication,BP,ACTN2;LAMA1;NRTN;CDKN1A;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;PIK3R1;LAMA5;ITGB5;PRKACB;ITGB8;MPZL1;SDC4;GAS6;DLL1;TICAM1;RIN3;CASP4;PDE4B;DHH;FOXO4;ITGA3;PDK4;CTGF;CLDN3;CGN;GPSM1
2244,GO:0019693,0.967929038992641,0.159137583195522,1,15,ribose phosphate metabolic process,BP,PDE4B
2369,GO:0022612,0.96799455014432,0.162603573805904,1,12,gland morphogenesis,BP,LAMA5
2386,GO:0022891,0.968649703462505,0.155602280419552,1,16,substrate-specific transmembrane transporter activity,MF,GAS6
87,GO:0001071,0.968771978854038,0.161438300648304,1,11,nucleic acid binding transcription factor activity,MF,FOXO4
542,GO:0003700,0.968771978854038,0.161438300648304,1,11,transcription factor activity, sequence-specific DNA binding,MF,FOXO4
4584,GO:0048518,0.969004749851292,0.0555361099500018,23,142,positive regulation of biological process,BP,ACTN2;PNP;CDKN1A;KITLG;RHOB;PIK3R1;HEXB;MFGE8;PRKACB;ITGB8;SDC4;GAS6;DLL1;TICAM1;HMGN5;RBMS3;CLDN1;PDE4B;FOXO4;ITGA3;CTGF;ESPN;MARK4
3958,GO:0044057,0.969103656152914,0.0950254097864019,3,29,regulation of system process,BP,GAS6;PDE4B;CTGF
4311,GO:0045944,0.969151399383462,0.0855075280703227,4,34,positive regulation of transcription from RNA polymerase II promoter,BP,PIK3R1;HEXB;DLL1;FOXO4
6573,GO:1901575,0.969216055084606,0.0737357712791226,6,54,organic substance catabolic process,BP,PNP;GPRASP1;HEXB;SDC4;PDE4B;AOX1
6688,GO:1902532,0.969320735173384,0.15505080595146,1,14,negative regulation of intracellular signal transduction,BP,ITGA3
1777,GO:0012506,0.969588777801185,0.0938110486681712,3,29,vesicle membrane,CC,SNX21;SERPINA5;TMEM163
2560,GO:0030659,0.969588777801185,0.0938110486681712,3,29,cytoplasmic vesicle membrane,CC,SNX21;SERPINA5;TMEM163
4942,GO:0051246,0.970342283592568,0.0638060937358582,9,71,regulation of protein metabolic process,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6;SERPINA5;TICAM1;RBMS3;CTGF
6687,GO:1902531,0.972408281799483,0.0620596568918735,8,61,regulation of intracellular signal transduction,BP,RHOJ;KITLG;RHOB;PIK3R1;GAS6;TICAM1;ITGA3;CTGF
2394,GO:0023052,0.97291502130648,0.0480369541994925,31,176,signaling,BP,ACTN2;LAMA1;NRTN;CDKN1A;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;PIK3R1;LAMA5;ITGB5;PRKACB;ITGB8;MPZL1;SDC4;GAS6;DLL1;TICAM1;RIN3;CASP4;PDE4B;DHH;FOXO4;ITGA3;PDK4;CTGF;CLDN3;CGN;GPSM1
4062,GO:0044700,0.97291502130648,0.0480369541994925,31,176,single organism signaling,BP,ACTN2;LAMA1;NRTN;CDKN1A;GPRASP1;NUAK2;RHOJ;DKK3;KITLG;RHOB;PIK3R1;LAMA5;ITGB5;PRKACB;ITGB8;MPZL1;SDC4;GAS6;DLL1;TICAM1;RIN3;CASP4;PDE4B;DHH;FOXO4;ITGA3;PDK4;CTGF;CLDN3;CGN;GPSM1
3903,GO:0043542,0.973666573266285,0.139639296222371,1,13,endothelial cell migration,BP,RHOB
217,GO:0001932,0.973895739206154,0.0642774443626322,6,51,regulation of protein phosphorylation,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6;CTGF
1631,GO:0010562,0.974274731915664,0.0632494428714995,6,54,positive regulation of phosphorus metabolic process,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6;CTGF
4308,GO:0045937,0.974274731915664,0.0632494428714995,6,54,positive regulation of phosphate metabolic process,BP,CDKN1A;KITLG;PRKACB;SDC4;GAS6;CTGF
5242,GO:0060255,0.974720824460818,0.047909924509045,18,115,regulation of macromolecule metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;PRKACB;ITGB8;SDC4;GAS6;SERPINA5;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3;CTGF
129,GO:0001649,0.974757937042891,0.134219290103515,1,14,osteoblast differentiation,BP,DHH
4763,GO:0050767,0.975350710163684,0.0944527824078745,2,21,regulation of neurogenesis,BP,DLL1;ITGA3
4614,GO:0048589,0.975954020771813,0.0914567674568059,2,24,developmental growth,BP,DLL1;DHCR7
3931,GO:0043623,0.976042278038992,0.129096022803369,1,14,cellular protein complex assembly,BP,FHOD3
670,GO:0004888,0.97657000335331,0.126043903131714,1,15,transmembrane signaling receptor activity,MF,CLDN3
1659,GO:0010648,0.976706906007814,0.0585471743599016,6,48,negative regulation of cell communication,BP,GPRASP1;DKK3;PRKACB;GAS6;TICAM1;ITGA3
2396,GO:0023057,0.976706906007814,0.0585471743599016,6,48,negative regulation of signaling,BP,GPRASP1;DKK3;PRKACB;GAS6;TICAM1;ITGA3
2834,GO:0032101,0.977863613304971,0.0863094571161327,2,22,regulation of response to external stimulus,BP,GAS6;CASP4
4628,GO:0048638,0.978210856735736,0.118578935239132,1,16,regulation of developmental growth,BP,DLL1
3256,GO:0034622,0.978256745652786,0.119162828361829,1,15,cellular macromolecular complex assembly,BP,FHOD3
4765,GO:0050769,0.978588361068708,0.118678620332332,1,14,positive regulation of neurogenesis,BP,ITGA3
4290,GO:0045893,0.978847817133864,0.057216443377041,5,43,positive regulation of transcription, DNA-templated,BP,PIK3R1;HEXB;DLL1;HMGN5;FOXO4
6712,GO:1902680,0.978847817133864,0.057216443377041,5,43,positive regulation of RNA biosynthetic process,BP,PIK3R1;HEXB;DLL1;HMGN5;FOXO4
6804,GO:1903508,0.978847817133864,0.057216443377041,5,43,positive regulation of nucleic acid-templated transcription,BP,PIK3R1;HEXB;DLL1;HMGN5;FOXO4
1657,GO:0010646,0.979015943448516,0.0424954317341597,14,96,regulation of cell communication,BP,ACTN2;GPRASP1;RHOJ;DKK3;KITLG;RHOB;PIK3R1;PRKACB;GAS6;DLL1;TICAM1;ITGA3;CTGF;GPSM1
3862,GO:0043408,0.97907459791027,0.0683301817644968,3,33,regulation of MAPK cascade,BP,KITLG;GAS6;CTGF
3979,GO:0044242,0.979373543964119,0.111548534879134,1,20,cellular lipid catabolic process,BP,HEXB
4865,GO:0051046,0.979650678161062,0.0794658848927121,2,26,regulation of secretion,BP,SDC4;GAS6
138,GO:0001664,0.980228227389849,0.108954421707374,1,18,G-protein coupled receptor binding,MF,REEP1
1423,GO:0009056,0.980334299576407,0.0459637995878917,8,67,catabolic process,BP,PNP;GPRASP1;HEXB;SDC4;TICAM1;PON2;PDE4B;AOX1
4001,GO:0044297,0.980546208081147,0.10882255305486,1,16,cell body,CC,ACSL4
1548,GO:0009892,0.980858201197247,0.0468433079068938,7,58,negative regulation of metabolic process,BP,CDKN1A;DKK3;CAMSAP3;ITGB8;GAS6;SERPINA5;CTGF
1549,GO:0009893,0.981165936513313,0.0379853409567455,15,105,positive regulation of metabolic process,BP,CDKN1A;KITLG;PIK3R1;HEXB;PRKACB;ITGB8;SDC4;GAS6;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3;CTGF
2698,GO:0031323,0.981324288534044,0.0361474554967846,19,124,regulation of cellular metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;HEXB;PRKACB;CAMSAP3;SDC4;GAS6;SERPINA5;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;ITGA3;PDK4;CTGF
4306,GO:0045935,0.98148365003177,0.0478562211438458,6,51,positive regulation of nucleobase-containing compound metabolic process,BP,KITLG;PIK3R1;HEXB;DLL1;HMGN5;FOXO4
2391,GO:0023014,0.981514803365356,0.0506718639190319,5,47,signal transduction by protein phosphorylation,BP,ACTN2;NRTN;KITLG;GAS6;CTGF
5105,GO:0051962,0.981763525882717,0.104315225199147,1,15,positive regulation of nervous system development,BP,ITGA3
3860,GO:0043406,0.981814385193289,0.103380584133972,1,16,positive regulation of MAP kinase activity,BP,KITLG
3362,GO:0035556,0.981862920102095,0.0378742248454697,13,93,intracellular signal transduction,BP,ACTN2;NRTN;CDKN1A;NUAK2;RHOJ;KITLG;RHOB;PIK3R1;GAS6;TICAM1;CASP4;ITGA3;CTGF
1112,GO:0006914,0.982003290146047,0.104092226341956,1,14,autophagy,BP,TICAM1
4289,GO:0045892,0.982503650984256,0.0714790410790865,2,22,negative regulation of transcription, DNA-templated,BP,DKK3;GAS6
6803,GO:1903507,0.982503650984256,0.0714790410790865,2,22,negative regulation of nucleic acid-templated transcription,BP,DKK3;GAS6
1552,GO:0009896,0.982565647725043,0.100804700105087,1,15,positive regulation of catabolic process,BP,TICAM1
4950,GO:0051254,0.982915539933653,0.0476005562719346,5,44,positive regulation of RNA metabolic process,BP,PIK3R1;HEXB;DLL1;HMGN5;FOXO4
2393,GO:0023051,0.983156969810111,0.0348738691912168,14,99,regulation of signaling,BP,ACTN2;GPRASP1;RHOJ;DKK3;KITLG;RHOB;PIK3R1;PRKACB;GAS6;DLL1;TICAM1;ITGA3;CTGF;GPSM1
2387,GO:0022892,0.983515638548663,0.0939074210447838,1,20,substrate-specific transporter activity,MF,GAS6
6954,GO:1905114,0.983955711605579,0.0658104123378012,2,25,cell surface receptor signaling pathway involved in cell-cell signaling,BP,DKK3;ITGA3
6689,GO:1902533,0.984525523655956,0.0471436486525297,4,42,positive regulation of intracellular signal transduction,BP,KITLG;GAS6;TICAM1;CTGF
2700,GO:0031325,0.984990146609731,0.0319236937290341,13,97,positive regulation of cellular metabolic process,BP,CDKN1A;KITLG;PIK3R1;HEXB;PRKACB;SDC4;GAS6;DLL1;TICAM1;HMGN5;RBMS3;FOXO4;CTGF
6711,GO:1902679,0.985397217612405,0.0614749891012892,2,23,negative regulation of RNA biosynthetic process,BP,DKK3;GAS6
1681,GO:0010720,0.986356967070521,0.0829092656132814,1,16,positive regulation of cell development,BP,ITGA3
6448,GO:0099600,0.986447008047432,0.0819447174928623,1,17,transmembrane receptor activity,MF,CLDN3
5198,GO:0060070,0.986970974531024,0.0790092363621746,1,18,canonical Wnt signaling pathway,BP,DKK3
5251,GO:0060284,0.987246800871578,0.0545930069462412,2,25,regulation of cell development,BP,DLL1;ITGA3
1941,GO:0016042,0.988031769629433,0.072333953692804,1,23,lipid catabolic process,BP,HEXB
5919,GO:0071900,0.989053998919545,0.0476517120279635,2,28,regulation of protein serine/threonine kinase activity,BP,CDKN1A;KITLG
2437,GO:0030139,0.989105963984972,0.0687007121112806,1,18,endocytic vesicle,CC,ITGB5
4611,GO:0048584,0.989370567706544,0.0267391252386428,8,68,positive regulation of response to stimulus,BP,KITLG;PIK3R1;PRKACB;GAS6;DLL1;TICAM1;PDE4B;CTGF
166,GO:0001763,0.990453696999528,0.0619249047038327,1,18,morphogenesis of a branching structure,BP,LAMA5
4675,GO:0048754,0.990453696999528,0.0619249047038327,1,18,branching morphogenesis of an epithelial tube,BP,LAMA5
5513,GO:0061138,0.990453696999528,0.0619249047038327,1,18,morphogenesis of a branching epithelium,BP,LAMA5
5263,GO:0060322,0.990777613117007,0.0416646570427776,2,26,head development,BP,DLL1;CRISPLD2
5832,GO:0071407,0.99131304649595,0.0578569285365169,1,17,cellular response to organic cyclic compound,BP,PDE4B
7070,GO:2000113,0.991442238308252,0.0391657315961055,2,26,negative regulation of cellular macromolecule biosynthetic process,BP,DKK3;GAS6
5921,GO:0071902,0.991720490023079,0.0547163586839225,1,20,positive regulation of protein serine/threonine kinase activity,BP,KITLG
4949,GO:0051253,0.991828394704997,0.0378534034788178,2,25,negative regulation of RNA metabolic process,BP,DKK3;GAS6
1568,GO:0009967,0.992613965419184,0.0212647602378358,6,59,positive regulation of signal transduction,BP,KITLG;PIK3R1;GAS6;DLL1;TICAM1;CTGF
4305,GO:0045934,0.993711479487252,0.0301938504715948,2,27,negative regulation of nucleobase-containing compound metabolic process,BP,DKK3;GAS6
1628,GO:0010558,0.994022604278928,0.0288307244602029,2,28,negative regulation of macromolecule biosynthetic process,BP,DKK3;GAS6
3859,GO:0043405,0.99412746812423,0.0413497403401363,1,21,regulation of MAP kinase activity,BP,KITLG
1658,GO:0010647,0.994290972454292,0.0169064238403382,6,61,positive regulation of cell communication,BP,KITLG;PIK3R1;GAS6;DLL1;TICAM1;CTGF
2395,GO:0023056,0.994290972454292,0.0169064238403382,6,61,positive regulation of signaling,BP,KITLG;PIK3R1;GAS6;DLL1;TICAM1;CTGF
4139,GO:0045165,0.994633811485493,0.0384463750880691,1,21,cell fate commitment,BP,DLL1
2160,GO:0018193,0.995310445060565,0.0232074783088356,2,32,peptidyl-amino acid modification,BP,KITLG;GAS6
2699,GO:0031324,0.995651704901746,0.0142621276836821,5,54,negative regulation of cellular metabolic process,BP,CDKN1A;DKK3;CAMSAP3;GAS6;SERPINA5
1218,GO:0007267,0.995671913827074,0.0141646794839485,5,56,cell-cell signaling,BP,DKK3;MPZL1;DLL1;DHH;ITGA3
1546,GO:0009890,0.995775804331699,0.0213093909677719,2,31,negative regulation of biosynthetic process,BP,DKK3;GAS6
2702,GO:0031327,0.995775804331699,0.0213093909677719,2,31,negative regulation of cellular biosynthetic process,BP,DKK3;GAS6
4907,GO:0051172,0.995903381952865,0.0207635552346072,2,31,negative regulation of nitrogen compound metabolic process,BP,DKK3;GAS6
1543,GO:0009887,0.996838221435126,0.0118412620604216,4,47,animal organ morphogenesis,BP,MYO7A;LAMA5;DLL1;CTGF
1249,GO:0007420,0.997659903859093,0.0192829828637908,1,23,brain development,BP,DLL1
2704,GO:0031329,0.998237092835439,0.0152338260598619,1,23,regulation of cellular catabolic process,BP,TICAM1
1550,GO:0009894,0.999336742610438,0.00657338088951217,1,26,regulation of catabolic process,BP,TICAM1
1248,GO:0007417,0.999674958345286,0.00348675747325969,1,31,central nervous system development,BP,DLL1
6757,GO:1903050,0.999999999999997,0.245050311763662,0,6,regulation of proteolysis involved in cellular protein catabolic process,BP,
1,GO:0000002,1,0.759355645182739,0,1,mitochondrial genome maintenance,BP,
3,GO:0000018,1,0.84462400233258,0,1,regulation of DNA recombination,BP,
4,GO:0000030,1,0.987980034753378,0,1,mannosyltransferase activity,MF,
5,GO:0000038,1,0.765260800063365,0,1,very long-chain fatty acid metabolic process,BP,
6,GO:0000041,1,0.40944570434788,0,4,transition metal ion transport,BP,
7,GO:0000045,1,0.559123898229656,0,2,autophagosome assembly,BP,
9,GO:0000070,1,0.853799544891606,0,1,mitotic sister chromatid segregation,BP,
17,GO:0000118,1,0.702569048854651,0,1,histone deacetylase complex,CC,
18,GO:0000122,1,0.013310878303057,0,16,negative regulation of transcription from RNA polymerase II promoter,BP,
19,GO:0000132,1,0.980495002631481,0,1,establishment of mitotic spindle orientation,BP,
21,GO:0000145,1,0.788139761849395,0,1,exocyst,CC,
23,GO:0000149,1,0.649062903400574,0,2,SNARE binding,MF,
24,GO:0000151,1,0.531250681140482,0,2,ubiquitin ligase complex,CC,
25,GO:0000155,1,0.767624987207694,0,1,phosphorelay sensor kinase activity,MF,
26,GO:0000160,1,0.767624987207694,0,1,phosphorelay signal transduction system,BP,
29,GO:0000185,1,0.916263843517582,0,1,activation of MAPKKK activity,BP,
30,GO:0000186,1,0.508039375219735,0,3,activation of MAPKK activity,BP,
31,GO:0000187,1,0.100673874812252,0,9,activation of MAPK activity,BP,
32,GO:0000188,1,0.776747906170104,0,1,inactivation of MAPK activity,BP,
33,GO:0000209,1,0.295911042589911,0,5,protein polyubiquitination,BP,
35,GO:0000228,1,0.702569048854651,0,1,nuclear chromosome,CC,
36,GO:0000242,1,0.840417410506357,0,1,pericentriolar material,CC,
37,GO:0000245,1,0.912530916414626,0,1,spliceosomal complex assembly,BP,
38,GO:0000247,1,0.94047143183814,0,1,C-8 sterol isomerase activity,MF,
39,GO:0000248,1,0.725770278597532,0,1,C-5 sterol desaturase activity,MF,
40,GO:0000255,1,0.727749574179032,0,1,allantoin metabolic process,BP,
41,GO:0000271,1,0.460529819197213,0,3,polysaccharide biosynthetic process,BP,
44,GO:0000281,1,0.700469233394229,0,1,mitotic cytokinesis,BP,
45,GO:0000285,1,0.912109332341801,0,1,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
48,GO:0000303,1,0.609084076257617,0,2,response to superoxide,BP,
49,GO:0000305,1,0.609084076257617,0,2,response to oxygen radical,BP,
51,GO:0000313,1,0.911789827211774,0,2,organellar ribosome,CC,
52,GO:0000315,1,0.911789827211774,0,2,organellar large ribosomal subunit,CC,
54,GO:0000375,1,0.912530916414626,0,1,RNA splicing, via transesterification reactions,BP,
55,GO:0000377,1,0.912530916414626,0,1,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
56,GO:0000398,1,0.912530916414626,0,1,mRNA splicing, via spliceosome,BP,
57,GO:0000502,1,0.957091557538293,0,1,proteasome complex,CC,
58,GO:0000578,1,0.4514017854829,0,3,embryonic axis specification,BP,
60,GO:0000790,1,0.702569048854651,0,1,nuclear chromatin,CC,
61,GO:0000792,1,0.759613150389312,0,1,heterochromatin,CC,
62,GO:0000803,1,0.702569048854651,0,1,sex chromosome,CC,
63,GO:0000805,1,0.702569048854651,0,1,X chromosome,CC,
64,GO:0000806,1,0.702569048854651,0,1,Y chromosome,CC,
65,GO:0000819,1,0.853799544891606,0,1,sister chromatid segregation,BP,
69,GO:0000922,1,0.564703412413181,0,3,spindle pole,CC,
71,GO:0000932,1,0.727749574179032,0,1,P-body,CC,
72,GO:0000959,1,0.831795738218181,0,2,mitochondrial RNA metabolic process,BP,
73,GO:0000963,1,0.831795738218181,0,2,mitochondrial RNA processing,BP,
74,GO:0000975,1,0.0921748710197254,0,8,regulatory region DNA binding,MF,
75,GO:0000976,1,0.586878413092328,0,2,transcription regulatory region sequence-specific DNA binding,MF,
76,GO:0000977,1,0.586878413092328,0,2,RNA polymerase II regulatory region sequence-specific DNA binding,MF,
77,GO:0000979,1,0.766387473815025,0,1,RNA polymerase II core promoter sequence-specific DNA binding,MF,
79,GO:0000982,1,0.451743625073485,0,3,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
80,GO:0000983,1,0.785634671671933,0,1,transcription factor activity, RNA polymerase II core promoter sequence-specific,MF,
83,GO:0001012,1,0.586878413092328,0,2,RNA polymerase II regulatory region DNA binding,MF,
84,GO:0001046,1,0.766387473815025,0,1,core promoter sequence-specific DNA binding,MF,
85,GO:0001047,1,0.431918863209425,0,3,core promoter binding,MF,
86,GO:0001067,1,0.0921748710197254,0,8,regulatory region nucleic acid binding,MF,
88,GO:0001076,1,0.187904741823755,0,5,transcription factor activity, RNA polymerase II transcription factor binding,MF,
89,GO:0001077,1,0.590537374659276,0,2,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
90,GO:0001078,1,0.766387473815025,0,1,transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
91,GO:0001085,1,0.750376170507387,0,2,RNA polymerase II transcription factor binding,MF,
93,GO:0001102,1,0.750376170507387,0,2,RNA polymerase II activating transcription factor binding,MF,
94,GO:0001104,1,0.413848903679594,0,3,RNA polymerase II transcription cofactor activity,MF,
95,GO:0001105,1,0.772107268247692,0,1,RNA polymerase II transcription coactivator activity,MF,
96,GO:0001106,1,0.537125335201245,0,2,RNA polymerase II transcription corepressor activity,MF,
97,GO:0001134,1,0.744061959631107,0,1,transcription factor activity, transcription factor recruiting,MF,
98,GO:0001135,1,0.744061959631107,0,1,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
99,GO:0001190,1,0.475408520948778,0,2,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,
100,GO:0001191,1,0.253858935545947,0,4,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
101,GO:0001227,1,0.766387473815025,0,1,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
102,GO:0001228,1,0.590537374659276,0,2,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
106,GO:0001504,1,0.736861399765623,0,2,neurotransmitter uptake,BP,
107,GO:0001505,1,0.530287593538485,0,4,regulation of neurotransmitter levels,BP,
108,GO:0001508,1,0.536674541671135,0,2,action potential,BP,
109,GO:0001510,1,0.959711323077247,0,1,RNA methylation,BP,
110,GO:0001516,1,0.678851702335802,0,2,prostaglandin biosynthetic process,BP,
111,GO:0001522,1,0.866821396494009,0,1,pseudouridine synthesis,BP,
114,GO:0001533,1,0.133174298320685,0,6,cornified envelope,CC,
116,GO:0001556,1,0.948166622322516,0,2,oocyte maturation,BP,
118,GO:0001561,1,0.701058425428131,0,2,fatty acid alpha-oxidation,BP,
119,GO:0001562,1,0.940900393371674,0,1,response to protozoan,BP,
121,GO:0001569,1,0.588206296866904,0,3,branching involved in blood vessel morphogenesis,BP,
122,GO:0001570,1,0.155288709442556,0,6,vasculogenesis,BP,
125,GO:0001608,1,0.775603503393362,0,1,G-protein coupled nucleotide receptor activity,MF,
126,GO:0001609,1,0.7728397953467,0,1,G-protein coupled adenosine receptor activity,MF,
127,GO:0001614,1,0.775603503393362,0,1,purinergic nucleotide receptor activity,MF,
131,GO:0001653,1,0.733539537631441,0,1,peptide receptor activity,MF,
134,GO:0001656,1,0.108677090388254,0,11,metanephros development,BP,
137,GO:0001659,1,0.608072264548057,0,2,temperature homeostasis,BP,
144,GO:0001701,1,0.00682011608832224,0,16,in utero embryonic development,BP,
145,GO:0001702,1,0.347452584834534,0,3,gastrulation with mouth forming second,BP,
147,GO:0001705,1,0.74668493948331,0,1,ectoderm formation,BP,
152,GO:0001710,1,0.847043438938523,0,1,mesodermal cell fate commitment,BP,
153,GO:0001712,1,0.74668493948331,0,1,ectodermal cell fate commitment,BP,
154,GO:0001715,1,0.74668493948331,0,1,ectodermal cell fate specification,BP,
155,GO:0001726,1,0.347579454077045,0,4,ruffle,CC,
156,GO:0001736,1,0.487351167396069,0,3,establishment of planar polarity,BP,
158,GO:0001741,1,0.702569048854651,0,1,XY body,CC,
159,GO:0001743,1,0.762142819578083,0,1,optic placode formation,BP,
165,GO:0001759,1,0.359830123918929,0,7,organ induction,BP,
168,GO:0001771,1,0.741809137632914,0,1,immunological synapse formation,BP,
169,GO:0001773,1,0.964117353714657,0,1,myeloid dendritic cell activation,BP,
180,GO:0001821,1,0.802011392875838,0,1,histamine secretion,BP,
183,GO:0001824,1,0.759613150389312,0,1,blastocyst development,BP,
184,GO:0001832,1,0.759613150389312,0,1,blastocyst growth,BP,
185,GO:0001833,1,0.759613150389312,0,1,inner cell mass cell proliferation,BP,
186,GO:0001836,1,0.558615786158671,0,4,release of cytochrome c from mitochondria,BP,
187,GO:0001837,1,0.0766064414629709,0,9,epithelial to mesenchymal transition,BP,
189,GO:0001839,1,0.951532941209886,0,1,neural plate morphogenesis,BP,
190,GO:0001840,1,0.951532941209886,0,1,neural plate development,BP,
192,GO:0001842,1,0.739713014367407,0,1,neural fold formation,BP,
194,GO:0001844,1,0.823241180606138,0,1,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
196,GO:0001848,1,0.774707989551907,0,1,complement binding,MF,
202,GO:0001892,1,0.145375230320965,0,7,embryonic placenta development,BP,
203,GO:0001893,1,0.320637608837842,0,4,maternal placenta development,BP,
205,GO:0001895,1,0.573086235489244,0,2,retina homeostasis,BP,
206,GO:0001906,1,0.521386562536156,0,3,cell killing,BP,
207,GO:0001909,1,0.645957155587161,0,2,leukocyte mediated cytotoxicity,BP,
208,GO:0001910,1,0.836041871517245,0,1,regulation of leukocyte mediated cytotoxicity,BP,
209,GO:0001912,1,0.836041871517245,0,1,positive regulation of leukocyte mediated cytotoxicity,BP,
210,GO:0001913,1,0.645957155587161,0,2,T cell mediated cytotoxicity,BP,
211,GO:0001914,1,0.836041871517245,0,1,regulation of T cell mediated cytotoxicity,BP,
212,GO:0001916,1,0.836041871517245,0,1,positive regulation of T cell mediated cytotoxicity,BP,
214,GO:0001927,1,0.788139761849395,0,1,exocyst assembly,BP,
215,GO:0001928,1,0.788139761849395,0,1,regulation of exocyst assembly,BP,
216,GO:0001931,1,0.741809137632914,0,1,uropod,CC,
220,GO:0001935,1,0.148004940369311,0,8,endothelial cell proliferation,BP,
221,GO:0001936,1,0.148004940369311,0,8,regulation of endothelial cell proliferation,BP,
222,GO:0001938,1,0.148004940369311,0,8,positive regulation of endothelial cell proliferation,BP,
223,GO:0001941,1,0.710990121109279,0,2,postsynaptic membrane organization,BP,
226,GO:0001945,1,0.729399174163633,0,1,lymph vessel development,BP,
232,GO:0001957,1,0.89251195457963,0,1,intramembranous ossification,BP,
233,GO:0001958,1,0.448699022931459,0,4,endochondral ossification,BP,
237,GO:0001963,1,0.977811028321075,0,1,synaptic transmission, dopaminergic,BP,
240,GO:0001973,1,0.7728397953467,0,1,adenosine receptor signaling pathway,BP,
241,GO:0001974,1,0.632811082554425,0,4,blood vessel remodeling,BP,
243,GO:0001990,1,0.802011392875838,0,1,regulation of systemic arterial blood pressure by hormone,BP,
245,GO:0002011,1,0.11148835297982,0,7,morphogenesis of an epithelial sheet,BP,
247,GO:0002026,1,0.80818803699794,0,1,regulation of the force of heart contraction,BP,
248,GO:0002027,1,0.227720816910536,0,5,regulation of heart rate,BP,
249,GO:0002028,1,0.383939740799148,0,4,regulation of sodium ion transport,BP,
251,GO:0002042,1,0.448970932754634,0,2,cell migration involved in sprouting angiogenesis,BP,
252,GO:0002043,1,0.847043438938523,0,1,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
253,GO:0002052,1,0.616704084333269,0,1,positive regulation of neuroblast proliferation,BP,
254,GO:0002053,1,0.527239189772458,0,2,positive regulation of mesenchymal cell proliferation,BP,
258,GO:0002063,1,0.89251195457963,0,1,chondrocyte development,BP,
266,GO:0002072,1,0.683299665437994,0,1,optic cup morphogenesis involved in camera-type eye development,BP,
268,GO:0002082,1,0.772573466595224,0,1,regulation of oxidative phosphorylation,BP,
269,GO:0002084,1,0.829582597377115,0,1,protein depalmitoylation,BP,
271,GO:0002087,1,0.7728397953467,0,1,regulation of respiratory gaseous exchange by neurological system process,BP,
272,GO:0002088,1,0.175705766879642,0,7,lens development in camera-type eye,BP,
273,GO:0002089,1,0.847043438938523,0,1,lens morphogenesis in camera-type eye,BP,
277,GO:0002159,1,0.773025354548079,0,1,desmosome assembly,BP,
278,GO:0002193,1,0.616704084333269,0,1,MAML1-RBP-Jkappa- ICN1 complex,CC,
279,GO:0002200,1,0.84462400233258,0,1,somatic diversification of immune receptors,BP,
280,GO:0002204,1,0.84462400233258,0,1,somatic recombination of immunoglobulin genes involved in immune response,BP,
281,GO:0002208,1,0.84462400233258,0,1,somatic diversification of immunoglobulins involved in immune response,BP,
287,GO:0002228,1,0.77312897108567,0,1,natural killer cell mediated immunity,BP,
289,GO:0002244,1,0.303755832528146,0,4,hematopoietic progenitor cell differentiation,BP,
290,GO:0002250,1,0.256784998503491,0,7,adaptive immune response,BP,
291,GO:0002251,1,0.824648598151267,0,1,organ or tissue specific immune response,BP,
294,GO:0002260,1,0.530812553953919,0,3,lymphocyte homeostasis,BP,
299,GO:0002277,1,0.964117353714657,0,1,myeloid dendritic cell activation involved in immune response,BP,
300,GO:0002279,1,0.561734632247565,0,2,mast cell activation involved in immune response,BP,
304,GO:0002286,1,0.59198071976356,0,2,T cell activation involved in immune response,BP,
305,GO:0002287,1,0.766387473815025,0,1,alpha-beta T cell activation involved in immune response,BP,
306,GO:0002292,1,0.766387473815025,0,1,T cell differentiation involved in immune response,BP,
307,GO:0002293,1,0.766387473815025,0,1,alpha-beta T cell differentiation involved in immune response,BP,
308,GO:0002294,1,0.766387473815025,0,1,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
309,GO:0002295,1,0.766387473815025,0,1,T-helper cell lineage commitment,BP,
313,GO:0002318,1,0.75321100610424,0,1,myeloid progenitor cell differentiation,BP,
314,GO:0002320,1,0.52181526023997,0,2,lymphoid progenitor cell differentiation,BP,
315,GO:0002323,1,0.77312897108567,0,1,natural killer cell activation involved in immune response,BP,
316,GO:0002328,1,0.616704084333269,0,1,pro-B cell differentiation,BP,
318,GO:0002360,1,0.766387473815025,0,1,T cell lineage commitment,BP,
319,GO:0002363,1,0.766387473815025,0,1,alpha-beta T cell lineage commitment,BP,
322,GO:0002374,1,0.683299665437994,0,1,cytokine secretion involved in immune response,BP,
324,GO:0002377,1,0.811935014956657,0,2,immunoglobulin production,BP,
325,GO:0002381,1,0.84462400233258,0,1,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
326,GO:0002385,1,0.824648598151267,0,1,mucosal immune response,BP,
327,GO:0002386,1,0.824648598151267,0,1,immune response in mucosal-associated lymphoid tissue,BP,
329,GO:0002414,1,0.824648598151267,0,1,immunoglobulin transcytosis in epithelial cells,BP,
330,GO:0002415,1,0.824648598151267,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
334,GO:0002437,1,0.616704084333269,0,1,inflammatory response to antigenic stimulus,BP,
339,GO:0002448,1,0.561734632247565,0,2,mast cell mediated immunity,BP,
340,GO:0002449,1,0.545020867517136,0,3,lymphocyte mediated immunity,BP,
341,GO:0002456,1,0.645957155587161,0,2,T cell mediated immunity,BP,
342,GO:0002460,1,0.512473222480516,0,4,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
346,GO:0002495,1,0.918279589618496,0,2,antigen processing and presentation of peptide antigen via MHC class II,BP,
347,GO:0002504,1,0.918279589618496,0,2,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
350,GO:0002523,1,0.75321100610424,0,1,leukocyte migration involved in inflammatory response,BP,
351,GO:0002526,1,0.269830532610291,0,5,acute inflammatory response,BP,
352,GO:0002544,1,0.846876006292841,0,1,chronic inflammatory response,BP,
353,GO:0002548,1,0.747687650826525,0,2,monocyte chemotaxis,BP,
354,GO:0002551,1,0.80818803699794,0,1,mast cell chemotaxis,BP,
355,GO:0002562,1,0.84462400233258,0,1,somatic diversification of immune receptors via germline recombination within a single locus,BP,
358,GO:0002577,1,0.964117353714657,0,1,regulation of antigen processing and presentation,BP,
359,GO:0002579,1,0.964117353714657,0,1,positive regulation of antigen processing and presentation,BP,
360,GO:0002580,1,0.964117353714657,0,1,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
361,GO:0002582,1,0.964117353714657,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
362,GO:0002583,1,0.964117353714657,0,1,regulation of antigen processing and presentation of peptide antigen,BP,
363,GO:0002585,1,0.964117353714657,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
364,GO:0002586,1,0.964117353714657,0,1,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
365,GO:0002588,1,0.964117353714657,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
366,GO:0002637,1,0.811935014956657,0,2,regulation of immunoglobulin production,BP,
367,GO:0002639,1,0.811935014956657,0,2,positive regulation of immunoglobulin production,BP,
368,GO:0002673,1,0.415205860414832,0,3,regulation of acute inflammatory response,BP,
369,GO:0002674,1,0.7728397953467,0,1,negative regulation of acute inflammatory response,BP,
370,GO:0002675,1,0.695760832683338,0,1,positive regulation of acute inflammatory response,BP,
371,GO:0002679,1,0.695760832683338,0,1,respiratory burst involved in defense response,BP,
376,GO:0002686,1,0.7728397953467,0,1,negative regulation of leukocyte migration,BP,
380,GO:0002691,1,0.836041871517245,0,1,regulation of cellular extravasation,BP,
381,GO:0002693,1,0.836041871517245,0,1,positive regulation of cellular extravasation,BP,
385,GO:0002697,1,0.357406101373363,0,5,regulation of immune effector process,BP,
386,GO:0002699,1,0.462593008021272,0,4,positive regulation of immune effector process,BP,
387,GO:0002700,1,0.554146930998532,0,3,regulation of production of molecular mediator of immune response,BP,
388,GO:0002702,1,0.554146930998532,0,3,positive regulation of production of molecular mediator of immune response,BP,
389,GO:0002703,1,0.705832124875209,0,2,regulation of leukocyte mediated immunity,BP,
390,GO:0002705,1,0.705832124875209,0,2,positive regulation of leukocyte mediated immunity,BP,
391,GO:0002706,1,0.705832124875209,0,2,regulation of lymphocyte mediated immunity,BP,
392,GO:0002708,1,0.705832124875209,0,2,positive regulation of lymphocyte mediated immunity,BP,
393,GO:0002709,1,0.836041871517245,0,1,regulation of T cell mediated immunity,BP,
394,GO:0002711,1,0.836041871517245,0,1,positive regulation of T cell mediated immunity,BP,
395,GO:0002712,1,0.84462400233258,0,1,regulation of B cell mediated immunity,BP,
396,GO:0002714,1,0.84462400233258,0,1,positive regulation of B cell mediated immunity,BP,
397,GO:0002718,1,0.683299665437994,0,1,regulation of cytokine production involved in immune response,BP,
398,GO:0002720,1,0.683299665437994,0,1,positive regulation of cytokine production involved in immune response,BP,
399,GO:0002739,1,0.683299665437994,0,1,regulation of cytokine secretion involved in immune response,BP,
400,GO:0002741,1,0.683299665437994,0,1,positive regulation of cytokine secretion involved in immune response,BP,
412,GO:0002793,1,0.277050949022411,0,7,positive regulation of peptide secretion,BP,
413,GO:0002819,1,0.680317669260332,0,3,regulation of adaptive immune response,BP,
414,GO:0002821,1,0.680317669260332,0,3,positive regulation of adaptive immune response,BP,
415,GO:0002822,1,0.705832124875209,0,2,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
416,GO:0002824,1,0.705832124875209,0,2,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
417,GO:0002831,1,0.769446945848083,0,1,regulation of response to biotic stimulus,BP,
418,GO:0002833,1,0.769446945848083,0,1,positive regulation of response to biotic stimulus,BP,
419,GO:0002889,1,0.84462400233258,0,1,regulation of immunoglobulin mediated immune response,BP,
420,GO:0002891,1,0.84462400233258,0,1,positive regulation of immunoglobulin mediated immune response,BP,
421,GO:0002920,1,0.774707989551907,0,1,regulation of humoral immune response,BP,
422,GO:0002931,1,0.715195272373916,0,2,response to ischemia,BP,
423,GO:0002934,1,0.773025354548079,0,1,desmosome organization,BP,
428,GO:0003009,1,0.772573466595224,0,1,skeletal muscle contraction,BP,
433,GO:0003016,1,0.544772054222145,0,2,respiratory system process,BP,
434,GO:0003018,1,0.152469632302714,0,9,vascular process in circulatory system,BP,
435,GO:0003044,1,0.802011392875838,0,1,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
436,GO:0003062,1,0.767624987207694,0,1,regulation of heart rate by chemical signal,BP,
437,GO:0003064,1,0.767624987207694,0,1,regulation of heart rate by hormone,BP,
440,GO:0003085,1,0.774603477995536,0,1,negative regulation of systemic arterial blood pressure,BP,
444,GO:0003096,1,0.734045967558083,0,1,renal sodium ion transport,BP,
445,GO:0003100,1,0.802011392875838,0,1,regulation of systemic arterial blood pressure by endothelin,BP,
447,GO:0003128,1,0.847043438938523,0,1,heart field specification,BP,
448,GO:0003129,1,0.650648483368427,0,2,heart induction,BP,
449,GO:0003130,1,0.650648483368427,0,2,BMP signaling pathway involved in heart induction,BP,
450,GO:0003133,1,0.650648483368427,0,2,endodermal-mesodermal cell signaling,BP,
451,GO:0003134,1,0.650648483368427,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
452,GO:0003139,1,0.847043438938523,0,1,secondary heart field specification,BP,
454,GO:0003148,1,0.805861577277274,0,2,outflow tract septum morphogenesis,BP,
455,GO:0003149,1,0.847043438938523,0,1,membranous septum morphogenesis,BP,
456,GO:0003151,1,0.341184982059312,0,5,outflow tract morphogenesis,BP,
457,GO:0003156,1,0.0839288881731588,0,11,regulation of animal organ formation,BP,
458,GO:0003157,1,0.475161788613757,0,2,endocardium development,BP,
461,GO:0003160,1,0.616704084333269,0,1,endocardium morphogenesis,BP,
462,GO:0003161,1,0.616704084333269,0,1,cardiac conduction system development,BP,
463,GO:0003162,1,0.616704084333269,0,1,atrioventricular node development,BP,
464,GO:0003169,1,0.616704084333269,0,1,coronary vein morphogenesis,BP,
465,GO:0003170,1,0.141175963557232,0,7,heart valve development,BP,
466,GO:0003171,1,0.217691541823888,0,5,atrioventricular valve development,BP,
467,GO:0003174,1,0.36323246560584,0,3,mitral valve development,BP,
468,GO:0003175,1,0.766387473815025,0,1,tricuspid valve development,BP,
469,GO:0003176,1,0.52181526023997,0,2,aortic valve development,BP,
470,GO:0003177,1,0.315198988376353,0,4,pulmonary valve development,BP,
471,GO:0003179,1,0.141175963557232,0,7,heart valve morphogenesis,BP,
472,GO:0003180,1,0.52181526023997,0,2,aortic valve morphogenesis,BP,
473,GO:0003181,1,0.217691541823888,0,5,atrioventricular valve morphogenesis,BP,
474,GO:0003183,1,0.36323246560584,0,3,mitral valve morphogenesis,BP,
475,GO:0003184,1,0.315198988376353,0,4,pulmonary valve morphogenesis,BP,
476,GO:0003186,1,0.766387473815025,0,1,tricuspid valve morphogenesis,BP,
477,GO:0003188,1,0.369844943638855,0,3,heart valve formation,BP,
478,GO:0003190,1,0.369844943638855,0,3,atrioventricular valve formation,BP,
479,GO:0003192,1,0.47186732494017,0,2,mitral valve formation,BP,
480,GO:0003195,1,0.766387473815025,0,1,tricuspid valve formation,BP,
481,GO:0003197,1,0.168384538805183,0,7,endocardial cushion development,BP,
482,GO:0003198,1,0.354064112471136,0,4,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
483,GO:0003203,1,0.199538778107753,0,6,endocardial cushion morphogenesis,BP,
484,GO:0003205,1,0.0481979703718169,0,12,cardiac chamber development,BP,
485,GO:0003206,1,0.0836654302759243,0,10,cardiac chamber morphogenesis,BP,
486,GO:0003207,1,0.616704084333269,0,1,cardiac chamber formation,BP,
487,GO:0003208,1,0.483784071740881,0,2,cardiac ventricle morphogenesis,BP,
488,GO:0003209,1,0.189929225237737,0,5,cardiac atrium morphogenesis,BP,
489,GO:0003211,1,0.616704084333269,0,1,cardiac ventricle formation,BP,
490,GO:0003213,1,0.420443447349155,0,2,cardiac right atrium morphogenesis,BP,
491,GO:0003214,1,0.616704084333269,0,1,cardiac left ventricle morphogenesis,BP,
492,GO:0003215,1,0.616704084333269,0,1,cardiac right ventricle morphogenesis,BP,
493,GO:0003219,1,0.616704084333269,0,1,cardiac right ventricle formation,BP,
494,GO:0003222,1,0.616704084333269,0,1,ventricular trabecula myocardium morphogenesis,BP,
495,GO:0003228,1,0.772581840319793,0,1,atrial cardiac muscle tissue development,BP,
496,GO:0003229,1,0.616704084333269,0,1,ventricular cardiac muscle tissue development,BP,
497,GO:0003230,1,0.189929225237737,0,5,cardiac atrium development,BP,
498,GO:0003231,1,0.0943973091143166,0,8,cardiac ventricle development,BP,
499,GO:0003241,1,0.616704084333269,0,1,growth involved in heart morphogenesis,BP,
500,GO:0003256,1,0.616704084333269,0,1,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
501,GO:0003264,1,0.616704084333269,0,1,regulation of cardioblast proliferation,BP,
502,GO:0003266,1,0.616704084333269,0,1,regulation of secondary heart field cardioblast proliferation,BP,
503,GO:0003270,1,0.616704084333269,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
504,GO:0003272,1,0.260831800022279,0,5,endocardial cushion formation,BP,
505,GO:0003273,1,0.616704084333269,0,1,cell migration involved in endocardial cushion formation,BP,
506,GO:0003274,1,0.7717087498744,0,1,endocardial cushion fusion,BP,
507,GO:0003279,1,0.065662807363607,0,10,cardiac septum development,BP,
508,GO:0003281,1,0.0943973091143166,0,8,ventricular septum development,BP,
509,GO:0003283,1,0.590889809654547,0,2,atrial septum development,BP,
510,GO:0003284,1,0.7717087498744,0,1,septum primum development,BP,
511,GO:0003289,1,0.7717087498744,0,1,atrial septum primum morphogenesis,BP,
512,GO:0003298,1,0.802011392875838,0,1,physiological muscle hypertrophy,BP,
513,GO:0003300,1,0.802011392875838,0,1,cardiac muscle hypertrophy,BP,
514,GO:0003301,1,0.802011392875838,0,1,physiological cardiac muscle hypertrophy,BP,
515,GO:0003306,1,0.524515311070018,0,2,Wnt signaling pathway involved in heart development,BP,
516,GO:0003307,1,0.768607936468567,0,1,regulation of Wnt signaling pathway involved in heart development,BP,
517,GO:0003308,1,0.768607936468567,0,1,negative regulation of Wnt signaling pathway involved in heart development,BP,
520,GO:0003333,1,0.753709329340452,0,1,amino acid transmembrane transport,BP,
521,GO:0003337,1,0.615679892549457,0,3,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
522,GO:0003338,1,0.255495249106823,0,7,metanephros morphogenesis,BP,
523,GO:0003339,1,0.727424355983898,0,2,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
524,GO:0003344,1,0.309985952648018,0,3,pericardium morphogenesis,BP,
525,GO:0003348,1,0.475161788613757,0,2,cardiac endothelial cell differentiation,BP,
526,GO:0003365,1,0.661948364956753,0,1,establishment of cell polarity involved in ameboidal cell migration,BP,
528,GO:0003401,1,0.566834388804615,0,3,axis elongation,BP,
529,GO:0003402,1,0.683299665437994,0,1,planar cell polarity pathway involved in axis elongation,BP,
530,GO:0003408,1,0.683299665437994,0,1,optic cup formation involved in camera-type eye development,BP,
531,GO:0003413,1,0.990258279272685,0,1,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
532,GO:0003416,1,0.990258279272685,0,1,endochondral bone growth,BP,
533,GO:0003417,1,0.990258279272685,0,1,growth plate cartilage development,BP,
534,GO:0003418,1,0.990258279272685,0,1,growth plate cartilage chondrocyte differentiation,BP,
535,GO:0003419,1,0.990258279272685,0,1,growth plate cartilage chondrocyte proliferation,BP,
540,GO:0003690,1,0.353998281195572,0,4,double-stranded DNA binding,MF,
541,GO:0003696,1,0.785634671671933,0,1,satellite DNA binding,MF,
543,GO:0003707,1,0.715839724297779,0,1,steroid hormone receptor activity,MF,
546,GO:0003714,1,0.307822342466266,0,4,transcription corepressor activity,MF,
548,GO:0003725,1,0.741809137632914,0,1,double-stranded RNA binding,MF,
551,GO:0003735,1,0.911789827211774,0,2,structural constituent of ribosome,MF,
552,GO:0003746,1,0.814426450750734,0,1,translation elongation factor activity,MF,
556,GO:0003841,1,0.747989056481557,0,1,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
558,GO:0003857,1,0.959711323077247,0,1,3-hydroxyacyl-CoA dehydrogenase activity,MF,
559,GO:0003858,1,0.772107268247692,0,1,3-hydroxybutyrate dehydrogenase activity,MF,
560,GO:0003873,1,0.726704948244745,0,1,6-phosphofructo-2-kinase activity,MF,
561,GO:0003874,1,0.961115666336063,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
563,GO:0003940,1,0.79288915251973,0,1,L-iduronidase activity,MF,
564,GO:0003985,1,0.79777800716672,0,1,acetyl-CoA C-acetyltransferase activity,MF,
565,GO:0003986,1,0.954572941883903,0,1,acetyl-CoA hydrolase activity,MF,
566,GO:0003988,1,0.79777800716672,0,1,acetyl-CoA C-acyltransferase activity,MF,
567,GO:0003993,1,0.881309723479957,0,1,acid phosphatase activity,MF,
568,GO:0003995,1,0.787449377631317,0,1,acyl-CoA dehydrogenase activity,MF,
571,GO:0004033,1,0.96937950284859,0,1,aldo-keto reductase (NADP) activity,MF,
573,GO:0004095,1,0.594698093472827,0,2,carnitine O-palmitoyltransferase activity,MF,
577,GO:0004129,1,0.96937950284859,0,1,cytochrome-c oxidase activity,MF,
578,GO:0004139,1,0.856527711611377,0,1,deoxyribose-phosphate aldolase activity,MF,
579,GO:0004165,1,0.77766081607843,0,1,dodecenoyl-CoA delta-isomerase activity,MF,
580,GO:0004174,1,0.782663874445418,0,1,electron-transferring-flavoprotein dehydrogenase activity,MF,
582,GO:0004177,1,0.828965869670895,0,1,aminopeptidase activity,MF,
583,GO:0004180,1,0.828965869670895,0,1,carboxypeptidase activity,MF,
584,GO:0004181,1,0.828965869670895,0,1,metallocarboxypeptidase activity,MF,
586,GO:0004252,1,0.430500204872187,0,3,serine-type endopeptidase activity,MF,
587,GO:0004298,1,0.957091557538293,0,1,threonine-type endopeptidase activity,MF,
588,GO:0004300,1,0.729128893358089,0,2,enoyl-CoA hydratase activity,MF,
589,GO:0004303,1,0.832074326646381,0,1,estradiol 17-beta-dehydrogenase activity,MF,
590,GO:0004312,1,0.480703239123137,0,2,fatty acid synthase activity,MF,
591,GO:0004313,1,0.629141955360923,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
592,GO:0004314,1,0.629141955360923,0,1,[acyl-carrier-protein] S-malonyltransferase activity,MF,
593,GO:0004315,1,0.629141955360923,0,1,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
594,GO:0004316,1,0.629141955360923,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
595,GO:0004317,1,0.629141955360923,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
596,GO:0004319,1,0.629141955360923,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
597,GO:0004320,1,0.629141955360923,0,1,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
598,GO:0004321,1,0.779691480475156,0,1,fatty-acyl-CoA synthase activity,MF,
599,GO:0004331,1,0.726704948244745,0,1,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
600,GO:0004341,1,0.824053991557742,0,1,gluconolactonase activity,MF,
601,GO:0004364,1,0.970787931478979,0,1,glutathione transferase activity,MF,
602,GO:0004375,1,0.747430985543844,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
603,GO:0004379,1,0.706584649959871,0,1,glycylpeptide N-tetradecanoyltransferase activity,MF,
604,GO:0004383,1,0.561352584806235,0,2,guanylate cyclase activity,MF,
605,GO:0004407,1,0.702569048854651,0,1,histone deacetylase activity,MF,
607,GO:0004448,1,0.783708505287183,0,1,isocitrate dehydrogenase activity,MF,
608,GO:0004450,1,0.783708505287183,0,1,isocitrate dehydrogenase (NADP+) activity,MF,
609,GO:0004454,1,0.77994876250451,0,1,ketohexokinase activity,MF,
610,GO:0004457,1,0.808990561965705,0,1,lactate dehydrogenase activity,MF,
611,GO:0004458,1,0.808990561965705,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
612,GO:0004464,1,0.970787931478979,0,1,leukotriene-C4 synthase activity,MF,
613,GO:0004466,1,0.787449377631317,0,1,long-chain-acyl-CoA dehydrogenase activity,MF,
615,GO:0004470,1,0.926933149462279,0,1,malic enzyme activity,MF,
617,GO:0004505,1,0.955102554249325,0,1,phenylalanine 4-monooxygenase activity,MF,
618,GO:0004508,1,0.83270324466729,0,1,steroid 17-alpha-monooxygenase activity,MF,
619,GO:0004518,1,0.704002033216449,0,2,nuclease activity,MF,
620,GO:0004519,1,0.704002033216449,0,2,endonuclease activity,MF,
621,GO:0004521,1,0.735427962909408,0,1,endoribonuclease activity,MF,
622,GO:0004540,1,0.704002033216449,0,2,ribonuclease activity,MF,
624,GO:0004557,1,0.906943268947671,0,1,alpha-galactosidase activity,MF,
626,GO:0004576,1,0.938788431047363,0,1,oligosaccharyl transferase activity,MF,
627,GO:0004581,1,0.938788431047363,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
628,GO:0004582,1,0.987980034753378,0,1,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
629,GO:0004601,1,0.970787931478979,0,1,peroxidase activity,MF,
630,GO:0004602,1,0.970787931478979,0,1,glutathione peroxidase activity,MF,
631,GO:0004603,1,0.94047143183814,0,1,phenylethanolamine N-methyltransferase activity,MF,
632,GO:0004620,1,0.595880552242621,0,3,phospholipase activity,MF,
633,GO:0004622,1,0.829582597377115,0,1,lysophospholipase activity,MF,
634,GO:0004623,1,0.930530251776604,0,1,phospholipase A2 activity,MF,
635,GO:0004629,1,0.7728397953467,0,1,phospholipase C activity,MF,
637,GO:0004673,1,0.767624987207694,0,1,protein histidine kinase activity,MF,
639,GO:0004675,1,0.7717087498744,0,1,transmembrane receptor protein serine/threonine kinase activity,MF,
642,GO:0004697,1,0.76233671886302,0,1,protein kinase C activity,MF,
643,GO:0004702,1,0.50952328334188,0,3,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,
644,GO:0004707,1,0.850746232868273,0,1,MAP kinase activity,MF,
645,GO:0004709,1,0.77766081607843,0,1,MAP kinase kinase kinase activity,MF,
646,GO:0004712,1,0.772639837730134,0,1,protein serine/threonine/tyrosine kinase activity,MF,
647,GO:0004713,1,0.334803148848509,0,7,protein tyrosine kinase activity,MF,
648,GO:0004714,1,0.553972073712847,0,2,transmembrane receptor protein tyrosine kinase activity,MF,
649,GO:0004716,1,0.742334532829423,0,1,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
652,GO:0004730,1,0.866821396494009,0,1,pseudouridylate synthase activity,MF,
655,GO:0004745,1,0.768607936468567,0,1,retinol dehydrogenase activity,MF,
657,GO:0004842,1,0.181508718041437,0,5,ubiquitin-protein transferase activity,MF,
660,GO:0004859,1,0.987456549281,0,1,phospholipase inhibitor activity,MF,
663,GO:0004862,1,0.777135023329378,0,1,cAMP-dependent protein kinase inhibitor activity,MF,
669,GO:0004879,1,0.715839724297779,0,1,RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,MF,
671,GO:0004896,1,0.727749574179032,0,1,cytokine receptor activity,MF,
673,GO:0004935,1,0.628065409479983,0,2,adrenergic receptor activity,MF,
674,GO:0004936,1,0.628065409479983,0,2,alpha-adrenergic receptor activity,MF,
675,GO:0004938,1,0.628065409479983,0,2,alpha2-adrenergic receptor activity,MF,
676,GO:0004970,1,0.701293732953001,0,1,ionotropic glutamate receptor activity,MF,
677,GO:0004971,1,0.701293732953001,0,1,AMPA glutamate receptor activity,MF,
678,GO:0005024,1,0.7717087498744,0,1,transforming growth factor beta-activated receptor activity,MF,
679,GO:0005025,1,0.7717087498744,0,1,transforming growth factor beta receptor activity, type I,MF,
680,GO:0005057,1,0.312268656201936,0,5,signal transducer activity, downstream of receptor,MF,
688,GO:0005104,1,0.776684183529193,0,4,fibroblast growth factor receptor binding,MF,
689,GO:0005105,1,0.832762924264021,0,2,type 1 fibroblast growth factor receptor binding,MF,
690,GO:0005109,1,0.087339295489043,0,10,frizzled binding,MF,
691,GO:0005110,1,0.683299665437994,0,1,frizzled-2 binding,MF,
692,GO:0005111,1,0.816428392050351,0,3,type 2 fibroblast growth factor receptor binding,MF,
695,GO:0005115,1,0.683299665437994,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
696,GO:0005123,1,0.762712607721979,0,2,death receptor binding,MF,
699,GO:0005127,1,0.84462400233258,0,1,ciliary neurotrophic factor receptor binding,MF,
700,GO:0005138,1,0.964117353714657,0,1,interleukin-6 receptor binding,MF,
701,GO:0005146,1,0.744061959631107,0,1,leukemia inhibitory factor receptor binding,MF,
702,GO:0005154,1,0.440297532632687,0,3,epidermal growth factor receptor binding,MF,
705,GO:0005160,1,0.230704902913575,0,6,transforming growth factor beta receptor binding,MF,
706,GO:0005161,1,0.564090278700448,0,2,platelet-derived growth factor receptor binding,MF,
707,GO:0005164,1,0.750187185736748,0,2,tumor necrosis factor receptor binding,MF,
711,GO:0005172,1,0.730958015688662,0,1,vascular endothelial growth factor receptor binding,MF,
714,GO:0005179,1,0.608908768724733,0,3,hormone activity,MF,
716,GO:0005200,1,0.321125526738033,0,3,structural constituent of cytoskeleton,MF,
720,GO:0005225,1,0.812175389134332,0,1,volume-sensitive anion channel activity,MF,
721,GO:0005230,1,0.701293732953001,0,1,extracellular ligand-gated ion channel activity,MF,
722,GO:0005231,1,0.701293732953001,0,1,excitatory extracellular ligand-gated ion channel activity,MF,
723,GO:0005234,1,0.701293732953001,0,1,extracellular-glutamate-gated ion channel activity,MF,
724,GO:0005242,1,0.594073994250696,0,2,inward rectifier potassium channel activity,MF,
725,GO:0005243,1,0.47912052143449,0,3,gap junction channel activity,MF,
728,GO:0005246,1,0.82804560850235,0,1,calcium channel regulator activity,MF,
729,GO:0005249,1,0.385687523124419,0,4,voltage-gated potassium channel activity,MF,
730,GO:0005250,1,0.715726062684385,0,1,A-type (transient outward) potassium channel activity,MF,
731,GO:0005251,1,0.698475460212776,0,2,delayed rectifier potassium channel activity,MF,
732,GO:0005253,1,0.799628824156165,0,2,anion channel activity,MF,
733,GO:0005254,1,0.799628824156165,0,2,chloride channel activity,MF,
736,GO:0005267,1,0.385687523124419,0,4,potassium channel activity,MF,
737,GO:0005310,1,0.753709329340452,0,1,dicarboxylic acid transmembrane transporter activity,MF,
738,GO:0005313,1,0.753709329340452,0,1,L-glutamate transmembrane transporter activity,MF,
739,GO:0005314,1,0.753709329340452,0,1,high-affinity glutamate transmembrane transporter activity,MF,
740,GO:0005319,1,0.542581652832591,0,4,lipid transporter activity,MF,
741,GO:0005324,1,0.946578828055197,0,1,long-chain fatty acid transporter activity,MF,
742,GO:0005342,1,0.753709329340452,0,1,organic acid transmembrane transporter activity,MF,
743,GO:0005351,1,0.762750135837046,0,1,sugar:proton symporter activity,MF,
744,GO:0005355,1,0.792322370974488,0,1,glucose transmembrane transporter activity,MF,
745,GO:0005375,1,0.848890406189778,0,1,copper ion transmembrane transporter activity,MF,
746,GO:0005381,1,0.627464115095949,0,2,iron ion transmembrane transporter activity,MF,
747,GO:0005402,1,0.762750135837046,0,1,cation:sugar symporter activity,MF,
748,GO:0005484,1,0.773692700518389,0,1,SNAP receptor activity,MF,
750,GO:0005496,1,0.42624379614284,0,3,steroid binding,MF,
751,GO:0005499,1,0.715839724297779,0,1,vitamin D binding,MF,
753,GO:0005504,1,0.934677768125417,0,2,fatty acid binding,MF,
757,GO:0005513,1,0.77396315259318,0,1,detection of calcium ion,BP,
762,GO:0005521,1,0.680052141743098,0,2,lamin binding,MF,
763,GO:0005522,1,0.721712018608498,0,1,profilin binding,MF,
764,GO:0005523,1,0.886942633869416,0,2,tropomyosin binding,MF,
768,GO:0005540,1,0.829428176984302,0,1,hyaluronic acid binding,MF,
770,GO:0005544,1,0.650566632941793,0,2,calcium-dependent phospholipid binding,MF,
772,GO:0005547,1,0.772639837730134,0,1,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
773,GO:0005548,1,0.77139588570204,0,1,phospholipid transporter activity,MF,
787,GO:0005637,1,0.979258831445871,0,1,nuclear inner membrane,CC,
789,GO:0005641,1,0.846876006292841,0,1,nuclear envelope lumen,CC,
791,GO:0005667,1,0.422238931837816,0,3,transcription factor complex,CC,
801,GO:0005761,1,0.911789827211774,0,2,mitochondrial ribosome,CC,
802,GO:0005762,1,0.911789827211774,0,2,mitochondrial large ribosomal subunit,CC,
809,GO:0005771,1,0.77312897108567,0,1,multivesicular body,CC,
816,GO:0005782,1,0.523550634966784,0,4,peroxisomal matrix,CC,
821,GO:0005791,1,0.802011392875838,0,1,rough endoplasmic reticulum,CC,
822,GO:0005793,1,0.768850946478322,0,2,endoplasmic reticulum-Golgi intermediate compartment,CC,
825,GO:0005798,1,0.721712018608498,0,1,Golgi-associated vesicle,CC,
827,GO:0005802,1,0.64719579286822,0,2,trans-Golgi network,CC,
831,GO:0005819,1,0.365190647990817,0,5,spindle,CC,
833,GO:0005839,1,0.957091557538293,0,1,proteasome core complex,CC,
834,GO:0005840,1,0.911789827211774,0,2,ribosome,CC,
836,GO:0005859,1,0.657423063310495,0,1,muscle myosin complex,CC,
839,GO:0005876,1,0.717259055655535,0,2,spindle microtubule,CC,
840,GO:0005881,1,0.698572929356895,0,2,cytoplasmic microtubule,CC,
841,GO:0005882,1,0.553341448228999,0,2,intermediate filament,CC,
845,GO:0005890,1,0.984658110865059,0,1,sodium:potassium-exchanging ATPase complex,CC,
847,GO:0005901,1,0.712353706175808,0,1,caveola,CC,
850,GO:0005905,1,0.420384517670455,0,3,clathrin-coated pit,CC,
855,GO:0005916,1,0.727261279903572,0,1,fascia adherens,CC,
856,GO:0005921,1,0.386128624207899,0,4,gap junction,CC,
857,GO:0005922,1,0.386128624207899,0,4,connexin complex,CC,
865,GO:0005944,1,0.695760832683338,0,1,phosphatidylinositol 3-kinase complex, class IB,CC,
867,GO:0005960,1,0.747430985543844,0,1,glycine cleavage complex,CC,
869,GO:0005976,1,0.460529819197213,0,3,polysaccharide metabolic process,BP,
870,GO:0005977,1,0.772639837730134,0,1,glycogen metabolic process,BP,
871,GO:0005978,1,0.772639837730134,0,1,glycogen biosynthetic process,BP,
872,GO:0005979,1,0.772639837730134,0,1,regulation of glycogen biosynthetic process,BP,
873,GO:0005984,1,0.79288915251973,0,1,disaccharide metabolic process,BP,
875,GO:0006000,1,0.566205965874527,0,2,fructose metabolic process,BP,
876,GO:0006001,1,0.77994876250451,0,1,fructose catabolic process,BP,
877,GO:0006003,1,0.726704948244745,0,1,fructose 2,6-bisphosphate metabolic process,BP,
879,GO:0006007,1,0.560831865596554,0,2,glucose catabolic process,BP,
880,GO:0006011,1,0.918424128506729,0,1,UDP-glucose metabolic process,BP,
881,GO:0006012,1,0.918424128506729,0,1,galactose metabolic process,BP,
889,GO:0006073,1,0.772639837730134,0,1,cellular glucan metabolic process,BP,
895,GO:0006089,1,0.772573466595224,0,1,lactate metabolic process,BP,
897,GO:0006091,1,0.134684786259716,0,9,generation of precursor metabolites and energy,BP,
898,GO:0006094,1,0.676299498089533,0,3,gluconeogenesis,BP,
899,GO:0006096,1,0.560831865596554,0,2,glycolytic process,BP,
900,GO:0006097,1,0.783708505287183,0,1,glyoxylate cycle,BP,
901,GO:0006098,1,0.639377288766634,0,2,pentose-phosphate shunt,BP,
902,GO:0006099,1,0.726225560845341,0,2,tricarboxylic acid cycle,BP,
903,GO:0006101,1,0.527769249224089,0,3,citrate metabolic process,BP,
904,GO:0006102,1,0.783708505287183,0,1,isocitrate metabolic process,BP,
905,GO:0006103,1,0.493518994124593,0,3,2-oxoglutarate metabolic process,BP,
906,GO:0006105,1,0.727749574179032,0,1,succinate metabolic process,BP,
907,GO:0006107,1,0.67431410127539,0,2,oxaloacetate metabolic process,BP,
908,GO:0006108,1,0.926933149462279,0,1,malate metabolic process,BP,
910,GO:0006110,1,0.772573466595224,0,1,regulation of glycolytic process,BP,
911,GO:0006111,1,0.759355645182739,0,1,regulation of gluconeogenesis,BP,
912,GO:0006112,1,0.772639837730134,0,1,energy reserve metabolic process,BP,
913,GO:0006113,1,0.772573466595224,0,1,fermentation,BP,
914,GO:0006119,1,0.772573466595224,0,1,oxidative phosphorylation,BP,
916,GO:0006140,1,0.238320646022863,0,7,regulation of nucleotide metabolic process,BP,
922,GO:0006164,1,0.343168622380217,0,6,purine nucleotide biosynthetic process,BP,
923,GO:0006165,1,0.560831865596554,0,2,nucleoside diphosphate phosphorylation,BP,
924,GO:0006171,1,0.777837201051389,0,2,cAMP biosynthetic process,BP,
925,GO:0006182,1,0.55574090342791,0,3,cGMP biosynthetic process,BP,
928,GO:0006258,1,0.918424128506729,0,1,UDP-glucose catabolic process,BP,
931,GO:0006261,1,0.651360225257213,0,2,DNA-dependent DNA replication,BP,
933,GO:0006281,1,0.898343915684649,0,2,DNA repair,BP,
934,GO:0006282,1,0.980495002631481,0,1,regulation of DNA repair,BP,
935,GO:0006304,1,0.75126441332005,0,1,DNA modification,BP,
936,GO:0006305,1,0.75126441332005,0,1,DNA alkylation,BP,
937,GO:0006306,1,0.75126441332005,0,1,DNA methylation,BP,
938,GO:0006308,1,0.824053991557742,0,1,DNA catabolic process,BP,
939,GO:0006310,1,0.84462400233258,0,1,DNA recombination,BP,
943,GO:0006354,1,0.620242022485549,0,2,DNA-templated transcription, elongation,BP,
946,GO:0006359,1,0.773885510980933,0,1,regulation of transcription from RNA polymerase III promoter,BP,
947,GO:0006364,1,0.735427962909408,0,1,rRNA processing,BP,
950,GO:0006368,1,0.762142819578083,0,1,transcription elongation from RNA polymerase II promoter,BP,
951,GO:0006376,1,0.912530916414626,0,1,mRNA splice site selection,BP,
952,GO:0006383,1,0.773885510980933,0,1,transcription from RNA polymerase III promoter,BP,
954,GO:0006397,1,0.613278315619351,0,3,mRNA processing,BP,
955,GO:0006399,1,0.699925053118413,0,3,tRNA metabolic process,BP,
956,GO:0006400,1,0.831795738218181,0,2,tRNA modification,BP,
957,GO:0006401,1,0.401163524090605,0,3,RNA catabolic process,BP,
958,GO:0006402,1,0.401163524090605,0,3,mRNA catabolic process,BP,
960,GO:0006414,1,0.742312205428389,0,3,translational elongation,BP,
961,GO:0006415,1,0.911789827211774,0,2,translational termination,BP,
963,GO:0006457,1,0.990258279272685,0,1,protein folding,BP,
970,GO:0006473,1,0.744061959631107,0,1,protein acetylation,BP,
971,GO:0006475,1,0.744061959631107,0,1,internal protein amino acid acetylation,BP,
972,GO:0006476,1,0.702569048854651,0,1,protein deacetylation,BP,
973,GO:0006479,1,0.786028226867323,0,2,protein methylation,BP,
974,GO:0006486,1,0.530142433773315,0,4,protein glycosylation,BP,
975,GO:0006487,1,0.927473682729249,0,2,protein N-linked glycosylation,BP,
976,GO:0006493,1,0.764205661134551,0,2,protein O-linked glycosylation,BP,
978,GO:0006498,1,0.706584649959871,0,1,N-terminal protein lipidation,BP,
979,GO:0006499,1,0.706584649959871,0,1,N-terminal protein myristoylation,BP,
981,GO:0006505,1,0.987980034753378,0,1,GPI anchor metabolic process,BP,
982,GO:0006506,1,0.987980034753378,0,1,GPI anchor biosynthetic process,BP,
984,GO:0006511,1,0.298337307148616,0,5,ubiquitin-dependent protein catabolic process,BP,
987,GO:0006521,1,0.957091557538293,0,1,regulation of cellular amino acid metabolic process,BP,
988,GO:0006536,1,0.753709329340452,0,1,glutamate metabolic process,BP,
989,GO:0006537,1,0.753709329340452,0,1,glutamate biosynthetic process,BP,
990,GO:0006544,1,0.747430985543844,0,1,glycine metabolic process,BP,
991,GO:0006546,1,0.747430985543844,0,1,glycine catabolic process,BP,
992,GO:0006549,1,0.580033118531058,0,2,isoleucine metabolic process,BP,
993,GO:0006550,1,0.79777800716672,0,1,isoleucine catabolic process,BP,
995,GO:0006558,1,0.955102554249325,0,1,L-phenylalanine metabolic process,BP,
996,GO:0006559,1,0.955102554249325,0,1,L-phenylalanine catabolic process,BP,
997,GO:0006573,1,0.727749574179032,0,1,valine metabolic process,BP,
998,GO:0006575,1,0.245306498313515,0,6,cellular modified amino acid metabolic process,BP,
999,GO:0006576,1,0.764658144398332,0,1,cellular biogenic amine metabolic process,BP,
1000,GO:0006577,1,0.773315318531118,0,1,amino-acid betaine metabolic process,BP,
1001,GO:0006582,1,0.683299665437994,0,1,melanin metabolic process,BP,
1002,GO:0006584,1,0.689648605091128,0,2,catecholamine metabolic process,BP,
1003,GO:0006600,1,0.727749574179032,0,1,creatine metabolic process,BP,
1011,GO:0006635,1,0.0816587320239769,0,12,fatty acid beta-oxidation,BP,
1012,GO:0006636,1,0.491868974019838,0,3,unsaturated fatty acid biosynthetic process,BP,
1020,GO:0006651,1,0.957515383118201,0,1,diacylglycerol biosynthetic process,BP,
1021,GO:0006656,1,0.946578828055197,0,1,phosphatidylcholine biosynthetic process,BP,
1022,GO:0006658,1,0.930530251776604,0,1,phosphatidylserine metabolic process,BP,
1024,GO:0006662,1,0.930530251776604,0,1,glycerol ether metabolic process,BP,
1028,GO:0006677,1,0.906943268947671,0,1,glycosylceramide metabolic process,BP,
1032,GO:0006691,1,0.970787931478979,0,1,leukotriene metabolic process,BP,
1033,GO:0006692,1,0.678851702335802,0,2,prostanoid metabolic process,BP,
1034,GO:0006693,1,0.678851702335802,0,2,prostaglandin metabolic process,BP,
1037,GO:0006699,1,0.774318895616471,0,1,bile acid biosynthetic process,BP,
1040,GO:0006703,1,0.64387399071584,0,2,estrogen biosynthetic process,BP,
1043,GO:0006706,1,0.832074326646381,0,1,steroid catabolic process,BP,
1044,GO:0006710,1,0.832074326646381,0,1,androgen catabolic process,BP,
1048,GO:0006729,1,0.917920313188515,0,2,tetrahydrobiopterin biosynthetic process,BP,
1051,GO:0006734,1,0.519484357815665,0,3,NADH metabolic process,BP,
1052,GO:0006735,1,0.726704948244745,0,1,NADH regeneration,BP,
1054,GO:0006739,1,0.500346641087291,0,3,NADP metabolic process,BP,
1055,GO:0006740,1,0.783708505287183,0,1,NADPH regeneration,BP,
1056,GO:0006749,1,0.760687652953181,0,2,glutathione metabolic process,BP,
1057,GO:0006750,1,0.970787931478979,0,1,glutathione biosynthetic process,BP,
1059,GO:0006757,1,0.560831865596554,0,2,ATP generation from ADP,BP,
1064,GO:0006778,1,0.772107268247692,0,1,porphyrin-containing compound metabolic process,BP,
1068,GO:0006801,1,0.48776967460018,0,3,superoxide metabolic process,BP,
1076,GO:0006814,1,0.383939740799148,0,4,sodium ion transport,BP,
1078,GO:0006818,1,0.96937950284859,0,1,hydrogen transport,BP,
1080,GO:0006821,1,0.586367577311668,0,3,chloride transport,BP,
1081,GO:0006825,1,0.848890406189778,0,1,copper ion transport,BP,
1082,GO:0006826,1,0.483141948915495,0,3,iron ion transport,BP,
1083,GO:0006835,1,0.581939293736273,0,2,dicarboxylic acid transport,BP,
1084,GO:0006836,1,0.530287593538485,0,4,neurotransmitter transport,BP,
1086,GO:0006853,1,0.769709049906422,0,1,carnitine shuttle,BP,
1087,GO:0006855,1,0.94047143183814,0,1,drug transmembrane transport,BP,
1088,GO:0006862,1,0.873933946116982,0,1,nucleotide transport,BP,
1089,GO:0006865,1,0.581939293736273,0,2,amino acid transport,BP,
1095,GO:0006879,1,0.594354218853545,0,2,cellular iron ion homeostasis,BP,
1100,GO:0006890,1,0.744237831478502,0,2,retrograde vesicle-mediated transport, Golgi to ER,BP,
1101,GO:0006891,1,0.770050274238875,0,1,intra-Golgi vesicle-mediated transport,BP,
1102,GO:0006892,1,0.779727784357064,0,1,post-Golgi vesicle-mediated transport,BP,
1105,GO:0006904,1,0.614929398008082,0,3,vesicle docking involved in exocytosis,BP,
1106,GO:0006906,1,0.318440235603741,0,5,vesicle fusion,BP,
1107,GO:0006907,1,0.964117353714657,0,1,pinocytosis,BP,
1114,GO:0006919,1,0.582186482732116,0,5,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
1115,GO:0006924,1,0.645547562054588,0,2,activation-induced cell death of T cells,BP,
1120,GO:0006939,1,0.217859066337035,0,7,smooth muscle contraction,BP,
1121,GO:0006940,1,0.387822921788006,0,4,regulation of smooth muscle contraction,BP,
1128,GO:0006956,1,0.774707989551907,0,1,complement activation,BP,
1129,GO:0006957,1,0.774707989551907,0,1,complement activation, alternative pathway,BP,
1130,GO:0006959,1,0.367916003404559,0,4,humoral immune response,BP,
1134,GO:0006975,1,0.850746232868273,0,1,DNA damage induced protein phosphorylation,BP,
1140,GO:0007005,1,0.318640023410638,0,8,mitochondrion organization,BP,
1141,GO:0007006,1,0.75101951727364,0,2,mitochondrial membrane organization,BP,
1145,GO:0007016,1,0.690409015386517,0,1,cytoskeletal anchoring at plasma membrane,BP,
1147,GO:0007020,1,0.840417410506357,0,1,microtubule nucleation,BP,
1149,GO:0007030,1,0.585788010294756,0,1,Golgi organization,BP,
1150,GO:0007031,1,0.930530251776604,0,1,peroxisome organization,BP,
1151,GO:0007032,1,0.77312897108567,0,1,endosome organization,BP,
1161,GO:0007051,1,0.853799544891606,0,1,spindle organization,BP,
1162,GO:0007052,1,0.853799544891606,0,1,mitotic spindle organization,BP,
1163,GO:0007059,1,0.853799544891606,0,1,chromosome segregation,BP,
1165,GO:0007080,1,0.853799544891606,0,1,mitotic metaphase plate congression,BP,
1166,GO:0007088,1,0.312974966432206,0,6,regulation of mitotic nuclear division,BP,
1169,GO:0007098,1,0.705316075573745,0,2,centrosome cycle,BP,
1170,GO:0007126,1,0.298322823210782,0,4,meiotic nuclear division,BP,
1171,GO:0007140,1,0.793551790920396,0,1,male meiosis,BP,
1174,GO:0007156,1,0.119277670229477,0,6,homophilic cell adhesion via plasma membrane adhesion molecules,BP,
1175,GO:0007157,1,0.530919507615673,0,2,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
1180,GO:0007164,1,0.487351167396069,0,3,establishment of tissue polarity,BP,
1184,GO:0007168,1,0.72629372962817,0,2,receptor guanylyl cyclase signaling pathway,BP,
1187,GO:0007176,1,0.484614585660265,0,3,regulation of epidermal growth factor-activated receptor activity,BP,
1190,GO:0007182,1,0.847043438938523,0,1,common-partner SMAD protein phosphorylation,BP,
1191,GO:0007184,1,0.651360225257213,0,2,SMAD protein import into nucleus,BP,
1195,GO:0007189,1,0.506907931869612,0,3,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
1196,GO:0007193,1,0.7728397953467,0,1,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,
1198,GO:0007202,1,0.8098175575904,0,2,activation of phospholipase C activity,BP,
1199,GO:0007204,1,0.331225035275115,0,5,positive regulation of cytosolic calcium ion concentration,BP,
1200,GO:0007205,1,0.802011392875838,0,1,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
1201,GO:0007215,1,0.701293732953001,0,1,glutamate receptor signaling pathway,BP,
1204,GO:0007221,1,0.616704084333269,0,1,positive regulation of transcription of Notch receptor target,BP,
1205,GO:0007223,1,0.683299665437994,0,1,Wnt signaling pathway, calcium modulating pathway,BP,
1209,GO:0007252,1,0.772639837730134,0,1,I-kappaB phosphorylation,BP,
1211,GO:0007257,1,0.386132670855085,0,3,activation of JUN kinase activity,BP,
1212,GO:0007259,1,0.250772797455379,0,5,JAK-STAT cascade,BP,
1213,GO:0007260,1,0.45615332940787,0,3,tyrosine phosphorylation of STAT protein,BP,
1214,GO:0007263,1,0.766087200253996,0,1,nitric oxide mediated signal transduction,BP,
1219,GO:0007268,1,0.0582821288020909,0,14,chemical synaptic transmission,BP,
1220,GO:0007269,1,0.720729876174967,0,2,neurotransmitter secretion,BP,
1221,GO:0007270,1,0.755574997987556,0,2,neuron-neuron synaptic transmission,BP,
1233,GO:0007350,1,0.526258028218934,0,2,blastoderm segmentation,BP,
1234,GO:0007351,1,0.526258028218934,0,2,tripartite regional subdivision,BP,
1235,GO:0007354,1,0.771150420617929,0,1,zygotic determination of anterior/posterior axis, embryo,BP,
1236,GO:0007356,1,0.771150420617929,0,1,thorax and anterior abdomen determination,BP,
1242,GO:0007398,1,0.74668493948331,0,1,ectoderm development,BP,
1244,GO:0007405,1,0.520780469138251,0,2,neuroblast proliferation,BP,
1247,GO:0007416,1,0.248275860469593,0,5,synapse assembly,BP,
1254,GO:0007440,1,0.616704084333269,0,1,foregut morphogenesis,BP,
1255,GO:0007442,1,0.683299665437994,0,1,hindgut morphogenesis,BP,
1257,GO:0007494,1,0.683299665437994,0,1,midgut development,BP,
1259,GO:0007500,1,0.847043438938523,0,1,mesodermal cell fate determination,BP,
1266,GO:0007566,1,0.555265636143469,0,2,embryo implantation,BP,
1267,GO:0007567,1,0.802011392875838,0,1,parturition,BP,
1271,GO:0007585,1,0.436135529797865,0,3,respiratory gaseous exchange,BP,
1272,GO:0007586,1,0.494241246333565,0,4,digestion,BP,
1273,GO:0007588,1,0.405680753109514,0,4,excretion,BP,
1274,GO:0007589,1,0.172026297474129,0,7,body fluid secretion,BP,
1275,GO:0007595,1,0.534133063258502,0,2,lactation,BP,
1277,GO:0007598,1,0.776553764074905,0,1,blood coagulation, extrinsic pathway,BP,
1281,GO:0007602,1,0.629931202533517,0,2,phototransduction,BP,
1282,GO:0007603,1,0.706584649959871,0,1,phototransduction, visible light,BP,
1284,GO:0007606,1,0.773597169937423,0,1,sensory perception of chemical stimulus,BP,
1285,GO:0007608,1,0.773597169937423,0,1,sensory perception of smell,BP,
1288,GO:0007612,1,0.627988538125148,0,2,learning,BP,
1293,GO:0007622,1,0.597901784091742,0,2,rhythmic behavior,BP,
1294,GO:0007623,1,0.597901784091742,0,2,circadian rhythm,BP,
1296,GO:0007628,1,0.690409015386517,0,1,adult walking behavior,BP,
1297,GO:0007631,1,0.772776823282694,0,1,feeding behavior,BP,
1298,GO:0007638,1,0.581891717265043,0,2,mechanosensory behavior,BP,
1299,GO:0008009,1,0.968025854772146,0,1,chemokine activity,MF,
1306,GO:0008033,1,0.699925053118413,0,3,tRNA processing,BP,
1308,GO:0008045,1,0.951532941209886,0,1,motor neuron axon guidance,BP,
1313,GO:0008066,1,0.701293732953001,0,1,glutamate receptor activity,MF,
1314,GO:0008074,1,0.561352584806235,0,2,guanylate cyclase complex, soluble,CC,
1315,GO:0008076,1,0.385687523124419,0,4,voltage-gated potassium channel complex,CC,
1316,GO:0008078,1,0.951532941209886,0,1,mesodermal cell migration,BP,
1319,GO:0008091,1,0.253007693482569,0,3,spectrin,CC,
1322,GO:0008105,1,0.858923178696575,0,1,asymmetric protein localization,BP,
1323,GO:0008108,1,0.918424128506729,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
1324,GO:0008112,1,0.882316889029658,0,1,nicotinamide N-methyltransferase activity,MF,
1325,GO:0008113,1,0.897422464824754,0,1,peptide-methionine (S)-S-oxide reductase activity,MF,
1326,GO:0008124,1,0.955102554249325,0,1,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
1328,GO:0008135,1,0.814426450750734,0,1,translation factor activity, RNA binding,MF,
1329,GO:0008138,1,0.776747906170104,0,1,protein tyrosine/serine/threonine phosphatase activity,MF,
1334,GO:0008168,1,0.829674820070559,0,2,methyltransferase activity,MF,
1335,GO:0008170,1,0.829674820070559,0,2,N-methyltransferase activity,MF,
1336,GO:0008180,1,0.661948364956753,0,1,COP9 signalosome,CC,
1338,GO:0008198,1,0.59010387556905,0,3,ferrous iron binding,MF,
1339,GO:0008199,1,0.681046843793816,0,2,ferric iron binding,MF,
1340,GO:0008200,1,0.734045967558083,0,1,ion channel inhibitor activity,MF,
1344,GO:0008206,1,0.774318895616471,0,1,bile acid metabolic process,BP,
1347,GO:0008210,1,0.64387399071584,0,2,estrogen metabolic process,BP,
1350,GO:0008213,1,0.786028226867323,0,2,protein alkylation,BP,
1353,GO:0008227,1,0.628065409479983,0,2,G-protein coupled amine receptor activity,MF,
1356,GO:0008235,1,0.828965869670895,0,1,metalloexopeptidase activity,MF,
1357,GO:0008236,1,0.430500204872187,0,3,serine-type peptidase activity,MF,
1358,GO:0008237,1,0.828965869670895,0,1,metallopeptidase activity,MF,
1359,GO:0008238,1,0.593136511959265,0,2,exopeptidase activity,MF,
1371,GO:0008328,1,0.541683009071215,0,2,ionotropic glutamate receptor complex,CC,
1373,GO:0008344,1,0.674942417417461,0,2,adult locomotory behavior,BP,
1376,GO:0008361,1,0.215946350964283,0,6,regulation of cell size,BP,
1378,GO:0008374,1,0.443947837608693,0,3,O-acyltransferase activity,MF,
1380,GO:0008378,1,0.773597169937423,0,1,galactosyltransferase activity,MF,
1382,GO:0008385,1,0.964117353714657,0,1,IkappaB kinase complex,CC,
1387,GO:0008434,1,0.715839724297779,0,1,calcitriol receptor activity,MF,
1388,GO:0008443,1,0.726704948244745,0,1,phosphofructokinase activity,MF,
1389,GO:0008474,1,0.829582597377115,0,1,palmitoyl-(protein) hydrolase activity,MF,
1390,GO:0008480,1,0.764658144398332,0,1,sarcosine dehydrogenase activity,MF,
1391,GO:0008499,1,0.773597169937423,0,1,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
1392,GO:0008506,1,0.762750135837046,0,1,sucrose:proton symporter activity,MF,
1393,GO:0008509,1,0.602123590805222,0,3,anion transmembrane transporter activity,MF,
1394,GO:0008514,1,0.753709329340452,0,1,organic anion transmembrane transporter activity,MF,
1395,GO:0008515,1,0.762750135837046,0,1,sucrose transmembrane transporter activity,MF,
1396,GO:0008528,1,0.733539537631441,0,1,G-protein coupled peptide receptor activity,MF,
1397,GO:0008532,1,0.773597169937423,0,1,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
1400,GO:0008565,1,0.77139588570204,0,1,protein transporter activity,MF,
1405,GO:0008595,1,0.526258028218934,0,2,anterior/posterior axis specification, embryo,BP,
1406,GO:0008603,1,0.777135023329378,0,1,cAMP-dependent protein kinase regulator activity,MF,
1410,GO:0008631,1,0.704798885072753,0,2,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
1411,GO:0008637,1,0.558615786158671,0,4,apoptotic mitochondrial changes,BP,
1416,GO:0008656,1,0.964117353714657,0,1,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
1417,GO:0008670,1,0.928899738732417,0,1,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
1418,GO:0008709,1,0.959711323077247,0,1,cholate 7-alpha-dehydrogenase activity,MF,
1419,GO:0008757,1,0.829674820070559,0,2,S-adenosylmethionine-dependent methyltransferase activity,MF,
1420,GO:0008970,1,0.930530251776604,0,1,phosphatidylcholine 1-acylhydrolase activity,MF,
1421,GO:0009052,1,0.746946287086585,0,1,pentose-phosphate shunt, non-oxidative branch,BP,
1427,GO:0009060,1,0.560412758851256,0,3,aerobic respiration,BP,
1428,GO:0009062,1,0.0565181223012226,0,14,fatty acid catabolic process,BP,
1429,GO:0009063,1,0.416224922237047,0,5,cellular amino acid catabolic process,BP,
1430,GO:0009064,1,0.753709329340452,0,1,glutamine family amino acid metabolic process,BP,
1433,GO:0009069,1,0.747430985543844,0,1,serine family amino acid metabolic process,BP,
1434,GO:0009071,1,0.747430985543844,0,1,serine family amino acid catabolic process,BP,
1435,GO:0009072,1,0.955102554249325,0,1,aromatic amino acid family metabolic process,BP,
1436,GO:0009074,1,0.955102554249325,0,1,aromatic amino acid family catabolic process,BP,
1437,GO:0009081,1,0.556415802921744,0,3,branched-chain amino acid metabolic process,BP,
1438,GO:0009083,1,0.765493379179867,0,2,branched-chain amino acid catabolic process,BP,
1439,GO:0009084,1,0.753709329340452,0,1,glutamine family amino acid biosynthetic process,BP,
1444,GO:0009109,1,0.76138364931296,0,2,coenzyme catabolic process,BP,
1445,GO:0009110,1,0.589380214877251,0,2,vitamin biosynthetic process,BP,
1451,GO:0009120,1,0.856527711611377,0,1,deoxyribonucleoside metabolic process,BP,
1452,GO:0009123,1,0.560831865596554,0,2,nucleoside monophosphate metabolic process,BP,
1453,GO:0009126,1,0.560831865596554,0,2,purine nucleoside monophosphate metabolic process,BP,
1454,GO:0009132,1,0.535082332905269,0,3,nucleoside diphosphate metabolic process,BP,
1455,GO:0009135,1,0.560831865596554,0,2,purine nucleoside diphosphate metabolic process,BP,
1456,GO:0009141,1,0.40377753084348,0,3,nucleoside triphosphate metabolic process,BP,
1457,GO:0009144,1,0.40377753084348,0,3,purine nucleoside triphosphate metabolic process,BP,
1459,GO:0009152,1,0.343168622380217,0,6,purine ribonucleotide biosynthetic process,BP,
1461,GO:0009161,1,0.560831865596554,0,2,ribonucleoside monophosphate metabolic process,BP,
1465,GO:0009167,1,0.560831865596554,0,2,purine ribonucleoside monophosphate metabolic process,BP,
1466,GO:0009179,1,0.560831865596554,0,2,purine ribonucleoside diphosphate metabolic process,BP,
1467,GO:0009185,1,0.560831865596554,0,2,ribonucleoside diphosphate metabolic process,BP,
1469,GO:0009190,1,0.431316283576613,0,5,cyclic nucleotide biosynthetic process,BP,
1470,GO:0009199,1,0.40377753084348,0,3,ribonucleoside triphosphate metabolic process,BP,
1471,GO:0009205,1,0.40377753084348,0,3,purine ribonucleoside triphosphate metabolic process,BP,
1473,GO:0009225,1,0.918424128506729,0,1,nucleotide-sugar metabolic process,BP,
1474,GO:0009227,1,0.918424128506729,0,1,nucleotide-sugar catabolic process,BP,
1475,GO:0009237,1,0.772107268247692,0,1,siderophore metabolic process,BP,
1476,GO:0009247,1,0.987980034753378,0,1,glycolipid biosynthetic process,BP,
1477,GO:0009250,1,0.772639837730134,0,1,glucan biosynthetic process,BP,
1479,GO:0009260,1,0.343168622380217,0,6,ribonucleotide biosynthetic process,BP,
1481,GO:0009262,1,0.856527711611377,0,1,deoxyribonucleotide metabolic process,BP,
1482,GO:0009264,1,0.856527711611377,0,1,deoxyribonucleotide catabolic process,BP,
1485,GO:0009295,1,0.787449377631317,0,1,nucleoid,CC,
1486,GO:0009303,1,0.957515383118201,0,1,rRNA transcription,BP,
1488,GO:0009308,1,0.731680740893358,0,2,amine metabolic process,BP,
1489,GO:0009310,1,0.764658144398332,0,1,amine catabolic process,BP,
1493,GO:0009395,1,0.773787430346066,0,2,phospholipid catabolic process,BP,
1494,GO:0009404,1,0.774318895616471,0,1,toxin metabolic process,BP,
1496,GO:0009409,1,0.787449377631317,0,1,response to cold,BP,
1501,GO:0009437,1,0.773315318531118,0,1,carnitine metabolic process,BP,
1502,GO:0009448,1,0.753709329340452,0,1,gamma-aminobutyric acid metabolic process,BP,
1503,GO:0009449,1,0.753709329340452,0,1,gamma-aminobutyric acid biosynthetic process,BP,
1504,GO:0009451,1,0.831795738218181,0,2,RNA modification,BP,
1506,GO:0009581,1,0.486058695089103,0,3,detection of external stimulus,BP,
1507,GO:0009582,1,0.486058695089103,0,3,detection of abiotic stimulus,BP,
1508,GO:0009583,1,0.629931202533517,0,2,detection of light stimulus,BP,
1509,GO:0009584,1,0.706584649959871,0,1,detection of visible light,BP,
1510,GO:0009593,1,0.596506259303693,0,2,detection of chemical stimulus,BP,
1514,GO:0009612,1,0.160095710853364,0,8,response to mechanical stimulus,BP,
1517,GO:0009620,1,0.80818803699794,0,1,response to fungus,BP,
1519,GO:0009635,1,0.774318895616471,0,1,response to herbicide,BP,
1523,GO:0009712,1,0.689648605091128,0,2,catechol-containing compound metabolic process,BP,
1524,GO:0009713,1,0.94047143183814,0,1,catechol-containing compound biosynthetic process,BP,
1526,GO:0009720,1,0.77139588570204,0,1,detection of hormone stimulus,BP,
1528,GO:0009726,1,0.77139588570204,0,1,detection of endogenous stimulus,BP,
1530,GO:0009744,1,0.77994876250451,0,1,response to sucrose,BP,
1533,GO:0009750,1,0.77994876250451,0,1,response to fructose,BP,
1534,GO:0009755,1,0.447295427694081,0,3,hormone-mediated signaling pathway,BP,
1551,GO:0009895,1,0.0492233759552184,0,11,negative regulation of catabolic process,BP,
1555,GO:0009912,1,0.434313343403453,0,2,auditory receptor cell fate commitment,BP,
1557,GO:0009914,1,0.0954460689529752,0,10,hormone transport,BP,
1559,GO:0009922,1,0.765260800063365,0,1,fatty acid elongase activity,MF,
1560,GO:0009925,1,0.773132814998767,0,1,basal plasma membrane,CC,
1561,GO:0009946,1,0.980495002631481,0,1,proximal/distal axis specification,BP,
1562,GO:0009948,1,0.398012164356377,0,4,anterior/posterior axis specification,BP,
1563,GO:0009950,1,0.895381066641334,0,1,dorsal/ventral axis specification,BP,
1570,GO:0009975,1,0.561352584806235,0,2,cyclase activity,MF,
1571,GO:0009982,1,0.866821396494009,0,1,pseudouridine synthase activity,MF,
1574,GO:0009988,1,0.741809137632914,0,1,cell-cell recognition,BP,
1576,GO:0009994,1,0.540880018854252,0,4,oocyte differentiation,BP,
1577,GO:0009996,1,0.74668493948331,0,1,negative regulation of cell fate specification,BP,
1579,GO:0010002,1,0.616704084333269,0,1,cardioblast differentiation,BP,
1584,GO:0010039,1,0.594354218853545,0,2,response to iron ion,BP,
1585,GO:0010043,1,0.77994876250451,0,1,response to zinc ion,BP,
1586,GO:0010092,1,0.469524406139926,0,6,specification of animal organ identity,BP,
1587,GO:0010159,1,0.847043438938523,0,1,specification of animal organ position,BP,
1590,GO:0010193,1,0.802011392875838,0,1,response to ozone,BP,
1593,GO:0010226,1,0.712353706175808,0,1,response to lithium ion,BP,
1596,GO:0010259,1,0.802011392875838,0,1,multicellular organism aging,BP,
1600,GO:0010385,1,0.771150420617929,0,1,double-stranded methylated DNA binding,MF,
1602,GO:0010453,1,0.632051517392295,0,2,regulation of cell fate commitment,BP,
1603,GO:0010454,1,0.74668493948331,0,1,negative regulation of cell fate commitment,BP,
1604,GO:0010459,1,0.690409015386517,0,1,negative regulation of heart rate,BP,
1605,GO:0010460,1,0.802011392875838,0,1,positive regulation of heart rate,BP,
1606,GO:0010463,1,0.251760797544089,0,5,mesenchymal cell proliferation,BP,
1607,GO:0010464,1,0.445943316812848,0,3,regulation of mesenchymal cell proliferation,BP,
1612,GO:0010470,1,0.74668493948331,0,1,regulation of gastrulation,BP,
1613,GO:0010498,1,0.244805059078421,0,6,proteasomal protein catabolic process,BP,
1615,GO:0010507,1,0.283760801859536,0,4,negative regulation of autophagy,BP,
1618,GO:0010511,1,0.77252698579057,0,1,regulation of phosphatidylinositol biosynthetic process,BP,
1619,GO:0010512,1,0.77252698579057,0,1,negative regulation of phosphatidylinositol biosynthetic process,BP,
1620,GO:0010517,1,0.8098175575904,0,2,regulation of phospholipase activity,BP,
1621,GO:0010518,1,0.8098175575904,0,2,positive regulation of phospholipase activity,BP,
1622,GO:0010522,1,0.77396315259318,0,1,regulation of calcium ion transport into cytosol,BP,
1623,GO:0010523,1,0.77396315259318,0,1,negative regulation of calcium ion transport into cytosol,BP,
1624,GO:0010543,1,0.77252698579057,0,1,regulation of platelet activation,BP,
1625,GO:0010544,1,0.77252698579057,0,1,negative regulation of platelet activation,BP,
1629,GO:0010559,1,0.78247392253484,0,1,regulation of glycoprotein biosynthetic process,BP,
1630,GO:0010561,1,0.78247392253484,0,1,negative regulation of glycoprotein biosynthetic process,BP,
1636,GO:0010586,1,0.940900393371674,0,1,miRNA metabolic process,BP,
1639,GO:0010596,1,0.616704084333269,0,1,negative regulation of endothelial cell migration,BP,
1643,GO:0010611,1,0.802011392875838,0,1,regulation of cardiac muscle hypertrophy,BP,
1644,GO:0010613,1,0.802011392875838,0,1,positive regulation of cardiac muscle hypertrophy,BP,
1650,GO:0010633,1,0.616704084333269,0,1,negative regulation of epithelial cell migration,BP,
1654,GO:0010640,1,0.77252698579057,0,1,regulation of platelet-derived growth factor receptor signaling pathway,BP,
1655,GO:0010642,1,0.77252698579057,0,1,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
1656,GO:0010644,1,0.77396315259318,0,1,cell communication by electrical coupling,BP,
1660,GO:0010649,1,0.77396315259318,0,1,regulation of cell communication by electrical coupling,BP,
1661,GO:0010656,1,0.540485574995823,0,3,negative regulation of muscle cell apoptotic process,BP,
1662,GO:0010657,1,0.540485574995823,0,3,muscle cell apoptotic process,BP,
1663,GO:0010658,1,0.67472473251609,0,2,striated muscle cell apoptotic process,BP,
1664,GO:0010659,1,0.912530916414626,0,1,cardiac muscle cell apoptotic process,BP,
1665,GO:0010660,1,0.540485574995823,0,3,regulation of muscle cell apoptotic process,BP,
1666,GO:0010662,1,0.67472473251609,0,2,regulation of striated muscle cell apoptotic process,BP,
1667,GO:0010664,1,0.67472473251609,0,2,negative regulation of striated muscle cell apoptotic process,BP,
1668,GO:0010665,1,0.912530916414626,0,1,regulation of cardiac muscle cell apoptotic process,BP,
1669,GO:0010667,1,0.912530916414626,0,1,negative regulation of cardiac muscle cell apoptotic process,BP,
1670,GO:0010668,1,0.74668493948331,0,1,ectodermal cell differentiation,BP,
1671,GO:0010669,1,0.961431612339441,0,1,epithelial structure maintenance,BP,
1673,GO:0010676,1,0.403265799606927,0,4,positive regulation of cellular carbohydrate metabolic process,BP,
1674,GO:0010677,1,0.772573466595224,0,1,negative regulation of cellular carbohydrate metabolic process,BP,
1675,GO:0010700,1,0.628065409479983,0,2,negative regulation of norepinephrine secretion,BP,
1678,GO:0010715,1,0.747095520096568,0,1,regulation of extracellular matrix disassembly,BP,
1679,GO:0010717,1,0.364293986403279,0,3,regulation of epithelial to mesenchymal transition,BP,
1680,GO:0010718,1,0.364293986403279,0,3,positive regulation of epithelial to mesenchymal transition,BP,
1683,GO:0010724,1,0.766387473815025,0,1,regulation of definitive erythrocyte differentiation,BP,
1684,GO:0010742,1,0.77139588570204,0,1,macrophage derived foam cell differentiation,BP,
1685,GO:0010743,1,0.77139588570204,0,1,regulation of macrophage derived foam cell differentiation,BP,
1686,GO:0010745,1,0.77139588570204,0,1,negative regulation of macrophage derived foam cell differentiation,BP,
1687,GO:0010746,1,0.772639837730134,0,1,regulation of plasma membrane long-chain fatty acid transport,BP,
1688,GO:0010748,1,0.772639837730134,0,1,negative regulation of plasma membrane long-chain fatty acid transport,BP,
1691,GO:0010763,1,0.772639837730134,0,1,positive regulation of fibroblast migration,BP,
1692,GO:0010765,1,0.760685280339522,0,2,positive regulation of sodium ion transport,BP,
1693,GO:0010766,1,0.734045967558083,0,1,negative regulation of sodium ion transport,BP,
1694,GO:0010769,1,0.27906846441837,0,5,regulation of cell morphogenesis involved in differentiation,BP,
1695,GO:0010770,1,0.895381066641334,0,1,positive regulation of cell morphogenesis involved in differentiation,BP,
1696,GO:0010771,1,0.471265868471169,0,3,negative regulation of cell morphogenesis involved in differentiation,BP,
1697,GO:0010799,1,0.383741412018965,0,3,regulation of peptidyl-threonine phosphorylation,BP,
1698,GO:0010800,1,0.383741412018965,0,3,positive regulation of peptidyl-threonine phosphorylation,BP,
1705,GO:0010818,1,0.474594104725211,0,2,T cell chemotaxis,BP,
1706,GO:0010819,1,0.683299665437994,0,1,regulation of T cell chemotaxis,BP,
1707,GO:0010820,1,0.683299665437994,0,1,positive regulation of T cell chemotaxis,BP,
1708,GO:0010821,1,0.558615786158671,0,4,regulation of mitochondrion organization,BP,
1709,GO:0010822,1,0.793580550170555,0,2,positive regulation of mitochondrion organization,BP,
1710,GO:0010823,1,0.704798885072753,0,2,negative regulation of mitochondrion organization,BP,
1711,GO:0010824,1,0.770050274238875,0,1,regulation of centrosome duplication,BP,
1714,GO:0010830,1,0.616704084333269,0,1,regulation of myotube differentiation,BP,
1715,GO:0010832,1,0.616704084333269,0,1,negative regulation of myotube differentiation,BP,
1716,GO:0010837,1,0.511075016231692,0,3,regulation of keratinocyte proliferation,BP,
1717,GO:0010838,1,0.980495002631481,0,1,positive regulation of keratinocyte proliferation,BP,
1718,GO:0010839,1,0.521432197223409,0,2,negative regulation of keratinocyte proliferation,BP,
1720,GO:0010862,1,0.216672951862658,0,6,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
1721,GO:0010863,1,0.8098175575904,0,2,positive regulation of phospholipase C activity,BP,
1722,GO:0010866,1,0.824053991557742,0,1,regulation of triglyceride biosynthetic process,BP,
1723,GO:0010867,1,0.824053991557742,0,1,positive regulation of triglyceride biosynthetic process,BP,
1724,GO:0010869,1,0.802011392875838,0,1,regulation of receptor biosynthetic process,BP,
1725,GO:0010870,1,0.802011392875838,0,1,positive regulation of receptor biosynthetic process,BP,
1726,GO:0010872,1,0.761625090232792,0,2,regulation of cholesterol esterification,BP,
1727,GO:0010873,1,0.987456549281,0,1,positive regulation of cholesterol esterification,BP,
1728,GO:0010874,1,0.77139588570204,0,1,regulation of cholesterol efflux,BP,
1729,GO:0010875,1,0.77139588570204,0,1,positive regulation of cholesterol efflux,BP,
1731,GO:0010878,1,0.77139588570204,0,1,cholesterol storage,BP,
1732,GO:0010880,1,0.77396315259318,0,1,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1733,GO:0010881,1,0.77396315259318,0,1,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
1734,GO:0010882,1,0.77396315259318,0,1,regulation of cardiac muscle contraction by calcium ion signaling,BP,
1735,GO:0010883,1,0.77139588570204,0,1,regulation of lipid storage,BP,
1736,GO:0010885,1,0.77139588570204,0,1,regulation of cholesterol storage,BP,
1737,GO:0010887,1,0.77139588570204,0,1,negative regulation of cholesterol storage,BP,
1738,GO:0010888,1,0.77139588570204,0,1,negative regulation of lipid storage,BP,
1739,GO:0010893,1,0.340266905528456,0,4,positive regulation of steroid biosynthetic process,BP,
1741,GO:0010896,1,0.695760832683338,0,1,regulation of triglyceride catabolic process,BP,
1742,GO:0010897,1,0.695760832683338,0,1,negative regulation of triglyceride catabolic process,BP,
1743,GO:0010899,1,0.987456549281,0,1,regulation of phosphatidylcholine catabolic process,BP,
1744,GO:0010900,1,0.987456549281,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
1746,GO:0010907,1,0.403265799606927,0,4,positive regulation of glucose metabolic process,BP,
1747,GO:0010915,1,0.987456549281,0,1,regulation of very-low-density lipoprotein particle clearance,BP,
1748,GO:0010916,1,0.987456549281,0,1,negative regulation of very-low-density lipoprotein particle clearance,BP,
1749,GO:0010917,1,0.823241180606138,0,1,negative regulation of mitochondrial membrane potential,BP,
1751,GO:0010922,1,0.632934568662545,0,2,positive regulation of phosphatase activity,BP,
1755,GO:0010935,1,0.683299665437994,0,1,regulation of macrophage cytokine production,BP,
1756,GO:0010939,1,0.684270209699463,0,3,regulation of necrotic cell death,BP,
1763,GO:0010955,1,0.912530916414626,0,1,negative regulation of protein processing,BP,
1765,GO:0010962,1,0.772639837730134,0,1,regulation of glucan biosynthetic process,BP,
1769,GO:0010977,1,0.471265868471169,0,3,negative regulation of neuron projection development,BP,
1770,GO:0010979,1,0.715839724297779,0,1,regulation of vitamin D 24-hydroxylase activity,BP,
1771,GO:0010980,1,0.715839724297779,0,1,positive regulation of vitamin D 24-hydroxylase activity,BP,
1772,GO:0010984,1,0.987456549281,0,1,regulation of lipoprotein particle clearance,BP,
1773,GO:0010985,1,0.987456549281,0,1,negative regulation of lipoprotein particle clearance,BP,
1774,GO:0010996,1,0.581891717265043,0,2,response to auditory stimulus,BP,
1779,GO:0014004,1,0.767161529299525,0,1,microglia differentiation,BP,
1780,GO:0014005,1,0.767161529299525,0,1,microglia development,BP,
1781,GO:0014009,1,0.616704084333269,0,1,glial cell proliferation,BP,
1782,GO:0014013,1,0.214093916736295,0,5,regulation of gliogenesis,BP,
1783,GO:0014014,1,0.616704084333269,0,1,negative regulation of gliogenesis,BP,
1784,GO:0014015,1,0.295859586422093,0,4,positive regulation of gliogenesis,BP,
1789,GO:0014037,1,0.460450686845129,0,3,Schwann cell differentiation,BP,
1790,GO:0014044,1,0.596034044399365,0,2,Schwann cell development,BP,
1791,GO:0014045,1,0.638884656670793,0,2,establishment of endothelial blood-brain barrier,BP,
1792,GO:0014046,1,0.977811028321075,0,1,dopamine secretion,BP,
1793,GO:0014047,1,0.581939293736273,0,2,glutamate secretion,BP,
1794,GO:0014048,1,0.7728397953467,0,1,regulation of glutamate secretion,BP,
1795,GO:0014050,1,0.7728397953467,0,1,negative regulation of glutamate secretion,BP,
1796,GO:0014059,1,0.977811028321075,0,1,regulation of dopamine secretion,BP,
1797,GO:0014060,1,0.628065409479983,0,2,regulation of epinephrine secretion,BP,
1798,GO:0014061,1,0.628065409479983,0,2,regulation of norepinephrine secretion,BP,
1801,GO:0014068,1,0.578648808295639,0,2,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
1804,GO:0014072,1,0.836041871517245,0,1,response to isoquinoline alkaloid,BP,
1805,GO:0014074,1,0.31953333533193,0,4,response to purine-containing compound,BP,
1806,GO:0014701,1,0.77396315259318,0,1,junctional sarcoplasmic reticulum membrane,CC,
1807,GO:0014704,1,0.508340711730239,0,2,intercalated disc,CC,
1809,GO:0014719,1,0.858923178696575,0,1,skeletal muscle satellite cell activation,BP,
1810,GO:0014728,1,0.772573466595224,0,1,regulation of the force of skeletal muscle contraction,BP,
1811,GO:0014731,1,0.630314916494616,0,1,spectrin-associated cytoskeleton,CC,
1812,GO:0014732,1,0.772573466595224,0,1,skeletal muscle atrophy,BP,
1813,GO:0014733,1,0.772573466595224,0,1,regulation of skeletal muscle adaptation,BP,
1814,GO:0014735,1,0.912530916414626,0,1,regulation of muscle atrophy,BP,
1815,GO:0014736,1,0.912530916414626,0,1,negative regulation of muscle atrophy,BP,
1816,GO:0014742,1,0.802011392875838,0,1,positive regulation of muscle hypertrophy,BP,
1817,GO:0014743,1,0.802011392875838,0,1,regulation of muscle hypertrophy,BP,
1818,GO:0014745,1,0.912530916414626,0,1,negative regulation of muscle adaptation,BP,
1820,GO:0014808,1,0.706007587608521,0,2,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1822,GO:0014819,1,0.772573466595224,0,1,regulation of skeletal muscle contraction,BP,
1823,GO:0014820,1,0.802011392875838,0,1,tonic smooth muscle contraction,BP,
1824,GO:0014821,1,0.784111429578473,0,2,phasic smooth muscle contraction,BP,
1825,GO:0014823,1,0.476676604825398,0,3,response to activity,BP,
1826,GO:0014824,1,0.802011392875838,0,1,artery smooth muscle contraction,BP,
1827,GO:0014826,1,0.802011392875838,0,1,vein smooth muscle contraction,BP,
1828,GO:0014829,1,0.706596862307829,0,2,vascular smooth muscle contraction,BP,
1829,GO:0014834,1,0.640946849891508,0,2,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
1830,GO:0014854,1,0.772573466595224,0,1,response to inactivity,BP,
1831,GO:0014855,1,0.457088272337105,0,3,striated muscle cell proliferation,BP,
1832,GO:0014862,1,0.772573466595224,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
1833,GO:0014866,1,0.657423063310495,0,1,skeletal myofibril assembly,BP,
1834,GO:0014870,1,0.772573466595224,0,1,response to muscle inactivity,BP,
1835,GO:0014874,1,0.704738262413964,0,2,response to stimulus involved in regulation of muscle adaptation,BP,
1836,GO:0014876,1,0.912530916414626,0,1,response to injury involved in regulation of muscle adaptation,BP,
1837,GO:0014877,1,0.772573466595224,0,1,response to muscle inactivity involved in regulation of muscle adaptation,BP,
1838,GO:0014883,1,0.772573466595224,0,1,transition between fast and slow fiber,BP,
1839,GO:0014888,1,0.772573466595224,0,1,striated muscle adaptation,BP,
1840,GO:0014889,1,0.704738262413964,0,2,muscle atrophy,BP,
1841,GO:0014891,1,0.772573466595224,0,1,striated muscle atrophy,BP,
1842,GO:0014894,1,0.772573466595224,0,1,response to denervation involved in regulation of muscle adaptation,BP,
1843,GO:0014896,1,0.802011392875838,0,1,muscle hypertrophy,BP,
1844,GO:0014897,1,0.802011392875838,0,1,striated muscle hypertrophy,BP,
1845,GO:0014902,1,0.616704084333269,0,1,myotube differentiation,BP,
1849,GO:0015002,1,0.96937950284859,0,1,heme-copper terminal oxidase activity,MF,
1850,GO:0015012,1,0.740273334426387,0,1,heparan sulfate proteoglycan biosynthetic process,BP,
1852,GO:0015065,1,0.775603503393362,0,1,uridine nucleotide receptor activity,MF,
1854,GO:0015077,1,0.280539597242812,0,6,monovalent inorganic cation transmembrane transporter activity,MF,
1855,GO:0015078,1,0.96937950284859,0,1,hydrogen ion transmembrane transporter activity,MF,
1856,GO:0015079,1,0.385687523124419,0,4,potassium ion transmembrane transporter activity,MF,
1857,GO:0015081,1,0.753709329340452,0,1,sodium ion transmembrane transporter activity,MF,
1859,GO:0015091,1,0.773132814998767,0,1,ferric iron transmembrane transporter activity,MF,
1860,GO:0015095,1,0.89585450261785,0,1,magnesium ion transmembrane transporter activity,MF,
1861,GO:0015103,1,0.799628824156165,0,2,inorganic anion transmembrane transporter activity,MF,
1862,GO:0015108,1,0.799628824156165,0,2,chloride transmembrane transporter activity,MF,
1863,GO:0015144,1,0.603836627920827,0,2,carbohydrate transmembrane transporter activity,MF,
1864,GO:0015145,1,0.792322370974488,0,1,monosaccharide transmembrane transporter activity,MF,
1865,GO:0015149,1,0.792322370974488,0,1,hexose transmembrane transporter activity,MF,
1866,GO:0015154,1,0.762750135837046,0,1,disaccharide transmembrane transporter activity,MF,
1867,GO:0015157,1,0.762750135837046,0,1,oligosaccharide transmembrane transporter activity,MF,
1868,GO:0015171,1,0.753709329340452,0,1,amino acid transmembrane transporter activity,MF,
1869,GO:0015172,1,0.753709329340452,0,1,acidic amino acid transmembrane transporter activity,MF,
1870,GO:0015179,1,0.753709329340452,0,1,L-amino acid transmembrane transporter activity,MF,
1871,GO:0015197,1,0.77139588570204,0,1,peptide transporter activity,MF,
1872,GO:0015232,1,0.753567240984294,0,1,heme transporter activity,MF,
1873,GO:0015238,1,0.94047143183814,0,1,drug transmembrane transporter activity,MF,
1874,GO:0015245,1,0.946578828055197,0,1,fatty acid transporter activity,MF,
1875,GO:0015248,1,0.596781289094949,0,2,sterol transporter activity,MF,
1877,GO:0015271,1,0.715726062684385,0,1,outward rectifier potassium channel activity,MF,
1878,GO:0015276,1,0.415627313273182,0,3,ligand-gated ion channel activity,MF,
1879,GO:0015291,1,0.574316548364949,0,2,secondary active transmembrane transporter activity,MF,
1880,GO:0015293,1,0.574316548364949,0,2,symporter activity,MF,
1881,GO:0015294,1,0.574316548364949,0,2,solute:cation symporter activity,MF,
1882,GO:0015295,1,0.762750135837046,0,1,solute:proton symporter activity,MF,
1883,GO:0015370,1,0.753709329340452,0,1,solute:sodium symporter activity,MF,
1884,GO:0015399,1,0.77139588570204,0,1,primary active transmembrane transporter activity,MF,
1885,GO:0015405,1,0.77139588570204,0,1,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
1886,GO:0015485,1,0.596781289094949,0,2,cholesterol binding,MF,
1892,GO:0015682,1,0.773132814998767,0,1,ferric iron transport,BP,
1893,GO:0015684,1,0.773132814998767,0,1,ferrous iron transport,BP,
1894,GO:0015693,1,0.89585450261785,0,1,magnesium ion transport,BP,
1895,GO:0015696,1,0.784111429578473,0,2,ammonium transport,BP,
1896,GO:0015698,1,0.586367577311668,0,3,inorganic anion transport,BP,
1899,GO:0015732,1,0.802011392875838,0,1,prostaglandin transport,BP,
1900,GO:0015740,1,0.753709329340452,0,1,C4-dicarboxylate transport,BP,
1901,GO:0015748,1,0.665230023235977,0,3,organophosphate ester transport,BP,
1904,GO:0015766,1,0.762750135837046,0,1,disaccharide transport,BP,
1905,GO:0015770,1,0.762750135837046,0,1,sucrose transport,BP,
1906,GO:0015772,1,0.762750135837046,0,1,oligosaccharide transport,BP,
1907,GO:0015800,1,0.753709329340452,0,1,acidic amino acid transport,BP,
1908,GO:0015807,1,0.753709329340452,0,1,L-amino acid transport,BP,
1909,GO:0015810,1,0.753709329340452,0,1,aspartate transport,BP,
1910,GO:0015813,1,0.753709329340452,0,1,L-glutamate transport,BP,
1912,GO:0015837,1,0.381946439099446,0,5,amine transport,BP,
1913,GO:0015844,1,0.495456528227319,0,4,monoamine transport,BP,
1915,GO:0015850,1,0.213538617802308,0,9,organic hydroxy compound transport,BP,
1916,GO:0015858,1,0.7728397953467,0,1,nucleoside transport,BP,
1917,GO:0015865,1,0.873933946116982,0,1,purine nucleotide transport,BP,
1918,GO:0015868,1,0.873933946116982,0,1,purine ribonucleotide transport,BP,
1919,GO:0015872,1,0.977811028321075,0,1,dopamine transport,BP,
1920,GO:0015874,1,0.628065409479983,0,2,norepinephrine transport,BP,
1921,GO:0015886,1,0.753567240984294,0,1,heme transport,BP,
1924,GO:0015909,1,0.562146426047154,0,3,long-chain fatty acid transport,BP,
1925,GO:0015911,1,0.772639837730134,0,1,plasma membrane long-chain fatty acid transport,BP,
1926,GO:0015914,1,0.761625090232792,0,2,phospholipid transport,BP,
1927,GO:0015918,1,0.589149177457556,0,3,sterol transport,BP,
1928,GO:0015925,1,0.906943268947671,0,1,galactosidase activity,MF,
1930,GO:0015931,1,0.675073196156851,0,2,nucleobase-containing compound transport,BP,
1931,GO:0015934,1,0.911789827211774,0,2,large ribosomal subunit,CC,
1932,GO:0015936,1,0.76138364931296,0,2,coenzyme A metabolic process,BP,
1933,GO:0015937,1,0.79777800716672,0,1,coenzyme A biosynthetic process,BP,
1934,GO:0015938,1,0.954572941883903,0,1,coenzyme A catabolic process,BP,
1935,GO:0015939,1,0.629141955360923,0,1,pantothenate metabolic process,BP,
1936,GO:0015980,1,0.186675809280208,0,8,energy derivation by oxidation of organic compounds,BP,
1937,GO:0015992,1,0.96937950284859,0,1,proton transport,BP,
1943,GO:0016048,1,0.7728397953467,0,1,detection of temperature stimulus,BP,
1946,GO:0016051,1,0.254703969680975,0,7,carbohydrate biosynthetic process,BP,
1949,GO:0016054,1,0.0225306220699739,0,19,organic acid catabolic process,BP,
1951,GO:0016056,1,0.706584649959871,0,1,rhodopsin mediated signaling pathway,BP,
1952,GO:0016064,1,0.84462400233258,0,1,immunoglobulin mediated immune response,BP,
1954,GO:0016071,1,0.211322117495003,0,7,mRNA metabolic process,BP,
1955,GO:0016072,1,0.704002033216449,0,2,rRNA metabolic process,BP,
1956,GO:0016079,1,0.839437618379272,0,1,synaptic vesicle exocytosis,BP,
1964,GO:0016137,1,0.906943268947671,0,1,glycoside metabolic process,BP,
1965,GO:0016139,1,0.906943268947671,0,1,glycoside catabolic process,BP,
1966,GO:0016176,1,0.77252698579057,0,1,superoxide-generating NADPH oxidase activator activity,MF,
1970,GO:0016209,1,0.737035123423743,0,2,antioxidant activity,MF,
1972,GO:0016236,1,0.133512866607531,0,7,macroautophagy,BP,
1973,GO:0016239,1,0.476350608539855,0,3,positive regulation of macroautophagy,BP,
1974,GO:0016241,1,0.133512866607531,0,7,regulation of macroautophagy,BP,
1975,GO:0016242,1,0.401165290126154,0,3,negative regulation of macroautophagy,BP,
1976,GO:0016247,1,0.597873285059642,0,3,channel regulator activity,MF,
1977,GO:0016248,1,0.734045967558083,0,1,channel inhibitor activity,MF,
1978,GO:0016264,1,0.684858187930548,0,2,gap junction assembly,BP,
1979,GO:0016266,1,0.773597169937423,0,1,O-glycan processing,BP,
1980,GO:0016289,1,0.954572941883903,0,1,CoA hydrolase activity,MF,
1981,GO:0016295,1,0.629141955360923,0,1,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
1982,GO:0016296,1,0.629141955360923,0,1,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
1983,GO:0016297,1,0.629141955360923,0,1,acyl-[acyl-carrier-protein] hydrolase activity,MF,
1984,GO:0016298,1,0.595880552242621,0,3,lipase activity,MF,
1987,GO:0016307,1,0.475693326264154,0,3,phosphatidylinositol phosphate kinase activity,MF,
1995,GO:0016332,1,0.744287228075405,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
1998,GO:0016339,1,0.538967553362078,0,2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
1999,GO:0016342,1,0.517356611930352,0,2,catenin complex,CC,
2001,GO:0016361,1,0.7717087498744,0,1,activin receptor activity, type I,MF,
2002,GO:0016363,1,0.50701452795433,0,2,nuclear matrix,CC,
2004,GO:0016406,1,0.594698093472827,0,2,carnitine O-acyltransferase activity,MF,
2005,GO:0016407,1,0.50123966406928,0,2,acetyltransferase activity,MF,
2006,GO:0016408,1,0.621549809110183,0,2,C-acyltransferase activity,MF,
2007,GO:0016409,1,0.594698093472827,0,2,palmitoyltransferase activity,MF,
2008,GO:0016410,1,0.706584649959871,0,1,N-acyltransferase activity,MF,
2009,GO:0016411,1,0.747989056481557,0,1,acylglycerol O-acyltransferase activity,MF,
2010,GO:0016416,1,0.594698093472827,0,2,O-palmitoyltransferase activity,MF,
2011,GO:0016417,1,0.629141955360923,0,1,S-acyltransferase activity,MF,
2012,GO:0016418,1,0.629141955360923,0,1,S-acetyltransferase activity,MF,
2013,GO:0016419,1,0.629141955360923,0,1,S-malonyltransferase activity,MF,
2014,GO:0016420,1,0.629141955360923,0,1,malonyltransferase activity,MF,
2015,GO:0016441,1,0.847043438938523,0,1,posttranscriptional gene silencing,BP,
2016,GO:0016444,1,0.84462400233258,0,1,somatic cell DNA recombination,BP,
2017,GO:0016445,1,0.84462400233258,0,1,somatic diversification of immunoglobulins,BP,
2018,GO:0016447,1,0.84462400233258,0,1,somatic recombination of immunoglobulin gene segments,BP,
2019,GO:0016453,1,0.79777800716672,0,1,C-acetyltransferase activity,MF,
2020,GO:0016458,1,0.847043438938523,0,1,gene silencing,BP,
2022,GO:0016460,1,0.657423063310495,0,1,myosin II complex,CC,
2026,GO:0016480,1,0.773885510980933,0,1,negative regulation of transcription from RNA polymerase III promoter,BP,
2027,GO:0016482,1,0.368257453903382,0,4,cytosolic transport,BP,
2030,GO:0016502,1,0.775603503393362,0,1,nucleotide receptor activity,MF,
2031,GO:0016504,1,0.964117353714657,0,1,peptidase activator activity,MF,
2032,GO:0016505,1,0.964117353714657,0,1,peptidase activator activity involved in apoptotic process,MF,
2034,GO:0016528,1,0.668054258009661,0,3,sarcoplasm,CC,
2035,GO:0016529,1,0.706007587608521,0,2,sarcoplasmic reticulum,CC,
2037,GO:0016556,1,0.866821396494009,0,1,mRNA modification,BP,
2040,GO:0016570,1,0.522059841320532,0,2,histone modification,BP,
2041,GO:0016573,1,0.744061959631107,0,1,histone acetylation,BP,
2042,GO:0016575,1,0.702569048854651,0,1,histone deacetylation,BP,
2044,GO:0016580,1,0.702569048854651,0,1,Sin3 complex,CC,
2045,GO:0016594,1,0.747430985543844,0,1,glycine binding,MF,
2046,GO:0016595,1,0.753709329340452,0,1,glutamate binding,MF,
2047,GO:0016597,1,0.426439925098447,0,3,amino acid binding,MF,
2048,GO:0016600,1,0.712353706175808,0,1,flotillin complex,CC,
2050,GO:0016605,1,0.690409015386517,0,1,PML body,CC,
2053,GO:0016615,1,0.926933149462279,0,1,malate dehydrogenase activity,MF,
2058,GO:0016638,1,0.747430985543844,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
2059,GO:0016642,1,0.747430985543844,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
2060,GO:0016645,1,0.597948594844221,0,2,oxidoreductase activity, acting on the CH-NH group of donors,MF,
2061,GO:0016649,1,0.782663874445418,0,1,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
2062,GO:0016651,1,0.928899738732417,0,1,oxidoreductase activity, acting on NAD(P)H,MF,
2063,GO:0016667,1,0.648572856849771,0,3,oxidoreductase activity, acting on a sulfur group of donors,MF,
2064,GO:0016671,1,0.897422464824754,0,1,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
2065,GO:0016675,1,0.96937950284859,0,1,oxidoreductase activity, acting on a heme group of donors,MF,
2066,GO:0016676,1,0.96937950284859,0,1,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
2067,GO:0016684,1,0.737035123423743,0,2,oxidoreductase activity, acting on peroxide as acceptor,MF,
2069,GO:0016706,1,0.867164964013753,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
2071,GO:0016714,1,0.955102554249325,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
2072,GO:0016717,1,0.725770278597532,0,1,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
2073,GO:0016722,1,0.782663874445418,0,1,oxidoreductase activity, oxidizing metal ions,MF,
2077,GO:0016741,1,0.829674820070559,0,2,transferase activity, transferring one-carbon groups,MF,
2079,GO:0016747,1,0.0912619080011131,0,8,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
2083,GO:0016765,1,0.970787931478979,0,1,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
2086,GO:0016775,1,0.767624987207694,0,1,phosphotransferase activity, nitrogenous group as acceptor,MF,
2087,GO:0016779,1,0.918424128506729,0,1,nucleotidyltransferase activity,MF,
2090,GO:0016790,1,0.497364292993667,0,3,thiolester hydrolase activity,MF,
2093,GO:0016805,1,0.593136511959265,0,2,dipeptidase activity,MF,
2094,GO:0016810,1,0.548484933205903,0,2,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
2095,GO:0016811,1,0.548484933205903,0,2,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
2098,GO:0016820,1,0.77139588570204,0,1,hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,MF,
2099,GO:0016829,1,0.0653611384986297,0,14,lyase activity,MF,
2100,GO:0016830,1,0.458752143448042,0,4,carbon-carbon lyase activity,MF,
2101,GO:0016832,1,0.712938121124514,0,2,aldehyde-lyase activity,MF,
2102,GO:0016835,1,0.363117449769248,0,6,carbon-oxygen lyase activity,MF,
2103,GO:0016836,1,0.37811269871428,0,5,hydro-lyase activity,MF,
2104,GO:0016838,1,0.961115666336063,0,1,carbon-oxygen lyase activity, acting on phosphates,MF,
2105,GO:0016846,1,0.970787931478979,0,1,carbon-sulfur lyase activity,MF,
2106,GO:0016849,1,0.561352584806235,0,2,phosphorus-oxygen lyase activity,MF,
2111,GO:0016866,1,0.866821396494009,0,1,intramolecular transferase activity,MF,
2115,GO:0016885,1,0.79777800716672,0,1,ligase activity, forming carbon-carbon bonds,MF,
2117,GO:0016898,1,0.808990561965705,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
2119,GO:0016918,1,0.961431612339441,0,1,retinal binding,MF,
2120,GO:0016936,1,0.839313920136394,0,2,galactoside binding,MF,
2121,GO:0016941,1,0.733539537631441,0,1,natriuretic peptide receptor activity,MF,
2122,GO:0017002,1,0.7717087498744,0,1,activin-activated receptor activity,MF,
2125,GO:0017017,1,0.776747906170104,0,1,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
2127,GO:0017024,1,0.964117353714657,0,1,myosin I binding,MF,
2129,GO:0017040,1,0.781565991555791,0,1,ceramidase activity,MF,
2132,GO:0017053,1,0.766387473815025,0,1,transcriptional repressor complex,CC,
2134,GO:0017080,1,0.984658110865059,0,1,sodium channel regulator activity,MF,
2135,GO:0017081,1,0.734045967558083,0,1,chloride channel regulator activity,MF,
2136,GO:0017085,1,0.774318895616471,0,1,response to insecticide,BP,
2140,GO:0017127,1,0.596781289094949,0,2,cholesterol transporter activity,MF,
2141,GO:0017133,1,0.782663874445418,0,1,mitochondrial electron transfer flavoprotein complex,CC,
2143,GO:0017143,1,0.774318895616471,0,1,insecticide metabolic process,BP,
2144,GO:0017145,1,0.394180846033465,0,3,stem cell division,BP,
2145,GO:0017147,1,0.572781342788712,0,2,Wnt-protein binding,MF,
2146,GO:0017148,1,0.615256950424503,0,3,negative regulation of translation,BP,
2147,GO:0017156,1,0.400129940637676,0,3,calcium ion regulated exocytosis,BP,
2149,GO:0017158,1,0.400129940637676,0,3,regulation of calcium ion-dependent exocytosis,BP,
2150,GO:0017171,1,0.430500204872187,0,3,serine hydrolase activity,MF,
2151,GO:0018008,1,0.706584649959871,0,1,N-terminal peptidyl-glycine N-myristoylation,BP,
2152,GO:0018103,1,0.987980034753378,0,1,protein C-linked glycosylation,BP,
2154,GO:0018107,1,0.227126078565151,0,5,peptidyl-threonine phosphorylation,BP,
2156,GO:0018125,1,0.831604178158584,0,1,peptidyl-cysteine methylation,BP,
2158,GO:0018146,1,0.773597169937423,0,1,keratan sulfate biosynthetic process,BP,
2159,GO:0018149,1,0.797490690939829,0,1,peptide cross-linking,BP,
2161,GO:0018196,1,0.927473682729249,0,2,peptidyl-asparagine modification,BP,
2162,GO:0018198,1,0.831604178158584,0,1,peptidyl-cysteine modification,BP,
2163,GO:0018201,1,0.706584649959871,0,1,peptidyl-glycine modification,BP,
2164,GO:0018205,1,0.744061959631107,0,1,peptidyl-lysine modification,BP,
2166,GO:0018210,1,0.227126078565151,0,5,peptidyl-threonine modification,BP,
2167,GO:0018211,1,0.987980034753378,0,1,peptidyl-tryptophan modification,BP,
2169,GO:0018279,1,0.927473682729249,0,2,protein N-linked glycosylation via asparagine,BP,
2170,GO:0018317,1,0.987980034753378,0,1,protein C-linked glycosylation via tryptophan,BP,
2171,GO:0018377,1,0.706584649959871,0,1,protein myristoylation,BP,
2172,GO:0018393,1,0.744061959631107,0,1,internal peptidyl-lysine acetylation,BP,
2173,GO:0018394,1,0.744061959631107,0,1,peptidyl-lysine acetylation,BP,
2174,GO:0018406,1,0.987980034753378,0,1,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
2176,GO:0018879,1,0.774318895616471,0,1,biphenyl metabolic process,BP,
2177,GO:0018894,1,0.774318895616471,0,1,dibenzo-p-dioxin metabolic process,BP,
2178,GO:0018904,1,0.930530251776604,0,1,ether metabolic process,BP,
2179,GO:0018958,1,0.363262854738773,0,4,phenol-containing compound metabolic process,BP,
2180,GO:0018963,1,0.774318895616471,0,1,phthalate metabolic process,BP,
2188,GO:0019107,1,0.706584649959871,0,1,myristoyltransferase activity,MF,
2189,GO:0019166,1,0.83176074627617,0,1,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
2190,GO:0019171,1,0.629141955360923,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
2191,GO:0019184,1,0.749419979896661,0,2,nonribosomal peptide biosynthetic process,BP,
2192,GO:0019199,1,0.426648282082382,0,3,transmembrane receptor protein kinase activity,MF,
2193,GO:0019200,1,0.566205965874527,0,2,carbohydrate kinase activity,MF,
2194,GO:0019203,1,0.726704948244745,0,1,carbohydrate phosphatase activity,MF,
2196,GO:0019208,1,0.768607936468567,0,1,phosphatase regulator activity,MF,
2199,GO:0019211,1,0.768607936468567,0,1,phosphatase activator activity,MF,
2200,GO:0019213,1,0.702569048854651,0,1,deacetylase activity,MF,
2201,GO:0019215,1,0.694600625869364,0,1,intermediate filament binding,MF,
2209,GO:0019226,1,0.5193278025715,0,2,transmission of nerve impulse,BP,
2210,GO:0019229,1,0.387721740237495,0,4,regulation of vasoconstriction,BP,
2211,GO:0019233,1,0.507502424295925,0,3,sensory perception of pain,BP,
2212,GO:0019290,1,0.772107268247692,0,1,siderophore biosynthetic process,BP,
2214,GO:0019319,1,0.676299498089533,0,3,hexose biosynthetic process,BP,
2215,GO:0019320,1,0.400529770159544,0,4,hexose catabolic process,BP,
2219,GO:0019367,1,0.765260800063365,0,1,fatty acid elongation, saturated fatty acid,BP,
2220,GO:0019369,1,0.846876006292841,0,1,arachidonic acid metabolic process,BP,
2221,GO:0019370,1,0.970787931478979,0,1,leukotriene biosynthetic process,BP,
2222,GO:0019371,1,0.846876006292841,0,1,cyclooxygenase pathway,BP,
2225,GO:0019388,1,0.918424128506729,0,1,galactose catabolic process,BP,
2227,GO:0019430,1,0.609084076257617,0,2,removal of superoxide radicals,BP,
2228,GO:0019432,1,0.824053991557742,0,1,triglyceride biosynthetic process,BP,
2229,GO:0019433,1,0.658361905269106,0,2,triglyceride catabolic process,BP,
2232,GO:0019464,1,0.747430985543844,0,1,glycine decarboxylation via glycine cleavage system,BP,
2234,GO:0019530,1,0.727749574179032,0,1,taurine metabolic process,BP,
2235,GO:0019534,1,0.77139588570204,0,1,toxin transporter activity,MF,
2238,GO:0019659,1,0.772573466595224,0,1,glucose catabolic process to lactate,BP,
2239,GO:0019660,1,0.772573466595224,0,1,glycolytic fermentation,BP,
2240,GO:0019661,1,0.772573466595224,0,1,glucose catabolic process to lactate via pyruvate,BP,
2242,GO:0019682,1,0.497933229401435,0,3,glyceraldehyde-3-phosphate metabolic process,BP,
2243,GO:0019692,1,0.856527711611377,0,1,deoxyribose phosphate metabolic process,BP,
2245,GO:0019694,1,0.727749574179032,0,1,alkanesulfonate metabolic process,BP,
2246,GO:0019695,1,0.764658144398332,0,1,choline metabolic process,BP,
2247,GO:0019722,1,0.380617130105391,0,5,calcium-mediated signaling,BP,
2248,GO:0019724,1,0.84462400233258,0,1,B cell mediated immunity,BP,
2250,GO:0019730,1,0.80818803699794,0,1,antimicrobial humoral response,BP,
2251,GO:0019748,1,0.407128451730179,0,3,secondary metabolic process,BP,
2253,GO:0019787,1,0.181508718041437,0,5,ubiquitin-like protein transferase activity,MF,
2254,GO:0019825,1,0.83270324466729,0,1,oxygen binding,MF,
2258,GO:0019841,1,0.961431612339441,0,1,retinol binding,MF,
2260,GO:0019843,1,0.659829010742269,0,3,rRNA binding,MF,
2261,GO:0019852,1,0.798710693678701,0,2,L-ascorbic acid metabolic process,BP,
2262,GO:0019853,1,0.824053991557742,0,1,L-ascorbic acid biosynthetic process,BP,
2265,GO:0019869,1,0.734045967558083,0,1,chloride channel inhibitor activity,MF,
2268,GO:0019886,1,0.952501034079192,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
2270,GO:0019894,1,0.585788010294756,0,1,kinesin binding,MF,
2279,GO:0019905,1,0.649062903400574,0,2,syntaxin binding,MF,
2282,GO:0019932,1,0.290558548184026,0,6,second-messenger-mediated signaling,BP,
2283,GO:0019934,1,0.766087200253996,0,1,cGMP-mediated signaling,BP,
2284,GO:0019935,1,0.766087200253996,0,1,cyclic-nucleotide-mediated signaling,BP,
2285,GO:0019941,1,0.298337307148616,0,5,modification-dependent protein catabolic process,BP,
2287,GO:0019955,1,0.7717087498744,0,1,cytokine binding,MF,
2289,GO:0021502,1,0.739713014367407,0,1,neural fold elevation formation,BP,
2291,GO:0021515,1,0.616704084333269,0,1,cell differentiation in spinal cord,BP,
2293,GO:0021533,1,0.858923178696575,0,1,cell differentiation in hindbrain,BP,
2294,GO:0021536,1,0.21730482596793,0,7,diencephalon development,BP,
2295,GO:0021537,1,0.305649357151132,0,5,telencephalon development,BP,
2296,GO:0021543,1,0.69181233655095,0,2,pallium development,BP,
2297,GO:0021544,1,0.951532941209886,0,1,subpallium development,BP,
2298,GO:0021545,1,0.753709329340452,0,1,cranial nerve development,BP,
2305,GO:0021681,1,0.858923178696575,0,1,cerebellar granular layer development,BP,
2306,GO:0021683,1,0.858923178696575,0,1,cerebellar granular layer morphogenesis,BP,
2307,GO:0021684,1,0.858923178696575,0,1,cerebellar granular layer formation,BP,
2317,GO:0021707,1,0.858923178696575,0,1,cerebellar granule cell differentiation,BP,
2318,GO:0021772,1,0.683299665437994,0,1,olfactory bulb development,BP,
2320,GO:0021784,1,0.977811028321075,0,1,postganglionic parasympathetic fiber development,BP,
2321,GO:0021797,1,0.762142819578083,0,1,forebrain anterior/posterior pattern specification,BP,
2322,GO:0021798,1,0.951532941209886,0,1,forebrain dorsal/ventral pattern formation,BP,
2323,GO:0021846,1,0.817173526284874,0,2,cell proliferation in forebrain,BP,
2324,GO:0021871,1,0.274769328375908,0,6,forebrain regionalization,BP,
2325,GO:0021872,1,0.494582073588699,0,3,forebrain generation of neurons,BP,
2326,GO:0021877,1,0.762142819578083,0,1,forebrain neuron fate commitment,BP,
2327,GO:0021879,1,0.494582073588699,0,3,forebrain neuron differentiation,BP,
2328,GO:0021881,1,0.762142819578083,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
2329,GO:0021884,1,0.649958689434067,0,2,forebrain neuron development,BP,
2330,GO:0021885,1,0.742334532829423,0,1,forebrain cell migration,BP,
2331,GO:0021889,1,0.683299665437994,0,1,olfactory bulb interneuron differentiation,BP,
2332,GO:0021891,1,0.683299665437994,0,1,olfactory bulb interneuron development,BP,
2333,GO:0021898,1,0.762142819578083,0,1,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
2334,GO:0021903,1,0.951532941209886,0,1,rostrocaudal neural tube patterning,BP,
2337,GO:0021952,1,0.690409015386517,0,1,central nervous system projection neuron axonogenesis,BP,
2338,GO:0021953,1,0.200369345814731,0,7,central nervous system neuron differentiation,BP,
2339,GO:0021954,1,0.447797525195585,0,3,central nervous system neuron development,BP,
2340,GO:0021955,1,0.690409015386517,0,1,central nervous system neuron axonogenesis,BP,
2341,GO:0021978,1,0.650648483368427,0,2,telencephalon regionalization,BP,
2342,GO:0021983,1,0.21730482596793,0,7,pituitary gland development,BP,
2343,GO:0021984,1,0.543726638241655,0,3,adenohypophysis development,BP,
2344,GO:0021987,1,0.727261279903572,0,1,cerebral cortex development,BP,
2345,GO:0021988,1,0.683299665437994,0,1,olfactory lobe development,BP,
2346,GO:0021999,1,0.762142819578083,0,1,neural plate anterior/posterior regionalization,BP,
2348,GO:0022009,1,0.638884656670793,0,2,central nervous system vasculogenesis,BP,
2349,GO:0022011,1,0.596034044399365,0,2,myelination in peripheral nervous system,BP,
2351,GO:0022400,1,0.706584649959871,0,1,regulation of rhodopsin mediated signaling pathway,BP,
2359,GO:0022410,1,0.597901784091742,0,2,circadian sleep/wake cycle process,BP,
2363,GO:0022600,1,0.494241246333565,0,4,digestive system process,BP,
2370,GO:0022613,1,0.670811049987923,0,2,ribonucleoprotein complex biogenesis,BP,
2371,GO:0022614,1,0.741809137632914,0,1,membrane to membrane docking,BP,
2372,GO:0022617,1,0.53152295742947,0,2,extracellular matrix disassembly,BP,
2373,GO:0022618,1,0.912530916414626,0,1,ribonucleoprotein complex assembly,BP,
2375,GO:0022804,1,0.44218602022372,0,3,active transmembrane transporter activity,MF,
2376,GO:0022824,1,0.701293732953001,0,1,transmitter-gated ion channel activity,MF,
2377,GO:0022829,1,0.47912052143449,0,3,wide pore channel activity,MF,
2379,GO:0022834,1,0.415627313273182,0,3,ligand-gated channel activity,MF,
2380,GO:0022835,1,0.701293732953001,0,1,transmitter-gated channel activity,MF,
2389,GO:0022900,1,0.739728399798486,0,2,electron transport chain,BP,
2390,GO:0022904,1,0.739728399798486,0,2,respiratory electron transport chain,BP,
2392,GO:0023019,1,0.951532941209886,0,1,signal transduction involved in regulation of gene expression,BP,
2397,GO:0023061,1,0.0680351573813048,0,12,signal release,BP,
2400,GO:0030004,1,0.631296473034083,0,3,cellular monovalent inorganic cation homeostasis,BP,
2409,GO:0030032,1,0.853289383796874,0,1,lamellipodium assembly,BP,
2420,GO:0030056,1,0.685786047637105,0,1,hemidesmosome,CC,
2421,GO:0030057,1,0.125629473503949,0,6,desmosome,CC,
2422,GO:0030060,1,0.926933149462279,0,1,L-malate dehydrogenase activity,MF,
2423,GO:0030061,1,0.774318895616471,0,1,mitochondrial crista,CC,
2424,GO:0030072,1,0.440312509392878,0,5,peptide hormone secretion,BP,
2425,GO:0030073,1,0.550056869556048,0,4,insulin secretion,BP,
2426,GO:0030091,1,0.897422464824754,0,1,protein repair,BP,
2435,GO:0030135,1,0.0968588537823333,0,8,coated vesicle,CC,
2436,GO:0030136,1,0.122956697076459,0,7,clathrin-coated vesicle,CC,
2439,GO:0030145,1,0.791173779933116,0,2,manganese ion binding,MF,
2443,GO:0030157,1,0.734045967558083,0,1,pancreatic juice secretion,BP,
2444,GO:0030159,1,0.762142819578083,0,1,receptor signaling complex scaffold activity,MF,
2446,GO:0030163,1,0.0510599326594139,0,13,protein catabolic process,BP,
2447,GO:0030165,1,0.572781342788712,0,2,PDZ domain binding,MF,
2448,GO:0030166,1,0.740273334426387,0,1,proteoglycan biosynthetic process,BP,
2453,GO:0030177,1,0.127833297338075,0,10,positive regulation of Wnt signaling pathway,BP,
2457,GO:0030185,1,0.802011392875838,0,1,nitric oxide transport,BP,
2458,GO:0030193,1,0.32980944227499,0,4,regulation of blood coagulation,BP,
2459,GO:0030195,1,0.480134923451189,0,3,negative regulation of blood coagulation,BP,
2461,GO:0030201,1,0.740273334426387,0,1,heparan sulfate proteoglycan metabolic process,BP,
2464,GO:0030205,1,0.79288915251973,0,1,dermatan sulfate metabolic process,BP,
2466,GO:0030209,1,0.79288915251973,0,1,dermatan sulfate catabolic process,BP,
2468,GO:0030213,1,0.77252698579057,0,1,hyaluronan biosynthetic process,BP,
2470,GO:0030216,1,0.0295702614248541,0,10,keratinocyte differentiation,BP,
2472,GO:0030218,1,0.499595345029787,0,3,erythrocyte differentiation,BP,
2473,GO:0030219,1,0.766387473815025,0,1,megakaryocyte differentiation,BP,
2474,GO:0030220,1,0.766387473815025,0,1,platelet formation,BP,
2475,GO:0030224,1,0.847043438938523,0,1,monocyte differentiation,BP,
2476,GO:0030225,1,0.402563009398434,0,4,macrophage differentiation,BP,
2478,GO:0030235,1,0.772639837730134,0,1,nitric-oxide synthase regulator activity,MF,
2479,GO:0030237,1,0.744587511205584,0,1,female sex determination,BP,
2482,GO:0030241,1,0.657423063310495,0,1,skeletal muscle myosin thick filament assembly,BP,
2483,GO:0030246,1,0.802460245363781,0,2,carbohydrate binding,MF,
2487,GO:0030276,1,0.839437618379272,0,1,clathrin binding,MF,
2488,GO:0030277,1,0.961431612339441,0,1,maintenance of gastrointestinal epithelium,BP,
2489,GO:0030278,1,0.0633075374857539,0,10,regulation of ossification,BP,
2490,GO:0030279,1,0.616704084333269,0,1,negative regulation of ossification,BP,
2491,GO:0030280,1,0.553341448228999,0,2,structural constituent of epidermis,MF,
2492,GO:0030282,1,0.21011728381818,0,6,bone mineralization,BP,
2493,GO:0030283,1,0.959711323077247,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
2498,GO:0030301,1,0.589149177457556,0,3,cholesterol transport,BP,
2499,GO:0030307,1,0.432604801012919,0,4,positive regulation of cell growth,BP,
2501,GO:0030309,1,0.773597169937423,0,1,poly-N-acetyllactosamine metabolic process,BP,
2502,GO:0030311,1,0.773597169937423,0,1,poly-N-acetyllactosamine biosynthetic process,BP,
2503,GO:0030314,1,0.77396315259318,0,1,junctional membrane complex,CC,
2505,GO:0030317,1,0.824053991557742,0,1,flagellated sperm motility,BP,
2510,GO:0030326,1,0.143703900162161,0,8,embryonic limb morphogenesis,BP,
2523,GO:0030431,1,0.597901784091742,0,2,sleep,BP,
2524,GO:0030432,1,0.977811028321075,0,1,peristalsis,BP,
2525,GO:0030449,1,0.774707989551907,0,1,regulation of complement activation,BP,
2526,GO:0030485,1,0.88139376547355,0,1,smooth muscle contractile fiber,CC,
2527,GO:0030488,1,0.959711323077247,0,1,tRNA methylation,BP,
2528,GO:0030496,1,0.672555151786547,0,2,midbody,CC,
2529,GO:0030497,1,0.765260800063365,0,1,fatty acid elongation,BP,
2530,GO:0030500,1,0.21011728381818,0,6,regulation of bone mineralization,BP,
2531,GO:0030501,1,0.21011728381818,0,6,positive regulation of bone mineralization,BP,
2532,GO:0030506,1,0.308254038215629,0,3,ankyrin binding,MF,
2536,GO:0030512,1,0.82090903190856,0,1,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
2537,GO:0030513,1,0.52181526023997,0,2,positive regulation of BMP signaling pathway,BP,
2538,GO:0030514,1,0.325807409203705,0,3,negative regulation of BMP signaling pathway,BP,
2539,GO:0030515,1,0.954572941883903,0,1,snoRNA binding,MF,
2540,GO:0030516,1,0.611439543999529,0,2,regulation of axon extension,BP,
2541,GO:0030517,1,0.611439543999529,0,2,negative regulation of axon extension,BP,
2542,GO:0030522,1,0.715839724297779,0,1,intracellular receptor signaling pathway,BP,
2543,GO:0030529,1,0.339798521027926,0,6,intracellular ribonucleoprotein complex,CC,
2544,GO:0030534,1,0.56371548798174,0,3,adult behavior,BP,
2545,GO:0030538,1,0.980495002631481,0,1,embryonic genitalia morphogenesis,BP,
2547,GO:0030540,1,0.36766202906952,0,5,female genitalia development,BP,
2553,GO:0030574,1,0.828965869670895,0,1,collagen catabolic process,BP,
2555,GO:0030594,1,0.701293732953001,0,1,neurotransmitter receptor activity,MF,
2557,GO:0030641,1,0.631296473034083,0,3,regulation of cellular pH,BP,
2558,GO:0030656,1,0.715839724297779,0,1,regulation of vitamin metabolic process,BP,
2561,GO:0030660,1,0.721712018608498,0,1,Golgi-associated vesicle membrane,CC,
2562,GO:0030662,1,0.41199932189379,0,3,coated vesicle membrane,CC,
2563,GO:0030665,1,0.41199932189379,0,3,clathrin-coated vesicle membrane,CC,
2564,GO:0030666,1,0.0427151820182423,0,13,endocytic vesicle membrane,CC,
2566,GO:0030669,1,0.534019898252239,0,2,clathrin-coated endocytic vesicle membrane,CC,
2567,GO:0030670,1,0.414501802657995,0,4,phagocytic vesicle membrane,CC,
2569,GO:0030673,1,0.7728397953467,0,1,axolemma,CC,
2571,GO:0030677,1,0.959711323077247,0,1,ribonuclease P complex,CC,
2572,GO:0030678,1,0.959711323077247,0,1,mitochondrial ribonuclease P complex,CC,
2574,GO:0030728,1,0.767464593952245,0,1,ovulation,BP,
2575,GO:0030742,1,0.755696467167836,0,2,GTP-dependent protein binding,MF,
2576,GO:0030760,1,0.882316889029658,0,1,pyridine N-methyltransferase activity,MF,
2577,GO:0030799,1,0.309762310303124,0,6,regulation of cyclic nucleotide metabolic process,BP,
2578,GO:0030800,1,0.802011392875838,0,1,negative regulation of cyclic nucleotide metabolic process,BP,
2579,GO:0030801,1,0.387365087001124,0,5,positive regulation of cyclic nucleotide metabolic process,BP,
2580,GO:0030802,1,0.564239357132328,0,4,regulation of cyclic nucleotide biosynthetic process,BP,
2581,GO:0030803,1,0.802011392875838,0,1,negative regulation of cyclic nucleotide biosynthetic process,BP,
2582,GO:0030804,1,0.704348604065564,0,3,positive regulation of cyclic nucleotide biosynthetic process,BP,
2583,GO:0030808,1,0.564239357132328,0,4,regulation of nucleotide biosynthetic process,BP,
2584,GO:0030809,1,0.802011392875838,0,1,negative regulation of nucleotide biosynthetic process,BP,
2585,GO:0030810,1,0.704348604065564,0,3,positive regulation of nucleotide biosynthetic process,BP,
2586,GO:0030814,1,0.621887253217057,0,4,regulation of cAMP metabolic process,BP,
2587,GO:0030815,1,0.802011392875838,0,1,negative regulation of cAMP metabolic process,BP,
2588,GO:0030816,1,0.783831602075014,0,2,positive regulation of cAMP metabolic process,BP,
2589,GO:0030817,1,0.777837201051389,0,2,regulation of cAMP biosynthetic process,BP,
2590,GO:0030818,1,0.802011392875838,0,1,negative regulation of cAMP biosynthetic process,BP,
2591,GO:0030819,1,0.970007741874261,0,1,positive regulation of cAMP biosynthetic process,BP,
2592,GO:0030823,1,0.495452849042376,0,3,regulation of cGMP metabolic process,BP,
2593,GO:0030825,1,0.495452849042376,0,3,positive regulation of cGMP metabolic process,BP,
2594,GO:0030826,1,0.72629372962817,0,2,regulation of cGMP biosynthetic process,BP,
2595,GO:0030828,1,0.72629372962817,0,2,positive regulation of cGMP biosynthetic process,BP,
2602,GO:0030838,1,0.964117353714657,0,1,positive regulation of actin filament polymerization,BP,
2603,GO:0030849,1,0.702569048854651,0,1,autosome,CC,
2604,GO:0030850,1,0.256577019121625,0,5,prostate gland development,BP,
2605,GO:0030851,1,0.766387473815025,0,1,granulocyte differentiation,BP,
2609,GO:0030858,1,0.167302075474865,0,7,positive regulation of epithelial cell differentiation,BP,
2610,GO:0030859,1,0.506147921111534,0,2,polarized epithelial cell differentiation,BP,
2613,GO:0030865,1,0.721712018608498,0,1,cortical cytoskeleton organization,BP,
2614,GO:0030866,1,0.721712018608498,0,1,cortical actin cytoskeleton organization,BP,
2616,GO:0030877,1,0.762142819578083,0,1,beta-catenin destruction complex,CC,
2617,GO:0030878,1,0.932942238066546,0,2,thyroid gland development,BP,
2618,GO:0030879,1,0.0538124745612155,0,11,mammary gland development,BP,
2622,GO:0030900,1,0.0198409644630439,0,15,forebrain development,BP,
2623,GO:0030901,1,0.471588486803689,0,3,midbrain development,BP,
2625,GO:0030903,1,0.683299665437994,0,1,notochord development,BP,
2626,GO:0030910,1,0.762142819578083,0,1,olfactory placode formation,BP,
2627,GO:0030916,1,0.932942238066546,0,2,otic vesicle formation,BP,
2628,GO:0030917,1,0.951532941209886,0,1,midbrain-hindbrain boundary development,BP,
2629,GO:0030947,1,0.639174285726716,0,3,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
2630,GO:0030949,1,0.639174285726716,0,3,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
2634,GO:0030976,1,0.808804407871666,0,1,thiamine pyrophosphate binding,MF,
2635,GO:0031000,1,0.77396315259318,0,1,response to caffeine,BP,
2639,GO:0031023,1,0.705316075573745,0,2,microtubule organizing center organization,BP,
2641,GO:0031033,1,0.657423063310495,0,1,myosin filament organization,BP,
2642,GO:0031034,1,0.657423063310495,0,1,myosin filament assembly,BP,
2643,GO:0031045,1,0.839437618379272,0,1,dense core granule,CC,
2644,GO:0031047,1,0.847043438938523,0,1,gene silencing by RNA,BP,
2645,GO:0031050,1,0.847043438938523,0,1,dsRNA fragmentation,BP,
2646,GO:0031056,1,0.744061959631107,0,1,regulation of histone modification,BP,
2647,GO:0031058,1,0.744061959631107,0,1,positive regulation of histone modification,BP,
2648,GO:0031069,1,0.604513831936949,0,2,hair follicle morphogenesis,BP,
2649,GO:0031072,1,0.7728397953467,0,1,heat shock protein binding,MF,
2650,GO:0031076,1,0.381345935736892,0,4,embryonic camera-type eye development,BP,
2658,GO:0031102,1,0.75321100610424,0,1,neuron projection regeneration,BP,
2659,GO:0031103,1,0.75321100610424,0,1,axon regeneration,BP,
2660,GO:0031109,1,0.717259055655535,0,2,microtubule polymerization or depolymerization,BP,
2661,GO:0031110,1,0.853799544891606,0,1,regulation of microtubule polymerization or depolymerization,BP,
2662,GO:0031112,1,0.853799544891606,0,1,positive regulation of microtubule polymerization or depolymerization,BP,
2663,GO:0031113,1,0.853799544891606,0,1,regulation of microtubule polymerization,BP,
2664,GO:0031116,1,0.853799544891606,0,1,positive regulation of microtubule polymerization,BP,
2665,GO:0031119,1,0.866821396494009,0,1,tRNA pseudouridine synthesis,BP,
2666,GO:0031122,1,0.640101013874304,0,2,cytoplasmic microtubule organization,BP,
2667,GO:0031128,1,0.238319987407336,0,9,developmental induction,BP,
2668,GO:0031133,1,0.858923178696575,0,1,regulation of axon diameter,BP,
2670,GO:0031145,1,0.957091557538293,0,1,anaphase-promoting complex-dependent catabolic process,BP,
2671,GO:0031146,1,0.957091557538293,0,1,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
2673,GO:0031177,1,0.629141955360923,0,1,phosphopantetheine binding,MF,
2674,GO:0031201,1,0.773692700518389,0,1,SNARE complex,CC,
2677,GO:0031223,1,0.581891717265043,0,2,auditory behavior,BP,
2682,GO:0031232,1,0.773132814998767,0,1,extrinsic component of external side of plasma membrane,CC,
2683,GO:0031234,1,0.544097130289503,0,2,extrinsic component of cytoplasmic side of plasma membrane,CC,
2684,GO:0031235,1,0.630314916494616,0,1,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
2687,GO:0031254,1,0.741809137632914,0,1,cell trailing edge,CC,
2688,GO:0031256,1,0.564319531118768,0,2,leading edge membrane,CC,
2689,GO:0031264,1,0.750187185736748,0,2,death-inducing signaling complex,CC,
2690,GO:0031265,1,0.836041871517245,0,1,CD95 death-inducing signaling complex,CC,
2696,GO:0031304,1,0.782663874445418,0,1,intrinsic component of mitochondrial inner membrane,CC,
2697,GO:0031305,1,0.782663874445418,0,1,integral component of mitochondrial inner membrane,CC,
2705,GO:0031330,1,0.0839399908278587,0,9,negative regulation of cellular catabolic process,BP,
2708,GO:0031334,1,0.383408622281772,0,5,positive regulation of protein complex assembly,BP,
2709,GO:0031338,1,0.710176573837243,0,1,regulation of vesicle fusion,BP,
2710,GO:0031341,1,0.836041871517245,0,1,regulation of cell killing,BP,
2711,GO:0031343,1,0.836041871517245,0,1,positive regulation of cell killing,BP,
2716,GO:0031348,1,0.513966795721809,0,3,negative regulation of defense response,BP,
2718,GO:0031365,1,0.706584649959871,0,1,N-terminal protein amino acid modification,BP,
2720,GO:0031397,1,0.957091557538293,0,1,negative regulation of protein ubiquitination,BP,
2727,GO:0031418,1,0.867164964013753,0,1,L-ascorbic acid binding,MF,
2728,GO:0031424,1,0.133174298320685,0,6,keratinization,BP,
2730,GO:0031434,1,0.77766081607843,0,1,mitogen-activated protein kinase kinase binding,MF,
2736,GO:0031501,1,0.987980034753378,0,1,mannosyltransferase complex,CC,
2737,GO:0031503,1,0.531092130892399,0,3,protein complex localization,BP,
2739,GO:0031528,1,0.741809137632914,0,1,microvillus membrane,CC,
2740,GO:0031529,1,0.940900393371674,0,1,ruffle organization,BP,
2741,GO:0031532,1,0.786958599253139,0,3,actin cytoskeleton reorganization,BP,
2745,GO:0031581,1,0.685786047637105,0,1,hemidesmosome assembly,BP,
2746,GO:0031583,1,0.802011392875838,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
2747,GO:0031588,1,0.759355645182739,0,1,nucleotide-activated protein kinase complex,CC,
2749,GO:0031624,1,0.685812470298157,0,1,ubiquitin conjugating enzyme binding,MF,
2751,GO:0031638,1,0.649026828744246,0,2,zymogen activation,BP,
2752,GO:0031639,1,0.776794728605423,0,1,plasminogen activation,BP,
2753,GO:0031640,1,0.80818803699794,0,1,killing of cells of other organism,BP,
2754,GO:0031641,1,0.772639837730134,0,1,regulation of myelination,BP,
2755,GO:0031644,1,0.507502424295925,0,3,regulation of neurological system process,BP,
2757,GO:0031648,1,0.768607936468567,0,1,protein destabilization,BP,
2758,GO:0031657,1,0.757459225760006,0,2,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
2759,GO:0031659,1,0.757459225760006,0,2,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
2761,GO:0031664,1,0.769446945848083,0,1,regulation of lipopolysaccharide-mediated signaling pathway,BP,
2762,GO:0031666,1,0.769446945848083,0,1,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
2768,GO:0031683,1,0.7728397953467,0,1,G-protein beta/gamma-subunit complex binding,MF,
2769,GO:0031690,1,0.820477274682133,0,1,adrenergic receptor binding,MF,
2770,GO:0031694,1,0.820477274682133,0,1,alpha-2A adrenergic receptor binding,MF,
2771,GO:0031705,1,0.802011392875838,0,1,bombesin receptor binding,MF,
2772,GO:0031707,1,0.802011392875838,0,1,endothelin A receptor binding,MF,
2773,GO:0031708,1,0.802011392875838,0,1,endothelin B receptor binding,MF,
2774,GO:0031730,1,0.980783972303563,0,1,CCR5 chemokine receptor binding,MF,
2775,GO:0031731,1,0.968025854772146,0,1,CCR6 chemokine receptor binding,MF,
2776,GO:0031779,1,0.970007741874261,0,1,melanocortin receptor binding,MF,
2777,GO:0031780,1,0.970007741874261,0,1,corticotropin hormone receptor binding,MF,
2778,GO:0031781,1,0.970007741874261,0,1,type 3 melanocortin receptor binding,MF,
2779,GO:0031782,1,0.970007741874261,0,1,type 4 melanocortin receptor binding,MF,
2780,GO:0031783,1,0.970007741874261,0,1,type 5 melanocortin receptor binding,MF,
2785,GO:0031907,1,0.523550634966784,0,4,microbody lumen,CC,
2787,GO:0031932,1,0.568749625020634,0,2,TORC2 complex,CC,
2791,GO:0031945,1,0.744587511205584,0,1,positive regulation of glucocorticoid metabolic process,BP,
2794,GO:0031948,1,0.744587511205584,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
2795,GO:0031952,1,0.77252698579057,0,1,regulation of protein autophosphorylation,BP,
2796,GO:0031954,1,0.77252698579057,0,1,positive regulation of protein autophosphorylation,BP,
2810,GO:0031994,1,0.685786047637105,0,1,insulin-like growth factor I binding,MF,
2811,GO:0031998,1,0.772639837730134,0,1,regulation of fatty acid beta-oxidation,BP,
2812,GO:0031999,1,0.772639837730134,0,1,negative regulation of fatty acid beta-oxidation,BP,
2814,GO:0032007,1,0.412840000358506,0,3,negative regulation of TOR signaling,BP,
2816,GO:0032024,1,0.961431612339441,0,1,positive regulation of insulin secretion,BP,
2817,GO:0032026,1,0.769446945848083,0,1,response to magnesium ion,BP,
2818,GO:0032029,1,0.585788010294756,0,1,myosin tail binding,MF,
2819,GO:0032036,1,0.585788010294756,0,1,myosin heavy chain binding,MF,
2820,GO:0032042,1,0.759355645182739,0,1,mitochondrial DNA metabolic process,BP,
2821,GO:0032052,1,0.715839724297779,0,1,bile acid binding,MF,
2822,GO:0032055,1,0.759355645182739,0,1,negative regulation of translation in response to stress,BP,
2823,GO:0032069,1,0.772639837730134,0,1,regulation of nuclease activity,BP,
2824,GO:0032070,1,0.772639837730134,0,1,regulation of deoxyribonuclease activity,BP,
2825,GO:0032071,1,0.772639837730134,0,1,regulation of endodeoxyribonuclease activity,BP,
2826,GO:0032075,1,0.772639837730134,0,1,positive regulation of nuclease activity,BP,
2827,GO:0032077,1,0.772639837730134,0,1,positive regulation of deoxyribonuclease activity,BP,
2828,GO:0032079,1,0.772639837730134,0,1,positive regulation of endodeoxyribonuclease activity,BP,
2829,GO:0032088,1,0.713006963402964,0,2,negative regulation of NF-kappaB transcription factor activity,BP,
2830,GO:0032090,1,0.964117353714657,0,1,Pyrin domain binding,MF,
2831,GO:0032091,1,0.465421527172051,0,3,negative regulation of protein binding,BP,
2833,GO:0032094,1,0.772639837730134,0,1,response to food,BP,
2835,GO:0032102,1,0.0746801203857882,0,9,negative regulation of response to external stimulus,BP,
2846,GO:0032225,1,0.977811028321075,0,1,regulation of synaptic transmission, dopaminergic,BP,
2847,GO:0032228,1,0.7728397953467,0,1,regulation of synaptic transmission, GABAergic,BP,
2848,GO:0032229,1,0.7728397953467,0,1,negative regulation of synaptic transmission, GABAergic,BP,
2851,GO:0032239,1,0.7728397953467,0,1,regulation of nucleobase-containing compound transport,BP,
2852,GO:0032241,1,0.7728397953467,0,1,positive regulation of nucleobase-containing compound transport,BP,
2853,GO:0032242,1,0.7728397953467,0,1,regulation of nucleoside transport,BP,
2854,GO:0032244,1,0.7728397953467,0,1,positive regulation of nucleoside transport,BP,
2855,GO:0032252,1,0.695760832683338,0,1,secretory granule localization,BP,
2856,GO:0032259,1,0.468684491304211,0,6,methylation,BP,
2863,GO:0032273,1,0.823059497299489,0,2,positive regulation of protein polymerization,BP,
2864,GO:0032274,1,0.767464593952245,0,1,gonadotropin secretion,BP,
2865,GO:0032276,1,0.767464593952245,0,1,regulation of gonadotropin secretion,BP,
2866,GO:0032277,1,0.767464593952245,0,1,negative regulation of gonadotropin secretion,BP,
2867,GO:0032278,1,0.767464593952245,0,1,positive regulation of gonadotropin secretion,BP,
2869,GO:0032281,1,0.541683009071215,0,2,AMPA glutamate receptor complex,CC,
2870,GO:0032287,1,0.772639837730134,0,1,peripheral nervous system myelin maintenance,BP,
2871,GO:0032292,1,0.596034044399365,0,2,peripheral nervous system axon ensheathment,BP,
2872,GO:0032303,1,0.802011392875838,0,1,regulation of icosanoid secretion,BP,
2873,GO:0032305,1,0.802011392875838,0,1,positive regulation of icosanoid secretion,BP,
2874,GO:0032306,1,0.802011392875838,0,1,regulation of prostaglandin secretion,BP,
2875,GO:0032308,1,0.802011392875838,0,1,positive regulation of prostaglandin secretion,BP,
2876,GO:0032309,1,0.802011392875838,0,1,icosanoid secretion,BP,
2877,GO:0032310,1,0.802011392875838,0,1,prostaglandin secretion,BP,
2878,GO:0032311,1,0.957515383118201,0,1,angiogenin-PRI complex,CC,
2880,GO:0032331,1,0.847043438938523,0,1,negative regulation of chondrocyte differentiation,BP,
2881,GO:0032332,1,0.686437070468383,0,2,positive regulation of chondrocyte differentiation,BP,
2886,GO:0032346,1,0.572342152026815,0,2,positive regulation of aldosterone metabolic process,BP,
2889,GO:0032349,1,0.572342152026815,0,2,positive regulation of aldosterone biosynthetic process,BP,
2892,GO:0032352,1,0.572342152026815,0,2,positive regulation of hormone metabolic process,BP,
2894,GO:0032354,1,0.47677780538375,0,2,response to follicle-stimulating hormone,BP,
2896,GO:0032364,1,0.744287228075405,0,1,oxygen homeostasis,BP,
2897,GO:0032365,1,0.458526295966965,0,3,intracellular lipid transport,BP,
2898,GO:0032366,1,0.596781289094949,0,2,intracellular sterol transport,BP,
2899,GO:0032367,1,0.596781289094949,0,2,intracellular cholesterol transport,BP,
2900,GO:0032368,1,0.361195147527799,0,5,regulation of lipid transport,BP,
2901,GO:0032369,1,0.762853855341402,0,2,negative regulation of lipid transport,BP,
2902,GO:0032370,1,0.474866679356144,0,3,positive regulation of lipid transport,BP,
2903,GO:0032371,1,0.761625090232792,0,2,regulation of sterol transport,BP,
2904,GO:0032372,1,0.987456549281,0,1,negative regulation of sterol transport,BP,
2905,GO:0032373,1,0.77139588570204,0,1,positive regulation of sterol transport,BP,
2906,GO:0032374,1,0.761625090232792,0,2,regulation of cholesterol transport,BP,
2907,GO:0032375,1,0.987456549281,0,1,negative regulation of cholesterol transport,BP,
2908,GO:0032376,1,0.77139588570204,0,1,positive regulation of cholesterol transport,BP,
2913,GO:0032400,1,0.637127334830935,0,2,melanosome localization,BP,
2914,GO:0032401,1,0.637127334830935,0,2,establishment of melanosome localization,BP,
2915,GO:0032402,1,0.637127334830935,0,2,melanosome transport,BP,
2923,GO:0032418,1,0.561734632247565,0,2,lysosome localization,BP,
2927,GO:0032427,1,0.721712018608498,0,1,GBD domain binding,MF,
2928,GO:0032429,1,0.957515383118201,0,1,regulation of phospholipase A2 activity,BP,
2929,GO:0032430,1,0.957515383118201,0,1,positive regulation of phospholipase A2 activity,BP,
2930,GO:0032431,1,0.957515383118201,0,1,activation of phospholipase A2 activity,BP,
2931,GO:0032433,1,0.812175389134332,0,1,filopodium tip,CC,
2932,GO:0032434,1,0.410697033458851,0,3,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
2933,GO:0032436,1,0.529224004541781,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
2934,GO:0032438,1,0.908975838289389,0,1,melanosome organization,BP,
2937,GO:0032459,1,0.823241180606138,0,1,regulation of protein oligomerization,BP,
2938,GO:0032461,1,0.823241180606138,0,1,positive regulation of protein oligomerization,BP,
2940,GO:0032480,1,0.865293262820488,0,2,negative regulation of type I interferon production,BP,
2942,GO:0032495,1,0.616704084333269,0,1,response to muramyl dipeptide,BP,
2947,GO:0032506,1,0.700469233394229,0,1,cytokinetic process,BP,
2948,GO:0032507,1,0.532782060363931,0,2,maintenance of protein location in cell,BP,
2949,GO:0032515,1,0.824053991557742,0,1,negative regulation of phosphoprotein phosphatase activity,BP,
2950,GO:0032526,1,0.0848514465747221,0,11,response to retinoic acid,BP,
2952,GO:0032536,1,0.638884656670793,0,2,regulation of cell projection size,BP,
2953,GO:0032542,1,0.759355645182739,0,1,sulfiredoxin activity,MF,
2954,GO:0032543,1,0.742312205428389,0,3,mitochondrial translation,BP,
2961,GO:0032570,1,0.784021941884902,0,1,response to progesterone,BP,
2963,GO:0032585,1,0.77312897108567,0,1,multivesicular body membrane,CC,
2964,GO:0032587,1,0.730958015688662,0,1,ruffle membrane,CC,
2965,GO:0032589,1,0.7728397953467,0,1,neuron projection membrane,CC,
2966,GO:0032592,1,0.782663874445418,0,1,integral component of mitochondrial membrane,CC,
2968,GO:0032605,1,0.767464593952245,0,1,hepatocyte growth factor production,BP,
2970,GO:0032607,1,0.897578402296713,0,1,interferon-alpha production,BP,
2973,GO:0032610,1,0.968025854772146,0,1,interleukin-1 alpha production,BP,
2974,GO:0032611,1,0.658592740887016,0,2,interleukin-1 beta production,BP,
2978,GO:0032633,1,0.47186732494017,0,2,interleukin-4 production,BP,
2980,GO:0032637,1,0.550029796535746,0,3,interleukin-8 production,BP,
2983,GO:0032646,1,0.767464593952245,0,1,regulation of hepatocyte growth factor production,BP,
2984,GO:0032647,1,0.897578402296713,0,1,regulation of interferon-alpha production,BP,
2987,GO:0032650,1,0.968025854772146,0,1,regulation of interleukin-1 alpha production,BP,
2988,GO:0032651,1,0.658592740887016,0,2,regulation of interleukin-1 beta production,BP,
2992,GO:0032673,1,0.766387473815025,0,1,regulation of interleukin-4 production,BP,
2994,GO:0032677,1,0.550029796535746,0,3,regulation of interleukin-8 production,BP,
2996,GO:0032686,1,0.767464593952245,0,1,negative regulation of hepatocyte growth factor production,BP,
2997,GO:0032687,1,0.897578402296713,0,1,negative regulation of interferon-alpha production,BP,
2998,GO:0032688,1,0.865293262820488,0,2,negative regulation of interferon-beta production,BP,
3002,GO:0032713,1,0.766387473815025,0,1,negative regulation of interleukin-4 production,BP,
3008,GO:0032730,1,0.968025854772146,0,1,positive regulation of interleukin-1 alpha production,BP,
3009,GO:0032731,1,0.658592740887016,0,2,positive regulation of interleukin-1 beta production,BP,
3010,GO:0032732,1,0.637340676459349,0,3,positive regulation of interleukin-1 production,BP,
3011,GO:0032733,1,0.964117353714657,0,1,positive regulation of interleukin-10 production,BP,
3014,GO:0032757,1,0.550029796535746,0,3,positive regulation of interleukin-8 production,BP,
3016,GO:0032762,1,0.80818803699794,0,1,mast cell cytokine production,BP,
3017,GO:0032768,1,0.469997928690402,0,5,regulation of monooxygenase activity,BP,
3018,GO:0032769,1,0.906943268947671,0,1,negative regulation of monooxygenase activity,BP,
3019,GO:0032770,1,0.755379396227222,0,2,positive regulation of monooxygenase activity,BP,
3021,GO:0032780,1,0.824053991557742,0,1,negative regulation of ATPase activity,BP,
3022,GO:0032781,1,0.80789126280944,0,2,positive regulation of ATPase activity,BP,
3023,GO:0032784,1,0.620242022485549,0,2,regulation of DNA-templated transcription, elongation,BP,
3024,GO:0032785,1,0.762142819578083,0,1,negative regulation of DNA-templated transcription, elongation,BP,
3026,GO:0032794,1,0.549769817564845,0,2,GTPase activating protein binding,MF,
3027,GO:0032795,1,0.7728397953467,0,1,heterotrimeric G-protein binding,MF,
3028,GO:0032800,1,0.802011392875838,0,1,receptor biosynthetic process,BP,
3030,GO:0032808,1,0.980495002631481,0,1,lacrimal gland development,BP,
3031,GO:0032811,1,0.628065409479983,0,2,negative regulation of epinephrine secretion,BP,
3032,GO:0032813,1,0.684270209699463,0,3,tumor necrosis factor receptor superfamily binding,MF,
3037,GO:0032835,1,0.200139266203848,0,6,glomerulus development,BP,
3038,GO:0032836,1,0.771150420617929,0,1,glomerular basement membrane development,BP,
3041,GO:0032846,1,0.454096231543212,0,3,positive regulation of homeostatic process,BP,
3046,GO:0032873,1,0.772639837730134,0,1,negative regulation of stress-activated MAPK cascade,BP,
3050,GO:0032881,1,0.596359050696602,0,2,regulation of polysaccharide metabolic process,BP,
3051,GO:0032885,1,0.596359050696602,0,2,regulation of polysaccharide biosynthetic process,BP,
3053,GO:0032890,1,0.477746426126693,0,3,regulation of organic acid transport,BP,
3054,GO:0032891,1,0.596601273650365,0,2,negative regulation of organic acid transport,BP,
3055,GO:0032892,1,0.802011392875838,0,1,positive regulation of organic acid transport,BP,
3056,GO:0032898,1,0.7728397953467,0,1,neurotrophin production,BP,
3057,GO:0032899,1,0.7728397953467,0,1,regulation of neurotrophin production,BP,
3058,GO:0032900,1,0.7728397953467,0,1,negative regulation of neurotrophin production,BP,
3059,GO:0032924,1,0.449859799747963,0,4,activin receptor signaling pathway,BP,
3060,GO:0032925,1,0.587306432743225,0,3,regulation of activin receptor signaling pathway,BP,
3061,GO:0032926,1,0.599163497255171,0,2,negative regulation of activin receptor signaling pathway,BP,
3062,GO:0032934,1,0.596781289094949,0,2,sterol binding,MF,
3064,GO:0032941,1,0.555479336886487,0,3,secretion by tissue,BP,
3069,GO:0032947,1,0.762142819578083,0,1,protein complex scaffold,MF,
3076,GO:0032982,1,0.657423063310495,0,1,myosin filament,CC,
3081,GO:0032994,1,0.987456549281,0,1,protein-lipid complex,CC,
3082,GO:0033002,1,0.0978464036951685,0,11,muscle cell proliferation,BP,
3083,GO:0033010,1,0.75321100610424,0,1,paranodal junction,CC,
3084,GO:0033013,1,0.772107268247692,0,1,tetrapyrrole metabolic process,BP,
3085,GO:0033017,1,0.77396315259318,0,1,sarcoplasmic reticulum membrane,CC,
3086,GO:0033018,1,0.77396315259318,0,1,sarcoplasmic reticulum lumen,CC,
3096,GO:0033044,1,0.744061959631107,0,1,regulation of chromosome organization,BP,
3098,GO:0033077,1,0.210567710536366,0,6,T cell differentiation in thymus,BP,
3099,GO:0033079,1,0.630272358048551,0,2,immature T cell proliferation,BP,
3100,GO:0033080,1,0.630272358048551,0,2,immature T cell proliferation in thymus,BP,
3101,GO:0033081,1,0.847043438938523,0,1,regulation of T cell differentiation in thymus,BP,
3102,GO:0033083,1,0.847043438938523,0,1,regulation of immature T cell proliferation,BP,
3103,GO:0033084,1,0.847043438938523,0,1,regulation of immature T cell proliferation in thymus,BP,
3104,GO:0033085,1,0.847043438938523,0,1,negative regulation of T cell differentiation in thymus,BP,
3105,GO:0033087,1,0.847043438938523,0,1,negative regulation of immature T cell proliferation,BP,
3106,GO:0033088,1,0.847043438938523,0,1,negative regulation of immature T cell proliferation in thymus,BP,
3107,GO:0033093,1,0.619584542279476,0,2,Weibel-Palade body,CC,
3111,GO:0033139,1,0.744061959631107,0,1,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
3112,GO:0033141,1,0.744061959631107,0,1,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
3116,GO:0033162,1,0.702489681922357,0,2,melanosome membrane,CC,
3117,GO:0033173,1,0.772573466595224,0,1,calcineurin-NFAT signaling cascade,BP,
3118,GO:0033185,1,0.987980034753378,0,1,dolichol-phosphate-mannose synthase complex,CC,
3121,GO:0033238,1,0.957091557538293,0,1,regulation of cellular amine metabolic process,BP,
3122,GO:0033267,1,0.411448486412457,0,3,axon part,CC,
3123,GO:0033268,1,0.690409015386517,0,1,node of Ranvier,CC,
3124,GO:0033270,1,0.690409015386517,0,1,paranode region of axon,CC,
3127,GO:0033278,1,0.527239189772458,0,2,cell proliferation in midbrain,BP,
3128,GO:0033280,1,0.528834412968773,0,2,response to vitamin D,BP,
3130,GO:0033306,1,0.83176074627617,0,1,phytol metabolic process,BP,
3132,GO:0033344,1,0.761625090232792,0,2,cholesterol efflux,BP,
3133,GO:0033363,1,0.908975838289389,0,1,secretory granule organization,BP,
3135,GO:0033483,1,0.744287228075405,0,1,gas homeostasis,BP,
3139,GO:0033539,1,0.581900331887074,0,3,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
3140,GO:0033549,1,0.776747906170104,0,1,MAP kinase phosphatase activity,MF,
3142,GO:0033558,1,0.702569048854651,0,1,protein deacetylase activity,MF,
3143,GO:0033559,1,0.491868974019838,0,3,unsaturated fatty acid metabolic process,BP,
3145,GO:0033563,1,0.951532941209886,0,1,dorsal/ventral axon guidance,BP,
3146,GO:0033572,1,0.773132814998767,0,1,transferrin transport,BP,
3147,GO:0033574,1,0.594418682686151,0,2,response to testosterone,BP,
3148,GO:0033598,1,0.683299665437994,0,1,mammary gland epithelial cell proliferation,BP,
3149,GO:0033603,1,0.977811028321075,0,1,positive regulation of dopamine secretion,BP,
3150,GO:0033604,1,0.506907931869612,0,3,negative regulation of catecholamine secretion,BP,
3151,GO:0033605,1,0.977811028321075,0,1,positive regulation of catecholamine secretion,BP,
3152,GO:0033612,1,0.29621254838725,0,6,receptor serine/threonine kinase binding,MF,
3153,GO:0033613,1,0.750376170507387,0,2,activating transcription factor binding,MF,
3154,GO:0033627,1,0.393610844633435,0,3,cell adhesion mediated by integrin,BP,
3155,GO:0033628,1,0.539824381398152,0,2,regulation of cell adhesion mediated by integrin,BP,
3156,GO:0033631,1,0.730958015688662,0,1,cell-cell adhesion mediated by integrin,BP,
3159,GO:0033687,1,0.768607936468567,0,1,osteoblast proliferation,BP,
3160,GO:0033688,1,0.768607936468567,0,1,regulation of osteoblast proliferation,BP,
3161,GO:0033690,1,0.768607936468567,0,1,positive regulation of osteoblast proliferation,BP,
3162,GO:0033692,1,0.597187745179843,0,2,cellular polysaccharide biosynthetic process,BP,
3163,GO:0033700,1,0.761625090232792,0,2,phospholipid efflux,BP,
3166,GO:0033865,1,0.76138364931296,0,2,nucleoside bisphosphate metabolic process,BP,
3167,GO:0033866,1,0.79777800716672,0,1,nucleoside bisphosphate biosynthetic process,BP,
3168,GO:0033869,1,0.954572941883903,0,1,nucleoside bisphosphate catabolic process,BP,
3169,GO:0033875,1,0.76138364931296,0,2,ribonucleoside bisphosphate metabolic process,BP,
3171,GO:0034030,1,0.79777800716672,0,1,ribonucleoside bisphosphate biosynthetic process,BP,
3172,GO:0034031,1,0.954572941883903,0,1,ribonucleoside bisphosphate catabolic process,BP,
3173,GO:0034032,1,0.76138364931296,0,2,purine nucleoside bisphosphate metabolic process,BP,
3174,GO:0034033,1,0.79777800716672,0,1,purine nucleoside bisphosphate biosynthetic process,BP,
3175,GO:0034034,1,0.954572941883903,0,1,purine nucleoside bisphosphate catabolic process,BP,
3176,GO:0034040,1,0.77139588570204,0,1,lipid-transporting ATPase activity,MF,
3177,GO:0034041,1,0.77139588570204,0,1,sterol-transporting ATPase activity,MF,
3180,GO:0034101,1,0.499595345029787,0,3,erythrocyte homeostasis,BP,
3182,GO:0034104,1,0.763459376420346,0,1,negative regulation of tissue remodeling,BP,
3183,GO:0034105,1,0.715839724297779,0,1,positive regulation of tissue remodeling,BP,
3185,GO:0034113,1,0.376967258797032,0,3,heterotypic cell-cell adhesion,BP,
3186,GO:0034114,1,0.739713014367407,0,1,regulation of heterotypic cell-cell adhesion,BP,
3187,GO:0034116,1,0.739713014367407,0,1,positive regulation of heterotypic cell-cell adhesion,BP,
3194,GO:0034219,1,0.792322370974488,0,1,carbohydrate transmembrane transport,BP,
3196,GO:0034236,1,0.777135023329378,0,1,protein kinase A catalytic subunit binding,MF,
3197,GO:0034243,1,0.762142819578083,0,1,regulation of transcription elongation from RNA polymerase II promoter,BP,
3198,GO:0034244,1,0.762142819578083,0,1,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
3200,GO:0034249,1,0.615256950424503,0,3,negative regulation of cellular amide metabolic process,BP,
3202,GO:0034260,1,0.358283781182839,0,4,negative regulation of GTPase activity,BP,
3204,GO:0034285,1,0.77994876250451,0,1,response to disaccharide,BP,
3205,GO:0034308,1,0.799560407603664,0,2,primary alcohol metabolic process,BP,
3211,GO:0034340,1,0.40991162256991,0,4,response to type I interferon,BP,
3217,GO:0034358,1,0.987456549281,0,1,plasma lipoprotein particle,CC,
3218,GO:0034361,1,0.987456549281,0,1,very-low-density lipoprotein particle,CC,
3219,GO:0034364,1,0.987456549281,0,1,high-density lipoprotein particle,CC,
3220,GO:0034367,1,0.761625090232792,0,2,macromolecular complex remodeling,BP,
3221,GO:0034368,1,0.761625090232792,0,2,protein-lipid complex remodeling,BP,
3222,GO:0034369,1,0.761625090232792,0,2,plasma lipoprotein particle remodeling,BP,
3223,GO:0034374,1,0.77139588570204,0,1,low-density lipoprotein particle remodeling,BP,
3224,GO:0034375,1,0.761625090232792,0,2,high-density lipoprotein particle remodeling,BP,
3225,GO:0034377,1,0.987456549281,0,1,plasma lipoprotein particle assembly,BP,
3226,GO:0034379,1,0.987456549281,0,1,very-low-density lipoprotein particle assembly,BP,
3227,GO:0034381,1,0.987456549281,0,1,plasma lipoprotein particle clearance,BP,
3228,GO:0034382,1,0.987456549281,0,1,chylomicron remnant clearance,BP,
3229,GO:0034385,1,0.987456549281,0,1,triglyceride-rich plasma lipoprotein particle,CC,
3230,GO:0034390,1,0.802011392875838,0,1,smooth muscle cell apoptotic process,BP,
3231,GO:0034391,1,0.802011392875838,0,1,regulation of smooth muscle cell apoptotic process,BP,
3232,GO:0034392,1,0.802011392875838,0,1,negative regulation of smooth muscle cell apoptotic process,BP,
3234,GO:0034399,1,0.50701452795433,0,2,nuclear periphery,CC,
3235,GO:0034405,1,0.772639837730134,0,1,response to fluid shear stress,BP,
3237,GO:0034433,1,0.761625090232792,0,2,steroid esterification,BP,
3238,GO:0034434,1,0.761625090232792,0,2,sterol esterification,BP,
3239,GO:0034435,1,0.761625090232792,0,2,cholesterol esterification,BP,
3240,GO:0034436,1,0.77139588570204,0,1,glycoprotein transport,BP,
3241,GO:0034437,1,0.77139588570204,0,1,glycoprotein transporter activity,MF,
3244,GO:0034447,1,0.987456549281,0,1,very-low-density lipoprotein particle clearance,BP,
3245,GO:0034452,1,0.585788010294756,0,1,dynactin binding,MF,
3247,GO:0034470,1,0.513923283988516,0,4,ncRNA processing,BP,
3249,GO:0034505,1,0.861324182910351,0,1,tooth mineralization,BP,
3257,GO:0034629,1,0.788139761849395,0,1,cellular protein complex localization,BP,
3258,GO:0034632,1,0.961431612339441,0,1,retinol transporter activity,MF,
3259,GO:0034633,1,0.961431612339441,0,1,retinol transport,BP,
3260,GO:0034637,1,0.597187745179843,0,2,cellular carbohydrate biosynthetic process,BP,
3261,GO:0034638,1,0.987456549281,0,1,phosphatidylcholine catabolic process,BP,
3269,GO:0034660,1,0.462363326032458,0,6,ncRNA metabolic process,BP,
3273,GO:0034694,1,0.619191496630601,0,2,response to prostaglandin,BP,
3274,GO:0034695,1,0.772639837730134,0,1,response to prostaglandin E,BP,
3275,GO:0034696,1,0.802011392875838,0,1,response to prostaglandin F,BP,
3277,GO:0034699,1,0.774318895616471,0,1,response to luteinizing hormone,BP,
3281,GO:0034705,1,0.385687523124419,0,4,potassium channel complex,CC,
3282,GO:0034707,1,0.799628824156165,0,2,chloride channel complex,CC,
3284,GO:0034755,1,0.812175389134332,0,1,iron ion transmembrane transport,BP,
3294,GO:0035005,1,0.522008788735231,0,2,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
3296,GO:0035019,1,0.471924343048865,0,4,somatic stem cell population maintenance,BP,
3301,GO:0035054,1,0.768607936468567,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
3302,GO:0035065,1,0.744061959631107,0,1,regulation of histone acetylation,BP,
3303,GO:0035066,1,0.744061959631107,0,1,positive regulation of histone acetylation,BP,
3304,GO:0035088,1,0.506147921111534,0,2,establishment or maintenance of apical/basal cell polarity,BP,
3305,GO:0035089,1,0.506147921111534,0,2,establishment of apical/basal cell polarity,BP,
3307,GO:0035094,1,0.620540715082229,0,2,response to nicotine,BP,
3308,GO:0035107,1,0.140742889369069,0,9,appendage morphogenesis,BP,
3309,GO:0035108,1,0.140742889369069,0,9,limb morphogenesis,BP,
3310,GO:0035112,1,0.942652774379259,0,2,genitalia morphogenesis,BP,
3311,GO:0035113,1,0.143703900162161,0,8,embryonic appendage morphogenesis,BP,
3312,GO:0035115,1,0.768859115887169,0,2,embryonic forelimb morphogenesis,BP,
3313,GO:0035116,1,0.380501121518704,0,5,embryonic hindlimb morphogenesis,BP,
3314,GO:0035136,1,0.768859115887169,0,2,forelimb morphogenesis,BP,
3315,GO:0035137,1,0.380501121518704,0,5,hindlimb morphogenesis,BP,
3317,GO:0035150,1,0.152469632302714,0,9,regulation of tube size,BP,
3319,GO:0035194,1,0.847043438938523,0,1,posttranscriptional gene silencing by RNA,BP,
3320,GO:0035195,1,0.847043438938523,0,1,gene silencing by miRNA,BP,
3321,GO:0035196,1,0.847043438938523,0,1,production of miRNAs involved in gene silencing by miRNA,BP,
3323,GO:0035235,1,0.701293732953001,0,1,ionotropic glutamate receptor signaling pathway,BP,
3325,GO:0035249,1,0.7728397953467,0,1,synaptic transmission, glutamatergic,BP,
3326,GO:0035250,1,0.773597169937423,0,1,UDP-galactosyltransferase activity,MF,
3327,GO:0035251,1,0.938788431047363,0,1,UDP-glucosyltransferase activity,MF,
3328,GO:0035257,1,0.715839724297779,0,1,nuclear hormone receptor binding,MF,
3331,GO:0035268,1,0.987980034753378,0,1,protein mannosylation,BP,
3332,GO:0035269,1,0.987980034753378,0,1,protein O-linked mannosylation,BP,
3337,GO:0035296,1,0.152469632302714,0,9,regulation of tube diameter,BP,
3339,GO:0035304,1,0.636427817201237,0,2,regulation of protein dephosphorylation,BP,
3341,GO:0035306,1,0.488383304803299,0,3,positive regulation of dephosphorylation,BP,
3342,GO:0035307,1,0.7728397953467,0,1,positive regulation of protein dephosphorylation,BP,
3343,GO:0035308,1,0.824053991557742,0,1,negative regulation of protein dephosphorylation,BP,
3344,GO:0035313,1,0.490185010102864,0,3,wound healing, spreading of epidermal cells,BP,
3346,GO:0035329,1,0.661948364956753,0,1,hippo signaling,BP,
3353,GO:0035411,1,0.74668493948331,0,1,catenin import into nucleus,BP,
3354,GO:0035412,1,0.74668493948331,0,1,regulation of catenin import into nucleus,BP,
3355,GO:0035418,1,0.586435697619115,0,2,protein localization to synapse,BP,
3356,GO:0035428,1,0.792322370974488,0,1,hexose transmembrane transport,BP,
3357,GO:0035434,1,0.848890406189778,0,1,copper ion transmembrane transport,BP,
3360,GO:0035493,1,0.773692700518389,0,1,SNARE complex assembly,BP,
3361,GO:0035502,1,0.771150420617929,0,1,metanephric part of ureteric bud development,BP,
3363,GO:0035567,1,0.310126480416102,0,5,non-canonical Wnt signaling pathway,BP,
3364,GO:0035577,1,0.646292828256697,0,2,azurophil granule membrane,CC,
3366,GO:0035579,1,0.466175559067523,0,3,specific granule membrane,CC,
3367,GO:0035580,1,0.77312897108567,0,1,specific granule lumen,CC,
3368,GO:0035584,1,0.968025854772146,0,1,calcium-mediated signaling using intracellular calcium source,BP,
3369,GO:0035586,1,0.598896779922525,0,2,purinergic receptor activity,MF,
3370,GO:0035587,1,0.598896779922525,0,2,purinergic receptor signaling pathway,BP,
3371,GO:0035588,1,0.598896779922525,0,2,G-protein coupled purinergic receptor signaling pathway,BP,
3372,GO:0035589,1,0.775603503393362,0,1,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
3373,GO:0035590,1,0.775603503393362,0,1,purinergic nucleotide receptor signaling pathway,BP,
3375,GO:0035601,1,0.582324608535223,0,2,protein deacylation,BP,
3376,GO:0035623,1,0.766486369353892,0,1,renal glucose absorption,BP,
3377,GO:0035624,1,0.628065409479983,0,2,receptor transactivation,BP,
3378,GO:0035625,1,0.628065409479983,0,2,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
3379,GO:0035630,1,0.768607936468567,0,1,bone mineralization involved in bone maturation,BP,
3380,GO:0035635,1,0.712353706175808,0,1,entry of bacterium into host cell,BP,
3381,GO:0035637,1,0.0827137874480661,0,10,multicellular organismal signaling,BP,
3384,GO:0035646,1,0.908975838289389,0,1,endosome to melanosome transport,BP,
3385,GO:0035650,1,0.908975838289389,0,1,AP-1 adaptor complex binding,MF,
3386,GO:0035651,1,0.908975838289389,0,1,AP-3 adaptor complex binding,MF,
3387,GO:0035655,1,0.596359050696602,0,2,interleukin-18-mediated signaling pathway,BP,
3388,GO:0035659,1,0.858923178696575,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
3391,GO:0035697,1,0.836041871517245,0,1,CD8-positive, alpha-beta T cell extravasation,BP,
3392,GO:0035698,1,0.836041871517245,0,1,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
3394,GO:0035710,1,0.766387473815025,0,1,CD4-positive, alpha-beta T cell activation,BP,
3395,GO:0035725,1,0.984658110865059,0,1,sodium ion transmembrane transport,BP,
3396,GO:0035728,1,0.765858508486771,0,1,response to hepatocyte growth factor,BP,
3397,GO:0035729,1,0.765858508486771,0,1,cellular response to hepatocyte growth factor stimulus,BP,
3398,GO:0035747,1,0.695760832683338,0,1,natural killer cell chemotaxis,BP,
3400,GO:0035766,1,0.89251195457963,0,1,cell chemotaxis to fibroblast growth factor,BP,
3401,GO:0035767,1,0.549984195939634,0,2,endothelial cell chemotaxis,BP,
3402,GO:0035768,1,0.89251195457963,0,1,endothelial cell chemotaxis to fibroblast growth factor,BP,
3403,GO:0035770,1,0.727749574179032,0,1,ribonucleoprotein granule,CC,
3404,GO:0035787,1,0.77252698579057,0,1,cell migration involved in kidney development,BP,
3405,GO:0035788,1,0.77252698579057,0,1,cell migration involved in metanephros development,BP,
3406,GO:0035789,1,0.77252698579057,0,1,metanephric mesenchymal cell migration,BP,
3407,GO:0035791,1,0.77252698579057,0,1,platelet-derived growth factor receptor-beta signaling pathway,BP,
3408,GO:0035793,1,0.77252698579057,0,1,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
3409,GO:0035794,1,0.823241180606138,0,1,positive regulation of mitochondrial membrane permeability,BP,
3410,GO:0035795,1,0.912530916414626,0,1,negative regulation of mitochondrial membrane permeability,BP,
3411,GO:0035801,1,0.771150420617929,0,1,adrenal cortex development,BP,
3412,GO:0035802,1,0.771150420617929,0,1,adrenal cortex formation,BP,
3413,GO:0035809,1,0.587774428067184,0,2,regulation of urine volume,BP,
3414,GO:0035810,1,0.587774428067184,0,2,positive regulation of urine volume,BP,
3415,GO:0035812,1,0.453432950730039,0,3,renal sodium excretion,BP,
3416,GO:0035813,1,0.453432950730039,0,3,regulation of renal sodium excretion,BP,
3417,GO:0035814,1,0.7728397953467,0,1,negative regulation of renal sodium excretion,BP,
3418,GO:0035815,1,0.587774428067184,0,2,positive regulation of renal sodium excretion,BP,
3419,GO:0035821,1,0.80818803699794,0,1,modification of morphology or physiology of other organism,BP,
3420,GO:0035844,1,0.847043438938523,0,1,cloaca development,BP,
3421,GO:0035850,1,0.196676189104766,0,7,epithelial cell differentiation involved in kidney development,BP,
3422,GO:0035855,1,0.766387473815025,0,1,megakaryocyte development,BP,
3423,GO:0035859,1,0.759355645182739,0,1,Seh1-associated complex,CC,
3425,GO:0035877,1,0.762712607721979,0,2,death effector domain binding,MF,
3426,GO:0035878,1,0.685786047637105,0,1,nail development,BP,
3428,GO:0035886,1,0.475668378950991,0,2,vascular smooth muscle cell differentiation,BP,
3429,GO:0035900,1,0.940900393371674,0,1,response to isolation stress,BP,
3431,GO:0035904,1,0.334476105988684,0,4,aorta development,BP,
3432,GO:0035907,1,0.785634671671933,0,1,dorsal aorta development,BP,
3433,GO:0035909,1,0.334476105988684,0,4,aorta morphogenesis,BP,
3434,GO:0035912,1,0.785634671671933,0,1,dorsal aorta morphogenesis,BP,
3435,GO:0035914,1,0.581150326486365,0,2,skeletal muscle cell differentiation,BP,
3437,GO:0035929,1,0.769446945848083,0,1,steroid hormone secretion,BP,
3438,GO:0035930,1,0.769446945848083,0,1,corticosteroid hormone secretion,BP,
3439,GO:0035931,1,0.769446945848083,0,1,mineralocorticoid secretion,BP,
3440,GO:0035932,1,0.769446945848083,0,1,aldosterone secretion,BP,
3441,GO:0035939,1,0.785634671671933,0,1,microsatellite binding,MF,
3442,GO:0035962,1,0.746946287086585,0,1,response to interleukin-13,BP,
3443,GO:0035963,1,0.746946287086585,0,1,cellular response to interleukin-13,BP,
3446,GO:0035970,1,0.776747906170104,0,1,peptidyl-threonine dephosphorylation,BP,
3449,GO:0035989,1,0.847043438938523,0,1,tendon development,BP,
3450,GO:0035990,1,0.847043438938523,0,1,tendon cell differentiation,BP,
3451,GO:0035992,1,0.847043438938523,0,1,tendon formation,BP,
3452,GO:0035993,1,0.847043438938523,0,1,deltoid tuberosity development,BP,
3453,GO:0035994,1,0.802011392875838,0,1,response to muscle stretch,BP,
3454,GO:0036003,1,0.467514029642658,0,2,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
3455,GO:0036010,1,0.741809137632914,0,1,protein localization to endosome,BP,
3463,GO:0036035,1,0.763459376420346,0,1,osteoclast development,BP,
3464,GO:0036041,1,0.946578828055197,0,1,long-chain fatty acid binding,MF,
3466,GO:0036072,1,0.89251195457963,0,1,direct ossification,BP,
3467,GO:0036075,1,0.448699022931459,0,4,replacement ossification,BP,
3468,GO:0036089,1,0.700469233394229,0,1,cleavage furrow formation,BP,
3469,GO:0036091,1,0.759355645182739,0,1,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
3472,GO:0036109,1,0.725770278597532,0,1,alpha-linolenic acid metabolic process,BP,
3473,GO:0036118,1,0.739713014367407,0,1,hyaluranon cable assembly,BP,
3474,GO:0036149,1,0.930530251776604,0,1,phosphatidylinositol acyl-chain remodeling,BP,
3475,GO:0036150,1,0.930530251776604,0,1,phosphatidylserine acyl-chain remodeling,BP,
3476,GO:0036151,1,0.695788058436051,0,2,phosphatidylcholine acyl-chain remodeling,BP,
3477,GO:0036152,1,0.695788058436051,0,2,phosphatidylethanolamine acyl-chain remodeling,BP,
3478,GO:0036166,1,0.77252698579057,0,1,phenotypic switching,BP,
3481,GO:0036257,1,0.77312897108567,0,1,multivesicular body organization,BP,
3483,GO:0036294,1,0.20714241787389,0,7,cellular response to decreased oxygen levels,BP,
3485,GO:0036304,1,0.785634671671933,0,1,umbilical cord morphogenesis,BP,
3488,GO:0036342,1,0.683299665437994,0,1,post-anal tail morphogenesis,BP,
3489,GO:0036344,1,0.766387473815025,0,1,platelet morphogenesis,BP,
3490,GO:0036376,1,0.984658110865059,0,1,sodium ion export from cell,BP,
3492,GO:0036461,1,0.908975838289389,0,1,BLOC-2 complex binding,MF,
3493,GO:0036462,1,0.836041871517245,0,1,TRAIL-activated apoptotic signaling pathway,BP,
3494,GO:0036464,1,0.727749574179032,0,1,cytoplasmic ribonucleoprotein granule,CC,
3495,GO:0036465,1,0.720729876174967,0,2,synaptic vesicle recycling,BP,
3496,GO:0036473,1,0.704798885072753,0,2,cell death in response to oxidative stress,BP,
3498,GO:0036490,1,0.759355645182739,0,1,regulation of translation in response to endoplasmic reticulum stress,BP,
3499,GO:0036498,1,0.787449377631317,0,1,IRE1-mediated unfolded protein response,BP,
3500,GO:0036514,1,0.683299665437994,0,1,dopaminergic neuron axon guidance,BP,
3501,GO:0036515,1,0.683299665437994,0,1,serotonergic neuron axon guidance,BP,
3502,GO:0036517,1,0.683299665437994,0,1,chemoattraction of serotonergic neuron axon,BP,
3503,GO:0036518,1,0.683299665437994,0,1,chemorepulsion of dopaminergic neuron axon,BP,
3504,GO:0038001,1,0.77252698579057,0,1,paracrine signaling,BP,
3506,GO:0038028,1,0.75126441332005,0,1,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
3507,GO:0038030,1,0.378393344447835,0,3,non-canonical Wnt signaling pathway via MAPK cascade,BP,
3508,GO:0038031,1,0.50948949116115,0,2,non-canonical Wnt signaling pathway via JNK cascade,BP,
3510,GO:0038060,1,0.766087200253996,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,
3511,GO:0038061,1,0.739324330319736,0,2,NIK/NF-kappaB signaling,BP,
3512,GO:0038062,1,0.747095520096568,0,1,protein tyrosine kinase collagen receptor activity,MF,
3513,GO:0038063,1,0.747095520096568,0,1,collagen-activated tyrosine kinase receptor signaling pathway,BP,
3514,GO:0038064,1,0.747095520096568,0,1,collagen receptor activity,MF,
3515,GO:0038065,1,0.747095520096568,0,1,collagen-activated signaling pathway,BP,
3516,GO:0038066,1,0.703993319191288,0,2,p38MAPK cascade,BP,
3517,GO:0038083,1,0.747095520096568,0,1,peptidyl-tyrosine autophosphorylation,BP,
3525,GO:0038132,1,0.685786047637105,0,1,neuregulin binding,MF,
3527,GO:0038179,1,0.765858508486771,0,1,neurotrophin signaling pathway,BP,
3528,GO:0038181,1,0.715839724297779,0,1,bile acid receptor activity,MF,
3529,GO:0038183,1,0.715839724297779,0,1,bile acid signaling pathway,BP,
3530,GO:0038186,1,0.715839724297779,0,1,lithocholic acid receptor activity,MF,
3531,GO:0038201,1,0.568749625020634,0,2,TOR complex,CC,
3532,GO:0038202,1,0.759355645182739,0,1,TORC1 signaling,BP,
3533,GO:0038203,1,0.749764257384907,0,1,TORC2 signaling,BP,
3535,GO:0039706,1,0.650648483368427,0,2,co-receptor binding,MF,
3536,GO:0040001,1,0.980495002631481,0,1,establishment of mitotic spindle localization,BP,
3542,GO:0040014,1,0.372130039893835,0,4,regulation of multicellular organism growth,BP,
3544,GO:0040018,1,0.501698273573431,0,2,positive regulation of multicellular organism growth,BP,
3545,GO:0040019,1,0.291613511271606,0,5,positive regulation of embryonic development,BP,
3546,GO:0040020,1,0.37705358089801,0,3,regulation of meiotic nuclear division,BP,
3547,GO:0040029,1,0.847043438938523,0,1,regulation of gene expression, epigenetic,BP,
3549,GO:0040036,1,0.508052033122485,0,2,regulation of fibroblast growth factor receptor signaling pathway,BP,
3550,GO:0040037,1,0.508052033122485,0,2,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
3553,GO:0042036,1,0.526989534912202,0,3,negative regulation of cytokine biosynthetic process,BP,
3554,GO:0042044,1,0.802011392875838,0,1,fluid transport,BP,
3555,GO:0042045,1,0.802011392875838,0,1,epithelial fluid transport,BP,
3556,GO:0042056,1,0.415507790345512,0,5,chemoattractant activity,MF,
3557,GO:0042058,1,0.239476937490592,0,6,regulation of epidermal growth factor receptor signaling pathway,BP,
3558,GO:0042059,1,0.77766081607843,0,1,negative regulation of epidermal growth factor receptor signaling pathway,BP,
3561,GO:0042074,1,0.429242486666914,0,3,cell migration involved in gastrulation,BP,
3562,GO:0042088,1,0.940900393371674,0,1,T-helper 1 type immune response,BP,
3564,GO:0042093,1,0.766387473815025,0,1,T-helper cell differentiation,BP,
3565,GO:0042095,1,0.766387473815025,0,1,interferon-gamma biosynthetic process,BP,
3566,GO:0042097,1,0.766387473815025,0,1,interleukin-4 biosynthetic process,BP,
3570,GO:0042104,1,0.805928986539668,0,2,positive regulation of activated T cell proliferation,BP,
3580,GO:0042147,1,0.497804477700087,0,3,retrograde transport, endosome to Golgi,BP,
3584,GO:0042159,1,0.829582597377115,0,1,lipoprotein catabolic process,BP,
3585,GO:0042168,1,0.772107268247692,0,1,heme metabolic process,BP,
3586,GO:0042171,1,0.747989056481557,0,1,lysophosphatidic acid acyltransferase activity,MF,
3588,GO:0042176,1,0.122472941840518,0,8,regulation of protein catabolic process,BP,
3591,GO:0042219,1,0.764658144398332,0,1,cellular modified amino acid catabolic process,BP,
3592,GO:0042220,1,0.836041871517245,0,1,response to cocaine,BP,
3594,GO:0042222,1,0.968025854772146,0,1,interleukin-1 biosynthetic process,BP,
3595,GO:0042246,1,0.386289674802093,0,4,tissue regeneration,BP,
3596,GO:0042249,1,0.683299665437994,0,1,establishment of planar polarity of embryonic epithelium,BP,
3597,GO:0042254,1,0.735427962909408,0,1,ribosome biogenesis,BP,
3598,GO:0042267,1,0.77312897108567,0,1,natural killer cell mediated cytotoxicity,BP,
3601,GO:0042297,1,0.772776823282694,0,1,vocal learning,BP,
3608,GO:0042310,1,0.341132446045241,0,5,vasoconstriction,BP,
3609,GO:0042311,1,0.7728397953467,0,1,vasodilation,BP,
3610,GO:0042313,1,0.802011392875838,0,1,protein kinase C deactivation,BP,
3611,GO:0042321,1,0.7728397953467,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
3612,GO:0042323,1,0.7728397953467,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
3619,GO:0042345,1,0.67472473251609,0,2,regulation of NF-kappaB import into nucleus,BP,
3620,GO:0042347,1,0.739713014367407,0,1,negative regulation of NF-kappaB import into nucleus,BP,
3621,GO:0042348,1,0.67472473251609,0,2,NF-kappaB import into nucleus,BP,
3623,GO:0042362,1,0.715839724297779,0,1,fat-soluble vitamin biosynthetic process,BP,
3624,GO:0042364,1,0.824053991557742,0,1,water-soluble vitamin biosynthetic process,BP,
3625,GO:0042368,1,0.715839724297779,0,1,vitamin D biosynthetic process,BP,
3626,GO:0042379,1,0.949401628742594,0,2,chemokine receptor binding,MF,
3627,GO:0042383,1,0.715987445840058,0,2,sarcolemma,CC,
3629,GO:0042398,1,0.970787931478979,0,1,cellular modified amino acid biosynthetic process,BP,
3630,GO:0042402,1,0.764658144398332,0,1,cellular biogenic amine catabolic process,BP,
3631,GO:0042414,1,0.94047143183814,0,1,epinephrine metabolic process,BP,
3632,GO:0042417,1,0.733539537631441,0,1,dopamine metabolic process,BP,
3633,GO:0042418,1,0.94047143183814,0,1,epinephrine biosynthetic process,BP,
3634,GO:0042423,1,0.94047143183814,0,1,catecholamine biosynthetic process,BP,
3635,GO:0042426,1,0.764658144398332,0,1,choline catabolic process,BP,
3636,GO:0042438,1,0.683299665437994,0,1,melanin biosynthetic process,BP,
3637,GO:0042440,1,0.526913895151291,0,2,pigment metabolic process,BP,
3640,GO:0042447,1,0.832074326646381,0,1,hormone catabolic process,BP,
3641,GO:0042448,1,0.83270324466729,0,1,progesterone metabolic process,BP,
3648,GO:0042474,1,0.802011392875838,0,1,middle ear morphogenesis,BP,
3651,GO:0042481,1,0.426197283234698,0,5,regulation of odontogenesis,BP,
3652,GO:0042482,1,0.529986464868856,0,3,positive regulation of odontogenesis,BP,
3653,GO:0042487,1,0.618863965828301,0,3,regulation of odontogenesis of dentin-containing tooth,BP,
3656,GO:0042492,1,0.705715026621473,0,1,gamma-delta T cell differentiation,BP,
3658,GO:0042501,1,0.744061959631107,0,1,serine phosphorylation of STAT protein,BP,
3659,GO:0042503,1,0.45615332940787,0,3,tyrosine phosphorylation of Stat3 protein,BP,
3660,GO:0042506,1,0.727749574179032,0,1,tyrosine phosphorylation of Stat5 protein,BP,
3661,GO:0042508,1,0.744061959631107,0,1,tyrosine phosphorylation of Stat1 protein,BP,
3662,GO:0042509,1,0.45615332940787,0,3,regulation of tyrosine phosphorylation of STAT protein,BP,
3663,GO:0042510,1,0.744061959631107,0,1,regulation of tyrosine phosphorylation of Stat1 protein,BP,
3664,GO:0042511,1,0.744061959631107,0,1,positive regulation of tyrosine phosphorylation of Stat1 protein,BP,
3665,GO:0042516,1,0.45615332940787,0,3,regulation of tyrosine phosphorylation of Stat3 protein,BP,
3666,GO:0042517,1,0.45615332940787,0,3,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,
3667,GO:0042522,1,0.727749574179032,0,1,regulation of tyrosine phosphorylation of Stat5 protein,BP,
3668,GO:0042523,1,0.727749574179032,0,1,positive regulation of tyrosine phosphorylation of Stat5 protein,BP,
3669,GO:0042531,1,0.45615332940787,0,3,positive regulation of tyrosine phosphorylation of STAT protein,BP,
3670,GO:0042537,1,0.774318895616471,0,1,benzene-containing compound metabolic process,BP,
3673,GO:0042551,1,0.690409015386517,0,1,neuron maturation,BP,
3675,GO:0042554,1,0.802011392875838,0,1,superoxide anion generation,BP,
3676,GO:0042558,1,0.917920313188515,0,2,pteridine-containing compound metabolic process,BP,
3677,GO:0042559,1,0.917920313188515,0,2,pteridine-containing compound biosynthetic process,BP,
3679,GO:0042572,1,0.961431612339441,0,1,retinol metabolic process,BP,
3682,GO:0042581,1,0.359472705450558,0,4,specific granule,CC,
3684,GO:0042583,1,0.80818803699794,0,1,chromaffin granule,CC,
3685,GO:0042587,1,0.629141955360923,0,1,glycogen granule,CC,
3686,GO:0042588,1,0.831604178158584,0,1,zymogen granule,CC,
3692,GO:0042626,1,0.77139588570204,0,1,ATPase activity, coupled to transmembrane movement of substances,MF,
3693,GO:0042627,1,0.987456549281,0,1,chylomicron,CC,
3694,GO:0042629,1,0.561734632247565,0,2,mast cell granule,CC,
3695,GO:0042632,1,0.730000373127536,0,2,cholesterol homeostasis,BP,
3697,GO:0042634,1,0.61294668211829,0,2,regulation of hair cycle,BP,
3698,GO:0042635,1,0.61294668211829,0,2,positive regulation of hair cycle,BP,
3699,GO:0042640,1,0.683299665437994,0,1,anagen,BP,
3700,GO:0042645,1,0.787449377631317,0,1,mitochondrial nucleoid,CC,
3701,GO:0042659,1,0.74668493948331,0,1,regulation of cell fate specification,BP,
3702,GO:0042665,1,0.74668493948331,0,1,regulation of ectodermal cell fate specification,BP,
3703,GO:0042666,1,0.74668493948331,0,1,negative regulation of ectodermal cell fate specification,BP,
3705,GO:0042693,1,0.582804858604775,0,3,muscle cell fate commitment,BP,
3706,GO:0042695,1,0.683299665437994,0,1,thelarche,BP,
3709,GO:0042730,1,0.776794728605423,0,1,fibrinolysis,BP,
3710,GO:0042733,1,0.304633683905903,0,4,embryonic digit morphogenesis,BP,
3711,GO:0042734,1,0.7728397953467,0,1,presynaptic membrane,CC,
3712,GO:0042742,1,0.75400586513926,0,3,defense response to bacterium,BP,
3713,GO:0042745,1,0.597901784091742,0,2,circadian sleep/wake cycle,BP,
3714,GO:0042747,1,0.774318895616471,0,1,circadian sleep/wake cycle, REM sleep,BP,
3715,GO:0042748,1,0.7728397953467,0,1,circadian sleep/wake cycle, non-REM sleep,BP,
3716,GO:0042749,1,0.7728397953467,0,1,regulation of circadian sleep/wake cycle,BP,
3717,GO:0042752,1,0.7728397953467,0,1,regulation of circadian rhythm,BP,
3718,GO:0042754,1,0.7728397953467,0,1,negative regulation of circadian rhythm,BP,
3719,GO:0042759,1,0.765260800063365,0,1,long-chain fatty acid biosynthetic process,BP,
3720,GO:0042761,1,0.765260800063365,0,1,very long-chain fatty acid biosynthetic process,BP,
3725,GO:0042787,1,0.499330425288352,0,3,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
3728,GO:0042813,1,0.572781342788712,0,2,Wnt-activated receptor activity,MF,
3730,GO:0042832,1,0.940900393371674,0,1,defense response to protozoan,BP,
3732,GO:0042940,1,0.753709329340452,0,1,D-amino acid transport,BP,
3733,GO:0042953,1,0.89202924648779,0,1,lipoprotein transport,BP,
3734,GO:0042974,1,0.715839724297779,0,1,retinoic acid receptor binding,MF,
3735,GO:0042976,1,0.727749574179032,0,1,activation of Janus kinase activity,BP,
3736,GO:0042977,1,0.727749574179032,0,1,activation of JAK2 kinase activity,BP,
3738,GO:0042982,1,0.77139588570204,0,1,amyloid precursor protein metabolic process,BP,
3739,GO:0042987,1,0.77139588570204,0,1,amyloid precursor protein catabolic process,BP,
3742,GO:0042992,1,0.739713014367407,0,1,negative regulation of transcription factor import into nucleus,BP,
3748,GO:0043014,1,0.742522245952368,0,1,alpha-tubulin binding,MF,
3750,GO:0043021,1,0.735427962909408,0,1,ribonucleoprotein complex binding,MF,
3754,GO:0043029,1,0.530812553953919,0,3,T cell homeostasis,BP,
3755,GO:0043030,1,0.509668605177751,0,2,regulation of macrophage activation,BP,
3756,GO:0043032,1,0.683299665437994,0,1,positive regulation of macrophage activation,BP,
3769,GO:0043090,1,0.753709329340452,0,1,amino acid import,BP,
3770,GO:0043092,1,0.753709329340452,0,1,L-amino acid import,BP,
3775,GO:0043113,1,0.727261279903572,0,1,receptor clustering,BP,
3776,GO:0043114,1,0.733539537631441,0,1,regulation of vascular permeability,BP,
3779,GO:0043124,1,0.545082628052663,0,3,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
3784,GO:0043161,1,0.298337307148616,0,5,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
3790,GO:0043178,1,0.573527140548586,0,3,alcohol binding,MF,
3791,GO:0043179,1,0.802011392875838,0,1,rhythmic excitation,BP,
3792,GO:0043184,1,0.730958015688662,0,1,vascular endothelial growth factor receptor 2 binding,MF,
3793,GO:0043194,1,0.690409015386517,0,1,axon initial segment,CC,
3794,GO:0043195,1,0.597416765103847,0,2,terminal bouton,CC,
3796,GO:0043198,1,0.693561778427278,0,1,dendritic shaft,CC,
3798,GO:0043201,1,0.759355645182739,0,1,response to leucine,BP,
3800,GO:0043203,1,0.690409015386517,0,1,axon hillock,CC,
3801,GO:0043204,1,0.65643362541075,0,1,perikaryon,CC,
3804,GO:0043217,1,0.772639837730134,0,1,myelin maintenance,BP,
3805,GO:0043218,1,0.75321100610424,0,1,compact myelin,CC,
3806,GO:0043220,1,0.75321100610424,0,1,Schmidt-Lanterman incisure,CC,
3823,GO:0043255,1,0.451999579856708,0,3,regulation of carbohydrate biosynthetic process,BP,
3835,GO:0043278,1,0.836041871517245,0,1,response to morphine,BP,
3836,GO:0043279,1,0.400140393236058,0,4,response to alkaloid,BP,
3840,GO:0043295,1,0.846876006292841,0,1,glutathione binding,MF,
3844,GO:0043303,1,0.561734632247565,0,2,mast cell degranulation,BP,
3846,GO:0043316,1,0.77312897108567,0,1,cytotoxic T cell degranulation,BP,
3847,GO:0043320,1,0.77312897108567,0,1,natural killer cell degranulation,BP,
3848,GO:0043325,1,0.772639837730134,0,1,phosphatidylinositol-3,4-bisphosphate binding,MF,
3851,GO:0043367,1,0.766387473815025,0,1,CD4-positive, alpha-beta T cell differentiation,BP,
3852,GO:0043368,1,0.766387473815025,0,1,positive T cell selection,BP,
3853,GO:0043369,1,0.766387473815025,0,1,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
3854,GO:0043373,1,0.766387473815025,0,1,CD4-positive, alpha-beta T cell lineage commitment,BP,
3855,GO:0043392,1,0.785634671671933,0,1,negative regulation of DNA binding,BP,
3857,GO:0043401,1,0.447295427694081,0,3,steroid hormone mediated signaling pathway,BP,
3858,GO:0043403,1,0.640946849891508,0,2,skeletal muscle tissue regeneration,BP,
3861,GO:0043407,1,0.485579442144574,0,3,negative regulation of MAP kinase activity,BP,
3863,GO:0043409,1,0.277393112408388,0,5,negative regulation of MAPK cascade,BP,
3866,GO:0043413,1,0.530142433773315,0,4,macromolecule glycosylation,BP,
3867,GO:0043414,1,0.565901219301263,0,4,macromolecule methylation,BP,
3871,GO:0043455,1,0.683299665437994,0,1,regulation of secondary metabolic process,BP,
3872,GO:0043457,1,0.579845180760997,0,2,regulation of cellular respiration,BP,
3873,GO:0043462,1,0.80789126280944,0,2,regulation of ATPase activity,BP,
3874,GO:0043465,1,0.772573466595224,0,1,regulation of fermentation,BP,
3875,GO:0043467,1,0.447180693819068,0,3,regulation of generation of precursor metabolites and energy,BP,
3876,GO:0043470,1,0.772573466595224,0,1,regulation of carbohydrate catabolic process,BP,
3878,GO:0043476,1,0.908975838289389,0,1,pigment accumulation,BP,
3879,GO:0043482,1,0.908975838289389,0,1,cellular pigment accumulation,BP,
3881,GO:0043485,1,0.908975838289389,0,1,endosome to pigment granule transport,BP,
3882,GO:0043487,1,0.530769617355726,0,4,regulation of RNA stability,BP,
3883,GO:0043488,1,0.530769617355726,0,4,regulation of mRNA stability,BP,
3884,GO:0043489,1,0.977811028321075,0,1,RNA stabilization,BP,
3886,GO:0043492,1,0.77139588570204,0,1,ATPase activity, coupled to movement of substances,MF,
3888,GO:0043500,1,0.564594036016047,0,3,muscle adaptation,BP,
3889,GO:0043501,1,0.772573466595224,0,1,skeletal muscle adaptation,BP,
3890,GO:0043502,1,0.564594036016047,0,3,regulation of muscle adaptation,BP,
3891,GO:0043506,1,0.236169773321779,0,5,regulation of JUN kinase activity,BP,
3892,GO:0043507,1,0.236169773321779,0,5,positive regulation of JUN kinase activity,BP,
3893,GO:0043516,1,0.823241180606138,0,1,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
3894,GO:0043517,1,0.823241180606138,0,1,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
3895,GO:0043523,1,0.316807510324884,0,7,regulation of neuron apoptotic process,BP,
3896,GO:0043524,1,0.316807510324884,0,7,negative regulation of neuron apoptotic process,BP,
3898,GO:0043532,1,0.661948364956753,0,1,angiostatin binding,MF,
3899,GO:0043534,1,0.17508811034182,0,5,blood vessel endothelial cell migration,BP,
3900,GO:0043535,1,0.366613215071441,0,3,regulation of blood vessel endothelial cell migration,BP,
3901,GO:0043536,1,0.596359050696602,0,2,positive regulation of blood vessel endothelial cell migration,BP,
3902,GO:0043537,1,0.616704084333269,0,1,negative regulation of blood vessel endothelial cell migration,BP,
3904,GO:0043543,1,0.525054199940052,0,2,protein acylation,BP,
3911,GO:0043552,1,0.77252698579057,0,1,positive regulation of phosphatidylinositol 3-kinase activity,BP,
3912,GO:0043555,1,0.759355645182739,0,1,regulation of translation in response to stress,BP,
3916,GO:0043567,1,0.768607936468567,0,1,regulation of insulin-like growth factor receptor signaling pathway,BP,
3917,GO:0043569,1,0.768607936468567,0,1,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
3918,GO:0043576,1,0.7728397953467,0,1,regulation of respiratory gaseous exchange,BP,
3920,GO:0043584,1,0.58842292401898,0,2,nose development,BP,
3921,GO:0043585,1,0.772776823282694,0,1,nose morphogenesis,BP,
3926,GO:0043616,1,0.511075016231692,0,3,keratinocyte proliferation,BP,
3927,GO:0043618,1,0.447168859680348,0,3,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
3928,GO:0043619,1,0.759355645182739,0,1,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
3929,GO:0043620,1,0.447168859680348,0,3,regulation of DNA-templated transcription in response to stress,BP,
3930,GO:0043621,1,0.585788010294756,0,1,protein self-association,MF,
3934,GO:0043632,1,0.298337307148616,0,5,modification-dependent macromolecule catabolic process,BP,
3935,GO:0043648,1,0.264953533098598,0,6,dicarboxylic acid metabolic process,BP,
3936,GO:0043650,1,0.753709329340452,0,1,dicarboxylic acid biosynthetic process,BP,
3937,GO:0043651,1,0.725770278597532,0,1,linoleic acid metabolic process,BP,
3938,GO:0043666,1,0.824053991557742,0,1,regulation of phosphoprotein phosphatase activity,BP,
3939,GO:0043679,1,0.489485037073022,0,3,axon terminus,CC,
3941,GO:0043691,1,0.77139588570204,0,1,reverse cholesterol transport,BP,
3942,GO:0043696,1,0.77252698579057,0,1,dedifferentiation,BP,
3943,GO:0043697,1,0.77252698579057,0,1,cell dedifferentiation,BP,
3944,GO:0043783,1,0.782663874445418,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
3945,GO:0043900,1,0.262912997355695,0,5,regulation of multi-organism process,BP,
3946,GO:0043901,1,0.72816431156769,0,2,negative regulation of multi-organism process,BP,
3947,GO:0043902,1,0.362672006357845,0,3,positive regulation of multi-organism process,BP,
3948,GO:0043903,1,0.452702433061824,0,2,regulation of symbiosis, encompassing mutualism through parasitism,BP,
3949,GO:0043931,1,0.768607936468567,0,1,ossification involved in bone maturation,BP,
3952,GO:0043966,1,0.744061959631107,0,1,histone H3 acetylation,BP,
3953,GO:0043974,1,0.744061959631107,0,1,histone H3-K27 acetylation,BP,
3954,GO:0044028,1,0.75126441332005,0,1,DNA hypomethylation,BP,
3955,GO:0044029,1,0.75126441332005,0,1,hypomethylation of CpG island,BP,
3956,GO:0044030,1,0.75126441332005,0,1,regulation of DNA methylation,BP,
3957,GO:0044042,1,0.772639837730134,0,1,glucan metabolic process,BP,
3959,GO:0044058,1,0.719603765000934,0,2,regulation of digestive system process,BP,
3960,GO:0044060,1,0.387303256926779,0,3,regulation of endocrine process,BP,
3961,GO:0044062,1,0.453432950730039,0,3,regulation of excretion,BP,
3962,GO:0044065,1,0.7728397953467,0,1,regulation of respiratory system process,BP,
3963,GO:0044070,1,0.38720035007832,0,4,regulation of anion transport,BP,
3966,GO:0044088,1,0.559123898229656,0,2,regulation of vacuole organization,BP,
3968,GO:0044090,1,0.788139761849395,0,1,positive regulation of vacuole organization,BP,
3969,GO:0044091,1,0.727261279903572,0,1,membrane biogenesis,BP,
3972,GO:0044106,1,0.731680740893358,0,2,cellular amine metabolic process,BP,
3973,GO:0044212,1,0.0921748710197254,0,8,transcription regulatory region DNA binding,MF,
3980,GO:0044243,1,0.828965869670895,0,1,multicellular organismal catabolic process,BP,
3986,GO:0044257,1,0.095179944067441,0,10,cellular protein catabolic process,BP,
3990,GO:0044264,1,0.597187745179843,0,2,cellular polysaccharide metabolic process,BP,
3991,GO:0044265,1,0.0370964919092721,0,13,cellular macromolecule catabolic process,BP,
3998,GO:0044282,1,0.00858825540244038,0,23,small molecule catabolic process,BP,
4000,GO:0044291,1,0.381944517063657,0,3,cell-cell contact zone,CC,
4002,GO:0044304,1,0.532920536410391,0,2,main axon,CC,
4003,GO:0044306,1,0.379452491246428,0,4,neuron projection terminus,CC,
4005,GO:0044319,1,0.36520745822237,0,4,wound healing, spreading of cells,BP,
4006,GO:0044320,1,0.767464593952245,0,1,cellular response to leptin stimulus,BP,
4007,GO:0044321,1,0.475441440800469,0,3,response to leptin,BP,
4009,GO:0044331,1,0.496178299930354,0,2,cell-cell adhesion mediated by cadherin,BP,
4010,GO:0044338,1,0.895381066641334,0,1,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
4011,GO:0044339,1,0.895381066641334,0,1,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
4012,GO:0044340,1,0.895381066641334,0,1,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
4015,GO:0044351,1,0.964117353714657,0,1,macropinocytosis,BP,
4016,GO:0044364,1,0.80818803699794,0,1,disruption of cells of other organism,BP,
4019,GO:0044390,1,0.685812470298157,0,1,ubiquitin-like protein conjugating enzyme binding,MF,
4020,GO:0044391,1,0.911789827211774,0,2,ribosomal subunit,CC,
4050,GO:0044454,1,0.702569048854651,0,1,nuclear chromosome part,CC,
4051,GO:0044455,1,0.605525581182968,0,2,mitochondrial membrane part,CC,
4056,GO:0044539,1,0.946578828055197,0,1,long-chain fatty acid import,BP,
4057,GO:0044548,1,0.942803698939128,0,1,S100 protein binding,MF,
4058,GO:0044550,1,0.526913895151291,0,2,secondary metabolite biosynthetic process,BP,
4059,GO:0044557,1,0.7728397953467,0,1,relaxation of smooth muscle,BP,
4073,GO:0044728,1,0.75126441332005,0,1,DNA methylation or demethylation,BP,
4074,GO:0044729,1,0.771150420617929,0,1,hemi-methylated DNA-binding,MF,
4076,GO:0044752,1,0.784021941884902,0,1,response to human chorionic gonadotropin,BP,
4080,GO:0044766,1,0.600902693109142,0,2,multi-organism transport,BP,
4088,GO:0044798,1,0.715839724297779,0,1,nuclear transcription factor complex,CC,
4097,GO:0044848,1,0.683299665437994,0,1,biological phase,BP,
4098,GO:0044851,1,0.683299665437994,0,1,hair cycle phase,BP,
4099,GO:0044853,1,0.517356611930352,0,2,plasma membrane raft,CC,
4100,GO:0044872,1,0.89202924648779,0,1,lipoprotein localization,BP,
4102,GO:0045009,1,0.702489681922357,0,2,chitosome,CC,
4104,GO:0045019,1,0.747147771262379,0,2,negative regulation of nitric oxide biosynthetic process,BP,
4105,GO:0045022,1,0.741809137632914,0,1,early endosome to late endosome transport,BP,
4108,GO:0045028,1,0.775603503393362,0,1,G-protein coupled purinergic nucleotide receptor activity,MF,
4109,GO:0045029,1,0.775603503393362,0,1,UDP-activated nucleotide receptor activity,MF,
4110,GO:0045054,1,0.77312897108567,0,1,constitutive secretory pathway,BP,
4112,GO:0045056,1,0.824648598151267,0,1,transcytosis,BP,
4113,GO:0045058,1,0.540205421801221,0,2,T cell selection,BP,
4114,GO:0045061,1,0.705715026621473,0,1,thymic T cell selection,BP,
4115,GO:0045069,1,0.452702433061824,0,2,regulation of viral genome replication,BP,
4116,GO:0045070,1,0.616704084333269,0,1,positive regulation of viral genome replication,BP,
4117,GO:0045071,1,0.735427962909408,0,1,negative regulation of viral genome replication,BP,
4118,GO:0045072,1,0.766387473815025,0,1,regulation of interferon-gamma biosynthetic process,BP,
4120,GO:0045078,1,0.766387473815025,0,1,positive regulation of interferon-gamma biosynthetic process,BP,
4125,GO:0045103,1,0.694600625869364,0,1,intermediate filament-based process,BP,
4126,GO:0045104,1,0.694600625869364,0,1,intermediate filament cytoskeleton organization,BP,
4127,GO:0045109,1,0.694600625869364,0,1,intermediate filament organization,BP,
4128,GO:0045110,1,0.694600625869364,0,1,intermediate filament bundle assembly,BP,
4129,GO:0045111,1,0.553341448228999,0,2,intermediate filament cytoskeleton,CC,
4130,GO:0045117,1,0.802011392875838,0,1,azole transport,BP,
4132,GO:0045123,1,0.581177560910638,0,2,cellular extravasation,BP,
4134,GO:0045125,1,0.845873160582363,0,1,bioactive lipid receptor activity,MF,
4135,GO:0045136,1,0.683299665437994,0,1,development of secondary sexual characteristics,BP,
4137,GO:0045161,1,0.690409015386517,0,1,neuronal ion channel clustering,BP,
4138,GO:0045162,1,0.690409015386517,0,1,clustering of voltage-gated sodium channels,BP,
4145,GO:0045185,1,0.532782060363931,0,2,maintenance of protein location,BP,
4146,GO:0045187,1,0.7728397953467,0,1,regulation of circadian sleep/wake cycle, sleep,BP,
4147,GO:0045188,1,0.7728397953467,0,1,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
4148,GO:0045190,1,0.84462400233258,0,1,isotype switching,BP,
4149,GO:0045191,1,0.84462400233258,0,1,regulation of isotype switching,BP,
4150,GO:0045197,1,0.506147921111534,0,2,establishment or maintenance of epithelial cell apical/basal polarity,BP,
4151,GO:0045198,1,0.506147921111534,0,2,establishment of epithelial cell apical/basal polarity,BP,
4154,GO:0045211,1,0.175230744152043,0,5,postsynaptic membrane,CC,
4159,GO:0045251,1,0.782663874445418,0,1,electron transfer flavoprotein complex,CC,
4160,GO:0045294,1,0.561592060367718,0,2,alpha-catenin binding,MF,
4161,GO:0045295,1,0.517356611930352,0,2,gamma-catenin binding,MF,
4165,GO:0045333,1,0.309564290389689,0,6,cellular respiration,BP,
4166,GO:0045334,1,0.534019898252239,0,2,clathrin-coated endocytic vesicle,CC,
4168,GO:0045349,1,0.897578402296713,0,1,interferon-alpha biosynthetic process,BP,
4171,GO:0045354,1,0.897578402296713,0,1,regulation of interferon-alpha biosynthetic process,BP,
4172,GO:0045355,1,0.897578402296713,0,1,negative regulation of interferon-alpha biosynthetic process,BP,
4174,GO:0045358,1,0.897578402296713,0,1,negative regulation of interferon-beta biosynthetic process,BP,
4176,GO:0045360,1,0.968025854772146,0,1,regulation of interleukin-1 biosynthetic process,BP,
4177,GO:0045362,1,0.968025854772146,0,1,positive regulation of interleukin-1 biosynthetic process,BP,
4178,GO:0045402,1,0.766387473815025,0,1,regulation of interleukin-4 biosynthetic process,BP,
4179,GO:0045403,1,0.766387473815025,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
4182,GO:0045444,1,0.0929805573199079,0,11,fat cell differentiation,BP,
4187,GO:0045485,1,0.725770278597532,0,1,omega-6 fatty acid desaturase activity,MF,
4188,GO:0045494,1,0.741996739331776,0,1,photoreceptor cell maintenance,BP,
4189,GO:0045505,1,0.585788010294756,0,1,dynein intermediate chain binding,MF,
4191,GO:0045542,1,0.77139588570204,0,1,positive regulation of cholesterol biosynthetic process,BP,
4192,GO:0045576,1,0.561734632247565,0,2,mast cell activation,BP,
4194,GO:0045581,1,0.847043438938523,0,1,negative regulation of T cell differentiation,BP,
4199,GO:0045598,1,0.184905494771211,0,6,regulation of fat cell differentiation,BP,
4200,GO:0045599,1,0.397687562577644,0,3,negative regulation of fat cell differentiation,BP,
4201,GO:0045600,1,0.469244553794353,0,3,positive regulation of fat cell differentiation,BP,
4202,GO:0045601,1,0.324969504373239,0,4,regulation of endothelial cell differentiation,BP,
4203,GO:0045603,1,0.324969504373239,0,4,positive regulation of endothelial cell differentiation,BP,
4206,GO:0045606,1,0.372503767995516,0,3,positive regulation of epidermal cell differentiation,BP,
4209,GO:0045616,1,0.440578969327929,0,2,regulation of keratinocyte differentiation,BP,
4210,GO:0045618,1,0.440578969327929,0,2,positive regulation of keratinocyte differentiation,BP,
4212,GO:0045620,1,0.847043438938523,0,1,negative regulation of lymphocyte differentiation,BP,
4221,GO:0045646,1,0.766387473815025,0,1,regulation of erythrocyte differentiation,BP,
4222,GO:0045649,1,0.62161785416203,0,2,regulation of macrophage differentiation,BP,
4223,GO:0045651,1,0.62161785416203,0,2,positive regulation of macrophage differentiation,BP,
4229,GO:0045667,1,0.0937420733775607,0,9,regulation of osteoblast differentiation,BP,
4230,GO:0045668,1,0.616704084333269,0,1,negative regulation of osteoblast differentiation,BP,
4231,GO:0045669,1,0.153795160436562,0,8,positive regulation of osteoblast differentiation,BP,
4236,GO:0045684,1,0.2268813739057,0,5,positive regulation of epidermis development,BP,
4237,GO:0045685,1,0.295859586422093,0,4,regulation of glial cell differentiation,BP,
4238,GO:0045686,1,0.616704084333269,0,1,negative regulation of glial cell differentiation,BP,
4239,GO:0045687,1,0.295859586422093,0,4,positive regulation of glial cell differentiation,BP,
4240,GO:0045717,1,0.777482661852506,0,2,negative regulation of fatty acid biosynthetic process,BP,
4241,GO:0045723,1,0.824053991557742,0,1,positive regulation of fatty acid biosynthetic process,BP,
4242,GO:0045725,1,0.772639837730134,0,1,positive regulation of glycogen biosynthetic process,BP,
4244,GO:0045730,1,0.695760832683338,0,1,respiratory burst,BP,
4245,GO:0045732,1,0.158469663672785,0,7,positive regulation of protein catabolic process,BP,
4247,GO:0045737,1,0.498473448569692,0,4,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
4248,GO:0045739,1,0.980495002631481,0,1,positive regulation of DNA repair,BP,
4250,GO:0045741,1,0.484614585660265,0,3,positive regulation of epidermal growth factor-activated receptor activity,BP,
4251,GO:0045742,1,0.309174414566576,0,5,positive regulation of epidermal growth factor receptor signaling pathway,BP,
4253,GO:0045745,1,0.80818803699794,0,1,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
4254,GO:0045746,1,0.580588514462228,0,2,negative regulation of Notch signaling pathway,BP,
4258,GO:0045776,1,0.598122207576261,0,2,negative regulation of blood pressure,BP,
4259,GO:0045777,1,0.7728397953467,0,1,positive regulation of blood pressure,BP,
4260,GO:0045778,1,0.104109728928758,0,9,positive regulation of ossification,BP,
4261,GO:0045779,1,0.763459376420346,0,1,negative regulation of bone resorption,BP,
4265,GO:0045792,1,0.600334451542625,0,2,negative regulation of cell size,BP,
4266,GO:0045793,1,0.802011392875838,0,1,positive regulation of cell size,BP,
4267,GO:0045806,1,0.880789775836636,0,2,negative regulation of endocytosis,BP,
4269,GO:0045820,1,0.772573466595224,0,1,negative regulation of glycolytic process,BP,
4270,GO:0045822,1,0.369713009056681,0,3,negative regulation of heart contraction,BP,
4272,GO:0045824,1,0.665985274604568,0,2,negative regulation of innate immune response,BP,
4273,GO:0045830,1,0.84462400233258,0,1,positive regulation of isotype switching,BP,
4275,GO:0045834,1,0.116172716885542,0,10,positive regulation of lipid metabolic process,BP,
4276,GO:0045835,1,0.744061959631107,0,1,negative regulation of meiotic nuclear division,BP,
4277,GO:0045836,1,0.508052033122485,0,2,positive regulation of meiotic nuclear division,BP,
4278,GO:0045837,1,0.823241180606138,0,1,negative regulation of membrane potential,BP,
4279,GO:0045839,1,0.626137569807627,0,2,negative regulation of mitotic nuclear division,BP,
4280,GO:0045840,1,0.588832185904984,0,3,positive regulation of mitotic nuclear division,BP,
4281,GO:0045843,1,0.417411910590457,0,6,negative regulation of striated muscle tissue development,BP,
4283,GO:0045851,1,0.631296473034083,0,3,pH reduction,BP,
4291,GO:0045907,1,0.633492613842847,0,2,positive regulation of vasoconstriction,BP,
4292,GO:0045911,1,0.84462400233258,0,1,positive regulation of DNA recombination,BP,
4293,GO:0045912,1,0.772573466595224,0,1,negative regulation of carbohydrate metabolic process,BP,
4294,GO:0045913,1,0.3105506297857,0,5,positive regulation of carbohydrate metabolic process,BP,
4295,GO:0045920,1,0.616704084333269,0,1,negative regulation of exocytosis,BP,
4297,GO:0045922,1,0.600145143697321,0,3,negative regulation of fatty acid metabolic process,BP,
4298,GO:0045923,1,0.824053991557742,0,1,positive regulation of fatty acid metabolic process,BP,
4302,GO:0045931,1,0.577169767512925,0,4,positive regulation of mitotic cell cycle,BP,
4303,GO:0045932,1,0.439921060267205,0,3,negative regulation of muscle contraction,BP,
4310,GO:0045940,1,0.335823562953959,0,5,positive regulation of steroid metabolic process,BP,
4312,GO:0045955,1,0.616704084333269,0,1,negative regulation of calcium ion-dependent exocytosis,BP,
4313,GO:0045980,1,0.619138163811396,0,2,negative regulation of nucleotide metabolic process,BP,
4314,GO:0045981,1,0.298260202812131,0,6,positive regulation of nucleotide metabolic process,BP,
4315,GO:0045986,1,0.633656961767903,0,2,negative regulation of smooth muscle contraction,BP,
4316,GO:0045987,1,0.802011392875838,0,1,positive regulation of smooth muscle contraction,BP,
4317,GO:0045988,1,0.537064383703859,0,2,negative regulation of striated muscle contraction,BP,
4321,GO:0046006,1,0.805928986539668,0,2,regulation of activated T cell proliferation,BP,
4322,GO:0046031,1,0.560831865596554,0,2,ADP metabolic process,BP,
4323,GO:0046034,1,0.560831865596554,0,2,ATP metabolic process,BP,
4324,GO:0046039,1,0.721712018608498,0,1,GTP metabolic process,BP,
4326,GO:0046068,1,0.37861096392828,0,4,cGMP metabolic process,BP,
4330,GO:0046121,1,0.856527711611377,0,1,deoxyribonucleoside catabolic process,BP,
4333,GO:0046146,1,0.917920313188515,0,2,tetrahydrobiopterin metabolic process,BP,
4334,GO:0046148,1,0.683299665437994,0,1,pigment biosynthetic process,BP,
4337,GO:0046189,1,0.642369897885339,0,2,phenol-containing compound biosynthetic process,BP,
4340,GO:0046322,1,0.607914483032923,0,2,negative regulation of fatty acid oxidation,BP,
4345,GO:0046329,1,0.772639837730134,0,1,negative regulation of JNK cascade,BP,
4348,GO:0046332,1,0.450805484036685,0,3,SMAD binding,MF,
4349,GO:0046339,1,0.957515383118201,0,1,diacylglycerol metabolic process,BP,
4350,GO:0046356,1,0.76138364931296,0,2,acetyl-CoA catabolic process,BP,
4351,GO:0046364,1,0.55667704252826,0,4,monosaccharide biosynthetic process,BP,
4352,GO:0046365,1,0.400529770159544,0,4,monosaccharide catabolic process,BP,
4353,GO:0046386,1,0.856527711611377,0,1,deoxyribose phosphate catabolic process,BP,
4354,GO:0046390,1,0.343168622380217,0,6,ribose phosphate biosynthetic process,BP,
4356,GO:0046395,1,0.0225306220699739,0,19,carboxylic acid catabolic process,BP,
4358,GO:0046425,1,0.279960203179925,0,4,regulation of JAK-STAT cascade,BP,
4359,GO:0046427,1,0.279960203179925,0,4,positive regulation of JAK-STAT cascade,BP,
4361,GO:0046449,1,0.727749574179032,0,1,creatinine metabolic process,BP,
4362,GO:0046456,1,0.477266519273929,0,4,icosanoid biosynthetic process,BP,
4363,GO:0046457,1,0.678851702335802,0,2,prostanoid biosynthetic process,BP,
4364,GO:0046460,1,0.788912096076336,0,2,neutral lipid biosynthetic process,BP,
4365,GO:0046461,1,0.658361905269106,0,2,neutral lipid catabolic process,BP,
4366,GO:0046463,1,0.788912096076336,0,2,acylglycerol biosynthetic process,BP,
4367,GO:0046464,1,0.658361905269106,0,2,acylglycerol catabolic process,BP,
4369,GO:0046467,1,0.987980034753378,0,1,membrane lipid biosynthetic process,BP,
4370,GO:0046470,1,0.649981865539549,0,4,phosphatidylcholine metabolic process,BP,
4372,GO:0046475,1,0.987456549281,0,1,glycerophospholipid catabolic process,BP,
4373,GO:0046477,1,0.906943268947671,0,1,glycosylceramide catabolic process,BP,
4376,GO:0046485,1,0.930530251776604,0,1,ether lipid metabolic process,BP,
4378,GO:0046487,1,0.585220672724785,0,2,glyoxylate metabolic process,BP,
4382,GO:0046503,1,0.649971906628124,0,3,glycerolipid catabolic process,BP,
4385,GO:0046527,1,0.938788431047363,0,1,glucosyltransferase activity,MF,
4387,GO:0046532,1,0.616704084333269,0,1,regulation of photoreceptor cell differentiation,BP,
4388,GO:0046533,1,0.616704084333269,0,1,negative regulation of photoreceptor cell differentiation,BP,
4389,GO:0046541,1,0.980495002631481,0,1,saliva secretion,BP,
4390,GO:0046543,1,0.683299665437994,0,1,development of secondary female sexual characteristics,BP,
4397,GO:0046605,1,0.770050274238875,0,1,regulation of centrosome cycle,BP,
4398,GO:0046620,1,0.205433859666736,0,7,regulation of organ growth,BP,
4399,GO:0046621,1,0.961431612339441,0,1,negative regulation of organ growth,BP,
4400,GO:0046622,1,0.213942020429909,0,6,positive regulation of organ growth,BP,
4402,GO:0046629,1,0.705715026621473,0,1,gamma-delta T cell activation,BP,
4413,GO:0046676,1,0.767464593952245,0,1,negative regulation of insulin secretion,BP,
4414,GO:0046677,1,0.456332456142859,0,3,response to antibiotic,BP,
4415,GO:0046683,1,0.414082016753327,0,3,response to organophosphorus,BP,
4417,GO:0046686,1,0.579233811433808,0,3,response to cadmium ion,BP,
4418,GO:0046697,1,0.416225462190178,0,3,decidualization,BP,
4420,GO:0046717,1,0.465974091869409,0,3,acid secretion,BP,
4422,GO:0046777,1,0.260217212482011,0,5,protein autophosphorylation,BP,
4423,GO:0046785,1,0.717259055655535,0,2,microtubule polymerization,BP,
4424,GO:0046789,1,0.767464593952245,0,1,host cell surface receptor binding,MF,
4425,GO:0046794,1,0.706584649959871,0,1,transport of virus,BP,
4426,GO:0046812,1,0.767464593952245,0,1,host cell surface binding,MF,
4434,GO:0046835,1,0.566205965874527,0,2,carbohydrate phosphorylation,BP,
4438,GO:0046851,1,0.763459376420346,0,1,negative regulation of bone remodeling,BP,
4440,GO:0046864,1,0.961431612339441,0,1,isoprenoid transport,BP,
4441,GO:0046865,1,0.961431612339441,0,1,terpenoid transport,BP,
4444,GO:0046875,1,0.506752767180867,0,2,ephrin receptor binding,MF,
4445,GO:0046877,1,0.980495002631481,0,1,regulation of saliva secretion,BP,
4446,GO:0046879,1,0.0954460689529752,0,10,hormone secretion,BP,
4447,GO:0046880,1,0.767464593952245,0,1,regulation of follicle-stimulating hormone secretion,BP,
4448,GO:0046881,1,0.767464593952245,0,1,positive regulation of follicle-stimulating hormone secretion,BP,
4449,GO:0046882,1,0.767464593952245,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
4450,GO:0046883,1,0.0954460689529752,0,10,regulation of hormone secretion,BP,
4451,GO:0046884,1,0.767464593952245,0,1,follicle-stimulating hormone secretion,BP,
4453,GO:0046886,1,0.572342152026815,0,2,positive regulation of hormone biosynthetic process,BP,
4454,GO:0046887,1,0.453937440986745,0,4,positive regulation of hormone secretion,BP,
4455,GO:0046888,1,0.14343586790778,0,7,negative regulation of hormone secretion,BP,
4456,GO:0046889,1,0.203280545240218,0,7,positive regulation of lipid biosynthetic process,BP,
4458,GO:0046902,1,0.75101951727364,0,2,regulation of mitochondrial membrane permeability,BP,
4464,GO:0046915,1,0.532073791791975,0,3,transition metal ion transmembrane transporter activity,MF,
4468,GO:0046939,1,0.560831865596554,0,2,nucleotide phosphorylation,BP,
4470,GO:0046943,1,0.753709329340452,0,1,carboxylic acid transmembrane transporter activity,MF,
4474,GO:0046952,1,0.79777800716672,0,1,ketone body catabolic process,BP,
4475,GO:0046965,1,0.715839724297779,0,1,retinoid X receptor binding,MF,
4478,GO:0046997,1,0.764658144398332,0,1,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
4479,GO:0047015,1,0.959711323077247,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
4482,GO:0047117,1,0.629141955360923,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
4483,GO:0047144,1,0.747989056481557,0,1,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
4484,GO:0047442,1,0.83270324466729,0,1,17-alpha-hydroxyprogesterone aldolase activity,MF,
4485,GO:0047451,1,0.629141955360923,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
4489,GO:0047750,1,0.94047143183814,0,1,cholestenol delta-isomerase activity,MF,
4490,GO:0047760,1,0.779691480475156,0,1,butyrate-CoA ligase activity,MF,
4491,GO:0047860,1,0.926933149462279,0,1,diiodophenylpyruvate reductase activity,MF,
4493,GO:0048008,1,0.591108785556086,0,2,platelet-derived growth factor receptor signaling pathway,BP,
4496,GO:0048011,1,0.765858508486771,0,1,neurotrophin TRK receptor signaling pathway,BP,
4497,GO:0048012,1,0.765858508486771,0,1,hepatocyte growth factor receptor signaling pathway,BP,
4498,GO:0048013,1,0.686066092637886,0,2,ephrin receptor signaling pathway,BP,
4500,GO:0048016,1,0.619138163811396,0,2,inositol phosphate-mediated signaling,BP,
4503,GO:0048020,1,0.949401628742594,0,2,CCR chemokine receptor binding,MF,
4504,GO:0048021,1,0.683299665437994,0,1,regulation of melanin biosynthetic process,BP,
4505,GO:0048022,1,0.683299665437994,0,1,negative regulation of melanin biosynthetic process,BP,
4506,GO:0048029,1,0.867164964013753,0,1,monosaccharide binding,MF,
4508,GO:0048038,1,0.782663874445418,0,1,quinone binding,MF,
4509,GO:0048039,1,0.782663874445418,0,1,ubiquinone binding,MF,
4511,GO:0048048,1,0.295591791652209,0,4,embryonic eye morphogenesis,BP,
4515,GO:0048103,1,0.394180846033465,0,3,somatic stem cell division,BP,
4519,GO:0048147,1,0.952501034079192,0,1,negative regulation of fibroblast proliferation,BP,
4520,GO:0048148,1,0.836041871517245,0,1,behavioral response to cocaine,BP,
4521,GO:0048156,1,0.942803698939128,0,1,tau protein binding,MF,
4522,GO:0048167,1,0.366262110313897,0,5,regulation of synaptic plasticity,BP,
4523,GO:0048168,1,0.686464756051545,0,3,regulation of neuronal synaptic plasticity,BP,
4524,GO:0048169,1,0.940900393371674,0,1,regulation of long-term neuronal synaptic plasticity,BP,
4525,GO:0048175,1,0.767464593952245,0,1,hepatocyte growth factor biosynthetic process,BP,
4526,GO:0048176,1,0.767464593952245,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
4527,GO:0048178,1,0.767464593952245,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
4528,GO:0048179,1,0.7717087498744,0,1,activin receptor complex,CC,
4529,GO:0048185,1,0.599163497255171,0,2,activin binding,MF,
4532,GO:0048237,1,0.802011392875838,0,1,rough endoplasmic reticulum lumen,CC,
4533,GO:0048241,1,0.628065409479983,0,2,epinephrine transport,BP,
4534,GO:0048242,1,0.628065409479983,0,2,epinephrine secretion,BP,
4535,GO:0048243,1,0.628065409479983,0,2,norepinephrine secretion,BP,
4536,GO:0048244,1,0.867164964013753,0,1,phytanoyl-CoA dioxygenase activity,MF,
4538,GO:0048251,1,0.657423063310495,0,1,elastic fiber assembly,BP,
4539,GO:0048255,1,0.977811028321075,0,1,mRNA stabilization,BP,
4540,GO:0048259,1,0.680585779356651,0,3,regulation of receptor-mediated endocytosis,BP,
4541,GO:0048260,1,0.773132814998767,0,1,positive regulation of receptor-mediated endocytosis,BP,
4542,GO:0048261,1,0.880789775836636,0,2,negative regulation of receptor-mediated endocytosis,BP,
4543,GO:0048262,1,0.7717087498744,0,1,determination of dorsal/ventral asymmetry,BP,
4544,GO:0048263,1,0.7717087498744,0,1,determination of dorsal identity,BP,
4545,GO:0048278,1,0.614929398008082,0,3,vesicle docking,BP,
4546,GO:0048284,1,0.318440235603741,0,5,organelle fusion,BP,
4548,GO:0048286,1,0.476263798149626,0,4,lung alveolus development,BP,
4549,GO:0048289,1,0.84462400233258,0,1,isotype switching to IgE isotypes,BP,
4550,GO:0048293,1,0.84462400233258,0,1,regulation of isotype switching to IgE isotypes,BP,
4551,GO:0048295,1,0.84462400233258,0,1,positive regulation of isotype switching to IgE isotypes,BP,
4552,GO:0048305,1,0.961431612339441,0,1,immunoglobulin secretion,BP,
4553,GO:0048306,1,0.729502086950164,0,2,calcium-dependent protein binding,MF,
4554,GO:0048318,1,0.762142819578083,0,1,axial mesoderm development,BP,
4555,GO:0048319,1,0.762142819578083,0,1,axial mesoderm morphogenesis,BP,
4556,GO:0048320,1,0.762142819578083,0,1,axial mesoderm formation,BP,
4559,GO:0048339,1,0.683299665437994,0,1,paraxial mesoderm development,BP,
4560,GO:0048340,1,0.683299665437994,0,1,paraxial mesoderm morphogenesis,BP,
4561,GO:0048341,1,0.683299665437994,0,1,paraxial mesoderm formation,BP,
4562,GO:0048382,1,0.951532941209886,0,1,mesendoderm development,BP,
4563,GO:0048389,1,0.847043438938523,0,1,intermediate mesoderm development,BP,
4564,GO:0048390,1,0.847043438938523,0,1,intermediate mesoderm morphogenesis,BP,
4565,GO:0048391,1,0.847043438938523,0,1,intermediate mesoderm formation,BP,
4566,GO:0048392,1,0.847043438938523,0,1,intermediate mesodermal cell differentiation,BP,
4567,GO:0048407,1,0.77252698579057,0,1,platelet-derived growth factor binding,MF,
4572,GO:0048483,1,0.977811028321075,0,1,autonomic nervous system development,BP,
4573,GO:0048484,1,0.977811028321075,0,1,enteric nervous system development,BP,
4574,GO:0048485,1,0.977811028321075,0,1,sympathetic nervous system development,BP,
4575,GO:0048486,1,0.977811028321075,0,1,parasympathetic nervous system development,BP,
4576,GO:0048488,1,0.839437618379272,0,1,synaptic vesicle endocytosis,BP,
4577,GO:0048489,1,0.556560338819078,0,3,synaptic vesicle transport,BP,
4580,GO:0048512,1,0.597901784091742,0,2,circadian behavior,BP,
4586,GO:0048520,1,0.772776823282694,0,1,positive regulation of behavior,BP,
4587,GO:0048521,1,0.7728397953467,0,1,negative regulation of behavior,BP,
4590,GO:0048524,1,0.616704084333269,0,1,positive regulation of viral process,BP,
4591,GO:0048525,1,0.735427962909408,0,1,negative regulation of viral process,BP,
4592,GO:0048531,1,0.773597169937423,0,1,beta-1,3-galactosyltransferase activity,MF,
4595,GO:0048535,1,0.836041871517245,0,1,lymph node development,BP,
4596,GO:0048536,1,0.81965039816158,0,2,spleen development,BP,
4597,GO:0048537,1,0.845372895917985,0,1,mucosal-associated lymphoid tissue development,BP,
4598,GO:0048538,1,0.81965039816158,0,2,thymus development,BP,
4599,GO:0048541,1,0.845372895917985,0,1,Peyer's patch development,BP,
4601,GO:0048546,1,0.268194187711608,0,5,digestive tract morphogenesis,BP,
4602,GO:0048557,1,0.980495002631481,0,1,embryonic digestive tract morphogenesis,BP,
4606,GO:0048566,1,0.757593592245352,0,2,embryonic digestive tract development,BP,
4609,GO:0048570,1,0.683299665437994,0,1,notochord morphogenesis,BP,
4613,GO:0048588,1,0.364815764831574,0,4,developmental cell growth,BP,
4617,GO:0048596,1,0.389138828489643,0,3,embryonic camera-type eye morphogenesis,BP,
4619,GO:0048599,1,0.540880018854252,0,4,oocyte development,BP,
4626,GO:0048635,1,0.417411910590457,0,6,negative regulation of muscle organ development,BP,
4630,GO:0048640,1,0.497104189741532,0,4,negative regulation of developmental growth,BP,
4632,GO:0048642,1,0.942803698939128,0,1,negative regulation of skeletal muscle tissue development,BP,
4635,GO:0048645,1,0.180441451417972,0,9,animal organ formation,BP,
4637,GO:0048659,1,0.217641161153686,0,8,smooth muscle cell proliferation,BP,
4638,GO:0048660,1,0.217641161153686,0,8,regulation of smooth muscle cell proliferation,BP,
4639,GO:0048661,1,0.315019765133666,0,5,positive regulation of smooth muscle cell proliferation,BP,
4640,GO:0048662,1,0.702192871777727,0,2,negative regulation of smooth muscle cell proliferation,BP,
4645,GO:0048668,1,0.895381066641334,0,1,collateral sprouting,BP,
4646,GO:0048669,1,0.895381066641334,0,1,collateral sprouting in absence of injury,BP,
4647,GO:0048670,1,0.895381066641334,0,1,regulation of collateral sprouting,BP,
4648,GO:0048672,1,0.895381066641334,0,1,positive regulation of collateral sprouting,BP,
4649,GO:0048675,1,0.611439543999529,0,2,axon extension,BP,
4650,GO:0048678,1,0.75321100610424,0,1,response to axon injury,BP,
4651,GO:0048696,1,0.895381066641334,0,1,regulation of collateral sprouting in absence of injury,BP,
4652,GO:0048697,1,0.895381066641334,0,1,positive regulation of collateral sprouting in absence of injury,BP,
4654,GO:0048701,1,0.847043438938523,0,1,embryonic cranial skeleton morphogenesis,BP,
4655,GO:0048704,1,0.476397782503784,0,3,embryonic skeletal system morphogenesis,BP,
4657,GO:0048706,1,0.31154474521039,0,5,embryonic skeletal system development,BP,
4659,GO:0048709,1,0.472346543935792,0,2,oligodendrocyte differentiation,BP,
4660,GO:0048710,1,0.295859586422093,0,4,regulation of astrocyte differentiation,BP,
4661,GO:0048711,1,0.295859586422093,0,4,positive regulation of astrocyte differentiation,BP,
4662,GO:0048713,1,0.616704084333269,0,1,regulation of oligodendrocyte differentiation,BP,
4663,GO:0048715,1,0.616704084333269,0,1,negative regulation of oligodendrocyte differentiation,BP,
4665,GO:0048730,1,0.604513831936949,0,2,epidermis morphogenesis,BP,
4668,GO:0048736,1,0.0955784605631093,0,10,appendage development,BP,
4670,GO:0048739,1,0.556344081786918,0,2,cardiac muscle fiber development,BP,
4671,GO:0048745,1,0.654185016837647,0,2,smooth muscle tissue development,BP,
4672,GO:0048747,1,0.556344081786918,0,2,muscle fiber development,BP,
4673,GO:0048752,1,0.980495002631481,0,1,semicircular canal morphogenesis,BP,
4674,GO:0048753,1,0.908975838289389,0,1,pigment granule organization,BP,
4676,GO:0048757,1,0.908975838289389,0,1,pigment granule maturation,BP,
4680,GO:0048786,1,0.7728397953467,0,1,presynaptic active zone,CC,
4681,GO:0048791,1,0.839437618379272,0,1,calcium ion-regulated exocytosis of neurotransmitter,BP,
4682,GO:0048799,1,0.768607936468567,0,1,animal organ maturation,BP,
4684,GO:0048807,1,0.942652774379259,0,2,female genitalia morphogenesis,BP,
4685,GO:0048808,1,0.980495002631481,0,1,male genitalia morphogenesis,BP,
4687,GO:0048813,1,0.595260442405648,0,2,dendrite morphogenesis,BP,
4688,GO:0048814,1,0.693561778427278,0,1,regulation of dendrite morphogenesis,BP,
4689,GO:0048818,1,0.683299665437994,0,1,positive regulation of hair follicle maturation,BP,
4690,GO:0048819,1,0.683299665437994,0,1,regulation of hair follicle maturation,BP,
4691,GO:0048820,1,0.683299665437994,0,1,hair follicle maturation,BP,
4693,GO:0048841,1,0.611439543999529,0,2,regulation of axon extension involved in axon guidance,BP,
4694,GO:0048843,1,0.611439543999529,0,2,negative regulation of axon extension involved in axon guidance,BP,
4695,GO:0048844,1,0.217436108178356,0,6,artery morphogenesis,BP,
4696,GO:0048845,1,0.448970932754634,0,2,venous blood vessel morphogenesis,BP,
4697,GO:0048846,1,0.611439543999529,0,2,axon extension involved in axon guidance,BP,
4698,GO:0048850,1,0.683299665437994,0,1,hypophysis morphogenesis,BP,
4699,GO:0048852,1,0.683299665437994,0,1,diencephalon morphogenesis,BP,
4700,GO:0048853,1,0.649958689434067,0,2,forebrain morphogenesis,BP,
4701,GO:0048854,1,0.471829432891442,0,3,brain morphogenesis,BP,
4704,GO:0048861,1,0.744061959631107,0,1,leukemia inhibitory factor signaling pathway,BP,
4712,GO:0050000,1,0.853799544891606,0,1,chromosome localization,BP,
4713,GO:0050220,1,0.846876006292841,0,1,prostaglandin-E synthase activity,MF,
4714,GO:0050277,1,0.746946287086585,0,1,sedoheptulokinase activity,MF,
4715,GO:0050308,1,0.726704948244745,0,1,sugar-phosphatase activity,MF,
4717,GO:0050431,1,0.7717087498744,0,1,transforming growth factor beta binding,MF,
4718,GO:0050432,1,0.495456528227319,0,4,catecholamine secretion,BP,
4719,GO:0050433,1,0.495456528227319,0,4,regulation of catecholamine secretion,BP,
4720,GO:0050508,1,0.740273334426387,0,1,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
4721,GO:0050543,1,0.946578828055197,0,1,icosatetraenoic acid binding,MF,
4723,GO:0050655,1,0.79288915251973,0,1,dermatan sulfate proteoglycan metabolic process,BP,
4731,GO:0050673,1,0.0171294786124761,0,17,epithelial cell proliferation,BP,
4732,GO:0050674,1,0.980495002631481,0,1,urothelial cell proliferation,BP,
4733,GO:0050675,1,0.980495002631481,0,1,regulation of urothelial cell proliferation,BP,
4734,GO:0050677,1,0.980495002631481,0,1,positive regulation of urothelial cell proliferation,BP,
4735,GO:0050678,1,0.0171294786124761,0,17,regulation of epithelial cell proliferation,BP,
4736,GO:0050679,1,0.0523067403690311,0,13,positive regulation of epithelial cell proliferation,BP,
4737,GO:0050680,1,0.196257207387235,0,6,negative regulation of epithelial cell proliferation,BP,
4738,GO:0050699,1,0.939498236501115,0,1,WW domain binding,MF,
4740,GO:0050702,1,0.658592740887016,0,2,interleukin-1 beta secretion,BP,
4742,GO:0050706,1,0.658592740887016,0,2,regulation of interleukin-1 beta secretion,BP,
4748,GO:0050714,1,0.35980865518051,0,6,positive regulation of protein secretion,BP,
4749,GO:0050715,1,0.658592740887016,0,2,positive regulation of cytokine secretion,BP,
4750,GO:0050716,1,0.658592740887016,0,2,positive regulation of interleukin-1 secretion,BP,
4751,GO:0050718,1,0.658592740887016,0,2,positive regulation of interleukin-1 beta secretion,BP,
4752,GO:0050719,1,0.968025854772146,0,1,interleukin-1 alpha biosynthetic process,BP,
4753,GO:0050721,1,0.968025854772146,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
4754,GO:0050726,1,0.968025854772146,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
4756,GO:0050728,1,0.573129872362355,0,2,negative regulation of inflammatory response,BP,
4757,GO:0050729,1,0.474594104725211,0,2,positive regulation of inflammatory response,BP,
4766,GO:0050770,1,0.404123276565647,0,4,regulation of axonogenesis,BP,
4767,GO:0050771,1,0.471265868471169,0,3,negative regulation of axonogenesis,BP,
4768,GO:0050772,1,0.895381066641334,0,1,positive regulation of axonogenesis,BP,
4769,GO:0050773,1,0.42175263034302,0,3,regulation of dendrite development,BP,
4771,GO:0050777,1,0.665985274604568,0,2,negative regulation of immune response,BP,
4773,GO:0050786,1,0.942803698939128,0,1,RAGE receptor binding,MF,
4776,GO:0050792,1,0.452702433061824,0,2,regulation of viral process,BP,
4779,GO:0050795,1,0.596707375173205,0,2,regulation of behavior,BP,
4780,GO:0050796,1,0.550056869556048,0,4,regulation of insulin secretion,BP,
4781,GO:0050798,1,0.805928986539668,0,2,activated T cell proliferation,BP,
4783,GO:0050802,1,0.597901784091742,0,2,circadian sleep/wake cycle, sleep,BP,
4784,GO:0050803,1,0.350144647404796,0,4,regulation of synapse structure or activity,BP,
4785,GO:0050804,1,0.147795874322471,0,10,modulation of synaptic transmission,BP,
4786,GO:0050805,1,0.7728397953467,0,1,negative regulation of synaptic transmission,BP,
4787,GO:0050806,1,0.470363437777151,0,4,positive regulation of synaptic transmission,BP,
4788,GO:0050807,1,0.350144647404796,0,4,regulation of synapse organization,BP,
4793,GO:0050818,1,0.32980944227499,0,4,regulation of coagulation,BP,
4794,GO:0050819,1,0.480134923451189,0,3,negative regulation of coagulation,BP,
4796,GO:0050829,1,0.779059418001785,0,2,defense response to Gram-negative bacterium,BP,
4797,GO:0050830,1,0.80818803699794,0,1,defense response to Gram-positive bacterium,BP,
4798,GO:0050832,1,0.80818803699794,0,1,defense response to fungus,BP,
4801,GO:0050848,1,0.491634465003323,0,3,regulation of calcium-mediated signaling,BP,
4802,GO:0050849,1,0.597419662173836,0,2,negative regulation of calcium-mediated signaling,BP,
4805,GO:0050853,1,0.765858508486771,0,1,B cell receptor signaling pathway,BP,
4814,GO:0050872,1,0.980495002631481,0,1,white fat cell differentiation,BP,
4815,GO:0050873,1,0.925905699129385,0,2,brown fat cell differentiation,BP,
4818,GO:0050879,1,0.772573466595224,0,1,multicellular organismal movement,BP,
4819,GO:0050880,1,0.152469632302714,0,9,regulation of blood vessel size,BP,
4820,GO:0050881,1,0.772573466595224,0,1,musculoskeletal movement,BP,
4822,GO:0050886,1,0.309759269131796,0,4,endocrine process,BP,
4825,GO:0050892,1,0.715839724297779,0,1,intestinal absorption,BP,
4829,GO:0050906,1,0.7728397953467,0,1,detection of stimulus involved in sensory perception,BP,
4830,GO:0050918,1,0.350502682000012,0,6,positive chemotaxis,BP,
4831,GO:0050919,1,0.683299665437994,0,1,negative chemotaxis,BP,
4834,GO:0050922,1,0.375935924423922,0,3,negative regulation of chemotaxis,BP,
4835,GO:0050926,1,0.828803437471209,0,2,regulation of positive chemotaxis,BP,
4836,GO:0050927,1,0.828803437471209,0,2,positive regulation of positive chemotaxis,BP,
4837,GO:0050930,1,0.828803437471209,0,2,induction of positive chemotaxis,BP,
4841,GO:0050951,1,0.7728397953467,0,1,sensory perception of temperature stimulus,BP,
4845,GO:0050961,1,0.7728397953467,0,1,detection of temperature stimulus involved in sensory perception,BP,
4846,GO:0050965,1,0.7728397953467,0,1,detection of temperature stimulus involved in sensory perception of pain,BP,
4847,GO:0050994,1,0.241496161482621,0,6,regulation of lipid catabolic process,BP,
4848,GO:0050995,1,0.408721883568746,0,4,negative regulation of lipid catabolic process,BP,
4849,GO:0050996,1,0.759355645182739,0,1,positive regulation of lipid catabolic process,BP,
4851,GO:0050999,1,0.673034244009855,0,3,regulation of nitric-oxide synthase activity,BP,
4852,GO:0051000,1,0.772639837730134,0,1,positive regulation of nitric-oxide synthase activity,BP,
4853,GO:0051001,1,0.906943268947671,0,1,negative regulation of nitric-oxide synthase activity,BP,
4854,GO:0051004,1,0.987456549281,0,1,regulation of lipoprotein lipase activity,BP,
4855,GO:0051005,1,0.987456549281,0,1,negative regulation of lipoprotein lipase activity,BP,
4859,GO:0051018,1,0.777135023329378,0,1,protein kinase A binding,MF,
4861,GO:0051023,1,0.961431612339441,0,1,regulation of immunoglobulin secretion,BP,
4862,GO:0051024,1,0.961431612339441,0,1,positive regulation of immunoglobulin secretion,BP,
4863,GO:0051040,1,0.768607936468567,0,1,regulation of calcium-independent cell-cell adhesion,BP,
4864,GO:0051042,1,0.768607936468567,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
4872,GO:0051053,1,0.815955200689553,0,2,negative regulation of DNA metabolic process,BP,
4885,GO:0051100,1,0.364748540613359,0,4,negative regulation of binding,BP,
4886,GO:0051101,1,0.584011907271083,0,2,regulation of DNA binding,BP,
4887,GO:0051117,1,0.788139761849395,0,1,ATPase binding,MF,
4888,GO:0051119,1,0.603836627920827,0,2,sugar transmembrane transporter activity,MF,
4896,GO:0051149,1,0.304302035120864,0,5,positive regulation of muscle cell differentiation,BP,
4899,GO:0051153,1,0.172555292734856,0,6,regulation of striated muscle cell differentiation,BP,
4900,GO:0051154,1,0.35238011958558,0,3,negative regulation of striated muscle cell differentiation,BP,
4901,GO:0051155,1,0.494438579548644,0,3,positive regulation of striated muscle cell differentiation,BP,
4902,GO:0051156,1,0.639377288766634,0,2,glucose 6-phosphate metabolic process,BP,
4912,GO:0051181,1,0.753567240984294,0,1,cofactor transport,BP,
4914,GO:0051184,1,0.753567240984294,0,1,cofactor transporter activity,MF,
4916,GO:0051187,1,0.76138364931296,0,2,cofactor catabolic process,BP,
4919,GO:0051194,1,0.772573466595224,0,1,positive regulation of cofactor metabolic process,BP,
4920,GO:0051195,1,0.772573466595224,0,1,negative regulation of cofactor metabolic process,BP,
4922,GO:0051197,1,0.772573466595224,0,1,positive regulation of coenzyme metabolic process,BP,
4923,GO:0051198,1,0.772573466595224,0,1,negative regulation of coenzyme metabolic process,BP,
4924,GO:0051204,1,0.823241180606138,0,1,protein insertion into mitochondrial membrane,BP,
4926,GO:0051208,1,0.706007587608521,0,2,sequestering of calcium ion,BP,
4927,GO:0051209,1,0.706007587608521,0,2,release of sequestered calcium ion into cytosol,BP,
4928,GO:0051213,1,0.867164964013753,0,1,dioxygenase activity,MF,
4931,GO:0051220,1,0.772639837730134,0,1,cytoplasmic sequestering of protein,BP,
4935,GO:0051233,1,0.89202924648779,0,1,spindle midzone,CC,
4938,GO:0051238,1,0.706007587608521,0,2,sequestering of metal ion,BP,
4960,GO:0051279,1,0.77396315259318,0,1,regulation of release of sequestered calcium ion into cytosol,BP,
4961,GO:0051280,1,0.77396315259318,0,1,negative regulation of release of sequestered calcium ion into cytosol,BP,
4962,GO:0051282,1,0.706007587608521,0,2,regulation of sequestering of calcium ion,BP,
4963,GO:0051283,1,0.706007587608521,0,2,negative regulation of sequestering of calcium ion,BP,
4964,GO:0051284,1,0.77396315259318,0,1,positive regulation of sequestering of calcium ion,BP,
4968,GO:0051293,1,0.980495002631481,0,1,establishment of spindle localization,BP,
4969,GO:0051294,1,0.980495002631481,0,1,establishment of spindle orientation,BP,
4970,GO:0051297,1,0.705316075573745,0,2,centrosome organization,BP,
4971,GO:0051298,1,0.770050274238875,0,1,centrosome duplication,BP,
4974,GO:0051303,1,0.853799544891606,0,1,establishment of chromosome localization,BP,
4975,GO:0051310,1,0.853799544891606,0,1,metaphase plate congression,BP,
4979,GO:0051340,1,0.824053991557742,0,1,regulation of ligase activity,BP,
4980,GO:0051341,1,0.309025524262336,0,7,regulation of oxidoreductase activity,BP,
4981,GO:0051342,1,0.824053991557742,0,1,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
4982,GO:0051344,1,0.824053991557742,0,1,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
4987,GO:0051352,1,0.824053991557742,0,1,negative regulation of ligase activity,BP,
4988,GO:0051353,1,0.355418646959904,0,5,positive regulation of oxidoreductase activity,BP,
4989,GO:0051354,1,0.906943268947671,0,1,negative regulation of oxidoreductase activity,BP,
4991,GO:0051379,1,0.628065409479983,0,2,epinephrine binding,MF,
4994,GO:0051402,1,0.264066087459839,0,8,neuron apoptotic process,BP,
4997,GO:0051427,1,0.708761260985198,0,2,hormone receptor binding,MF,
4998,GO:0051428,1,0.990258279272685,0,1,peptide hormone receptor binding,MF,
4999,GO:0051436,1,0.957091557538293,0,1,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,
5000,GO:0051437,1,0.957091557538293,0,1,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,BP,
5001,GO:0051438,1,0.593828646088471,0,3,regulation of ubiquitin-protein transferase activity,BP,
5002,GO:0051439,1,0.957091557538293,0,1,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,
5003,GO:0051443,1,0.593828646088471,0,3,positive regulation of ubiquitin-protein transferase activity,BP,
5004,GO:0051444,1,0.957091557538293,0,1,negative regulation of ubiquitin-protein transferase activity,BP,
5006,GO:0051446,1,0.508052033122485,0,2,positive regulation of meiotic cell cycle,BP,
5008,GO:0051452,1,0.631296473034083,0,3,intracellular pH reduction,BP,
5009,GO:0051453,1,0.631296473034083,0,3,regulation of intracellular pH,BP,
5010,GO:0051480,1,0.244686573264377,0,6,regulation of cytosolic calcium ion concentration,BP,
5011,GO:0051482,1,0.802011392875838,0,1,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
5022,GO:0051539,1,0.782663874445418,0,1,4 iron, 4 sulfur cluster binding,MF,
5024,GO:0051541,1,0.78247392253484,0,1,elastin metabolic process,BP,
5025,GO:0051542,1,0.78247392253484,0,1,elastin biosynthetic process,BP,
5026,GO:0051543,1,0.78247392253484,0,1,regulation of elastin biosynthetic process,BP,
5027,GO:0051545,1,0.78247392253484,0,1,negative regulation of elastin biosynthetic process,BP,
5028,GO:0051546,1,0.767105322391154,0,2,keratinocyte migration,BP,
5029,GO:0051547,1,0.767105322391154,0,2,regulation of keratinocyte migration,BP,
5030,GO:0051549,1,0.767105322391154,0,2,positive regulation of keratinocyte migration,BP,
5031,GO:0051580,1,0.977811028321075,0,1,regulation of neurotransmitter uptake,BP,
5032,GO:0051583,1,0.977811028321075,0,1,dopamine uptake involved in synaptic transmission,BP,
5033,GO:0051584,1,0.977811028321075,0,1,regulation of dopamine uptake involved in synaptic transmission,BP,
5034,GO:0051588,1,0.977811028321075,0,1,regulation of neurotransmitter transport,BP,
5035,GO:0051591,1,0.414082016753327,0,3,response to cAMP,BP,
5036,GO:0051592,1,0.357367523798465,0,4,response to calcium ion,BP,
5037,GO:0051597,1,0.942803698939128,0,1,response to methylmercury,BP,
5038,GO:0051601,1,0.788139761849395,0,1,exocyst localization,BP,
5039,GO:0051602,1,0.807638801744803,0,1,response to electrical stimulus,BP,
5040,GO:0051603,1,0.200969458933758,0,7,proteolysis involved in cellular protein catabolic process,BP,
5042,GO:0051606,1,0.288491804070743,0,5,detection of stimulus,BP,
5044,GO:0051608,1,0.802011392875838,0,1,histamine transport,BP,
5051,GO:0051651,1,0.532782060363931,0,2,maintenance of location in cell,BP,
5052,GO:0051653,1,0.980495002631481,0,1,spindle localization,BP,
5054,GO:0051668,1,0.727261279903572,0,1,localization within membrane,BP,
5056,GO:0051693,1,0.232360499581587,0,4,actin filament capping,BP,
5057,GO:0051694,1,0.920019200387051,0,1,pointed-end actin filament capping,BP,
5063,GO:0051721,1,0.772639837730134,0,1,protein phosphatase 2A binding,MF,
5065,GO:0051767,1,0.776243687039352,0,2,nitric-oxide synthase biosynthetic process,BP,
5066,GO:0051769,1,0.776243687039352,0,2,regulation of nitric-oxide synthase biosynthetic process,BP,
5067,GO:0051770,1,0.968025854772146,0,1,positive regulation of nitric-oxide synthase biosynthetic process,BP,
5068,GO:0051771,1,0.802011392875838,0,1,negative regulation of nitric-oxide synthase biosynthetic process,BP,
5069,GO:0051781,1,0.734909810151537,0,2,positive regulation of cell division,BP,
5070,GO:0051783,1,0.116208295212699,0,9,regulation of nuclear division,BP,
5071,GO:0051784,1,0.46503240903401,0,3,negative regulation of nuclear division,BP,
5072,GO:0051785,1,0.297701940280897,0,5,positive regulation of nuclear division,BP,
5073,GO:0051797,1,0.61294668211829,0,2,regulation of hair follicle development,BP,
5074,GO:0051798,1,0.61294668211829,0,2,positive regulation of hair follicle development,BP,
5078,GO:0051881,1,0.823241180606138,0,1,regulation of mitochondrial membrane potential,BP,
5079,GO:0051884,1,0.683299665437994,0,1,regulation of timing of anagen,BP,
5080,GO:0051885,1,0.683299665437994,0,1,positive regulation of timing of anagen,BP,
5085,GO:0051899,1,0.615161825742223,0,2,membrane depolarization,BP,
5089,GO:0051926,1,0.77396315259318,0,1,negative regulation of calcium ion transport,BP,
5090,GO:0051928,1,0.636169602512695,0,2,positive regulation of calcium ion transport,BP,
5091,GO:0051930,1,0.507502424295925,0,3,regulation of sensory perception of pain,BP,
5092,GO:0051931,1,0.507502424295925,0,3,regulation of sensory perception,BP,
5093,GO:0051932,1,0.7728397953467,0,1,synaptic transmission, GABAergic,BP,
5094,GO:0051934,1,0.977811028321075,0,1,catecholamine uptake involved in synaptic transmission,BP,
5095,GO:0051937,1,0.495456528227319,0,4,catecholamine transport,BP,
5096,GO:0051938,1,0.753709329340452,0,1,L-glutamate import,BP,
5097,GO:0051940,1,0.977811028321075,0,1,regulation of catecholamine uptake involved in synaptic transmission,BP,
5098,GO:0051952,1,0.381946439099446,0,5,regulation of amine transport,BP,
5099,GO:0051953,1,0.390836007414419,0,4,negative regulation of amine transport,BP,
5100,GO:0051954,1,0.977811028321075,0,1,positive regulation of amine transport,BP,
5101,GO:0051955,1,0.7728397953467,0,1,regulation of amino acid transport,BP,
5102,GO:0051956,1,0.7728397953467,0,1,negative regulation of amino acid transport,BP,
5106,GO:0051963,1,0.482924293995526,0,3,regulation of synapse assembly,BP,
5107,GO:0051964,1,0.683299665437994,0,1,negative regulation of synapse assembly,BP,
5108,GO:0051965,1,0.858923178696575,0,1,positive regulation of synapse assembly,BP,
5109,GO:0051966,1,0.7728397953467,0,1,regulation of synaptic transmission, glutamatergic,BP,
5110,GO:0051967,1,0.7728397953467,0,1,negative regulation of synaptic transmission, glutamatergic,BP,
5111,GO:0051990,1,0.783708505287183,0,1,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
5114,GO:0052652,1,0.431316283576613,0,5,cyclic purine nucleotide metabolic process,BP,
5116,GO:0052692,1,0.906943268947671,0,1,raffinose alpha-galactosidase activity,MF,
5117,GO:0052739,1,0.930530251776604,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
5118,GO:0052740,1,0.930530251776604,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
5126,GO:0055008,1,0.18915357816944,0,5,cardiac muscle tissue morphogenesis,BP,
5127,GO:0055009,1,0.772581840319793,0,1,atrial cardiac muscle tissue morphogenesis,BP,
5128,GO:0055010,1,0.616704084333269,0,1,ventricular cardiac muscle tissue morphogenesis,BP,
5130,GO:0055017,1,0.365736497269766,0,4,cardiac muscle tissue growth,BP,
5131,GO:0055018,1,0.847043438938523,0,1,regulation of cardiac muscle fiber development,BP,
5132,GO:0055020,1,0.847043438938523,0,1,positive regulation of cardiac muscle fiber development,BP,
5133,GO:0055021,1,0.365736497269766,0,4,regulation of cardiac muscle tissue growth,BP,
5134,GO:0055022,1,0.961431612339441,0,1,negative regulation of cardiac muscle tissue growth,BP,
5135,GO:0055023,1,0.380699831458361,0,3,positive regulation of cardiac muscle tissue growth,BP,
5136,GO:0055024,1,0.120798526666792,0,9,regulation of cardiac muscle tissue development,BP,
5137,GO:0055025,1,0.233603428208251,0,5,positive regulation of cardiac muscle tissue development,BP,
5138,GO:0055026,1,0.523974683777206,0,4,negative regulation of cardiac muscle tissue development,BP,
5139,GO:0055037,1,0.0945337162079199,0,9,recycling endosome,CC,
5140,GO:0055038,1,0.410766704479666,0,4,recycling endosome membrane,CC,
5141,GO:0055056,1,0.792322370974488,0,1,D-glucose transmembrane transporter activity,MF,
5145,GO:0055072,1,0.352345989204463,0,4,iron ion homeostasis,BP,
5147,GO:0055075,1,0.767624987207694,0,1,potassium ion homeostasis,BP,
5149,GO:0055078,1,0.453432950730039,0,3,sodium ion homeostasis,BP,
5151,GO:0055081,1,0.730000373127536,0,2,anion homeostasis,BP,
5155,GO:0055088,1,0.553658233729333,0,3,lipid homeostasis,BP,
5156,GO:0055090,1,0.759355645182739,0,1,acylglycerol homeostasis,BP,
5157,GO:0055091,1,0.730000373127536,0,2,phospholipid homeostasis,BP,
5158,GO:0055092,1,0.730000373127536,0,2,sterol homeostasis,BP,
5160,GO:0055094,1,0.77139588570204,0,1,response to lipoprotein particle,BP,
5161,GO:0055099,1,0.77139588570204,0,1,response to high density lipoprotein particle,BP,
5162,GO:0055102,1,0.987456549281,0,1,lipase inhibitor activity,MF,
5165,GO:0055118,1,0.537064383703859,0,2,negative regulation of cardiac muscle contraction,BP,
5168,GO:0055131,1,0.767624987207694,0,1,C3HC4-type RING finger domain binding,MF,
5169,GO:0060019,1,0.712948997189876,0,2,radial glial cell differentiation,BP,
5170,GO:0060021,1,0.334927003659861,0,4,palate development,BP,
5171,GO:0060024,1,0.802011392875838,0,1,rhythmic synaptic transmission,BP,
5172,GO:0060026,1,0.683299665437994,0,1,convergent extension,BP,
5173,GO:0060027,1,0.683299665437994,0,1,convergent extension involved in gastrulation,BP,
5174,GO:0060028,1,0.683299665437994,0,1,convergent extension involved in axis elongation,BP,
5175,GO:0060029,1,0.683299665437994,0,1,convergent extension involved in organogenesis,BP,
5176,GO:0060031,1,0.683299665437994,0,1,mediolateral intercalation,BP,
5177,GO:0060037,1,0.458718789384699,0,4,pharyngeal system development,BP,
5178,GO:0060038,1,0.457088272337105,0,3,cardiac muscle cell proliferation,BP,
5179,GO:0060039,1,0.182120389957377,0,5,pericardium development,BP,
5182,GO:0060043,1,0.457088272337105,0,3,regulation of cardiac muscle cell proliferation,BP,
5183,GO:0060044,1,0.961431612339441,0,1,negative regulation of cardiac muscle cell proliferation,BP,
5184,GO:0060045,1,0.475702340867696,0,2,positive regulation of cardiac muscle cell proliferation,BP,
5187,GO:0060054,1,0.628285809545088,0,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,
5188,GO:0060056,1,0.715839724297779,0,1,mammary gland involution,BP,
5189,GO:0060057,1,0.715839724297779,0,1,apoptotic process involved in mammary gland involution,BP,
5190,GO:0060058,1,0.715839724297779,0,1,positive regulation of apoptotic process involved in mammary gland involution,BP,
5191,GO:0060059,1,0.961431612339441,0,1,embryonic retina morphogenesis in camera-type eye,BP,
5192,GO:0060061,1,0.895381066641334,0,1,Spemann organizer formation,BP,
5193,GO:0060064,1,0.895381066641334,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
5194,GO:0060065,1,0.434636455196259,0,4,uterus development,BP,
5195,GO:0060066,1,0.858923178696575,0,1,oviduct development,BP,
5196,GO:0060067,1,0.683299665437994,0,1,cervix development,BP,
5197,GO:0060068,1,0.486711453198731,0,3,vagina development,BP,
5199,GO:0060071,1,0.487351167396069,0,3,Wnt signaling pathway, planar cell polarity pathway,BP,
5200,GO:0060075,1,0.774603477995536,0,1,regulation of resting membrane potential,BP,
5202,GO:0060078,1,0.464371580386323,0,3,regulation of postsynaptic membrane potential,BP,
5203,GO:0060079,1,0.464371580386323,0,3,excitatory postsynaptic potential,BP,
5204,GO:0060087,1,0.7728397953467,0,1,relaxation of vascular smooth muscle,BP,
5211,GO:0060120,1,0.434313343403453,0,2,inner ear receptor cell fate commitment,BP,
5213,GO:0060126,1,0.744587511205584,0,1,somatotropin secreting cell differentiation,BP,
5214,GO:0060128,1,0.731178396258439,0,2,corticotropin hormone secreting cell differentiation,BP,
5215,GO:0060129,1,0.543726638241655,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
5218,GO:0060137,1,0.802011392875838,0,1,maternal process involved in parturition,BP,
5219,GO:0060147,1,0.847043438938523,0,1,regulation of posttranscriptional gene silencing,BP,
5220,GO:0060148,1,0.847043438938523,0,1,positive regulation of posttranscriptional gene silencing,BP,
5221,GO:0060155,1,0.908975838289389,0,1,platelet dense granule organization,BP,
5222,GO:0060157,1,0.656750036700198,0,2,urinary bladder development,BP,
5223,GO:0060170,1,0.585788010294756,0,1,ciliary membrane,CC,
5224,GO:0060173,1,0.0955784605631093,0,10,limb development,BP,
5225,GO:0060174,1,0.87785864177312,0,2,limb bud formation,BP,
5226,GO:0060178,1,0.788139761849395,0,1,regulation of exocyst localization,BP,
5228,GO:0060191,1,0.799574433154174,0,3,regulation of lipase activity,BP,
5229,GO:0060192,1,0.987456549281,0,1,negative regulation of lipase activity,BP,
5230,GO:0060193,1,0.8098175575904,0,2,positive regulation of lipase activity,BP,
5231,GO:0060197,1,0.847043438938523,0,1,cloacal septation,BP,
5233,GO:0060215,1,0.766387473815025,0,1,primitive hemopoiesis,BP,
5234,GO:0060216,1,0.766387473815025,0,1,definitive hemopoiesis,BP,
5235,GO:0060228,1,0.987456549281,0,1,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
5236,GO:0060231,1,0.261631034703709,0,6,mesenchymal to epithelial transition,BP,
5237,GO:0060235,1,0.847043438938523,0,1,lens induction in camera-type eye,BP,
5238,GO:0060236,1,0.853799544891606,0,1,regulation of mitotic spindle organization,BP,
5240,GO:0060251,1,0.616704084333269,0,1,regulation of glial cell proliferation,BP,
5241,GO:0060253,1,0.616704084333269,0,1,negative regulation of glial cell proliferation,BP,
5243,GO:0060260,1,0.766486369353892,0,1,regulation of transcription initiation from RNA polymerase II promoter,BP,
5244,GO:0060261,1,0.766486369353892,0,1,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
5246,GO:0060272,1,0.476397782503784,0,3,embryonic skeletal joint morphogenesis,BP,
5247,GO:0060278,1,0.767464593952245,0,1,regulation of ovulation,BP,
5248,GO:0060279,1,0.767464593952245,0,1,positive regulation of ovulation,BP,
5249,GO:0060281,1,0.990258279272685,0,1,regulation of oocyte development,BP,
5250,GO:0060283,1,0.990258279272685,0,1,negative regulation of oocyte development,BP,
5252,GO:0060291,1,0.942803698939128,0,1,long-term synaptic potentiation,BP,
5253,GO:0060292,1,0.7728397953467,0,1,long term synaptic depression,BP,
5254,GO:0060297,1,0.802011392875838,0,1,regulation of sarcomere organization,BP,
5255,GO:0060298,1,0.802011392875838,0,1,positive regulation of sarcomere organization,BP,
5256,GO:0060306,1,0.593581351210114,0,2,regulation of membrane repolarization,BP,
5257,GO:0060307,1,0.767624987207694,0,1,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
5258,GO:0060314,1,0.77396315259318,0,1,regulation of ryanodine-sensitive calcium-release channel activity,BP,
5259,GO:0060315,1,0.77396315259318,0,1,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
5260,GO:0060317,1,0.208547764625294,0,6,cardiac epithelial to mesenchymal transition,BP,
5261,GO:0060318,1,0.766387473815025,0,1,definitive erythrocyte differentiation,BP,
5262,GO:0060319,1,0.766387473815025,0,1,primitive erythrocyte differentiation,BP,
5268,GO:0060333,1,0.854852279502456,0,2,interferon-gamma-mediated signaling pathway,BP,
5269,GO:0060337,1,0.40991162256991,0,4,type I interferon signaling pathway,BP,
5270,GO:0060338,1,0.57074540073126,0,2,regulation of type I interferon-mediated signaling pathway,BP,
5271,GO:0060340,1,0.57074540073126,0,2,positive regulation of type I interferon-mediated signaling pathway,BP,
5273,GO:0060343,1,0.755187760875045,0,2,trabecula formation,BP,
5274,GO:0060347,1,0.755187760875045,0,2,heart trabecula formation,BP,
5275,GO:0060348,1,0.153805571200782,0,10,bone development,BP,
5276,GO:0060349,1,0.444166064709639,0,5,bone morphogenesis,BP,
5277,GO:0060350,1,0.444166064709639,0,5,endochondral bone morphogenesis,BP,
5278,GO:0060351,1,0.990258279272685,0,1,cartilage development involved in endochondral bone morphogenesis,BP,
5279,GO:0060359,1,0.836041871517245,0,1,response to ammonium ion,BP,
5280,GO:0060363,1,0.847043438938523,0,1,cranial suture morphogenesis,BP,
5281,GO:0060374,1,0.766387473815025,0,1,mast cell differentiation,BP,
5282,GO:0060375,1,0.766387473815025,0,1,regulation of mast cell differentiation,BP,
5283,GO:0060377,1,0.766387473815025,0,1,negative regulation of mast cell differentiation,BP,
5284,GO:0060379,1,0.616704084333269,0,1,cardiac muscle cell myoblast differentiation,BP,
5285,GO:0060389,1,0.216672951862658,0,6,pathway-restricted SMAD protein phosphorylation,BP,
5286,GO:0060390,1,0.651360225257213,0,2,regulation of SMAD protein import into nucleus,BP,
5287,GO:0060391,1,0.651360225257213,0,2,positive regulation of SMAD protein import into nucleus,BP,
5288,GO:0060393,1,0.216672951862658,0,6,regulation of pathway-restricted SMAD protein phosphorylation,BP,
5289,GO:0060395,1,0.282003537519768,0,5,SMAD protein signal transduction,BP,
5291,GO:0060397,1,0.727749574179032,0,1,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
5293,GO:0060402,1,0.706007587608521,0,2,calcium ion transport into cytosol,BP,
5294,GO:0060411,1,0.113710248112396,0,8,cardiac septum morphogenesis,BP,
5295,GO:0060412,1,0.163026263008916,0,6,ventricular septum morphogenesis,BP,
5296,GO:0060413,1,0.590889809654547,0,2,atrial septum morphogenesis,BP,
5297,GO:0060415,1,0.18915357816944,0,5,muscle tissue morphogenesis,BP,
5299,GO:0060419,1,0.281056084984674,0,5,heart growth,BP,
5300,GO:0060420,1,0.281056084984674,0,5,regulation of heart growth,BP,
5301,GO:0060421,1,0.29261744432234,0,4,positive regulation of heart growth,BP,
5302,GO:0060423,1,0.609226769269985,0,2,foregut regionalization,BP,
5303,GO:0060424,1,0.609226769269985,0,2,lung field specification,BP,
5304,GO:0060425,1,0.264115912515245,0,7,lung morphogenesis,BP,
5305,GO:0060426,1,0.574420711452922,0,2,lung vasculature development,BP,
5306,GO:0060428,1,0.367094152128261,0,5,lung epithelium development,BP,
5308,GO:0060430,1,0.757593592245352,0,2,lung saccule development,BP,
5309,GO:0060431,1,0.609226769269985,0,2,primary lung bud formation,BP,
5310,GO:0060432,1,0.980495002631481,0,1,lung pattern specification process,BP,
5311,GO:0060433,1,0.630017641475263,0,2,bronchus development,BP,
5312,GO:0060435,1,0.980495002631481,0,1,bronchiole development,BP,
5313,GO:0060436,1,0.980495002631481,0,1,bronchiole morphogenesis,BP,
5314,GO:0060437,1,0.980495002631481,0,1,lung growth,BP,
5315,GO:0060438,1,0.630017641475263,0,2,trachea development,BP,
5316,GO:0060439,1,0.630017641475263,0,2,trachea morphogenesis,BP,
5317,GO:0060440,1,0.847043438938523,0,1,trachea formation,BP,
5318,GO:0060441,1,0.505201122213899,0,4,epithelial tube branching involved in lung morphogenesis,BP,
5319,GO:0060442,1,0.626137569807627,0,2,branching involved in prostate gland morphogenesis,BP,
5320,GO:0060443,1,0.223299024565207,0,6,mammary gland morphogenesis,BP,
5321,GO:0060444,1,0.269898707741644,0,4,branching involved in mammary gland duct morphogenesis,BP,
5323,GO:0060447,1,0.980495002631481,0,1,bud outgrowth involved in lung branching,BP,
5324,GO:0060449,1,0.830442121421211,0,2,bud elongation involved in lung branching,BP,
5326,GO:0060457,1,0.734045967558083,0,1,negative regulation of digestive system process,BP,
5327,GO:0060462,1,0.744061959631107,0,1,lung lobe development,BP,
5328,GO:0060463,1,0.744061959631107,0,1,lung lobe morphogenesis,BP,
5329,GO:0060479,1,0.980495002631481,0,1,lung cell differentiation,BP,
5330,GO:0060482,1,0.744287228075405,0,1,lobar bronchus development,BP,
5332,GO:0060487,1,0.980495002631481,0,1,lung epithelial cell differentiation,BP,
5334,GO:0060492,1,0.609226769269985,0,2,lung induction,BP,
5335,GO:0060495,1,0.980495002631481,0,1,cell-cell signaling involved in lung development,BP,
5336,GO:0060496,1,0.980495002631481,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
5337,GO:0060501,1,0.772581840319793,0,1,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
5338,GO:0060502,1,0.654019608777945,0,2,epithelial cell proliferation involved in lung morphogenesis,BP,
5339,GO:0060503,1,0.847043438938523,0,1,bud dilation involved in lung branching,BP,
5340,GO:0060510,1,0.980495002631481,0,1,Type II pneumocyte differentiation,BP,
5341,GO:0060512,1,0.256577019121625,0,5,prostate gland morphogenesis,BP,
5342,GO:0060513,1,0.418322557566142,0,4,prostatic bud formation,BP,
5343,GO:0060525,1,0.616704084333269,0,1,prostate glandular acinus development,BP,
5344,GO:0060528,1,0.616704084333269,0,1,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
5345,GO:0060534,1,0.744287228075405,0,1,trachea cartilage development,BP,
5346,GO:0060535,1,0.744287228075405,0,1,trachea cartilage morphogenesis,BP,
5347,GO:0060536,1,0.744287228075405,0,1,cartilage morphogenesis,BP,
5350,GO:0060539,1,0.595398987331613,0,2,diaphragm development,BP,
5352,GO:0060544,1,0.750187185736748,0,2,regulation of necroptotic process,BP,
5353,GO:0060546,1,0.836041871517245,0,1,negative regulation of necroptotic process,BP,
5354,GO:0060547,1,0.762712607721979,0,2,negative regulation of necrotic cell death,BP,
5356,GO:0060556,1,0.715839724297779,0,1,regulation of vitamin D biosynthetic process,BP,
5357,GO:0060558,1,0.715839724297779,0,1,regulation of calcidiol 1-monooxygenase activity,BP,
5358,GO:0060560,1,0.171344599017189,0,7,developmental growth involved in morphogenesis,BP,
5359,GO:0060561,1,0.228148525690558,0,4,apoptotic process involved in morphogenesis,BP,
5362,GO:0060571,1,0.253358387370927,0,6,morphogenesis of an epithelial fold,BP,
5363,GO:0060572,1,0.253358387370927,0,6,morphogenesis of an epithelial bud,BP,
5367,GO:0060584,1,0.802011392875838,0,1,regulation of prostaglandin-endoperoxide synthase activity,BP,
5368,GO:0060585,1,0.802011392875838,0,1,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
5369,GO:0060586,1,0.769446945848083,0,1,multicellular organismal iron ion homeostasis,BP,
5371,GO:0060592,1,0.830442121421211,0,2,mammary gland formation,BP,
5372,GO:0060594,1,0.980495002631481,0,1,mammary gland specification,BP,
5373,GO:0060595,1,0.980495002631481,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
5374,GO:0060599,1,0.683299665437994,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
5375,GO:0060601,1,0.418322557566142,0,4,lateral sprouting from an epithelium,BP,
5376,GO:0060602,1,0.566834388804615,0,3,branch elongation of an epithelium,BP,
5377,GO:0060603,1,0.264438935011425,0,5,mammary gland duct morphogenesis,BP,
5379,GO:0060612,1,0.556886136745987,0,3,adipose tissue development,BP,
5380,GO:0060615,1,0.980495002631481,0,1,mammary gland bud formation,BP,
5382,GO:0060638,1,0.527943239711943,0,3,mesenchymal-epithelial cell signaling,BP,
5383,GO:0060644,1,0.772639837730134,0,1,mammary gland epithelial cell differentiation,BP,
5384,GO:0060648,1,0.980495002631481,0,1,mammary gland bud morphogenesis,BP,
5385,GO:0060661,1,0.980495002631481,0,1,submandibular salivary gland formation,BP,
5386,GO:0060664,1,0.980495002631481,0,1,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
5387,GO:0060665,1,0.980495002631481,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
5388,GO:0060667,1,0.980495002631481,0,1,branch elongation involved in salivary gland morphogenesis,BP,
5389,GO:0060669,1,0.549926653380295,0,2,embryonic placenta morphogenesis,BP,
5392,GO:0060676,1,0.977811028321075,0,1,ureteric bud formation,BP,
5393,GO:0060677,1,0.847043438938523,0,1,ureteric bud elongation,BP,
5394,GO:0060681,1,0.847043438938523,0,1,branch elongation involved in ureteric bud branching,BP,
5395,GO:0060684,1,0.7293102325714,0,2,epithelial-mesenchymal cell signaling,BP,
5396,GO:0060685,1,0.426849692581485,0,3,regulation of prostatic bud formation,BP,
5397,GO:0060686,1,0.426849692581485,0,3,negative regulation of prostatic bud formation,BP,
5398,GO:0060687,1,0.626137569807627,0,2,regulation of branching involved in prostate gland morphogenesis,BP,
5399,GO:0060688,1,0.247529209205782,0,7,regulation of morphogenesis of a branching structure,BP,
5400,GO:0060693,1,0.980495002631481,0,1,regulation of branching involved in salivary gland morphogenesis,BP,
5401,GO:0060696,1,0.773787430346066,0,2,regulation of phospholipid catabolic process,BP,
5402,GO:0060706,1,0.57431853127151,0,2,cell differentiation involved in embryonic placenta development,BP,
5403,GO:0060707,1,0.744061959631107,0,1,trophoblast giant cell differentiation,BP,
5404,GO:0060708,1,0.744061959631107,0,1,spongiotrophoblast differentiation,BP,
5405,GO:0060709,1,0.772639837730134,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
5406,GO:0060710,1,0.549926653380295,0,2,chorio-allantoic fusion,BP,
5407,GO:0060711,1,0.255706871461645,0,5,labyrinthine layer development,BP,
5408,GO:0060712,1,0.57431853127151,0,2,spongiotrophoblast layer development,BP,
5409,GO:0060713,1,0.549926653380295,0,2,labyrinthine layer morphogenesis,BP,
5410,GO:0060716,1,0.467774080950942,0,3,labyrinthine layer blood vessel development,BP,
5411,GO:0060740,1,0.256577019121625,0,5,prostate gland epithelium morphogenesis,BP,
5412,GO:0060742,1,0.616704084333269,0,1,epithelial cell differentiation involved in prostate gland development,BP,
5413,GO:0060744,1,0.683299665437994,0,1,mammary gland branching involved in thelarche,BP,
5414,GO:0060745,1,0.532332965707556,0,2,mammary gland branching involved in pregnancy,BP,
5415,GO:0060748,1,0.744587511205584,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
5416,GO:0060749,1,0.747095520096568,0,1,mammary gland alveolus development,BP,
5417,GO:0060750,1,0.683299665437994,0,1,epithelial cell proliferation involved in mammary gland duct elongation,BP,
5418,GO:0060751,1,0.683299665437994,0,1,branch elongation involved in mammary gland duct branching,BP,
5422,GO:0060762,1,0.683299665437994,0,1,regulation of branching involved in mammary gland duct morphogenesis,BP,
5423,GO:0060767,1,0.616704084333269,0,1,epithelial cell proliferation involved in prostate gland development,BP,
5424,GO:0060768,1,0.616704084333269,0,1,regulation of epithelial cell proliferation involved in prostate gland development,BP,
5425,GO:0060775,1,0.683299665437994,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
5426,GO:0060788,1,0.762142819578083,0,1,ectodermal placode formation,BP,
5427,GO:0060795,1,0.632051517392295,0,2,cell fate commitment involved in formation of primary germ layer,BP,
5428,GO:0060804,1,0.768607936468567,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
5429,GO:0060809,1,0.683299665437994,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
5430,GO:0060823,1,0.762142819578083,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
5435,GO:0060840,1,0.217436108178356,0,6,artery development,BP,
5436,GO:0060841,1,0.448970932754634,0,2,venous blood vessel development,BP,
5438,GO:0060843,1,0.616704084333269,0,1,venous endothelial cell differentiation,BP,
5443,GO:0060856,1,0.638884656670793,0,2,establishment of blood-brain barrier,BP,
5444,GO:0060872,1,0.980495002631481,0,1,semicircular canal development,BP,
5445,GO:0060876,1,0.980495002631481,0,1,semicircular canal formation,BP,
5446,GO:0060879,1,0.980495002631481,0,1,semicircular canal fusion,BP,
5447,GO:0060896,1,0.762142819578083,0,1,neural plate pattern specification,BP,
5448,GO:0060897,1,0.762142819578083,0,1,neural plate regionalization,BP,
5449,GO:0060900,1,0.527372840765883,0,2,embryonic camera-type eye formation,BP,
5450,GO:0060907,1,0.683299665437994,0,1,positive regulation of macrophage cytokine production,BP,
5451,GO:0060911,1,0.594573512181127,0,2,cardiac cell fate commitment,BP,
5452,GO:0060914,1,0.847043438938523,0,1,heart formation,BP,
5453,GO:0060915,1,0.980495002631481,0,1,mesenchymal cell differentiation involved in lung development,BP,
5454,GO:0060923,1,0.594573512181127,0,2,cardiac muscle cell fate commitment,BP,
5455,GO:0060947,1,0.616704084333269,0,1,cardiac vascular smooth muscle cell differentiation,BP,
5456,GO:0060948,1,0.616704084333269,0,1,cardiac vascular smooth muscle cell development,BP,
5457,GO:0060956,1,0.475161788613757,0,2,endocardial cell differentiation,BP,
5458,GO:0060957,1,0.7717087498744,0,1,endocardial cell fate commitment,BP,
5459,GO:0060964,1,0.847043438938523,0,1,regulation of gene silencing by miRNA,BP,
5460,GO:0060966,1,0.847043438938523,0,1,regulation of gene silencing by RNA,BP,
5461,GO:0060968,1,0.847043438938523,0,1,regulation of gene silencing,BP,
5463,GO:0060973,1,0.616704084333269,0,1,cell migration involved in heart development,BP,
5464,GO:0060976,1,0.52181526023997,0,2,coronary vasculature development,BP,
5465,GO:0060977,1,0.616704084333269,0,1,coronary vasculature morphogenesis,BP,
5466,GO:0060979,1,0.616704084333269,0,1,vasculogenesis involved in coronary vascular morphogenesis,BP,
5467,GO:0060982,1,0.616704084333269,0,1,coronary artery morphogenesis,BP,
5468,GO:0060986,1,0.387303256926779,0,3,endocrine hormone secretion,BP,
5469,GO:0060992,1,0.774318895616471,0,1,response to fungicide,BP,
5471,GO:0060994,1,0.847043438938523,0,1,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
5473,GO:0060997,1,0.858923178696575,0,1,dendritic spine morphogenesis,BP,
5474,GO:0061004,1,0.847043438938523,0,1,pattern specification involved in kidney development,BP,
5475,GO:0061005,1,0.145507202104044,0,8,cell differentiation involved in kidney development,BP,
5477,GO:0061013,1,0.401163524090605,0,3,regulation of mRNA catabolic process,BP,
5478,GO:0061014,1,0.749764257384907,0,1,positive regulation of mRNA catabolic process,BP,
5481,GO:0061027,1,0.785634671671933,0,1,umbilical cord development,BP,
5483,GO:0061029,1,0.772776823282694,0,1,eyelid development in camera-type eye,BP,
5484,GO:0061032,1,0.771150420617929,0,1,visceral serous pericardium development,BP,
5485,GO:0061033,1,0.980495002631481,0,1,secretion by lung epithelial cell involved in lung growth,BP,
5487,GO:0061036,1,0.303251470000608,0,5,positive regulation of cartilage development,BP,
5488,GO:0061037,1,0.847043438938523,0,1,negative regulation of cartilage development,BP,
5489,GO:0061038,1,0.66338844784811,0,2,uterus morphogenesis,BP,
5490,GO:0061041,1,0.178883816742507,0,7,regulation of wound healing,BP,
5491,GO:0061045,1,0.356482584598008,0,4,negative regulation of wound healing,BP,
5492,GO:0061046,1,0.515446521736516,0,3,regulation of branching involved in lung morphogenesis,BP,
5493,GO:0061047,1,0.515446521736516,0,3,positive regulation of branching involved in lung morphogenesis,BP,
5494,GO:0061049,1,0.802011392875838,0,1,cell growth involved in cardiac muscle cell development,BP,
5495,GO:0061050,1,0.802011392875838,0,1,regulation of cell growth involved in cardiac muscle cell development,BP,
5496,GO:0061051,1,0.802011392875838,0,1,positive regulation of cell growth involved in cardiac muscle cell development,BP,
5498,GO:0061054,1,0.744587511205584,0,1,dermatome development,BP,
5500,GO:0061072,1,0.609226769269985,0,2,iris morphogenesis,BP,
5501,GO:0061081,1,0.683299665437994,0,1,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
5505,GO:0061101,1,0.543726638241655,0,3,neuroendocrine cell differentiation,BP,
5507,GO:0061110,1,0.80818803699794,0,1,dense core granule biogenesis,BP,
5508,GO:0061115,1,0.980495002631481,0,1,lung proximal/distal axis specification,BP,
5509,GO:0061117,1,0.961431612339441,0,1,negative regulation of heart growth,BP,
5512,GO:0061136,1,0.410697033458851,0,3,regulation of proteasomal protein catabolic process,BP,
5514,GO:0061140,1,0.980495002631481,0,1,lung secretory cell differentiation,BP,
5515,GO:0061143,1,0.772776823282694,0,1,alveolar primary septum development,BP,
5516,GO:0061146,1,0.845372895917985,0,1,Peyer's patch morphogenesis,BP,
5517,GO:0061149,1,0.847043438938523,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
5518,GO:0061150,1,0.847043438938523,0,1,renal system segmentation,BP,
5519,GO:0061151,1,0.847043438938523,0,1,BMP signaling pathway involved in renal system segmentation,BP,
5521,GO:0061155,1,0.847043438938523,0,1,pulmonary artery endothelial tube morphogenesis,BP,
5522,GO:0061156,1,0.654185016837647,0,2,pulmonary artery morphogenesis,BP,
5523,GO:0061162,1,0.506147921111534,0,2,establishment of monopolar cell polarity,BP,
5524,GO:0061180,1,0.103021171658664,0,9,mammary gland epithelium development,BP,
5525,GO:0061183,1,0.744587511205584,0,1,regulation of dermatome development,BP,
5526,GO:0061184,1,0.744587511205584,0,1,positive regulation of dermatome development,BP,
5527,GO:0061205,1,0.574827695505362,0,2,paramesonephric duct development,BP,
5528,GO:0061209,1,0.650648483368427,0,2,cell proliferation involved in mesonephros development,BP,
5529,GO:0061213,1,0.594424342578438,0,3,positive regulation of mesonephros development,BP,
5530,GO:0061216,1,0.847043438938523,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
5531,GO:0061217,1,0.502868411895998,0,4,regulation of mesonephros development,BP,
5532,GO:0061218,1,0.847043438938523,0,1,negative regulation of mesonephros development,BP,
5533,GO:0061227,1,0.847043438938523,0,1,pattern specification involved in mesonephros development,BP,
5534,GO:0061245,1,0.506147921111534,0,2,establishment or maintenance of bipolar cell polarity,BP,
5537,GO:0061302,1,0.579779081851963,0,2,smooth muscle cell-matrix adhesion,BP,
5538,GO:0061303,1,0.679416849665588,0,2,cornea development in camera-type eye,BP,
5539,GO:0061311,1,0.163507263204782,0,6,cell surface receptor signaling pathway involved in heart development,BP,
5540,GO:0061312,1,0.653278949255139,0,2,BMP signaling pathway involved in heart development,BP,
5541,GO:0061314,1,0.483784071740881,0,2,Notch signaling involved in heart development,BP,
5542,GO:0061318,1,0.652805308656883,0,2,renal filtration cell differentiation,BP,
5543,GO:0061323,1,0.847043438938523,0,1,cell proliferation involved in heart morphogenesis,BP,
5544,GO:0061325,1,0.847043438938523,0,1,cell proliferation involved in outflow tract morphogenesis,BP,
5547,GO:0061337,1,0.110735647772393,0,9,cardiac conduction,BP,
5548,GO:0061339,1,0.506147921111534,0,2,establishment or maintenance of monopolar cell polarity,BP,
5549,GO:0061341,1,0.683299665437994,0,1,non-canonical Wnt signaling pathway involved in heart development,BP,
5550,GO:0061343,1,0.7717087498744,0,1,cell adhesion involved in heart morphogenesis,BP,
5551,GO:0061346,1,0.683299665437994,0,1,planar cell polarity pathway involved in heart morphogenesis,BP,
5552,GO:0061347,1,0.683299665437994,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
5553,GO:0061348,1,0.683299665437994,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
5554,GO:0061349,1,0.683299665437994,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
5555,GO:0061350,1,0.683299665437994,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
5556,GO:0061351,1,0.127707863440854,0,8,neural precursor cell proliferation,BP,
5557,GO:0061354,1,0.683299665437994,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
5558,GO:0061369,1,0.744587511205584,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
5561,GO:0061377,1,0.747095520096568,0,1,mammary gland lobule development,BP,
5562,GO:0061383,1,0.342822078043671,0,4,trabecula morphogenesis,BP,
5563,GO:0061384,1,0.342822078043671,0,4,heart trabecula morphogenesis,BP,
5564,GO:0061387,1,0.611439543999529,0,2,regulation of extent of cell growth,BP,
5565,GO:0061418,1,0.590006277990704,0,2,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
5566,GO:0061419,1,0.616704084333269,0,1,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
5568,GO:0061437,1,0.200139266203848,0,6,renal system vasculature development,BP,
5569,GO:0061438,1,0.847043438938523,0,1,renal system vasculature morphogenesis,BP,
5570,GO:0061439,1,0.847043438938523,0,1,kidney vasculature morphogenesis,BP,
5571,GO:0061440,1,0.200139266203848,0,6,kidney vasculature development,BP,
5572,GO:0061443,1,0.7717087498744,0,1,endocardial cushion cell differentiation,BP,
5573,GO:0061445,1,0.7717087498744,0,1,endocardial cushion cell fate commitment,BP,
5576,GO:0061462,1,0.701441456494016,0,1,protein localization to lysosome,BP,
5577,GO:0061515,1,0.447606037253482,0,3,myeloid cell development,BP,
5578,GO:0061525,1,0.683299665437994,0,1,hindgut development,BP,
5581,GO:0061614,1,0.593237440512914,0,2,pri-miRNA transcription from RNA polymerase II promoter,BP,
5582,GO:0061615,1,0.726704948244745,0,1,glycolytic process through fructose-6-phosphate,BP,
5583,GO:0061620,1,0.726704948244745,0,1,glycolytic process through glucose-6-phosphate,BP,
5584,GO:0061621,1,0.726704948244745,0,1,canonical glycolysis,BP,
5585,GO:0061624,1,0.77994876250451,0,1,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
5586,GO:0061626,1,0.847043438938523,0,1,pharyngeal arch artery morphogenesis,BP,
5587,GO:0061630,1,0.685812470298157,0,1,ubiquitin protein ligase activity,MF,
5588,GO:0061640,1,0.700469233394229,0,1,cytoskeleton-dependent cytokinesis,BP,
5589,GO:0061642,1,0.683299665437994,0,1,chemoattraction of axon,BP,
5590,GO:0061643,1,0.683299665437994,0,1,chemorepulsion of axon,BP,
5591,GO:0061659,1,0.685812470298157,0,1,ubiquitin-like protein ligase activity,MF,
5593,GO:0061700,1,0.759355645182739,0,1,GATOR2 complex,CC,
5595,GO:0061718,1,0.726704948244745,0,1,glucose catabolic process to pyruvate,BP,
5596,GO:0061724,1,0.759355645182739,0,1,lipophagy,BP,
5599,GO:0065005,1,0.987456549281,0,1,protein-lipid complex assembly,BP,
5603,GO:0070003,1,0.957091557538293,0,1,threonine-type peptidase activity,MF,
5606,GO:0070016,1,0.762142819578083,0,1,armadillo repeat domain binding,MF,
5607,GO:0070050,1,0.742334532829423,0,1,neuron cellular homeostasis,BP,
5611,GO:0070064,1,0.727749574179032,0,1,proline-rich region binding,MF,
5612,GO:0070075,1,0.980495002631481,0,1,tear secretion,BP,
5614,GO:0070085,1,0.530142433773315,0,4,glycosylation,BP,
5615,GO:0070098,1,0.776243687039352,0,2,chemokine-mediated signaling pathway,BP,
5616,GO:0070099,1,0.802011392875838,0,1,regulation of chemokine-mediated signaling pathway,BP,
5617,GO:0070101,1,0.802011392875838,0,1,positive regulation of chemokine-mediated signaling pathway,BP,
5618,GO:0070125,1,0.742312205428389,0,3,mitochondrial translational elongation,BP,
5619,GO:0070126,1,0.911789827211774,0,2,mitochondrial translational termination,BP,
5620,GO:0070129,1,0.814426450750734,0,1,regulation of mitochondrial translation,BP,
5621,GO:0070141,1,0.772639837730134,0,1,response to UV-A,BP,
5624,GO:0070162,1,0.658315839000761,0,1,adiponectin secretion,BP,
5625,GO:0070163,1,0.658315839000761,0,1,regulation of adiponectin secretion,BP,
5626,GO:0070164,1,0.658315839000761,0,1,negative regulation of adiponectin secretion,BP,
5629,GO:0070169,1,0.180377447388554,0,7,positive regulation of biomineral tissue development,BP,
5630,GO:0070170,1,0.861324182910351,0,1,regulation of tooth mineralization,BP,
5631,GO:0070172,1,0.861324182910351,0,1,positive regulation of tooth mineralization,BP,
5632,GO:0070195,1,0.727749574179032,0,1,growth hormone receptor complex,CC,
5634,GO:0070227,1,0.372111962874546,0,4,lymphocyte apoptotic process,BP,
5635,GO:0070228,1,0.48282215808587,0,3,regulation of lymphocyte apoptotic process,BP,
5636,GO:0070229,1,0.707858533970136,0,2,negative regulation of lymphocyte apoptotic process,BP,
5637,GO:0070230,1,0.683299665437994,0,1,positive regulation of lymphocyte apoptotic process,BP,
5638,GO:0070231,1,0.372111962874546,0,4,T cell apoptotic process,BP,
5639,GO:0070232,1,0.48282215808587,0,3,regulation of T cell apoptotic process,BP,
5640,GO:0070233,1,0.707858533970136,0,2,negative regulation of T cell apoptotic process,BP,
5641,GO:0070234,1,0.683299665437994,0,1,positive regulation of T cell apoptotic process,BP,
5642,GO:0070235,1,0.836041871517245,0,1,regulation of activation-induced cell death of T cells,BP,
5643,GO:0070236,1,0.836041871517245,0,1,negative regulation of activation-induced cell death of T cells,BP,
5644,GO:0070242,1,0.578289226263527,0,2,thymocyte apoptotic process,BP,
5645,GO:0070243,1,0.578289226263527,0,2,regulation of thymocyte apoptotic process,BP,
5646,GO:0070244,1,0.847043438938523,0,1,negative regulation of thymocyte apoptotic process,BP,
5647,GO:0070245,1,0.683299665437994,0,1,positive regulation of thymocyte apoptotic process,BP,
5649,GO:0070254,1,0.7728397953467,0,1,mucus secretion,BP,
5650,GO:0070255,1,0.7728397953467,0,1,regulation of mucus secretion,BP,
5651,GO:0070256,1,0.7728397953467,0,1,negative regulation of mucus secretion,BP,
5654,GO:0070268,1,0.133174298320685,0,6,cornification,BP,
5659,GO:0070294,1,0.734045967558083,0,1,renal sodium ion absorption,BP,
5660,GO:0070296,1,0.706007587608521,0,2,sarcoplasmic reticulum calcium ion transport,BP,
5663,GO:0070303,1,0.772639837730134,0,1,negative regulation of stress-activated protein kinase signaling cascade,BP,
5665,GO:0070306,1,0.505382858624592,0,3,lens fiber cell differentiation,BP,
5666,GO:0070307,1,0.505382858624592,0,3,lens fiber cell development,BP,
5670,GO:0070328,1,0.759355645182739,0,1,triglyceride homeostasis,BP,
5671,GO:0070341,1,0.980495002631481,0,1,fat cell proliferation,BP,
5672,GO:0070343,1,0.980495002631481,0,1,white fat cell proliferation,BP,
5673,GO:0070344,1,0.980495002631481,0,1,regulation of fat cell proliferation,BP,
5674,GO:0070346,1,0.980495002631481,0,1,positive regulation of fat cell proliferation,BP,
5675,GO:0070350,1,0.980495002631481,0,1,regulation of white fat cell proliferation,BP,
5676,GO:0070352,1,0.980495002631481,0,1,positive regulation of white fat cell proliferation,BP,
5679,GO:0070373,1,0.744061959631107,0,1,negative regulation of ERK1 and ERK2 cascade,BP,
5682,GO:0070384,1,0.980495002631481,0,1,Harderian gland development,BP,
5683,GO:0070391,1,0.968025854772146,0,1,response to lipoteichoic acid,BP,
5684,GO:0070402,1,0.584093089869264,0,2,NADPH binding,MF,
5686,GO:0070411,1,0.762142819578083,0,1,I-SMAD binding,MF,
5687,GO:0070444,1,0.727261279903572,0,1,oligodendrocyte progenitor proliferation,BP,
5688,GO:0070445,1,0.727261279903572,0,1,regulation of oligodendrocyte progenitor proliferation,BP,
5689,GO:0070471,1,0.820477274682133,0,1,uterine smooth muscle contraction,BP,
5690,GO:0070472,1,0.820477274682133,0,1,regulation of uterine smooth muscle contraction,BP,
5691,GO:0070473,1,0.820477274682133,0,1,negative regulation of uterine smooth muscle contraction,BP,
5693,GO:0070486,1,0.739713014367407,0,1,leukocyte aggregation,BP,
5694,GO:0070487,1,0.739713014367407,0,1,monocyte aggregation,BP,
5696,GO:0070509,1,0.54473043206437,0,3,calcium ion import,BP,
5697,GO:0070513,1,0.897578402296713,0,1,death domain binding,MF,
5698,GO:0070525,1,0.831795738218181,0,2,tRNA threonylcarbamoyladenosine metabolic process,BP,
5700,GO:0070528,1,0.527201589783988,0,2,protein kinase C signaling,BP,
5701,GO:0070538,1,0.946578828055197,0,1,oleic acid binding,MF,
5703,GO:0070555,1,0.580387793470605,0,4,response to interleukin-1,BP,
5705,GO:0070561,1,0.715839724297779,0,1,vitamin D receptor signaling pathway,BP,
5706,GO:0070569,1,0.918424128506729,0,1,uridylyltransferase activity,MF,
5707,GO:0070585,1,0.635633238156511,0,2,protein localization to mitochondrion,BP,
5710,GO:0070627,1,0.773132814998767,0,1,ferrous iron import,BP,
5711,GO:0070633,1,0.802011392875838,0,1,transepithelial transport,BP,
5714,GO:0070644,1,0.715839724297779,0,1,vitamin D response element binding,MF,
5724,GO:0070670,1,0.469138604711294,0,2,response to interleukin-4,BP,
5727,GO:0070696,1,0.355237869619532,0,5,transmembrane receptor protein serine/threonine kinase binding,MF,
5728,GO:0070700,1,0.355237869619532,0,5,BMP receptor binding,MF,
5729,GO:0070704,1,0.725770278597532,0,1,sterol desaturase activity,MF,
5730,GO:0070724,1,0.768607936468567,0,1,BMP receptor complex,CC,
5732,GO:0070728,1,0.759355645182739,0,1,leucine binding,MF,
5733,GO:0070742,1,0.537968728737878,0,2,C2H2 zinc finger domain binding,MF,
5734,GO:0070777,1,0.753709329340452,0,1,D-aspartate transport,BP,
5735,GO:0070779,1,0.753709329340452,0,1,D-aspartate import,BP,
5736,GO:0070820,1,0.325177697311272,0,4,tertiary granule,CC,
5737,GO:0070821,1,0.600483420584598,0,2,tertiary granule membrane,CC,
5738,GO:0070822,1,0.702569048854651,0,1,Sin3-type complex,CC,
5742,GO:0070849,1,0.772639837730134,0,1,response to epidermal growth factor,BP,
5743,GO:0070851,1,0.252520583911075,0,9,growth factor receptor binding,MF,
5744,GO:0070852,1,0.690409015386517,0,1,cell body fiber,CC,
5745,GO:0070857,1,0.774318895616471,0,1,regulation of bile acid biosynthetic process,BP,
5746,GO:0070859,1,0.774318895616471,0,1,positive regulation of bile acid biosynthetic process,BP,
5747,GO:0070873,1,0.772639837730134,0,1,regulation of glycogen metabolic process,BP,
5748,GO:0070875,1,0.772639837730134,0,1,positive regulation of glycogen metabolic process,BP,
5749,GO:0070884,1,0.772573466595224,0,1,regulation of calcineurin-NFAT signaling cascade,BP,
5750,GO:0070885,1,0.772573466595224,0,1,negative regulation of calcineurin-NFAT signaling cascade,BP,
5752,GO:0070900,1,0.831795738218181,0,2,mitochondrial tRNA modification,BP,
5753,GO:0070901,1,0.959711323077247,0,1,mitochondrial tRNA methylation,BP,
5754,GO:0070902,1,0.866821396494009,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
5755,GO:0070915,1,0.845873160582363,0,1,lysophosphatidic acid receptor activity,MF,
5756,GO:0070918,1,0.847043438938523,0,1,production of small RNA involved in gene silencing by RNA,BP,
5757,GO:0070920,1,0.847043438938523,0,1,regulation of production of small RNA involved in gene silencing by RNA,BP,
5759,GO:0070936,1,0.897578402296713,0,1,protein K48-linked ubiquitination,BP,
5761,GO:0070977,1,0.768607936468567,0,1,bone maturation,BP,
5763,GO:0070996,1,0.970007741874261,0,1,type 1 melanocortin receptor binding,MF,
5764,GO:0070997,1,0.128028603852081,0,11,neuron death,BP,
5765,GO:0071062,1,0.730958015688662,0,1,alphav-beta3 integrin-vitronectin complex,CC,
5766,GO:0071071,1,0.572328210833513,0,3,regulation of phospholipid biosynthetic process,BP,
5767,GO:0071072,1,0.77252698579057,0,1,negative regulation of phospholipid biosynthetic process,BP,
5768,GO:0071073,1,0.946578828055197,0,1,positive regulation of phospholipid biosynthetic process,BP,
5776,GO:0071223,1,0.968025854772146,0,1,cellular response to lipoteichoic acid,BP,
5778,GO:0071230,1,0.531977050670702,0,2,cellular response to amino acid stimulus,BP,
5779,GO:0071233,1,0.759355645182739,0,1,cellular response to leucine,BP,
5780,GO:0071236,1,0.774318895616471,0,1,cellular response to antibiotic,BP,
5783,GO:0071260,1,0.45397539497948,0,4,cellular response to mechanical stimulus,BP,
5786,GO:0071276,1,0.597746613678264,0,2,cellular response to cadmium ion,BP,
5787,GO:0071277,1,0.547413307615747,0,2,cellular response to calcium ion,BP,
5788,GO:0071281,1,0.594354218853545,0,2,cellular response to iron ion,BP,
5790,GO:0071285,1,0.712353706175808,0,1,cellular response to lithium ion,BP,
5792,GO:0071300,1,0.176240681516948,0,7,cellular response to retinoic acid,BP,
5793,GO:0071305,1,0.715839724297779,0,1,cellular response to vitamin D,BP,
5796,GO:0071312,1,0.598773530135544,0,2,cellular response to alkaloid,BP,
5797,GO:0071313,1,0.77396315259318,0,1,cellular response to caffeine,BP,
5798,GO:0071320,1,0.414082016753327,0,3,cellular response to cAMP,BP,
5803,GO:0071335,1,0.980495002631481,0,1,hair follicle cell proliferation,BP,
5804,GO:0071336,1,0.980495002631481,0,1,regulation of hair follicle cell proliferation,BP,
5805,GO:0071338,1,0.980495002631481,0,1,positive regulation of hair follicle cell proliferation,BP,
5808,GO:0071347,1,0.580387793470605,0,4,cellular response to interleukin-1,BP,
5809,GO:0071351,1,0.596359050696602,0,2,cellular response to interleukin-18,BP,
5810,GO:0071353,1,0.469138604711294,0,2,cellular response to interleukin-4,BP,
5812,GO:0071357,1,0.40991162256991,0,4,cellular response to type I interferon,BP,
5813,GO:0071359,1,0.667217985580352,0,2,cellular response to dsRNA,BP,
5814,GO:0071360,1,0.788139761849395,0,1,cellular response to exogenous dsRNA,BP,
5816,GO:0071364,1,0.772639837730134,0,1,cellular response to epidermal growth factor stimulus,BP,
5817,GO:0071371,1,0.366756475269185,0,3,cellular response to gonadotropin stimulus,BP,
5818,GO:0071372,1,0.47677780538375,0,2,cellular response to follicle-stimulating hormone stimulus,BP,
5819,GO:0071373,1,0.774318895616471,0,1,cellular response to luteinizing hormone stimulus,BP,
5823,GO:0071379,1,0.772639837730134,0,1,cellular response to prostaglandin stimulus,BP,
5824,GO:0071380,1,0.772639837730134,0,1,cellular response to prostaglandin E stimulus,BP,
5825,GO:0071383,1,0.16853640995876,0,7,cellular response to steroid hormone stimulus,BP,
5826,GO:0071384,1,0.380734276495856,0,4,cellular response to corticosteroid stimulus,BP,
5827,GO:0071385,1,0.380734276495856,0,4,cellular response to glucocorticoid stimulus,BP,
5828,GO:0071389,1,0.802011392875838,0,1,cellular response to mineralocorticoid stimulus,BP,
5829,GO:0071394,1,0.741809137632914,0,1,cellular response to testosterone stimulus,BP,
5833,GO:0071415,1,0.77396315259318,0,1,cellular response to purine-containing compound,BP,
5836,GO:0071435,1,0.767624987207694,0,1,potassium ion export,BP,
5837,GO:0071436,1,0.984658110865059,0,1,sodium ion export,BP,
5840,GO:0071450,1,0.609084076257617,0,2,cellular response to oxygen radical,BP,
5841,GO:0071451,1,0.609084076257617,0,2,cellular response to superoxide,BP,
5842,GO:0071453,1,0.20714241787389,0,7,cellular response to oxygen levels,BP,
5843,GO:0071456,1,0.20714241787389,0,7,cellular response to hypoxia,BP,
5852,GO:0071505,1,0.77252698579057,0,1,response to mycophenolic acid,BP,
5853,GO:0071506,1,0.77252698579057,0,1,cellular response to mycophenolic acid,BP,
5854,GO:0071514,1,0.75126441332005,0,1,genetic imprinting,BP,
5855,GO:0071542,1,0.448418616771072,0,4,dopaminergic neuron differentiation,BP,
5857,GO:0071549,1,0.606579507537129,0,2,cellular response to dexamethasone stimulus,BP,
5858,GO:0071550,1,0.750187185736748,0,2,death-inducing signaling complex assembly,BP,
5859,GO:0071553,1,0.775603503393362,0,1,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
5862,GO:0071599,1,0.932942238066546,0,2,otic vesicle development,BP,
5863,GO:0071600,1,0.932942238066546,0,2,otic vesicle morphogenesis,BP,
5865,GO:0071617,1,0.747989056481557,0,1,lysophospholipid acyltransferase activity,MF,
5867,GO:0071622,1,0.603579898448483,0,2,regulation of granulocyte chemotaxis,BP,
5868,GO:0071624,1,0.802011392875838,0,1,positive regulation of granulocyte chemotaxis,BP,
5869,GO:0071674,1,0.747687650826525,0,2,mononuclear cell migration,BP,
5870,GO:0071680,1,0.712353706175808,0,1,response to indole-3-methanol,BP,
5871,GO:0071681,1,0.712353706175808,0,1,cellular response to indole-3-methanol,BP,
5872,GO:0071688,1,0.657423063310495,0,1,striated muscle myosin thick filament assembly,BP,
5873,GO:0071695,1,0.524515311070018,0,2,anatomical structure maturation,BP,
5874,GO:0071696,1,0.762142819578083,0,1,ectodermal placode development,BP,
5875,GO:0071697,1,0.762142819578083,0,1,ectodermal placode morphogenesis,BP,
5876,GO:0071698,1,0.762142819578083,0,1,olfactory placode development,BP,
5877,GO:0071699,1,0.762142819578083,0,1,olfactory placode morphogenesis,BP,
5882,GO:0071709,1,0.727261279903572,0,1,membrane assembly,BP,
5883,GO:0071715,1,0.802011392875838,0,1,icosanoid transport,BP,
5884,GO:0071731,1,0.766087200253996,0,1,response to nitric oxide,BP,
5885,GO:0071732,1,0.766087200253996,0,1,cellular response to nitric oxide,BP,
5886,GO:0071733,1,0.766387473815025,0,1,transcriptional activation by promoter-enhancer looping,BP,
5892,GO:0071800,1,0.741809137632914,0,1,podosome assembly,BP,
5893,GO:0071801,1,0.741809137632914,0,1,regulation of podosome assembly,BP,
5894,GO:0071803,1,0.741809137632914,0,1,positive regulation of podosome assembly,BP,
5898,GO:0071825,1,0.761625090232792,0,2,protein-lipid complex subunit organization,BP,
5899,GO:0071826,1,0.912530916414626,0,1,ribonucleoprotein complex subunit organization,BP,
5900,GO:0071827,1,0.761625090232792,0,2,plasma lipoprotein particle organization,BP,
5901,GO:0071830,1,0.987456549281,0,1,triglyceride-rich lipoprotein particle clearance,BP,
5903,GO:0071847,1,0.763459376420346,0,1,TNFSF11-mediated signaling pathway,BP,
5905,GO:0071855,1,0.777837201051389,0,2,neuropeptide receptor binding,MF,
5912,GO:0071875,1,0.506907931869612,0,3,adrenergic receptor signaling pathway,BP,
5913,GO:0071880,1,0.506907931869612,0,3,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
5914,GO:0071883,1,0.628065409479983,0,2,activation of MAPK activity by adrenergic receptor signaling pathway,BP,
5916,GO:0071889,1,0.772639837730134,0,1,14-3-3 protein binding,MF,
5917,GO:0071893,1,0.847043438938523,0,1,BMP signaling pathway involved in nephric duct formation,BP,
5923,GO:0071955,1,0.710176573837243,0,1,recycling endosome to Golgi transport,BP,
5924,GO:0071963,1,0.853289383796874,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
5926,GO:0071985,1,0.77312897108567,0,1,multivesicular body sorting pathway,BP,
5929,GO:0072007,1,0.418692324248418,0,3,mesangial cell differentiation,BP,
5930,GO:0072008,1,0.418692324248418,0,3,glomerular mesangial cell differentiation,BP,
5932,GO:0072010,1,0.652805308656883,0,2,glomerular epithelium development,BP,
5933,GO:0072012,1,0.200139266203848,0,6,glomerulus vasculature development,BP,
5935,GO:0072015,1,0.847043438938523,0,1,glomerular visceral epithelial cell development,BP,
5936,GO:0072017,1,0.451847036496121,0,2,distal tubule development,BP,
5937,GO:0072019,1,0.79777800716672,0,1,proximal convoluted tubule development,BP,
5939,GO:0072033,1,0.744587511205584,0,1,renal vesicle formation,BP,
5940,GO:0072034,1,0.744587511205584,0,1,renal vesicle induction,BP,
5941,GO:0072038,1,0.739713014367407,0,1,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
5942,GO:0072039,1,0.739713014367407,0,1,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
5943,GO:0072040,1,0.739713014367407,0,1,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
5944,GO:0072044,1,0.387422564706529,0,3,collecting duct development,BP,
5945,GO:0072048,1,0.847043438938523,0,1,renal system pattern specification,BP,
5946,GO:0072049,1,0.847043438938523,0,1,comma-shaped body morphogenesis,BP,
5947,GO:0072050,1,0.652805308656883,0,2,S-shaped body morphogenesis,BP,
5948,GO:0072053,1,0.744287228075405,0,1,renal inner medulla development,BP,
5949,GO:0072054,1,0.744287228075405,0,1,renal outer medulla development,BP,
5950,GO:0072060,1,0.744287228075405,0,1,outer medullary collecting duct development,BP,
5951,GO:0072061,1,0.744287228075405,0,1,inner medullary collecting duct development,BP,
5954,GO:0072074,1,0.357917208456281,0,4,kidney mesenchyme development,BP,
5955,GO:0072075,1,0.423386279351185,0,3,metanephric mesenchyme development,BP,
5956,GO:0072076,1,0.739713014367407,0,1,nephrogenic mesenchyme development,BP,
5957,GO:0072077,1,0.457518278704408,0,4,renal vesicle morphogenesis,BP,
5959,GO:0072079,1,0.842134578426593,0,2,nephron tubule formation,BP,
5961,GO:0072087,1,0.457518278704408,0,4,renal vesicle development,BP,
5965,GO:0072095,1,0.847043438938523,0,1,regulation of branch elongation involved in ureteric bud branching,BP,
5966,GO:0072096,1,0.847043438938523,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
5967,GO:0072097,1,0.847043438938523,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
5968,GO:0072098,1,0.847043438938523,0,1,anterior/posterior pattern specification involved in kidney development,BP,
5969,GO:0072099,1,0.847043438938523,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
5970,GO:0072100,1,0.847043438938523,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
5971,GO:0072101,1,0.847043438938523,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
5972,GO:0072102,1,0.847043438938523,0,1,glomerulus morphogenesis,BP,
5973,GO:0072103,1,0.847043438938523,0,1,glomerulus vasculature morphogenesis,BP,
5974,GO:0072104,1,0.847043438938523,0,1,glomerular capillary formation,BP,
5975,GO:0072106,1,0.977811028321075,0,1,regulation of ureteric bud formation,BP,
5976,GO:0072107,1,0.977811028321075,0,1,positive regulation of ureteric bud formation,BP,
5977,GO:0072108,1,0.727424355983898,0,2,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
5978,GO:0072109,1,0.200139266203848,0,6,glomerular mesangium development,BP,
5979,GO:0072110,1,0.371468307305589,0,4,glomerular mesangial cell proliferation,BP,
5980,GO:0072111,1,0.284522263131004,0,5,cell proliferation involved in kidney development,BP,
5981,GO:0072112,1,0.652805308656883,0,2,glomerular visceral epithelial cell differentiation,BP,
5982,GO:0072124,1,0.371468307305589,0,4,regulation of glomerular mesangial cell proliferation,BP,
5983,GO:0072125,1,0.482060401284023,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
5984,GO:0072126,1,0.77252698579057,0,1,positive regulation of glomerular mesangial cell proliferation,BP,
5985,GO:0072131,1,0.739713014367407,0,1,kidney mesenchyme morphogenesis,BP,
5986,GO:0072132,1,0.118785303565444,0,8,mesenchyme morphogenesis,BP,
5987,GO:0072133,1,0.739713014367407,0,1,metanephric mesenchyme morphogenesis,BP,
5988,GO:0072134,1,0.739713014367407,0,1,nephrogenic mesenchyme morphogenesis,BP,
5989,GO:0072135,1,0.739713014367407,0,1,kidney mesenchymal cell proliferation,BP,
5990,GO:0072136,1,0.739713014367407,0,1,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
5991,GO:0072138,1,0.650648483368427,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
5992,GO:0072143,1,0.418692324248418,0,3,mesangial cell development,BP,
5993,GO:0072144,1,0.418692324248418,0,3,glomerular mesangial cell development,BP,
5995,GO:0072156,1,0.734045967558083,0,1,distal tubule morphogenesis,BP,
5996,GO:0072160,1,0.744061959631107,0,1,nephron tubule epithelial cell differentiation,BP,
5997,GO:0072161,1,0.630272358048551,0,2,mesenchymal cell differentiation involved in kidney development,BP,
5998,GO:0072162,1,0.744587511205584,0,1,metanephric mesenchymal cell differentiation,BP,
6001,GO:0072166,1,0.771150420617929,0,1,posterior mesonephric tubule development,BP,
6002,GO:0072170,1,0.326974016081274,0,4,metanephric tubule development,BP,
6004,GO:0072172,1,0.977811028321075,0,1,mesonephric tubule formation,BP,
6005,GO:0072173,1,0.744587511205584,0,1,metanephric tubule morphogenesis,BP,
6006,GO:0072174,1,0.744587511205584,0,1,metanephric tubule formation,BP,
6008,GO:0072176,1,0.617389050555616,0,2,nephric duct development,BP,
6009,GO:0072178,1,0.617389050555616,0,2,nephric duct morphogenesis,BP,
6010,GO:0072179,1,0.847043438938523,0,1,nephric duct formation,BP,
6011,GO:0072182,1,0.744061959631107,0,1,regulation of nephron tubule epithelial cell differentiation,BP,
6012,GO:0072189,1,0.847043438938523,0,1,ureter development,BP,
6013,GO:0072190,1,0.847043438938523,0,1,ureter urothelium development,BP,
6014,GO:0072191,1,0.847043438938523,0,1,ureter smooth muscle development,BP,
6015,GO:0072192,1,0.847043438938523,0,1,ureter epithelial cell differentiation,BP,
6016,GO:0072193,1,0.847043438938523,0,1,ureter smooth muscle cell differentiation,BP,
6017,GO:0072197,1,0.847043438938523,0,1,ureter morphogenesis,BP,
6018,GO:0072198,1,0.847043438938523,0,1,mesenchymal cell proliferation involved in ureter development,BP,
6019,GO:0072199,1,0.847043438938523,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
6020,GO:0072200,1,0.847043438938523,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
6021,GO:0072201,1,0.578289226263527,0,2,negative regulation of mesenchymal cell proliferation,BP,
6022,GO:0072202,1,0.352468487078638,0,5,cell differentiation involved in metanephros development,BP,
6023,GO:0072203,1,0.569846823344909,0,2,cell proliferation involved in metanephros development,BP,
6024,GO:0072205,1,0.630017641475263,0,2,metanephric collecting duct development,BP,
6025,GO:0072207,1,0.25117997135526,0,5,metanephric epithelium development,BP,
6026,GO:0072209,1,0.77252698579057,0,1,metanephric mesangial cell differentiation,BP,
6027,GO:0072210,1,0.270804666753722,0,6,metanephric nephron development,BP,
6028,GO:0072215,1,0.365162034344226,0,5,regulation of metanephros development,BP,
6029,GO:0072216,1,0.431962433077324,0,4,positive regulation of metanephros development,BP,
6030,GO:0072217,1,0.652805308656883,0,2,negative regulation of metanephros development,BP,
6031,GO:0072223,1,0.595205896691855,0,2,metanephric glomerular mesangium development,BP,
6032,GO:0072224,1,0.595205896691855,0,2,metanephric glomerulus development,BP,
6033,GO:0072229,1,0.79777800716672,0,1,metanephric proximal convoluted tubule development,BP,
6034,GO:0072234,1,0.440523943213157,0,3,metanephric nephron tubule development,BP,
6035,GO:0072236,1,0.744287228075405,0,1,metanephric loop of Henle development,BP,
6036,GO:0072237,1,0.79777800716672,0,1,metanephric proximal tubule development,BP,
6037,GO:0072239,1,0.595205896691855,0,2,metanephric glomerulus vasculature development,BP,
6038,GO:0072243,1,0.440523943213157,0,3,metanephric nephron epithelium development,BP,
6039,GO:0072254,1,0.77252698579057,0,1,metanephric glomerular mesangial cell differentiation,BP,
6040,GO:0072255,1,0.77252698579057,0,1,metanephric glomerular mesangial cell development,BP,
6041,GO:0072257,1,0.744061959631107,0,1,metanephric nephron tubule epithelial cell differentiation,BP,
6042,GO:0072262,1,0.771150420617929,0,1,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
6043,GO:0072273,1,0.351834321763723,0,5,metanephric nephron morphogenesis,BP,
6044,GO:0072278,1,0.847043438938523,0,1,metanephric comma-shaped body morphogenesis,BP,
6045,GO:0072283,1,0.615679892549457,0,3,metanephric renal vesicle morphogenesis,BP,
6046,GO:0072284,1,0.652805308656883,0,2,metanephric S-shaped body morphogenesis,BP,
6047,GO:0072298,1,0.771150420617929,0,1,regulation of metanephric glomerulus development,BP,
6048,GO:0072299,1,0.771150420617929,0,1,negative regulation of metanephric glomerulus development,BP,
6049,GO:0072301,1,0.771150420617929,0,1,regulation of metanephric glomerular mesangial cell proliferation,BP,
6050,GO:0072302,1,0.771150420617929,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
6051,GO:0072307,1,0.744061959631107,0,1,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
6052,GO:0072310,1,0.847043438938523,0,1,glomerular epithelial cell development,BP,
6053,GO:0072311,1,0.652805308656883,0,2,glomerular epithelial cell differentiation,BP,
6054,GO:0072320,1,0.812175389134332,0,1,volume-sensitive chloride channel activity,MF,
6055,GO:0072329,1,0.0443960301529584,0,15,monocarboxylic acid catabolic process,BP,
6059,GO:0072338,1,0.727749574179032,0,1,cellular lactam metabolic process,BP,
6061,GO:0072350,1,0.527769249224089,0,3,tricarboxylic acid metabolic process,BP,
6064,GO:0072376,1,0.60108671753504,0,2,protein activation cascade,BP,
6065,GO:0072378,1,0.776553764074905,0,1,blood coagulation, fibrin clot formation,BP,
6071,GO:0072497,1,0.895381066641334,0,1,mesenchymal stem cell differentiation,BP,
6072,GO:0072498,1,0.476397782503784,0,3,embryonic skeletal joint development,BP,
6076,GO:0072510,1,0.773132814998767,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
6078,GO:0072512,1,0.773132814998767,0,1,trivalent inorganic cation transport,BP,
6086,GO:0072558,1,0.964117353714657,0,1,NLRP1 inflammasome complex,CC,
6088,GO:0072562,1,0.443030182030888,0,3,blood microparticle,CC,
6089,GO:0072574,1,0.799352334912417,0,1,hepatocyte proliferation,BP,
6090,GO:0072575,1,0.799352334912417,0,1,epithelial cell proliferation involved in liver morphogenesis,BP,
6091,GO:0072576,1,0.799352334912417,0,1,liver morphogenesis,BP,
6094,GO:0072584,1,0.89202924648779,0,1,caveolin-mediated endocytosis,BP,
6097,GO:0072595,1,0.772639837730134,0,1,maintenance of protein localization in organelle,BP,
6098,GO:0072602,1,0.616704084333269,0,1,interleukin-4 secretion,BP,
6100,GO:0072606,1,0.658592740887016,0,2,interleukin-8 secretion,BP,
6101,GO:0072608,1,0.964117353714657,0,1,interleukin-10 secretion,BP,
6102,GO:0072655,1,0.635633238156511,0,2,establishment of protein localization to mitochondrion,BP,
6103,GO:0072656,1,0.772639837730134,0,1,maintenance of protein location in mitochondrion,BP,
6107,GO:0072665,1,0.701441456494016,0,1,protein localization to vacuole,BP,
6108,GO:0072672,1,0.695760832683338,0,1,neutrophil extravasation,BP,
6110,GO:0072678,1,0.272722236587438,0,6,T cell migration,BP,
6111,GO:0072679,1,0.968025854772146,0,1,thymocyte migration,BP,
6112,GO:0072683,1,0.836041871517245,0,1,T cell extravasation,BP,
6113,GO:0075733,1,0.706584649959871,0,1,intracellular transport of virus,BP,
6119,GO:0086001,1,0.536674541671135,0,2,cardiac muscle cell action potential,BP,
6120,GO:0086002,1,0.536674541671135,0,2,cardiac muscle cell action potential involved in contraction,BP,
6123,GO:0086005,1,0.536674541671135,0,2,ventricular cardiac muscle cell action potential,BP,
6124,GO:0086008,1,0.767624987207694,0,1,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
6125,GO:0086009,1,0.593581351210114,0,2,membrane repolarization,BP,
6126,GO:0086010,1,0.767624987207694,0,1,membrane depolarization during action potential,BP,
6127,GO:0086011,1,0.767624987207694,0,1,membrane repolarization during action potential,BP,
6128,GO:0086013,1,0.767624987207694,0,1,membrane repolarization during cardiac muscle cell action potential,BP,
6129,GO:0086019,1,0.77396315259318,0,1,cell-cell signaling involved in cardiac conduction,BP,
6130,GO:0086023,1,0.80818803699794,0,1,adrenergic receptor signaling pathway involved in heart process,BP,
6131,GO:0086029,1,0.77396315259318,0,1,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
6132,GO:0086030,1,0.80818803699794,0,1,adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
6133,GO:0086036,1,0.984658110865059,0,1,regulation of cardiac muscle cell membrane potential,BP,
6134,GO:0086042,1,0.699985546439166,0,1,cardiac muscle cell-cardiac muscle cell adhesion,BP,
6135,GO:0086065,1,0.541124263434706,0,2,cell communication involved in cardiac conduction,BP,
6136,GO:0086068,1,0.77396315259318,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
6137,GO:0086069,1,0.699985546439166,0,1,bundle of His cell to Purkinje myocyte communication,BP,
6138,GO:0086073,1,0.699985546439166,0,1,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
6139,GO:0086080,1,0.699985546439166,0,1,protein binding involved in heterotypic cell-cell adhesion,MF,
6140,GO:0086083,1,0.699985546439166,0,1,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
6141,GO:0086091,1,0.536674541671135,0,2,regulation of heart rate by cardiac conduction,BP,
6143,GO:0086103,1,0.80818803699794,0,1,G-protein coupled receptor signaling pathway involved in heart process,BP,
6144,GO:0089711,1,0.753709329340452,0,1,L-glutamate transmembrane transport,BP,
6145,GO:0089720,1,0.762712607721979,0,2,caspase binding,MF,
6149,GO:0090005,1,0.721712018608498,0,1,negative regulation of establishment of protein localization to plasma membrane,BP,
6150,GO:0090009,1,0.683299665437994,0,1,primitive streak formation,BP,
6151,GO:0090022,1,0.603579898448483,0,2,regulation of neutrophil chemotaxis,BP,
6152,GO:0090023,1,0.802011392875838,0,1,positive regulation of neutrophil chemotaxis,BP,
6154,GO:0090031,1,0.572342152026815,0,2,positive regulation of steroid hormone biosynthetic process,BP,
6156,GO:0090036,1,0.683299665437994,0,1,regulation of protein kinase C signaling,BP,
6157,GO:0090037,1,0.683299665437994,0,1,positive regulation of protein kinase C signaling,BP,
6158,GO:0090049,1,0.616704084333269,0,1,regulation of cell migration involved in sprouting angiogenesis,BP,
6159,GO:0090051,1,0.616704084333269,0,1,negative regulation of cell migration involved in sprouting angiogenesis,BP,
6163,GO:0090077,1,0.77139588570204,0,1,foam cell differentiation,BP,
6167,GO:0090100,1,0.132365707056141,0,7,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
6168,GO:0090101,1,0.204875023839848,0,5,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
6169,GO:0090102,1,0.683299665437994,0,1,cochlea development,BP,
6170,GO:0090103,1,0.683299665437994,0,1,cochlea morphogenesis,BP,
6173,GO:0090131,1,0.88139376547355,0,1,mesenchyme migration,BP,
6175,GO:0090133,1,0.951532941209886,0,1,mesendoderm migration,BP,
6176,GO:0090134,1,0.951532941209886,0,1,cell migration involved in mesendoderm migration,BP,
6178,GO:0090138,1,0.75321100610424,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
6180,GO:0090162,1,0.506147921111534,0,2,establishment of epithelial cell polarity,BP,
6181,GO:0090174,1,0.318440235603741,0,5,organelle membrane fusion,BP,
6182,GO:0090175,1,0.487351167396069,0,3,regulation of establishment of planar polarity,BP,
6183,GO:0090177,1,0.683299665437994,0,1,establishment of planar polarity involved in neural tube closure,BP,
6184,GO:0090178,1,0.683299665437994,0,1,regulation of establishment of planar polarity involved in neural tube closure,BP,
6185,GO:0090179,1,0.683299665437994,0,1,planar cell polarity pathway involved in neural tube closure,BP,
6187,GO:0090183,1,0.156441349035387,0,8,regulation of kidney development,BP,
6188,GO:0090184,1,0.212815950351779,0,7,positive regulation of kidney development,BP,
6189,GO:0090185,1,0.482060401284023,0,3,negative regulation of kidney development,BP,
6190,GO:0090186,1,0.734045967558083,0,1,regulation of pancreatic juice secretion,BP,
6191,GO:0090188,1,0.734045967558083,0,1,negative regulation of pancreatic juice secretion,BP,
6192,GO:0090189,1,0.653135349149442,0,3,regulation of branching involved in ureteric bud morphogenesis,BP,
6193,GO:0090190,1,0.771582043984842,0,2,positive regulation of branching involved in ureteric bud morphogenesis,BP,
6194,GO:0090191,1,0.847043438938523,0,1,negative regulation of branching involved in ureteric bud morphogenesis,BP,
6195,GO:0090192,1,0.371468307305589,0,4,regulation of glomerulus development,BP,
6196,GO:0090193,1,0.77252698579057,0,1,positive regulation of glomerulus development,BP,
6197,GO:0090194,1,0.482060401284023,0,3,negative regulation of glomerulus development,BP,
6198,GO:0090195,1,0.964117353714657,0,1,chemokine secretion,BP,
6199,GO:0090196,1,0.964117353714657,0,1,regulation of chemokine secretion,BP,
6200,GO:0090197,1,0.964117353714657,0,1,positive regulation of chemokine secretion,BP,
6201,GO:0090199,1,0.558615786158671,0,4,regulation of release of cytochrome c from mitochondria,BP,
6202,GO:0090200,1,0.793580550170555,0,2,positive regulation of release of cytochrome c from mitochondria,BP,
6203,GO:0090201,1,0.704798885072753,0,2,negative regulation of release of cytochrome c from mitochondria,BP,
6204,GO:0090202,1,0.766387473815025,0,1,gene looping,BP,
6205,GO:0090205,1,0.77139588570204,0,1,positive regulation of cholesterol metabolic process,BP,
6206,GO:0090207,1,0.572809274841558,0,2,regulation of triglyceride metabolic process,BP,
6207,GO:0090208,1,0.824053991557742,0,1,positive regulation of triglyceride metabolic process,BP,
6208,GO:0090209,1,0.695760832683338,0,1,negative regulation of triglyceride metabolic process,BP,
6209,GO:0090218,1,0.77252698579057,0,1,positive regulation of lipid kinase activity,BP,
6210,GO:0090224,1,0.853799544891606,0,1,regulation of spindle organization,BP,
6212,GO:0090263,1,0.187492896632981,0,8,positive regulation of canonical Wnt signaling pathway,BP,
6213,GO:0090276,1,0.550056869556048,0,4,regulation of peptide hormone secretion,BP,
6214,GO:0090277,1,0.961431612339441,0,1,positive regulation of peptide hormone secretion,BP,
6215,GO:0090278,1,0.767464593952245,0,1,negative regulation of peptide hormone secretion,BP,
6216,GO:0090279,1,0.597383608773887,0,2,regulation of calcium ion import,BP,
6217,GO:0090280,1,0.77252698579057,0,1,positive regulation of calcium ion import,BP,
6218,GO:0090281,1,0.77396315259318,0,1,negative regulation of calcium ion import,BP,
6220,GO:0090288,1,0.197564659332809,0,5,negative regulation of cellular response to growth factor stimulus,BP,
6221,GO:0090303,1,0.736038381997267,0,2,positive regulation of wound healing,BP,
6223,GO:0090305,1,0.704002033216449,0,2,nucleic acid phosphodiester bond hydrolysis,BP,
6226,GO:0090322,1,0.609084076257617,0,2,regulation of superoxide metabolic process,BP,
6227,GO:0090324,1,0.772573466595224,0,1,negative regulation of oxidative phosphorylation,BP,
6228,GO:0090329,1,0.651360225257213,0,2,regulation of DNA-dependent DNA replication,BP,
6230,GO:0090383,1,0.631296473034083,0,3,phagosome acidification,BP,
6231,GO:0090385,1,0.694899331907002,0,2,phagosome-lysosome fusion,BP,
6236,GO:0090484,1,0.94047143183814,0,1,drug transporter activity,MF,
6237,GO:0090493,1,0.977811028321075,0,1,catecholamine uptake,BP,
6238,GO:0090494,1,0.977811028321075,0,1,dopamine uptake,BP,
6239,GO:0090501,1,0.704002033216449,0,2,RNA phosphodiester bond hydrolysis,BP,
6240,GO:0090502,1,0.735427962909408,0,1,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
6241,GO:0090504,1,0.36520745822237,0,4,epiboly,BP,
6242,GO:0090505,1,0.36520745822237,0,4,epiboly involved in wound healing,BP,
6243,GO:0090526,1,0.759355645182739,0,1,regulation of gluconeogenesis involved in cellular glucose homeostasis,BP,
6244,GO:0090533,1,0.984658110865059,0,1,cation-transporting ATPase complex,CC,
6246,GO:0090559,1,0.75101951727364,0,2,regulation of membrane permeability,BP,
6247,GO:0090575,1,0.715839724297779,0,1,RNA polymerase II transcription factor complex,CC,
6248,GO:0090579,1,0.766387473815025,0,1,dsDNA loop formation,BP,
6250,GO:0090598,1,0.980495002631481,0,1,male anatomical structure morphogenesis,BP,
6251,GO:0090630,1,0.484471293292979,0,2,activation of GTPase activity,BP,
6252,GO:0090646,1,0.831795738218181,0,2,mitochondrial tRNA processing,BP,
6253,GO:0090659,1,0.690409015386517,0,1,walking behavior,BP,
6254,GO:0090677,1,0.77252698579057,0,1,reversible differentiation,BP,
6255,GO:0090678,1,0.77252698579057,0,1,cell dedifferentiation involved in phenotypic switching,BP,
6256,GO:0097006,1,0.761625090232792,0,2,regulation of plasma lipoprotein particle levels,BP,
6258,GO:0097011,1,0.772639837730134,0,1,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
6259,GO:0097012,1,0.772639837730134,0,1,response to granulocyte macrophage colony-stimulating factor,BP,
6262,GO:0097021,1,0.845372895917985,0,1,lymphocyte migration into lymphoid organs,BP,
6266,GO:0097049,1,0.836041871517245,0,1,motor neuron apoptotic process,BP,
6267,GO:0097058,1,0.84462400233258,0,1,CRLF-CLCF1 complex,CC,
6268,GO:0097059,1,0.84462400233258,0,1,CNTFR-CLCF1 complex,CC,
6272,GO:0097070,1,0.772776823282694,0,1,ductus arteriosus closure,BP,
6273,GO:0097084,1,0.616704084333269,0,1,vascular smooth muscle cell development,BP,
6274,GO:0097089,1,0.867164964013753,0,1,methyl-branched fatty acid metabolic process,BP,
6275,GO:0097091,1,0.727261279903572,0,1,synaptic vesicle clustering,BP,
6276,GO:0097094,1,0.847043438938523,0,1,craniofacial suture morphogenesis,BP,
6279,GO:0097104,1,0.727261279903572,0,1,postsynaptic membrane assembly,BP,
6280,GO:0097106,1,0.727261279903572,0,1,postsynaptic density organization,BP,
6282,GO:0097118,1,0.727261279903572,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
6283,GO:0097119,1,0.727261279903572,0,1,postsynaptic density protein 95 clustering,BP,
6285,GO:0097152,1,0.739713014367407,0,1,mesenchymal cell apoptotic process,BP,
6288,GO:0097164,1,0.279557332613251,0,7,ammonium ion metabolic process,BP,
6290,GO:0097178,1,0.940900393371674,0,1,ruffle assembly,BP,
6296,GO:0097186,1,0.685786047637105,0,1,amelogenesis,BP,
6302,GO:0097197,1,0.860809323373874,0,1,tetraspanin-enriched microdomain,CC,
6304,GO:0097202,1,0.836041871517245,0,1,activation of cysteine-type endopeptidase activity,BP,
6309,GO:0097278,1,0.77312897108567,0,1,complement-dependent cytotoxicity,BP,
6310,GO:0097284,1,0.695760832683338,0,1,hepatocyte apoptotic process,BP,
6311,GO:0097286,1,0.773132814998767,0,1,iron ion import,BP,
6312,GO:0097296,1,0.750187185736748,0,2,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
6315,GO:0097306,1,0.549769817564845,0,2,cellular response to alcohol,BP,
6316,GO:0097325,1,0.683299665437994,0,1,melanocyte proliferation,BP,
6318,GO:0097340,1,0.912530916414626,0,1,inhibition of cysteine-type endopeptidase activity,BP,
6319,GO:0097341,1,0.912530916414626,0,1,zymogen inhibition,BP,
6321,GO:0097345,1,0.823241180606138,0,1,mitochondrial outer membrane permeabilization,BP,
6323,GO:0097381,1,0.585788010294756,0,1,photoreceptor disc membrane,CC,
6324,GO:0097386,1,0.784021941884902,0,1,glial cell projection,CC,
6328,GO:0097449,1,0.784021941884902,0,1,astrocyte projection,CC,
6330,GO:0097459,1,0.773132814998767,0,1,iron ion import into cell,BP,
6331,GO:0097460,1,0.773132814998767,0,1,ferrous iron import into cell,BP,
6332,GO:0097479,1,0.403749937047917,0,4,synaptic vesicle localization,BP,
6333,GO:0097480,1,0.556560338819078,0,3,establishment of synaptic vesicle localization,BP,
6335,GO:0097502,1,0.987980034753378,0,1,mannosylation,BP,
6336,GO:0097527,1,0.836041871517245,0,1,necroptotic signaling pathway,BP,
6339,GO:0097531,1,0.80818803699794,0,1,mast cell migration,BP,
6341,GO:0097553,1,0.706007587608521,0,2,calcium ion transmembrane import into cytosol,BP,
6342,GO:0097581,1,0.853289383796874,0,1,lamellipodium organization,BP,
6344,GO:0097623,1,0.767624987207694,0,1,potassium ion export across plasma membrane,BP,
6347,GO:0097696,1,0.250772797455379,0,5,STAT cascade,BP,
6350,GO:0097720,1,0.772573466595224,0,1,calcineurin-mediated signaling,BP,
6351,GO:0097722,1,0.824053991557742,0,1,sperm motility,BP,
6356,GO:0097746,1,0.152469632302714,0,9,regulation of blood vessel diameter,BP,
6357,GO:0097755,1,0.765223072483455,0,2,positive regulation of blood vessel diameter,BP,
6358,GO:0097756,1,0.211436307300932,0,7,negative regulation of blood vessel diameter,BP,
6359,GO:0098531,1,0.715839724297779,0,1,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,
6360,GO:0098533,1,0.984658110865059,0,1,ATPase dependent transmembrane transport complex,CC,
6365,GO:0098573,1,0.782663874445418,0,1,intrinsic component of mitochondrial membrane,CC,
6369,GO:0098596,1,0.772776823282694,0,1,imitative learning,BP,
6370,GO:0098597,1,0.772776823282694,0,1,observational learning,BP,
6371,GO:0098598,1,0.772776823282694,0,1,learned vocalization behavior or vocal learning,BP,
6372,GO:0098599,1,0.829582597377115,0,1,palmitoyl hydrolase activity,MF,
6375,GO:0098631,1,0.540465870973634,0,2,protein binding involved in cell adhesion,MF,
6376,GO:0098632,1,0.540465870973634,0,2,protein binding involved in cell-cell adhesion,MF,
6378,GO:0098641,1,0.773025354548079,0,1,cadherin binding involved in cell-cell adhesion,MF,
6380,GO:0098656,1,0.356450861122199,0,5,anion transmembrane transport,BP,
6381,GO:0098657,1,0.56905912465365,0,3,import into cell,BP,
6382,GO:0098659,1,0.773132814998767,0,1,inorganic cation import into cell,BP,
6384,GO:0098661,1,0.799628824156165,0,2,inorganic anion transmembrane transport,BP,
6386,GO:0098668,1,0.767624987207694,0,1,potassium ion export from cell,BP,
6388,GO:0098732,1,0.582324608535223,0,2,macromolecule deacylation,BP,
6389,GO:0098734,1,0.829582597377115,0,1,macromolecule depalmitoylation,BP,
6392,GO:0098751,1,0.584553369226978,0,2,bone cell development,BP,
6393,GO:0098754,1,0.447951813611951,0,4,detoxification,BP,
6397,GO:0098781,1,0.957515383118201,0,1,ncRNA transcription,BP,
6398,GO:0098791,1,0.64719579286822,0,2,Golgi subcompartment,CC,
6403,GO:0098798,1,0.782663874445418,0,1,mitochondrial protein complex,CC,
6407,GO:0098810,1,0.977811028321075,0,1,neurotransmitter reuptake,BP,
6408,GO:0098811,1,0.475408520948778,0,2,transcriptional repressor activity, RNA polymerase II activating transcription factor binding,MF,
6409,GO:0098813,1,0.853799544891606,0,1,nuclear chromosome segregation,BP,
6410,GO:0098815,1,0.858923178696575,0,1,modulation of excitatory postsynaptic potential,BP,
6416,GO:0098868,1,0.990258279272685,0,1,bone growth,BP,
6417,GO:0098869,1,0.447951813611951,0,4,cellular oxidant detoxification,BP,
6418,GO:0098878,1,0.541683009071215,0,2,neurotransmitter receptor complex,CC,
6419,GO:0098900,1,0.699985546439166,0,1,regulation of action potential,BP,
6420,GO:0098901,1,0.699985546439166,0,1,regulation of cardiac muscle cell action potential,BP,
6421,GO:0098911,1,0.699985546439166,0,1,regulation of ventricular cardiac muscle cell action potential,BP,
6422,GO:0098915,1,0.767624987207694,0,1,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
6423,GO:0098916,1,0.0582821288020909,0,14,anterograde trans-synaptic signaling,BP,
6424,GO:0098927,1,0.741809137632914,0,1,vesicle-mediated transport between endosomal compartments,BP,
6426,GO:0099003,1,0.556560338819078,0,3,vesicle-mediated transport in synapse,BP,
6427,GO:0099023,1,0.788139761849395,0,1,tethering complex,CC,
6429,GO:0099054,1,0.586435697619115,0,2,presynapse assembly,BP,
6430,GO:0099068,1,0.425551443415109,0,3,postsynapse assembly,BP,
6433,GO:0099084,1,0.727261279903572,0,1,postsynaptic specialization organization,BP,
6434,GO:0099094,1,0.415627313273182,0,3,ligand-gated cation channel activity,MF,
6435,GO:0099106,1,0.607344984180653,0,2,ion channel regulator activity,MF,
6438,GO:0099504,1,0.523407611732739,0,3,synaptic vesicle cycle,BP,
6441,GO:0099531,1,0.704595556506536,0,3,presynaptic process involved in chemical synaptic transmission,BP,
6442,GO:0099536,1,0.0582821288020909,0,14,synaptic signaling,BP,
6443,GO:0099537,1,0.0582821288020909,0,14,trans-synaptic signaling,BP,
6444,GO:0099565,1,0.357848694520298,0,4,chemical synaptic transmission, postsynaptic,BP,
6447,GO:0099587,1,0.773132814998767,0,1,inorganic ion import into cell,BP,
6449,GO:0099622,1,0.767624987207694,0,1,cardiac muscle cell membrane repolarization,BP,
6450,GO:0099623,1,0.767624987207694,0,1,regulation of cardiac muscle cell membrane repolarization,BP,
6451,GO:0099625,1,0.767624987207694,0,1,ventricular cardiac muscle cell membrane repolarization,BP,
6452,GO:0099643,1,0.720729876174967,0,2,signal release from synapse,BP,
6453,GO:0100002,1,0.772639837730134,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
6455,GO:0101003,1,0.694600625869364,0,1,ficolin-1-rich granule membrane,CC,
6457,GO:0102009,1,0.828965869670895,0,1,proline dipeptidase activity,MF,
6458,GO:0102132,1,0.629141955360923,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
6459,GO:0102336,1,0.765260800063365,0,1,3-oxo-arachidoyl-CoA synthase activity,MF,
6460,GO:0102337,1,0.765260800063365,0,1,3-oxo-cerotoyl-CoA synthase activity,MF,
6461,GO:0102338,1,0.765260800063365,0,1,3-oxo-lignoceronyl-CoA synthase activity,MF,
6465,GO:1900006,1,0.739713014367407,0,1,positive regulation of dendrite development,BP,
6466,GO:1900019,1,0.683299665437994,0,1,regulation of protein kinase C activity,BP,
6467,GO:1900020,1,0.683299665437994,0,1,positive regulation of protein kinase C activity,BP,
6468,GO:1900027,1,0.940900393371674,0,1,regulation of ruffle assembly,BP,
6469,GO:1900029,1,0.940900393371674,0,1,positive regulation of ruffle assembly,BP,
6470,GO:1900046,1,0.32980944227499,0,4,regulation of hemostasis,BP,
6471,GO:1900047,1,0.480134923451189,0,3,negative regulation of hemostasis,BP,
6476,GO:1900104,1,0.739713014367407,0,1,regulation of hyaluranon cable assembly,BP,
6477,GO:1900106,1,0.739713014367407,0,1,positive regulation of hyaluranon cable assembly,BP,
6478,GO:1900125,1,0.77252698579057,0,1,regulation of hyaluronan biosynthetic process,BP,
6479,GO:1900127,1,0.77252698579057,0,1,positive regulation of hyaluronan biosynthetic process,BP,
6486,GO:1900186,1,0.89202924648779,0,1,negative regulation of clathrin-dependent endocytosis,BP,
6487,GO:1900193,1,0.990258279272685,0,1,regulation of oocyte maturation,BP,
6488,GO:1900194,1,0.990258279272685,0,1,negative regulation of oocyte maturation,BP,
6489,GO:1900238,1,0.77252698579057,0,1,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
6490,GO:1900239,1,0.77252698579057,0,1,regulation of phenotypic switching,BP,
6491,GO:1900241,1,0.77252698579057,0,1,positive regulation of phenotypic switching,BP,
6492,GO:1900274,1,0.8098175575904,0,2,regulation of phospholipase C activity,BP,
6493,GO:1900371,1,0.564239357132328,0,4,regulation of purine nucleotide biosynthetic process,BP,
6494,GO:1900372,1,0.802011392875838,0,1,negative regulation of purine nucleotide biosynthetic process,BP,
6495,GO:1900373,1,0.704348604065564,0,3,positive regulation of purine nucleotide biosynthetic process,BP,
6496,GO:1900376,1,0.683299665437994,0,1,regulation of secondary metabolite biosynthetic process,BP,
6497,GO:1900377,1,0.683299665437994,0,1,negative regulation of secondary metabolite biosynthetic process,BP,
6498,GO:1900407,1,0.428244796966903,0,4,regulation of cellular response to oxidative stress,BP,
6499,GO:1900408,1,0.704798885072753,0,2,negative regulation of cellular response to oxidative stress,BP,
6500,GO:1900409,1,0.824053991557742,0,1,positive regulation of cellular response to oxidative stress,BP,
6501,GO:1900452,1,0.7728397953467,0,1,regulation of long term synaptic depression,BP,
6502,GO:1900453,1,0.7728397953467,0,1,negative regulation of long term synaptic depression,BP,
6503,GO:1900542,1,0.238320646022863,0,7,regulation of purine nucleotide metabolic process,BP,
6504,GO:1900543,1,0.619138163811396,0,2,negative regulation of purine nucleotide metabolic process,BP,
6505,GO:1900544,1,0.298260202812131,0,6,positive regulation of purine nucleotide metabolic process,BP,
6506,GO:1900736,1,0.80818803699794,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
6507,GO:1900738,1,0.80818803699794,0,1,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
6508,GO:1900739,1,0.823241180606138,0,1,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
6509,GO:1900740,1,0.823241180606138,0,1,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
6510,GO:1900744,1,0.703993319191288,0,2,regulation of p38MAPK cascade,BP,
6511,GO:1900745,1,0.703993319191288,0,2,positive regulation of p38MAPK cascade,BP,
6513,GO:1900750,1,0.846876006292841,0,1,oligopeptide binding,MF,
6514,GO:1900864,1,0.831795738218181,0,2,mitochondrial RNA modification,BP,
6519,GO:1901020,1,0.77396315259318,0,1,negative regulation of calcium ion transmembrane transporter activity,BP,
6520,GO:1901021,1,0.824053991557742,0,1,positive regulation of calcium ion transmembrane transporter activity,BP,
6521,GO:1901028,1,0.823241180606138,0,1,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
6522,GO:1901030,1,0.823241180606138,0,1,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
6523,GO:1901031,1,0.461676334643176,0,3,regulation of response to reactive oxygen species,BP,
6524,GO:1901033,1,0.824053991557742,0,1,positive regulation of response to reactive oxygen species,BP,
6525,GO:1901052,1,0.764658144398332,0,1,sarcosine metabolic process,BP,
6526,GO:1901053,1,0.764658144398332,0,1,sarcosine catabolic process,BP,
6527,GO:1901068,1,0.721712018608498,0,1,guanosine-containing compound metabolic process,BP,
6530,GO:1901079,1,0.80818803699794,0,1,positive regulation of relaxation of muscle,BP,
6531,GO:1901099,1,0.740523664251331,0,3,negative regulation of signal transduction in absence of ligand,BP,
6535,GO:1901145,1,0.739713014367407,0,1,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
6536,GO:1901184,1,0.186497494020921,0,7,regulation of ERBB signaling pathway,BP,
6537,GO:1901185,1,0.607998691581982,0,2,negative regulation of ERBB signaling pathway,BP,
6538,GO:1901186,1,0.309174414566576,0,5,positive regulation of ERBB signaling pathway,BP,
6539,GO:1901201,1,0.616704084333269,0,1,regulation of extracellular matrix assembly,BP,
6540,GO:1901213,1,0.401807386392961,0,3,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
6541,GO:1901214,1,0.153882397020182,0,10,regulation of neuron death,BP,
6542,GO:1901215,1,0.196159883413417,0,9,negative regulation of neuron death,BP,
6543,GO:1901264,1,0.520024019634637,0,3,carbohydrate derivative transport,BP,
6547,GO:1901317,1,0.824053991557742,0,1,regulation of flagellated sperm motility,BP,
6548,GO:1901318,1,0.824053991557742,0,1,negative regulation of flagellated sperm motility,BP,
6549,GO:1901338,1,0.628065409479983,0,2,catecholamine binding,MF,
6560,GO:1901476,1,0.603836627920827,0,2,carbohydrate transporter activity,MF,
6561,GO:1901505,1,0.77139588570204,0,1,carbohydrate derivative transporter activity,MF,
6562,GO:1901522,1,0.358412236160415,0,3,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
6563,GO:1901532,1,0.616704084333269,0,1,regulation of hematopoietic progenitor cell differentiation,BP,
6564,GO:1901533,1,0.616704084333269,0,1,negative regulation of hematopoietic progenitor cell differentiation,BP,
6565,GO:1901550,1,0.813226353939148,0,1,regulation of endothelial cell development,BP,
6566,GO:1901552,1,0.813226353939148,0,1,positive regulation of endothelial cell development,BP,
6571,GO:1901570,1,0.477266519273929,0,4,fatty acid derivative biosynthetic process,BP,
6572,GO:1901571,1,0.802011392875838,0,1,fatty acid derivative transport,BP,
6576,GO:1901606,1,0.434002025239946,0,4,alpha-amino acid catabolic process,BP,
6580,GO:1901618,1,0.77139588570204,0,1,organic hydroxy compound transmembrane transporter activity,MF,
6583,GO:1901623,1,0.683299665437994,0,1,regulation of lymphocyte chemotaxis,BP,
6584,GO:1901626,1,0.727261279903572,0,1,regulation of postsynaptic membrane organization,BP,
6591,GO:1901668,1,0.824053991557742,0,1,regulation of superoxide dismutase activity,BP,
6592,GO:1901671,1,0.824053991557742,0,1,positive regulation of superoxide dismutase activity,BP,
6593,GO:1901674,1,0.744061959631107,0,1,regulation of histone H3-K27 acetylation,BP,
6594,GO:1901676,1,0.744061959631107,0,1,positive regulation of histone H3-K27 acetylation,BP,
6595,GO:1901678,1,0.753567240984294,0,1,iron coordination entity transport,BP,
6597,GO:1901685,1,0.970787931478979,0,1,glutathione derivative metabolic process,BP,
6598,GO:1901687,1,0.970787931478979,0,1,glutathione derivative biosynthetic process,BP,
6603,GO:1901722,1,0.371468307305589,0,4,regulation of cell proliferation involved in kidney development,BP,
6604,GO:1901723,1,0.482060401284023,0,3,negative regulation of cell proliferation involved in kidney development,BP,
6605,GO:1901724,1,0.77252698579057,0,1,positive regulation of cell proliferation involved in kidney development,BP,
6606,GO:1901796,1,0.635633238156511,0,2,regulation of signal transduction by p53 class mediator,BP,
6607,GO:1901798,1,0.823241180606138,0,1,positive regulation of signal transduction by p53 class mediator,BP,
6608,GO:1901800,1,0.529224004541781,0,2,positive regulation of proteasomal protein catabolic process,BP,
6611,GO:1901862,1,0.417411910590457,0,6,negative regulation of muscle tissue development,BP,
6618,GO:1901894,1,0.824053991557742,0,1,regulation of calcium-transporting ATPase activity,BP,
6619,GO:1901896,1,0.824053991557742,0,1,positive regulation of calcium-transporting ATPase activity,BP,
6622,GO:1901899,1,0.80818803699794,0,1,positive regulation of relaxation of cardiac muscle,BP,
6623,GO:1901963,1,0.847043438938523,0,1,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
6624,GO:1901964,1,0.847043438938523,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
6625,GO:1901976,1,0.772639837730134,0,1,regulation of cell cycle checkpoint,BP,
6627,GO:1901983,1,0.744061959631107,0,1,regulation of protein acetylation,BP,
6628,GO:1901985,1,0.744061959631107,0,1,positive regulation of protein acetylation,BP,
6633,GO:1901998,1,0.6561386509155,0,2,toxin transport,BP,
6634,GO:1902001,1,0.594177005724249,0,2,fatty acid transmembrane transport,BP,
6635,GO:1902010,1,0.759355645182739,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
6638,GO:1902041,1,0.617078123005341,0,3,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
6639,GO:1902042,1,0.750187185736748,0,2,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
6640,GO:1902043,1,0.687923419427266,0,2,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
6641,GO:1902074,1,0.802011392875838,0,1,response to salt,BP,
6642,GO:1902098,1,0.715839724297779,0,1,calcitriol binding,MF,
6646,GO:1902108,1,0.75101951727364,0,2,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
6647,GO:1902109,1,0.912530916414626,0,1,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
6648,GO:1902110,1,0.823241180606138,0,1,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
6651,GO:1902121,1,0.715839724297779,0,1,lithocholic acid binding,MF,
6652,GO:1902170,1,0.766087200253996,0,1,cellular response to reactive nitrogen species,BP,
6653,GO:1902175,1,0.704798885072753,0,2,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
6654,GO:1902176,1,0.704798885072753,0,2,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
6655,GO:1902221,1,0.955102554249325,0,1,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
6656,GO:1902222,1,0.955102554249325,0,1,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
6658,GO:1902235,1,0.823241180606138,0,1,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
6659,GO:1902237,1,0.823241180606138,0,1,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
6660,GO:1902263,1,0.616704084333269,0,1,apoptotic process involved in embryonic digit morphogenesis,BP,
6661,GO:1902271,1,0.715839724297779,0,1,D3 vitamins binding,MF,
6662,GO:1902275,1,0.744061959631107,0,1,regulation of chromatin organization,BP,
6663,GO:1902282,1,0.767624987207694,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
6664,GO:1902284,1,0.611439543999529,0,2,neuron projection extension involved in neuron projection guidance,BP,
6665,GO:1902302,1,0.767624987207694,0,1,regulation of potassium ion export,BP,
6666,GO:1902303,1,0.767624987207694,0,1,negative regulation of potassium ion export,BP,
6667,GO:1902305,1,0.984658110865059,0,1,regulation of sodium ion transmembrane transport,BP,
6668,GO:1902307,1,0.984658110865059,0,1,positive regulation of sodium ion transmembrane transport,BP,
6669,GO:1902311,1,0.848890406189778,0,1,regulation of copper ion transmembrane transport,BP,
6670,GO:1902337,1,0.528834412968773,0,2,regulation of apoptotic process involved in morphogenesis,BP,
6671,GO:1902338,1,0.739713014367407,0,1,negative regulation of apoptotic process involved in morphogenesis,BP,
6672,GO:1902339,1,0.715839724297779,0,1,positive regulation of apoptotic process involved in morphogenesis,BP,
6673,GO:1902369,1,0.536295320432933,0,2,negative regulation of RNA catabolic process,BP,
6674,GO:1902373,1,0.536295320432933,0,2,negative regulation of mRNA catabolic process,BP,
6675,GO:1902379,1,0.683299665437994,0,1,chemoattractant activity involved in axon guidance,MF,
6679,GO:1902455,1,0.739713014367407,0,1,negative regulation of stem cell population maintenance,BP,
6680,GO:1902473,1,0.586435697619115,0,2,regulation of protein localization to synapse,BP,
6681,GO:1902474,1,0.586435697619115,0,2,positive regulation of protein localization to synapse,BP,
6682,GO:1902475,1,0.753709329340452,0,1,L-alpha-amino acid transmembrane transport,BP,
6683,GO:1902476,1,0.799628824156165,0,2,chloride transmembrane transport,BP,
6686,GO:1902524,1,0.897578402296713,0,1,positive regulation of protein K48-linked ubiquitination,BP,
6692,GO:1902555,1,0.959711323077247,0,1,endoribonuclease complex,CC,
6694,GO:1902579,1,0.600902693109142,0,2,multi-organism localization,BP,
6696,GO:1902581,1,0.706584649959871,0,1,multi-organism cellular localization,BP,
6698,GO:1902583,1,0.706584649959871,0,1,multi-organism intracellular transport,BP,
6701,GO:1902600,1,0.96937950284859,0,1,hydrogen ion transmembrane transport,BP,
6704,GO:1902622,1,0.603579898448483,0,2,regulation of neutrophil migration,BP,
6705,GO:1902624,1,0.802011392875838,0,1,positive regulation of neutrophil migration,BP,
6708,GO:1902656,1,0.706007587608521,0,2,calcium ion import into cytosol,BP,
6709,GO:1902667,1,0.611439543999529,0,2,regulation of axon guidance,BP,
6710,GO:1902668,1,0.611439543999529,0,2,negative regulation of axon guidance,BP,
6713,GO:1902686,1,0.823241180606138,0,1,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
6714,GO:1902688,1,0.772573466595224,0,1,regulation of NAD metabolic process,BP,
6715,GO:1902690,1,0.772573466595224,0,1,positive regulation of NAD metabolic process,BP,
6716,GO:1902692,1,0.616704084333269,0,1,regulation of neuroblast proliferation,BP,
6717,GO:1902742,1,0.228148525690558,0,4,apoptotic process involved in development,BP,
6722,GO:1902850,1,0.853799544891606,0,1,microtubule cytoskeleton organization involved in mitosis,BP,
6723,GO:1902858,1,0.79777800716672,0,1,propionyl-CoA metabolic process,BP,
6724,GO:1902860,1,0.79777800716672,0,1,propionyl-CoA biosynthetic process,BP,
6725,GO:1902882,1,0.324166462520714,0,5,regulation of response to oxidative stress,BP,
6726,GO:1902883,1,0.704798885072753,0,2,negative regulation of response to oxidative stress,BP,
6727,GO:1902884,1,0.824053991557742,0,1,positive regulation of response to oxidative stress,BP,
6728,GO:1902893,1,0.593237440512914,0,2,regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
6729,GO:1902894,1,0.77252698579057,0,1,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
6730,GO:1902895,1,0.593237440512914,0,2,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
6731,GO:1902897,1,0.727261279903572,0,1,regulation of postsynaptic density protein 95 clustering,BP,
6736,GO:1902914,1,0.897578402296713,0,1,regulation of protein polyubiquitination,BP,
6737,GO:1902916,1,0.897578402296713,0,1,positive regulation of protein polyubiquitination,BP,
6739,GO:1902932,1,0.77139588570204,0,1,positive regulation of alcohol biosynthetic process,BP,
6741,GO:1902946,1,0.741809137632914,0,1,protein localization to early endosome,BP,
6742,GO:1902965,1,0.741809137632914,0,1,regulation of protein localization to early endosome,BP,
6743,GO:1902966,1,0.741809137632914,0,1,positive regulation of protein localization to early endosome,BP,
6744,GO:1903010,1,0.628684677670176,0,2,regulation of bone development,BP,
6745,GO:1903011,1,0.628684677670176,0,2,negative regulation of bone development,BP,
6746,GO:1903018,1,0.78247392253484,0,1,regulation of glycoprotein metabolic process,BP,
6747,GO:1903019,1,0.78247392253484,0,1,negative regulation of glycoprotein metabolic process,BP,
6748,GO:1903025,1,0.744061959631107,0,1,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
6749,GO:1903034,1,0.178883816742507,0,7,regulation of response to wounding,BP,
6750,GO:1903035,1,0.356482584598008,0,4,negative regulation of response to wounding,BP,
6751,GO:1903036,1,0.736038381997267,0,2,positive regulation of response to wounding,BP,
6755,GO:1903046,1,0.298322823210782,0,4,meiotic cell cycle process,BP,
6758,GO:1903052,1,0.316347691062576,0,5,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
6759,GO:1903053,1,0.459924504220161,0,2,regulation of extracellular matrix organization,BP,
6761,GO:1903077,1,0.721712018608498,0,1,negative regulation of protein localization to plasma membrane,BP,
6764,GO:1903131,1,0.847043438938523,0,1,mononuclear cell differentiation,BP,
6765,GO:1903140,1,0.813226353939148,0,1,regulation of establishment of endothelial barrier,BP,
6766,GO:1903142,1,0.813226353939148,0,1,positive regulation of establishment of endothelial barrier,BP,
6768,GO:1903170,1,0.77396315259318,0,1,negative regulation of calcium ion transmembrane transport,BP,
6769,GO:1903173,1,0.83176074627617,0,1,fatty alcohol metabolic process,BP,
6770,GO:1903201,1,0.704798885072753,0,2,regulation of oxidative stress-induced cell death,BP,
6771,GO:1903202,1,0.704798885072753,0,2,negative regulation of oxidative stress-induced cell death,BP,
6772,GO:1903232,1,0.908975838289389,0,1,melanosome assembly,BP,
6773,GO:1903273,1,0.984658110865059,0,1,regulation of sodium ion export,BP,
6774,GO:1903275,1,0.984658110865059,0,1,positive regulation of sodium ion export,BP,
6775,GO:1903276,1,0.984658110865059,0,1,regulation of sodium ion export from cell,BP,
6776,GO:1903278,1,0.984658110865059,0,1,positive regulation of sodium ion export from cell,BP,
6777,GO:1903305,1,0.255705056606821,0,5,regulation of regulated secretory pathway,BP,
6778,GO:1903306,1,0.616704084333269,0,1,negative regulation of regulated secretory pathway,BP,
6779,GO:1903307,1,0.642517886134607,0,2,positive regulation of regulated secretory pathway,BP,
6780,GO:1903311,1,0.401163524090605,0,3,regulation of mRNA metabolic process,BP,
6781,GO:1903312,1,0.536295320432933,0,2,negative regulation of mRNA metabolic process,BP,
6782,GO:1903313,1,0.749764257384907,0,1,positive regulation of mRNA metabolic process,BP,
6784,GO:1903318,1,0.912530916414626,0,1,negative regulation of protein maturation,BP,
6786,GO:1903321,1,0.957091557538293,0,1,negative regulation of protein modification by small protein conjugation or removal,BP,
6789,GO:1903362,1,0.180766960310111,0,7,regulation of cellular protein catabolic process,BP,
6790,GO:1903364,1,0.233598017381709,0,6,positive regulation of cellular protein catabolic process,BP,
6795,GO:1903427,1,0.747147771262379,0,2,negative regulation of reactive oxygen species biosynthetic process,BP,
6797,GO:1903429,1,0.990258279272685,0,1,regulation of cell maturation,BP,
6798,GO:1903430,1,0.990258279272685,0,1,negative regulation of cell maturation,BP,
6799,GO:1903432,1,0.759355645182739,0,1,regulation of TORC1 signaling,BP,
6800,GO:1903433,1,0.77312897108567,0,1,regulation of constitutive secretory pathway,BP,
6801,GO:1903435,1,0.77312897108567,0,1,positive regulation of constitutive secretory pathway,BP,
6807,GO:1903514,1,0.706007587608521,0,2,calcium ion transport from endoplasmic reticulum to cytosol,BP,
6808,GO:1903519,1,0.715839724297779,0,1,regulation of mammary gland involution,BP,
6809,GO:1903521,1,0.715839724297779,0,1,positive regulation of mammary gland involution,BP,
6811,GO:1903523,1,0.369713009056681,0,3,negative regulation of blood circulation,BP,
6827,GO:1903578,1,0.772573466595224,0,1,regulation of ATP metabolic process,BP,
6828,GO:1903579,1,0.772573466595224,0,1,negative regulation of ATP metabolic process,BP,
6829,GO:1903580,1,0.772573466595224,0,1,positive regulation of ATP metabolic process,BP,
6830,GO:1903610,1,0.824053991557742,0,1,regulation of calcium-dependent ATPase activity,BP,
6831,GO:1903611,1,0.824053991557742,0,1,negative regulation of calcium-dependent ATPase activity,BP,
6832,GO:1903624,1,0.824053991557742,0,1,regulation of DNA catabolic process,BP,
6833,GO:1903625,1,0.824053991557742,0,1,negative regulation of DNA catabolic process,BP,
6834,GO:1903627,1,0.824053991557742,0,1,regulation of dUTP diphosphatase activity,BP,
6835,GO:1903629,1,0.824053991557742,0,1,positive regulation of dUTP diphosphatase activity,BP,
6836,GO:1903630,1,0.824053991557742,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
6837,GO:1903631,1,0.824053991557742,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
6838,GO:1903633,1,0.824053991557742,0,1,regulation of leucine-tRNA ligase activity,BP,
6839,GO:1903634,1,0.824053991557742,0,1,negative regulation of leucine-tRNA ligase activity,BP,
6840,GO:1903649,1,0.741809137632914,0,1,regulation of cytoplasmic transport,BP,
6841,GO:1903651,1,0.741809137632914,0,1,positive regulation of cytoplasmic transport,BP,
6843,GO:1903671,1,0.616704084333269,0,1,negative regulation of sprouting angiogenesis,BP,
6848,GO:1903715,1,0.772573466595224,0,1,regulation of aerobic respiration,BP,
6849,GO:1903719,1,0.772639837730134,0,1,regulation of I-kappaB phosphorylation,BP,
6850,GO:1903721,1,0.772639837730134,0,1,positive regulation of I-kappaB phosphorylation,BP,
6852,GO:1903726,1,0.76274238112857,0,2,negative regulation of phospholipid metabolic process,BP,
6853,GO:1903727,1,0.731071755736076,0,2,positive regulation of phospholipid metabolic process,BP,
6855,GO:1903747,1,0.823241180606138,0,1,regulation of establishment of protein localization to mitochondrion,BP,
6856,GO:1903749,1,0.823241180606138,0,1,positive regulation of establishment of protein localization to mitochondrion,BP,
6857,GO:1903779,1,0.552696464743527,0,4,regulation of cardiac conduction,BP,
6858,GO:1903792,1,0.596601273650365,0,2,negative regulation of anion transport,BP,
6859,GO:1903793,1,0.802011392875838,0,1,positive regulation of anion transport,BP,
6860,GO:1903798,1,0.847043438938523,0,1,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
6861,GO:1903800,1,0.847043438938523,0,1,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
6862,GO:1903825,1,0.446970891235675,0,3,organic acid transmembrane transport,BP,
6866,GO:1903830,1,0.89585450261785,0,1,magnesium ion transmembrane transport,BP,
6868,GO:1903845,1,0.82090903190856,0,1,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
6869,GO:1903847,1,0.448970932754634,0,2,regulation of aorta morphogenesis,BP,
6870,GO:1903849,1,0.448970932754634,0,2,positive regulation of aorta morphogenesis,BP,
6871,GO:1903867,1,0.739713014367407,0,1,extraembryonic membrane development,BP,
6872,GO:1903900,1,0.452702433061824,0,2,regulation of viral life cycle,BP,
6873,GO:1903901,1,0.735427962909408,0,1,negative regulation of viral life cycle,BP,
6874,GO:1903902,1,0.616704084333269,0,1,positive regulation of viral life cycle,BP,
6875,GO:1903959,1,0.772639837730134,0,1,regulation of anion transmembrane transport,BP,
6876,GO:1903960,1,0.772639837730134,0,1,negative regulation of anion transmembrane transport,BP,
6879,GO:1904023,1,0.772573466595224,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
6880,GO:1904025,1,0.772573466595224,0,1,positive regulation of glucose catabolic process to lactate via pyruvate,BP,
6889,GO:1904177,1,0.930530251776604,0,1,regulation of adipose tissue development,BP,
6890,GO:1904238,1,0.418692324248418,0,3,pericyte cell differentiation,BP,
6891,GO:1904251,1,0.774318895616471,0,1,regulation of bile acid metabolic process,BP,
6892,GO:1904253,1,0.774318895616471,0,1,positive regulation of bile acid metabolic process,BP,
6893,GO:1904262,1,0.759355645182739,0,1,negative regulation of TORC1 signaling,BP,
6895,GO:1904376,1,0.721712018608498,0,1,negative regulation of protein localization to cell periphery,BP,
6898,GO:1904406,1,0.747147771262379,0,2,negative regulation of nitric oxide metabolic process,BP,
6900,GO:1904427,1,0.824053991557742,0,1,positive regulation of calcium ion transmembrane transport,BP,
6901,GO:1904502,1,0.759355645182739,0,1,regulation of lipophagy,BP,
6902,GO:1904504,1,0.759355645182739,0,1,positive regulation of lipophagy,BP,
6908,GO:1904659,1,0.792322370974488,0,1,glucose transmembrane transport,BP,
6909,GO:1904666,1,0.957091557538293,0,1,regulation of ubiquitin protein ligase activity,BP,
6910,GO:1904667,1,0.957091557538293,0,1,negative regulation of ubiquitin protein ligase activity,BP,
6911,GO:1904668,1,0.957091557538293,0,1,positive regulation of ubiquitin protein ligase activity,BP,
6912,GO:1904672,1,0.739713014367407,0,1,regulation of somatic stem cell population maintenance,BP,
6913,GO:1904673,1,0.739713014367407,0,1,negative regulation of somatic stem cell population maintenance,BP,
6914,GO:1904705,1,0.77252698579057,0,1,regulation of vascular smooth muscle cell proliferation,BP,
6915,GO:1904707,1,0.77252698579057,0,1,positive regulation of vascular smooth muscle cell proliferation,BP,
6916,GO:1904724,1,0.783708505287183,0,1,tertiary granule lumen,CC,
6917,GO:1904738,1,0.77252698579057,0,1,vascular associated smooth muscle cell migration,BP,
6918,GO:1904746,1,0.739713014367407,0,1,negative regulation of apoptotic process involved in development,BP,
6919,GO:1904747,1,0.715839724297779,0,1,positive regulation of apoptotic process involved in development,BP,
6920,GO:1904748,1,0.528834412968773,0,2,regulation of apoptotic process involved in development,BP,
6921,GO:1904752,1,0.77252698579057,0,1,regulation of vascular associated smooth muscle cell migration,BP,
6922,GO:1904754,1,0.77252698579057,0,1,positive regulation of vascular associated smooth muscle cell migration,BP,
6924,GO:1904833,1,0.824053991557742,0,1,positive regulation of removal of superoxide radicals,BP,
6925,GO:1904837,1,0.765444705029491,0,1,beta-catenin-TCF complex assembly,BP,
6926,GO:1904847,1,0.89251195457963,0,1,regulation of cell chemotaxis to fibroblast growth factor,BP,
6927,GO:1904849,1,0.89251195457963,0,1,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
6928,GO:1904861,1,0.586435697619115,0,2,excitatory synapse assembly,BP,
6929,GO:1904862,1,0.683299665437994,0,1,inhibitory synapse assembly,BP,
6930,GO:1904885,1,0.762142819578083,0,1,beta-catenin destruction complex assembly,BP,
6931,GO:1904886,1,0.762142819578083,0,1,beta-catenin destruction complex disassembly,BP,
6932,GO:1904888,1,0.847043438938523,0,1,cranial skeletal system development,BP,
6933,GO:1904889,1,0.858923178696575,0,1,regulation of excitatory synapse assembly,BP,
6934,GO:1904891,1,0.858923178696575,0,1,positive regulation of excitatory synapse assembly,BP,
6935,GO:1904892,1,0.279960203179925,0,4,regulation of STAT cascade,BP,
6936,GO:1904894,1,0.279960203179925,0,4,positive regulation of STAT cascade,BP,
6937,GO:1904933,1,0.683299665437994,0,1,regulation of cell proliferation in midbrain,BP,
6938,GO:1904934,1,0.683299665437994,0,1,negative regulation of cell proliferation in midbrain,BP,
6939,GO:1904938,1,0.683299665437994,0,1,planar cell polarity pathway involved in axon guidance,BP,
6940,GO:1904948,1,0.471588486803689,0,3,midbrain dopaminergic neuron differentiation,BP,
6941,GO:1904949,1,0.984658110865059,0,1,ATPase complex,CC,
6944,GO:1904953,1,0.471588486803689,0,3,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
6945,GO:1904954,1,0.691460606934131,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
6946,GO:1904955,1,0.683299665437994,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
6947,GO:1905005,1,0.7717087498744,0,1,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
6948,GO:1905007,1,0.7717087498744,0,1,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
6949,GO:1905037,1,0.559123898229656,0,2,autophagosome organization,BP,
6950,GO:1905039,1,0.446970891235675,0,3,carboxylic acid transmembrane transport,BP,
6951,GO:1905063,1,0.77252698579057,0,1,regulation of vascular smooth muscle cell differentiation,BP,
6952,GO:1905064,1,0.77252698579057,0,1,negative regulation of vascular smooth muscle cell differentiation,BP,
6953,GO:1905069,1,0.739713014367407,0,1,allantois development,BP,
6955,GO:1905174,1,0.77252698579057,0,1,regulation of vascular smooth muscle cell dedifferentiation,BP,
6956,GO:1905176,1,0.77252698579057,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
6957,GO:1905207,1,0.281998267997105,0,5,regulation of cardiocyte differentiation,BP,
6958,GO:1905208,1,0.57333143609041,0,2,negative regulation of cardiocyte differentiation,BP,
6959,GO:1905209,1,0.494438579548644,0,3,positive regulation of cardiocyte differentiation,BP,
6960,GO:1905269,1,0.744061959631107,0,1,positive regulation of chromatin organization,BP,
6961,GO:1905276,1,0.667988403557977,0,2,regulation of epithelial tube formation,BP,
6962,GO:1905278,1,0.977811028321075,0,1,positive regulation of epithelial tube formation,BP,
6963,GO:1905314,1,0.315198988376353,0,4,semi-lunar valve development,BP,
6964,GO:1905330,1,0.0958458018747681,0,11,regulation of morphogenesis of an epithelium,BP,
6965,GO:1905331,1,0.426849692581485,0,3,negative regulation of morphogenesis of an epithelium,BP,
6966,GO:1905332,1,0.277246787190708,0,6,positive regulation of morphogenesis of an epithelium,BP,
6967,GO:1905348,1,0.959711323077247,0,1,endonuclease complex,CC,
6968,GO:1905368,1,0.957091557538293,0,1,peptidase complex,CC,
6969,GO:1905369,1,0.957091557538293,0,1,endopeptidase complex,CC,
6970,GO:1905383,1,0.858923178696575,0,1,protein localization to presynapse,BP,
6971,GO:1905384,1,0.858923178696575,0,1,regulation of protein localization to presynapse,BP,
6972,GO:1905386,1,0.858923178696575,0,1,positive regulation of protein localization to presynapse,BP,
6973,GO:1905438,1,0.683299665437994,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
6974,GO:1905456,1,0.616704084333269,0,1,regulation of lymphoid progenitor cell differentiation,BP,
6975,GO:1905457,1,0.616704084333269,0,1,negative regulation of lymphoid progenitor cell differentiation,BP,
6976,GO:1905474,1,0.895381066641334,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
6978,GO:1905476,1,0.721712018608498,0,1,negative regulation of protein localization to membrane,BP,
6980,GO:1905651,1,0.448970932754634,0,2,regulation of artery morphogenesis,BP,
6981,GO:1905653,1,0.448970932754634,0,2,positive regulation of artery morphogenesis,BP,
6982,GO:1905666,1,0.741809137632914,0,1,regulation of protein localization to endosome,BP,
6983,GO:1905668,1,0.741809137632914,0,1,positive regulation of protein localization to endosome,BP,
6984,GO:1905709,1,0.912530916414626,0,1,negative regulation of membrane permeability,BP,
6985,GO:1905710,1,0.823241180606138,0,1,positive regulation of membrane permeability,BP,
6986,GO:1905809,1,0.683299665437994,0,1,negative regulation of synapse organization,BP,
6987,GO:1905867,1,0.684858187930548,0,2,epididymis development,BP,
6988,GO:1905874,1,0.727261279903572,0,1,regulation of postsynaptic density organization,BP,
6989,GO:1905879,1,0.990258279272685,0,1,regulation of oogenesis,BP,
6990,GO:1905880,1,0.990258279272685,0,1,negative regulation of oogenesis,BP,
6993,GO:1905939,1,0.573613683873091,0,2,regulation of gonad development,BP,
6994,GO:1905940,1,0.573613683873091,0,2,negative regulation of gonad development,BP,
6995,GO:1905941,1,0.771150420617929,0,1,positive regulation of gonad development,BP,
6996,GO:1905950,1,0.792322370974488,0,1,monosaccharide transmembrane transport,BP,
6997,GO:1905952,1,0.361195147527799,0,5,regulation of lipid localization,BP,
6998,GO:1905953,1,0.587867084852947,0,3,negative regulation of lipid localization,BP,
6999,GO:1905954,1,0.474866679356144,0,3,positive regulation of lipid localization,BP,
7000,GO:1990001,1,0.912530916414626,0,1,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
7001,GO:1990089,1,0.772639837730134,0,1,response to nerve growth factor,BP,
7002,GO:1990090,1,0.772639837730134,0,1,cellular response to nerve growth factor stimulus,BP,
7003,GO:1990111,1,0.957091557538293,0,1,spermatoproteasome complex,CC,
7004,GO:1990124,1,0.536295320432933,0,2,messenger ribonucleoprotein complex,CC,
7005,GO:1990134,1,0.705715026621473,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
7006,GO:1990138,1,0.455940668753686,0,3,neuron projection extension,BP,
7009,GO:1990204,1,0.747430985543844,0,1,oxidoreductase complex,CC,
7013,GO:1990316,1,0.759355645182739,0,1,ATG1/ULK1 kinase complex,CC,
7015,GO:1990418,1,0.772639837730134,0,1,response to insulin-like growth factor stimulus,BP,
7019,GO:1990459,1,0.773132814998767,0,1,transferrin receptor binding,MF,
7020,GO:1990481,1,0.866821396494009,0,1,mRNA pseudouridine synthesis,BP,
7021,GO:1990542,1,0.769709049906422,0,1,mitochondrial transmembrane transport,BP,
7023,GO:1990712,1,0.773132814998767,0,1,HFE-transferrin receptor complex,CC,
7024,GO:1990748,1,0.447951813611951,0,4,cellular detoxification,BP,
7025,GO:1990769,1,0.839437618379272,0,1,proximal neuron projection,CC,
7027,GO:1990777,1,0.987456549281,0,1,lipoprotein particle,CC,
7031,GO:1990837,1,0.460283188271964,0,3,sequence-specific double-stranded DNA binding,MF,
7033,GO:1990851,1,0.767873022660652,0,1,Wnt-Frizzled-LRP5/6 complex,CC,
7034,GO:1990874,1,0.77252698579057,0,1,vascular smooth muscle cell proliferation,BP,
7035,GO:1990904,1,0.339798521027926,0,6,ribonucleoprotein complex,CC,
7036,GO:1990909,1,0.691460606934131,0,2,Wnt signalosome,CC,
7037,GO:1990936,1,0.77252698579057,0,1,vascular smooth muscle cell dedifferentiation,BP,
7038,GO:1990967,1,0.851084530129521,0,1,multi-organism toxin transport,BP,
7039,GO:2000004,1,0.847043438938523,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
7040,GO:2000005,1,0.847043438938523,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
7041,GO:2000006,1,0.847043438938523,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
7042,GO:2000007,1,0.847043438938523,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
7045,GO:2000015,1,0.7717087498744,0,1,regulation of determination of dorsal identity,BP,
7046,GO:2000017,1,0.7717087498744,0,1,positive regulation of determination of dorsal identity,BP,
7047,GO:2000018,1,0.573613683873091,0,2,regulation of male gonad development,BP,
7048,GO:2000019,1,0.744587511205584,0,1,negative regulation of male gonad development,BP,
7049,GO:2000020,1,0.771150420617929,0,1,positive regulation of male gonad development,BP,
7050,GO:2000021,1,0.318904076479571,0,5,regulation of ion homeostasis,BP,
7052,GO:2000027,1,0.00916299853805709,0,20,regulation of organ morphogenesis,BP,
7053,GO:2000036,1,0.739713014367407,0,1,regulation of stem cell population maintenance,BP,
7055,GO:2000047,1,0.683299665437994,0,1,regulation of cell-cell adhesion mediated by cadherin,BP,
7056,GO:2000049,1,0.683299665437994,0,1,positive regulation of cell-cell adhesion mediated by cadherin,BP,
7057,GO:2000050,1,0.683299665437994,0,1,regulation of non-canonical Wnt signaling pathway,BP,
7058,GO:2000052,1,0.683299665437994,0,1,positive regulation of non-canonical Wnt signaling pathway,BP,
7059,GO:2000058,1,0.729271978159941,0,2,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
7060,GO:2000060,1,0.729271978159941,0,2,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
7063,GO:2000066,1,0.744587511205584,0,1,positive regulation of cortisol biosynthetic process,BP,
7064,GO:2000097,1,0.776794728605423,0,1,regulation of smooth muscle cell-matrix adhesion,BP,
7065,GO:2000105,1,0.651360225257213,0,2,positive regulation of DNA-dependent DNA replication,BP,
7068,GO:2000108,1,0.683299665437994,0,1,positive regulation of leukocyte apoptotic process,BP,
7073,GO:2000121,1,0.609084076257617,0,2,regulation of removal of superoxide radicals,BP,
7075,GO:2000136,1,0.52181526023997,0,2,regulation of cell proliferation involved in heart morphogenesis,BP,
7076,GO:2000137,1,0.847043438938523,0,1,negative regulation of cell proliferation involved in heart morphogenesis,BP,
7077,GO:2000138,1,0.847043438938523,0,1,positive regulation of cell proliferation involved in heart morphogenesis,BP,
7078,GO:2000142,1,0.766486369353892,0,1,regulation of DNA-templated transcription, initiation,BP,
7079,GO:2000144,1,0.766486369353892,0,1,positive regulation of DNA-templated transcription, initiation,BP,
7083,GO:2000177,1,0.242730076947234,0,4,regulation of neural precursor cell proliferation,BP,
7084,GO:2000178,1,0.545590374569449,0,2,negative regulation of neural precursor cell proliferation,BP,
7085,GO:2000179,1,0.616704084333269,0,1,positive regulation of neural precursor cell proliferation,BP,
7087,GO:2000191,1,0.619191496630601,0,2,regulation of fatty acid transport,BP,
7088,GO:2000192,1,0.772639837730134,0,1,negative regulation of fatty acid transport,BP,
7089,GO:2000193,1,0.802011392875838,0,1,positive regulation of fatty acid transport,BP,
7090,GO:2000194,1,0.771150420617929,0,1,regulation of female gonad development,BP,
7091,GO:2000195,1,0.771150420617929,0,1,negative regulation of female gonad development,BP,
7093,GO:2000224,1,0.744587511205584,0,1,regulation of testosterone biosynthetic process,BP,
7094,GO:2000225,1,0.744587511205584,0,1,negative regulation of testosterone biosynthetic process,BP,
7097,GO:2000243,1,0.29902396543644,0,4,positive regulation of reproductive process,BP,
7098,GO:2000249,1,0.940900393371674,0,1,regulation of actin cytoskeleton reorganization,BP,
7099,GO:2000251,1,0.940900393371674,0,1,positive regulation of actin cytoskeleton reorganization,BP,
7100,GO:2000257,1,0.774707989551907,0,1,regulation of protein activation cascade,BP,
7103,GO:2000272,1,0.77396315259318,0,1,negative regulation of receptor activity,BP,
7106,GO:2000279,1,0.824053991557742,0,1,negative regulation of DNA biosynthetic process,BP,
7107,GO:2000345,1,0.799352334912417,0,1,regulation of hepatocyte proliferation,BP,
7108,GO:2000346,1,0.799352334912417,0,1,negative regulation of hepatocyte proliferation,BP,
7111,GO:2000369,1,0.89202924648779,0,1,regulation of clathrin-dependent endocytosis,BP,
7113,GO:2000378,1,0.747147771262379,0,2,negative regulation of reactive oxygen species metabolic process,BP,
7115,GO:2000383,1,0.74668493948331,0,1,regulation of ectoderm development,BP,
7116,GO:2000384,1,0.74668493948331,0,1,negative regulation of ectoderm development,BP,
7117,GO:2000401,1,0.393762880705433,0,5,regulation of lymphocyte migration,BP,
7118,GO:2000403,1,0.532209597936942,0,4,positive regulation of lymphocyte migration,BP,
7119,GO:2000404,1,0.532209597936942,0,4,regulation of T cell migration,BP,
7120,GO:2000406,1,0.532209597936942,0,4,positive regulation of T cell migration,BP,
7121,GO:2000407,1,0.836041871517245,0,1,regulation of T cell extravasation,BP,
7122,GO:2000409,1,0.836041871517245,0,1,positive regulation of T cell extravasation,BP,
7125,GO:2000449,1,0.836041871517245,0,1,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
7126,GO:2000451,1,0.836041871517245,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
7127,GO:2000452,1,0.836041871517245,0,1,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
7128,GO:2000454,1,0.836041871517245,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
7129,GO:2000463,1,0.858923178696575,0,1,positive regulation of excitatory postsynaptic potential,BP,
7130,GO:2000479,1,0.589581611345571,0,2,regulation of cAMP-dependent protein kinase activity,BP,
7131,GO:2000480,1,0.777135023329378,0,1,negative regulation of cAMP-dependent protein kinase activity,BP,
7132,GO:2000482,1,0.658592740887016,0,2,regulation of interleukin-8 secretion,BP,
7133,GO:2000484,1,0.658592740887016,0,2,positive regulation of interleukin-8 secretion,BP,
7139,GO:2000542,1,0.74668493948331,0,1,negative regulation of gastrulation,BP,
7140,GO:2000544,1,0.89251195457963,0,1,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
7141,GO:2000546,1,0.89251195457963,0,1,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
7142,GO:2000573,1,0.77252698579057,0,1,positive regulation of DNA biosynthetic process,BP,
7143,GO:2000586,1,0.77252698579057,0,1,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
7144,GO:2000587,1,0.77252698579057,0,1,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
7145,GO:2000589,1,0.77252698579057,0,1,regulation of metanephric mesenchymal cell migration,BP,
7146,GO:2000591,1,0.77252698579057,0,1,positive regulation of metanephric mesenchymal cell migration,BP,
7147,GO:2000628,1,0.940900393371674,0,1,regulation of miRNA metabolic process,BP,
7148,GO:2000630,1,0.940900393371674,0,1,positive regulation of miRNA metabolic process,BP,
7149,GO:2000637,1,0.847043438938523,0,1,positive regulation of gene silencing by miRNA,BP,
7150,GO:2000641,1,0.741809137632914,0,1,regulation of early endosome to late endosome transport,BP,
7151,GO:2000643,1,0.741809137632914,0,1,positive regulation of early endosome to late endosome transport,BP,
7153,GO:2000649,1,0.984658110865059,0,1,regulation of sodium ion transmembrane transporter activity,BP,
7154,GO:2000653,1,0.75126441332005,0,1,regulation of genetic imprinting,BP,
7157,GO:2000677,1,0.584011907271083,0,2,regulation of transcription regulatory region DNA binding,BP,
7158,GO:2000678,1,0.785634671671933,0,1,negative regulation of transcription regulatory region DNA binding,BP,
7159,GO:2000696,1,0.727424355983898,0,2,regulation of epithelial cell differentiation involved in kidney development,BP,
7160,GO:2000698,1,0.727424355983898,0,2,positive regulation of epithelial cell differentiation involved in kidney development,BP,
7161,GO:2000705,1,0.80818803699794,0,1,regulation of dense core granule biogenesis,BP,
7162,GO:2000707,1,0.80818803699794,0,1,positive regulation of dense core granule biogenesis,BP,
7163,GO:2000725,1,0.281998267997105,0,5,regulation of cardiac muscle cell differentiation,BP,
7164,GO:2000726,1,0.57333143609041,0,2,negative regulation of cardiac muscle cell differentiation,BP,
7165,GO:2000727,1,0.494438579548644,0,3,positive regulation of cardiac muscle cell differentiation,BP,
7166,GO:2000736,1,0.602849967626727,0,2,regulation of stem cell differentiation,BP,
7167,GO:2000737,1,0.616704084333269,0,1,negative regulation of stem cell differentiation,BP,
7168,GO:2000756,1,0.744061959631107,0,1,regulation of peptidyl-lysine acetylation,BP,
7169,GO:2000758,1,0.744061959631107,0,1,positive regulation of peptidyl-lysine acetylation,BP,
7170,GO:2000778,1,0.964117353714657,0,1,positive regulation of interleukin-6 secretion,BP,
7171,GO:2000785,1,0.559123898229656,0,2,regulation of autophagosome assembly,BP,
7172,GO:2000786,1,0.788139761849395,0,1,positive regulation of autophagosome assembly,BP,
7173,GO:2000794,1,0.772581840319793,0,1,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
7174,GO:2000807,1,0.727261279903572,0,1,regulation of synaptic vesicle clustering,BP,
7175,GO:2000809,1,0.727261279903572,0,1,positive regulation of synaptic vesicle clustering,BP,
7178,GO:2000820,1,0.785634671671933,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
7179,GO:2000826,1,0.307864251643518,0,4,regulation of heart morphogenesis,BP,
7180,GO:2000831,1,0.769446945848083,0,1,regulation of steroid hormone secretion,BP,
7181,GO:2000833,1,0.769446945848083,0,1,positive regulation of steroid hormone secretion,BP,
7182,GO:2000846,1,0.769446945848083,0,1,regulation of corticosteroid hormone secretion,BP,
7183,GO:2000848,1,0.769446945848083,0,1,positive regulation of corticosteroid hormone secretion,BP,
7184,GO:2000855,1,0.769446945848083,0,1,regulation of mineralocorticoid secretion,BP,
7185,GO:2000857,1,0.769446945848083,0,1,positive regulation of mineralocorticoid secretion,BP,
7186,GO:2000858,1,0.769446945848083,0,1,regulation of aldosterone secretion,BP,
7187,GO:2000860,1,0.769446945848083,0,1,positive regulation of aldosterone secretion,BP,
7188,GO:2000973,1,0.616704084333269,0,1,regulation of pro-B cell differentiation,BP,
7189,GO:2000974,1,0.616704084333269,0,1,negative regulation of pro-B cell differentiation,BP,
7192,GO:2001012,1,0.630272358048551,0,2,mesenchymal cell differentiation involved in renal system development,BP,
7193,GO:2001014,1,0.942803698939128,0,1,regulation of skeletal muscle cell differentiation,BP,
7194,GO:2001015,1,0.942803698939128,0,1,negative regulation of skeletal muscle cell differentiation,BP,
7195,GO:2001020,1,0.807093964700726,0,2,regulation of response to DNA damage stimulus,BP,
7196,GO:2001022,1,0.807093964700726,0,2,positive regulation of response to DNA damage stimulus,BP,
7197,GO:2001026,1,0.549984195939634,0,2,regulation of endothelial cell chemotaxis,BP,
7198,GO:2001027,1,0.616704084333269,0,1,negative regulation of endothelial cell chemotaxis,BP,
7199,GO:2001028,1,0.89251195457963,0,1,positive regulation of endothelial cell chemotaxis,BP,
7200,GO:2001044,1,0.799352334912417,0,1,regulation of integrin-mediated signaling pathway,BP,
7201,GO:2001046,1,0.799352334912417,0,1,positive regulation of integrin-mediated signaling pathway,BP,
7202,GO:2001053,1,0.739713014367407,0,1,regulation of mesenchymal cell apoptotic process,BP,
7203,GO:2001054,1,0.739713014367407,0,1,negative regulation of mesenchymal cell apoptotic process,BP,
7206,GO:2001074,1,0.771150420617929,0,1,regulation of metanephric ureteric bud development,BP,
7207,GO:2001076,1,0.771150420617929,0,1,positive regulation of metanephric ureteric bud development,BP,
7211,GO:2001179,1,0.964117353714657,0,1,regulation of interleukin-10 secretion,BP,
7212,GO:2001181,1,0.964117353714657,0,1,positive regulation of interleukin-10 secretion,BP,
7213,GO:2001198,1,0.95194955598523,0,1,regulation of dendritic cell differentiation,BP,
7214,GO:2001199,1,0.95194955598523,0,1,negative regulation of dendritic cell differentiation,BP,
7215,GO:2001204,1,0.763459376420346,0,1,regulation of osteoclast development,BP,
7216,GO:2001205,1,0.763459376420346,0,1,negative regulation of osteoclast development,BP,
7217,GO:2001212,1,0.785634671671933,0,1,regulation of vasculogenesis,BP,
7218,GO:2001233,1,0.108509270028752,0,14,regulation of apoptotic signaling pathway,BP,
7219,GO:2001234,1,0.243778044426957,0,9,negative regulation of apoptotic signaling pathway,BP,
7220,GO:2001235,1,0.436537700644639,0,6,positive regulation of apoptotic signaling pathway,BP,
7221,GO:2001236,1,0.19264220331283,0,12,regulation of extrinsic apoptotic signaling pathway,BP,
7222,GO:2001237,1,0.328939561629161,0,8,negative regulation of extrinsic apoptotic signaling pathway,BP,
7223,GO:2001238,1,0.635639835071021,0,4,positive regulation of extrinsic apoptotic signaling pathway,BP,
7224,GO:2001239,1,0.740523664251331,0,3,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
7225,GO:2001240,1,0.740523664251331,0,3,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
7226,GO:2001242,1,0.558615786158671,0,4,regulation of intrinsic apoptotic signaling pathway,BP,
7227,GO:2001243,1,0.704798885072753,0,2,negative regulation of intrinsic apoptotic signaling pathway,BP,
7228,GO:2001244,1,0.823241180606138,0,1,positive regulation of intrinsic apoptotic signaling pathway,BP,
7229,GO:2001245,1,0.946578828055197,0,1,regulation of phosphatidylcholine biosynthetic process,BP,
7230,GO:2001252,1,0.744061959631107,0,1,positive regulation of chromosome organization,BP,
7232,GO:2001258,1,0.77396315259318,0,1,negative regulation of cation channel activity,BP,
7234,GO:2001267,1,0.750187185736748,0,2,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
7235,GO:2001269,1,0.750187185736748,0,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
7238,GO:2001286,1,0.89202924648779,0,1,regulation of caveolin-mediated endocytosis,BP,
7239,GO:2001287,1,0.89202924648779,0,1,negative regulation of caveolin-mediated endocytosis,BP,
672,GO:0004930,1,0.130883174853867,0,8,G-protein coupled receptor activity,MF,
4634,GO:0048644,1,0.139850037029512,0,6,muscle organ morphogenesis,BP,
